| Description | Single-cell expression data from drug perturbation across cell lines in over 95 million cells |
| Measurement | gene expression by RNA-seq |
| Association | gene-drug perturbation associations by differential expression of gene following drug perturbation |
| Category | transcriptomics |
| Resource | Tahoe Therapeutics |
| Citation(s) | |
| Last Updated | 2025 Jul 07 |
| Stats |
|
Gene Attribute
Gene Similarity
Attribute Similarity
UMAP
18900 sets of genes differentially expressed following drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
| Gene Set | Description |
|---|---|
| Verapamil_COLO 205 | Verapamil perturbation in COLO 205 cell line |
| Trametinib (DMSO_HepG2/C3A | Trametinib (DMSO perturbation in HepG2/C3A cell line |
| Estrone sulfate (potassium)_HepG2/C3A | Estrone sulfate (potassium) perturbation in HepG2/C3A cell line |
| Clofarabine_HepG2/C3A | Clofarabine perturbation in HepG2/C3A cell line |
| Budesonide_HepG2/C3A | Budesonide perturbation in HepG2/C3A cell line |
| Doxorubicin (hydrochloride)_COLO 205 | Doxorubicin (hydrochloride) perturbation in COLO 205 cell line |
| Carbidopa (monohydrate)_HepG2/C3A | Carbidopa (monohydrate) perturbation in HepG2/C3A cell line |
| Entrectinib_HepG2/C3A | Entrectinib perturbation in HepG2/C3A cell line |
| Irinotecan (hydrochloride)_HepG2/C3A | Irinotecan (hydrochloride) perturbation in HepG2/C3A cell line |
| Benproperine (phosphate)_COLO 205 | Benproperine (phosphate) perturbation in COLO 205 cell line |
| Radotinib_HepG2/C3A | Radotinib perturbation in HepG2/C3A cell line |
| Methyl aminolevulinate (hydrochloride)_HepG2/C3A | Methyl aminolevulinate (hydrochloride) perturbation in HepG2/C3A cell line |
| NVP-BHG712_C32 | NVP-BHG712 perturbation in C32 cell line |
| Abiraterone acetate_C32 | Abiraterone acetate perturbation in C32 cell line |
| Trametinib_C32 | Trametinib perturbation in C32 cell line |
| Pyridoxine (hydrochloride)_C32 | Pyridoxine (hydrochloride) perturbation in C32 cell line |
| Entrectinib_C32 | Entrectinib perturbation in C32 cell line |
| Vortioxetine_HepG2/C3A | Vortioxetine perturbation in HepG2/C3A cell line |
| Amsacrine_HepG2/C3A | Amsacrine perturbation in HepG2/C3A cell line |
| Sonidegib_C32 | Sonidegib perturbation in C32 cell line |
| Rucaparib (phosphate)_C32 | Rucaparib (phosphate) perturbation in C32 cell line |
| Naproxen_HepG2/C3A | Naproxen perturbation in HepG2/C3A cell line |
| Apalutamide_C32 | Apalutamide perturbation in C32 cell line |
| Lactate (calcium)_HepG2/C3A | Lactate (calcium) perturbation in HepG2/C3A cell line |
| Ponatinib_HepG2/C3A | Ponatinib perturbation in HepG2/C3A cell line |
| Daidzin_C32 | Daidzin perturbation in C32 cell line |
| Econazole_HepG2/C3A | Econazole perturbation in HepG2/C3A cell line |
| Thymopentin_HepG2/C3A | Thymopentin perturbation in HepG2/C3A cell line |
| Benztropine (mesylate)_C32 | Benztropine (mesylate) perturbation in C32 cell line |
| Omeprazole_HepG2/C3A | Omeprazole perturbation in HepG2/C3A cell line |
| Darolutamide_HepG2/C3A | Darolutamide perturbation in HepG2/C3A cell line |
| Clobetasol propionate_HepG2/C3A | Clobetasol propionate perturbation in HepG2/C3A cell line |
| Tetracycline (hydrochloride)_C32 | Tetracycline (hydrochloride) perturbation in C32 cell line |
| Artesunate_C32 | Artesunate perturbation in C32 cell line |
| Dexamethasone_HepG2/C3A | Dexamethasone perturbation in HepG2/C3A cell line |
| Cinacalcet_HepG2/C3A | Cinacalcet perturbation in HepG2/C3A cell line |
| Belinostat_C32 | Belinostat perturbation in C32 cell line |
| Almonertinib (mesylate)_HepG2/C3A | Almonertinib (mesylate) perturbation in HepG2/C3A cell line |
| Esmolol (hydrochloride)_C32 | Esmolol (hydrochloride) perturbation in C32 cell line |
| Budesonide_C32 | Budesonide perturbation in C32 cell line |
| Doxycycline (monohydrate)_HepG2/C3A | Doxycycline (monohydrate) perturbation in HepG2/C3A cell line |
| Elagolix sodium_C32 | Elagolix sodium perturbation in C32 cell line |
| Fulvestrant_HepG2/C3A | Fulvestrant perturbation in HepG2/C3A cell line |
| Cyclosporin A_HepG2/C3A | Cyclosporin A perturbation in HepG2/C3A cell line |
| Bendamustine_C32 | Bendamustine perturbation in C32 cell line |
| Fostamatinib (disodium hexahydrate)_C32 | Fostamatinib (disodium hexahydrate) perturbation in C32 cell line |
| Malotilate_HepG2/C3A | Malotilate perturbation in HepG2/C3A cell line |
| Decitabine_HepG2/C3A | Decitabine perturbation in HepG2/C3A cell line |
| Triamcinolone_HepG2/C3A | Triamcinolone perturbation in HepG2/C3A cell line |
| Demeclocycline_HepG2/C3A | Demeclocycline perturbation in HepG2/C3A cell line |
| Norepinephrine (hydrochloride)_HepG2/C3A | Norepinephrine (hydrochloride) perturbation in HepG2/C3A cell line |
| Dimethyl fumarate_HepG2/C3A | Dimethyl fumarate perturbation in HepG2/C3A cell line |
| Larotrectinib_C32 | Larotrectinib perturbation in C32 cell line |
| Phenytoin (sodium)_HepG2/C3A | Phenytoin (sodium) perturbation in HepG2/C3A cell line |
| Bexarotene_C32 | Bexarotene perturbation in C32 cell line |
| Vinblastine (sulfate)_C32 | Vinblastine (sulfate) perturbation in C32 cell line |
| Finasteride_HepG2/C3A | Finasteride perturbation in HepG2/C3A cell line |
| Folic acid_C32 | Folic acid perturbation in C32 cell line |
| Roxadustat_C32 | Roxadustat perturbation in C32 cell line |
| Torkinib_HepG2/C3A | Torkinib perturbation in HepG2/C3A cell line |
| Cobimetinib_C32 | Cobimetinib perturbation in C32 cell line |
| Dapagliflozin_HepG2/C3A | Dapagliflozin perturbation in HepG2/C3A cell line |
| Citalopram (hydrobromide)_C32 | Citalopram (hydrobromide) perturbation in C32 cell line |
| Filgotinib_HepG2/C3A | Filgotinib perturbation in HepG2/C3A cell line |
| TAK-733_HepG2/C3A | TAK-733 perturbation in HepG2/C3A cell line |
| Flutamide_HepG2/C3A | Flutamide perturbation in HepG2/C3A cell line |
| Bestatin (hydrochloride)_C32 | Bestatin (hydrochloride) perturbation in C32 cell line |
| Methylprednisolone succinate_C32 | Methylprednisolone succinate perturbation in C32 cell line |
| Carbamazepine_C32 | Carbamazepine perturbation in C32 cell line |
| Panobinostat_C32 | Panobinostat perturbation in C32 cell line |
| γ-Oryzanol_HepG2/C3A | γ-Oryzanol perturbation in HepG2/C3A cell line |
| Sunitinib_HepG2/C3A | Sunitinib perturbation in HepG2/C3A cell line |
| Sildenafil_HepG2/C3A | Sildenafil perturbation in HepG2/C3A cell line |
| Torkinib_C32 | Torkinib perturbation in C32 cell line |
| DTP3_C32 | DTP3 perturbation in C32 cell line |
| Uridine_HepG2/C3A | Uridine perturbation in HepG2/C3A cell line |
| Elimusertib hydrochloride_C32 | Elimusertib hydrochloride perturbation in C32 cell line |
| Idarubicin (hydrochloride)_C32 | Idarubicin (hydrochloride) perturbation in C32 cell line |
| Citalopram (hydrobromide)_HepG2/C3A | Citalopram (hydrobromide) perturbation in HepG2/C3A cell line |
| TAK-733_C32 | TAK-733 perturbation in C32 cell line |
| Filgotinib_C32 | Filgotinib perturbation in C32 cell line |
| Salicylic acid_HepG2/C3A | Salicylic acid perturbation in HepG2/C3A cell line |
| Alpelisib_C32 | Alpelisib perturbation in C32 cell line |
| Bestatin (hydrochloride)_HepG2/C3A | Bestatin (hydrochloride) perturbation in HepG2/C3A cell line |
| Methylprednisolone succinate_HepG2/C3A | Methylprednisolone succinate perturbation in HepG2/C3A cell line |
| Valdecoxib_HepG2/C3A | Valdecoxib perturbation in HepG2/C3A cell line |
| Carbamazepine_HepG2/C3A | Carbamazepine perturbation in HepG2/C3A cell line |
| Berbamine (dihydrochloride)_HepG2/C3A | Berbamine (dihydrochloride) perturbation in HepG2/C3A cell line |
| Imiquimod (hydrochloride)_C32 | Imiquimod (hydrochloride) perturbation in C32 cell line |
| Bendamustine_HepG2/C3A | Bendamustine perturbation in HepG2/C3A cell line |
| Pioglitazone_C32 | Pioglitazone perturbation in C32 cell line |
| Methylthiouracil_HepG2/C3A | Methylthiouracil perturbation in HepG2/C3A cell line |
| Erythromycin_HepG2/C3A | Erythromycin perturbation in HepG2/C3A cell line |
| Encorafenib_HepG2/C3A | Encorafenib perturbation in HepG2/C3A cell line |
| Decitabine_C32 | Decitabine perturbation in C32 cell line |
| Glycyrrhizic acid_HepG2/C3A | Glycyrrhizic acid perturbation in HepG2/C3A cell line |
| (R)-Verapamil (hydrochloride)_HepG2/C3A | (R)-Verapamil (hydrochloride) perturbation in HepG2/C3A cell line |
| Larotrectinib_HepG2/C3A | Larotrectinib perturbation in HepG2/C3A cell line |
| Phenytoin (sodium)_C32 | Phenytoin (sodium) perturbation in C32 cell line |
| Lumateperone (tosylate)_HepG2/C3A | Lumateperone (tosylate) perturbation in HepG2/C3A cell line |
| Omeprazole (sodium)_C32 | Omeprazole (sodium) perturbation in C32 cell line |
| Ligustrazine_HepG2/C3A | Ligustrazine perturbation in HepG2/C3A cell line |
| Relugolix_C32 | Relugolix perturbation in C32 cell line |
| Tranilast_HepG2/C3A | Tranilast perturbation in HepG2/C3A cell line |
| Arbutin_HepG2/C3A | Arbutin perturbation in HepG2/C3A cell line |
| Nimesulide_C32 | Nimesulide perturbation in C32 cell line |
| Phenylephrine (hydrochloride)_C32 | Phenylephrine (hydrochloride) perturbation in C32 cell line |
| Ferulic acid_HepG2/C3A | Ferulic acid perturbation in HepG2/C3A cell line |
| Infigratinib_HepG2/C3A | Infigratinib perturbation in HepG2/C3A cell line |
| AT7519_C32 | AT7519 perturbation in C32 cell line |
| Ribociclib_HepG2/C3A | Ribociclib perturbation in HepG2/C3A cell line |
| Minodronic acid_C32 | Minodronic acid perturbation in C32 cell line |
| Verteporfin_HepG2/C3A | Verteporfin perturbation in HepG2/C3A cell line |
| Pemetrexed_HepG2/C3A | Pemetrexed perturbation in HepG2/C3A cell line |
| Lopinavir_C32 | Lopinavir perturbation in C32 cell line |
| Ataluren_HepG2/C3A | Ataluren perturbation in HepG2/C3A cell line |
| Fingolimod (hydrochloride)_C32 | Fingolimod (hydrochloride) perturbation in C32 cell line |
| CP21R7_C32 | CP21R7 perturbation in C32 cell line |
| NVP-BHG712_HepG2/C3A | NVP-BHG712 perturbation in HepG2/C3A cell line |
| Abiraterone acetate_HepG2/C3A | Abiraterone acetate perturbation in HepG2/C3A cell line |
| Brimonidine_HepG2/C3A | Brimonidine perturbation in HepG2/C3A cell line |
| Doxorubicin (hydrochloride)_HepG2/C3A | Doxorubicin (hydrochloride) perturbation in HepG2/C3A cell line |
| Trametinib_HepG2/C3A | Trametinib perturbation in HepG2/C3A cell line |
| Rutin (trihydrate)_HepG2/C3A | Rutin (trihydrate) perturbation in HepG2/C3A cell line |
| 5-Fluorouracil_C32 | 5-Fluorouracil perturbation in C32 cell line |
| Pexidartinib (hydrochloride)_C32 | Pexidartinib (hydrochloride) perturbation in C32 cell line |
| Rucaparib (phosphate)_HepG2/C3A | Rucaparib (phosphate) perturbation in HepG2/C3A cell line |
| Apalutamide_HepG2/C3A | Apalutamide perturbation in HepG2/C3A cell line |
| Lactate (calcium)_C32 | Lactate (calcium) perturbation in C32 cell line |
| Proglumide_C32 | Proglumide perturbation in C32 cell line |
| Econazole_C32 | Econazole perturbation in C32 cell line |
| Binimetinib_C32 | Binimetinib perturbation in C32 cell line |
| MK-3903_NCI-H1792 | MK-3903 perturbation in NCI-H1792 cell line |
| Tolcapone_NCI-H1792 | Tolcapone perturbation in NCI-H1792 cell line |
| Tranilast_NCI-H1792 | Tranilast perturbation in NCI-H1792 cell line |
| NG25_NCI-H1792 | NG25 perturbation in NCI-H1792 cell line |
| 9-ING-41_A549 | 9-ING-41 perturbation in A549 cell line |
| Temsirolimus_A549 | Temsirolimus perturbation in A549 cell line |
| Vilanterol_NCI-H1792 | Vilanterol perturbation in NCI-H1792 cell line |
| Triclosan_A549 | Triclosan perturbation in A549 cell line |
| Anethole trithione_NCI-H1792 | Anethole trithione perturbation in NCI-H1792 cell line |
| (R)-Verapamil (hydrochloride)_NCI-H460 | (R)-Verapamil (hydrochloride) perturbation in NCI-H460 cell line |
| Irinotecan_NCI-H1792 | Irinotecan perturbation in NCI-H1792 cell line |
| Cinacalcet_A549 | Cinacalcet perturbation in A549 cell line |
| Elagolix sodium_NCI-H1792 | Elagolix sodium perturbation in NCI-H1792 cell line |
| Relugolix_A549 | Relugolix perturbation in A549 cell line |
| BI-78D3_NCI-H1792 | BI-78D3 perturbation in NCI-H1792 cell line |
| Cabozantinib (S-malate)_A549 | Cabozantinib (S-malate) perturbation in A549 cell line |
| Oleic acid_NCI-H1792 | Oleic acid perturbation in NCI-H1792 cell line |
| Proglumide_A549 | Proglumide perturbation in A549 cell line |
| Tomivosertib_NCI-H1792 | Tomivosertib perturbation in NCI-H1792 cell line |
| Baicalin_A549 | Baicalin perturbation in A549 cell line |
| Tofacitinib_A549 | Tofacitinib perturbation in A549 cell line |
| 4EGI-1_NCI-H1792 | 4EGI-1 perturbation in NCI-H1792 cell line |
| NVP-BHG712_NCI-H1792 | NVP-BHG712 perturbation in NCI-H1792 cell line |
| venetoclax_NCI-H1792 | venetoclax perturbation in NCI-H1792 cell line |
| BAY1125976_NCI-H1792 | BAY1125976 perturbation in NCI-H1792 cell line |
| Diammonium Glycyrrhizinate_A549 | Diammonium Glycyrrhizinate perturbation in A549 cell line |
| Clonidine (hydrochloride)_A549 | Clonidine (hydrochloride) perturbation in A549 cell line |
| Belzutifan_NCI-H1792 | Belzutifan perturbation in NCI-H1792 cell line |
| Pralsetinib_A549 | Pralsetinib perturbation in A549 cell line |
| AZD-8055_NCI-H1792 | AZD-8055 perturbation in NCI-H1792 cell line |
| 8-Hydroxyquinoline_NCI-H1792 | 8-Hydroxyquinoline perturbation in NCI-H1792 cell line |
| Aliskiren_A549 | Aliskiren perturbation in A549 cell line |
| Sinomenine_NCI-H1792 | Sinomenine perturbation in NCI-H1792 cell line |
| Retinoic acid_H4 | Retinoic acid perturbation in H4 cell line |
| AZD-7648_NCI-H1792 | AZD-7648 perturbation in NCI-H1792 cell line |
| Temuterkib_A549 | Temuterkib perturbation in A549 cell line |
| Mitoxantrone (dihydrochloride)_NCI-H1792 | Mitoxantrone (dihydrochloride) perturbation in NCI-H1792 cell line |
| Neratinib_NCI-H1792 | Neratinib perturbation in NCI-H1792 cell line |
| AZD-8055_NCI-H460 | AZD-8055 perturbation in NCI-H460 cell line |
| Azithromycin (hydrate)_NCI-H1792 | Azithromycin (hydrate) perturbation in NCI-H1792 cell line |
| PH-797804_NCI-H1792 | PH-797804 perturbation in NCI-H1792 cell line |
| Salicylic acid_NCI-H1792 | Salicylic acid perturbation in NCI-H1792 cell line |
| AZD2858_NCI-H1792 | AZD2858 perturbation in NCI-H1792 cell line |
| LB-100_A549 | LB-100 perturbation in A549 cell line |
| GSK1059615_NCI-H1792 | GSK1059615 perturbation in NCI-H1792 cell line |
| Torkinib_A549 | Torkinib perturbation in A549 cell line |
| Berberine (chloride hydrate)_NCI-H1792 | Berberine (chloride hydrate) perturbation in NCI-H1792 cell line |
| MK-8353_A549 | MK-8353 perturbation in A549 cell line |
| Estrone sulfate (potassium)_NCI-H1792 | Estrone sulfate (potassium) perturbation in NCI-H1792 cell line |
| BI-78D3_NCI-H460 | BI-78D3 perturbation in NCI-H460 cell line |
| Aspirin_A549 | Aspirin perturbation in A549 cell line |
| Sodium Salicylate_A549 | Sodium Salicylate perturbation in A549 cell line |
| Bimatoprost_A549 | Bimatoprost perturbation in A549 cell line |
| Ritonavir_AsPC-1 | Ritonavir perturbation in AsPC-1 cell line |
| Encorafenib_NCI-H1792 | Encorafenib perturbation in NCI-H1792 cell line |
| Bentamapimod_NCI-H1792 | Bentamapimod perturbation in NCI-H1792 cell line |
| Demeclocycline_A549 | Demeclocycline perturbation in A549 cell line |
| BI-3406_A549 | BI-3406 perturbation in A549 cell line |
| Olanzapine_NCI-H1792 | Olanzapine perturbation in NCI-H1792 cell line |
| Ixazomib_NCI-H1792 | Ixazomib perturbation in NCI-H1792 cell line |
| Goserelin (acetate)_NCI-H1792 | Goserelin (acetate) perturbation in NCI-H1792 cell line |
| Almonertinib (hydrochloride)_A549 | Almonertinib (hydrochloride) perturbation in A549 cell line |
| Capmatinib_NCI-H460 | Capmatinib perturbation in NCI-H460 cell line |
| Lumateperone (tosylate)_NCI-H1792 | Lumateperone (tosylate) perturbation in NCI-H1792 cell line |
| Busulfan_NCI-H1792 | Busulfan perturbation in NCI-H1792 cell line |
| Tazarotene_NCI-H1792 | Tazarotene perturbation in NCI-H1792 cell line |
| Docetaxel_A549 | Docetaxel perturbation in A549 cell line |
| Busulfan_A549 | Busulfan perturbation in A549 cell line |
| Triclosan_NCI-H460 | Triclosan perturbation in NCI-H460 cell line |
| Lenalidomide (hemihydrate)_A549 | Lenalidomide (hemihydrate) perturbation in A549 cell line |
| Norepinephrine (hydrochloride)_NCI-H1792 | Norepinephrine (hydrochloride) perturbation in NCI-H1792 cell line |
| APTO-253_NCI-H1792 | APTO-253 perturbation in NCI-H1792 cell line |
| Sodium Salicylate_CFPAC-1 | Sodium Salicylate perturbation in CFPAC-1 cell line |
| Vinblastine (sulfate)_A549 | Vinblastine (sulfate) perturbation in A549 cell line |
| Triamcinolone_NCI-H1792 | Triamcinolone perturbation in NCI-H1792 cell line |
| Demeclocycline_NCI-H1792 | Demeclocycline perturbation in NCI-H1792 cell line |
| BI-3406_NCI-H1792 | BI-3406 perturbation in NCI-H1792 cell line |
| Neratinib_AsPC-1 | Neratinib perturbation in AsPC-1 cell line |
| ERK5-IN-2_NCI-H1792 | ERK5-IN-2 perturbation in NCI-H1792 cell line |
| Bimatoprost_NCI-H1792 | Bimatoprost perturbation in NCI-H1792 cell line |
| Sodium Salicylate_NCI-H1792 | Sodium Salicylate perturbation in NCI-H1792 cell line |
| Acetohexamide_NCI-H1792 | Acetohexamide perturbation in NCI-H1792 cell line |
| Fluvoxamine (maleate)_A549 | Fluvoxamine (maleate) perturbation in A549 cell line |
| IQ 1_NCI-H1792 | IQ 1 perturbation in NCI-H1792 cell line |
| MK-8353_NCI-H1792 | MK-8353 perturbation in NCI-H1792 cell line |
| DT-061_NCI-H1792 | DT-061 perturbation in NCI-H1792 cell line |
| Torkinib_NCI-H1792 | Torkinib perturbation in NCI-H1792 cell line |
| LY-2584702 (tosylate salt)_NCI-H1792 | LY-2584702 (tosylate salt) perturbation in NCI-H1792 cell line |
| RMC-6236_NCI-H1792 | RMC-6236 perturbation in NCI-H1792 cell line |
| LB-100_NCI-H1792 | LB-100 perturbation in NCI-H1792 cell line |
| Celecoxib_NCI-H1792 | Celecoxib perturbation in NCI-H1792 cell line |
| Retinoic acid_NCI-H1792 | Retinoic acid perturbation in NCI-H1792 cell line |
| LJI308_NCI-H1792 | LJI308 perturbation in NCI-H1792 cell line |
| Dabrafenib_NCI-H1792 | Dabrafenib perturbation in NCI-H1792 cell line |
| Rapamycin_NCI-H460 | Rapamycin perturbation in NCI-H460 cell line |
| Vortioxetine_NCI-H460 | Vortioxetine perturbation in NCI-H460 cell line |
| Alpelisib_NCI-H1792 | Alpelisib perturbation in NCI-H1792 cell line |
| Citalopram (hydrobromide)_A549 | Citalopram (hydrobromide) perturbation in A549 cell line |
| Ouabain (Octahydrate)_NCI-H1792 | Ouabain (Octahydrate) perturbation in NCI-H1792 cell line |
| Tucidinostat_NCI-H1792 | Tucidinostat perturbation in NCI-H1792 cell line |
| Vemurafenib_NCI-H460 | Vemurafenib perturbation in NCI-H460 cell line |
| Mitoxantrone (dihydrochloride)_A549 | Mitoxantrone (dihydrochloride) perturbation in A549 cell line |
| Sapanisertib_A549 | Sapanisertib perturbation in A549 cell line |
| Radotinib_NCI-H460 | Radotinib perturbation in NCI-H460 cell line |
| Docetaxel (Trihydrate)_A549 | Docetaxel (Trihydrate) perturbation in A549 cell line |
| Anastrozole_NCI-H1792 | Anastrozole perturbation in NCI-H1792 cell line |
| Vemurafenib_NCI-H1792 | Vemurafenib perturbation in NCI-H1792 cell line |
| Radotinib_NCI-H1792 | Radotinib perturbation in NCI-H1792 cell line |
| 8-Hydroxyquinoline_A549 | 8-Hydroxyquinoline perturbation in A549 cell line |
| CP21R7_NCI-H1792 | CP21R7 perturbation in NCI-H1792 cell line |
| Sinomenine_A549 | Sinomenine perturbation in A549 cell line |
| Vortioxetine_NCI-H1792 | Vortioxetine perturbation in NCI-H1792 cell line |
| Tofacitinib_CFPAC-1 | Tofacitinib perturbation in CFPAC-1 cell line |
| Baicalin_CFPAC-1 | Baicalin perturbation in CFPAC-1 cell line |
| AZD-8055_A549 | AZD-8055 perturbation in A549 cell line |
| Belzutifan_A549 | Belzutifan perturbation in A549 cell line |
| Sulfisoxazole_A549 | Sulfisoxazole perturbation in A549 cell line |
| Apalutamide_A549 | Apalutamide perturbation in A549 cell line |
| Ropivacaine (hydrochloride monohydrate)_NCI-H1792 | Ropivacaine (hydrochloride monohydrate) perturbation in NCI-H1792 cell line |
| Entrectinib_A549 | Entrectinib perturbation in A549 cell line |
| Ralimetinib dimesylate_NCI-H1792 | Ralimetinib dimesylate perturbation in NCI-H1792 cell line |
| BAY1125976_A549 | BAY1125976 perturbation in A549 cell line |
| Abemaciclib_NCI-H1792 | Abemaciclib perturbation in NCI-H1792 cell line |
| Tofacitinib_NCI-H1792 | Tofacitinib perturbation in NCI-H1792 cell line |
| BI-78D3_NCI-H2030 | BI-78D3 perturbation in NCI-H2030 cell line |
| Tomivosertib_A549 | Tomivosertib perturbation in A549 cell line |
| Asciminib_A549 | Asciminib perturbation in A549 cell line |
| Cysteamine (hydrochloride)_A549 | Cysteamine (hydrochloride) perturbation in A549 cell line |
| BI-78D3_A549 | BI-78D3 perturbation in A549 cell line |
| Bortezomib_NCI-H1792 | Bortezomib perturbation in NCI-H1792 cell line |
| Elagolix sodium_A549 | Elagolix sodium perturbation in A549 cell line |
| Irinotecan_A549 | Irinotecan perturbation in A549 cell line |
| Lipoic acid_A549 | Lipoic acid perturbation in A549 cell line |
| Bimatoprost_NCI-H460 | Bimatoprost perturbation in NCI-H460 cell line |
| Pimitespib_NCI-H1792 | Pimitespib perturbation in NCI-H1792 cell line |
| Anethole trithione_A549 | Anethole trithione perturbation in A549 cell line |
| Gallic acid (hydrate)_A549 | Gallic acid (hydrate) perturbation in A549 cell line |
| Triclosan_NCI-H1792 | Triclosan perturbation in NCI-H1792 cell line |
| Minodronic acid_NCI-H1792 | Minodronic acid perturbation in NCI-H1792 cell line |
| Doxycycline (monohydrate)_NCI-H1792 | Doxycycline (monohydrate) perturbation in NCI-H1792 cell line |
| 9-ING-41_NCI-H1792 | 9-ING-41 perturbation in NCI-H1792 cell line |
| Bimiralisib_NCI-H1792 | Bimiralisib perturbation in NCI-H1792 cell line |
| Tolcapone_A549 | Tolcapone perturbation in A549 cell line |
| Gemfibrozil_NCI-H1792 | Gemfibrozil perturbation in NCI-H1792 cell line |
| Fulvestrant_NCI-H1792 | Fulvestrant perturbation in NCI-H1792 cell line |
| ETC-206_NCI-H1792 | ETC-206 perturbation in NCI-H1792 cell line |
| Belumosudil (mesylate)_NCI-H1792 | Belumosudil (mesylate) perturbation in NCI-H1792 cell line |
| Afatinib_A549 | Afatinib perturbation in A549 cell line |
| Meloxicam_A549 | Meloxicam perturbation in A549 cell line |
| Lopinavir_A549 | Lopinavir perturbation in A549 cell line |
| Mitoxantrone (dihydrochloride)_SW 1271 | Mitoxantrone (dihydrochloride) perturbation in SW 1271 cell line |
| Ligustrazine_SW 1271 | Ligustrazine perturbation in SW 1271 cell line |
| Aprepitant_A549 | Aprepitant perturbation in A549 cell line |
| Vitamin K4_SW 1088 | Vitamin K4 perturbation in SW 1088 cell line |
| Lenalidomide (hemihydrate)_RKO | Lenalidomide (hemihydrate) perturbation in RKO cell line |
| Ranolazine_A-172 | Ranolazine perturbation in A-172 cell line |
| Benproperine (phosphate)_SW 900 | Benproperine (phosphate) perturbation in SW 900 cell line |
| S-Adenosyl-L-methionine (disulfate tosylate)_NCI-H2122 | S-Adenosyl-L-methionine (disulfate tosylate) perturbation in NCI-H2122 cell line |
| NG25_CHP-212 | NG25 perturbation in CHP-212 cell line |
| Raltitrexed_A498 | Raltitrexed perturbation in A498 cell line |
| OTS514_KATO III | OTS514 perturbation in KATO III cell line |
| Darolutamide_SW 1088 | Darolutamide perturbation in SW 1088 cell line |
| Trimetrexate_NCI-H661 | Trimetrexate perturbation in NCI-H661 cell line |
| Aprepitant_A-427 | Aprepitant perturbation in A-427 cell line |
| Dihydroartemisinin_HT-29 | Dihydroartemisinin perturbation in HT-29 cell line |
| Doxorubicin (hydrochloride)_NCI-H1792 | Doxorubicin (hydrochloride) perturbation in NCI-H1792 cell line |
| Canagliflozin (hemihydrate)_NCI-H661 | Canagliflozin (hemihydrate) perturbation in NCI-H661 cell line |
| Imiquimod (maleate)_HOP62 | Imiquimod (maleate) perturbation in HOP62 cell line |
| Macitentan_SW 1088 | Macitentan perturbation in SW 1088 cell line |
| Belumosudil_SW1417 | Belumosudil perturbation in SW1417 cell line |
| Benztropine (mesylate)_RKO | Benztropine (mesylate) perturbation in RKO cell line |
| Abemaciclib_PANC-1 | Abemaciclib perturbation in PANC-1 cell line |
| AZD1390_NCI-H596 | AZD1390 perturbation in NCI-H596 cell line |
| Paclitaxel_RKO | Paclitaxel perturbation in RKO cell line |
| Neratinib (maleate)_A-427 | Neratinib (maleate) perturbation in A-427 cell line |
| Pentoxifylline_SW 900 | Pentoxifylline perturbation in SW 900 cell line |
| Ritonavir_HepG2/C3A | Ritonavir perturbation in HepG2/C3A cell line |
| Panobinostat_COLO 205 | Panobinostat perturbation in COLO 205 cell line |
| Idarubicin (hydrochloride)_HepG2/C3A | Idarubicin (hydrochloride) perturbation in HepG2/C3A cell line |
| Bortezomib_PANC-1 | Bortezomib perturbation in PANC-1 cell line |
| Monocrotaline_KATO III | Monocrotaline perturbation in KATO III cell line |
| Temsirolimus_HS-578T | Temsirolimus perturbation in HS-578T cell line |
| Tucidinostat_SW 1088 | Tucidinostat perturbation in SW 1088 cell line |
| Aspirin_hTERT-HPNE | Aspirin perturbation in hTERT-HPNE cell line |
| Ornidazole_NCI-H1792 | Ornidazole perturbation in NCI-H1792 cell line |
| Resveratrol_A498 | Resveratrol perturbation in A498 cell line |
| Bortezomib_NCI-H23 | Bortezomib perturbation in NCI-H23 cell line |
| Temsirolimus_RKO | Temsirolimus perturbation in RKO cell line |
| Resveratrol_HepG2/C3A | Resveratrol perturbation in HepG2/C3A cell line |
| Eplerenone_HT-29 | Eplerenone perturbation in HT-29 cell line |
| Docetaxel (Trihydrate)_AsPC-1 | Docetaxel (Trihydrate) perturbation in AsPC-1 cell line |
| Tucatinib_CHP-212 | Tucatinib perturbation in CHP-212 cell line |
| Canagliflozin_NCI-H1792 | Canagliflozin perturbation in NCI-H1792 cell line |
| Panobinostat_A-427 | Panobinostat perturbation in A-427 cell line |
| Cepharanthine_A-427 | Cepharanthine perturbation in A-427 cell line |
| Cytarabine_NCI-H2122 | Cytarabine perturbation in NCI-H2122 cell line |
| Retinoic acid_A498 | Retinoic acid perturbation in A498 cell line |
| Regorafenib_A-427 | Regorafenib perturbation in A-427 cell line |
| Triamcinolone_CHP-212 | Triamcinolone perturbation in CHP-212 cell line |
| Lipoic acid_A-172 | Lipoic acid perturbation in A-172 cell line |
| Vismodegib_HT-29 | Vismodegib perturbation in HT-29 cell line |
| Aprepitant_HT-29 | Aprepitant perturbation in HT-29 cell line |
| Cyclosporin A_NCI-H2122 | Cyclosporin A perturbation in NCI-H2122 cell line |
| Niclosamide (olamine)_HS-578T | Niclosamide (olamine) perturbation in HS-578T cell line |
| ULK-101_HepG2/C3A | ULK-101 perturbation in HepG2/C3A cell line |
| Torkinib_CHP-212 | Torkinib perturbation in CHP-212 cell line |
| Eplerenone_NCI-H661 | Eplerenone perturbation in NCI-H661 cell line |
| Levobupivacaine (hydrochloride)_NCI-H1792 | Levobupivacaine (hydrochloride) perturbation in NCI-H1792 cell line |
| Panobinostat_LoVo | Panobinostat perturbation in LoVo cell line |
| Capmatinib_SW 1088 | Capmatinib perturbation in SW 1088 cell line |
| Methyl aminolevulinate (hydrochloride)_NCI-H1792 | Methyl aminolevulinate (hydrochloride) perturbation in NCI-H1792 cell line |
| Ritonavir_NCI-H23 | Ritonavir perturbation in NCI-H23 cell line |
| Terfenadine_HepG2/C3A | Terfenadine perturbation in HepG2/C3A cell line |
| Anethole trithione_HepG2/C3A | Anethole trithione perturbation in HepG2/C3A cell line |
| Furosemide_RKO | Furosemide perturbation in RKO cell line |
| Ritonavir_RKO | Ritonavir perturbation in RKO cell line |
| Pemetrexed_COLO 205 | Pemetrexed perturbation in COLO 205 cell line |
| Cloxacillin (sodium)_RKO | Cloxacillin (sodium) perturbation in RKO cell line |
| Berbamine_RKO | Berbamine perturbation in RKO cell line |
| Delamanid_SK-MEL-2 | Delamanid perturbation in SK-MEL-2 cell line |
| Tofacitinib (citrate)_HS-578T | Tofacitinib (citrate) perturbation in HS-578T cell line |
| Bimatoprost_RKO | Bimatoprost perturbation in RKO cell line |
| 5-Fluorouracil_AN3 CA | 5-Fluorouracil perturbation in AN3 CA cell line |
| OTS514_HepG2/C3A | OTS514 perturbation in HepG2/C3A cell line |
| Bexarotene_HS-578T | Bexarotene perturbation in HS-578T cell line |
| Pentagastrin_RKO | Pentagastrin perturbation in RKO cell line |
| Menadione_NCI-H661 | Menadione perturbation in NCI-H661 cell line |
| 8-Hydroxyquinoline_HepG2/C3A | 8-Hydroxyquinoline perturbation in HepG2/C3A cell line |
| Silodosin_HepG2/C3A | Silodosin perturbation in HepG2/C3A cell line |
| 5-Azacytidine_LoVo | 5-Azacytidine perturbation in LoVo cell line |
| Benztropine (mesylate)_HepG2/C3A | Benztropine (mesylate) perturbation in HepG2/C3A cell line |
| ULK-101_NCI-H2347 | ULK-101 perturbation in NCI-H2347 cell line |
| Panobinostat_NCI-H661 | Panobinostat perturbation in NCI-H661 cell line |
| Vitamin K4_Hs 766T | Vitamin K4 perturbation in Hs 766T cell line |
| Talc_Hs 766T | Talc perturbation in Hs 766T cell line |
| Oxaprozin_SW 1271 | Oxaprozin perturbation in SW 1271 cell line |
| Celecoxib_LOX-IMVI | Celecoxib perturbation in LOX-IMVI cell line |
| Adenine_A498 | Adenine perturbation in A498 cell line |
| Artesunate_KATO III | Artesunate perturbation in KATO III cell line |
| Arbutin_KATO III | Arbutin perturbation in KATO III cell line |
| Voriconazole_KATO III | Voriconazole perturbation in KATO III cell line |
| Meloxicam_J82 | Meloxicam perturbation in J82 cell line |
| vincristine_KATO III | vincristine perturbation in KATO III cell line |
| Drospirenone_A-427 | Drospirenone perturbation in A-427 cell line |
| Anethole trithione_LoVo | Anethole trithione perturbation in LoVo cell line |
| Pemetrexed_KATO III | Pemetrexed perturbation in KATO III cell line |
| Triamcinolone_NCI-H661 | Triamcinolone perturbation in NCI-H661 cell line |
| Neratinib (maleate)_NCI-H23 | Neratinib (maleate) perturbation in NCI-H23 cell line |
| Dihydroartemisinin_NCI-H661 | Dihydroartemisinin perturbation in NCI-H661 cell line |
| Arbutin_MIA PaCa-2 | Arbutin perturbation in MIA PaCa-2 cell line |
| Posaconazole_HT-29 | Posaconazole perturbation in HT-29 cell line |
| Dihydroartemisinin_PANC-1 | Dihydroartemisinin perturbation in PANC-1 cell line |
| 8-Hydroxyquinoline_C32 | 8-Hydroxyquinoline perturbation in C32 cell line |
| Lactate (calcium)_SW480 | Lactate (calcium) perturbation in SW480 cell line |
| Artesunate_A-427 | Artesunate perturbation in A-427 cell line |
| Lactate (calcium)_LS 180 | Lactate (calcium) perturbation in LS 180 cell line |
| Trametinib (DMSO_HCT15 | Trametinib (DMSO perturbation in HCT15 cell line |
| Ritonavir_HS-578T | Ritonavir perturbation in HS-578T cell line |
| Paclitaxel_KATO III | Paclitaxel perturbation in KATO III cell line |
| Posaconazole_NCI-H661 | Posaconazole perturbation in NCI-H661 cell line |
| Binimetinib_SW480 | Binimetinib perturbation in SW480 cell line |
| 5-Azacytidine_COLO 205 | 5-Azacytidine perturbation in COLO 205 cell line |
| Irinotecan (hydrochloride)_MIA PaCa-2 | Irinotecan (hydrochloride) perturbation in MIA PaCa-2 cell line |
| Dihydroartemisinin_Hs 766T | Dihydroartemisinin perturbation in Hs 766T cell line |
| Eplerenone_KATO III | Eplerenone perturbation in KATO III cell line |
| Niclosamide (olamine)_MIA PaCa-2 | Niclosamide (olamine) perturbation in MIA PaCa-2 cell line |
| Artesunate_SW48 | Artesunate perturbation in SW48 cell line |
| Elimusertib hydrochloride_PANC-1 | Elimusertib hydrochloride perturbation in PANC-1 cell line |
| Crizotinib (hydrochloride)_RKO | Crizotinib (hydrochloride) perturbation in RKO cell line |
| Artesunate_C-33 A | Artesunate perturbation in C-33 A cell line |
| SBI-0640756_HepG2/C3A | SBI-0640756 perturbation in HepG2/C3A cell line |
| Elimusertib hydrochloride_NCI-H661 | Elimusertib hydrochloride perturbation in NCI-H661 cell line |
| Encorafenib_SNU-1 | Encorafenib perturbation in SNU-1 cell line |
| Trametinib (DMSO_SW480 | Trametinib (DMSO perturbation in SW480 cell line |
| Neratinib (maleate)_A498 | Neratinib (maleate) perturbation in A498 cell line |
| Dihydroartemisinin_NCI-H2030 | Dihydroartemisinin perturbation in NCI-H2030 cell line |
| Neratinib (maleate)_C-33 A | Neratinib (maleate) perturbation in C-33 A cell line |
| Adenine_RKO | Adenine perturbation in RKO cell line |
| Sunitinib_J82 | Sunitinib perturbation in J82 cell line |
| Crizotinib (hydrochloride)_LoVo | Crizotinib (hydrochloride) perturbation in LoVo cell line |
| Crizotinib (hydrochloride)_MIA PaCa-2 | Crizotinib (hydrochloride) perturbation in MIA PaCa-2 cell line |
| Methylprednisolone succinate_KATO III | Methylprednisolone succinate perturbation in KATO III cell line |
| Dihydroartemisinin_SW1417 | Dihydroartemisinin perturbation in SW1417 cell line |
| Temuterkib_NCI-H661 | Temuterkib perturbation in NCI-H661 cell line |
| Dihydroartemisinin_BT-474 | Dihydroartemisinin perturbation in BT-474 cell line |
| Docetaxel_SW1417 | Docetaxel perturbation in SW1417 cell line |
| Methotrexate_MIA PaCa-2 | Methotrexate perturbation in MIA PaCa-2 cell line |
| Dihydroartemisinin_SW 1271 | Dihydroartemisinin perturbation in SW 1271 cell line |
| Temsirolimus_NCI-H661 | Temsirolimus perturbation in NCI-H661 cell line |
| Temsirolimus_PANC-1 | Temsirolimus perturbation in PANC-1 cell line |
| Neratinib (maleate)_LoVo | Neratinib (maleate) perturbation in LoVo cell line |
| Rimonabant_MIA PaCa-2 | Rimonabant perturbation in MIA PaCa-2 cell line |
| Encorafenib_J82 | Encorafenib perturbation in J82 cell line |
| LJI308_BT-474 | LJI308 perturbation in BT-474 cell line |
| SBI-0640756_NCI-H661 | SBI-0640756 perturbation in NCI-H661 cell line |
| Rapamycin_HT-29 | Rapamycin perturbation in HT-29 cell line |
| Crizotinib (hydrochloride)_A498 | Crizotinib (hydrochloride) perturbation in A498 cell line |
| Capmatinib_RKO | Capmatinib perturbation in RKO cell line |
| Neratinib (maleate)_J82 | Neratinib (maleate) perturbation in J82 cell line |
| Artemether_KATO III | Artemether perturbation in KATO III cell line |
| Dihydroartemisinin_LS 180 | Dihydroartemisinin perturbation in LS 180 cell line |
| Trametinib (DMSO_COLO 205 | Trametinib (DMSO perturbation in COLO 205 cell line |
| Dihydroartemisinin_SW480 | Dihydroartemisinin perturbation in SW480 cell line |
| Artesunate_RKO | Artesunate perturbation in RKO cell line |
| Minodronic acid_RKO | Minodronic acid perturbation in RKO cell line |
| Tucidinostat_C-33 A | Tucidinostat perturbation in C-33 A cell line |
| Decitabine_KATO III | Decitabine perturbation in KATO III cell line |
| Dihydroartemisinin_KATO III | Dihydroartemisinin perturbation in KATO III cell line |
| Elimusertib hydrochloride_A-427 | Elimusertib hydrochloride perturbation in A-427 cell line |
| Econazole_SNU-1 | Econazole perturbation in SNU-1 cell line |
| Trametinib_HT-29 | Trametinib perturbation in HT-29 cell line |
| Pentagastrin_KATO III | Pentagastrin perturbation in KATO III cell line |
| Ataluren_PANC-1 | Ataluren perturbation in PANC-1 cell line |
| Dihydroartemisinin_LoVo | Dihydroartemisinin perturbation in LoVo cell line |
| Pemetrexed_A-172 | Pemetrexed perturbation in A-172 cell line |
| Elimusertib hydrochloride_SW48 | Elimusertib hydrochloride perturbation in SW48 cell line |
| Elimusertib hydrochloride_C-33 A | Elimusertib hydrochloride perturbation in C-33 A cell line |
| Artesunate_NCI-H661 | Artesunate perturbation in NCI-H661 cell line |
| Adenine_HT-29 | Adenine perturbation in HT-29 cell line |
| Encorafenib_SW480 | Encorafenib perturbation in SW480 cell line |
| Olanzapine_RPMI-7951 | Olanzapine perturbation in RPMI-7951 cell line |
| Balsalazide (sodium hydrate)_NCI-H661 | Balsalazide (sodium hydrate) perturbation in NCI-H661 cell line |
| Dihydroartemisinin_A-427 | Dihydroartemisinin perturbation in A-427 cell line |
| Arbutin_HT-29 | Arbutin perturbation in HT-29 cell line |
| Elimusertib hydrochloride_KATO III | Elimusertib hydrochloride perturbation in KATO III cell line |
| S-Adenosyl-L-methionine (disulfate tosylate)_PANC-1 | S-Adenosyl-L-methionine (disulfate tosylate) perturbation in PANC-1 cell line |
| Drospirenone_NCI-H661 | Drospirenone perturbation in NCI-H661 cell line |
| Dihydroartemisinin_AN3 CA | Dihydroartemisinin perturbation in AN3 CA cell line |
| Dihydroartemisinin_SW48 | Dihydroartemisinin perturbation in SW48 cell line |
| Dihydroartemisinin_A498 | Dihydroartemisinin perturbation in A498 cell line |
| Neratinib (maleate)_NCI-H2030 | Neratinib (maleate) perturbation in NCI-H2030 cell line |
| Pemetrexed_HT-29 | Pemetrexed perturbation in HT-29 cell line |
| Crizotinib (hydrochloride)_SW480 | Crizotinib (hydrochloride) perturbation in SW480 cell line |
| Encorafenib_SW 1271 | Encorafenib perturbation in SW 1271 cell line |
| Dihydroartemisinin_SW 900 | Dihydroartemisinin perturbation in SW 900 cell line |
| Ataluren_HT-29 | Ataluren perturbation in HT-29 cell line |
| Irinotecan (hydrochloride)_SW480 | Irinotecan (hydrochloride) perturbation in SW480 cell line |
| Salicylic acid_NCI-H661 | Salicylic acid perturbation in NCI-H661 cell line |
| Methylthiouracil_HT-29 | Methylthiouracil perturbation in HT-29 cell line |
| Encorafenib_Hs 766T | Encorafenib perturbation in Hs 766T cell line |
| Ponatinib_MIA PaCa-2 | Ponatinib perturbation in MIA PaCa-2 cell line |
| Lactate (calcium)_SNU-423 | Lactate (calcium) perturbation in SNU-423 cell line |
| Meloxicam_COLO 205 | Meloxicam perturbation in COLO 205 cell line |
| Mifepristone_NCI-H2030 | Mifepristone perturbation in NCI-H2030 cell line |
| Vortioxetine_MIA PaCa-2 | Vortioxetine perturbation in MIA PaCa-2 cell line |
| Meloxicam_SW 1271 | Meloxicam perturbation in SW 1271 cell line |
| Clonidine (hydrochloride)_LoVo | Clonidine (hydrochloride) perturbation in LoVo cell line |
| Artesunate_BT-474 | Artesunate perturbation in BT-474 cell line |
| Arbutin_SW 1271 | Arbutin perturbation in SW 1271 cell line |
| Naproxen_KATO III | Naproxen perturbation in KATO III cell line |
| c-Kit-IN-1_SW 1271 | c-Kit-IN-1 perturbation in SW 1271 cell line |
| Trametinib_SW480 | Trametinib perturbation in SW480 cell line |
| Elimusertib hydrochloride_RKO | Elimusertib hydrochloride perturbation in RKO cell line |
| Trametinib_COLO 205 | Trametinib perturbation in COLO 205 cell line |
| Binimetinib_SW48 | Binimetinib perturbation in SW48 cell line |
| Peretinoin_RKO | Peretinoin perturbation in RKO cell line |
| Irinotecan (hydrochloride)_BT-474 | Irinotecan (hydrochloride) perturbation in BT-474 cell line |
| Elagolix sodium_SW480 | Elagolix sodium perturbation in SW480 cell line |
| Crizotinib (hydrochloride)_HT-29 | Crizotinib (hydrochloride) perturbation in HT-29 cell line |
| ML264_LS 180 | ML264 perturbation in LS 180 cell line |
| Meloxicam_SW480 | Meloxicam perturbation in SW480 cell line |
| Afatinib_SW480 | Afatinib perturbation in SW480 cell line |
| Trametinib_SW1417 | Trametinib perturbation in SW1417 cell line |
| Paclitaxel_SW1417 | Paclitaxel perturbation in SW1417 cell line |
| Trametinib_SW 1271 | Trametinib perturbation in SW 1271 cell line |
| Clobetasol propionate_MIA PaCa-2 | Clobetasol propionate perturbation in MIA PaCa-2 cell line |
| Encorafenib_NCI-H661 | Encorafenib perturbation in NCI-H661 cell line |
| (S)-Crizotinib_SW 1271 | (S)-Crizotinib perturbation in SW 1271 cell line |
| Doxorubicin (hydrochloride)_AN3 CA | Doxorubicin (hydrochloride) perturbation in AN3 CA cell line |
| Entrectinib_AN3 CA | Entrectinib perturbation in AN3 CA cell line |
| Harringtonine_C32 | Harringtonine perturbation in C32 cell line |
| Carbamazepine_AN3 CA | Carbamazepine perturbation in AN3 CA cell line |
| Pemigatinib_AN3 CA | Pemigatinib perturbation in AN3 CA cell line |
| Pimitespib_AN3 CA | Pimitespib perturbation in AN3 CA cell line |
| Belumosudil (mesylate)_AN3 CA | Belumosudil (mesylate) perturbation in AN3 CA cell line |
| Perindopril (erbumine)_AN3 CA | Perindopril (erbumine) perturbation in AN3 CA cell line |
| 8-Hydroxyquinoline_SW48 | 8-Hydroxyquinoline perturbation in SW48 cell line |
| S-Adenosyl-L-methionine (disulfate tosylate)_SW48 | S-Adenosyl-L-methionine (disulfate tosylate) perturbation in SW48 cell line |
| Aspirin_HEC-1-A | Aspirin perturbation in HEC-1-A cell line |
| AZD-7648_SHP-77 | AZD-7648 perturbation in SHP-77 cell line |
| 8-Hydroxyquinoline_SHP-77 | 8-Hydroxyquinoline perturbation in SHP-77 cell line |
| Acetazolamide_Panc 03.27 | Acetazolamide perturbation in Panc 03.27 cell line |
| Abemaciclib_AsPC-1 | Abemaciclib perturbation in AsPC-1 cell line |
| Estrone sulfate (potassium)_RKO | Estrone sulfate (potassium) perturbation in RKO cell line |
| Relugolix_SW480 | Relugolix perturbation in SW480 cell line |
| Everolimus_NCI-H2122 | Everolimus perturbation in NCI-H2122 cell line |
| Tofacitinib_SW480 | Tofacitinib perturbation in SW480 cell line |
| Lumateperone (tosylate)_SNU-1 | Lumateperone (tosylate) perturbation in SNU-1 cell line |
| Bicalutamide_NCI-H2030 | Bicalutamide perturbation in NCI-H2030 cell line |
| LY2090314_A-427 | LY2090314 perturbation in A-427 cell line |
| Vitamin K4_SW480 | Vitamin K4 perturbation in SW480 cell line |
| Fluvoxamine (maleate)_SNU-1 | Fluvoxamine (maleate) perturbation in SNU-1 cell line |
| Bosentan (hydrate)_H4 | Bosentan (hydrate) perturbation in H4 cell line |
| Verteporfin_A-427 | Verteporfin perturbation in A-427 cell line |
| Ivabradine (hydrochloride)_A-427 | Ivabradine (hydrochloride) perturbation in A-427 cell line |
| Orlistat_NCI-H23 | Orlistat perturbation in NCI-H23 cell line |
| Crizotinib (hydrochloride)_LOX-IMVI | Crizotinib (hydrochloride) perturbation in LOX-IMVI cell line |
| Mifepristone_C-33 A | Mifepristone perturbation in C-33 A cell line |
| Triclosan_COLO 205 | Triclosan perturbation in COLO 205 cell line |
| Fluvoxamine (maleate)_AN3 CA | Fluvoxamine (maleate) perturbation in AN3 CA cell line |
| Belumosudil_BT-474 | Belumosudil perturbation in BT-474 cell line |
| Lopinavir_SK-MEL-2 | Lopinavir perturbation in SK-MEL-2 cell line |
| Bimatoprost_SW1417 | Bimatoprost perturbation in SW1417 cell line |
| Regorafenib_A549 | Regorafenib perturbation in A549 cell line |
| Rosiglitazone_A-427 | Rosiglitazone perturbation in A-427 cell line |
| DTP3_SW480 | DTP3 perturbation in SW480 cell line |
| Temuterkib_HCT15 | Temuterkib perturbation in HCT15 cell line |
| Finasteride_NCI-H2030 | Finasteride perturbation in NCI-H2030 cell line |
| Ritonavir_A549 | Ritonavir perturbation in A549 cell line |
| Penfluridol_NCI-H2030 | Penfluridol perturbation in NCI-H2030 cell line |
| Plicamycin_NCI-H2030 | Plicamycin perturbation in NCI-H2030 cell line |
| Bimatoprost_SW480 | Bimatoprost perturbation in SW480 cell line |
| ETC-206_HEC-1-A | ETC-206 perturbation in HEC-1-A cell line |
| Pentoxifylline_KATO III | Pentoxifylline perturbation in KATO III cell line |
| Torkinib_AsPC-1 | Torkinib perturbation in AsPC-1 cell line |
| Vitamin K4_SK-MEL-2 | Vitamin K4 perturbation in SK-MEL-2 cell line |
| Ritonavir_BT-474 | Ritonavir perturbation in BT-474 cell line |
| Orlistat_AN3 CA | Orlistat perturbation in AN3 CA cell line |
| Cepharanthine_NCI-H2030 | Cepharanthine perturbation in NCI-H2030 cell line |
| Olanzapine_SW480 | Olanzapine perturbation in SW480 cell line |
| Vinblastine (sulfate)_SW480 | Vinblastine (sulfate) perturbation in SW480 cell line |
| Goserelin (acetate)_SW480 | Goserelin (acetate) perturbation in SW480 cell line |
| Bergenin_Panc 03.27 | Bergenin perturbation in Panc 03.27 cell line |
| LB-100_AN3 CA | LB-100 perturbation in AN3 CA cell line |
| Olanzapine_A549 | Olanzapine perturbation in A549 cell line |
| Lumateperone (tosylate)_SW480 | Lumateperone (tosylate) perturbation in SW480 cell line |
| Lucanthone_A-427 | Lucanthone perturbation in A-427 cell line |
| Asciminib_SK-MEL-2 | Asciminib perturbation in SK-MEL-2 cell line |
| Docetaxel (Trihydrate)_SW 1271 | Docetaxel (Trihydrate) perturbation in SW 1271 cell line |
| Fluvoxamine (maleate)_SW480 | Fluvoxamine (maleate) perturbation in SW480 cell line |
| GSK1059615_NCI-H2030 | GSK1059615 perturbation in NCI-H2030 cell line |
| Bicalutamide_RKO | Bicalutamide perturbation in RKO cell line |
| Lucanthone_AN3 CA | Lucanthone perturbation in AN3 CA cell line |
| Bendamustine_NCI-H2030 | Bendamustine perturbation in NCI-H2030 cell line |
| Fluvoxamine (maleate)_NCI-H2030 | Fluvoxamine (maleate) perturbation in NCI-H2030 cell line |
| Lenalidomide (hemihydrate)_SW 1271 | Lenalidomide (hemihydrate) perturbation in SW 1271 cell line |
| Berberine (chloride hydrate)_SW480 | Berberine (chloride hydrate) perturbation in SW480 cell line |
| Meloxicam_SK-MEL-2 | Meloxicam perturbation in SK-MEL-2 cell line |
| Pyridoxine (hydrochloride)_HEC-1-A | Pyridoxine (hydrochloride) perturbation in HEC-1-A cell line |
| Verteporfin_HT-29 | Verteporfin perturbation in HT-29 cell line |
| Clonidine (hydrochloride)_RKO | Clonidine (hydrochloride) perturbation in RKO cell line |
| Bicalutamide_A-427 | Bicalutamide perturbation in A-427 cell line |
| Tolcapone_NCI-H2030 | Tolcapone perturbation in NCI-H2030 cell line |
| Trametinib (DMSO_RKO | Trametinib (DMSO perturbation in RKO cell line |
| DTP3_NCI-H23 | DTP3 perturbation in NCI-H23 cell line |
| ETC-206_SHP-77 | ETC-206 perturbation in SHP-77 cell line |
| Quinestrol_SHP-77 | Quinestrol perturbation in SHP-77 cell line |
| Bestatin (hydrochloride)_HEC-1-A | Bestatin (hydrochloride) perturbation in HEC-1-A cell line |
| Adenine_SW480 | Adenine perturbation in SW480 cell line |
| Adagrasib_SW 1271 | Adagrasib perturbation in SW 1271 cell line |
| Lopinavir_C-33 A | Lopinavir perturbation in C-33 A cell line |
| Tofacitinib (citrate)_SK-MEL-2 | Tofacitinib (citrate) perturbation in SK-MEL-2 cell line |
| Doxycycline (monohydrate)_AN3 CA | Doxycycline (monohydrate) perturbation in AN3 CA cell line |
| Voriconazole_SW1417 | Voriconazole perturbation in SW1417 cell line |
| Palmatine (chloride)_SW480 | Palmatine (chloride) perturbation in SW480 cell line |
| Pyridoxine (hydrochloride)_SW480 | Pyridoxine (hydrochloride) perturbation in SW480 cell line |
| Indacaterol (maleate)_HT-29 | Indacaterol (maleate) perturbation in HT-29 cell line |
| Osimertinib (mesylate)_SK-MEL-2 | Osimertinib (mesylate) perturbation in SK-MEL-2 cell line |
| EX229_SHP-77 | EX229 perturbation in SHP-77 cell line |
| Adagrasib_SW480 | Adagrasib perturbation in SW480 cell line |
| Quinestrol_LoVo | Quinestrol perturbation in LoVo cell line |
| Estrone sulfate (potassium)_PANC-1 | Estrone sulfate (potassium) perturbation in PANC-1 cell line |
| Crizotinib (hydrochloride)_SK-MEL-2 | Crizotinib (hydrochloride) perturbation in SK-MEL-2 cell line |
| Estrone sulfate (potassium)_HEC-1-A | Estrone sulfate (potassium) perturbation in HEC-1-A cell line |
| Silodosin_NCI-H2030 | Silodosin perturbation in NCI-H2030 cell line |
| EX229_HepG2/C3A | EX229 perturbation in HepG2/C3A cell line |
| Abemaciclib_HepG2/C3A | Abemaciclib perturbation in HepG2/C3A cell line |
| Bortezomib_HepG2/C3A | Bortezomib perturbation in HepG2/C3A cell line |
| Verapamil_HepG2/C3A | Verapamil perturbation in HepG2/C3A cell line |
| Cytarabine (hydrochloride)_HepG2/C3A | Cytarabine (hydrochloride) perturbation in HepG2/C3A cell line |
| Imiquimod (hydrochloride)_HepG2/C3A | Imiquimod (hydrochloride) perturbation in HepG2/C3A cell line |
| Berbamine_HepG2/C3A | Berbamine perturbation in HepG2/C3A cell line |
| Levobupivacaine (hydrochloride)_HepG2/C3A | Levobupivacaine (hydrochloride) perturbation in HepG2/C3A cell line |
| AZD2858_HepG2/C3A | AZD2858 perturbation in HepG2/C3A cell line |
| Digitoxin_HepG2/C3A | Digitoxin perturbation in HepG2/C3A cell line |
| Panobinostat_J82 | Panobinostat perturbation in J82 cell line |
| Erdafitinib _HepG2/C3A | Erdafitinib perturbation in HepG2/C3A cell line |
| Vinblastine (sulfate)_LOX-IMVI | Vinblastine (sulfate) perturbation in LOX-IMVI cell line |
| Voriconazole_NCI-H1792 | Voriconazole perturbation in NCI-H1792 cell line |
| Ferulic acid_J82 | Ferulic acid perturbation in J82 cell line |
| Epirubicin (hydrochloride)_COLO 205 | Epirubicin (hydrochloride) perturbation in COLO 205 cell line |
| Edoxaban (tosylate monohydrate)_COLO 205 | Edoxaban (tosylate monohydrate) perturbation in COLO 205 cell line |
| Drospirenone_A498 | Drospirenone perturbation in A498 cell line |
| Tolmetin_SW 900 | Tolmetin perturbation in SW 900 cell line |
| Larotrectinib sulfate_NCI-H2347 | Larotrectinib sulfate perturbation in NCI-H2347 cell line |
| Dimethyl fumarate_A-172 | Dimethyl fumarate perturbation in A-172 cell line |
| APTO-253_A-172 | APTO-253 perturbation in A-172 cell line |
| Benztropine (mesylate)_A498 | Benztropine (mesylate) perturbation in A498 cell line |
| Silodosin_A498 | Silodosin perturbation in A498 cell line |
| Mifepristone_J82 | Mifepristone perturbation in J82 cell line |
| Fluvoxamine_hTERT-HPNE | Fluvoxamine perturbation in hTERT-HPNE cell line |
| Riluzole hydrochloride_J82 | Riluzole hydrochloride perturbation in J82 cell line |
| Cinacalcet_hTERT-HPNE | Cinacalcet perturbation in hTERT-HPNE cell line |
| Cytarabine (hydrochloride)_hTERT-HPNE | Cytarabine (hydrochloride) perturbation in hTERT-HPNE cell line |
| Rucaparib (phosphate)_SW 900 | Rucaparib (phosphate) perturbation in SW 900 cell line |
| Mozavaptan_H4 | Mozavaptan perturbation in H4 cell line |
| Belinostat_J82 | Belinostat perturbation in J82 cell line |
| Arbutin_NCI-H1792 | Arbutin perturbation in NCI-H1792 cell line |
| Fluvoxamine_RPMI-7951 | Fluvoxamine perturbation in RPMI-7951 cell line |
| Lidocaine (hydrochloride)_SNU-423 | Lidocaine (hydrochloride) perturbation in SNU-423 cell line |
| Asciminib_C32 | Asciminib perturbation in C32 cell line |
| vincristine_NCI-H1792 | vincristine perturbation in NCI-H1792 cell line |
| Daidzin_A498 | Daidzin perturbation in A498 cell line |
| Phenylephrine (hydrochloride)_hTERT-HPNE | Phenylephrine (hydrochloride) perturbation in hTERT-HPNE cell line |
| Vortioxetine_COLO 205 | Vortioxetine perturbation in COLO 205 cell line |
| Malotilate_A-172 | Malotilate perturbation in A-172 cell line |
| c-Kit-IN-1_J82 | c-Kit-IN-1 perturbation in J82 cell line |
| Apalutamide_SW 900 | Apalutamide perturbation in SW 900 cell line |
| Finasteride_H4 | Finasteride perturbation in H4 cell line |
| Tetracycline (hydrochloride)_J82 | Tetracycline (hydrochloride) perturbation in J82 cell line |
| Canagliflozin_A-172 | Canagliflozin perturbation in A-172 cell line |
| Amsacrine_COLO 205 | Amsacrine perturbation in COLO 205 cell line |
| Bexarotene_LOX-IMVI | Bexarotene perturbation in LOX-IMVI cell line |
| BI-3406_A-172 | BI-3406 perturbation in A-172 cell line |
| Demeclocycline_A-172 | Demeclocycline perturbation in A-172 cell line |
| Decitabine_A-172 | Decitabine perturbation in A-172 cell line |
| Larotrectinib sulfate_LOX-IMVI | Larotrectinib sulfate perturbation in LOX-IMVI cell line |
| Asciminib_NCI-H2122 | Asciminib perturbation in NCI-H2122 cell line |
| Rimonabant_NCI-H2347 | Rimonabant perturbation in NCI-H2347 cell line |
| Ivabradine (hydrochloride)_SNU-423 | Ivabradine (hydrochloride) perturbation in SNU-423 cell line |
| Mifepristone_NCI-H1792 | Mifepristone perturbation in NCI-H1792 cell line |
| Edoxaban (tosylate monohydrate)_HepG2/C3A | Edoxaban (tosylate monohydrate) perturbation in HepG2/C3A cell line |
| Tirabrutinib_A-172 | Tirabrutinib perturbation in A-172 cell line |
| Macitentan_A-172 | Macitentan perturbation in A-172 cell line |
| Apalutamide_A498 | Apalutamide perturbation in A498 cell line |
| Tazarotene_NCI-H2347 | Tazarotene perturbation in NCI-H2347 cell line |
| Daidzin_SW 900 | Daidzin perturbation in SW 900 cell line |
| Ferulic acid_NCI-H1792 | Ferulic acid perturbation in NCI-H1792 cell line |
| Irinotecan (hydrochloride)_A498 | Irinotecan (hydrochloride) perturbation in A498 cell line |
| Pimozide_SW 900 | Pimozide perturbation in SW 900 cell line |
| Folic acid_NCI-H2347 | Folic acid perturbation in NCI-H2347 cell line |
| Rutin (trihydrate)_C32 | Rutin (trihydrate) perturbation in C32 cell line |
| Idarubicin (hydrochloride)_Hs 766T | Idarubicin (hydrochloride) perturbation in Hs 766T cell line |
| Retinoic acid_Hs 766T | Retinoic acid perturbation in Hs 766T cell line |
| Omeprazole (sodium)_H4 | Omeprazole (sodium) perturbation in H4 cell line |
| palbociclib_J82 | palbociclib perturbation in J82 cell line |
| Darolutamide_hTERT-HPNE | Darolutamide perturbation in hTERT-HPNE cell line |
| Verapamil_RPMI-7951 | Verapamil perturbation in RPMI-7951 cell line |
| Diphenhydramine_A498 | Diphenhydramine perturbation in A498 cell line |
| Cyclosporin A_A-172 | Cyclosporin A perturbation in A-172 cell line |
| Tetracycline (hydrochloride)_NCI-H1792 | Tetracycline (hydrochloride) perturbation in NCI-H1792 cell line |
| Vismodegib_J82 | Vismodegib perturbation in J82 cell line |
| TAK-733_Hs 766T | TAK-733 perturbation in Hs 766T cell line |
| Ivermectin_hTERT-HPNE | Ivermectin perturbation in hTERT-HPNE cell line |
| Pentagastrin_A-172 | Pentagastrin perturbation in A-172 cell line |
| Bisoprolol (hemifumarate)_SW 900 | Bisoprolol (hemifumarate) perturbation in SW 900 cell line |
| Benztropine (mesylate)_SW 900 | Benztropine (mesylate) perturbation in SW 900 cell line |
| Zileuton_A-172 | Zileuton perturbation in A-172 cell line |
| Mebendazole_A-172 | Mebendazole perturbation in A-172 cell line |
| Sonidegib_A498 | Sonidegib perturbation in A498 cell line |
| L-Eflornithine (monohydrochloride)_hTERT-HPNE | L-Eflornithine (monohydrochloride) perturbation in hTERT-HPNE cell line |
| Imiquimod (hydrochloride)_A-172 | Imiquimod (hydrochloride) perturbation in A-172 cell line |
| Pioglitazone_A-172 | Pioglitazone perturbation in A-172 cell line |
| Clobetasol propionate_RPMI-7951 | Clobetasol propionate perturbation in RPMI-7951 cell line |
| Penfluridol_H4 | Penfluridol perturbation in H4 cell line |
| Fedratinib (hydrochloride hydrate)_J82 | Fedratinib (hydrochloride hydrate) perturbation in J82 cell line |
| Bexarotene_NCI-H23 | Bexarotene perturbation in NCI-H23 cell line |
| Penfluridol_A-172 | Penfluridol perturbation in A-172 cell line |
| Ferulic acid_SNU-423 | Ferulic acid perturbation in SNU-423 cell line |
| Esmolol (hydrochloride)_SNU-423 | Esmolol (hydrochloride) perturbation in SNU-423 cell line |
| Plicamycin_A-172 | Plicamycin perturbation in A-172 cell line |
| Pexidartinib (hydrochloride)_HepG2/C3A | Pexidartinib (hydrochloride) perturbation in HepG2/C3A cell line |
| Mifepristone_HOP62 | Mifepristone perturbation in HOP62 cell line |
| Imiquimod (hydrochloride)_H4 | Imiquimod (hydrochloride) perturbation in H4 cell line |
| Pexidartinib (hydrochloride)_SW 1088 | Pexidartinib (hydrochloride) perturbation in SW 1088 cell line |
| Hexylresorcinol_NCI-H1792 | Hexylresorcinol perturbation in NCI-H1792 cell line |
| Berbamine (dihydrochloride)_NCI-H2347 | Berbamine (dihydrochloride) perturbation in NCI-H2347 cell line |
| XRK3F2_A-172 | XRK3F2 perturbation in A-172 cell line |
| Aspirin_A-172 | Aspirin perturbation in A-172 cell line |
| Estrone sulfate (potassium)_NCI-H2347 | Estrone sulfate (potassium) perturbation in NCI-H2347 cell line |
| Niclosamide (olamine)_A498 | Niclosamide (olamine) perturbation in A498 cell line |
| Trametinib (DMSO_Hs 766T | Trametinib (DMSO perturbation in Hs 766T cell line |
| Medroxyprogesterone acetate_HS-578T | Medroxyprogesterone acetate perturbation in HS-578T cell line |
| Bestatin_HepG2/C3A | Bestatin perturbation in HepG2/C3A cell line |
| Acetohexamide_A-172 | Acetohexamide perturbation in A-172 cell line |
| Mifepristone_SNU-423 | Mifepristone perturbation in SNU-423 cell line |
| Ixazomib citrate_NCI-H2347 | Ixazomib citrate perturbation in NCI-H2347 cell line |
| Ivabradine (hydrochloride)_NCI-H1792 | Ivabradine (hydrochloride) perturbation in NCI-H1792 cell line |
| venetoclax_SW 900 | venetoclax perturbation in SW 900 cell line |
| Trifluridine_A498 | Trifluridine perturbation in A498 cell line |
| Cyclosporin A_H4 | Cyclosporin A perturbation in H4 cell line |
| Carbidopa (monohydrate)_SW 900 | Carbidopa (monohydrate) perturbation in SW 900 cell line |
| Fenofibrate_HepG2/C3A | Fenofibrate perturbation in HepG2/C3A cell line |
| Omeprazole (sodium)_A-172 | Omeprazole (sodium) perturbation in A-172 cell line |
| Lidocaine (hydrochloride)_J82 | Lidocaine (hydrochloride) perturbation in J82 cell line |
| Belumosudil_A-172 | Belumosudil perturbation in A-172 cell line |
| Rutin (trihydrate)_A498 | Rutin (trihydrate) perturbation in A498 cell line |
| MK-8353_A-172 | MK-8353 perturbation in A-172 cell line |
| BI-78D3_J82 | BI-78D3 perturbation in J82 cell line |
| Brimonidine_SW 900 | Brimonidine perturbation in SW 900 cell line |
| Tirabrutinib_H4 | Tirabrutinib perturbation in H4 cell line |
| Binimetinib_COLO 205 | Binimetinib perturbation in COLO 205 cell line |
| Sulfatinib_H4 | Sulfatinib perturbation in H4 cell line |
| Captopril_A-172 | Captopril perturbation in A-172 cell line |
| Decitabine_H4 | Decitabine perturbation in H4 cell line |
| Paclitaxel_A498 | Paclitaxel perturbation in A498 cell line |
| Demeclocycline_NCI-H661 | Demeclocycline perturbation in NCI-H661 cell line |
| Ivabradine (hydrochloride)_J82 | Ivabradine (hydrochloride) perturbation in J82 cell line |
| (S)-Crizotinib_A-172 | (S)-Crizotinib perturbation in A-172 cell line |
| Verapamil_A549 | Verapamil perturbation in A549 cell line |
| Trametinib_SW 900 | Trametinib perturbation in SW 900 cell line |
| Arbutin_SNU-423 | Arbutin perturbation in SNU-423 cell line |
| Canagliflozin_H4 | Canagliflozin perturbation in H4 cell line |
| Finasteride_A-172 | Finasteride perturbation in A-172 cell line |
| Voriconazole_SNU-423 | Voriconazole perturbation in SNU-423 cell line |
| Perindopril (erbumine)_HepG2/C3A | Perindopril (erbumine) perturbation in HepG2/C3A cell line |
| Altretamine_HepG2/C3A | Altretamine perturbation in HepG2/C3A cell line |
| Eplerenone_A498 | Eplerenone perturbation in A498 cell line |
| Entrectinib_SW 900 | Entrectinib perturbation in SW 900 cell line |
| Temsirolimus_RPMI-7951 | Temsirolimus perturbation in RPMI-7951 cell line |
| Meloxicam_SNU-423 | Meloxicam perturbation in SNU-423 cell line |
| Altretamine_SW 1088 | Altretamine perturbation in SW 1088 cell line |
| Ataluren_NCI-H1792 | Ataluren perturbation in NCI-H1792 cell line |
| OTS514_SW 900 | OTS514 perturbation in SW 900 cell line |
| Vismodegib_SNU-423 | Vismodegib perturbation in SNU-423 cell line |
| Mozavaptan_A-172 | Mozavaptan perturbation in A-172 cell line |
| Irinotecan_J82 | Irinotecan perturbation in J82 cell line |
| Tadalafil_NCI-H2347 | Tadalafil perturbation in NCI-H2347 cell line |
| Pemetrexed_NCI-H1792 | Pemetrexed perturbation in NCI-H1792 cell line |
| Verteporfin_NCI-H1792 | Verteporfin perturbation in NCI-H1792 cell line |
| Lipoic acid_J82 | Lipoic acid perturbation in J82 cell line |
| Sivelestat (sodium tetrahydrate)_NCI-H2347 | Sivelestat (sodium tetrahydrate) perturbation in NCI-H2347 cell line |
| Clobetasol propionate_A549 | Clobetasol propionate perturbation in A549 cell line |
| Peretinoin_A-172 | Peretinoin perturbation in A-172 cell line |
| Penfluridol_HS-578T | Penfluridol perturbation in HS-578T cell line |
| Phenytoin (sodium)_A-172 | Phenytoin (sodium) perturbation in A-172 cell line |
| Nevirapine_A498 | Nevirapine perturbation in A498 cell line |
| ERK5-IN-2_A-172 | ERK5-IN-2 perturbation in A-172 cell line |
| Pyridoxine_A-172 | Pyridoxine perturbation in A-172 cell line |
| Bimatoprost_A-172 | Bimatoprost perturbation in A-172 cell line |
| Fumaric acid_A-172 | Fumaric acid perturbation in A-172 cell line |
| Tranilast_SNU-423 | Tranilast perturbation in SNU-423 cell line |
| Medroxyprogesterone acetate_A-172 | Medroxyprogesterone acetate perturbation in A-172 cell line |
| L-Eflornithine (monohydrochloride)_HepG2/C3A | L-Eflornithine (monohydrochloride) perturbation in HepG2/C3A cell line |
| Sulfisoxazole_CFPAC-1 | Sulfisoxazole perturbation in CFPAC-1 cell line |
| Eplerenone_NCI-H1792 | Eplerenone perturbation in NCI-H1792 cell line |
| Trametinib (DMSO_H4 | Trametinib (DMSO perturbation in H4 cell line |
| Abiraterone acetate_NCI-H1792 | Abiraterone acetate perturbation in NCI-H1792 cell line |
| Filgotinib_A-172 | Filgotinib perturbation in A-172 cell line |
| Silodosin_SNU-423 | Silodosin perturbation in SNU-423 cell line |
| Vortioxetine_hTERT-HPNE | Vortioxetine perturbation in hTERT-HPNE cell line |
| Flutamide_H4 | Flutamide perturbation in H4 cell line |
| Rapamycin_hTERT-HPNE | Rapamycin perturbation in hTERT-HPNE cell line |
| Mozavaptan_NCI-H596 | Mozavaptan perturbation in NCI-H596 cell line |
| Celecoxib_A-172 | Celecoxib perturbation in A-172 cell line |
| Vandetanib_hTERT-HPNE | Vandetanib perturbation in hTERT-HPNE cell line |
| Gallic acid (hydrate)_NCI-H2122 | Gallic acid (hydrate) perturbation in NCI-H2122 cell line |
| Elimusertib hydrochloride_A-172 | Elimusertib hydrochloride perturbation in A-172 cell line |
| Budesonide_SW 900 | Budesonide perturbation in SW 900 cell line |
| Pimozide_SNU-423 | Pimozide perturbation in SNU-423 cell line |
| Vortioxetine_RPMI-7951 | Vortioxetine perturbation in RPMI-7951 cell line |
| Regorafenib_H4 | Regorafenib perturbation in H4 cell line |
| Idarubicin (hydrochloride)_A-172 | Idarubicin (hydrochloride) perturbation in A-172 cell line |
| Edoxaban (tosylate monohydrate)_hTERT-HPNE | Edoxaban (tosylate monohydrate) perturbation in hTERT-HPNE cell line |
| Trimetrexate_H4 | Trimetrexate perturbation in H4 cell line |
| Dapagliflozin_A-172 | Dapagliflozin perturbation in A-172 cell line |
| Cilostazol_J82 | Cilostazol perturbation in J82 cell line |
| Trametinib_J82 | Trametinib perturbation in J82 cell line |
| Verteporfin_A498 | Verteporfin perturbation in A498 cell line |
| Pemetrexed_A498 | Pemetrexed perturbation in A498 cell line |
| Ivabradine (hydrochloride)_SW 900 | Ivabradine (hydrochloride) perturbation in SW 900 cell line |
| Berbamine_A-172 | Berbamine perturbation in A-172 cell line |
| Bestatin (hydrochloride)_LOX-IMVI | Bestatin (hydrochloride) perturbation in LOX-IMVI cell line |
| Nevirapine_NCI-H1792 | Nevirapine perturbation in NCI-H1792 cell line |
| Relugolix_COLO 205 | Relugolix perturbation in COLO 205 cell line |
| Ivabradine (hydrochloride)_A498 | Ivabradine (hydrochloride) perturbation in A498 cell line |
| Bosentan (hydrate)_A-172 | Bosentan (hydrate) perturbation in A-172 cell line |
| Lapatinib ditosylate_NCI-H661 | Lapatinib ditosylate perturbation in NCI-H661 cell line |
| Thymol_A-172 | Thymol perturbation in A-172 cell line |
| Rimonabant (Hydrochloride)_A-172 | Rimonabant (Hydrochloride) perturbation in A-172 cell line |
| Demeclocycline_Hs 766T | Demeclocycline perturbation in Hs 766T cell line |
| Cysteamine (hydrochloride)_J82 | Cysteamine (hydrochloride) perturbation in J82 cell line |
| Oleic acid_SW 900 | Oleic acid perturbation in SW 900 cell line |
| Gefitinib_A-172 | Gefitinib perturbation in A-172 cell line |
| Lidocaine (hydrochloride)_SW 900 | Lidocaine (hydrochloride) perturbation in SW 900 cell line |
| Niclosamide (olamine)_NCI-H1792 | Niclosamide (olamine) perturbation in NCI-H1792 cell line |
| Entecavir (monohydrate)_A-172 | Entecavir (monohydrate) perturbation in A-172 cell line |
| Mifepristone_C32 | Mifepristone perturbation in C32 cell line |
| Cloxacillin (sodium)_A-172 | Cloxacillin (sodium) perturbation in A-172 cell line |
| AZD-8055_HOP62 | AZD-8055 perturbation in HOP62 cell line |
| NVP-BHG712_J82 | NVP-BHG712 perturbation in J82 cell line |
| Fluvoxamine_HepG2/C3A | Fluvoxamine perturbation in HepG2/C3A cell line |
| Carbidopa (monohydrate)_J82 | Carbidopa (monohydrate) perturbation in J82 cell line |
| Procainamide (hydrochloride)_J82 | Procainamide (hydrochloride) perturbation in J82 cell line |
| Nevirapine_J82 | Nevirapine perturbation in J82 cell line |
| Vitamin K4_hTERT-HPNE | Vitamin K4 perturbation in hTERT-HPNE cell line |
| Canagliflozin (hemihydrate)_A-172 | Canagliflozin (hemihydrate) perturbation in A-172 cell line |
| Sonidegib_SNU-423 | Sonidegib perturbation in SNU-423 cell line |
| Dorzolamide (hydrochloride)_A-172 | Dorzolamide (hydrochloride) perturbation in A-172 cell line |
| L-Thyroxine (sodium salt pentahydrate)_H4 | L-Thyroxine (sodium salt pentahydrate) perturbation in H4 cell line |
| Balsalazide (sodium hydrate)_SNU-423 | Balsalazide (sodium hydrate) perturbation in SNU-423 cell line |
| Simotinib_H4 | Simotinib perturbation in H4 cell line |
| Tolmetin_SNU-423 | Tolmetin perturbation in SNU-423 cell line |
| Vemurafenib_RPMI-7951 | Vemurafenib perturbation in RPMI-7951 cell line |
| Clobetasol propionate_COLO 205 | Clobetasol propionate perturbation in COLO 205 cell line |
| Apalutamide_NCI-H1792 | Apalutamide perturbation in NCI-H1792 cell line |
| Drospirenone_J82 | Drospirenone perturbation in J82 cell line |
| Ferulic acid_A498 | Ferulic acid perturbation in A498 cell line |
| Cepharanthine_A-172 | Cepharanthine perturbation in A-172 cell line |
| Sildenafil_NCI-H2347 | Sildenafil perturbation in NCI-H2347 cell line |
| Resveratrol_LOX-IMVI | Resveratrol perturbation in LOX-IMVI cell line |
| Irinotecan (hydrochloride)_NCI-H1792 | Irinotecan (hydrochloride) perturbation in NCI-H1792 cell line |
| L-Thyroxine (sodium salt pentahydrate)_A-172 | L-Thyroxine (sodium salt pentahydrate) perturbation in A-172 cell line |
| Pasireotide (acetate)_A-172 | Pasireotide (acetate) perturbation in A-172 cell line |
| Benztropine (mesylate)_J82 | Benztropine (mesylate) perturbation in J82 cell line |
| Simotinib_A-172 | Simotinib perturbation in A-172 cell line |
| Flumatinib (mesylate)_A-172 | Flumatinib (mesylate) perturbation in A-172 cell line |
| Binimetinib_hTERT-HPNE | Binimetinib perturbation in hTERT-HPNE cell line |
| Hesperidin_J82 | Hesperidin perturbation in J82 cell line |
| Temsirolimus_SW 1088 | Temsirolimus perturbation in SW 1088 cell line |
| S-Adenosyl-L-methionine (disulfate tosylate)_J82 | S-Adenosyl-L-methionine (disulfate tosylate) perturbation in J82 cell line |
| Canagliflozin (hemihydrate)_H4 | Canagliflozin (hemihydrate) perturbation in H4 cell line |
| Adenine_J82 | Adenine perturbation in J82 cell line |
| Mifepristone_A498 | Mifepristone perturbation in A498 cell line |
| Silodosin_J82 | Silodosin perturbation in J82 cell line |
| Fusidic acid_A-172 | Fusidic acid perturbation in A-172 cell line |
| 8-Hydroxyquinoline_J82 | 8-Hydroxyquinoline perturbation in J82 cell line |
| Abemaciclib_hTERT-HPNE | Abemaciclib perturbation in hTERT-HPNE cell line |
| Darinaparsin_LOX-IMVI | Darinaparsin perturbation in LOX-IMVI cell line |
| Entecavir (monohydrate)_H4 | Entecavir (monohydrate) perturbation in H4 cell line |
| Altretamine_hTERT-HPNE | Altretamine perturbation in hTERT-HPNE cell line |
| Cytarabine_A-172 | Cytarabine perturbation in A-172 cell line |
| Sonidegib_NCI-H1792 | Sonidegib perturbation in NCI-H1792 cell line |
| Meloxicam_SW 900 | Meloxicam perturbation in SW 900 cell line |
| Balsalazide (sodium hydrate)_NCI-H1792 | Balsalazide (sodium hydrate) perturbation in NCI-H1792 cell line |
| Pemigatinib_SK-MEL-2 | Pemigatinib perturbation in SK-MEL-2 cell line |
| Carbidopa (monohydrate)_CFPAC-1 | Carbidopa (monohydrate) perturbation in CFPAC-1 cell line |
| Daidzin_J82 | Daidzin perturbation in J82 cell line |
| Voriconazole_SW 900 | Voriconazole perturbation in SW 900 cell line |
| Furosemide_A-172 | Furosemide perturbation in A-172 cell line |
| Diphenhydramine_NCI-H1792 | Diphenhydramine perturbation in NCI-H1792 cell line |
| Doxorubicin (hydrochloride)_SNU-423 | Doxorubicin (hydrochloride) perturbation in SNU-423 cell line |
| Tetracycline (hydrochloride)_A498 | Tetracycline (hydrochloride) perturbation in A498 cell line |
| Lapatinib ditosylate_A-172 | Lapatinib ditosylate perturbation in A-172 cell line |
| Rucaparib (phosphate)_NCI-H1792 | Rucaparib (phosphate) perturbation in NCI-H1792 cell line |
| Posaconazole_A-172 | Posaconazole perturbation in A-172 cell line |
| Sildenafil_LOX-IMVI | Sildenafil perturbation in LOX-IMVI cell line |
| Pyridoxine (hydrochloride)_SNU-423 | Pyridoxine (hydrochloride) perturbation in SNU-423 cell line |
| Terfenadine_A498 | Terfenadine perturbation in A498 cell line |
| Resveratrol_NCI-H2347 | Resveratrol perturbation in NCI-H2347 cell line |
| Saquinavir_SW 900 | Saquinavir perturbation in SW 900 cell line |
| Cysteamine (hydrochloride)_HOP62 | Cysteamine (hydrochloride) perturbation in HOP62 cell line |
| LJI308_A-172 | LJI308 perturbation in A-172 cell line |
| Brimonidine_SNU-423 | Brimonidine perturbation in SNU-423 cell line |
| Tetracycline (hydrochloride)_SW 900 | Tetracycline (hydrochloride) perturbation in SW 900 cell line |
| Trimetrexate_A-172 | Trimetrexate perturbation in A-172 cell line |
| Arbutin_A498 | Arbutin perturbation in A498 cell line |
| Dapagliflozin_H4 | Dapagliflozin perturbation in H4 cell line |
| Sulfisoxazole_J82 | Sulfisoxazole perturbation in J82 cell line |
| Clobetasol propionate_SW1417 | Clobetasol propionate perturbation in SW1417 cell line |
| Palmatine (chloride)_CFPAC-1 | Palmatine (chloride) perturbation in CFPAC-1 cell line |
| Irinotecan (hydrochloride)_J82 | Irinotecan (hydrochloride) perturbation in J82 cell line |
| Voriconazole_A498 | Voriconazole perturbation in A498 cell line |
| EX229_RPMI-7951 | EX229 perturbation in RPMI-7951 cell line |
| Fenofibrate_hTERT-HPNE | Fenofibrate perturbation in hTERT-HPNE cell line |
| AT7519_COLO 205 | AT7519 perturbation in COLO 205 cell line |
| Abiraterone acetate_SNU-423 | Abiraterone acetate perturbation in SNU-423 cell line |
| Meloxicam_A498 | Meloxicam perturbation in A498 cell line |
| Cysteamine (hydrochloride)_SNU-423 | Cysteamine (hydrochloride) perturbation in SNU-423 cell line |
| Benztropine (mesylate)_NCI-H1792 | Benztropine (mesylate) perturbation in NCI-H1792 cell line |
| Bisoprolol (hemifumarate)_NCI-H1792 | Bisoprolol (hemifumarate) perturbation in NCI-H1792 cell line |
| Vismodegib_A498 | Vismodegib perturbation in A498 cell line |
| Carbidopa (monohydrate)_SNU-423 | Carbidopa (monohydrate) perturbation in SNU-423 cell line |
| Cobimetinib_LOX-IMVI | Cobimetinib perturbation in LOX-IMVI cell line |
| Megestrol_A-172 | Megestrol perturbation in A-172 cell line |
| XRK3F2_Hs 766T | XRK3F2 perturbation in Hs 766T cell line |
| Diphenhydramine_J82 | Diphenhydramine perturbation in J82 cell line |
| Flutamide_A-172 | Flutamide perturbation in A-172 cell line |
| Mifepristone_SW 900 | Mifepristone perturbation in SW 900 cell line |
| Penfluridol_Hs 766T | Penfluridol perturbation in Hs 766T cell line |
| Nevirapine_SNU-423 | Nevirapine perturbation in SNU-423 cell line |
| crizotinib_A-172 | crizotinib perturbation in A-172 cell line |
| LB-100_NCI-H661 | LB-100 perturbation in NCI-H661 cell line |
| Balsalazide (sodium hydrate)_J82 | Balsalazide (sodium hydrate) perturbation in J82 cell line |
| Filgotinib_H4 | Filgotinib perturbation in H4 cell line |
| Volasertib_A-172 | Volasertib perturbation in A-172 cell line |
| Sonidegib_J82 | Sonidegib perturbation in J82 cell line |
| 18β-Glycyrrhetinic acid_A-172 | 18β-Glycyrrhetinic acid perturbation in A-172 cell line |
| Trametinib (DMSO_A-172 | Trametinib (DMSO perturbation in A-172 cell line |
| Tranilast_A498 | Tranilast perturbation in A498 cell line |
| NG25_A498 | NG25 perturbation in A498 cell line |
| Tolmetin_J82 | Tolmetin perturbation in J82 cell line |
| 5-Fluorouracil_A-172 | 5-Fluorouracil perturbation in A-172 cell line |
| Methotrexate_NCI-H1792 | Methotrexate perturbation in NCI-H1792 cell line |
| Idoxuridine_A-172 | Idoxuridine perturbation in A-172 cell line |
| Carbamazepine_SNU-423 | Carbamazepine perturbation in SNU-423 cell line |
| Ligustrazine_A498 | Ligustrazine perturbation in A498 cell line |
| Valdecoxib_SNU-423 | Valdecoxib perturbation in SNU-423 cell line |
| Pravastatin (sodium)_A-172 | Pravastatin (sodium) perturbation in A-172 cell line |
| Homoharringtonine_A498 | Homoharringtonine perturbation in A498 cell line |
| Selinexor _J82 | Selinexor perturbation in J82 cell line |
| Rapamycin_A-172 | Rapamycin perturbation in A-172 cell line |
| Diphenhydramine_NCI-H2347 | Diphenhydramine perturbation in NCI-H2347 cell line |
| Relugolix_Hs 766T | Relugolix perturbation in Hs 766T cell line |
| Uridine_NCI-H1792 | Uridine perturbation in NCI-H1792 cell line |
| Digitoxin_SNU-423 | Digitoxin perturbation in SNU-423 cell line |
| Bexarotene_SW 900 | Bexarotene perturbation in SW 900 cell line |
| Amsacrine_A-172 | Amsacrine perturbation in A-172 cell line |
| Idarubicin (hydrochloride)_RPMI-7951 | Idarubicin (hydrochloride) perturbation in RPMI-7951 cell line |
| Roxadustat_A498 | Roxadustat perturbation in A498 cell line |
| Methylprednisolone succinate_SNU-423 | Methylprednisolone succinate perturbation in SNU-423 cell line |
| Larotrectinib sulfate_SW 900 | Larotrectinib sulfate perturbation in SW 900 cell line |
| Sonidegib_NCI-H2347 | Sonidegib perturbation in NCI-H2347 cell line |
| Lenalidomide (hemihydrate)_SW 900 | Lenalidomide (hemihydrate) perturbation in SW 900 cell line |
| TAK-733_hTERT-HPNE | TAK-733 perturbation in hTERT-HPNE cell line |
| Edoxaban (tosylate monohydrate)_A-172 | Edoxaban (tosylate monohydrate) perturbation in A-172 cell line |
| Idarubicin (hydrochloride)_hTERT-HPNE | Idarubicin (hydrochloride) perturbation in hTERT-HPNE cell line |
| Retinoic acid_hTERT-HPNE | Retinoic acid perturbation in hTERT-HPNE cell line |
| Dapagliflozin_hTERT-HPNE | Dapagliflozin perturbation in hTERT-HPNE cell line |
| Sulfatinib_HepG2/C3A | Sulfatinib perturbation in HepG2/C3A cell line |
| Orlistat_SNU-423 | Orlistat perturbation in SNU-423 cell line |
| Vandetanib_A-172 | Vandetanib perturbation in A-172 cell line |
| Gallic acid_SNU-423 | Gallic acid perturbation in SNU-423 cell line |
| Artemether_SW 900 | Artemether perturbation in SW 900 cell line |
| Cobimetinib_J82 | Cobimetinib perturbation in J82 cell line |
| Folic acid_A498 | Folic acid perturbation in A498 cell line |
| Fenofibrate_H4 | Fenofibrate perturbation in H4 cell line |
| Allantoin_J82 | Allantoin perturbation in J82 cell line |
| Rucaparib (phosphate)_LOX-IMVI | Rucaparib (phosphate) perturbation in LOX-IMVI cell line |
| TAK-901_NCI-H1792 | TAK-901 perturbation in NCI-H1792 cell line |
| Apalutamide_NCI-H2347 | Apalutamide perturbation in NCI-H2347 cell line |
| Sapanisertib_J82 | Sapanisertib perturbation in J82 cell line |
| Entecavir (monohydrate)_RPMI-7951 | Entecavir (monohydrate) perturbation in RPMI-7951 cell line |
| 8-Hydroxyquinoline_LOX-IMVI | 8-Hydroxyquinoline perturbation in LOX-IMVI cell line |
| LY-2584702 (tosylate salt)_hTERT-HPNE | LY-2584702 (tosylate salt) perturbation in hTERT-HPNE cell line |
| Darinaparsin_J82 | Darinaparsin perturbation in J82 cell line |
| Rimonabant_SW 900 | Rimonabant perturbation in SW 900 cell line |
| Methotrexate_J82 | Methotrexate perturbation in J82 cell line |
| Auranofin_H4 | Auranofin perturbation in H4 cell line |
| Neratinib (maleate)_SW 900 | Neratinib (maleate) perturbation in SW 900 cell line |
| Decitabine_SW 1088 | Decitabine perturbation in SW 1088 cell line |
| Canagliflozin_HepG2/C3A | Canagliflozin perturbation in HepG2/C3A cell line |
| Resveratrol_J82 | Resveratrol perturbation in J82 cell line |
| Dorzolamide (hydrochloride)_RPMI-7951 | Dorzolamide (hydrochloride) perturbation in RPMI-7951 cell line |
| Pioglitazone_COLO 205 | Pioglitazone perturbation in COLO 205 cell line |
| Tirabrutinib_COLO 205 | Tirabrutinib perturbation in COLO 205 cell line |
| Thymopentin_H4 | Thymopentin perturbation in H4 cell line |
| Fingolimod (hydrochloride)_A-172 | Fingolimod (hydrochloride) perturbation in A-172 cell line |
| Ixazomib_A498 | Ixazomib perturbation in A498 cell line |
| Larotrectinib sulfate_A498 | Larotrectinib sulfate perturbation in A498 cell line |
| Roxadustat_SW 900 | Roxadustat perturbation in SW 900 cell line |
| Methyl aminolevulinate (hydrochloride)_A-172 | Methyl aminolevulinate (hydrochloride) perturbation in A-172 cell line |
| Sildenafil_J82 | Sildenafil perturbation in J82 cell line |
| Thymol_RPMI-7951 | Thymol perturbation in RPMI-7951 cell line |
| Bexarotene_A498 | Bexarotene perturbation in A498 cell line |
| Indacaterol (maleate)_J82 | Indacaterol (maleate) perturbation in J82 cell line |
| Larotrectinib_A498 | Larotrectinib perturbation in A498 cell line |
| Sivelestat (sodium tetrahydrate)_C32 | Sivelestat (sodium tetrahydrate) perturbation in C32 cell line |
| Dapagliflozin ((2S)-1,2-propanediol, hydrate)_SNU-423 | Dapagliflozin ((2S)-1,2-propanediol, hydrate) perturbation in SNU-423 cell line |
| LY-2584702 (tosylate salt)_RPMI-7951 | LY-2584702 (tosylate salt) perturbation in RPMI-7951 cell line |
| Nevirapine_NCI-H2347 | Nevirapine perturbation in NCI-H2347 cell line |
| Cytarabine_RPMI-7951 | Cytarabine perturbation in RPMI-7951 cell line |
| Valdecoxib_J82 | Valdecoxib perturbation in J82 cell line |
| Sivelestat (sodium tetrahydrate)_A498 | Sivelestat (sodium tetrahydrate) perturbation in A498 cell line |
| Econazole_A-172 | Econazole perturbation in A-172 cell line |
| Carbamazepine_J82 | Carbamazepine perturbation in J82 cell line |
| Dapagliflozin_A549 | Dapagliflozin perturbation in A549 cell line |
| Tadalafil_A498 | Tadalafil perturbation in A498 cell line |
| Selinexor _SNU-423 | Selinexor perturbation in SNU-423 cell line |
| Imiquimod (maleate)_J82 | Imiquimod (maleate) perturbation in J82 cell line |
| Baicalin_A-172 | Baicalin perturbation in A-172 cell line |
| Digitoxin_J82 | Digitoxin perturbation in J82 cell line |
| Citalopram (hydrobromide)_SNU-423 | Citalopram (hydrobromide) perturbation in SNU-423 cell line |
| Topotecan (hydrochloride)_A498 | Topotecan (hydrochloride) perturbation in A498 cell line |
| Glycyrrhizic acid_A498 | Glycyrrhizic acid perturbation in A498 cell line |
| AT7519_Hs 766T | AT7519 perturbation in Hs 766T cell line |
| Flumatinib (mesylate)_hTERT-HPNE | Flumatinib (mesylate) perturbation in hTERT-HPNE cell line |
| Thymopentin_A-172 | Thymopentin perturbation in A-172 cell line |
| Posaconazole_RPMI-7951 | Posaconazole perturbation in RPMI-7951 cell line |
| Binimetinib_A-172 | Binimetinib perturbation in A-172 cell line |
| Orlistat_J82 | Orlistat perturbation in J82 cell line |
| Plicamycin_COLO 205 | Plicamycin perturbation in COLO 205 cell line |
| Tofacitinib (citrate)_SW 900 | Tofacitinib (citrate) perturbation in SW 900 cell line |
| GSK1059615_J82 | GSK1059615 perturbation in J82 cell line |
| Glasdegib_A498 | Glasdegib perturbation in A498 cell line |
| Auranofin_A-172 | Auranofin perturbation in A-172 cell line |
| Altretamine_A-172 | Altretamine perturbation in A-172 cell line |
| Cytarabine_hTERT-HPNE | Cytarabine perturbation in hTERT-HPNE cell line |
| Hydroxyfasudil_A498 | Hydroxyfasudil perturbation in A498 cell line |
| Artemether_C32 | Artemether perturbation in C32 cell line |
| Encorafenib_SW 900 | Encorafenib perturbation in SW 900 cell line |
| Digitoxin_NCI-H1792 | Digitoxin perturbation in NCI-H1792 cell line |
| Ropivacaine (hydrochloride monohydrate)_A-172 | Ropivacaine (hydrochloride monohydrate) perturbation in A-172 cell line |
| Regorafenib_hTERT-HPNE | Regorafenib perturbation in hTERT-HPNE cell line |
| Fostamatinib (disodium hexahydrate)_A498 | Fostamatinib (disodium hexahydrate) perturbation in A498 cell line |
| Imiquimod (maleate)_NCI-H1792 | Imiquimod (maleate) perturbation in NCI-H1792 cell line |
| Sapanisertib_SNU-423 | Sapanisertib perturbation in SNU-423 cell line |
| Entrectinib_NCI-H2347 | Entrectinib perturbation in NCI-H2347 cell line |
| Fenofibrate_A-172 | Fenofibrate perturbation in A-172 cell line |
| Darinaparsin_SNU-423 | Darinaparsin perturbation in SNU-423 cell line |
| Resveratrol_HOP62 | Resveratrol perturbation in HOP62 cell line |
| Omeprazole (sodium)_SW 1088 | Omeprazole (sodium) perturbation in SW 1088 cell line |
| Resveratrol_SNU-423 | Resveratrol perturbation in SNU-423 cell line |
| Pyridoxine (hydrochloride)_NCI-H2347 | Pyridoxine (hydrochloride) perturbation in NCI-H2347 cell line |
| Methotrexate_SNU-423 | Methotrexate perturbation in SNU-423 cell line |
| crizotinib_RPMI-7951 | crizotinib perturbation in RPMI-7951 cell line |
| Carbamazepine_NCI-H1792 | Carbamazepine perturbation in NCI-H1792 cell line |
| Ponatinib_A-172 | Ponatinib perturbation in A-172 cell line |
| Medroxyprogesterone acetate_COLO 205 | Medroxyprogesterone acetate perturbation in COLO 205 cell line |
| Delamanid_J82 | Delamanid perturbation in J82 cell line |
| Uridine_SNU-423 | Uridine perturbation in SNU-423 cell line |
| Gallic acid_NCI-H1792 | Gallic acid perturbation in NCI-H1792 cell line |
| crizotinib_hTERT-HPNE | crizotinib perturbation in hTERT-HPNE cell line |
| Pexidartinib (hydrochloride)_A-172 | Pexidartinib (hydrochloride) perturbation in A-172 cell line |
| Cilostazol_LOX-IMVI | Cilostazol perturbation in LOX-IMVI cell line |
| Ralimetinib dimesylate_A-172 | Ralimetinib dimesylate perturbation in A-172 cell line |
| Trametinib_LOX-IMVI | Trametinib perturbation in LOX-IMVI cell line |
| Trametinib (DMSO_hTERT-HPNE | Trametinib (DMSO perturbation in hTERT-HPNE cell line |
| Penfluridol_SW 1088 | Penfluridol perturbation in SW 1088 cell line |
| Bimiralisib_Hs 766T | Bimiralisib perturbation in Hs 766T cell line |
| Trimetrexate_RPMI-7951 | Trimetrexate perturbation in RPMI-7951 cell line |
| Regorafenib_RPMI-7951 | Regorafenib perturbation in RPMI-7951 cell line |
| (R)-Verapamil (hydrochloride)_SW 900 | (R)-Verapamil (hydrochloride) perturbation in SW 900 cell line |
| Acetohexamide_HepG2/C3A | Acetohexamide perturbation in HepG2/C3A cell line |
| EX229_A-172 | EX229 perturbation in A-172 cell line |
| Neratinib_HOP62 | Neratinib perturbation in HOP62 cell line |
| Orlistat_NCI-H1792 | Orlistat perturbation in NCI-H1792 cell line |
| Bestatin_A-172 | Bestatin perturbation in A-172 cell line |
| Sildenafil_HOP62 | Sildenafil perturbation in HOP62 cell line |
| Flutamide_hTERT-HPNE | Flutamide perturbation in hTERT-HPNE cell line |
| Tadalafil_SW 900 | Tadalafil perturbation in SW 900 cell line |
| Vortioxetine_H4 | Vortioxetine perturbation in H4 cell line |
| Pitavastatin (Calcium)_SNU-423 | Pitavastatin (Calcium) perturbation in SNU-423 cell line |
| Ixazomib citrate_A498 | Ixazomib citrate perturbation in A498 cell line |
| Idoxuridine_NCI-H661 | Idoxuridine perturbation in NCI-H661 cell line |
| Bexarotene_NCI-H2122 | Bexarotene perturbation in NCI-H2122 cell line |
| Sivelestat (sodium tetrahydrate)_SW 900 | Sivelestat (sodium tetrahydrate) perturbation in SW 900 cell line |
| Dapagliflozin ((2S)-1,2-propanediol, hydrate)_J82 | Dapagliflozin ((2S)-1,2-propanediol, hydrate) perturbation in J82 cell line |
| Adenosine_NCI-H1792 | Adenosine perturbation in NCI-H1792 cell line |
| Cinacalcet_A-172 | Cinacalcet perturbation in A-172 cell line |
| ULK-101_J82 | ULK-101 perturbation in J82 cell line |
| Fluvoxamine_A-172 | Fluvoxamine perturbation in A-172 cell line |
| Elimusertib hydrochloride_COLO 205 | Elimusertib hydrochloride perturbation in COLO 205 cell line |
| Ligustrazine_SNU-423 | Ligustrazine perturbation in SNU-423 cell line |
| Sivelestat (sodium tetrahydrate)_J82 | Sivelestat (sodium tetrahydrate) perturbation in J82 cell line |
| Valdecoxib_A498 | Valdecoxib perturbation in A498 cell line |
| Carbamazepine_A498 | Carbamazepine perturbation in A498 cell line |
| Dapagliflozin ((2S)-1,2-propanediol, hydrate)_SW 900 | Dapagliflozin ((2S)-1,2-propanediol, hydrate) perturbation in SW 900 cell line |
| AZD2858_SW 900 | AZD2858 perturbation in SW 900 cell line |
| Cytarabine (hydrochloride)_A-172 | Cytarabine (hydrochloride) perturbation in A-172 cell line |
| Infigratinib_NCI-H2347 | Infigratinib perturbation in NCI-H2347 cell line |
| Bicalutamide_A-172 | Bicalutamide perturbation in A-172 cell line |
| Almonertinib (mesylate)_A-172 | Almonertinib (mesylate) perturbation in A-172 cell line |
| Relugolix_HS-578T | Relugolix perturbation in HS-578T cell line |
| Ciclopirox_SNU-423 | Ciclopirox perturbation in SNU-423 cell line |
| Monocrotaline_SNU-423 | Monocrotaline perturbation in SNU-423 cell line |
| (R)-Verapamil (hydrochloride)_KATO III | (R)-Verapamil (hydrochloride) perturbation in KATO III cell line |
| Methylthiouracil_NCI-H1792 | Methylthiouracil perturbation in NCI-H1792 cell line |
| Tadalafil_J82 | Tadalafil perturbation in J82 cell line |
| Digitoxin_A498 | Digitoxin perturbation in A498 cell line |
| Canagliflozin_RPMI-7951 | Canagliflozin perturbation in RPMI-7951 cell line |
| Oxaprozin_J82 | Oxaprozin perturbation in J82 cell line |
| Imiquimod (maleate)_A498 | Imiquimod (maleate) perturbation in A498 cell line |
| Dimethyl fumarate_hTERT-HPNE | Dimethyl fumarate perturbation in hTERT-HPNE cell line |
| Vinblastine (sulfate)_CFPAC-1 | Vinblastine (sulfate) perturbation in CFPAC-1 cell line |
| Rosiglitazone_HOP62 | Rosiglitazone perturbation in HOP62 cell line |
| Glycyrrhizic acid_J82 | Glycyrrhizic acid perturbation in J82 cell line |
| Topotecan (hydrochloride)_J82 | Topotecan (hydrochloride) perturbation in J82 cell line |
| Bentamapimod_J82 | Bentamapimod perturbation in J82 cell line |
| PH-797804_SW 900 | PH-797804 perturbation in SW 900 cell line |
| Canagliflozin_hTERT-HPNE | Canagliflozin perturbation in hTERT-HPNE cell line |
| Nimesulide_A-172 | Nimesulide perturbation in A-172 cell line |
| Clofarabine_SNU-423 | Clofarabine perturbation in SNU-423 cell line |
| Orlistat_A498 | Orlistat perturbation in A498 cell line |
| Neratinib (maleate)_SNU-423 | Neratinib (maleate) perturbation in SNU-423 cell line |
| Glasdegib_J82 | Glasdegib perturbation in J82 cell line |
| Dihydroartemisinin_hTERT-HPNE | Dihydroartemisinin perturbation in hTERT-HPNE cell line |
| Menadione_J82 | Menadione perturbation in J82 cell line |
| Gallic acid_A498 | Gallic acid perturbation in A498 cell line |
| Hexylresorcinol_NCI-H2347 | Hexylresorcinol perturbation in NCI-H2347 cell line |
| Berbamine (dihydrochloride)_NCI-H1792 | Berbamine (dihydrochloride) perturbation in NCI-H1792 cell line |
| Clobetasol propionate_HS-578T | Clobetasol propionate perturbation in HS-578T cell line |
| Phenylephrine (hydrochloride)_A-172 | Phenylephrine (hydrochloride) perturbation in A-172 cell line |
| Olanzapine_SNU-423 | Olanzapine perturbation in SNU-423 cell line |
| Oxaprozin_NCI-H1792 | Oxaprozin perturbation in NCI-H1792 cell line |
| Pentagastrin_RPMI-7951 | Pentagastrin perturbation in RPMI-7951 cell line |
| Glycyrrhizic acid_NCI-H1792 | Glycyrrhizic acid perturbation in NCI-H1792 cell line |
| Topotecan (hydrochloride)_NCI-H1792 | Topotecan (hydrochloride) perturbation in NCI-H1792 cell line |
| Lidocaine (hydrochloride)_NCI-H2347 | Lidocaine (hydrochloride) perturbation in NCI-H2347 cell line |
| Sivelestat (sodium tetrahydrate)_NCI-H1792 | Sivelestat (sodium tetrahydrate) perturbation in NCI-H1792 cell line |
| ULK-101_NCI-H1792 | ULK-101 perturbation in NCI-H1792 cell line |
| Allopurinol_A-172 | Allopurinol perturbation in A-172 cell line |
| Tirabrutinib_hTERT-HPNE | Tirabrutinib perturbation in hTERT-HPNE cell line |
| Sapanisertib_NCI-H2122 | Sapanisertib perturbation in NCI-H2122 cell line |
| Methylthiouracil_J82 | Methylthiouracil perturbation in J82 cell line |
| Tadalafil_NCI-H1792 | Tadalafil perturbation in NCI-H1792 cell line |
| Clobetasol propionate_A-172 | Clobetasol propionate perturbation in A-172 cell line |
| Delamanid_A498 | Delamanid perturbation in A498 cell line |
| Pioglitazone_RPMI-7951 | Pioglitazone perturbation in RPMI-7951 cell line |
| Clopidogrel_A-172 | Clopidogrel perturbation in A-172 cell line |
| RMC-6236_COLO 205 | RMC-6236 perturbation in COLO 205 cell line |
| (R)-Verapamil (hydrochloride)_NCI-H1792 | (R)-Verapamil (hydrochloride) perturbation in NCI-H1792 cell line |
| Tirabrutinib (hydrochloride)_A-172 | Tirabrutinib (hydrochloride) perturbation in A-172 cell line |
| Harringtonine_A498 | Harringtonine perturbation in A498 cell line |
| Bexarotene_LoVo | Bexarotene perturbation in LoVo cell line |
| Berbamine (dihydrochloride)_J82 | Berbamine (dihydrochloride) perturbation in J82 cell line |
| Relugolix_A-172 | Relugolix perturbation in A-172 cell line |
| L-Eflornithine (monohydrochloride)_A-172 | L-Eflornithine (monohydrochloride) perturbation in A-172 cell line |
| Almonertinib (mesylate)_HS-578T | Almonertinib (mesylate) perturbation in HS-578T cell line |
| Hydroxyfasudil_NCI-H1792 | Hydroxyfasudil perturbation in NCI-H1792 cell line |
| Bexarotene_MIA PaCa-2 | Bexarotene perturbation in MIA PaCa-2 cell line |
| Larotrectinib sulfate_SNU-423 | Larotrectinib sulfate perturbation in SNU-423 cell line |
| Thymol_COLO 205 | Thymol perturbation in COLO 205 cell line |
| 5-Azacytidine_A-172 | 5-Azacytidine perturbation in A-172 cell line |
| Imiquimod (maleate)_SW 900 | Imiquimod (maleate) perturbation in SW 900 cell line |
| Bexarotene_SNU-423 | Bexarotene perturbation in SNU-423 cell line |
| Omeprazole_A-172 | Omeprazole perturbation in A-172 cell line |
| Bexarotene_HOP62 | Bexarotene perturbation in HOP62 cell line |
| Cyclosporin A_hTERT-HPNE | Cyclosporin A perturbation in hTERT-HPNE cell line |
| Larotrectinib_SNU-423 | Larotrectinib perturbation in SNU-423 cell line |
| Ritonavir_COLO 205 | Ritonavir perturbation in COLO 205 cell line |
| Osimertinib (mesylate)_A498 | Osimertinib (mesylate) perturbation in A498 cell line |
| Menadione_NCI-H1792 | Menadione perturbation in NCI-H1792 cell line |
| Carbamazepine_SW 900 | Carbamazepine perturbation in SW 900 cell line |
| Ivermectin_A-172 | Ivermectin perturbation in A-172 cell line |
| Valdecoxib_SW 900 | Valdecoxib perturbation in SW 900 cell line |
| Verapamil_A-172 | Verapamil perturbation in A-172 cell line |
| Fluvoxamine (maleate)_J82 | Fluvoxamine (maleate) perturbation in J82 cell line |
| Verapamil_H4 | Verapamil perturbation in H4 cell line |
| Ligustrazine_J82 | Ligustrazine perturbation in J82 cell line |
| Acetohexamide_hTERT-HPNE | Acetohexamide perturbation in hTERT-HPNE cell line |
| Omeprazole (sodium)_RPMI-7951 | Omeprazole (sodium) perturbation in RPMI-7951 cell line |
| Pitavastatin (Calcium)_SW 900 | Pitavastatin (Calcium) perturbation in SW 900 cell line |
| Rosiglitazone_J82 | Rosiglitazone perturbation in J82 cell line |
| Megestrol_HepG2/C3A | Megestrol perturbation in HepG2/C3A cell line |
| Belumosudil_RPMI-7951 | Belumosudil perturbation in RPMI-7951 cell line |
| Megestrol_SW 1088 | Megestrol perturbation in SW 1088 cell line |
| Monocrotaline_J82 | Monocrotaline perturbation in J82 cell line |
| MK-8353_RPMI-7951 | MK-8353 perturbation in RPMI-7951 cell line |
| Omeprazole_H4 | Omeprazole perturbation in H4 cell line |
| (R)-Verapamil (hydrochloride)_SNU-423 | (R)-Verapamil (hydrochloride) perturbation in SNU-423 cell line |
| Indacaterol (maleate)_SW 900 | Indacaterol (maleate) perturbation in SW 900 cell line |
| Neratinib_SW 900 | Neratinib perturbation in SW 900 cell line |
| Roxadustat_J82 | Roxadustat perturbation in J82 cell line |
| Penfluridol_hTERT-HPNE | Penfluridol perturbation in hTERT-HPNE cell line |
| Fulvestrant_A-172 | Fulvestrant perturbation in A-172 cell line |
| Mitoxantrone (dihydrochloride)_SW 900 | Mitoxantrone (dihydrochloride) perturbation in SW 900 cell line |
| Oxaprozin_SNU-423 | Oxaprozin perturbation in SNU-423 cell line |
| XRK3F2_hTERT-HPNE | XRK3F2 perturbation in hTERT-HPNE cell line |
| Uridine_SW 900 | Uridine perturbation in SW 900 cell line |
| Penfluridol_RPMI-7951 | Penfluridol perturbation in RPMI-7951 cell line |
| Clofarabine_J82 | Clofarabine perturbation in J82 cell line |
| Menadione_SNU-423 | Menadione perturbation in SNU-423 cell line |
| Rimonabant_J82 | Rimonabant perturbation in J82 cell line |
| Simotinib_COLO 205 | Simotinib perturbation in COLO 205 cell line |
| Methotrexate_SW 900 | Methotrexate perturbation in SW 900 cell line |
| Tranilast_LOX-IMVI | Tranilast perturbation in LOX-IMVI cell line |
| Doxycycline (monohydrate)_HS-578T | Doxycycline (monohydrate) perturbation in HS-578T cell line |
| GSK1059615_NCI-H2122 | GSK1059615 perturbation in NCI-H2122 cell line |
| Cobimetinib_A498 | Cobimetinib perturbation in A498 cell line |
| Omeprazole (sodium)_hTERT-HPNE | Omeprazole (sodium) perturbation in hTERT-HPNE cell line |
| Darolutamide_NCI-H661 | Darolutamide perturbation in NCI-H661 cell line |
| Regorafenib_HepG2/C3A | Regorafenib perturbation in HepG2/C3A cell line |
| Larotrectinib sulfate_NCI-H1792 | Larotrectinib sulfate perturbation in NCI-H1792 cell line |
| Sapanisertib_SW 900 | Sapanisertib perturbation in SW 900 cell line |
| Tazarotene_J82 | Tazarotene perturbation in J82 cell line |
| Belumosudil_hTERT-HPNE | Belumosudil perturbation in hTERT-HPNE cell line |
| Tazarotene_KATO III | Tazarotene perturbation in KATO III cell line |
| Folic acid_J82 | Folic acid perturbation in J82 cell line |
| Bexarotene_NCI-H1792 | Bexarotene perturbation in NCI-H1792 cell line |
| Allantoin_SW 900 | Allantoin perturbation in SW 900 cell line |
| Roxadustat_NCI-H1792 | Roxadustat perturbation in NCI-H1792 cell line |
| Cytarabine_HepG2/C3A | Cytarabine perturbation in HepG2/C3A cell line |
| Cobimetinib_SW 900 | Cobimetinib perturbation in SW 900 cell line |
| Artesunate_NCI-H2347 | Artesunate perturbation in NCI-H2347 cell line |
| Pyridoxine_RPMI-7951 | Pyridoxine perturbation in RPMI-7951 cell line |
| Vinblastine (sulfate)_J82 | Vinblastine (sulfate) perturbation in J82 cell line |
| Rosiglitazone_NCI-H1792 | Rosiglitazone perturbation in NCI-H1792 cell line |
| Docetaxel (Trihydrate)_A498 | Docetaxel (Trihydrate) perturbation in A498 cell line |
| Ferulic acid_LOX-IMVI | Ferulic acid perturbation in LOX-IMVI cell line |
| Methotrexate_A498 | Methotrexate perturbation in A498 cell line |
| Orlistat_C32 | Orlistat perturbation in C32 cell line |
| Minodronic acid_A-172 | Minodronic acid perturbation in A-172 cell line |
| Tetracycline (hydrochloride)_NCI-H2347 | Tetracycline (hydrochloride) perturbation in NCI-H2347 cell line |
| Medroxyprogesterone acetate_RPMI-7951 | Medroxyprogesterone acetate perturbation in RPMI-7951 cell line |
| Methylthiouracil_SNU-423 | Methylthiouracil perturbation in SNU-423 cell line |
| Quinestrol_A-172 | Quinestrol perturbation in A-172 cell line |
| Fumaric acid_hTERT-HPNE | Fumaric acid perturbation in hTERT-HPNE cell line |
| Trimetrexate_COLO 205 | Trimetrexate perturbation in COLO 205 cell line |
| Folic acid_NCI-H1792 | Folic acid perturbation in NCI-H1792 cell line |
| Bexarotene_J82 | Bexarotene perturbation in J82 cell line |
| Simotinib_HepG2/C3A | Simotinib perturbation in HepG2/C3A cell line |
| Larotrectinib sulfate_J82 | Larotrectinib sulfate perturbation in J82 cell line |
| Medroxyprogesterone acetate_hTERT-HPNE | Medroxyprogesterone acetate perturbation in hTERT-HPNE cell line |
| Flumatinib (mesylate)_HepG2/C3A | Flumatinib (mesylate) perturbation in HepG2/C3A cell line |
| Neratinib_A498 | Neratinib perturbation in A498 cell line |
| Bexarotene_KATO III | Bexarotene perturbation in KATO III cell line |
| Crizotinib (hydrochloride)_SW 900 | Crizotinib (hydrochloride) perturbation in SW 900 cell line |
| γ-Oryzanol_A498 | γ-Oryzanol perturbation in A498 cell line |
| Bicalutamide_H4 | Bicalutamide perturbation in H4 cell line |
| Mozavaptan_hTERT-HPNE | Mozavaptan perturbation in hTERT-HPNE cell line |
| Binimetinib_Hs 766T | Binimetinib perturbation in Hs 766T cell line |
| Regorafenib_COLO 205 | Regorafenib perturbation in COLO 205 cell line |
| Macitentan_A549 | Macitentan perturbation in A549 cell line |
| Cytarabine (hydrochloride)_H4 | Cytarabine (hydrochloride) perturbation in H4 cell line |
| Fluvoxamine (maleate)_SNU-423 | Fluvoxamine (maleate) perturbation in SNU-423 cell line |
| Neratinib (maleate)_NCI-H1792 | Neratinib (maleate) perturbation in NCI-H1792 cell line |
| Temsirolimus_A-172 | Temsirolimus perturbation in A-172 cell line |
| Mifepristone_NCI-H2347 | Mifepristone perturbation in NCI-H2347 cell line |
| Lucanthone_HepG2/C3A | Lucanthone perturbation in HepG2/C3A cell line |
| Fluvoxamine_H4 | Fluvoxamine perturbation in H4 cell line |
| Pyridoxine_hTERT-HPNE | Pyridoxine perturbation in hTERT-HPNE cell line |
| Sulfatinib_NCI-H1792 | Sulfatinib perturbation in NCI-H1792 cell line |
| Docetaxel_NCI-H1792 | Docetaxel perturbation in NCI-H1792 cell line |
| Mifepristone_A-172 | Mifepristone perturbation in A-172 cell line |
| Pentoxifylline_RPMI-7951 | Pentoxifylline perturbation in RPMI-7951 cell line |
| Fusidic acid_A498 | Fusidic acid perturbation in A498 cell line |
| XRK3F2_HOP62 | XRK3F2 perturbation in HOP62 cell line |
| Tirabrutinib_NCI-H1792 | Tirabrutinib perturbation in NCI-H1792 cell line |
| Tadalafil_hTERT-HPNE | Tadalafil perturbation in hTERT-HPNE cell line |
| Lucanthone_A498 | Lucanthone perturbation in A498 cell line |
| Flutamide_SW 900 | Flutamide perturbation in SW 900 cell line |
| Raltitrexed_Hs 766T | Raltitrexed perturbation in Hs 766T cell line |
| Belinostat_A-172 | Belinostat perturbation in A-172 cell line |
| Allantoin_COLO 205 | Allantoin perturbation in COLO 205 cell line |
| Tucidinostat_SW 900 | Tucidinostat perturbation in SW 900 cell line |
| Ferulic acid_A-172 | Ferulic acid perturbation in A-172 cell line |
| Nevirapine_Hs 766T | Nevirapine perturbation in Hs 766T cell line |
| Topotecan (hydrochloride)_hTERT-HPNE | Topotecan (hydrochloride) perturbation in hTERT-HPNE cell line |
| Simotinib_A498 | Simotinib perturbation in A498 cell line |
| Levobupivacaine (hydrochloride)_A498 | Levobupivacaine (hydrochloride) perturbation in A498 cell line |
| Menadione_RPMI-7951 | Menadione perturbation in RPMI-7951 cell line |
| Ouabain (Octahydrate)_SW 900 | Ouabain (Octahydrate) perturbation in SW 900 cell line |
| crizotinib_SW 900 | crizotinib perturbation in SW 900 cell line |
| Trimetrexate_SW 900 | Trimetrexate perturbation in SW 900 cell line |
| Citalopram (hydrobromide)_COLO 205 | Citalopram (hydrobromide) perturbation in COLO 205 cell line |
| Bexarotene_SW480 | Bexarotene perturbation in SW480 cell line |
| Tetracycline (hydrochloride)_A-172 | Tetracycline (hydrochloride) perturbation in A-172 cell line |
| Docetaxel (Trihydrate)_HepG2/C3A | Docetaxel (Trihydrate) perturbation in HepG2/C3A cell line |
| Meloxicam_HS-578T | Meloxicam perturbation in HS-578T cell line |
| Decitabine_J82 | Decitabine perturbation in J82 cell line |
| Glasdegib_hTERT-HPNE | Glasdegib perturbation in hTERT-HPNE cell line |
| Terfenadine_A-172 | Terfenadine perturbation in A-172 cell line |
| Mebendazole_NCI-H1792 | Mebendazole perturbation in NCI-H1792 cell line |
| Sivelestat (sodium tetrahydrate)_RPMI-7951 | Sivelestat (sodium tetrahydrate) perturbation in RPMI-7951 cell line |
| Zileuton_NCI-H1792 | Zileuton perturbation in NCI-H1792 cell line |
| Artesunate_A-172 | Artesunate perturbation in A-172 cell line |
| Omeprazole (sodium)_SNU-423 | Omeprazole (sodium) perturbation in SNU-423 cell line |
| Imiquimod (hydrochloride)_NCI-H1792 | Imiquimod (hydrochloride) perturbation in NCI-H1792 cell line |
| Pioglitazone_NCI-H1792 | Pioglitazone perturbation in NCI-H1792 cell line |
| Paclitaxel_Hs 766T | Paclitaxel perturbation in Hs 766T cell line |
| c-Kit-IN-1_A-172 | c-Kit-IN-1 perturbation in A-172 cell line |
| Belumosudil_SNU-423 | Belumosudil perturbation in SNU-423 cell line |
| Crizotinib (hydrochloride)_COLO 205 | Crizotinib (hydrochloride) perturbation in COLO 205 cell line |
| Voriconazole_A-172 | Voriconazole perturbation in A-172 cell line |
| MK-3903_A-172 | MK-3903 perturbation in A-172 cell line |
| Regorafenib_A498 | Regorafenib perturbation in A498 cell line |
| Daidzin_NCI-H596 | Daidzin perturbation in NCI-H596 cell line |
| Erlotinib_RPMI-7951 | Erlotinib perturbation in RPMI-7951 cell line |
| Dimethyl fumarate_NCI-H1792 | Dimethyl fumarate perturbation in NCI-H1792 cell line |
| Fluvoxamine (maleate)_RPMI-7951 | Fluvoxamine (maleate) perturbation in RPMI-7951 cell line |
| Lidocaine (hydrochloride)_NCI-H661 | Lidocaine (hydrochloride) perturbation in NCI-H661 cell line |
| Trametinib_Hs 766T | Trametinib perturbation in Hs 766T cell line |
| palbociclib_A-172 | palbociclib perturbation in A-172 cell line |
| Bexarotene_A549 | Bexarotene perturbation in A549 cell line |
| Cytarabine_SW 900 | Cytarabine perturbation in SW 900 cell line |
| Larotrectinib sulfate_A549 | Larotrectinib sulfate perturbation in A549 cell line |
| Tirabrutinib_J82 | Tirabrutinib perturbation in J82 cell line |
| Posaconazole_SW 900 | Posaconazole perturbation in SW 900 cell line |
| Sulfatinib_J82 | Sulfatinib perturbation in J82 cell line |
| Anastrozole_SW 900 | Anastrozole perturbation in SW 900 cell line |
| Verteporfin_H4 | Verteporfin perturbation in H4 cell line |
| Neratinib_COLO 205 | Neratinib perturbation in COLO 205 cell line |
| Mitoxantrone (dihydrochloride)_COLO 205 | Mitoxantrone (dihydrochloride) perturbation in COLO 205 cell line |
| Arbutin_A-172 | Arbutin perturbation in A-172 cell line |
| Atazanavir (sulfate)_hTERT-HPNE | Atazanavir (sulfate) perturbation in hTERT-HPNE cell line |
| Methylthiouracil_hTERT-HPNE | Methylthiouracil perturbation in hTERT-HPNE cell line |
| Aprepitant_A-172 | Aprepitant perturbation in A-172 cell line |
| Imiquimod (hydrochloride)_J82 | Imiquimod (hydrochloride) perturbation in J82 cell line |
| Flumatinib (mesylate)_SW 900 | Flumatinib (mesylate) perturbation in SW 900 cell line |
| Tolcapone_A-172 | Tolcapone perturbation in A-172 cell line |
| Berbamine (dihydrochloride)_hTERT-HPNE | Berbamine (dihydrochloride) perturbation in hTERT-HPNE cell line |
| Resveratrol_COLO 205 | Resveratrol perturbation in COLO 205 cell line |
| Fumaric acid_SNU-423 | Fumaric acid perturbation in SNU-423 cell line |
| vincristine_A-172 | vincristine perturbation in A-172 cell line |
| Tofacitinib (citrate)_RPMI-7951 | Tofacitinib (citrate) perturbation in RPMI-7951 cell line |
| Mifepristone_HS-578T | Mifepristone perturbation in HS-578T cell line |
| Atazanavir (sulfate)_RPMI-7951 | Atazanavir (sulfate) perturbation in RPMI-7951 cell line |
| Medroxyprogesterone acetate_SNU-423 | Medroxyprogesterone acetate perturbation in SNU-423 cell line |
| Pioglitazone_J82 | Pioglitazone perturbation in J82 cell line |
| Rifaximin_A498 | Rifaximin perturbation in A498 cell line |
| Sapanisertib_COLO 205 | Sapanisertib perturbation in COLO 205 cell line |
| Megestrol_A498 | Megestrol perturbation in A498 cell line |
| Cyclosporin A_J82 | Cyclosporin A perturbation in J82 cell line |
| Erlotinib_hTERT-HPNE | Erlotinib perturbation in hTERT-HPNE cell line |
| Fusidic acid_SW 900 | Fusidic acid perturbation in SW 900 cell line |
| Ixazomib citrate_hTERT-HPNE | Ixazomib citrate perturbation in hTERT-HPNE cell line |
| Crizotinib (hydrochloride)_HepG2/C3A | Crizotinib (hydrochloride) perturbation in HepG2/C3A cell line |
| Pentagastrin_J82 | Pentagastrin perturbation in J82 cell line |
| Peretinoin_SNU-423 | Peretinoin perturbation in SNU-423 cell line |
| Dihydroartemisinin_NCI-H1792 | Dihydroartemisinin perturbation in NCI-H1792 cell line |
| Decitabine_NCI-H1792 | Decitabine perturbation in NCI-H1792 cell line |
| Nevirapine_NCI-H596 | Nevirapine perturbation in NCI-H596 cell line |
| Adagrasib_A-172 | Adagrasib perturbation in A-172 cell line |
| Rosiglitazone_hTERT-HPNE | Rosiglitazone perturbation in hTERT-HPNE cell line |
| (S)-Crizotinib_NCI-H1792 | (S)-Crizotinib perturbation in NCI-H1792 cell line |
| Gallic acid_COLO 205 | Gallic acid perturbation in COLO 205 cell line |
| Isocorydine_NCI-H1792 | Isocorydine perturbation in NCI-H1792 cell line |
| Ligustrazine_hTERT-HPNE | Ligustrazine perturbation in hTERT-HPNE cell line |
| Homoharringtonine_hTERT-HPNE | Homoharringtonine perturbation in hTERT-HPNE cell line |
| Monocrotaline_hTERT-HPNE | Monocrotaline perturbation in hTERT-HPNE cell line |
| Omeprazole_NCI-H2347 | Omeprazole perturbation in NCI-H2347 cell line |
| Entecavir (monohydrate)_SW 900 | Entecavir (monohydrate) perturbation in SW 900 cell line |
| Orlistat_COLO 205 | Orlistat perturbation in COLO 205 cell line |
| Penfluridol_J82 | Penfluridol perturbation in J82 cell line |
| Roxadustat_hTERT-HPNE | Roxadustat perturbation in hTERT-HPNE cell line |
| ML264_A-172 | ML264 perturbation in A-172 cell line |
| Fedratinib (hydrochloride hydrate)_A-172 | Fedratinib (hydrochloride hydrate) perturbation in A-172 cell line |
| Neratinib (maleate)_RPMI-7951 | Neratinib (maleate) perturbation in RPMI-7951 cell line |
| Dimethyl fumarate_SNU-423 | Dimethyl fumarate perturbation in SNU-423 cell line |
| Aspirin_J82 | Aspirin perturbation in J82 cell line |
| Ataluren_A-172 | Ataluren perturbation in A-172 cell line |
| Clobetasol propionate_LOX-IMVI | Clobetasol propionate perturbation in LOX-IMVI cell line |
| Ornidazole_hTERT-HPNE | Ornidazole perturbation in hTERT-HPNE cell line |
| Thymol_SW 900 | Thymol perturbation in SW 900 cell line |
| Dapagliflozin_A498 | Dapagliflozin perturbation in A498 cell line |
| BI-78D3_A-172 | BI-78D3 perturbation in A-172 cell line |
| Mozavaptan_NCI-H1792 | Mozavaptan perturbation in NCI-H1792 cell line |
| Neratinib (maleate)_hTERT-HPNE | Neratinib (maleate) perturbation in hTERT-HPNE cell line |
| Berbamine_A498 | Berbamine perturbation in A498 cell line |
| Decitabine_SNU-423 | Decitabine perturbation in SNU-423 cell line |
| Carbamazepine_COLO 205 | Carbamazepine perturbation in COLO 205 cell line |
| Valdecoxib_COLO 205 | Valdecoxib perturbation in COLO 205 cell line |
| Sulfisoxazole_Hs 766T | Sulfisoxazole perturbation in Hs 766T cell line |
| Omeprazole (sodium)_J82 | Omeprazole (sodium) perturbation in J82 cell line |
| Rosiglitazone_RPMI-7951 | Rosiglitazone perturbation in RPMI-7951 cell line |
| Acetazolamide_COLO 205 | Acetazolamide perturbation in COLO 205 cell line |
| Oleic acid_A-172 | Oleic acid perturbation in A-172 cell line |
| Gefitinib_SW 900 | Gefitinib perturbation in SW 900 cell line |
| MK-8353_J82 | MK-8353 perturbation in J82 cell line |
| Homoharringtonine_RPMI-7951 | Homoharringtonine perturbation in RPMI-7951 cell line |
| Belumosudil_J82 | Belumosudil perturbation in J82 cell line |
| Rimonabant (Hydrochloride)_A498 | Rimonabant (Hydrochloride) perturbation in A498 cell line |
| Daptomycin_A549 | Daptomycin perturbation in A549 cell line |
| Penfluridol_NCI-H1792 | Penfluridol perturbation in NCI-H1792 cell line |
| Gallic acid_HepG2/C3A | Gallic acid perturbation in HepG2/C3A cell line |
| Elimusertib hydrochloride_SW 900 | Elimusertib hydrochloride perturbation in SW 900 cell line |
| Ribociclib_A-172 | Ribociclib perturbation in A-172 cell line |
| Clobetasol propionate_NCI-H460 | Clobetasol propionate perturbation in NCI-H460 cell line |
| Artemether_hTERT-HPNE | Artemether perturbation in hTERT-HPNE cell line |
| Lenalidomide (hemihydrate)_RPMI-7951 | Lenalidomide (hemihydrate) perturbation in RPMI-7951 cell line |
| Orlistat_HepG2/C3A | Orlistat perturbation in HepG2/C3A cell line |
| Docetaxel_SNU-423 | Docetaxel perturbation in SNU-423 cell line |
| GSK1059615_SW 1088 | GSK1059615 perturbation in SW 1088 cell line |
| Larotrectinib sulfate_RPMI-7951 | Larotrectinib sulfate perturbation in RPMI-7951 cell line |
| Bexarotene_RPMI-7951 | Bexarotene perturbation in RPMI-7951 cell line |
| Dapagliflozin_SW 900 | Dapagliflozin perturbation in SW 900 cell line |
| Bestatin (hydrochloride)_COLO 205 | Bestatin (hydrochloride) perturbation in COLO 205 cell line |
| Thymol_A498 | Thymol perturbation in A498 cell line |
| Azithromycin (hydrate)_COLO 205 | Azithromycin (hydrate) perturbation in COLO 205 cell line |
| Fumaric acid_J82 | Fumaric acid perturbation in J82 cell line |
| Filgotinib_SW 900 | Filgotinib perturbation in SW 900 cell line |
| Omeprazole (sodium)_NCI-H1792 | Omeprazole (sodium) perturbation in NCI-H1792 cell line |
| AZD-7648_Hs 766T | AZD-7648 perturbation in Hs 766T cell line |
| Larotrectinib sulfate_hTERT-HPNE | Larotrectinib sulfate perturbation in hTERT-HPNE cell line |
| Medroxyprogesterone acetate_J82 | Medroxyprogesterone acetate perturbation in J82 cell line |
| Ferulic acid_H4 | Ferulic acid perturbation in H4 cell line |
| Bexarotene_hTERT-HPNE | Bexarotene perturbation in hTERT-HPNE cell line |
| Medroxyprogesterone acetate_KATO III | Medroxyprogesterone acetate perturbation in KATO III cell line |
| Entecavir (monohydrate)_A498 | Entecavir (monohydrate) perturbation in A498 cell line |
| Irinotecan_A-172 | Irinotecan perturbation in A-172 cell line |
| Mozavaptan_J82 | Mozavaptan perturbation in J82 cell line |
| Infigratinib_A-172 | Infigratinib perturbation in A-172 cell line |
| Pyridoxine_J82 | Pyridoxine perturbation in J82 cell line |
| Phenytoin (sodium)_J82 | Phenytoin (sodium) perturbation in J82 cell line |
| Mifepristone_H4 | Mifepristone perturbation in H4 cell line |
| Carbamazepine_SW 1088 | Carbamazepine perturbation in SW 1088 cell line |
| Fenofibrate_LOX-IMVI | Fenofibrate perturbation in LOX-IMVI cell line |
| Tranilast_Hs 766T | Tranilast perturbation in Hs 766T cell line |
| Cobimetinib_RPMI-7951 | Cobimetinib perturbation in RPMI-7951 cell line |
| Fusidic acid_SNU-423 | Fusidic acid perturbation in SNU-423 cell line |
| Celecoxib_J82 | Celecoxib perturbation in J82 cell line |
| Diphenhydramine_H4 | Diphenhydramine perturbation in H4 cell line |
| Selinexor _hTERT-HPNE | Selinexor perturbation in hTERT-HPNE cell line |
| Rimonabant (Hydrochloride)_NCI-H1792 | Rimonabant (Hydrochloride) perturbation in NCI-H1792 cell line |
| PF-06260933_A-172 | PF-06260933 perturbation in A-172 cell line |
| Plicamycin_A498 | Plicamycin perturbation in A498 cell line |
| Filgotinib_J82 | Filgotinib perturbation in J82 cell line |
| L-Thyroxine (sodium salt pentahydrate)_SNU-423 | L-Thyroxine (sodium salt pentahydrate) perturbation in SNU-423 cell line |
| Simotinib_SNU-423 | Simotinib perturbation in SNU-423 cell line |
| Flumatinib (mesylate)_SNU-423 | Flumatinib (mesylate) perturbation in SNU-423 cell line |
| Cloxacillin (sodium)_NCI-H1792 | Cloxacillin (sodium) perturbation in NCI-H1792 cell line |
| Valdecoxib_A549 | Valdecoxib perturbation in A549 cell line |
| Retinoic acid_KATO III | Retinoic acid perturbation in KATO III cell line |
| Cilostazol_A-172 | Cilostazol perturbation in A-172 cell line |
| Methylthiouracil_SW 1088 | Methylthiouracil perturbation in SW 1088 cell line |
| Pexidartinib (hydrochloride)_LOX-IMVI | Pexidartinib (hydrochloride) perturbation in LOX-IMVI cell line |
| Dapagliflozin_J82 | Dapagliflozin perturbation in J82 cell line |
| Sulfatinib_C32 | Sulfatinib perturbation in C32 cell line |
| Berbamine_J82 | Berbamine perturbation in J82 cell line |
| Posaconazole_SNU-423 | Posaconazole perturbation in SNU-423 cell line |
| Canagliflozin (hemihydrate)_NCI-H1792 | Canagliflozin (hemihydrate) perturbation in NCI-H1792 cell line |
| Fostamatinib (disodium hexahydrate)_HepG2/C3A | Fostamatinib (disodium hexahydrate) perturbation in HepG2/C3A cell line |
| Fostamatinib (disodium hexahydrate)_SW 1088 | Fostamatinib (disodium hexahydrate) perturbation in SW 1088 cell line |
| Pentamidine (isethionate)_A-172 | Pentamidine (isethionate) perturbation in A-172 cell line |
| Belumosudil_A498 | Belumosudil perturbation in A498 cell line |
| Rutin (trihydrate)_A-172 | Rutin (trihydrate) perturbation in A-172 cell line |
| Indacaterol (maleate)_RPMI-7951 | Indacaterol (maleate) perturbation in RPMI-7951 cell line |
| Asciminib_A-172 | Asciminib perturbation in A-172 cell line |
| Pentoxifylline_HepG2/C3A | Pentoxifylline perturbation in HepG2/C3A cell line |
| Econazole_LOX-IMVI | Econazole perturbation in LOX-IMVI cell line |
| Terfenadine_Hs 766T | Terfenadine perturbation in Hs 766T cell line |
| Eplerenone_A-172 | Eplerenone perturbation in A-172 cell line |
| Pitavastatin (Calcium)_RPMI-7951 | Pitavastatin (Calcium) perturbation in RPMI-7951 cell line |
| Tetracycline (hydrochloride)_Hs 766T | Tetracycline (hydrochloride) perturbation in Hs 766T cell line |
| Bestatin (hydrochloride)_A549 | Bestatin (hydrochloride) perturbation in A549 cell line |
| Trametinib_HS-578T | Trametinib perturbation in HS-578T cell line |
| Cysteamine (hydrochloride)_A-172 | Cysteamine (hydrochloride) perturbation in A-172 cell line |
| Resveratrol_hTERT-HPNE | Resveratrol perturbation in hTERT-HPNE cell line |
| Glasdegib_SW 1088 | Glasdegib perturbation in SW 1088 cell line |
| Captopril_SW 900 | Captopril perturbation in SW 900 cell line |
| Methotrexate_hTERT-HPNE | Methotrexate perturbation in hTERT-HPNE cell line |
| Binimetinib_LOX-IMVI | Binimetinib perturbation in LOX-IMVI cell line |
| Trimetrexate_SNU-423 | Trimetrexate perturbation in SNU-423 cell line |
| TAK-901_RPMI-7951 | TAK-901 perturbation in RPMI-7951 cell line |
| Menadione_HepG2/C3A | Menadione perturbation in HepG2/C3A cell line |
| Uridine_hTERT-HPNE | Uridine perturbation in hTERT-HPNE cell line |
| Finasteride_A498 | Finasteride perturbation in A498 cell line |
| Methotrexate_RPMI-7951 | Methotrexate perturbation in RPMI-7951 cell line |
| Raltitrexed_A-172 | Raltitrexed perturbation in A-172 cell line |
| Thymopentin_NCI-H2347 | Thymopentin perturbation in NCI-H2347 cell line |
| Fumaric acid_A498 | Fumaric acid perturbation in A498 cell line |
| Atazanavir (sulfate)_COLO 205 | Atazanavir (sulfate) perturbation in COLO 205 cell line |
| Mifepristone_Hs 766T | Mifepristone perturbation in Hs 766T cell line |
| Benproperine (phosphate)_H4 | Benproperine (phosphate) perturbation in H4 cell line |
| Baicalin_NCI-H2347 | Baicalin perturbation in NCI-H2347 cell line |
| Uridine_RPMI-7951 | Uridine perturbation in RPMI-7951 cell line |
| Topotecan (hydrochloride)_HepG2/C3A | Topotecan (hydrochloride) perturbation in HepG2/C3A cell line |
| Erdafitinib _A-172 | Erdafitinib perturbation in A-172 cell line |
| Tucidinostat_SNU-423 | Tucidinostat perturbation in SNU-423 cell line |
| Carbidopa (monohydrate)_A-172 | Carbidopa (monohydrate) perturbation in A-172 cell line |
| Megestrol_SNU-423 | Megestrol perturbation in SNU-423 cell line |
| Tadalafil_SW 1088 | Tadalafil perturbation in SW 1088 cell line |
| Dapagliflozin_NCI-H1792 | Dapagliflozin perturbation in NCI-H1792 cell line |
| Mozavaptan_A498 | Mozavaptan perturbation in A498 cell line |
| Cloxacillin (sodium)_J82 | Cloxacillin (sodium) perturbation in J82 cell line |
| Sivelestat (sodium tetrahydrate)_HepG2/C3A | Sivelestat (sodium tetrahydrate) perturbation in HepG2/C3A cell line |
| AZD-7648_NCI-H661 | AZD-7648 perturbation in NCI-H661 cell line |
| Flutamide_SNU-423 | Flutamide perturbation in SNU-423 cell line |
| Bexarotene_BT-474 | Bexarotene perturbation in BT-474 cell line |
| Peretinoin_A498 | Peretinoin perturbation in A498 cell line |
| Phenytoin (sodium)_A498 | Phenytoin (sodium) perturbation in A498 cell line |
| Nevirapine_A-172 | Nevirapine perturbation in A-172 cell line |
| 8-Hydroxyquinoline_A-172 | 8-Hydroxyquinoline perturbation in A-172 cell line |
| Nevirapine_H4 | Nevirapine perturbation in H4 cell line |
| Lumateperone (tosylate)_COLO 205 | Lumateperone (tosylate) perturbation in COLO 205 cell line |
| Silodosin_A-172 | Silodosin perturbation in A-172 cell line |
| Adenine_A-172 | Adenine perturbation in A-172 cell line |
| Valdecoxib_hTERT-HPNE | Valdecoxib perturbation in hTERT-HPNE cell line |
| S-Adenosyl-L-methionine (disulfate tosylate)_A-172 | S-Adenosyl-L-methionine (disulfate tosylate) perturbation in A-172 cell line |
| Tazarotene_COLO 205 | Tazarotene perturbation in COLO 205 cell line |
| Pemigatinib_SW 900 | Pemigatinib perturbation in SW 900 cell line |
| Folic acid_COLO 205 | Folic acid perturbation in COLO 205 cell line |
| Lucanthone_J82 | Lucanthone perturbation in J82 cell line |
| Celecoxib_SNU-423 | Celecoxib perturbation in SNU-423 cell line |
| Carbidopa (monohydrate)_H4 | Carbidopa (monohydrate) perturbation in H4 cell line |
| Benproperine (phosphate)_A-172 | Benproperine (phosphate) perturbation in A-172 cell line |
| Regorafenib_NCI-H1792 | Regorafenib perturbation in NCI-H1792 cell line |
| Cepharanthine_J82 | Cepharanthine perturbation in J82 cell line |
| Bexarotene_SW 1088 | Bexarotene perturbation in SW 1088 cell line |
| Orlistat_RPMI-7951 | Orlistat perturbation in RPMI-7951 cell line |
| Imiquimod (maleate)_hTERT-HPNE | Imiquimod (maleate) perturbation in hTERT-HPNE cell line |
| olaparib_J82 | olaparib perturbation in J82 cell line |
| Drospirenone_A-172 | Drospirenone perturbation in A-172 cell line |
| Dimethyl fumarate_A498 | Dimethyl fumarate perturbation in A498 cell line |
| Imiquimod (hydrochloride)_SW 900 | Imiquimod (hydrochloride) perturbation in SW 900 cell line |
| Berberine (chloride hydrate)_RPMI-7951 | Berberine (chloride hydrate) perturbation in RPMI-7951 cell line |
| Rimonabant_COLO 205 | Rimonabant perturbation in COLO 205 cell line |
| Bexarotene_HepG2/C3A | Bexarotene perturbation in HepG2/C3A cell line |
| Larotrectinib sulfate_HepG2/C3A | Larotrectinib sulfate perturbation in HepG2/C3A cell line |
| Flumatinib (mesylate)_J82 | Flumatinib (mesylate) perturbation in J82 cell line |
| Zileuton_SW 900 | Zileuton perturbation in SW 900 cell line |
| Simotinib_J82 | Simotinib perturbation in J82 cell line |
| L-Thyroxine (sodium salt pentahydrate)_J82 | L-Thyroxine (sodium salt pentahydrate) perturbation in J82 cell line |
| Digitoxin_RPMI-7951 | Digitoxin perturbation in RPMI-7951 cell line |
| Dapagliflozin_SNU-423 | Dapagliflozin perturbation in SNU-423 cell line |
| Canagliflozin_A498 | Canagliflozin perturbation in A498 cell line |
| GSK1059615_hTERT-HPNE | GSK1059615 perturbation in hTERT-HPNE cell line |
| Retinoic acid_MIA PaCa-2 | Retinoic acid perturbation in MIA PaCa-2 cell line |
| Flutamide_NCI-H1792 | Flutamide perturbation in NCI-H1792 cell line |
| Orlistat_hTERT-HPNE | Orlistat perturbation in hTERT-HPNE cell line |
| Tirabrutinib_SW 900 | Tirabrutinib perturbation in SW 900 cell line |
| Posaconazole_J82 | Posaconazole perturbation in J82 cell line |
| MK-8353_NCI-H2122 | MK-8353 perturbation in NCI-H2122 cell line |
| Decitabine_A498 | Decitabine perturbation in A498 cell line |
| Berbamine_HOP62 | Berbamine perturbation in HOP62 cell line |
| Cytarabine_J82 | Cytarabine perturbation in J82 cell line |
| Valdecoxib_RPMI-7951 | Valdecoxib perturbation in RPMI-7951 cell line |
| Pimozide_A-172 | Pimozide perturbation in A-172 cell line |
| Furosemide_J82 | Furosemide perturbation in J82 cell line |
| Monocrotaline_COLO 205 | Monocrotaline perturbation in COLO 205 cell line |
| Artemether_HepG2/C3A | Artemether perturbation in HepG2/C3A cell line |
| Daidzin_A-172 | Daidzin perturbation in A-172 cell line |
| Ranolazine_A498 | Ranolazine perturbation in A498 cell line |
| Ciclopirox_COLO 205 | Ciclopirox perturbation in COLO 205 cell line |
| Verteporfin_Hs 766T | Verteporfin perturbation in Hs 766T cell line |
| Apalutamide_A-172 | Apalutamide perturbation in A-172 cell line |
| Rutin (trihydrate)_H4 | Rutin (trihydrate) perturbation in H4 cell line |
| Malotilate_SW 900 | Malotilate perturbation in SW 900 cell line |
| Idoxuridine_LOX-IMVI | Idoxuridine perturbation in LOX-IMVI cell line |
| Regorafenib_J82 | Regorafenib perturbation in J82 cell line |
| Cepharanthine_NCI-H1792 | Cepharanthine perturbation in NCI-H1792 cell line |
| Entrectinib_H4 | Entrectinib perturbation in H4 cell line |
| Sunitinib_A549 | Sunitinib perturbation in A549 cell line |
| Simotinib_NCI-H1792 | Simotinib perturbation in NCI-H1792 cell line |
| Tazarotene_HepG2/C3A | Tazarotene perturbation in HepG2/C3A cell line |
| L-Thyroxine (sodium salt pentahydrate)_NCI-H1792 | L-Thyroxine (sodium salt pentahydrate) perturbation in NCI-H1792 cell line |
| Dapagliflozin ((2S)-1,2-propanediol, hydrate)_RPMI-7951 | Dapagliflozin ((2S)-1,2-propanediol, hydrate) perturbation in RPMI-7951 cell line |
| Flumatinib (mesylate)_NCI-H1792 | Flumatinib (mesylate) perturbation in NCI-H1792 cell line |
| Folic acid_HepG2/C3A | Folic acid perturbation in HepG2/C3A cell line |
| Neratinib (maleate)_SW 1088 | Neratinib (maleate) perturbation in SW 1088 cell line |
| LJI308_J82 | LJI308 perturbation in J82 cell line |
| Sulfatinib_A498 | Sulfatinib perturbation in A498 cell line |
| Lenalidomide (hemihydrate)_COLO 205 | Lenalidomide (hemihydrate) perturbation in COLO 205 cell line |
| Tirabrutinib_A498 | Tirabrutinib perturbation in A498 cell line |
| Sulfisoxazole_A-172 | Sulfisoxazole perturbation in A-172 cell line |
| Trametinib_NCI-H661 | Trametinib perturbation in NCI-H661 cell line |
| Bexarotene_COLO 205 | Bexarotene perturbation in COLO 205 cell line |
| Larotrectinib sulfate_COLO 205 | Larotrectinib sulfate perturbation in COLO 205 cell line |
| Pitavastatin (Calcium)_A549 | Pitavastatin (Calcium) perturbation in A549 cell line |
| Sonidegib_A-172 | Sonidegib perturbation in A-172 cell line |
| Cytarabine_NCI-H1792 | Cytarabine perturbation in NCI-H1792 cell line |
| Dorzolamide (hydrochloride)_SNU-423 | Dorzolamide (hydrochloride) perturbation in SNU-423 cell line |
| APTO-253_SW 900 | APTO-253 perturbation in SW 900 cell line |
| Imiquimod (hydrochloride)_A498 | Imiquimod (hydrochloride) perturbation in A498 cell line |
| Balsalazide (sodium hydrate)_A-172 | Balsalazide (sodium hydrate) perturbation in A-172 cell line |
| crizotinib_J82 | crizotinib perturbation in J82 cell line |
| Dimethyl fumarate_SW 900 | Dimethyl fumarate perturbation in SW 900 cell line |
| AZD-8055_A-172 | AZD-8055 perturbation in A-172 cell line |
| Tolmetin_A-172 | Tolmetin perturbation in A-172 cell line |
| Ornidazole_HepG2/C3A | Ornidazole perturbation in HepG2/C3A cell line |
| Diphenhydramine_A-172 | Diphenhydramine perturbation in A-172 cell line |
| Cyclosporin A_A498 | Cyclosporin A perturbation in A498 cell line |
| Loperamide (hydrochloride)_COLO 205 | Loperamide (hydrochloride) perturbation in COLO 205 cell line |
| Dapagliflozin ((2S)-1,2-propanediol, hydrate)_hTERT-HPNE | Dapagliflozin ((2S)-1,2-propanediol, hydrate) perturbation in hTERT-HPNE cell line |
| Rucaparib (phosphate)_A-172 | Rucaparib (phosphate) perturbation in A-172 cell line |
| Pentagastrin_A498 | Pentagastrin perturbation in A498 cell line |
| Mifepristone_NCI-H596 | Mifepristone perturbation in NCI-H596 cell line |
| Benproperine (phosphate)_HS-578T | Benproperine (phosphate) perturbation in HS-578T cell line |
| Posaconazole_NCI-H1792 | Posaconazole perturbation in NCI-H1792 cell line |
| Tucidinostat_NCI-H2347 | Tucidinostat perturbation in NCI-H2347 cell line |
| Tetracycline (hydrochloride)_COLO 205 | Tetracycline (hydrochloride) perturbation in COLO 205 cell line |
| Baicalin_SNU-423 | Baicalin perturbation in SNU-423 cell line |
| Bestatin (hydrochloride)_H4 | Bestatin (hydrochloride) perturbation in H4 cell line |
| Citalopram (hydrobromide)_A-172 | Citalopram (hydrobromide) perturbation in A-172 cell line |
| Almonertinib (mesylate)_NCI-H2122 | Almonertinib (mesylate) perturbation in NCI-H2122 cell line |
| Niclosamide (olamine)_hTERT-HPNE | Niclosamide (olamine) perturbation in hTERT-HPNE cell line |
| Thymopentin_HOP62 | Thymopentin perturbation in HOP62 cell line |
| Binimetinib_HOP62 | Binimetinib perturbation in HOP62 cell line |
| Idoxuridine_J82 | Idoxuridine perturbation in J82 cell line |
| AZD1390_A498 | AZD1390 perturbation in A498 cell line |
| Megestrol_NCI-H2347 | Megestrol perturbation in NCI-H2347 cell line |
| Selinexor _A-172 | Selinexor perturbation in A-172 cell line |
| Berbamine (dihydrochloride)_HT-29 | Berbamine (dihydrochloride) perturbation in HT-29 cell line |
| Crizotinib (hydrochloride)_A-172 | Crizotinib (hydrochloride) perturbation in A-172 cell line |
| Pravastatin (sodium)_J82 | Pravastatin (sodium) perturbation in J82 cell line |
| Perindopril (erbumine)_SNU-423 | Perindopril (erbumine) perturbation in SNU-423 cell line |
| Mifepristone_COLO 205 | Mifepristone perturbation in COLO 205 cell line |
| Megestrol_LOX-IMVI | Megestrol perturbation in LOX-IMVI cell line |
| Pentamidine (isethionate)_hTERT-HPNE | Pentamidine (isethionate) perturbation in hTERT-HPNE cell line |
| Meloxicam_HepG2/C3A | Meloxicam perturbation in HepG2/C3A cell line |
| Resveratrol_HS-578T | Resveratrol perturbation in HS-578T cell line |
| Docetaxel (Trihydrate)_HS-578T | Docetaxel (Trihydrate) perturbation in HS-578T cell line |
| PF-06260933_RPMI-7951 | PF-06260933 perturbation in RPMI-7951 cell line |
| Doxorubicin (hydrochloride)_hTERT-HPNE | Doxorubicin (hydrochloride) perturbation in hTERT-HPNE cell line |
| Edoxaban (tosylate monohydrate)_J82 | Edoxaban (tosylate monohydrate) perturbation in J82 cell line |
| Aliskiren_NCI-H1792 | Aliskiren perturbation in NCI-H1792 cell line |
| Clopidogrel_C32 | Clopidogrel perturbation in C32 cell line |
| Aprepitant_HepG2/C3A | Aprepitant perturbation in HepG2/C3A cell line |
| Clobetasol propionate_C32 | Clobetasol propionate perturbation in C32 cell line |
| Resveratrol_A-172 | Resveratrol perturbation in A-172 cell line |
| Raltitrexed_RPMI-7951 | Raltitrexed perturbation in RPMI-7951 cell line |
| Idoxuridine_NCI-H1792 | Idoxuridine perturbation in NCI-H1792 cell line |
| Methotrexate_A-172 | Methotrexate perturbation in A-172 cell line |
| Vemurafenib_J82 | Vemurafenib perturbation in J82 cell line |
| Uridine_A-172 | Uridine perturbation in A-172 cell line |
| Tetracycline (hydrochloride)_SW 1088 | Tetracycline (hydrochloride) perturbation in SW 1088 cell line |
| Afatinib_COLO 205 | Afatinib perturbation in COLO 205 cell line |
| Ropivacaine (hydrochloride monohydrate)_SNU-423 | Ropivacaine (hydrochloride monohydrate) perturbation in SNU-423 cell line |
| Sapanisertib_A-172 | Sapanisertib perturbation in A-172 cell line |
| Clobetasol propionate_NCI-H2122 | Clobetasol propionate perturbation in NCI-H2122 cell line |
| Cysteamine (hydrochloride)_hTERT-HPNE | Cysteamine (hydrochloride) perturbation in hTERT-HPNE cell line |
| Nevirapine_RPMI-7951 | Nevirapine perturbation in RPMI-7951 cell line |
| Gallic acid_H4 | Gallic acid perturbation in H4 cell line |
| Mifepristone_HepG2/C3A | Mifepristone perturbation in HepG2/C3A cell line |
| Carbidopa (monohydrate)_hTERT-HPNE | Carbidopa (monohydrate) perturbation in hTERT-HPNE cell line |
| Indacaterol (maleate)_A-172 | Indacaterol (maleate) perturbation in A-172 cell line |
| Edoxaban (tosylate monohydrate)_NCI-H1792 | Edoxaban (tosylate monohydrate) perturbation in NCI-H1792 cell line |
| γ-Oryzanol_A-172 | γ-Oryzanol perturbation in A-172 cell line |
| Relugolix_NCI-H2122 | Relugolix perturbation in NCI-H2122 cell line |
| Fluvoxamine_C32 | Fluvoxamine perturbation in C32 cell line |
| Valdecoxib_H4 | Valdecoxib perturbation in H4 cell line |
| Mifepristone_SW 1088 | Mifepristone perturbation in SW 1088 cell line |
| Vitamin K4_J82 | Vitamin K4 perturbation in J82 cell line |
| Pexidartinib (hydrochloride)_SNU-423 | Pexidartinib (hydrochloride) perturbation in SNU-423 cell line |
| Flumatinib (mesylate)_NCI-H2347 | Flumatinib (mesylate) perturbation in NCI-H2347 cell line |
| L-Thyroxine (sodium salt pentahydrate)_NCI-H2347 | L-Thyroxine (sodium salt pentahydrate) perturbation in NCI-H2347 cell line |
| Radotinib_J82 | Radotinib perturbation in J82 cell line |
| Pasireotide (acetate)_NCI-H2347 | Pasireotide (acetate) perturbation in NCI-H2347 cell line |
| (R)-Verapamil (hydrochloride)_Hs 766T | (R)-Verapamil (hydrochloride) perturbation in Hs 766T cell line |
| Brimonidine_RPMI-7951 | Brimonidine perturbation in RPMI-7951 cell line |
| Posaconazole_LOX-IMVI | Posaconazole perturbation in LOX-IMVI cell line |
| Sildenafil_A-172 | Sildenafil perturbation in A-172 cell line |
| ULK-101_Hs 766T | ULK-101 perturbation in Hs 766T cell line |
| Methyl aminolevulinate (hydrochloride)_J82 | Methyl aminolevulinate (hydrochloride) perturbation in J82 cell line |
| TAK-901_A-172 | TAK-901 perturbation in A-172 cell line |
| Neratinib_H4 | Neratinib perturbation in H4 cell line |
| Digitoxin_A-172 | Digitoxin perturbation in A-172 cell line |
| Amsacrine_SNU-423 | Amsacrine perturbation in SNU-423 cell line |
| Benproperine (phosphate)_hTERT-HPNE | Benproperine (phosphate) perturbation in hTERT-HPNE cell line |
| Methylprednisolone succinate_A-172 | Methylprednisolone succinate perturbation in A-172 cell line |
| Imiquimod (maleate)_A-172 | Imiquimod (maleate) perturbation in A-172 cell line |
| L-Eflornithine (monohydrochloride)_SW 900 | L-Eflornithine (monohydrochloride) perturbation in SW 900 cell line |
| Thymopentin_J82 | Thymopentin perturbation in J82 cell line |
| Dorzolamide (hydrochloride)_NCI-H2347 | Dorzolamide (hydrochloride) perturbation in NCI-H2347 cell line |
| Benztropine (mesylate)_hTERT-HPNE | Benztropine (mesylate) perturbation in hTERT-HPNE cell line |
| Acetazolamide_A-172 | Acetazolamide perturbation in A-172 cell line |
| Silodosin_hTERT-HPNE | Silodosin perturbation in hTERT-HPNE cell line |
| 5-Fluorouracil_SNU-423 | 5-Fluorouracil perturbation in SNU-423 cell line |
| Fluvoxamine_A498 | Fluvoxamine perturbation in A498 cell line |
| Verapamil_SW 900 | Verapamil perturbation in SW 900 cell line |
| Cinacalcet_A498 | Cinacalcet perturbation in A498 cell line |
| Idoxuridine_SNU-423 | Idoxuridine perturbation in SNU-423 cell line |
| Carbamazepine_A-172 | Carbamazepine perturbation in A-172 cell line |
| S-Adenosyl-L-methionine (disulfate tosylate)_hTERT-HPNE | S-Adenosyl-L-methionine (disulfate tosylate) perturbation in hTERT-HPNE cell line |
| Bexarotene_HT-29 | Bexarotene perturbation in HT-29 cell line |
| Valdecoxib_A-172 | Valdecoxib perturbation in A-172 cell line |
| Cysteamine (hydrochloride)_SW480 | Cysteamine (hydrochloride) perturbation in SW480 cell line |
| Vortioxetine_SNU-423 | Vortioxetine perturbation in SNU-423 cell line |
| Rapamycin_SNU-423 | Rapamycin perturbation in SNU-423 cell line |
| Lenalidomide (hemihydrate)_Hs 766T | Lenalidomide (hemihydrate) perturbation in Hs 766T cell line |
| Sinomenine_hTERT-HPNE | Sinomenine perturbation in hTERT-HPNE cell line |
| Omeprazole_SW 900 | Omeprazole perturbation in SW 900 cell line |
| Entecavir (monohydrate)_NCI-H2347 | Entecavir (monohydrate) perturbation in NCI-H2347 cell line |
| Pexidartinib (hydrochloride)_NCI-H1792 | Pexidartinib (hydrochloride) perturbation in NCI-H1792 cell line |
| Altretamine_J82 | Altretamine perturbation in J82 cell line |
| Daidzin_hTERT-HPNE | Daidzin perturbation in hTERT-HPNE cell line |
| Phenylephrine (hydrochloride)_A498 | Phenylephrine (hydrochloride) perturbation in A498 cell line |
| Ivabradine (hydrochloride)_HepG2/C3A | Ivabradine (hydrochloride) perturbation in HepG2/C3A cell line |
| Nimesulide_A498 | Nimesulide perturbation in A498 cell line |
| GSK1059615_A-172 | GSK1059615 perturbation in A-172 cell line |
| Clobetasol propionate_SW 900 | Clobetasol propionate perturbation in SW 900 cell line |
| Orlistat_A-172 | Orlistat perturbation in A-172 cell line |
| Bestatin_NCI-H1792 | Bestatin perturbation in NCI-H1792 cell line |
| Betamethasone dipropionate_HepG2/C3A | Betamethasone dipropionate perturbation in HepG2/C3A cell line |
| Berberine (chloride hydrate)_A-172 | Berberine (chloride hydrate) perturbation in A-172 cell line |
| Methotrexate_H4 | Methotrexate perturbation in H4 cell line |
| Bisoprolol (hemifumarate)_RPMI-7951 | Bisoprolol (hemifumarate) perturbation in RPMI-7951 cell line |
| Pemetrexed_SW 1088 | Pemetrexed perturbation in SW 1088 cell line |
| Econazole_NCI-H1792 | Econazole perturbation in NCI-H1792 cell line |
| Balsalazide (sodium hydrate)_RPMI-7951 | Balsalazide (sodium hydrate) perturbation in RPMI-7951 cell line |
| AZD1390_AN3 CA | AZD1390 perturbation in AN3 CA cell line |
| Clobetasol propionate_A498 | Clobetasol propionate perturbation in A498 cell line |
| Nevirapine_A549 | Nevirapine perturbation in A549 cell line |
| Tolmetin_RPMI-7951 | Tolmetin perturbation in RPMI-7951 cell line |
| Dapagliflozin_NCI-H2347 | Dapagliflozin perturbation in NCI-H2347 cell line |
| Retinoic acid_NCI-H2347 | Retinoic acid perturbation in NCI-H2347 cell line |
| Gallic acid_HS-578T | Gallic acid perturbation in HS-578T cell line |
| Fenofibrate_J82 | Fenofibrate perturbation in J82 cell line |
| Ropivacaine (hydrochloride monohydrate)_J82 | Ropivacaine (hydrochloride monohydrate) perturbation in J82 cell line |
| Cobimetinib_H4 | Cobimetinib perturbation in H4 cell line |
| Thymopentin_NCI-H1792 | Thymopentin perturbation in NCI-H1792 cell line |
| Binimetinib_NCI-H1792 | Binimetinib perturbation in NCI-H1792 cell line |
| Bicalutamide_SW 900 | Bicalutamide perturbation in SW 900 cell line |
| Selinexor _NCI-H661 | Selinexor perturbation in NCI-H661 cell line |
| Dapagliflozin ((2S)-1,2-propanediol, hydrate)_A-172 | Dapagliflozin ((2S)-1,2-propanediol, hydrate) perturbation in A-172 cell line |
| Osimertinib (mesylate)_A-172 | Osimertinib (mesylate) perturbation in A-172 cell line |
| Verapamil_A498 | Verapamil perturbation in A498 cell line |
| Perindopril (erbumine)_NCI-H1792 | Perindopril (erbumine) perturbation in NCI-H1792 cell line |
| Sonidegib_hTERT-HPNE | Sonidegib perturbation in hTERT-HPNE cell line |
| Ralimetinib dimesylate_J82 | Ralimetinib dimesylate perturbation in J82 cell line |
| L-Eflornithine (monohydrochloride)_A498 | L-Eflornithine (monohydrochloride) perturbation in A498 cell line |
| Pexidartinib (hydrochloride)_J82 | Pexidartinib (hydrochloride) perturbation in J82 cell line |
| Betamethasone dipropionate_COLO 205 | Betamethasone dipropionate perturbation in COLO 205 cell line |
| Tolmetin_hTERT-HPNE | Tolmetin perturbation in hTERT-HPNE cell line |
| Rosiglitazone_Hs 766T | Rosiglitazone perturbation in Hs 766T cell line |
| Sulfisoxazole_RPMI-7951 | Sulfisoxazole perturbation in RPMI-7951 cell line |
| 5-Azacytidine_A498 | 5-Azacytidine perturbation in A498 cell line |
| Medroxyprogesterone acetate_NCI-H2347 | Medroxyprogesterone acetate perturbation in NCI-H2347 cell line |
| Pitavastatin (Calcium)_Hs 766T | Pitavastatin (Calcium) perturbation in Hs 766T cell line |
| Bexarotene_H4 | Bexarotene perturbation in H4 cell line |
| (S)-Crizotinib_LOX-IMVI | (S)-Crizotinib perturbation in LOX-IMVI cell line |
| Baicalin_A498 | Baicalin perturbation in A498 cell line |
| Gallic acid (hydrate)_RPMI-7951 | Gallic acid (hydrate) perturbation in RPMI-7951 cell line |
| Ferulic acid_hTERT-HPNE | Ferulic acid perturbation in hTERT-HPNE cell line |
| Fulvestrant_SNU-423 | Fulvestrant perturbation in SNU-423 cell line |
| Oxaprozin_A-172 | Oxaprozin perturbation in A-172 cell line |
| Gemfibrozil_SNU-423 | Gemfibrozil perturbation in SNU-423 cell line |
| Larotrectinib sulfate_H4 | Larotrectinib sulfate perturbation in H4 cell line |
| Topotecan (hydrochloride)_A-172 | Topotecan (hydrochloride) perturbation in A-172 cell line |
| Finasteride_LOX-IMVI | Finasteride perturbation in LOX-IMVI cell line |
| Terfenadine_RPMI-7951 | Terfenadine perturbation in RPMI-7951 cell line |
| Pexidartinib (hydrochloride)_SW 900 | Pexidartinib (hydrochloride) perturbation in SW 900 cell line |
| Thymopentin_A498 | Thymopentin perturbation in A498 cell line |
| ETC-206_SNU-423 | ETC-206 perturbation in SNU-423 cell line |
| Binimetinib_A498 | Binimetinib perturbation in A498 cell line |
| Gemcitabine_A-172 | Gemcitabine perturbation in A-172 cell line |
| Cytarabine (hydrochloride)_J82 | Cytarabine (hydrochloride) perturbation in J82 cell line |
| Sivelestat (sodium tetrahydrate)_A-172 | Sivelestat (sodium tetrahydrate) perturbation in A-172 cell line |
| Mifepristone_hTERT-HPNE | Mifepristone perturbation in hTERT-HPNE cell line |
| Fluvoxamine_J82 | Fluvoxamine perturbation in J82 cell line |
| ULK-101_A-172 | ULK-101 perturbation in A-172 cell line |
| Cinacalcet_J82 | Cinacalcet perturbation in J82 cell line |
| Bestatin_SW 900 | Bestatin perturbation in SW 900 cell line |
| Clobetasol propionate_NCI-H1792 | Clobetasol propionate perturbation in NCI-H1792 cell line |
| Tadalafil_A-172 | Tadalafil perturbation in A-172 cell line |
| Nevirapine_HepG2/C3A | Nevirapine perturbation in HepG2/C3A cell line |
| Entrectinib_COLO 205 | Entrectinib perturbation in COLO 205 cell line |
| Bicalutamide_J82 | Bicalutamide perturbation in J82 cell line |
| (R)-Verapamil (hydrochloride)_A-172 | (R)-Verapamil (hydrochloride) perturbation in A-172 cell line |
| Perindopril (erbumine)_A498 | Perindopril (erbumine) perturbation in A498 cell line |
| Altretamine_A498 | Altretamine perturbation in A498 cell line |
| Eplerenone_HepG2/C3A | Eplerenone perturbation in HepG2/C3A cell line |
| Mifepristone_RPMI-7951 | Mifepristone perturbation in RPMI-7951 cell line |
| Riluzole hydrochloride_RPMI-7951 | Riluzole hydrochloride perturbation in RPMI-7951 cell line |
| Olanzapine_H4 | Olanzapine perturbation in H4 cell line |
| 5-Azacytidine_NCI-H1792 | 5-Azacytidine perturbation in NCI-H1792 cell line |
| Futibatinib_A-172 | Futibatinib perturbation in A-172 cell line |
| Hydroxyurea_H4 | Hydroxyurea perturbation in H4 cell line |
| Menadione_A-172 | Menadione perturbation in A-172 cell line |
| Glasdegib_A-172 | Glasdegib perturbation in A-172 cell line |
| Verapamil_NCI-H1792 | Verapamil perturbation in NCI-H1792 cell line |
| Futibatinib_HS-578T | Futibatinib perturbation in HS-578T cell line |
| Saquinavir_hTERT-HPNE | Saquinavir perturbation in hTERT-HPNE cell line |
| Adenosine_A-172 | Adenosine perturbation in A-172 cell line |
| Allopurinol_J82 | Allopurinol perturbation in J82 cell line |
| vincristine_RPMI-7951 | vincristine perturbation in RPMI-7951 cell line |
| Penfluridol_LOX-IMVI | Penfluridol perturbation in LOX-IMVI cell line |
| Neratinib (maleate)_H4 | Neratinib (maleate) perturbation in H4 cell line |
| Cytarabine (hydrochloride)_NCI-H1792 | Cytarabine (hydrochloride) perturbation in NCI-H1792 cell line |
| Minodronic acid_SNU-423 | Minodronic acid perturbation in SNU-423 cell line |
| Clobetasol propionate_KATO III | Clobetasol propionate perturbation in KATO III cell line |
| Tranilast_RPMI-7951 | Tranilast perturbation in RPMI-7951 cell line |
| Tofacitinib (citrate)_A-172 | Tofacitinib (citrate) perturbation in A-172 cell line |
| Clopidogrel_J82 | Clopidogrel perturbation in J82 cell line |
| Clofarabine_H4 | Clofarabine perturbation in H4 cell line |
| Bicalutamide_NCI-H1792 | Bicalutamide perturbation in NCI-H1792 cell line |
| Cobimetinib_Hs 766T | Cobimetinib perturbation in Hs 766T cell line |
| Clobetasol propionate_J82 | Clobetasol propionate perturbation in J82 cell line |
| Atazanavir (sulfate)_A-172 | Atazanavir (sulfate) perturbation in A-172 cell line |
| Doxycycline (monohydrate)_SNU-423 | Doxycycline (monohydrate) perturbation in SNU-423 cell line |
| Methylthiouracil_A-172 | Methylthiouracil perturbation in A-172 cell line |
| Voriconazole_hTERT-HPNE | Voriconazole perturbation in hTERT-HPNE cell line |
| Fostamatinib (disodium hexahydrate)_A-172 | Fostamatinib (disodium hexahydrate) perturbation in A-172 cell line |
| Entrectinib_SW 1088 | Entrectinib perturbation in SW 1088 cell line |
| Carbidopa (monohydrate)_COLO 205 | Carbidopa (monohydrate) perturbation in COLO 205 cell line |
| Proglumide_SW 900 | Proglumide perturbation in SW 900 cell line |
| Rutin (trihydrate)_SW 1088 | Rutin (trihydrate) perturbation in SW 1088 cell line |
| Altretamine_SW 900 | Altretamine perturbation in SW 900 cell line |
| Vismodegib_hTERT-HPNE | Vismodegib perturbation in hTERT-HPNE cell line |
| Tubulin inhibitor 6_A-172 | Tubulin inhibitor 6 perturbation in A-172 cell line |
| Nimesulide_NCI-H1792 | Nimesulide perturbation in NCI-H1792 cell line |
| Omeprazole (sodium)_LOX-IMVI | Omeprazole (sodium) perturbation in LOX-IMVI cell line |
| Monocrotaline_H4 | Monocrotaline perturbation in H4 cell line |
| AT7519_SNU-423 | AT7519 perturbation in SNU-423 cell line |
| Omeprazole_J82 | Omeprazole perturbation in J82 cell line |
| Palmatine (chloride)_HepG2/C3A | Palmatine (chloride) perturbation in HepG2/C3A cell line |
| Rosiglitazone_NCI-H661 | Rosiglitazone perturbation in NCI-H661 cell line |
| Fluvoxamine (maleate)_A-172 | Fluvoxamine (maleate) perturbation in A-172 cell line |
| Verapamil_J82 | Verapamil perturbation in J82 cell line |
| Ixazomib citrate_A-172 | Ixazomib citrate perturbation in A-172 cell line |
| Ivermectin_J82 | Ivermectin perturbation in J82 cell line |
| Econazole_SW 900 | Econazole perturbation in SW 900 cell line |
| Trifluridine_HepG2/C3A | Trifluridine perturbation in HepG2/C3A cell line |
| Rosiglitazone_H4 | Rosiglitazone perturbation in H4 cell line |
| Binimetinib_SW 900 | Binimetinib perturbation in SW 900 cell line |
| Pexidartinib (hydrochloride)_A498 | Pexidartinib (hydrochloride) perturbation in A498 cell line |
| Thymopentin_SW 900 | Thymopentin perturbation in SW 900 cell line |
| L-Eflornithine (monohydrochloride)_J82 | L-Eflornithine (monohydrochloride) perturbation in J82 cell line |
| Estrone sulfate (potassium)_A-172 | Estrone sulfate (potassium) perturbation in A-172 cell line |
| Bortezomib_J82 | Bortezomib perturbation in J82 cell line |
| Berbamine (dihydrochloride)_A-172 | Berbamine (dihydrochloride) perturbation in A-172 cell line |
| Roxadustat_H4 | Roxadustat perturbation in H4 cell line |
| Phenylephrine (hydrochloride)_NCI-H1792 | Phenylephrine (hydrochloride) perturbation in NCI-H1792 cell line |
| Aliskiren_NCI-H2122 | Aliskiren perturbation in NCI-H2122 cell line |
| Arbutin_RPMI-7951 | Arbutin perturbation in RPMI-7951 cell line |
| Tirabrutinib_LOX-IMVI | Tirabrutinib perturbation in LOX-IMVI cell line |
| Tolmetin_SW 1088 | Tolmetin perturbation in SW 1088 cell line |
| Roxadustat_A-172 | Roxadustat perturbation in A-172 cell line |
| Fedratinib (hydrochloride hydrate)_hTERT-HPNE | Fedratinib (hydrochloride hydrate) perturbation in hTERT-HPNE cell line |
| Macitentan_LOX-IMVI | Macitentan perturbation in LOX-IMVI cell line |
| Almonertinib (hydrochloride)_NCI-H2347 | Almonertinib (hydrochloride) perturbation in NCI-H2347 cell line |
| Ornidazole_A-172 | Ornidazole perturbation in A-172 cell line |
| Rosiglitazone_A-172 | Rosiglitazone perturbation in A-172 cell line |
| Lidocaine (hydrochloride)_RPMI-7951 | Lidocaine (hydrochloride) perturbation in RPMI-7951 cell line |
| Cinacalcet_SNU-423 | Cinacalcet perturbation in SNU-423 cell line |
| Fluvoxamine_SNU-423 | Fluvoxamine perturbation in SNU-423 cell line |
| Ligustrazine_A-172 | Ligustrazine perturbation in A-172 cell line |
| Ixazomib citrate_H4 | Ixazomib citrate perturbation in H4 cell line |
| Pentagastrin_NCI-H2347 | Pentagastrin perturbation in NCI-H2347 cell line |
| Vitamin K4_SW 900 | Vitamin K4 perturbation in SW 900 cell line |
| Larotrectinib sulfate_HS-578T | Larotrectinib sulfate perturbation in HS-578T cell line |
| Aliskiren_SW 900 | Aliskiren perturbation in SW 900 cell line |
| Vortioxetine_A498 | Vortioxetine perturbation in A498 cell line |
| Pravastatin (sodium)_A498 | Pravastatin (sodium) perturbation in A498 cell line |
| Almonertinib (mesylate)_SNU-423 | Almonertinib (mesylate) perturbation in SNU-423 cell line |
| Lenalidomide (hemihydrate)_HS-578T | Lenalidomide (hemihydrate) perturbation in HS-578T cell line |
| Monocrotaline_A-172 | Monocrotaline perturbation in A-172 cell line |
| Vandetanib_A498 | Vandetanib perturbation in A498 cell line |
| Adenine_COLO 205 | Adenine perturbation in COLO 205 cell line |
| Busulfan_A-172 | Busulfan perturbation in A-172 cell line |
| Fostamatinib (disodium hexahydrate)_H4 | Fostamatinib (disodium hexahydrate) perturbation in H4 cell line |
| Chlorhexidine (diacetate)_A-172 | Chlorhexidine (diacetate) perturbation in A-172 cell line |
| Edoxaban (tosylate monohydrate)_A498 | Edoxaban (tosylate monohydrate) perturbation in A498 cell line |
| AT7519_NCI-H1792 | AT7519 perturbation in NCI-H1792 cell line |
| Nimesulide_SNU-423 | Nimesulide perturbation in SNU-423 cell line |
| Clofarabine_A-172 | Clofarabine perturbation in A-172 cell line |
| Piroxicam_A498 | Piroxicam perturbation in A498 cell line |
| Tirabrutinib_NCI-H2347 | Tirabrutinib perturbation in NCI-H2347 cell line |
| Bisoprolol (hemifumarate)_COLO 205 | Bisoprolol (hemifumarate) perturbation in COLO 205 cell line |
| Temsirolimus_NCI-H1792 | Temsirolimus perturbation in NCI-H1792 cell line |
| Neratinib (maleate)_A-172 | Neratinib (maleate) perturbation in A-172 cell line |
| Sulfatinib_NCI-H2347 | Sulfatinib perturbation in NCI-H2347 cell line |
| Adenosine_H4 | Adenosine perturbation in H4 cell line |
| Nafamostat (mesylate)_J82 | Nafamostat (mesylate) perturbation in J82 cell line |
| Balsalazide (sodium hydrate)_COLO 205 | Balsalazide (sodium hydrate) perturbation in COLO 205 cell line |
| Ivabradine (hydrochloride)_hTERT-HPNE | Ivabradine (hydrochloride) perturbation in hTERT-HPNE cell line |
| Vinblastine (sulfate)_A-172 | Vinblastine (sulfate) perturbation in A-172 cell line |
| Doxycycline (monohydrate)_J82 | Doxycycline (monohydrate) perturbation in J82 cell line |
| Clobetasol propionate_SNU-423 | Clobetasol propionate perturbation in SNU-423 cell line |
| AZD1390_NCI-H1792 | AZD1390 perturbation in NCI-H1792 cell line |
| Hydroxyurea_A-172 | Hydroxyurea perturbation in A-172 cell line |
| Irinotecan_RPMI-7951 | Irinotecan perturbation in RPMI-7951 cell line |
| Berberine (chloride hydrate)_Hs 766T | Berberine (chloride hydrate) perturbation in Hs 766T cell line |
| Clobetasol propionate_HOP62 | Clobetasol propionate perturbation in HOP62 cell line |
| GSK1059615_Hs 766T | GSK1059615 perturbation in Hs 766T cell line |
| Artemether_A-172 | Artemether perturbation in A-172 cell line |
| Omeprazole_SNU-423 | Omeprazole perturbation in SNU-423 cell line |
| (R)-Verapamil (hydrochloride)_H4 | (R)-Verapamil (hydrochloride) perturbation in H4 cell line |
| Apalutamide_COLO 205 | Apalutamide perturbation in COLO 205 cell line |
| Vortioxetine_SW 900 | Vortioxetine perturbation in SW 900 cell line |
| Hexylresorcinol_RPMI-7951 | Hexylresorcinol perturbation in RPMI-7951 cell line |
| Vitamin K4_A498 | Vitamin K4 perturbation in A498 cell line |
| Temsirolimus_J82 | Temsirolimus perturbation in J82 cell line |
| Idoxuridine_SW 900 | Idoxuridine perturbation in SW 900 cell line |
| Sivelestat (sodium tetrahydrate)_H4 | Sivelestat (sodium tetrahydrate) perturbation in H4 cell line |
| Radotinib_A498 | Radotinib perturbation in A498 cell line |
| Lenalidomide (hemihydrate)_A-172 | Lenalidomide (hemihydrate) perturbation in A-172 cell line |
| Ixazomib_A-172 | Ixazomib perturbation in A-172 cell line |
| Topotecan (hydrochloride)_H4 | Topotecan (hydrochloride) perturbation in H4 cell line |
| Glycyrrhizic acid_H4 | Glycyrrhizic acid perturbation in H4 cell line |
| Ivabradine (hydrochloride)_RPMI-7951 | Ivabradine (hydrochloride) perturbation in RPMI-7951 cell line |
| Thymopentin_C32 | Thymopentin perturbation in C32 cell line |
| Decitabine_LOX-IMVI | Decitabine perturbation in LOX-IMVI cell line |
| Larotrectinib sulfate_A-172 | Larotrectinib sulfate perturbation in A-172 cell line |
| 5-Azacytidine_SNU-423 | 5-Azacytidine perturbation in SNU-423 cell line |
| Lonafarnib_A-172 | Lonafarnib perturbation in A-172 cell line |
| Omeprazole_HOP62 | Omeprazole perturbation in HOP62 cell line |
| Bexarotene_A-172 | Bexarotene perturbation in A-172 cell line |
| Homoharringtonine_CHP-212 | Homoharringtonine perturbation in CHP-212 cell line |
| Vemurafenib_SNU-1 | Vemurafenib perturbation in SNU-1 cell line |
| Doxorubicin (hydrochloride)_A498 | Doxorubicin (hydrochloride) perturbation in A498 cell line |
| Epirubicin (hydrochloride)_SW48 | Epirubicin (hydrochloride) perturbation in SW48 cell line |
| Menadione_SHP-77 | Menadione perturbation in SHP-77 cell line |
| APTO-253_SHP-77 | APTO-253 perturbation in SHP-77 cell line |
| Vitamin K4_SHP-77 | Vitamin K4 perturbation in SHP-77 cell line |
| Entrectinib_SW48 | Entrectinib perturbation in SW48 cell line |
| Hydroxyfasudil_LS 180 | Hydroxyfasudil perturbation in LS 180 cell line |
| Elagolix sodium_LS 180 | Elagolix sodium perturbation in LS 180 cell line |
| Ivabradine (hydrochloride)_CHP-212 | Ivabradine (hydrochloride) perturbation in CHP-212 cell line |
| Fingolimod (hydrochloride)_COLO 205 | Fingolimod (hydrochloride) perturbation in COLO 205 cell line |
| Lactate (calcium)_BT-474 | Lactate (calcium) perturbation in BT-474 cell line |
| 5-Fluorouracil_HepG2/C3A | 5-Fluorouracil perturbation in HepG2/C3A cell line |
| Bergenin_SW 1271 | Bergenin perturbation in SW 1271 cell line |
| Radotinib_SW 1271 | Radotinib perturbation in SW 1271 cell line |
| Belinostat_SNU-423 | Belinostat perturbation in SNU-423 cell line |
| Proglumide_COLO 205 | Proglumide perturbation in COLO 205 cell line |
| Saquinavir_SNU-423 | Saquinavir perturbation in SNU-423 cell line |
| Auranofin_HepG2/C3A | Auranofin perturbation in HepG2/C3A cell line |
| Selinexor _SNU-1 | Selinexor perturbation in SNU-1 cell line |
| Cobimetinib_SNU-1 | Cobimetinib perturbation in SNU-1 cell line |
| Binimetinib_HepG2/C3A | Binimetinib perturbation in HepG2/C3A cell line |
| Bimiralisib_BT-474 | Bimiralisib perturbation in BT-474 cell line |
| Tazarotene_Panc 03.27 | Tazarotene perturbation in Panc 03.27 cell line |
| Harringtonine_NCI-H2347 | Harringtonine perturbation in NCI-H2347 cell line |
| Phenylephrine (hydrochloride)_COLO 205 | Phenylephrine (hydrochloride) perturbation in COLO 205 cell line |
| Capivasertib_HepG2/C3A | Capivasertib perturbation in HepG2/C3A cell line |
| Quinidine (15% dihydroquinidine)_hTERT-HPNE | Quinidine (15% dihydroquinidine) perturbation in hTERT-HPNE cell line |
| Homoharringtonine_SNU-1 | Homoharringtonine perturbation in SNU-1 cell line |
| Pimozide_CHP-212 | Pimozide perturbation in CHP-212 cell line |
| Harringtonine_NCI-H460 | Harringtonine perturbation in NCI-H460 cell line |
| Pimozide_CFPAC-1 | Pimozide perturbation in CFPAC-1 cell line |
| Busulfan_SNU-1 | Busulfan perturbation in SNU-1 cell line |
| Nevirapine_KATO III | Nevirapine perturbation in KATO III cell line |
| Futibatinib_Panc 03.27 | Futibatinib perturbation in Panc 03.27 cell line |
| Bosentan (hydrate)_HCT15 | Bosentan (hydrate) perturbation in HCT15 cell line |
| OTS514_SNU-423 | OTS514 perturbation in SNU-423 cell line |
| Clopidogrel_SW 1271 | Clopidogrel perturbation in SW 1271 cell line |
| Ranolazine_COLO 205 | Ranolazine perturbation in COLO 205 cell line |
| Pentagastrin_HepG2/C3A | Pentagastrin perturbation in HepG2/C3A cell line |
| Azithromycin (hydrate)_CFPAC-1 | Azithromycin (hydrate) perturbation in CFPAC-1 cell line |
| Harringtonine_CHP-212 | Harringtonine perturbation in CHP-212 cell line |
| Azithromycin (hydrate)_SNU-423 | Azithromycin (hydrate) perturbation in SNU-423 cell line |
| Dihydroartemisinin_HepG2/C3A | Dihydroartemisinin perturbation in HepG2/C3A cell line |
| PH-797804_SNU-423 | PH-797804 perturbation in SNU-423 cell line |
| Hydroxyurea_SHP-77 | Hydroxyurea perturbation in SHP-77 cell line |
| AZD2858_LoVo | AZD2858 perturbation in LoVo cell line |
| Lucanthone_hTERT-HPNE | Lucanthone perturbation in hTERT-HPNE cell line |
| Temsirolimus_Hs 766T | Temsirolimus perturbation in Hs 766T cell line |
| Medroxyprogesterone acetate_HepG2/C3A | Medroxyprogesterone acetate perturbation in HepG2/C3A cell line |
| Afatinib_SNU-1 | Afatinib perturbation in SNU-1 cell line |
| L-Thyroxine (sodium salt pentahydrate)_RPMI-7951 | L-Thyroxine (sodium salt pentahydrate) perturbation in RPMI-7951 cell line |
| Triamcinolone_SW 1271 | Triamcinolone perturbation in SW 1271 cell line |
| Captopril_HepG2/C3A | Captopril perturbation in HepG2/C3A cell line |
| XRK3F2_HepG2/C3A | XRK3F2 perturbation in HepG2/C3A cell line |
| Indacaterol (maleate)_SNU-423 | Indacaterol (maleate) perturbation in SNU-423 cell line |
| Canagliflozin (hemihydrate)_HepG2/C3A | Canagliflozin (hemihydrate) perturbation in HepG2/C3A cell line |
| Bosentan (hydrate)_HepG2/C3A | Bosentan (hydrate) perturbation in HepG2/C3A cell line |
| Cobimetinib_NCI-H2122 | Cobimetinib perturbation in NCI-H2122 cell line |
| Elimusertib hydrochloride_HepG2/C3A | Elimusertib hydrochloride perturbation in HepG2/C3A cell line |
| Benproperine (phosphate)_SNU-1 | Benproperine (phosphate) perturbation in SNU-1 cell line |
| Hydroxyurea_SNU-423 | Hydroxyurea perturbation in SNU-423 cell line |
| Lapatinib ditosylate_SW 1271 | Lapatinib ditosylate perturbation in SW 1271 cell line |
| Estrone sulfate (potassium)_J82 | Estrone sulfate (potassium) perturbation in J82 cell line |
| Imiquimod (hydrochloride)_hTERT-HPNE | Imiquimod (hydrochloride) perturbation in hTERT-HPNE cell line |
| Topotecan (hydrochloride)_SNU-423 | Topotecan (hydrochloride) perturbation in SNU-423 cell line |
| Glycyrrhizic acid_CHP-212 | Glycyrrhizic acid perturbation in CHP-212 cell line |
| Doxorubicin (hydrochloride)_SNU-1 | Doxorubicin (hydrochloride) perturbation in SNU-1 cell line |
| Panobinostat_SW1417 | Panobinostat perturbation in SW1417 cell line |
| OTS514_SNU-1 | OTS514 perturbation in SNU-1 cell line |
| Azithromycin (hydrate)_SW 1271 | Azithromycin (hydrate) perturbation in SW 1271 cell line |
| Ranolazine_J82 | Ranolazine perturbation in J82 cell line |
| Ranolazine_KATO III | Ranolazine perturbation in KATO III cell line |
| Cobimetinib_HepG2/C3A | Cobimetinib perturbation in HepG2/C3A cell line |
| Baicalin_SNU-1 | Baicalin perturbation in SNU-1 cell line |
| Aspirin_CHP-212 | Aspirin perturbation in CHP-212 cell line |
| Cloxacillin (sodium)_NCI-H2122 | Cloxacillin (sodium) perturbation in NCI-H2122 cell line |
| Captopril_CHP-212 | Captopril perturbation in CHP-212 cell line |
| Methotrexate_COLO 205 | Methotrexate perturbation in COLO 205 cell line |
| Omeprazole (sodium)_CHP-212 | Omeprazole (sodium) perturbation in CHP-212 cell line |
| Osimertinib (mesylate)_HepG2/C3A | Osimertinib (mesylate) perturbation in HepG2/C3A cell line |
| Neratinib_SW 1271 | Neratinib perturbation in SW 1271 cell line |
| Canagliflozin_SNU-423 | Canagliflozin perturbation in SNU-423 cell line |
| Cobimetinib_SW1417 | Cobimetinib perturbation in SW1417 cell line |
| Ciclopirox_RPMI-7951 | Ciclopirox perturbation in RPMI-7951 cell line |
| Zileuton_SNU-423 | Zileuton perturbation in SNU-423 cell line |
| Vandetanib_SNU-1 | Vandetanib perturbation in SNU-1 cell line |
| Erlotinib_SW 1088 | Erlotinib perturbation in SW 1088 cell line |
| Rosiglitazone_BT-474 | Rosiglitazone perturbation in BT-474 cell line |
| Atazanavir (sulfate)_HepG2/C3A | Atazanavir (sulfate) perturbation in HepG2/C3A cell line |
| Cytarabine_SNU-423 | Cytarabine perturbation in SNU-423 cell line |
| Tazarotene_SW1417 | Tazarotene perturbation in SW1417 cell line |
| Flutamide_CHP-212 | Flutamide perturbation in CHP-212 cell line |
| Estrone sulfate (potassium)_COLO 205 | Estrone sulfate (potassium) perturbation in COLO 205 cell line |
| 18β-Glycyrrhetinic acid_SNU-423 | 18β-Glycyrrhetinic acid perturbation in SNU-423 cell line |
| Trametinib (DMSO_SNU-423 | Trametinib (DMSO perturbation in SNU-423 cell line |
| Neratinib_hTERT-HPNE | Neratinib perturbation in hTERT-HPNE cell line |
| Homoharringtonine_SW 1271 | Homoharringtonine perturbation in SW 1271 cell line |
| 5-Azacytidine_SNU-1 | 5-Azacytidine perturbation in SNU-1 cell line |
| Entecavir (monohydrate)_CHP-212 | Entecavir (monohydrate) perturbation in CHP-212 cell line |
| Gemcitabine_SW 1271 | Gemcitabine perturbation in SW 1271 cell line |
| Phenylephrine (hydrochloride)_SNU-1 | Phenylephrine (hydrochloride) perturbation in SNU-1 cell line |
| Tolcapone_HepG2/C3A | Tolcapone perturbation in HepG2/C3A cell line |
| Harringtonine_H4 | Harringtonine perturbation in H4 cell line |
| OTS514_RPMI-7951 | OTS514 perturbation in RPMI-7951 cell line |
| Capmatinib_HepG2/C3A | Capmatinib perturbation in HepG2/C3A cell line |
| Elagolix sodium_SW1417 | Elagolix sodium perturbation in SW1417 cell line |
| OTS514_hTERT-HPNE | OTS514 perturbation in hTERT-HPNE cell line |
| Voriconazole_HepG2/C3A | Voriconazole perturbation in HepG2/C3A cell line |
| Plicamycin_SNU-1 | Plicamycin perturbation in SNU-1 cell line |
| Vismodegib_COLO 205 | Vismodegib perturbation in COLO 205 cell line |
| Vilanterol_SW 1088 | Vilanterol perturbation in SW 1088 cell line |
| Ralimetinib dimesylate_SNU-423 | Ralimetinib dimesylate perturbation in SNU-423 cell line |
| Pioglitazone_Panc 03.27 | Pioglitazone perturbation in Panc 03.27 cell line |
| Fingolimod (hydrochloride)_SNU-423 | Fingolimod (hydrochloride) perturbation in SNU-423 cell line |
| Ralimetinib dimesylate_SW 900 | Ralimetinib dimesylate perturbation in SW 900 cell line |
| Sunitinib_Hs 766T | Sunitinib perturbation in Hs 766T cell line |
| 8-Hydroxyquinoline_SW1417 | 8-Hydroxyquinoline perturbation in SW1417 cell line |
| Procainamide (hydrochloride)_HepG2/C3A | Procainamide (hydrochloride) perturbation in HepG2/C3A cell line |
| Asciminib_HepG2/C3A | Asciminib perturbation in HepG2/C3A cell line |
| Goserelin (acetate)_HCT15 | Goserelin (acetate) perturbation in HCT15 cell line |
| Homoharringtonine_HEC-1-A | Homoharringtonine perturbation in HEC-1-A cell line |
| Homoharringtonine_H4 | Homoharringtonine perturbation in H4 cell line |
| Cloxacillin (sodium)_SNU-1 | Cloxacillin (sodium) perturbation in SNU-1 cell line |
| Capivasertib_SNU-423 | Capivasertib perturbation in SNU-423 cell line |
| Doxorubicin (hydrochloride)_SW 1271 | Doxorubicin (hydrochloride) perturbation in SW 1271 cell line |
| Futibatinib_H4 | Futibatinib perturbation in H4 cell line |
| Daidzin_SW 1088 | Daidzin perturbation in SW 1088 cell line |
| Darolutamide_SNU-423 | Darolutamide perturbation in SNU-423 cell line |
| Verapamil_SNU-423 | Verapamil perturbation in SNU-423 cell line |
| Relugolix_SNU-423 | Relugolix perturbation in SNU-423 cell line |
| Betamethasone dipropionate_NCI-H1792 | Betamethasone dipropionate perturbation in NCI-H1792 cell line |
| Verteporfin_NCI-H23 | Verteporfin perturbation in NCI-H23 cell line |
| PF-06260933_A498 | PF-06260933 perturbation in A498 cell line |
| Niclosamide (olamine)_SHP-77 | Niclosamide (olamine) perturbation in SHP-77 cell line |
| Temsirolimus_HepG2/C3A | Temsirolimus perturbation in HepG2/C3A cell line |
| Trametinib_LoVo | Trametinib perturbation in LoVo cell line |
| Carbidopa (monohydrate)_LoVo | Carbidopa (monohydrate) perturbation in LoVo cell line |
| Vinblastine (sulfate)_SHP-77 | Vinblastine (sulfate) perturbation in SHP-77 cell line |
| Pitavastatin (Calcium)_LoVo | Pitavastatin (Calcium) perturbation in LoVo cell line |
| Panobinostat_HepG2/C3A | Panobinostat perturbation in HepG2/C3A cell line |
| PH-797804_SHP-77 | PH-797804 perturbation in SHP-77 cell line |
| AZD2858_A498 | AZD2858 perturbation in A498 cell line |
| Flutamide_SHP-77 | Flutamide perturbation in SHP-77 cell line |
| Dabrafenib_SHP-77 | Dabrafenib perturbation in SHP-77 cell line |
| Tucidinostat_A498 | Tucidinostat perturbation in A498 cell line |
| Erlotinib_HepG2/C3A | Erlotinib perturbation in HepG2/C3A cell line |
| Peretinoin_SHP-77 | Peretinoin perturbation in SHP-77 cell line |
| Vinblastine (sulfate)_HepG2/C3A | Vinblastine (sulfate) perturbation in HepG2/C3A cell line |
| Elimusertib hydrochloride_LoVo | Elimusertib hydrochloride perturbation in LoVo cell line |
| Bortezomib_SHP-77 | Bortezomib perturbation in SHP-77 cell line |
| Bortezomib_A498 | Bortezomib perturbation in A498 cell line |
| Amsacrine_SHP-77 | Amsacrine perturbation in SHP-77 cell line |
| Pimozide_A498 | Pimozide perturbation in A498 cell line |
| Elimusertib hydrochloride_Hs 766T | Elimusertib hydrochloride perturbation in Hs 766T cell line |
| Sulfisoxazole_AN3 CA | Sulfisoxazole perturbation in AN3 CA cell line |
| Abiraterone acetate_SW48 | Abiraterone acetate perturbation in SW48 cell line |
| Carbidopa (monohydrate)_A498 | Carbidopa (monohydrate) perturbation in A498 cell line |
| Alpelisib_PANC-1 | Alpelisib perturbation in PANC-1 cell line |
| Trametinib (DMSO_PANC-1 | Trametinib (DMSO perturbation in PANC-1 cell line |
| Afatinib_NCI-H1573 | Afatinib perturbation in NCI-H1573 cell line |
| Ribociclib_A498 | Ribociclib perturbation in A498 cell line |
| RMC-6236_PANC-1 | RMC-6236 perturbation in PANC-1 cell line |
| Filgotinib_PANC-1 | Filgotinib perturbation in PANC-1 cell line |
| Afatinib_A498 | Afatinib perturbation in A498 cell line |
| Glycyrrhizic acid_NCI-H1573 | Glycyrrhizic acid perturbation in NCI-H1573 cell line |
| Binimetinib_PANC-1 | Binimetinib perturbation in PANC-1 cell line |
| Futibatinib_A498 | Futibatinib perturbation in A498 cell line |
| Oxaliplatin_PANC-1 | Oxaliplatin perturbation in PANC-1 cell line |
| AT7519_PANC-1 | AT7519 perturbation in PANC-1 cell line |
| 9-ING-41_PANC-1 | 9-ING-41 perturbation in PANC-1 cell line |
| Cobimetinib_NCI-H1573 | Cobimetinib perturbation in NCI-H1573 cell line |
| Dapagliflozin ((2S)-1,2-propanediol, hydrate)_A498 | Dapagliflozin ((2S)-1,2-propanediol, hydrate) perturbation in A498 cell line |
| Belumosudil (mesylate)_PANC-1 | Belumosudil (mesylate) perturbation in PANC-1 cell line |
| Sunitinib_A498 | Sunitinib perturbation in A498 cell line |
| Indacaterol (maleate)_A498 | Indacaterol (maleate) perturbation in A498 cell line |
| Cepharanthine_A498 | Cepharanthine perturbation in A498 cell line |
| L-Thyroxine (sodium salt pentahydrate)_A498 | L-Thyroxine (sodium salt pentahydrate) perturbation in A498 cell line |
| Ribociclib_PANC-1 | Ribociclib perturbation in PANC-1 cell line |
| Elagolix sodium_PANC-1 | Elagolix sodium perturbation in PANC-1 cell line |
| Acetohexamide_KATO III | Acetohexamide perturbation in KATO III cell line |
| Megestrol_C32 | Megestrol perturbation in C32 cell line |
| Afatinib_PANC-1 | Afatinib perturbation in PANC-1 cell line |
| Regorafenib_AN3 CA | Regorafenib perturbation in AN3 CA cell line |
| Lucanthone_NCI-H1573 | Lucanthone perturbation in NCI-H1573 cell line |
| Idarubicin (hydrochloride)_KATO III | Idarubicin (hydrochloride) perturbation in KATO III cell line |
| Decitabine_NCI-H1573 | Decitabine perturbation in NCI-H1573 cell line |
| Benztropine (mesylate)_PANC-1 | Benztropine (mesylate) perturbation in PANC-1 cell line |
| Paclitaxel_PANC-1 | Paclitaxel perturbation in PANC-1 cell line |
| Trametinib_PANC-1 | Trametinib perturbation in PANC-1 cell line |
| GSK1059615_PANC-1 | GSK1059615 perturbation in PANC-1 cell line |
| Pitavastatin (Calcium)_PANC-1 | Pitavastatin (Calcium) perturbation in PANC-1 cell line |
| Cobimetinib_PANC-1 | Cobimetinib perturbation in PANC-1 cell line |
| Capivasertib_A498 | Capivasertib perturbation in A498 cell line |
| Malotilate_SNU-1 | Malotilate perturbation in SNU-1 cell line |
| Ralimetinib dimesylate_A498 | Ralimetinib dimesylate perturbation in A498 cell line |
| Encorafenib_PANC-1 | Encorafenib perturbation in PANC-1 cell line |
| Vitamin K4_NCI-H2030 | Vitamin K4 perturbation in NCI-H2030 cell line |
| Trametinib_NCI-H1573 | Trametinib perturbation in NCI-H1573 cell line |
| Talc_NCI-H2030 | Talc perturbation in NCI-H2030 cell line |
| Cytarabine (hydrochloride)_A549 | Cytarabine (hydrochloride) perturbation in A549 cell line |
| Ralimetinib dimesylate_COLO 205 | Ralimetinib dimesylate perturbation in COLO 205 cell line |
| Daptomycin_NCI-H460 | Daptomycin perturbation in NCI-H460 cell line |
| Tofacitinib_HepG2/C3A | Tofacitinib perturbation in HepG2/C3A cell line |
| Bortezomib_COLO 205 | Bortezomib perturbation in COLO 205 cell line |
| Lactate (calcium)_A549 | Lactate (calcium) perturbation in A549 cell line |
| 9-ING-41_NCI-H2030 | 9-ING-41 perturbation in NCI-H2030 cell line |
| Epirubicin (hydrochloride)_A549 | Epirubicin (hydrochloride) perturbation in A549 cell line |
| Amsacrine_A549 | Amsacrine perturbation in A549 cell line |
| Erlotinib_NCI-H1573 | Erlotinib perturbation in NCI-H1573 cell line |
| Ribociclib_NCI-H460 | Ribociclib perturbation in NCI-H460 cell line |
| Mifepristone_NCI-H460 | Mifepristone perturbation in NCI-H460 cell line |
| Lopinavir_NCI-H460 | Lopinavir perturbation in NCI-H460 cell line |
| Ipatasertib_NCI-H2030 | Ipatasertib perturbation in NCI-H2030 cell line |
| Bortezomib_NCI-H460 | Bortezomib perturbation in NCI-H460 cell line |
| Pemigatinib_NCI-H1573 | Pemigatinib perturbation in NCI-H1573 cell line |
| Ixazomib citrate_COLO 205 | Ixazomib citrate perturbation in COLO 205 cell line |
| Lactate (calcium)_NCI-H460 | Lactate (calcium) perturbation in NCI-H460 cell line |
| Vitamin K4_NCI-H460 | Vitamin K4 perturbation in NCI-H460 cell line |
| Bortezomib_C32 | Bortezomib perturbation in C32 cell line |
| Bortezomib_NCI-H1573 | Bortezomib perturbation in NCI-H1573 cell line |
| Trametinib (DMSO_NCI-H460 | Trametinib (DMSO perturbation in NCI-H460 cell line |
| Megestrol_NCI-H460 | Megestrol perturbation in NCI-H460 cell line |
| Doxorubicin (hydrochloride)_A549 | Doxorubicin (hydrochloride) perturbation in A549 cell line |
| Trametinib_A549 | Trametinib perturbation in A549 cell line |
| Rimonabant (Hydrochloride)_NCI-H460 | Rimonabant (Hydrochloride) perturbation in NCI-H460 cell line |
| Panobinostat_NCI-H460 | Panobinostat perturbation in NCI-H460 cell line |
| Betamethasone dipropionate_A549 | Betamethasone dipropionate perturbation in A549 cell line |
| Binimetinib_NCI-H1573 | Binimetinib perturbation in NCI-H1573 cell line |
| Esmolol (hydrochloride)_KATO III | Esmolol (hydrochloride) perturbation in KATO III cell line |
| Cloxacillin (sodium)_HT-29 | Cloxacillin (sodium) perturbation in HT-29 cell line |
| Mifepristone_KATO III | Mifepristone perturbation in KATO III cell line |
| HI-TOPK-032_BT-474 | HI-TOPK-032 perturbation in BT-474 cell line |
| Auranofin_BT-474 | Auranofin perturbation in BT-474 cell line |
| Ritonavir_HT-29 | Ritonavir perturbation in HT-29 cell line |
| Terfenadine_KATO III | Terfenadine perturbation in KATO III cell line |
| CP21R7_COLO 205 | CP21R7 perturbation in COLO 205 cell line |
| Talc_BT-474 | Talc perturbation in BT-474 cell line |
| Vismodegib_KATO III | Vismodegib perturbation in KATO III cell line |
| Temuterkib_COLO 205 | Temuterkib perturbation in COLO 205 cell line |
| EX229_BT-474 | EX229 perturbation in BT-474 cell line |
| Tranilast_KATO III | Tranilast perturbation in KATO III cell line |
| Afatinib_KATO III | Afatinib perturbation in KATO III cell line |
| Malotilate_HEC-1-A | Malotilate perturbation in HEC-1-A cell line |
| Idoxuridine_BT-474 | Idoxuridine perturbation in BT-474 cell line |
| Vortioxetine_BT-474 | Vortioxetine perturbation in BT-474 cell line |
| AZD-7648_NCI-H2122 | AZD-7648 perturbation in NCI-H2122 cell line |
| Dihydroartemisinin_HEC-1-A | Dihydroartemisinin perturbation in HEC-1-A cell line |
| Elagolix sodium_KATO III | Elagolix sodium perturbation in KATO III cell line |
| Piroxicam_BT-474 | Piroxicam perturbation in BT-474 cell line |
| APTO-253_HEC-1-A | APTO-253 perturbation in HEC-1-A cell line |
| Oleic acid_KATO III | Oleic acid perturbation in KATO III cell line |
| Econazole_COLO 205 | Econazole perturbation in COLO 205 cell line |
| Pemigatinib_HCT15 | Pemigatinib perturbation in HCT15 cell line |
| Baicalin_COLO 205 | Baicalin perturbation in COLO 205 cell line |
| Budesonide_KATO III | Budesonide perturbation in KATO III cell line |
| Mebendazole_HEC-1-A | Mebendazole perturbation in HEC-1-A cell line |
| Mifepristone_CFPAC-1 | Mifepristone perturbation in CFPAC-1 cell line |
| Radotinib_BT-474 | Radotinib perturbation in BT-474 cell line |
| Fingolimod (hydrochloride)_BT-474 | Fingolimod (hydrochloride) perturbation in BT-474 cell line |
| Triamcinolone_HCT15 | Triamcinolone perturbation in HCT15 cell line |
| Lipoic acid_KATO III | Lipoic acid perturbation in KATO III cell line |
| Vitamin K4_BT-474 | Vitamin K4 perturbation in BT-474 cell line |
| Meloxicam_NCI-H1573 | Meloxicam perturbation in NCI-H1573 cell line |
| Altretamine_A549 | Altretamine perturbation in A549 cell line |
| Imiquimod (hydrochloride)_HT-29 | Imiquimod (hydrochloride) perturbation in HT-29 cell line |
| Palmatine (chloride)_KATO III | Palmatine (chloride) perturbation in KATO III cell line |
| NG25_NCI-H1573 | NG25 perturbation in NCI-H1573 cell line |
| Betamethasone dipropionate_A498 | Betamethasone dipropionate perturbation in A498 cell line |
| Brimonidine_KATO III | Brimonidine perturbation in KATO III cell line |
| Minodronic acid_BT-474 | Minodronic acid perturbation in BT-474 cell line |
| Budesonide_A498 | Budesonide perturbation in A498 cell line |
| Cysteamine (hydrochloride)_KATO III | Cysteamine (hydrochloride) perturbation in KATO III cell line |
| Oxaliplatin_BT-474 | Oxaliplatin perturbation in BT-474 cell line |
| Raltitrexed_KATO III | Raltitrexed perturbation in KATO III cell line |
| Regorafenib_HEC-1-A | Regorafenib perturbation in HEC-1-A cell line |
| Artesunate_NCI-H1573 | Artesunate perturbation in NCI-H1573 cell line |
| Temsirolimus_BT-474 | Temsirolimus perturbation in BT-474 cell line |
| 8-Hydroxyquinoline_KATO III | 8-Hydroxyquinoline perturbation in KATO III cell line |
| Adenine_KATO III | Adenine perturbation in KATO III cell line |
| Artesunate_A498 | Artesunate perturbation in A498 cell line |
| Nimesulide_BT-474 | Nimesulide perturbation in BT-474 cell line |
| Pimozide_KATO III | Pimozide perturbation in KATO III cell line |
| Elagolix sodium_NCI-H1573 | Elagolix sodium perturbation in NCI-H1573 cell line |
| Piroxicam_LS 180 | Piroxicam perturbation in LS 180 cell line |
| Balsalazide (sodium hydrate)_KATO III | Balsalazide (sodium hydrate) perturbation in KATO III cell line |
| Rimonabant (Hydrochloride)_HEC-1-A | Rimonabant (Hydrochloride) perturbation in HEC-1-A cell line |
| Omeprazole (sodium)_BT-474 | Omeprazole (sodium) perturbation in BT-474 cell line |
| IQ 1_BT-474 | IQ 1 perturbation in BT-474 cell line |
| Clobetasol propionate_HT-29 | Clobetasol propionate perturbation in HT-29 cell line |
| Allantoin_KATO III | Allantoin perturbation in KATO III cell line |
| Isocorydine_BT-474 | Isocorydine perturbation in BT-474 cell line |
| Resveratrol_KATO III | Resveratrol perturbation in KATO III cell line |
| Econazole_HCT15 | Econazole perturbation in HCT15 cell line |
| Futibatinib_NCI-H1573 | Futibatinib perturbation in NCI-H1573 cell line |
| Mitoxantrone (dihydrochloride)_KATO III | Mitoxantrone (dihydrochloride) perturbation in KATO III cell line |
| Phenytoin (sodium)_BT-474 | Phenytoin (sodium) perturbation in BT-474 cell line |
| APTO-253_BT-474 | APTO-253 perturbation in BT-474 cell line |
| 9-ING-41_HT-29 | 9-ING-41 perturbation in HT-29 cell line |
| Mifepristone_Panc 03.27 | Mifepristone perturbation in Panc 03.27 cell line |
| Sodium Salicylate_COLO 205 | Sodium Salicylate perturbation in COLO 205 cell line |
| Adenosine_SW 900 | Adenosine perturbation in SW 900 cell line |
| Gallic acid_KATO III | Gallic acid perturbation in KATO III cell line |
| Nafamostat (mesylate)_HT-29 | Nafamostat (mesylate) perturbation in HT-29 cell line |
| Azithromycin (hydrate)_KATO III | Azithromycin (hydrate) perturbation in KATO III cell line |
| Delamanid_KATO III | Delamanid perturbation in KATO III cell line |
| Cyclosporin A_BT-474 | Cyclosporin A perturbation in BT-474 cell line |
| Cepharanthine_BT-474 | Cepharanthine perturbation in BT-474 cell line |
| Methyl aminolevulinate (hydrochloride)_HT-29 | Methyl aminolevulinate (hydrochloride) perturbation in HT-29 cell line |
| Medroxyprogesterone acetate_LS 180 | Medroxyprogesterone acetate perturbation in LS 180 cell line |
| Furosemide_BT-474 | Furosemide perturbation in BT-474 cell line |
| Dexmedetomidine_KATO III | Dexmedetomidine perturbation in KATO III cell line |
| Adenosine_KATO III | Adenosine perturbation in KATO III cell line |
| Regorafenib_BT-474 | Regorafenib perturbation in BT-474 cell line |
| AT7519_HEC-1-A | AT7519 perturbation in HEC-1-A cell line |
| Tofacitinib (citrate)_KATO III | Tofacitinib (citrate) perturbation in KATO III cell line |
| AZD1390_HCT15 | AZD1390 perturbation in HCT15 cell line |
| Flutamide_BT-474 | Flutamide perturbation in BT-474 cell line |
| Rifaximin_BT-474 | Rifaximin perturbation in BT-474 cell line |
| Berbamine (dihydrochloride)_KATO III | Berbamine (dihydrochloride) perturbation in KATO III cell line |
| Ouabain (Octahydrate)_BT-474 | Ouabain (Octahydrate) perturbation in BT-474 cell line |
| Fluvoxamine (maleate)_KATO III | Fluvoxamine (maleate) perturbation in KATO III cell line |
| Tucidinostat_BT-474 | Tucidinostat perturbation in BT-474 cell line |
| Minodronic acid_HEC-1-A | Minodronic acid perturbation in HEC-1-A cell line |
| Rosiglitazone_KATO III | Rosiglitazone perturbation in KATO III cell line |
| Ciclopirox_KATO III | Ciclopirox perturbation in KATO III cell line |
| LB-100_BT-474 | LB-100 perturbation in BT-474 cell line |
| Neratinib (maleate)_KATO III | Neratinib (maleate) perturbation in KATO III cell line |
| Flumatinib (mesylate)_COLO 205 | Flumatinib (mesylate) perturbation in COLO 205 cell line |
| Lumateperone (tosylate)_KATO III | Lumateperone (tosylate) perturbation in KATO III cell line |
| Berbamine_BT-474 | Berbamine perturbation in BT-474 cell line |
| Diammonium Glycyrrhizinate_HT-29 | Diammonium Glycyrrhizinate perturbation in HT-29 cell line |
| Hydroxyfasudil_LoVo | Hydroxyfasudil perturbation in LoVo cell line |
| Chlorhexidine (diacetate)_KATO III | Chlorhexidine (diacetate) perturbation in KATO III cell line |
| DTP3_BT-474 | DTP3 perturbation in BT-474 cell line |
| LY-2584702 (tosylate salt)_BT-474 | LY-2584702 (tosylate salt) perturbation in BT-474 cell line |
| Perindopril (erbumine)_HT-29 | Perindopril (erbumine) perturbation in HT-29 cell line |
| Lenalidomide (hemihydrate)_KATO III | Lenalidomide (hemihydrate) perturbation in KATO III cell line |
| LJI308_COLO 205 | LJI308 perturbation in COLO 205 cell line |
| Entecavir (monohydrate)_BT-474 | Entecavir (monohydrate) perturbation in BT-474 cell line |
| Ixazomib_KATO III | Ixazomib perturbation in KATO III cell line |
| Econazole_HT-29 | Econazole perturbation in HT-29 cell line |
| Lonafarnib_KATO III | Lonafarnib perturbation in KATO III cell line |
| Larotrectinib_KATO III | Larotrectinib perturbation in KATO III cell line |
| Digitoxin_BT-474 | Digitoxin perturbation in BT-474 cell line |
| DTP3_NCI-H1573 | DTP3 perturbation in NCI-H1573 cell line |
| Rifaximin_SW 900 | Rifaximin perturbation in SW 900 cell line |
| Lidocaine (hydrochloride)_HEC-1-A | Lidocaine (hydrochloride) perturbation in HEC-1-A cell line |
| Triamcinolone_KATO III | Triamcinolone perturbation in KATO III cell line |
| IQ 1_LoVo | IQ 1 perturbation in LoVo cell line |
| PH-797804_BT-474 | PH-797804 perturbation in BT-474 cell line |
| Torkinib_NCI-H2122 | Torkinib perturbation in NCI-H2122 cell line |
| Tirabrutinib_KATO III | Tirabrutinib perturbation in KATO III cell line |
| Rimonabant_LS 180 | Rimonabant perturbation in LS 180 cell line |
| Ribociclib_HEC-1-A | Ribociclib perturbation in HEC-1-A cell line |
| Zileuton_KATO III | Zileuton perturbation in KATO III cell line |
| Hexylresorcinol_HEC-1-A | Hexylresorcinol perturbation in HEC-1-A cell line |
| Medroxyprogesterone acetate_LoVo | Medroxyprogesterone acetate perturbation in LoVo cell line |
| Ipatasertib_COLO 205 | Ipatasertib perturbation in COLO 205 cell line |
| Tucidinostat_SW48 | Tucidinostat perturbation in SW48 cell line |
| Citalopram (hydrobromide)_BT-474 | Citalopram (hydrobromide) perturbation in BT-474 cell line |
| Regorafenib_NCI-H1573 | Regorafenib perturbation in NCI-H1573 cell line |
| Imiquimod (maleate)_COLO 205 | Imiquimod (maleate) perturbation in COLO 205 cell line |
| Triamcinolone_LoVo | Triamcinolone perturbation in LoVo cell line |
| vincristine_HCT15 | vincristine perturbation in HCT15 cell line |
| Omeprazole (sodium)_KATO III | Omeprazole (sodium) perturbation in KATO III cell line |
| Resveratrol_BT-474 | Resveratrol perturbation in BT-474 cell line |
| Pimozide_HT-29 | Pimozide perturbation in HT-29 cell line |
| Isocorydine_KATO III | Isocorydine perturbation in KATO III cell line |
| Meloxicam_HEC-1-A | Meloxicam perturbation in HEC-1-A cell line |
| palbociclib_HEC-1-A | palbociclib perturbation in HEC-1-A cell line |
| γ-Oryzanol_BT-474 | γ-Oryzanol perturbation in BT-474 cell line |
| Dinaciclib_A549 | Dinaciclib perturbation in A549 cell line |
| Tucidinostat_NCI-H2122 | Tucidinostat perturbation in NCI-H2122 cell line |
| Cyclosporin A_LoVo | Cyclosporin A perturbation in LoVo cell line |
| Phenytoin (sodium)_KATO III | Phenytoin (sodium) perturbation in KATO III cell line |
| Tranilast_HT-29 | Tranilast perturbation in HT-29 cell line |
| Ligustrazine_BT-474 | Ligustrazine perturbation in BT-474 cell line |
| Homoharringtonine_BT-474 | Homoharringtonine perturbation in BT-474 cell line |
| Tazarotene_BT-474 | Tazarotene perturbation in BT-474 cell line |
| Chlorhexidine (diacetate)_BT-474 | Chlorhexidine (diacetate) perturbation in BT-474 cell line |
| Gefitinib_KATO III | Gefitinib perturbation in KATO III cell line |
| Berbamine (dihydrochloride)_COLO 205 | Berbamine (dihydrochloride) perturbation in COLO 205 cell line |
| Adenine_HCT15 | Adenine perturbation in HCT15 cell line |
| Anethole trithione_HT-29 | Anethole trithione perturbation in HT-29 cell line |
| Thymol_KATO III | Thymol perturbation in KATO III cell line |
| Artesunate_HT-29 | Artesunate perturbation in HT-29 cell line |
| Medroxyprogesterone acetate_A498 | Medroxyprogesterone acetate perturbation in A498 cell line |
| Ixazomib_BT-474 | Ixazomib perturbation in BT-474 cell line |
| Larotrectinib sulfate_BT-474 | Larotrectinib sulfate perturbation in BT-474 cell line |
| Lucanthone_KATO III | Lucanthone perturbation in KATO III cell line |
| Topotecan (hydrochloride)_BT-474 | Topotecan (hydrochloride) perturbation in BT-474 cell line |
| Cepharanthine_KATO III | Cepharanthine perturbation in KATO III cell line |
| L-Thyroxine (sodium salt pentahydrate)_KATO III | L-Thyroxine (sodium salt pentahydrate) perturbation in KATO III cell line |
| Neratinib (maleate)_COLO 205 | Neratinib (maleate) perturbation in COLO 205 cell line |
| Pentoxifylline_BT-474 | Pentoxifylline perturbation in BT-474 cell line |
| Erythromycin_BT-474 | Erythromycin perturbation in BT-474 cell line |
| Palmatine (chloride)_HEC-1-A | Palmatine (chloride) perturbation in HEC-1-A cell line |
| Dexmedetomidine_BT-474 | Dexmedetomidine perturbation in BT-474 cell line |
| Rosiglitazone_COLO 205 | Rosiglitazone perturbation in COLO 205 cell line |
| Homoharringtonine_COLO 205 | Homoharringtonine perturbation in COLO 205 cell line |
| Regorafenib_KATO III | Regorafenib perturbation in KATO III cell line |
| Adenosine_BT-474 | Adenosine perturbation in BT-474 cell line |
| Neratinib_A549 | Neratinib perturbation in A549 cell line |
| Tofacitinib (citrate)_BT-474 | Tofacitinib (citrate) perturbation in BT-474 cell line |
| Lidocaine (hydrochloride)_HT-29 | Lidocaine (hydrochloride) perturbation in HT-29 cell line |
| Trimetrexate_KATO III | Trimetrexate perturbation in KATO III cell line |
| Oleic acid_HT-29 | Oleic acid perturbation in HT-29 cell line |
| Elagolix sodium_HT-29 | Elagolix sodium perturbation in HT-29 cell line |
| Tubulin inhibitor 6_BT-474 | Tubulin inhibitor 6 perturbation in BT-474 cell line |
| Tucidinostat_KATO III | Tucidinostat perturbation in KATO III cell line |
| Daptomycin_BT-474 | Daptomycin perturbation in BT-474 cell line |
| Alpelisib_KATO III | Alpelisib perturbation in KATO III cell line |
| Brimonidine_HEC-1-A | Brimonidine perturbation in HEC-1-A cell line |
| Flutamide_KATO III | Flutamide perturbation in KATO III cell line |
| Amsacrine_KATO III | Amsacrine perturbation in KATO III cell line |
| Elagolix sodium_BT-474 | Elagolix sodium perturbation in BT-474 cell line |
| Bimiralisib_A498 | Bimiralisib perturbation in A498 cell line |
| Anethole trithione_COLO 205 | Anethole trithione perturbation in COLO 205 cell line |
| Rapamycin_KATO III | Rapamycin perturbation in KATO III cell line |
| Tofacitinib (citrate)_HT-29 | Tofacitinib (citrate) perturbation in HT-29 cell line |
| Bisoprolol (hemifumarate)_A549 | Bisoprolol (hemifumarate) perturbation in A549 cell line |
| Ivermectin_NCI-H1573 | Ivermectin perturbation in NCI-H1573 cell line |
| Quinidine (15% dihydroquinidine)_KATO III | Quinidine (15% dihydroquinidine) perturbation in KATO III cell line |
| Ribociclib_BT-474 | Ribociclib perturbation in BT-474 cell line |
| Hexylresorcinol_BT-474 | Hexylresorcinol perturbation in BT-474 cell line |
| Glasdegib_HT-29 | Glasdegib perturbation in HT-29 cell line |
| Lactate (calcium)_LoVo | Lactate (calcium) perturbation in LoVo cell line |
| Pimozide_LS 180 | Pimozide perturbation in LS 180 cell line |
| Tolmetin_A549 | Tolmetin perturbation in A549 cell line |
| Pimitespib_NCI-H1573 | Pimitespib perturbation in NCI-H1573 cell line |
| Delamanid_HEC-1-A | Delamanid perturbation in HEC-1-A cell line |
| S-Adenosyl-L-methionine (disulfate tosylate)_LS 180 | S-Adenosyl-L-methionine (disulfate tosylate) perturbation in LS 180 cell line |
| Vitamin K4_KATO III | Vitamin K4 perturbation in KATO III cell line |
| Radotinib_KATO III | Radotinib perturbation in KATO III cell line |
| Mifepristone_BT-474 | Mifepristone perturbation in BT-474 cell line |
| Bergenin_KATO III | Bergenin perturbation in KATO III cell line |
| Larotrectinib_HT-29 | Larotrectinib perturbation in HT-29 cell line |
| Lidocaine (hydrochloride)_COLO 205 | Lidocaine (hydrochloride) perturbation in COLO 205 cell line |
| Rapamycin_LoVo | Rapamycin perturbation in LoVo cell line |
| Lenalidomide (hemihydrate)_HT-29 | Lenalidomide (hemihydrate) perturbation in HT-29 cell line |
| Temsirolimus_NCI-H1573 | Temsirolimus perturbation in NCI-H1573 cell line |
| Anethole trithione_BT-474 | Anethole trithione perturbation in BT-474 cell line |
| Crizotinib (hydrochloride)_HEC-1-A | Crizotinib (hydrochloride) perturbation in HEC-1-A cell line |
| c-Kit-IN-1_BT-474 | c-Kit-IN-1 perturbation in BT-474 cell line |
| Chlorhexidine (diacetate)_HT-29 | Chlorhexidine (diacetate) perturbation in HT-29 cell line |
| Neratinib (maleate)_HT-29 | Neratinib (maleate) perturbation in HT-29 cell line |
| Ropivacaine (hydrochloride monohydrate)_KATO III | Ropivacaine (hydrochloride monohydrate) perturbation in KATO III cell line |
| Infigratinib_COLO 205 | Infigratinib perturbation in COLO 205 cell line |
| Lactate (calcium)_KATO III | Lactate (calcium) perturbation in KATO III cell line |
| LY2090314_BT-474 | LY2090314 perturbation in BT-474 cell line |
| vincristine_BT-474 | vincristine perturbation in BT-474 cell line |
| Clotrimazole_KATO III | Clotrimazole perturbation in KATO III cell line |
| Allantoin_HCT15 | Allantoin perturbation in HCT15 cell line |
| S-Adenosyl-L-methionine (disulfate tosylate)_BT-474 | S-Adenosyl-L-methionine (disulfate tosylate) perturbation in BT-474 cell line |
| Cilostazol_COLO 205 | Cilostazol perturbation in COLO 205 cell line |
| Adenine_BT-474 | Adenine perturbation in BT-474 cell line |
| Benztropine (mesylate)_BT-474 | Benztropine (mesylate) perturbation in BT-474 cell line |
| Bisoprolol (hemifumarate)_BT-474 | Bisoprolol (hemifumarate) perturbation in BT-474 cell line |
| Resveratrol_HT-29 | Resveratrol perturbation in HT-29 cell line |
| Vitamin K4_NCI-H1573 | Vitamin K4 perturbation in NCI-H1573 cell line |
| Pimozide_BT-474 | Pimozide perturbation in BT-474 cell line |
| Lonafarnib_HEC-1-A | Lonafarnib perturbation in HEC-1-A cell line |
| Sulfisoxazole_BT-474 | Sulfisoxazole perturbation in BT-474 cell line |
| AZD-8055_BT-474 | AZD-8055 perturbation in BT-474 cell line |
| Relugolix_KATO III | Relugolix perturbation in KATO III cell line |
| Rucaparib (phosphate)_BT-474 | Rucaparib (phosphate) perturbation in BT-474 cell line |
| Pentoxifylline_HEC-1-A | Pentoxifylline perturbation in HEC-1-A cell line |
| AZD1390_KATO III | AZD1390 perturbation in KATO III cell line |
| S-Adenosyl-L-methionine (disulfate tosylate)_COLO 205 | S-Adenosyl-L-methionine (disulfate tosylate) perturbation in COLO 205 cell line |
| Delamanid_HT-29 | Delamanid perturbation in HT-29 cell line |
| OTS514_BT-474 | OTS514 perturbation in BT-474 cell line |
| Minodronic acid_KATO III | Minodronic acid perturbation in KATO III cell line |
| Cysteamine (hydrochloride)_BT-474 | Cysteamine (hydrochloride) perturbation in BT-474 cell line |
| Abiraterone acetate_BT-474 | Abiraterone acetate perturbation in BT-474 cell line |
| Tranilast_A549 | Tranilast perturbation in A549 cell line |
| Mifepristone_LS 180 | Mifepristone perturbation in LS 180 cell line |
| Raltitrexed_BT-474 | Raltitrexed perturbation in BT-474 cell line |
| Arbutin_A549 | Arbutin perturbation in A549 cell line |
| Temsirolimus_KATO III | Temsirolimus perturbation in KATO III cell line |
| Pyridoxine_HEC-1-A | Pyridoxine perturbation in HEC-1-A cell line |
| Pemigatinib_A-172 | Pemigatinib perturbation in A-172 cell line |
| Trifluridine_SHP-77 | Trifluridine perturbation in SHP-77 cell line |
| Hexylresorcinol_J82 | Hexylresorcinol perturbation in J82 cell line |
| Clobetasol propionate_NCI-H2030 | Clobetasol propionate perturbation in NCI-H2030 cell line |
| Dexamethasone_NCI-H2030 | Dexamethasone perturbation in NCI-H2030 cell line |
| Ponatinib_A549 | Ponatinib perturbation in A549 cell line |
| olaparib_A-172 | olaparib perturbation in A-172 cell line |
| Trametinib (DMSO_A549 | Trametinib (DMSO perturbation in A549 cell line |
| Lenalidomide (hemihydrate)_SHP-77 | Lenalidomide (hemihydrate) perturbation in SHP-77 cell line |
| Menadione_A498 | Menadione perturbation in A498 cell line |
| (R)-Verapamil (hydrochloride)_SHP-77 | (R)-Verapamil (hydrochloride) perturbation in SHP-77 cell line |
| Erlotinib_A498 | Erlotinib perturbation in A498 cell line |
| c-Kit-IN-1_SNU-1 | c-Kit-IN-1 perturbation in SNU-1 cell line |
| GSK1059615_SHP-77 | GSK1059615 perturbation in SHP-77 cell line |
| AZD1390_A-172 | AZD1390 perturbation in A-172 cell line |
| Clobetasol propionate_PANC-1 | Clobetasol propionate perturbation in PANC-1 cell line |
| Dexamethasone_PANC-1 | Dexamethasone perturbation in PANC-1 cell line |
| Pitavastatin (Calcium)_A498 | Pitavastatin (Calcium) perturbation in A498 cell line |
| Trametinib_A-172 | Trametinib perturbation in A-172 cell line |
| Proglumide_RKO | Proglumide perturbation in RKO cell line |
| Procainamide (hydrochloride)_A-172 | Procainamide (hydrochloride) perturbation in A-172 cell line |
| Cobimetinib_A-172 | Cobimetinib perturbation in A-172 cell line |
| Cobimetinib_HEC-1-A | Cobimetinib perturbation in HEC-1-A cell line |
| Dexamethasone_A498 | Dexamethasone perturbation in A498 cell line |
| Radotinib_CHP-212 | Radotinib perturbation in CHP-212 cell line |
| Tofacitinib_A498 | Tofacitinib perturbation in A498 cell line |
| Ligustrazine_HEC-1-A | Ligustrazine perturbation in HEC-1-A cell line |
| Ciclopirox_A-172 | Ciclopirox perturbation in A-172 cell line |
| Tazarotene_A-172 | Tazarotene perturbation in A-172 cell line |
| Lactate (calcium)_Hs 766T | Lactate (calcium) perturbation in Hs 766T cell line |
| Retinoic acid_AN3 CA | Retinoic acid perturbation in AN3 CA cell line |
| Cobimetinib_BT-474 | Cobimetinib perturbation in BT-474 cell line |
| Ipatasertib_BT-474 | Ipatasertib perturbation in BT-474 cell line |
| APTO-253_AN3 CA | APTO-253 perturbation in AN3 CA cell line |
| Afatinib_BT-474 | Afatinib perturbation in BT-474 cell line |
| Capmatinib_BT-474 | Capmatinib perturbation in BT-474 cell line |
| Panobinostat_HT-29 | Panobinostat perturbation in HT-29 cell line |
| Clonidine (hydrochloride)_HepG2/C3A | Clonidine (hydrochloride) perturbation in HepG2/C3A cell line |
| Rifaximin_HT-29 | Rifaximin perturbation in HT-29 cell line |
| DTP3_HepG2/C3A | DTP3 perturbation in HepG2/C3A cell line |
| HI-TOPK-032_NCI-H596 | HI-TOPK-032 perturbation in NCI-H596 cell line |
| Brimonidine_HT-29 | Brimonidine perturbation in HT-29 cell line |
| Voriconazole_HT-29 | Voriconazole perturbation in HT-29 cell line |
| Glasdegib_HepG2/C3A | Glasdegib perturbation in HepG2/C3A cell line |
| Pentamidine (isethionate)_NCI-H661 | Pentamidine (isethionate) perturbation in NCI-H661 cell line |
| Pyridoxine (hydrochloride)_HCT15 | Pyridoxine (hydrochloride) perturbation in HCT15 cell line |
| Lipoic acid_HepG2/C3A | Lipoic acid perturbation in HepG2/C3A cell line |
| Benproperine (phosphate)_C-33 A | Benproperine (phosphate) perturbation in C-33 A cell line |
| Lenalidomide (hemihydrate)_NCI-H1573 | Lenalidomide (hemihydrate) perturbation in NCI-H1573 cell line |
| Ritonavir_SW 900 | Ritonavir perturbation in SW 900 cell line |
| Idoxuridine_RKO | Idoxuridine perturbation in RKO cell line |
| Dexamethasone_MIA PaCa-2 | Dexamethasone perturbation in MIA PaCa-2 cell line |
| Bendamustine_NCI-H23 | Bendamustine perturbation in NCI-H23 cell line |
| Acetohexamide_HCT15 | Acetohexamide perturbation in HCT15 cell line |
| Arbutin_J82 | Arbutin perturbation in J82 cell line |
| Belumosudil_PANC-1 | Belumosudil perturbation in PANC-1 cell line |
| vincristine_J82 | vincristine perturbation in J82 cell line |
| Daidzin_A-427 | Daidzin perturbation in A-427 cell line |
| Decitabine_NCI-H661 | Decitabine perturbation in NCI-H661 cell line |
| Rifaximin_PANC-1 | Rifaximin perturbation in PANC-1 cell line |
| Benproperine (phosphate)_CFPAC-1 | Benproperine (phosphate) perturbation in CFPAC-1 cell line |
| Asciminib_J82 | Asciminib perturbation in J82 cell line |
| Lopinavir_SW 1271 | Lopinavir perturbation in SW 1271 cell line |
| Asciminib_CHP-212 | Asciminib perturbation in CHP-212 cell line |
| Docetaxel_NCI-H596 | Docetaxel perturbation in NCI-H596 cell line |
| SBI-0640756_NCI-H2030 | SBI-0640756 perturbation in NCI-H2030 cell line |
| Crizotinib (hydrochloride)_J82 | Crizotinib (hydrochloride) perturbation in J82 cell line |
| Homoharringtonine_SHP-77 | Homoharringtonine perturbation in SHP-77 cell line |
| Plicamycin_SW 1271 | Plicamycin perturbation in SW 1271 cell line |
| Erlotinib_A-427 | Erlotinib perturbation in A-427 cell line |
| Fumaric acid_NCI-H2030 | Fumaric acid perturbation in NCI-H2030 cell line |
| Lucanthone_RPMI-7951 | Lucanthone perturbation in RPMI-7951 cell line |
| Afatinib_Panc 03.27 | Afatinib perturbation in Panc 03.27 cell line |
| Rosiglitazone_AN3 CA | Rosiglitazone perturbation in AN3 CA cell line |
| Harringtonine_J82 | Harringtonine perturbation in J82 cell line |
| Vortioxetine_HT-29 | Vortioxetine perturbation in HT-29 cell line |
| Verapamil_NCI-H661 | Verapamil perturbation in NCI-H661 cell line |
| Rimonabant (Hydrochloride)_A-427 | Rimonabant (Hydrochloride) perturbation in A-427 cell line |
| Arbutin_NCI-H661 | Arbutin perturbation in NCI-H661 cell line |
| Megestrol_A-427 | Megestrol perturbation in A-427 cell line |
| Verteporfin_SK-MEL-2 | Verteporfin perturbation in SK-MEL-2 cell line |
| Estrone sulfate (potassium)_SW 1271 | Estrone sulfate (potassium) perturbation in SW 1271 cell line |
| Belumosudil_A-427 | Belumosudil perturbation in A-427 cell line |
| Lumateperone (tosylate)_NCI-H2030 | Lumateperone (tosylate) perturbation in NCI-H2030 cell line |
| Ouabain (Octahydrate)_J82 | Ouabain (Octahydrate) perturbation in J82 cell line |
| Harringtonine_PANC-1 | Harringtonine perturbation in PANC-1 cell line |
| Tirabrutinib (hydrochloride)_AN3 CA | Tirabrutinib (hydrochloride) perturbation in AN3 CA cell line |
| Regorafenib_NCI-H23 | Regorafenib perturbation in NCI-H23 cell line |
| Tirabrutinib (hydrochloride)_SHP-77 | Tirabrutinib (hydrochloride) perturbation in SHP-77 cell line |
| Everolimus_SW 1271 | Everolimus perturbation in SW 1271 cell line |
| Darolutamide_J82 | Darolutamide perturbation in J82 cell line |
| Cilostazol_NCI-H2030 | Cilostazol perturbation in NCI-H2030 cell line |
| Erlotinib_PANC-1 | Erlotinib perturbation in PANC-1 cell line |
| Pentoxifylline_NCI-H661 | Pentoxifylline perturbation in NCI-H661 cell line |
| Trifluridine_SW 1271 | Trifluridine perturbation in SW 1271 cell line |
| Sonidegib_NCI-H2122 | Sonidegib perturbation in NCI-H2122 cell line |
| Pioglitazone_HT-29 | Pioglitazone perturbation in HT-29 cell line |
| Gemcitabine_NCI-H2122 | Gemcitabine perturbation in NCI-H2122 cell line |
| Imiquimod (hydrochloride)_COLO 205 | Imiquimod (hydrochloride) perturbation in COLO 205 cell line |
| Omeprazole (sodium)_COLO 205 | Omeprazole (sodium) perturbation in COLO 205 cell line |
| Bexarotene_LS 180 | Bexarotene perturbation in LS 180 cell line |
| Apalutamide_HT-29 | Apalutamide perturbation in HT-29 cell line |
| Bisoprolol (hemifumarate)_HT-29 | Bisoprolol (hemifumarate) perturbation in HT-29 cell line |
| Minodronic acid_NCI-H2122 | Minodronic acid perturbation in NCI-H2122 cell line |
| Sunitinib_HT-29 | Sunitinib perturbation in HT-29 cell line |
| Bexarotene_HCT15 | Bexarotene perturbation in HCT15 cell line |
| Gallic acid_HT-29 | Gallic acid perturbation in HT-29 cell line |
| Talc_NCI-H2122 | Talc perturbation in NCI-H2122 cell line |
| Imiquimod (maleate)_HT-29 | Imiquimod (maleate) perturbation in HT-29 cell line |
| Lipoic acid_HOP62 | Lipoic acid perturbation in HOP62 cell line |
| Cytarabine_HT-29 | Cytarabine perturbation in HT-29 cell line |
| Ribociclib_SNU-1 | Ribociclib perturbation in SNU-1 cell line |
| Pemetrexed_SNU-1 | Pemetrexed perturbation in SNU-1 cell line |
| AZD-8055_SNU-1 | AZD-8055 perturbation in SNU-1 cell line |
| Sinomenine_SNU-1 | Sinomenine perturbation in SNU-1 cell line |
| Procainamide (hydrochloride)_SNU-1 | Procainamide (hydrochloride) perturbation in SNU-1 cell line |
| Clonidine (hydrochloride)_SNU-1 | Clonidine (hydrochloride) perturbation in SNU-1 cell line |
| Lenalidomide (hemihydrate)_SW1417 | Lenalidomide (hemihydrate) perturbation in SW1417 cell line |
| Oxaprozin_BT-474 | Oxaprozin perturbation in BT-474 cell line |
| Nimesulide_SNU-1 | Nimesulide perturbation in SNU-1 cell line |
| Docetaxel_SNU-1 | Docetaxel perturbation in SNU-1 cell line |
| Dihydroartemisinin_SNU-1 | Dihydroartemisinin perturbation in SNU-1 cell line |
| Trimetrexate_SNU-1 | Trimetrexate perturbation in SNU-1 cell line |
| Cytarabine_SNU-1 | Cytarabine perturbation in SNU-1 cell line |
| Dexamethasone_SNU-423 | Dexamethasone perturbation in SNU-423 cell line |
| Sapanisertib_LoVo | Sapanisertib perturbation in LoVo cell line |
| Rimonabant_LoVo | Rimonabant perturbation in LoVo cell line |
| LB-100_LoVo | LB-100 perturbation in LoVo cell line |
| Epirubicin (hydrochloride)_HEC-1-A | Epirubicin (hydrochloride) perturbation in HEC-1-A cell line |
| Hesperidin_AN3 CA | Hesperidin perturbation in AN3 CA cell line |
| Hexylresorcinol_CFPAC-1 | Hexylresorcinol perturbation in CFPAC-1 cell line |
| Lidocaine (hydrochloride)_LoVo | Lidocaine (hydrochloride) perturbation in LoVo cell line |
| Pyridoxine (hydrochloride)_NCI-H2122 | Pyridoxine (hydrochloride) perturbation in NCI-H2122 cell line |
| Verteporfin_LoVo | Verteporfin perturbation in LoVo cell line |
| Tetracycline (hydrochloride)_KATO III | Tetracycline (hydrochloride) perturbation in KATO III cell line |
| Triclosan_LS 180 | Triclosan perturbation in LS 180 cell line |
| Saquinavir_KATO III | Saquinavir perturbation in KATO III cell line |
| Ivabradine (hydrochloride)_LoVo | Ivabradine (hydrochloride) perturbation in LoVo cell line |
| Ribociclib_LoVo | Ribociclib perturbation in LoVo cell line |
| Raltitrexed_NCI-H2122 | Raltitrexed perturbation in NCI-H2122 cell line |
| Pexidartinib (hydrochloride)_BT-474 | Pexidartinib (hydrochloride) perturbation in BT-474 cell line |
| NVP-BHG712_NCI-H2122 | NVP-BHG712 perturbation in NCI-H2122 cell line |
| Adenine_NCI-H2122 | Adenine perturbation in NCI-H2122 cell line |
| Mifepristone_LoVo | Mifepristone perturbation in LoVo cell line |
| Artesunate_LoVo | Artesunate perturbation in LoVo cell line |
| Clonidine (hydrochloride)_BT-474 | Clonidine (hydrochloride) perturbation in BT-474 cell line |
| Lopinavir_RPMI-7951 | Lopinavir perturbation in RPMI-7951 cell line |
| Tetracycline (hydrochloride)_LoVo | Tetracycline (hydrochloride) perturbation in LoVo cell line |
| Proglumide_AsPC-1 | Proglumide perturbation in AsPC-1 cell line |
| Clopidogrel_LS 180 | Clopidogrel perturbation in LS 180 cell line |
| Bicalutamide_A549 | Bicalutamide perturbation in A549 cell line |
| Arbutin_LoVo | Arbutin perturbation in LoVo cell line |
| Indacaterol (maleate)_Panc 03.27 | Indacaterol (maleate) perturbation in Panc 03.27 cell line |
| Bicalutamide_LS 180 | Bicalutamide perturbation in LS 180 cell line |
| Tolmetin_NCI-H2122 | Tolmetin perturbation in NCI-H2122 cell line |
| Vismodegib_LoVo | Vismodegib perturbation in LoVo cell line |
| Rucaparib (phosphate)_NCI-H2122 | Rucaparib (phosphate) perturbation in NCI-H2122 cell line |
| Bisoprolol (hemifumarate)_LoVo | Bisoprolol (hemifumarate) perturbation in LoVo cell line |
| Benproperine (phosphate)_LoVo | Benproperine (phosphate) perturbation in LoVo cell line |
| Fulvestrant_BT-474 | Fulvestrant perturbation in BT-474 cell line |
| Adenine_LoVo | Adenine perturbation in LoVo cell line |
| Vilanterol_NCI-H2122 | Vilanterol perturbation in NCI-H2122 cell line |
| Daidzin_LoVo | Daidzin perturbation in LoVo cell line |
| Almonertinib (mesylate)_COLO 205 | Almonertinib (mesylate) perturbation in COLO 205 cell line |
| Anethole trithione_NCI-H2122 | Anethole trithione perturbation in NCI-H2122 cell line |
| Cilostazol_KATO III | Cilostazol perturbation in KATO III cell line |
| Pyridoxine (hydrochloride)_KATO III | Pyridoxine (hydrochloride) perturbation in KATO III cell line |
| palbociclib_NCI-H2122 | palbociclib perturbation in NCI-H2122 cell line |
| Belzutifan_LoVo | Belzutifan perturbation in LoVo cell line |
| Perindopril (erbumine)_LS 180 | Perindopril (erbumine) perturbation in LS 180 cell line |
| Apalutamide_LoVo | Apalutamide perturbation in LoVo cell line |
| LY2090314_NCI-H2122 | LY2090314 perturbation in NCI-H2122 cell line |
| Diphenhydramine_LoVo | Diphenhydramine perturbation in LoVo cell line |
| Tolmetin_LoVo | Tolmetin perturbation in LoVo cell line |
| 9-ING-41_BT-474 | 9-ING-41 perturbation in BT-474 cell line |
| Cinacalcet_BT-474 | Cinacalcet perturbation in BT-474 cell line |
| Elagolix sodium_NCI-H2122 | Elagolix sodium perturbation in NCI-H2122 cell line |
| Palmatine (chloride)_LoVo | Palmatine (chloride) perturbation in LoVo cell line |
| ML264_NCI-H2122 | ML264 perturbation in NCI-H2122 cell line |
| Proglumide_RPMI-7951 | Proglumide perturbation in RPMI-7951 cell line |
| Econazole_RPMI-7951 | Econazole perturbation in RPMI-7951 cell line |
| Rutin (trihydrate)_LoVo | Rutin (trihydrate) perturbation in LoVo cell line |
| Lidocaine (hydrochloride)_NCI-H2122 | Lidocaine (hydrochloride) perturbation in NCI-H2122 cell line |
| Cilostazol_LoVo | Cilostazol perturbation in LoVo cell line |
| Brimonidine_LoVo | Brimonidine perturbation in LoVo cell line |
| Clopidogrel_BT-474 | Clopidogrel perturbation in BT-474 cell line |
| Eplerenone_LoVo | Eplerenone perturbation in LoVo cell line |
| Asciminib_LoVo | Asciminib perturbation in LoVo cell line |
| venetoclax_LoVo | venetoclax perturbation in LoVo cell line |
| Rapamycin_LS 180 | Rapamycin perturbation in LS 180 cell line |
| Talc_RPMI-7951 | Talc perturbation in RPMI-7951 cell line |
| Verapamil_BT-474 | Verapamil perturbation in BT-474 cell line |
| Methylprednisolone succinate_LoVo | Methylprednisolone succinate perturbation in LoVo cell line |
| Imiquimod (maleate)_LoVo | Imiquimod (maleate) perturbation in LoVo cell line |
| Malotilate_AsPC-1 | Malotilate perturbation in AsPC-1 cell line |
| Regorafenib_LS 180 | Regorafenib perturbation in LS 180 cell line |
| Adenosine_NCI-H2122 | Adenosine perturbation in NCI-H2122 cell line |
| Pentagastrin_COLO 205 | Pentagastrin perturbation in COLO 205 cell line |
| Methotrexate_KATO III | Methotrexate perturbation in KATO III cell line |
| Zileuton_COLO 205 | Zileuton perturbation in COLO 205 cell line |
| Posaconazole_LS 180 | Posaconazole perturbation in LS 180 cell line |
| Simotinib_LS 180 | Simotinib perturbation in LS 180 cell line |
| Harringtonine_LoVo | Harringtonine perturbation in LoVo cell line |
| Lucanthone_LS 180 | Lucanthone perturbation in LS 180 cell line |
| Orlistat_KATO III | Orlistat perturbation in KATO III cell line |
| Larotrectinib_NCI-H1573 | Larotrectinib perturbation in NCI-H1573 cell line |
| Ipatasertib_LoVo | Ipatasertib perturbation in LoVo cell line |
| Docetaxel (Trihydrate)_LoVo | Docetaxel (Trihydrate) perturbation in LoVo cell line |
| Resveratrol_LoVo | Resveratrol perturbation in LoVo cell line |
| Methotrexate_LoVo | Methotrexate perturbation in LoVo cell line |
| Sunitinib_LoVo | Sunitinib perturbation in LoVo cell line |
| Neratinib_LoVo | Neratinib perturbation in LoVo cell line |
| Indacaterol (maleate)_LoVo | Indacaterol (maleate) perturbation in LoVo cell line |
| Ciclopirox_C32 | Ciclopirox perturbation in C32 cell line |
| olaparib_BT-474 | olaparib perturbation in BT-474 cell line |
| Ciclopirox_LoVo | Ciclopirox perturbation in LoVo cell line |
| Tadalafil_KATO III | Tadalafil perturbation in KATO III cell line |
| Rosiglitazone_LoVo | Rosiglitazone perturbation in LoVo cell line |
| Ornidazole_LoVo | Ornidazole perturbation in LoVo cell line |
| Isocorydine_LS 180 | Isocorydine perturbation in LS 180 cell line |
| Allantoin_NCI-H2122 | Allantoin perturbation in NCI-H2122 cell line |
| Chlorhexidine (diacetate)_LoVo | Chlorhexidine (diacetate) perturbation in LoVo cell line |
| Folic acid_LoVo | Folic acid perturbation in LoVo cell line |
| Loperamide (hydrochloride)_LoVo | Loperamide (hydrochloride) perturbation in LoVo cell line |
| Hydroxyurea_LoVo | Hydroxyurea perturbation in LoVo cell line |
| Estrone sulfate (potassium)_KATO III | Estrone sulfate (potassium) perturbation in KATO III cell line |
| Larotrectinib sulfate_LoVo | Larotrectinib sulfate perturbation in LoVo cell line |
| Megestrol_BT-474 | Megestrol perturbation in BT-474 cell line |
| Sunitinib_NCI-H2122 | Sunitinib perturbation in NCI-H2122 cell line |
| (R)-Verapamil (hydrochloride)_LoVo | (R)-Verapamil (hydrochloride) perturbation in LoVo cell line |
| Topotecan (hydrochloride)_LoVo | Topotecan (hydrochloride) perturbation in LoVo cell line |
| Azithromycin (hydrate)_C32 | Azithromycin (hydrate) perturbation in C32 cell line |
| Glasdegib_LoVo | Glasdegib perturbation in LoVo cell line |
| Dapagliflozin_BT-474 | Dapagliflozin perturbation in BT-474 cell line |
| Erythromycin_LoVo | Erythromycin perturbation in LoVo cell line |
| Gallic acid_C32 | Gallic acid perturbation in C32 cell line |
| Fostamatinib (disodium hexahydrate)_LoVo | Fostamatinib (disodium hexahydrate) perturbation in LoVo cell line |
| Malotilate_LS 180 | Malotilate perturbation in LS 180 cell line |
| Regorafenib_AsPC-1 | Regorafenib perturbation in AsPC-1 cell line |
| Norepinephrine (hydrochloride)_LS 180 | Norepinephrine (hydrochloride) perturbation in LS 180 cell line |
| Berbamine (dihydrochloride)_LoVo | Berbamine (dihydrochloride) perturbation in LoVo cell line |
| Canagliflozin (hemihydrate)_BT-474 | Canagliflozin (hemihydrate) perturbation in BT-474 cell line |
| Estrone sulfate (potassium)_LoVo | Estrone sulfate (potassium) perturbation in LoVo cell line |
| Ixazomib citrate_LoVo | Ixazomib citrate perturbation in LoVo cell line |
| Pentoxifylline_CFPAC-1 | Pentoxifylline perturbation in CFPAC-1 cell line |
| Erlotinib_LoVo | Erlotinib perturbation in LoVo cell line |
| Dimethyl fumarate_KATO III | Dimethyl fumarate perturbation in KATO III cell line |
| Ciclopirox_A549 | Ciclopirox perturbation in A549 cell line |
| Belumosudil_LoVo | Belumosudil perturbation in LoVo cell line |
| Folic acid_LS 180 | Folic acid perturbation in LS 180 cell line |
| Chlorhexidine (diacetate)_LS 180 | Chlorhexidine (diacetate) perturbation in LS 180 cell line |
| Finasteride_LoVo | Finasteride perturbation in LoVo cell line |
| (S)-Crizotinib_LoVo | (S)-Crizotinib perturbation in LoVo cell line |
| Lactate (calcium)_Panc 03.27 | Lactate (calcium) perturbation in Panc 03.27 cell line |
| Mozavaptan_LoVo | Mozavaptan perturbation in LoVo cell line |
| Ciclopirox_LS 180 | Ciclopirox perturbation in LS 180 cell line |
| Hydroxyurea_A549 | Hydroxyurea perturbation in A549 cell line |
| Cepharanthine_NCI-H2122 | Cepharanthine perturbation in NCI-H2122 cell line |
| Estrone sulfate (potassium)_LS 180 | Estrone sulfate (potassium) perturbation in LS 180 cell line |
| Decitabine_LoVo | Decitabine perturbation in LoVo cell line |
| Adenosine_LS 180 | Adenosine perturbation in LS 180 cell line |
| Fostamatinib (disodium hexahydrate)_LS 180 | Fostamatinib (disodium hexahydrate) perturbation in LS 180 cell line |
| Dabrafenib_NCI-H2122 | Dabrafenib perturbation in NCI-H2122 cell line |
| Macitentan_LoVo | Macitentan perturbation in LoVo cell line |
| Tirabrutinib_LoVo | Tirabrutinib perturbation in LoVo cell line |
| Sulfatinib_LoVo | Sulfatinib perturbation in LoVo cell line |
| Dapagliflozin ((2S)-1,2-propanediol, hydrate)_AsPC-1 | Dapagliflozin ((2S)-1,2-propanediol, hydrate) perturbation in AsPC-1 cell line |
| Topotecan (hydrochloride)_LS 180 | Topotecan (hydrochloride) perturbation in LS 180 cell line |
| Zileuton_LoVo | Zileuton perturbation in LoVo cell line |
| Almonertinib (hydrochloride)_LoVo | Almonertinib (hydrochloride) perturbation in LoVo cell line |
| Adenosine_A549 | Adenosine perturbation in A549 cell line |
| Dapagliflozin ((2S)-1,2-propanediol, hydrate)_LS 180 | Dapagliflozin ((2S)-1,2-propanediol, hydrate) perturbation in LS 180 cell line |
| Simotinib_LoVo | Simotinib perturbation in LoVo cell line |
| Levobupivacaine (hydrochloride)_LoVo | Levobupivacaine (hydrochloride) perturbation in LoVo cell line |
| Posaconazole_LoVo | Posaconazole perturbation in LoVo cell line |
| Crizotinib (hydrochloride)_RPMI-7951 | Crizotinib (hydrochloride) perturbation in RPMI-7951 cell line |
| Cytarabine_LoVo | Cytarabine perturbation in LoVo cell line |
| Trimetrexate_LoVo | Trimetrexate perturbation in LoVo cell line |
| GSK1059615_LS 180 | GSK1059615 perturbation in LS 180 cell line |
| Fostamatinib (disodium hexahydrate)_AsPC-1 | Fostamatinib (disodium hexahydrate) perturbation in AsPC-1 cell line |
| Tucidinostat_LoVo | Tucidinostat perturbation in LoVo cell line |
| Adenosine_COLO 205 | Adenosine perturbation in COLO 205 cell line |
| crizotinib_LoVo | crizotinib perturbation in LoVo cell line |
| Furosemide_KATO III | Furosemide perturbation in KATO III cell line |
| Rimonabant (Hydrochloride)_LoVo | Rimonabant (Hydrochloride) perturbation in LoVo cell line |
| Thymol_LoVo | Thymol perturbation in LoVo cell line |
| DTP3_LoVo | DTP3 perturbation in LoVo cell line |
| Elagolix sodium_Hs 766T | Elagolix sodium perturbation in Hs 766T cell line |
| Fluvoxamine (maleate)_BT-474 | Fluvoxamine (maleate) perturbation in BT-474 cell line |
| Ixazomib citrate_BT-474 | Ixazomib citrate perturbation in BT-474 cell line |
| Peretinoin_NCI-H2122 | Peretinoin perturbation in NCI-H2122 cell line |
| Canagliflozin (hemihydrate)_LoVo | Canagliflozin (hemihydrate) perturbation in LoVo cell line |
| Estrone sulfate (potassium)_BT-474 | Estrone sulfate (potassium) perturbation in BT-474 cell line |
| Medroxyprogesterone acetate_NCI-H2122 | Medroxyprogesterone acetate perturbation in NCI-H2122 cell line |
| Bergenin_LoVo | Bergenin perturbation in LoVo cell line |
| Pimozide_A549 | Pimozide perturbation in A549 cell line |
| Econazole_LoVo | Econazole perturbation in LoVo cell line |
| Penfluridol_Panc 03.27 | Penfluridol perturbation in Panc 03.27 cell line |
| Perindopril (erbumine)_LoVo | Perindopril (erbumine) perturbation in LoVo cell line |
| Altretamine_LoVo | Altretamine perturbation in LoVo cell line |
| Clotrimazole_CFPAC-1 | Clotrimazole perturbation in CFPAC-1 cell line |
| Auranofin_LoVo | Auranofin perturbation in LoVo cell line |
| Talc_LoVo | Talc perturbation in LoVo cell line |
| Diammonium Glycyrrhizinate_LoVo | Diammonium Glycyrrhizinate perturbation in LoVo cell line |
| Fenofibrate_LoVo | Fenofibrate perturbation in LoVo cell line |
| Naproxen_LoVo | Naproxen perturbation in LoVo cell line |
| Bestatin_LoVo | Bestatin perturbation in LoVo cell line |
| Clotrimazole_LoVo | Clotrimazole perturbation in LoVo cell line |
| Ralimetinib dimesylate_LoVo | Ralimetinib dimesylate perturbation in LoVo cell line |
| Pexidartinib (hydrochloride)_LoVo | Pexidartinib (hydrochloride) perturbation in LoVo cell line |
| Cilostazol_A549 | Cilostazol perturbation in A549 cell line |
| Econazole_KATO III | Econazole perturbation in KATO III cell line |
| Pravastatin (sodium)_LoVo | Pravastatin (sodium) perturbation in LoVo cell line |
| Vortioxetine_LoVo | Vortioxetine perturbation in LoVo cell line |
| Procainamide (hydrochloride)_LS 180 | Procainamide (hydrochloride) perturbation in LS 180 cell line |
| Proglumide_KATO III | Proglumide perturbation in KATO III cell line |
| Brimonidine_LS 180 | Brimonidine perturbation in LS 180 cell line |
| Piroxicam_LoVo | Piroxicam perturbation in LoVo cell line |
| Epirubicin (hydrochloride)_LoVo | Epirubicin (hydrochloride) perturbation in LoVo cell line |
| Cilostazol_LS 180 | Cilostazol perturbation in LS 180 cell line |
| Trifluridine_LS 180 | Trifluridine perturbation in LS 180 cell line |
| PF-06260933_LS 180 | PF-06260933 perturbation in LS 180 cell line |
| 9-ING-41_NCI-H2122 | 9-ING-41 perturbation in NCI-H2122 cell line |
| Radotinib_LoVo | Radotinib perturbation in LoVo cell line |
| Idoxuridine_NCI-H2122 | Idoxuridine perturbation in NCI-H2122 cell line |
| Rapamycin_NCI-H2122 | Rapamycin perturbation in NCI-H2122 cell line |
| Budesonide_LS 180 | Budesonide perturbation in LS 180 cell line |
| Hexylresorcinol_LS 180 | Hexylresorcinol perturbation in LS 180 cell line |
| Verteporfin_LS 180 | Verteporfin perturbation in LS 180 cell line |
| Sonidegib_BT-474 | Sonidegib perturbation in BT-474 cell line |
| Ivermectin_KATO III | Ivermectin perturbation in KATO III cell line |
| Tolmetin_BT-474 | Tolmetin perturbation in BT-474 cell line |
| L-Eflornithine (monohydrochloride)_KATO III | L-Eflornithine (monohydrochloride) perturbation in KATO III cell line |
| Trifluridine_BT-474 | Trifluridine perturbation in BT-474 cell line |
| Baicalin_NCI-H2122 | Baicalin perturbation in NCI-H2122 cell line |
| Almonertinib (mesylate)_LoVo | Almonertinib (mesylate) perturbation in LoVo cell line |
| Daidzin_COLO 205 | Daidzin perturbation in COLO 205 cell line |
| Fluvoxamine_LoVo | Fluvoxamine perturbation in LoVo cell line |
| Dexamethasone_LoVo | Dexamethasone perturbation in LoVo cell line |
| Pyridoxine (hydrochloride)_BT-474 | Pyridoxine (hydrochloride) perturbation in BT-474 cell line |
| Daidzin_AsPC-1 | Daidzin perturbation in AsPC-1 cell line |
| Entrectinib_BT-474 | Entrectinib perturbation in BT-474 cell line |
| Clopidogrel_LoVo | Clopidogrel perturbation in LoVo cell line |
| Tetracycline (hydrochloride)_LS 180 | Tetracycline (hydrochloride) perturbation in LS 180 cell line |
| Capivasertib_LoVo | Capivasertib perturbation in LoVo cell line |
| Bergenin_NCI-H1573 | Bergenin perturbation in NCI-H1573 cell line |
| Verapamil_LoVo | Verapamil perturbation in LoVo cell line |
| Esmolol (hydrochloride)_LS 180 | Esmolol (hydrochloride) perturbation in LS 180 cell line |
| Sulfisoxazole_COLO 205 | Sulfisoxazole perturbation in COLO 205 cell line |
| Aliskiren_SW 1271 | Aliskiren perturbation in SW 1271 cell line |
| Cloxacillin (sodium)_Hs 766T | Cloxacillin (sodium) perturbation in Hs 766T cell line |
| Vortioxetine_AsPC-1 | Vortioxetine perturbation in AsPC-1 cell line |
| Riluzole hydrochloride_KATO III | Riluzole hydrochloride perturbation in KATO III cell line |
| Vandetanib_COLO 205 | Vandetanib perturbation in COLO 205 cell line |
| Elagolix sodium_LoVo | Elagolix sodium perturbation in LoVo cell line |
| Temsirolimus_LS 180 | Temsirolimus perturbation in LS 180 cell line |
| Alpelisib_NCI-H596 | Alpelisib perturbation in NCI-H596 cell line |
| DTP3_HT-29 | DTP3 perturbation in HT-29 cell line |
| Idoxuridine_COLO 205 | Idoxuridine perturbation in COLO 205 cell line |
| Lopinavir_SW480 | Lopinavir perturbation in SW480 cell line |
| Fulvestrant_SW480 | Fulvestrant perturbation in SW480 cell line |
| AZD1390_SW480 | AZD1390 perturbation in SW480 cell line |
| Filgotinib_HT-29 | Filgotinib perturbation in HT-29 cell line |
| AZD1390_LS 180 | AZD1390 perturbation in LS 180 cell line |
| ETC-206_LS 180 | ETC-206 perturbation in LS 180 cell line |
| L-Eflornithine (monohydrochloride)_LS 180 | L-Eflornithine (monohydrochloride) perturbation in LS 180 cell line |
| Relugolix_LS 180 | Relugolix perturbation in LS 180 cell line |
| Clopidogrel_SW480 | Clopidogrel perturbation in SW480 cell line |
| Megestrol_HT-29 | Megestrol perturbation in HT-29 cell line |
| Dexamethasone_A549 | Dexamethasone perturbation in A549 cell line |
| Perindopril (erbumine)_COLO 205 | Perindopril (erbumine) perturbation in COLO 205 cell line |
| Ivermectin_LS 180 | Ivermectin perturbation in LS 180 cell line |
| 18β-Glycyrrhetinic acid_HT-29 | 18β-Glycyrrhetinic acid perturbation in HT-29 cell line |
| Ivermectin_SW480 | Ivermectin perturbation in SW480 cell line |
| Lidocaine (hydrochloride)_KATO III | Lidocaine (hydrochloride) perturbation in KATO III cell line |
| Panobinostat_SK-MEL-2 | Panobinostat perturbation in SK-MEL-2 cell line |
| 5-Azacytidine_SW480 | 5-Azacytidine perturbation in SW480 cell line |
| Tofacitinib_COLO 205 | Tofacitinib perturbation in COLO 205 cell line |
| Thymopentin_COLO 205 | Thymopentin perturbation in COLO 205 cell line |
| Pexidartinib (hydrochloride)_COLO 205 | Pexidartinib (hydrochloride) perturbation in COLO 205 cell line |
| Bestatin_COLO 205 | Bestatin perturbation in COLO 205 cell line |
| Dexamethasone_LS 180 | Dexamethasone perturbation in LS 180 cell line |
| Fluvoxamine_SW480 | Fluvoxamine perturbation in SW480 cell line |
| Phenylephrine (hydrochloride)_SW480 | Phenylephrine (hydrochloride) perturbation in SW480 cell line |
| Dexamethasone_SW480 | Dexamethasone perturbation in SW480 cell line |
| Simotinib_HT-29 | Simotinib perturbation in HT-29 cell line |
| Fenofibrate_COLO 205 | Fenofibrate perturbation in COLO 205 cell line |
| Infigratinib_KATO III | Infigratinib perturbation in KATO III cell line |
| Ponatinib_SW480 | Ponatinib perturbation in SW480 cell line |
| Nimesulide_COLO 205 | Nimesulide perturbation in COLO 205 cell line |
| Talc_SW480 | Talc perturbation in SW480 cell line |
| Pemigatinib_HT-29 | Pemigatinib perturbation in HT-29 cell line |
| Naproxen_SW480 | Naproxen perturbation in SW480 cell line |
| Fenofibrate_SW480 | Fenofibrate perturbation in SW480 cell line |
| Dexamethasone_COLO 205 | Dexamethasone perturbation in COLO 205 cell line |
| Cinacalcet_COLO 205 | Cinacalcet perturbation in COLO 205 cell line |
| Fluvoxamine_COLO 205 | Fluvoxamine perturbation in COLO 205 cell line |
| Sulfatinib_HT-29 | Sulfatinib perturbation in HT-29 cell line |
| Tirabrutinib_HT-29 | Tirabrutinib perturbation in HT-29 cell line |
| Bicalutamide_COLO 205 | Bicalutamide perturbation in COLO 205 cell line |
| Econazole_A549 | Econazole perturbation in A549 cell line |
| Ponatinib_LS 180 | Ponatinib perturbation in LS 180 cell line |
| L-Eflornithine (monohydrochloride)_COLO 205 | L-Eflornithine (monohydrochloride) perturbation in COLO 205 cell line |
| Radotinib_RPMI-7951 | Radotinib perturbation in RPMI-7951 cell line |
| Thymopentin_SW480 | Thymopentin perturbation in SW480 cell line |
| Proglumide_LS 180 | Proglumide perturbation in LS 180 cell line |
| APTO-253_HT-29 | APTO-253 perturbation in HT-29 cell line |
| Dimethyl fumarate_HT-29 | Dimethyl fumarate perturbation in HT-29 cell line |
| Altretamine_SW480 | Altretamine perturbation in SW480 cell line |
| Perindopril (erbumine)_SW480 | Perindopril (erbumine) perturbation in SW480 cell line |
| Tofacitinib_LS 180 | Tofacitinib perturbation in LS 180 cell line |
| Fingolimod (hydrochloride)_LS 180 | Fingolimod (hydrochloride) perturbation in LS 180 cell line |
| Pyridoxine_HT-29 | Pyridoxine perturbation in HT-29 cell line |
| Phenytoin (sodium)_HT-29 | Phenytoin (sodium) perturbation in HT-29 cell line |
| S-Adenosyl-L-methionine (disulfate tosylate)_KATO III | S-Adenosyl-L-methionine (disulfate tosylate) perturbation in KATO III cell line |
| Medroxyprogesterone acetate_Hs 766T | Medroxyprogesterone acetate perturbation in Hs 766T cell line |
| Vitamin K4_LS 180 | Vitamin K4 perturbation in LS 180 cell line |
| Methyl aminolevulinate (hydrochloride)_SW480 | Methyl aminolevulinate (hydrochloride) perturbation in SW480 cell line |
| Belumosudil_HT-29 | Belumosudil perturbation in HT-29 cell line |
| Oxaliplatin_COLO 205 | Oxaliplatin perturbation in COLO 205 cell line |
| Apalutamide_KATO III | Apalutamide perturbation in KATO III cell line |
| Pravastatin (sodium)_SW480 | Pravastatin (sodium) perturbation in SW480 cell line |
| Idoxuridine_LS 180 | Idoxuridine perturbation in LS 180 cell line |
| Vortioxetine_LS 180 | Vortioxetine perturbation in LS 180 cell line |
| Amsacrine_LS 180 | Amsacrine perturbation in LS 180 cell line |
| Edoxaban (tosylate monohydrate)_SW480 | Edoxaban (tosylate monohydrate) perturbation in SW480 cell line |
| 5-Azacytidine_HT-29 | 5-Azacytidine perturbation in HT-29 cell line |
| Megestrol_LS 180 | Megestrol perturbation in LS 180 cell line |
| Ivermectin_HT-29 | Ivermectin perturbation in HT-29 cell line |
| crizotinib_LS 180 | crizotinib perturbation in LS 180 cell line |
| Decitabine_COLO 205 | Decitabine perturbation in COLO 205 cell line |
| crizotinib_SW480 | crizotinib perturbation in SW480 cell line |
| Dimethyl fumarate_COLO 205 | Dimethyl fumarate perturbation in COLO 205 cell line |
| Trimetrexate_LS 180 | Trimetrexate perturbation in LS 180 cell line |
| APTO-253_COLO 205 | APTO-253 perturbation in COLO 205 cell line |
| Lucanthone_SW480 | Lucanthone perturbation in SW480 cell line |
| Flumatinib (mesylate)_SW480 | Flumatinib (mesylate) perturbation in SW480 cell line |
| Levobupivacaine (hydrochloride)_SW480 | Levobupivacaine (hydrochloride) perturbation in SW480 cell line |
| Dexamethasone_Hs 766T | Dexamethasone perturbation in Hs 766T cell line |
| olaparib_SW480 | olaparib perturbation in SW480 cell line |
| Menadione_C32 | Menadione perturbation in C32 cell line |
| Cepharanthine_LS 180 | Cepharanthine perturbation in LS 180 cell line |
| Posaconazole_SW480 | Posaconazole perturbation in SW480 cell line |
| Sulfatinib_COLO 205 | Sulfatinib perturbation in COLO 205 cell line |
| Cinacalcet_HT-29 | Cinacalcet perturbation in HT-29 cell line |
| Gemcitabine_C32 | Gemcitabine perturbation in C32 cell line |
| Pasireotide (acetate)_LS 180 | Pasireotide (acetate) perturbation in LS 180 cell line |
| Valdecoxib_KATO III | Valdecoxib perturbation in KATO III cell line |
| IQ 1_COLO 205 | IQ 1 perturbation in COLO 205 cell line |
| Rimonabant (Hydrochloride)_SW480 | Rimonabant (Hydrochloride) perturbation in SW480 cell line |
| Ciclopirox_NCI-H2122 | Ciclopirox perturbation in NCI-H2122 cell line |
| GSK1059615_KATO III | GSK1059615 perturbation in KATO III cell line |
| Aspirin_COLO 205 | Aspirin perturbation in COLO 205 cell line |
| Berberine (chloride hydrate)_KATO III | Berberine (chloride hydrate) perturbation in KATO III cell line |
| DTP3_LS 180 | DTP3 perturbation in LS 180 cell line |
| Thymol_LS 180 | Thymol perturbation in LS 180 cell line |
| Acetohexamide_COLO 205 | Acetohexamide perturbation in COLO 205 cell line |
| Canagliflozin (hemihydrate)_SW480 | Canagliflozin (hemihydrate) perturbation in SW480 cell line |
| Mozavaptan_COLO 205 | Mozavaptan perturbation in COLO 205 cell line |
| Phenytoin (sodium)_COLO 205 | Phenytoin (sodium) perturbation in COLO 205 cell line |
| Retinoic acid_LS 180 | Retinoic acid perturbation in LS 180 cell line |
| Filgotinib_SW480 | Filgotinib perturbation in SW480 cell line |
| Berbamine_LS 180 | Berbamine perturbation in LS 180 cell line |
| Berbamine_SW480 | Berbamine perturbation in SW480 cell line |
| Finasteride_COLO 205 | Finasteride perturbation in COLO 205 cell line |
| Filgotinib_LS 180 | Filgotinib perturbation in LS 180 cell line |
| Gemfibrozil_HT-29 | Gemfibrozil perturbation in HT-29 cell line |
| ULK-101_KATO III | ULK-101 perturbation in KATO III cell line |
| Mozavaptan_LS 180 | Mozavaptan perturbation in LS 180 cell line |
| Phenytoin (sodium)_LS 180 | Phenytoin (sodium) perturbation in LS 180 cell line |
| Pyridoxine_LS 180 | Pyridoxine perturbation in LS 180 cell line |
| Finasteride_SW480 | Finasteride perturbation in SW480 cell line |
| Fumaric acid_LS 180 | Fumaric acid perturbation in LS 180 cell line |
| Dapagliflozin_COLO 205 | Dapagliflozin perturbation in COLO 205 cell line |
| Berbamine_COLO 205 | Berbamine perturbation in COLO 205 cell line |
| (S)-Crizotinib_SW480 | (S)-Crizotinib perturbation in SW480 cell line |
| Filgotinib_COLO 205 | Filgotinib perturbation in COLO 205 cell line |
| Finasteride_LS 180 | Finasteride perturbation in LS 180 cell line |
| Phenytoin (sodium)_SW480 | Phenytoin (sodium) perturbation in SW480 cell line |
| Mozavaptan_SW480 | Mozavaptan perturbation in SW480 cell line |
| Entecavir (monohydrate)_COLO 205 | Entecavir (monohydrate) perturbation in COLO 205 cell line |
| Aspirin_SW480 | Aspirin perturbation in SW480 cell line |
| Plicamycin_SW480 | Plicamycin perturbation in SW480 cell line |
| Pravastatin (sodium)_HT-29 | Pravastatin (sodium) perturbation in HT-29 cell line |
| DTP3_COLO 205 | DTP3 perturbation in COLO 205 cell line |
| Acetohexamide_LS 180 | Acetohexamide perturbation in LS 180 cell line |
| Omeprazole (sodium)_SW480 | Omeprazole (sodium) perturbation in SW480 cell line |
| Zileuton_LS 180 | Zileuton perturbation in LS 180 cell line |
| Glycyrrhizic acid_LoVo | Glycyrrhizic acid perturbation in LoVo cell line |
| Posaconazole_COLO 205 | Posaconazole perturbation in COLO 205 cell line |
| Sulfatinib_SW480 | Sulfatinib perturbation in SW480 cell line |
| Bestatin_HT-29 | Bestatin perturbation in HT-29 cell line |
| Anastrozole_COLO 205 | Anastrozole perturbation in COLO 205 cell line |
| Mebendazole_SW480 | Mebendazole perturbation in SW480 cell line |
| Pasireotide (acetate)_COLO 205 | Pasireotide (acetate) perturbation in COLO 205 cell line |
| L-Thyroxine (sodium salt pentahydrate)_COLO 205 | L-Thyroxine (sodium salt pentahydrate) perturbation in COLO 205 cell line |
| Imiquimod (hydrochloride)_SW480 | Imiquimod (hydrochloride) perturbation in SW480 cell line |
| Macitentan_LS 180 | Macitentan perturbation in LS 180 cell line |
| Fusidic acid_COLO 205 | Fusidic acid perturbation in COLO 205 cell line |
| Auranofin_HT-29 | Auranofin perturbation in HT-29 cell line |
| Pitavastatin (Calcium)_SHP-77 | Pitavastatin (Calcium) perturbation in SHP-77 cell line |
| Megestrol_COLO 205 | Megestrol perturbation in COLO 205 cell line |
| Ranolazine_LS 180 | Ranolazine perturbation in LS 180 cell line |
| Proglumide_HT-29 | Proglumide perturbation in HT-29 cell line |
| Dimethyl fumarate_SW480 | Dimethyl fumarate perturbation in SW480 cell line |
| Tofacitinib (citrate)_LoVo | Tofacitinib (citrate) perturbation in LoVo cell line |
| Altretamine_HT-29 | Altretamine perturbation in HT-29 cell line |
| Decitabine_LS 180 | Decitabine perturbation in LS 180 cell line |
| Decitabine_SW480 | Decitabine perturbation in SW480 cell line |
| Canagliflozin_SW480 | Canagliflozin perturbation in SW480 cell line |
| Dimethyl fumarate_LS 180 | Dimethyl fumarate perturbation in LS 180 cell line |
| Ranolazine_SW480 | Ranolazine perturbation in SW480 cell line |
| Malotilate_SW480 | Malotilate perturbation in SW480 cell line |
| Lenalidomide (hemihydrate)_LS 180 | Lenalidomide (hemihydrate) perturbation in LS 180 cell line |
| Hydroxyurea_SW480 | Hydroxyurea perturbation in SW480 cell line |
| Larotrectinib sulfate_LS 180 | Larotrectinib sulfate perturbation in LS 180 cell line |
| Pitavastatin (Calcium)_COLO 205 | Pitavastatin (Calcium) perturbation in COLO 205 cell line |
| Entrectinib_HT-29 | Entrectinib perturbation in HT-29 cell line |
| Ornidazole_SW480 | Ornidazole perturbation in SW480 cell line |
| Neratinib (maleate)_LS 180 | Neratinib (maleate) perturbation in LS 180 cell line |
| Roxadustat_SW480 | Roxadustat perturbation in SW480 cell line |
| Imiquimod (hydrochloride)_KATO III | Imiquimod (hydrochloride) perturbation in KATO III cell line |
| Clofarabine_SW480 | Clofarabine perturbation in SW480 cell line |
| Chlorhexidine (diacetate)_SW480 | Chlorhexidine (diacetate) perturbation in SW480 cell line |
| AZD-8055_HT-29 | AZD-8055 perturbation in HT-29 cell line |
| Fostamatinib (disodium hexahydrate)_SW480 | Fostamatinib (disodium hexahydrate) perturbation in SW480 cell line |
| Sonidegib_HT-29 | Sonidegib perturbation in HT-29 cell line |
| Tofacitinib (citrate)_SW480 | Tofacitinib (citrate) perturbation in SW480 cell line |
| Atazanavir (sulfate)_SW480 | Atazanavir (sulfate) perturbation in SW480 cell line |
| Berbamine (dihydrochloride)_LS 180 | Berbamine (dihydrochloride) perturbation in LS 180 cell line |
| Methylprednisolone succinate_COLO 205 | Methylprednisolone succinate perturbation in COLO 205 cell line |
| Estrone sulfate (potassium)_SW480 | Estrone sulfate (potassium) perturbation in SW480 cell line |
| Atazanavir (sulfate)_LS 180 | Atazanavir (sulfate) perturbation in LS 180 cell line |
| Methylthiouracil_LS 180 | Methylthiouracil perturbation in LS 180 cell line |
| Ranolazine_LoVo | Ranolazine perturbation in LoVo cell line |
| Salicylic acid_COLO 205 | Salicylic acid perturbation in COLO 205 cell line |
| Tadalafil_SW480 | Tadalafil perturbation in SW480 cell line |
| Pentoxifylline_LS 180 | Pentoxifylline perturbation in LS 180 cell line |
| Dexmedetomidine_LS 180 | Dexmedetomidine perturbation in LS 180 cell line |
| Topotecan (hydrochloride)_SW480 | Topotecan (hydrochloride) perturbation in SW480 cell line |
| Oxaprozin_SW480 | Oxaprozin perturbation in SW480 cell line |
| Bimatoprost_KATO III | Bimatoprost perturbation in KATO III cell line |
| Silodosin_HT-29 | Silodosin perturbation in HT-29 cell line |
| Gemcitabine_LS 180 | Gemcitabine perturbation in LS 180 cell line |
| Delamanid_COLO 205 | Delamanid perturbation in COLO 205 cell line |
| Panobinostat_A498 | Panobinostat perturbation in A498 cell line |
| Peretinoin_KATO III | Peretinoin perturbation in KATO III cell line |
| Pyridoxine_KATO III | Pyridoxine perturbation in KATO III cell line |
| Pentoxifylline_COLO 205 | Pentoxifylline perturbation in COLO 205 cell line |
| Hydroxyfasudil_COLO 205 | Hydroxyfasudil perturbation in COLO 205 cell line |
| Omeprazole (sodium)_SHP-77 | Omeprazole (sodium) perturbation in SHP-77 cell line |
| Delamanid_SW480 | Delamanid perturbation in SW480 cell line |
| PH-797804_SW480 | PH-797804 perturbation in SW480 cell line |
| Filgotinib_KATO III | Filgotinib perturbation in KATO III cell line |
| Saquinavir_HT-29 | Saquinavir perturbation in HT-29 cell line |
| Tadalafil_COLO 205 | Tadalafil perturbation in COLO 205 cell line |
| Ritonavir_KATO III | Ritonavir perturbation in KATO III cell line |
| Acetazolamide_SW480 | Acetazolamide perturbation in SW480 cell line |
| Tetracycline (hydrochloride)_HT-29 | Tetracycline (hydrochloride) perturbation in HT-29 cell line |
| Digitoxin_SW480 | Digitoxin perturbation in SW480 cell line |
| Methylprednisolone succinate_SW480 | Methylprednisolone succinate perturbation in SW480 cell line |
| Orlistat_SW480 | Orlistat perturbation in SW480 cell line |
| Tofacitinib (citrate)_COLO 205 | Tofacitinib (citrate) perturbation in COLO 205 cell line |
| Entecavir (monohydrate)_KATO III | Entecavir (monohydrate) perturbation in KATO III cell line |
| Valdecoxib_LS 180 | Valdecoxib perturbation in LS 180 cell line |
| Carbamazepine_LS 180 | Carbamazepine perturbation in LS 180 cell line |
| Esmolol (hydrochloride)_HT-29 | Esmolol (hydrochloride) perturbation in HT-29 cell line |
| Indacaterol (maleate)_LS 180 | Indacaterol (maleate) perturbation in LS 180 cell line |
| Fusidic acid_KATO III | Fusidic acid perturbation in KATO III cell line |
| Chlorhexidine (diacetate)_COLO 205 | Chlorhexidine (diacetate) perturbation in COLO 205 cell line |
| Sodium Salicylate_NCI-H2122 | Sodium Salicylate perturbation in NCI-H2122 cell line |
| Sapanisertib_SW480 | Sapanisertib perturbation in SW480 cell line |
| Pasireotide (acetate)_KATO III | Pasireotide (acetate) perturbation in KATO III cell line |
| Resveratrol_LS 180 | Resveratrol perturbation in LS 180 cell line |
| Neratinib_SW480 | Neratinib perturbation in SW480 cell line |
| Ornidazole_COLO 205 | Ornidazole perturbation in COLO 205 cell line |
| Triamcinolone_A498 | Triamcinolone perturbation in A498 cell line |
| Uridine_LS 180 | Uridine perturbation in LS 180 cell line |
| Pitavastatin (Calcium)_SW480 | Pitavastatin (Calcium) perturbation in SW480 cell line |
| Indacaterol (maleate)_SW480 | Indacaterol (maleate) perturbation in SW480 cell line |
| Ouabain (Octahydrate)_KATO III | Ouabain (Octahydrate) perturbation in KATO III cell line |
| Adagrasib_HT-29 | Adagrasib perturbation in HT-29 cell line |
| Artemether_COLO 205 | Artemether perturbation in COLO 205 cell line |
| Crizotinib (hydrochloride)_LS 180 | Crizotinib (hydrochloride) perturbation in LS 180 cell line |
| AZD-8055_LS 180 | AZD-8055 perturbation in LS 180 cell line |
| Diphenhydramine_LS 180 | Diphenhydramine perturbation in LS 180 cell line |
| Artesunate_COLO 205 | Artesunate perturbation in COLO 205 cell line |
| Rucaparib (phosphate)_LS 180 | Rucaparib (phosphate) perturbation in LS 180 cell line |
| Riluzole hydrochloride_COLO 205 | Riluzole hydrochloride perturbation in COLO 205 cell line |
| Atazanavir (sulfate)_HT-29 | Atazanavir (sulfate) perturbation in HT-29 cell line |
| Ferulic acid_COLO 205 | Ferulic acid perturbation in COLO 205 cell line |
| Vilanterol_COLO 205 | Vilanterol perturbation in COLO 205 cell line |
| Sulfisoxazole_LS 180 | Sulfisoxazole perturbation in LS 180 cell line |
| Bisoprolol (hemifumarate)_SW480 | Bisoprolol (hemifumarate) perturbation in SW480 cell line |
| Drospirenone_SW480 | Drospirenone perturbation in SW480 cell line |
| S-Adenosyl-L-methionine (disulfate tosylate)_SW480 | S-Adenosyl-L-methionine (disulfate tosylate) perturbation in SW480 cell line |
| Daidzin_SW480 | Daidzin perturbation in SW480 cell line |
| Topotecan (hydrochloride)_HT-29 | Topotecan (hydrochloride) perturbation in HT-29 cell line |
| Pimozide_SW480 | Pimozide perturbation in SW480 cell line |
| Voriconazole_COLO 205 | Voriconazole perturbation in COLO 205 cell line |
| Aliskiren_KATO III | Aliskiren perturbation in KATO III cell line |
| Drospirenone_LS 180 | Drospirenone perturbation in LS 180 cell line |
| Saquinavir_COLO 205 | Saquinavir perturbation in COLO 205 cell line |
| Arbutin_COLO 205 | Arbutin perturbation in COLO 205 cell line |
| Benztropine (mesylate)_LS 180 | Benztropine (mesylate) perturbation in LS 180 cell line |
| Raltitrexed_LS 180 | Raltitrexed perturbation in LS 180 cell line |
| Thymopentin_KATO III | Thymopentin perturbation in KATO III cell line |
| Eplerenone_SW480 | Eplerenone perturbation in SW480 cell line |
| 5-Fluorouracil_LoVo | 5-Fluorouracil perturbation in LoVo cell line |
| Hydroxyurea_HT-29 | Hydroxyurea perturbation in HT-29 cell line |
| Altretamine_KATO III | Altretamine perturbation in KATO III cell line |
| Procainamide (hydrochloride)_SW480 | Procainamide (hydrochloride) perturbation in SW480 cell line |
| Carbidopa (monohydrate)_SW480 | Carbidopa (monohydrate) perturbation in SW480 cell line |
| Vandetanib_LoVo | Vandetanib perturbation in LoVo cell line |
| Cysteamine (hydrochloride)_LS 180 | Cysteamine (hydrochloride) perturbation in LS 180 cell line |
| Fedratinib (hydrochloride hydrate)_COLO 205 | Fedratinib (hydrochloride hydrate) perturbation in COLO 205 cell line |
| Edoxaban (tosylate monohydrate)_LoVo | Edoxaban (tosylate monohydrate) perturbation in LoVo cell line |
| Entrectinib_LS 180 | Entrectinib perturbation in LS 180 cell line |
| Entrectinib_SW480 | Entrectinib perturbation in SW480 cell line |
| Rutin (trihydrate)_SW480 | Rutin (trihydrate) perturbation in SW480 cell line |
| Ciclopirox_HT-29 | Ciclopirox perturbation in HT-29 cell line |
| Cilostazol_SW480 | Cilostazol perturbation in SW480 cell line |
| Pitavastatin (Calcium)_HT-29 | Pitavastatin (Calcium) perturbation in HT-29 cell line |
| Ivabradine (hydrochloride)_SW480 | Ivabradine (hydrochloride) perturbation in SW480 cell line |
| Cinacalcet_KATO III | Cinacalcet perturbation in KATO III cell line |
| Rutin (trihydrate)_COLO 205 | Rutin (trihydrate) perturbation in COLO 205 cell line |
| Uridine_HT-29 | Uridine perturbation in HT-29 cell line |
| Palmatine (chloride)_COLO 205 | Palmatine (chloride) perturbation in COLO 205 cell line |
| Phenylephrine (hydrochloride)_KATO III | Phenylephrine (hydrochloride) perturbation in KATO III cell line |
| Ivabradine (hydrochloride)_LS 180 | Ivabradine (hydrochloride) perturbation in LS 180 cell line |
| Fedratinib (hydrochloride hydrate)_SW480 | Fedratinib (hydrochloride hydrate) perturbation in SW480 cell line |
| Oleic acid_LS 180 | Oleic acid perturbation in LS 180 cell line |
| Budesonide_A549 | Budesonide perturbation in A549 cell line |
| Bortezomib_KATO III | Bortezomib perturbation in KATO III cell line |
| Pemetrexed_SW480 | Pemetrexed perturbation in SW480 cell line |
| Tolcapone_LS 180 | Tolcapone perturbation in LS 180 cell line |
| Bestatin (hydrochloride)_HT-29 | Bestatin (hydrochloride) perturbation in HT-29 cell line |
| Voriconazole_LS 180 | Voriconazole perturbation in LS 180 cell line |
| palbociclib_LS 180 | palbociclib perturbation in LS 180 cell line |
| Vismodegib_SW480 | Vismodegib perturbation in SW480 cell line |
| Drospirenone_COLO 205 | Drospirenone perturbation in COLO 205 cell line |
| Sonidegib_COLO 205 | Sonidegib perturbation in COLO 205 cell line |
| Terfenadine_LS 180 | Terfenadine perturbation in LS 180 cell line |
| Tolmetin_COLO 205 | Tolmetin perturbation in COLO 205 cell line |
| Ferulic acid_SW480 | Ferulic acid perturbation in SW480 cell line |
| Artesunate_LS 180 | Artesunate perturbation in LS 180 cell line |
| GSK1059615_HT-29 | GSK1059615 perturbation in HT-29 cell line |
| Riluzole hydrochloride_SW480 | Riluzole hydrochloride perturbation in SW480 cell line |
| Riluzole hydrochloride_LS 180 | Riluzole hydrochloride perturbation in LS 180 cell line |
| Oxaliplatin_KATO III | Oxaliplatin perturbation in KATO III cell line |
| Terfenadine_SW480 | Terfenadine perturbation in SW480 cell line |
| Tetracycline (hydrochloride)_SW480 | Tetracycline (hydrochloride) perturbation in SW480 cell line |
| Doxycycline (monohydrate)_SW480 | Doxycycline (monohydrate) perturbation in SW480 cell line |
| Berberine (chloride hydrate)_Panc 03.27 | Berberine (chloride hydrate) perturbation in Panc 03.27 cell line |
| Sinomenine_SW48 | Sinomenine perturbation in SW48 cell line |
| Fingolimod (hydrochloride)_AsPC-1 | Fingolimod (hydrochloride) perturbation in AsPC-1 cell line |
| Bortezomib_LS 180 | Bortezomib perturbation in LS 180 cell line |
| Ixazomib citrate_LOX-IMVI | Ixazomib citrate perturbation in LOX-IMVI cell line |
| Bortezomib_SW480 | Bortezomib perturbation in SW480 cell line |
| Clobetasol propionate_LS 180 | Clobetasol propionate perturbation in LS 180 cell line |
| 4EGI-1_SW48 | 4EGI-1 perturbation in SW48 cell line |
| Hexylresorcinol_SW48 | Hexylresorcinol perturbation in SW48 cell line |
| AZD1390_SW 1271 | AZD1390 perturbation in SW 1271 cell line |
| Bortezomib_AsPC-1 | Bortezomib perturbation in AsPC-1 cell line |
| Abemaciclib_LS 180 | Abemaciclib perturbation in LS 180 cell line |
| Capmatinib_NCI-H2122 | Capmatinib perturbation in NCI-H2122 cell line |
| Everolimus_SW48 | Everolimus perturbation in SW48 cell line |
| OTS514_LoVo | OTS514 perturbation in LoVo cell line |
| Tubulin inhibitor 6_Panc 03.27 | Tubulin inhibitor 6 perturbation in Panc 03.27 cell line |
| Tirabrutinib (hydrochloride)_BT-474 | Tirabrutinib (hydrochloride) perturbation in BT-474 cell line |
| BI-78D3_Panc 03.27 | BI-78D3 perturbation in Panc 03.27 cell line |
| Pyridoxine_SW 1271 | Pyridoxine perturbation in SW 1271 cell line |
| Bortezomib_Hs 766T | Bortezomib perturbation in Hs 766T cell line |
| Busulfan_SW48 | Busulfan perturbation in SW48 cell line |
| Chlorhexidine (diacetate)_SW48 | Chlorhexidine (diacetate) perturbation in SW48 cell line |
| (S)-Crizotinib_BT-474 | (S)-Crizotinib perturbation in BT-474 cell line |
| Everolimus_Panc 03.27 | Everolimus perturbation in Panc 03.27 cell line |
| LY2090314_Panc 03.27 | LY2090314 perturbation in Panc 03.27 cell line |
| Tofacitinib (citrate)_SW48 | Tofacitinib (citrate) perturbation in SW48 cell line |
| Meloxicam_Panc 03.27 | Meloxicam perturbation in Panc 03.27 cell line |
| Sinomenine_Panc 03.27 | Sinomenine perturbation in Panc 03.27 cell line |
| Balsalazide (sodium hydrate)_Panc 03.27 | Balsalazide (sodium hydrate) perturbation in Panc 03.27 cell line |
| AZD-8055_Panc 03.27 | AZD-8055 perturbation in Panc 03.27 cell line |
| Thymol_AsPC-1 | Thymol perturbation in AsPC-1 cell line |
| Bortezomib_A-172 | Bortezomib perturbation in A-172 cell line |
| Ixazomib citrate_J82 | Ixazomib citrate perturbation in J82 cell line |
| Ouabain (Octahydrate)_HepG2/C3A | Ouabain (Octahydrate) perturbation in HepG2/C3A cell line |
| OTS514_Panc 03.27 | OTS514 perturbation in Panc 03.27 cell line |
| Bortezomib_H4 | Bortezomib perturbation in H4 cell line |
| Resveratrol_SW48 | Resveratrol perturbation in SW48 cell line |
| Docetaxel (Trihydrate)_SW48 | Docetaxel (Trihydrate) perturbation in SW48 cell line |
| Pitavastatin (Calcium)_SW48 | Pitavastatin (Calcium) perturbation in SW48 cell line |
| Abemaciclib_Panc 03.27 | Abemaciclib perturbation in Panc 03.27 cell line |
| DT-061_LoVo | DT-061 perturbation in LoVo cell line |
| MK-8353_LoVo | MK-8353 perturbation in LoVo cell line |
| Thymopentin_Panc 03.27 | Thymopentin perturbation in Panc 03.27 cell line |
| Ixazomib citrate_RPMI-7951 | Ixazomib citrate perturbation in RPMI-7951 cell line |
| Rifaximin_SW48 | Rifaximin perturbation in SW48 cell line |
| Diammonium Glycyrrhizinate_Panc 03.27 | Diammonium Glycyrrhizinate perturbation in Panc 03.27 cell line |
| Bortezomib_NCI-H2347 | Bortezomib perturbation in NCI-H2347 cell line |
| Bortezomib_LOX-IMVI | Bortezomib perturbation in LOX-IMVI cell line |
| Tofacitinib (citrate)_LS 180 | Tofacitinib (citrate) perturbation in LS 180 cell line |
| Amsacrine_Panc 03.27 | Amsacrine perturbation in Panc 03.27 cell line |
| Bortezomib_RKO | Bortezomib perturbation in RKO cell line |
| Ritonavir_SW48 | Ritonavir perturbation in SW48 cell line |
| Methyl aminolevulinate (hydrochloride)_Panc 03.27 | Methyl aminolevulinate (hydrochloride) perturbation in Panc 03.27 cell line |
| Panobinostat_SW48 | Panobinostat perturbation in SW48 cell line |
| Tucatinib_SW48 | Tucatinib perturbation in SW48 cell line |
| Aliskiren_NCI-H2347 | Aliskiren perturbation in NCI-H2347 cell line |
| Demeclocycline_SW48 | Demeclocycline perturbation in SW48 cell line |
| Bortezomib_Panc 03.27 | Bortezomib perturbation in Panc 03.27 cell line |
| Lenalidomide (hemihydrate)_AsPC-1 | Lenalidomide (hemihydrate) perturbation in AsPC-1 cell line |
| Pemigatinib_SW48 | Pemigatinib perturbation in SW48 cell line |
| Ixazomib citrate_SW1417 | Ixazomib citrate perturbation in SW1417 cell line |
| Aspirin_Panc 03.27 | Aspirin perturbation in Panc 03.27 cell line |
| Sodium Salicylate_Panc 03.27 | Sodium Salicylate perturbation in Panc 03.27 cell line |
| Belumosudil (mesylate)_SHP-77 | Belumosudil (mesylate) perturbation in SHP-77 cell line |
| Tucidinostat_LOX-IMVI | Tucidinostat perturbation in LOX-IMVI cell line |
| Erythromycin_HT-29 | Erythromycin perturbation in HT-29 cell line |
| Bortezomib_A-427 | Bortezomib perturbation in A-427 cell line |
| Oxaliplatin_NCI-H2122 | Oxaliplatin perturbation in NCI-H2122 cell line |
| Bortezomib_SW48 | Bortezomib perturbation in SW48 cell line |
| Tirabrutinib (hydrochloride)_SW48 | Tirabrutinib (hydrochloride) perturbation in SW48 cell line |
| SBI-0640756_AN3 CA | SBI-0640756 perturbation in AN3 CA cell line |
| Auranofin_SW48 | Auranofin perturbation in SW48 cell line |
| Rifaximin_Panc 03.27 | Rifaximin perturbation in Panc 03.27 cell line |
| Amsacrine_SW48 | Amsacrine perturbation in SW48 cell line |
| Abemaciclib_A-427 | Abemaciclib perturbation in A-427 cell line |
| LB-100_Panc 03.27 | LB-100 perturbation in Panc 03.27 cell line |
| Bortezomib_CFPAC-1 | Bortezomib perturbation in CFPAC-1 cell line |
| Panobinostat_Panc 03.27 | Panobinostat perturbation in Panc 03.27 cell line |
| AZD-8055_AsPC-1 | AZD-8055 perturbation in AsPC-1 cell line |
| Bortezomib_MIA PaCa-2 | Bortezomib perturbation in MIA PaCa-2 cell line |
| Methyl aminolevulinate (hydrochloride)_SW48 | Methyl aminolevulinate (hydrochloride) perturbation in SW48 cell line |
| Bortezomib_LoVo | Bortezomib perturbation in LoVo cell line |
| Abemaciclib_SW1417 | Abemaciclib perturbation in SW1417 cell line |
| Bimatoprost_HCT15 | Bimatoprost perturbation in HCT15 cell line |
| MK-8353_HCT15 | MK-8353 perturbation in HCT15 cell line |
| Methylprednisolone succinate_LOX-IMVI | Methylprednisolone succinate perturbation in LOX-IMVI cell line |
| Lapatinib ditosylate_HCT15 | Lapatinib ditosylate perturbation in HCT15 cell line |
| Celecoxib_HCT15 | Celecoxib perturbation in HCT15 cell line |
| Lapatinib ditosylate_SW1417 | Lapatinib ditosylate perturbation in SW1417 cell line |
| Lipoic acid_HCT15 | Lipoic acid perturbation in HCT15 cell line |
| Triamcinolone_SNU-423 | Triamcinolone perturbation in SNU-423 cell line |
| AZD-8055_HCT15 | AZD-8055 perturbation in HCT15 cell line |
| 4EGI-1_HCT15 | 4EGI-1 perturbation in HCT15 cell line |
| Bimiralisib_NCI-H2122 | Bimiralisib perturbation in NCI-H2122 cell line |
| Aliskiren_BT-474 | Aliskiren perturbation in BT-474 cell line |
| Meloxicam_NCI-H1792 | Meloxicam perturbation in NCI-H1792 cell line |
| Ivabradine (hydrochloride)_CFPAC-1 | Ivabradine (hydrochloride) perturbation in CFPAC-1 cell line |
| Hydroxyurea_LOX-IMVI | Hydroxyurea perturbation in LOX-IMVI cell line |
| Hesperidin_A498 | Hesperidin perturbation in A498 cell line |
| Entrectinib_NCI-H2122 | Entrectinib perturbation in NCI-H2122 cell line |
| Ivabradine (hydrochloride)_MIA PaCa-2 | Ivabradine (hydrochloride) perturbation in MIA PaCa-2 cell line |
| Ornidazole_LOX-IMVI | Ornidazole perturbation in LOX-IMVI cell line |
| Elagolix sodium_CFPAC-1 | Elagolix sodium perturbation in CFPAC-1 cell line |
| Monocrotaline_LOX-IMVI | Monocrotaline perturbation in LOX-IMVI cell line |
| Fusidic acid_NCI-H596 | Fusidic acid perturbation in NCI-H596 cell line |
| S-Adenosyl-L-methionine (disulfate tosylate)_SW 900 | S-Adenosyl-L-methionine (disulfate tosylate) perturbation in SW 900 cell line |
| Cytarabine_SK-MEL-2 | Cytarabine perturbation in SK-MEL-2 cell line |
| Pemetrexed_CFPAC-1 | Pemetrexed perturbation in CFPAC-1 cell line |
| Tazarotene_RKO | Tazarotene perturbation in RKO cell line |
| Aprepitant_CFPAC-1 | Aprepitant perturbation in CFPAC-1 cell line |
| Ralimetinib dimesylate_SW 1088 | Ralimetinib dimesylate perturbation in SW 1088 cell line |
| Atazanavir (sulfate)_RKO | Atazanavir (sulfate) perturbation in RKO cell line |
| Rimonabant (Hydrochloride)_SK-MEL-2 | Rimonabant (Hydrochloride) perturbation in SK-MEL-2 cell line |
| Canagliflozin (hemihydrate)_SK-MEL-2 | Canagliflozin (hemihydrate) perturbation in SK-MEL-2 cell line |
| Pitavastatin (Calcium)_SNU-1 | Pitavastatin (Calcium) perturbation in SNU-1 cell line |
| Auranofin_AsPC-1 | Auranofin perturbation in AsPC-1 cell line |
| Vismodegib_CFPAC-1 | Vismodegib perturbation in CFPAC-1 cell line |
| Sunitinib_SNU-1 | Sunitinib perturbation in SNU-1 cell line |
| Tadalafil_RKO | Tadalafil perturbation in RKO cell line |
| Topotecan (hydrochloride)_RKO | Topotecan (hydrochloride) perturbation in RKO cell line |
| Econazole_SW 1088 | Econazole perturbation in SW 1088 cell line |
| Daidzin_AN3 CA | Daidzin perturbation in AN3 CA cell line |
| Asciminib_NCI-H1792 | Asciminib perturbation in NCI-H1792 cell line |
| Verapamil_NCI-H2030 | Verapamil perturbation in NCI-H2030 cell line |
| Fumaric acid_NCI-H596 | Fumaric acid perturbation in NCI-H596 cell line |
| Ouabain (Octahydrate)_NCI-H661 | Ouabain (Octahydrate) perturbation in NCI-H661 cell line |
| Dapagliflozin ((2S)-1,2-propanediol, hydrate)_NCI-H2347 | Dapagliflozin ((2S)-1,2-propanediol, hydrate) perturbation in NCI-H2347 cell line |
| Hesperidin_SNU-423 | Hesperidin perturbation in SNU-423 cell line |
| Tranilast_AN3 CA | Tranilast perturbation in AN3 CA cell line |
| Rucaparib (phosphate)_CFPAC-1 | Rucaparib (phosphate) perturbation in CFPAC-1 cell line |
| Vismodegib_NCI-H1573 | Vismodegib perturbation in NCI-H1573 cell line |
| Phenylephrine (hydrochloride)_AsPC-1 | Phenylephrine (hydrochloride) perturbation in AsPC-1 cell line |
| Bisoprolol (hemifumarate)_CFPAC-1 | Bisoprolol (hemifumarate) perturbation in CFPAC-1 cell line |
| Sulfisoxazole_MIA PaCa-2 | Sulfisoxazole perturbation in MIA PaCa-2 cell line |
| Valdecoxib_RKO | Valdecoxib perturbation in RKO cell line |
| Acetazolamide_LOX-IMVI | Acetazolamide perturbation in LOX-IMVI cell line |
| Aprepitant_NCI-H2122 | Aprepitant perturbation in NCI-H2122 cell line |
| Tirabrutinib (hydrochloride)_AsPC-1 | Tirabrutinib (hydrochloride) perturbation in AsPC-1 cell line |
| Tranilast_NCI-H2122 | Tranilast perturbation in NCI-H2122 cell line |
| Omeprazole (sodium)_SK-MEL-2 | Omeprazole (sodium) perturbation in SK-MEL-2 cell line |
| Dorzolamide (hydrochloride)_NCI-H661 | Dorzolamide (hydrochloride) perturbation in NCI-H661 cell line |
| Abiraterone acetate_CFPAC-1 | Abiraterone acetate perturbation in CFPAC-1 cell line |
| Cinacalcet_SW1417 | Cinacalcet perturbation in SW1417 cell line |
| Uridine_RKO | Uridine perturbation in RKO cell line |
| Docetaxel (Trihydrate)_RKO | Docetaxel (Trihydrate) perturbation in RKO cell line |
| Bicalutamide_SW1417 | Bicalutamide perturbation in SW1417 cell line |
| Pitavastatin (Calcium)_LOX-IMVI | Pitavastatin (Calcium) perturbation in LOX-IMVI cell line |
| Pitavastatin (Calcium)_RKO | Pitavastatin (Calcium) perturbation in RKO cell line |
| Sunitinib_LOX-IMVI | Sunitinib perturbation in LOX-IMVI cell line |
| Citalopram (hydrobromide)_LOX-IMVI | Citalopram (hydrobromide) perturbation in LOX-IMVI cell line |
| Niclosamide (olamine)_CFPAC-1 | Niclosamide (olamine) perturbation in CFPAC-1 cell line |
| Ivabradine (hydrochloride)_NCI-H2122 | Ivabradine (hydrochloride) perturbation in NCI-H2122 cell line |
| Capivasertib_BT-474 | Capivasertib perturbation in BT-474 cell line |
| BI-78D3_NCI-H1573 | BI-78D3 perturbation in NCI-H1573 cell line |
| Ivermectin_SW1417 | Ivermectin perturbation in SW1417 cell line |
| Canagliflozin_SK-MEL-2 | Canagliflozin perturbation in SK-MEL-2 cell line |
| Acetazolamide_SNU-423 | Acetazolamide perturbation in SNU-423 cell line |
| Valdecoxib_MIA PaCa-2 | Valdecoxib perturbation in MIA PaCa-2 cell line |
| Sulfisoxazole_RKO | Sulfisoxazole perturbation in RKO cell line |
| Doxycycline (monohydrate)_SK-MEL-2 | Doxycycline (monohydrate) perturbation in SK-MEL-2 cell line |
| Zileuton_HepG2/C3A | Zileuton perturbation in HepG2/C3A cell line |
| Delamanid_CFPAC-1 | Delamanid perturbation in CFPAC-1 cell line |
| Pitavastatin (Calcium)_NCI-H1792 | Pitavastatin (Calcium) perturbation in NCI-H1792 cell line |
| Dapagliflozin ((2S)-1,2-propanediol, hydrate)_CFPAC-1 | Dapagliflozin ((2S)-1,2-propanediol, hydrate) perturbation in CFPAC-1 cell line |
| MK-8353_SW1417 | MK-8353 perturbation in SW1417 cell line |
| Sunitinib_NCI-H1792 | Sunitinib perturbation in NCI-H1792 cell line |
| Hesperidin_LOX-IMVI | Hesperidin perturbation in LOX-IMVI cell line |
| crizotinib_A549 | crizotinib perturbation in A549 cell line |
| Carbamazepine_CFPAC-1 | Carbamazepine perturbation in CFPAC-1 cell line |
| Acetazolamide_CFPAC-1 | Acetazolamide perturbation in CFPAC-1 cell line |
| Canagliflozin (hemihydrate)_RPMI-7951 | Canagliflozin (hemihydrate) perturbation in RPMI-7951 cell line |
| Benproperine (phosphate)_LOX-IMVI | Benproperine (phosphate) perturbation in LOX-IMVI cell line |
| Silodosin_RKO | Silodosin perturbation in RKO cell line |
| Imiquimod (maleate)_CFPAC-1 | Imiquimod (maleate) perturbation in CFPAC-1 cell line |
| Hydroxyurea_A498 | Hydroxyurea perturbation in A498 cell line |
| Hesperidin_RKO | Hesperidin perturbation in RKO cell line |
| Orlistat_CFPAC-1 | Orlistat perturbation in CFPAC-1 cell line |
| Lopinavir_NCI-H596 | Lopinavir perturbation in NCI-H596 cell line |
| Larotrectinib_SW48 | Larotrectinib perturbation in SW48 cell line |
| Aspirin_AsPC-1 | Aspirin perturbation in AsPC-1 cell line |
| Canagliflozin (hemihydrate)_LS 180 | Canagliflozin (hemihydrate) perturbation in LS 180 cell line |
| Methotrexate_CFPAC-1 | Methotrexate perturbation in CFPAC-1 cell line |
| Omeprazole (sodium)_AsPC-1 | Omeprazole (sodium) perturbation in AsPC-1 cell line |
| Procainamide (hydrochloride)_RKO | Procainamide (hydrochloride) perturbation in RKO cell line |
| Verapamil_SK-MEL-2 | Verapamil perturbation in SK-MEL-2 cell line |
| Darolutamide_NCI-H596 | Darolutamide perturbation in NCI-H596 cell line |
| Pitavastatin (Calcium)_CFPAC-1 | Pitavastatin (Calcium) perturbation in CFPAC-1 cell line |
| Procainamide (hydrochloride)_LOX-IMVI | Procainamide (hydrochloride) perturbation in LOX-IMVI cell line |
| Proglumide_A-172 | Proglumide perturbation in A-172 cell line |
| Asciminib_NCI-H2347 | Asciminib perturbation in NCI-H2347 cell line |
| Captopril_AsPC-1 | Captopril perturbation in AsPC-1 cell line |
| Ornidazole_AN3 CA | Ornidazole perturbation in AN3 CA cell line |
| Crizotinib (hydrochloride)_CFPAC-1 | Crizotinib (hydrochloride) perturbation in CFPAC-1 cell line |
| Captopril_SW 1088 | Captopril perturbation in SW 1088 cell line |
| Valdecoxib_NCI-H1792 | Valdecoxib perturbation in NCI-H1792 cell line |
| Aspirin_SW 1088 | Aspirin perturbation in SW 1088 cell line |
| Rutin (trihydrate)_RKO | Rutin (trihydrate) perturbation in RKO cell line |
| Rutin (trihydrate)_LOX-IMVI | Rutin (trihydrate) perturbation in LOX-IMVI cell line |
| Entrectinib_LOX-IMVI | Entrectinib perturbation in LOX-IMVI cell line |
| Pitavastatin (Calcium)_MIA PaCa-2 | Pitavastatin (Calcium) perturbation in MIA PaCa-2 cell line |
| Betamethasone dipropionate_RKO | Betamethasone dipropionate perturbation in RKO cell line |
| Ivabradine (hydrochloride)_RKO | Ivabradine (hydrochloride) perturbation in RKO cell line |
| Dorzolamide (hydrochloride)_SW 1088 | Dorzolamide (hydrochloride) perturbation in SW 1088 cell line |
| Bexarotene_CFPAC-1 | Bexarotene perturbation in CFPAC-1 cell line |
| Tazarotene_MIA PaCa-2 | Tazarotene perturbation in MIA PaCa-2 cell line |
| Bestatin_SK-MEL-2 | Bestatin perturbation in SK-MEL-2 cell line |
| Ataluren_RKO | Ataluren perturbation in RKO cell line |
| Fedratinib (hydrochloride hydrate)_LOX-IMVI | Fedratinib (hydrochloride hydrate) perturbation in LOX-IMVI cell line |
| Roxadustat_CFPAC-1 | Roxadustat perturbation in CFPAC-1 cell line |
| Clofarabine_CFPAC-1 | Clofarabine perturbation in CFPAC-1 cell line |
| Tadalafil_SNU-423 | Tadalafil perturbation in SNU-423 cell line |
| Hydroxyurea_NCI-H1792 | Hydroxyurea perturbation in NCI-H1792 cell line |
| Atazanavir (sulfate)_CFPAC-1 | Atazanavir (sulfate) perturbation in CFPAC-1 cell line |
| Carbamazepine_NCI-H2122 | Carbamazepine perturbation in NCI-H2122 cell line |
| Aprepitant_LOX-IMVI | Aprepitant perturbation in LOX-IMVI cell line |
| Voriconazole_RKO | Voriconazole perturbation in RKO cell line |
| Dapagliflozin_SW1417 | Dapagliflozin perturbation in SW1417 cell line |
| Dapagliflozin ((2S)-1,2-propanediol, hydrate)_AN3 CA | Dapagliflozin ((2S)-1,2-propanediol, hydrate) perturbation in AN3 CA cell line |
| Glasdegib_SNU-423 | Glasdegib perturbation in SNU-423 cell line |
| Tadalafil_CFPAC-1 | Tadalafil perturbation in CFPAC-1 cell line |
| Ferulic acid_RKO | Ferulic acid perturbation in RKO cell line |
| Glycyrrhizic acid_CFPAC-1 | Glycyrrhizic acid perturbation in CFPAC-1 cell line |
| Flutamide_AsPC-1 | Flutamide perturbation in AsPC-1 cell line |
| Glasdegib_CFPAC-1 | Glasdegib perturbation in CFPAC-1 cell line |
| Erlotinib_MIA PaCa-2 | Erlotinib perturbation in MIA PaCa-2 cell line |
| Almonertinib (mesylate)_NCI-H661 | Almonertinib (mesylate) perturbation in NCI-H661 cell line |
| Cytarabine (hydrochloride)_NCI-H661 | Cytarabine (hydrochloride) perturbation in NCI-H661 cell line |
| Bosentan (hydrate)_NCI-H1573 | Bosentan (hydrate) perturbation in NCI-H1573 cell line |
| Imiquimod (maleate)_SW1417 | Imiquimod (maleate) perturbation in SW1417 cell line |
| Harringtonine_SW 1271 | Harringtonine perturbation in SW 1271 cell line |
| Captopril_MIA PaCa-2 | Captopril perturbation in MIA PaCa-2 cell line |
| Ipatasertib_HepG2/C3A | Ipatasertib perturbation in HepG2/C3A cell line |
| Clotrimazole_SNU-1 | Clotrimazole perturbation in SNU-1 cell line |
| Hexylresorcinol_NCI-H661 | Hexylresorcinol perturbation in NCI-H661 cell line |
| Methotrexate_AsPC-1 | Methotrexate perturbation in AsPC-1 cell line |
| Silodosin_SK-MEL-2 | Silodosin perturbation in SK-MEL-2 cell line |
| Benproperine (phosphate)_SK-MEL-2 | Benproperine (phosphate) perturbation in SK-MEL-2 cell line |
| Penfluridol_CFPAC-1 | Penfluridol perturbation in CFPAC-1 cell line |
| Indacaterol (maleate)_AsPC-1 | Indacaterol (maleate) perturbation in AsPC-1 cell line |
| Benztropine (mesylate)_NCI-H596 | Benztropine (mesylate) perturbation in NCI-H596 cell line |
| Captopril_CFPAC-1 | Captopril perturbation in CFPAC-1 cell line |
| Pitavastatin (Calcium)_AsPC-1 | Pitavastatin (Calcium) perturbation in AsPC-1 cell line |
| Lopinavir_NCI-H2347 | Lopinavir perturbation in NCI-H2347 cell line |
| Crizotinib (hydrochloride)_SW 1088 | Crizotinib (hydrochloride) perturbation in SW 1088 cell line |
| Omeprazole (sodium)_CFPAC-1 | Omeprazole (sodium) perturbation in CFPAC-1 cell line |
| Mitoxantrone (dihydrochloride)_AsPC-1 | Mitoxantrone (dihydrochloride) perturbation in AsPC-1 cell line |
| Monocrotaline_LS 180 | Monocrotaline perturbation in LS 180 cell line |
| Capivasertib_RKO | Capivasertib perturbation in RKO cell line |
| Ixazomib citrate_LS 180 | Ixazomib citrate perturbation in LS 180 cell line |
| Levobupivacaine (hydrochloride)_NCI-H2122 | Levobupivacaine (hydrochloride) perturbation in NCI-H2122 cell line |
| Macitentan_CFPAC-1 | Macitentan perturbation in CFPAC-1 cell line |
| Acetazolamide_AsPC-1 | Acetazolamide perturbation in AsPC-1 cell line |
| Valdecoxib_AsPC-1 | Valdecoxib perturbation in AsPC-1 cell line |
| Tirabrutinib (hydrochloride)_LOX-IMVI | Tirabrutinib (hydrochloride) perturbation in LOX-IMVI cell line |
| Imiquimod (hydrochloride)_CFPAC-1 | Imiquimod (hydrochloride) perturbation in CFPAC-1 cell line |
| Zileuton_CFPAC-1 | Zileuton perturbation in CFPAC-1 cell line |
| 5-Azacytidine_LOX-IMVI | 5-Azacytidine perturbation in LOX-IMVI cell line |
| Orlistat_AsPC-1 | Orlistat perturbation in AsPC-1 cell line |
| Verapamil_LOX-IMVI | Verapamil perturbation in LOX-IMVI cell line |
| Ritonavir_A498 | Ritonavir perturbation in A498 cell line |
| Aspirin_NCI-H1792 | Aspirin perturbation in NCI-H1792 cell line |
| Orlistat_NCI-H2030 | Orlistat perturbation in NCI-H2030 cell line |
| Ivabradine (hydrochloride)_A-172 | Ivabradine (hydrochloride) perturbation in A-172 cell line |
| Bosentan (hydrate)_SW48 | Bosentan (hydrate) perturbation in SW48 cell line |
| Methotrexate_SW1417 | Methotrexate perturbation in SW1417 cell line |
| crizotinib_A-427 | crizotinib perturbation in A-427 cell line |
| Indacaterol (maleate)_BT-474 | Indacaterol (maleate) perturbation in BT-474 cell line |
| Hydroxyurea_RPMI-7951 | Hydroxyurea perturbation in RPMI-7951 cell line |
| Ranolazine_CFPAC-1 | Ranolazine perturbation in CFPAC-1 cell line |
| Entrectinib_SK-MEL-2 | Entrectinib perturbation in SK-MEL-2 cell line |
| Acetazolamide_SW 1088 | Acetazolamide perturbation in SW 1088 cell line |
| Valdecoxib_SW 1088 | Valdecoxib perturbation in SW 1088 cell line |
| Canagliflozin (hemihydrate)_SW48 | Canagliflozin (hemihydrate) perturbation in SW48 cell line |
| Pitavastatin (Calcium)_SW1417 | Pitavastatin (Calcium) perturbation in SW1417 cell line |
| Imiquimod (maleate)_NCI-H2030 | Imiquimod (maleate) perturbation in NCI-H2030 cell line |
| Norepinephrine (hydrochloride)_NCI-H2122 | Norepinephrine (hydrochloride) perturbation in NCI-H2122 cell line |
| Ribociclib_SK-MEL-2 | Ribociclib perturbation in SK-MEL-2 cell line |
| Naproxen_LOX-IMVI | Naproxen perturbation in LOX-IMVI cell line |
| Betamethasone dipropionate_SK-MEL-2 | Betamethasone dipropionate perturbation in SK-MEL-2 cell line |
| Fostamatinib (disodium hexahydrate)_NCI-H2030 | Fostamatinib (disodium hexahydrate) perturbation in NCI-H2030 cell line |
| crizotinib_CFPAC-1 | crizotinib perturbation in CFPAC-1 cell line |
| Bestatin_LOX-IMVI | Bestatin perturbation in LOX-IMVI cell line |
| Clofarabine_BT-474 | Clofarabine perturbation in BT-474 cell line |
| Menadione_AsPC-1 | Menadione perturbation in AsPC-1 cell line |
| Thymopentin_RKO | Thymopentin perturbation in RKO cell line |
| Orlistat_LS 180 | Orlistat perturbation in LS 180 cell line |
| Pemetrexed_NCI-H596 | Pemetrexed perturbation in NCI-H596 cell line |
| Pentagastrin_NCI-H2122 | Pentagastrin perturbation in NCI-H2122 cell line |
| Oxaprozin_NCI-H2030 | Oxaprozin perturbation in NCI-H2030 cell line |
| Lonafarnib_NCI-H2030 | Lonafarnib perturbation in NCI-H2030 cell line |
| Bexarotene_NCI-H2030 | Bexarotene perturbation in NCI-H2030 cell line |
| Pitavastatin (Calcium)_LS 180 | Pitavastatin (Calcium) perturbation in LS 180 cell line |
| ULK-101_BT-474 | ULK-101 perturbation in BT-474 cell line |
| Dorzolamide (hydrochloride)_CFPAC-1 | Dorzolamide (hydrochloride) perturbation in CFPAC-1 cell line |
| Canagliflozin (hemihydrate)_CFPAC-1 | Canagliflozin (hemihydrate) perturbation in CFPAC-1 cell line |
| Bosentan (hydrate)_SNU-423 | Bosentan (hydrate) perturbation in SNU-423 cell line |
| Esmolol (hydrochloride)_SK-MEL-2 | Esmolol (hydrochloride) perturbation in SK-MEL-2 cell line |
| Ornidazole_NCI-H2030 | Ornidazole perturbation in NCI-H2030 cell line |
| Idoxuridine_NCI-H2347 | Idoxuridine perturbation in NCI-H2347 cell line |
| Tranilast_SW 1088 | Tranilast perturbation in SW 1088 cell line |
| Ataluren_BT-474 | Ataluren perturbation in BT-474 cell line |
| Flutamide_NCI-H2347 | Flutamide perturbation in NCI-H2347 cell line |
| Ouabain (Octahydrate)_RKO | Ouabain (Octahydrate) perturbation in RKO cell line |
| MK-3903_NCI-H2030 | MK-3903 perturbation in NCI-H2030 cell line |
| Flutamide_RKO | Flutamide perturbation in RKO cell line |
| AZD2858_HCT15 | AZD2858 perturbation in HCT15 cell line |
| Lucanthone_RKO | Lucanthone perturbation in RKO cell line |
| Triclosan_A498 | Triclosan perturbation in A498 cell line |
| olaparib_LOX-IMVI | olaparib perturbation in LOX-IMVI cell line |
| olaparib_RKO | olaparib perturbation in RKO cell line |
| Econazole_CFPAC-1 | Econazole perturbation in CFPAC-1 cell line |
| Bortezomib_NCI-H2122 | Bortezomib perturbation in NCI-H2122 cell line |
| Piroxicam_NCI-H1792 | Piroxicam perturbation in NCI-H1792 cell line |
| Ralimetinib dimesylate_HOP62 | Ralimetinib dimesylate perturbation in HOP62 cell line |
| Pitavastatin (Calcium)_A-172 | Pitavastatin (Calcium) perturbation in A-172 cell line |
| Auranofin_CFPAC-1 | Auranofin perturbation in CFPAC-1 cell line |
| Verapamil_NCI-H2122 | Verapamil perturbation in NCI-H2122 cell line |
| Bosentan (hydrate)_LOX-IMVI | Bosentan (hydrate) perturbation in LOX-IMVI cell line |
| Lopinavir_A-427 | Lopinavir perturbation in A-427 cell line |
| Rimonabant (Hydrochloride)_LOX-IMVI | Rimonabant (Hydrochloride) perturbation in LOX-IMVI cell line |
| Bosentan (hydrate)_RKO | Bosentan (hydrate) perturbation in RKO cell line |
| ETC-206_NCI-H2122 | ETC-206 perturbation in NCI-H2122 cell line |
| Vandetanib_SNU-423 | Vandetanib perturbation in SNU-423 cell line |
| Canagliflozin (hemihydrate)_LOX-IMVI | Canagliflozin (hemihydrate) perturbation in LOX-IMVI cell line |
| SBI-0640756_NCI-H2122 | SBI-0640756 perturbation in NCI-H2122 cell line |
| Methyl aminolevulinate (hydrochloride)_CFPAC-1 | Methyl aminolevulinate (hydrochloride) perturbation in CFPAC-1 cell line |
| Bendamustine_SK-MEL-2 | Bendamustine perturbation in SK-MEL-2 cell line |
| Voriconazole_BT-474 | Voriconazole perturbation in BT-474 cell line |
| Ivabradine (hydrochloride)_AsPC-1 | Ivabradine (hydrochloride) perturbation in AsPC-1 cell line |
| Idoxuridine_CFPAC-1 | Idoxuridine perturbation in CFPAC-1 cell line |
| Gemcitabine_NCI-H596 | Gemcitabine perturbation in NCI-H596 cell line |
| Ataluren_SW 1088 | Ataluren perturbation in SW 1088 cell line |
| Nafamostat (mesylate)_CFPAC-1 | Nafamostat (mesylate) perturbation in CFPAC-1 cell line |
| Thymopentin_SW48 | Thymopentin perturbation in SW48 cell line |
| Paclitaxel_NCI-H2030 | Paclitaxel perturbation in NCI-H2030 cell line |
| Auranofin_A498 | Auranofin perturbation in A498 cell line |
| Cilostazol_HepG2/C3A | Cilostazol perturbation in HepG2/C3A cell line |
| Imiquimod (maleate)_SK-MEL-2 | Imiquimod (maleate) perturbation in SK-MEL-2 cell line |
| Fusidic acid_SNU-1 | Fusidic acid perturbation in SNU-1 cell line |
| Valdecoxib_SK-MEL-2 | Valdecoxib perturbation in SK-MEL-2 cell line |
| Acetazolamide_SK-MEL-2 | Acetazolamide perturbation in SK-MEL-2 cell line |
| Temsirolimus_SNU-423 | Temsirolimus perturbation in SNU-423 cell line |
| Fedratinib (hydrochloride hydrate)_LS 180 | Fedratinib (hydrochloride hydrate) perturbation in LS 180 cell line |
| Captopril_LOX-IMVI | Captopril perturbation in LOX-IMVI cell line |
| Orlistat_SK-MEL-2 | Orlistat perturbation in SK-MEL-2 cell line |
| Clopidogrel_CFPAC-1 | Clopidogrel perturbation in CFPAC-1 cell line |
| Econazole_NCI-H2122 | Econazole perturbation in NCI-H2122 cell line |
| Sulfatinib_LOX-IMVI | Sulfatinib perturbation in LOX-IMVI cell line |
| Dinaciclib_HCT15 | Dinaciclib perturbation in HCT15 cell line |
| Naproxen_AN3 CA | Naproxen perturbation in AN3 CA cell line |
| Methotrexate_SK-MEL-2 | Methotrexate perturbation in SK-MEL-2 cell line |
| AZD-8055_NCI-H2030 | AZD-8055 perturbation in NCI-H2030 cell line |
| Verapamil_CFPAC-1 | Verapamil perturbation in CFPAC-1 cell line |
| Cyclosporin A_LOX-IMVI | Cyclosporin A perturbation in LOX-IMVI cell line |
| Pitavastatin (Calcium)_SK-MEL-2 | Pitavastatin (Calcium) perturbation in SK-MEL-2 cell line |
| Fostamatinib (disodium hexahydrate)_NCI-H661 | Fostamatinib (disodium hexahydrate) perturbation in NCI-H661 cell line |
| Indacaterol (maleate)_SK-MEL-2 | Indacaterol (maleate) perturbation in SK-MEL-2 cell line |
| Sunitinib_SK-MEL-2 | Sunitinib perturbation in SK-MEL-2 cell line |
| 5-Azacytidine_CFPAC-1 | 5-Azacytidine perturbation in CFPAC-1 cell line |
| Cyclosporin A_RKO | Cyclosporin A perturbation in RKO cell line |
| Quinidine (15% dihydroquinidine)_A498 | Quinidine (15% dihydroquinidine) perturbation in A498 cell line |
| (R)-Verapamil (hydrochloride)_HCT15 | (R)-Verapamil (hydrochloride) perturbation in HCT15 cell line |
| Cytarabine (hydrochloride)_CFPAC-1 | Cytarabine (hydrochloride) perturbation in CFPAC-1 cell line |
| Canagliflozin_RKO | Canagliflozin perturbation in RKO cell line |
| Ranolazine_RKO | Ranolazine perturbation in RKO cell line |
| Bimatoprost_NCI-H661 | Bimatoprost perturbation in NCI-H661 cell line |
| Zileuton_NCI-H661 | Zileuton perturbation in NCI-H661 cell line |
| Fingolimod (hydrochloride)_SW 1271 | Fingolimod (hydrochloride) perturbation in SW 1271 cell line |
| Ribociclib_J82 | Ribociclib perturbation in J82 cell line |
| crizotinib_NCI-H661 | crizotinib perturbation in NCI-H661 cell line |
| Tranilast_C32 | Tranilast perturbation in C32 cell line |
| Ribociclib_C-33 A | Ribociclib perturbation in C-33 A cell line |
| LJI308_NCI-H661 | LJI308 perturbation in NCI-H661 cell line |
| Irinotecan_SHP-77 | Irinotecan perturbation in SHP-77 cell line |
| Flumatinib (mesylate)_NCI-H661 | Flumatinib (mesylate) perturbation in NCI-H661 cell line |
| NG25_A-427 | NG25 perturbation in A-427 cell line |
| Gefitinib_NCI-H661 | Gefitinib perturbation in NCI-H661 cell line |
| Ritonavir_NCI-H661 | Ritonavir perturbation in NCI-H661 cell line |
| Lipoic acid_AN3 CA | Lipoic acid perturbation in AN3 CA cell line |
| Idarubicin (hydrochloride)_NCI-H661 | Idarubicin (hydrochloride) perturbation in NCI-H661 cell line |
| Saquinavir_SHP-77 | Saquinavir perturbation in SHP-77 cell line |
| ULK-101_A-427 | ULK-101 perturbation in A-427 cell line |
| Chlorhexidine (diacetate)_C-33 A | Chlorhexidine (diacetate) perturbation in C-33 A cell line |
| Chlorhexidine (diacetate)_A-427 | Chlorhexidine (diacetate) perturbation in A-427 cell line |
| Dimethyl fumarate_SW 1271 | Dimethyl fumarate perturbation in SW 1271 cell line |
| Bexarotene_A-427 | Bexarotene perturbation in A-427 cell line |
| Loperamide (hydrochloride)_CHP-212 | Loperamide (hydrochloride) perturbation in CHP-212 cell line |
| Regorafenib_SW 1271 | Regorafenib perturbation in SW 1271 cell line |
| Imiquimod (maleate)_C-33 A | Imiquimod (maleate) perturbation in C-33 A cell line |
| Fulvestrant_NCI-H661 | Fulvestrant perturbation in NCI-H661 cell line |
| Gemfibrozil_NCI-H661 | Gemfibrozil perturbation in NCI-H661 cell line |
| Uridine_C-33 A | Uridine perturbation in C-33 A cell line |
| Pemetrexed_NCI-H661 | Pemetrexed perturbation in NCI-H661 cell line |
| Almonertinib (mesylate)_NCI-H23 | Almonertinib (mesylate) perturbation in NCI-H23 cell line |
| Celecoxib_SHP-77 | Celecoxib perturbation in SHP-77 cell line |
| MK-3903_NCI-H661 | MK-3903 perturbation in NCI-H661 cell line |
| Ritonavir_SHP-77 | Ritonavir perturbation in SHP-77 cell line |
| Bendamustine_SW 1088 | Bendamustine perturbation in SW 1088 cell line |
| Aspirin_SHP-77 | Aspirin perturbation in SHP-77 cell line |
| S-Adenosyl-L-methionine (disulfate tosylate)_NCI-H661 | S-Adenosyl-L-methionine (disulfate tosylate) perturbation in NCI-H661 cell line |
| Chlorhexidine (diacetate)_SW 1088 | Chlorhexidine (diacetate) perturbation in SW 1088 cell line |
| 5-Fluorouracil_RKO | 5-Fluorouracil perturbation in RKO cell line |
| Ribociclib_SW 1271 | Ribociclib perturbation in SW 1271 cell line |
| GSK1059615_NCI-H661 | GSK1059615 perturbation in NCI-H661 cell line |
| Edoxaban (tosylate monohydrate)_CHP-212 | Edoxaban (tosylate monohydrate) perturbation in CHP-212 cell line |
| Goserelin (acetate)_NCI-H661 | Goserelin (acetate) perturbation in NCI-H661 cell line |
| 5-Fluorouracil_A-427 | 5-Fluorouracil perturbation in A-427 cell line |
| Nevirapine_SW 1088 | Nevirapine perturbation in SW 1088 cell line |
| Lopinavir_CHP-212 | Lopinavir perturbation in CHP-212 cell line |
| Fenofibrate_AN3 CA | Fenofibrate perturbation in AN3 CA cell line |
| Idoxuridine_SHP-77 | Idoxuridine perturbation in SHP-77 cell line |
| Dexmedetomidine_NCI-H661 | Dexmedetomidine perturbation in NCI-H661 cell line |
| Idoxuridine_C-33 A | Idoxuridine perturbation in C-33 A cell line |
| RMC-6236_Hs 766T | RMC-6236 perturbation in Hs 766T cell line |
| Bosentan (hydrate)_Hs 766T | Bosentan (hydrate) perturbation in Hs 766T cell line |
| Terfenadine_J82 | Terfenadine perturbation in J82 cell line |
| Ritonavir_Hs 766T | Ritonavir perturbation in Hs 766T cell line |
| Capivasertib_hTERT-HPNE | Capivasertib perturbation in hTERT-HPNE cell line |
| Clopidogrel_hTERT-HPNE | Clopidogrel perturbation in hTERT-HPNE cell line |
| Bortezomib_hTERT-HPNE | Bortezomib perturbation in hTERT-HPNE cell line |
| Megestrol_Hs 766T | Megestrol perturbation in Hs 766T cell line |
| Sodium Salicylate_A-172 | Sodium Salicylate perturbation in A-172 cell line |
| Bimiralisib_hTERT-HPNE | Bimiralisib perturbation in hTERT-HPNE cell line |
| Tucidinostat_Hs 766T | Tucidinostat perturbation in Hs 766T cell line |
| (S)-Crizotinib_HS-578T | (S)-Crizotinib perturbation in HS-578T cell line |
| Regorafenib_Hs 766T | Regorafenib perturbation in Hs 766T cell line |
| Tucatinib_HS-578T | Tucatinib perturbation in HS-578T cell line |
| PF-06260933_J82 | PF-06260933 perturbation in J82 cell line |
| 5-Fluorouracil_hTERT-HPNE | 5-Fluorouracil perturbation in hTERT-HPNE cell line |
| Macitentan_Hs 766T | Macitentan perturbation in Hs 766T cell line |
| Pentamidine (isethionate)_J82 | Pentamidine (isethionate) perturbation in J82 cell line |
| Doxorubicin (hydrochloride)_J82 | Doxorubicin (hydrochloride) perturbation in J82 cell line |
| Paclitaxel_J82 | Paclitaxel perturbation in J82 cell line |
| Vemurafenib_hTERT-HPNE | Vemurafenib perturbation in hTERT-HPNE cell line |
| APTO-253_Hs 766T | APTO-253 perturbation in Hs 766T cell line |
| RMC-6236_A-172 | RMC-6236 perturbation in A-172 cell line |
| Tofacitinib_hTERT-HPNE | Tofacitinib perturbation in hTERT-HPNE cell line |
| Benproperine (phosphate)_J82 | Benproperine (phosphate) perturbation in J82 cell line |
| ERK5-IN-2_Hs 766T | ERK5-IN-2 perturbation in Hs 766T cell line |
| Thymopentin_hTERT-HPNE | Thymopentin perturbation in hTERT-HPNE cell line |
| Trametinib_SNU-423 | Trametinib perturbation in SNU-423 cell line |
| Omeprazole (sodium)_Hs 766T | Omeprazole (sodium) perturbation in Hs 766T cell line |
| Lactate (calcium)_hTERT-HPNE | Lactate (calcium) perturbation in hTERT-HPNE cell line |
| Tucatinib_Hs 766T | Tucatinib perturbation in Hs 766T cell line |
| L-Thyroxine (sodium salt pentahydrate)_HS-578T | L-Thyroxine (sodium salt pentahydrate) perturbation in HS-578T cell line |
| Sodium Salicylate_Hs 766T | Sodium Salicylate perturbation in Hs 766T cell line |
| Ralimetinib dimesylate_hTERT-HPNE | Ralimetinib dimesylate perturbation in hTERT-HPNE cell line |
| Ivermectin_Hs 766T | Ivermectin perturbation in Hs 766T cell line |
| Allopurinol_Hs 766T | Allopurinol perturbation in Hs 766T cell line |
| Epirubicin (hydrochloride)_HS-578T | Epirubicin (hydrochloride) perturbation in HS-578T cell line |
| Bosentan (hydrate)_hTERT-HPNE | Bosentan (hydrate) perturbation in hTERT-HPNE cell line |
| Torkinib_hTERT-HPNE | Torkinib perturbation in hTERT-HPNE cell line |
| Thymol_hTERT-HPNE | Thymol perturbation in hTERT-HPNE cell line |
| Cinacalcet_Hs 766T | Cinacalcet perturbation in Hs 766T cell line |
| γ-Oryzanol_J82 | γ-Oryzanol perturbation in J82 cell line |
| olaparib_hTERT-HPNE | olaparib perturbation in hTERT-HPNE cell line |
| Simotinib_hTERT-HPNE | Simotinib perturbation in hTERT-HPNE cell line |
| LJI308_hTERT-HPNE | LJI308 perturbation in hTERT-HPNE cell line |
| Larotrectinib_NCI-H2122 | Larotrectinib perturbation in NCI-H2122 cell line |
| Megestrol_hTERT-HPNE | Megestrol perturbation in hTERT-HPNE cell line |
| Belumosudil (mesylate)_Hs 766T | Belumosudil (mesylate) perturbation in Hs 766T cell line |
| Erythromycin_J82 | Erythromycin perturbation in J82 cell line |
| Futibatinib_J82 | Futibatinib perturbation in J82 cell line |
| Erlotinib_J82 | Erlotinib perturbation in J82 cell line |
| Pexidartinib (hydrochloride)_Hs 766T | Pexidartinib (hydrochloride) perturbation in Hs 766T cell line |
| Tucatinib_hTERT-HPNE | Tucatinib perturbation in hTERT-HPNE cell line |
| Captopril_hTERT-HPNE | Captopril perturbation in hTERT-HPNE cell line |
| Busulfan_J82 | Busulfan perturbation in J82 cell line |
| Proglumide_Hs 766T | Proglumide perturbation in Hs 766T cell line |
| (S)-Crizotinib_hTERT-HPNE | (S)-Crizotinib perturbation in hTERT-HPNE cell line |
| Perindopril (erbumine)_Hs 766T | Perindopril (erbumine) perturbation in Hs 766T cell line |
| SBI-0640756_HS-578T | SBI-0640756 perturbation in HS-578T cell line |
| Doxycycline (monohydrate)_A-172 | Doxycycline (monohydrate) perturbation in A-172 cell line |
| Bestatin (hydrochloride)_NCI-H2122 | Bestatin (hydrochloride) perturbation in NCI-H2122 cell line |
| Balsalazide (sodium hydrate)_NCI-H596 | Balsalazide (sodium hydrate) perturbation in NCI-H596 cell line |
| Sonidegib_NCI-H596 | Sonidegib perturbation in NCI-H596 cell line |
| Tucatinib_SNU-423 | Tucatinib perturbation in SNU-423 cell line |
| Abiraterone acetate_Hs 766T | Abiraterone acetate perturbation in Hs 766T cell line |
| Futibatinib_hTERT-HPNE | Futibatinib perturbation in hTERT-HPNE cell line |
| Doxorubicin (hydrochloride)_Hs 766T | Doxorubicin (hydrochloride) perturbation in Hs 766T cell line |
| Bendamustine_hTERT-HPNE | Bendamustine perturbation in hTERT-HPNE cell line |
| Almonertinib (hydrochloride)_J82 | Almonertinib (hydrochloride) perturbation in J82 cell line |
| LY2090314_A-172 | LY2090314 perturbation in A-172 cell line |
| Tranilast_A-172 | Tranilast perturbation in A-172 cell line |
| Vismodegib_A-172 | Vismodegib perturbation in A-172 cell line |
| Plicamycin_J82 | Plicamycin perturbation in J82 cell line |
| Rucaparib (phosphate)_Hs 766T | Rucaparib (phosphate) perturbation in Hs 766T cell line |
| (S)-Crizotinib_J82 | (S)-Crizotinib perturbation in J82 cell line |
| Vinblastine (sulfate)_hTERT-HPNE | Vinblastine (sulfate) perturbation in hTERT-HPNE cell line |
| Hydroxyurea_hTERT-HPNE | Hydroxyurea perturbation in hTERT-HPNE cell line |
| 8-Hydroxyquinoline_Hs 766T | 8-Hydroxyquinoline perturbation in Hs 766T cell line |
| Adenine_Hs 766T | Adenine perturbation in Hs 766T cell line |
| Pemigatinib_SNU-423 | Pemigatinib perturbation in SNU-423 cell line |
| Bisoprolol (hemifumarate)_Hs 766T | Bisoprolol (hemifumarate) perturbation in Hs 766T cell line |
| Benproperine (phosphate)_Hs 766T | Benproperine (phosphate) perturbation in Hs 766T cell line |
| Afatinib_Hs 766T | Afatinib perturbation in Hs 766T cell line |
| Niclosamide (olamine)_A-172 | Niclosamide (olamine) perturbation in A-172 cell line |
| palbociclib_Hs 766T | palbociclib perturbation in Hs 766T cell line |
| Voriconazole_Hs 766T | Voriconazole perturbation in Hs 766T cell line |
| Cobimetinib_hTERT-HPNE | Cobimetinib perturbation in hTERT-HPNE cell line |
| Aprepitant_Hs 766T | Aprepitant perturbation in Hs 766T cell line |
| Gefitinib_J82 | Gefitinib perturbation in J82 cell line |
| Pentoxifylline_SW 1088 | Pentoxifylline perturbation in SW 1088 cell line |
| Vilanterol_Hs 766T | Vilanterol perturbation in Hs 766T cell line |
| Hesperidin_A-172 | Hesperidin perturbation in A-172 cell line |
| Sinomenine_A-172 | Sinomenine perturbation in A-172 cell line |
| Levobupivacaine (hydrochloride)_J82 | Levobupivacaine (hydrochloride) perturbation in J82 cell line |
| Ribociclib_Hs 766T | Ribociclib perturbation in Hs 766T cell line |
| Hexylresorcinol_Hs 766T | Hexylresorcinol perturbation in Hs 766T cell line |
| Berberine (chloride hydrate)_hTERT-HPNE | Berberine (chloride hydrate) perturbation in hTERT-HPNE cell line |
| PH-797804_hTERT-HPNE | PH-797804 perturbation in hTERT-HPNE cell line |
| 8-Hydroxyquinoline_HS-578T | 8-Hydroxyquinoline perturbation in HS-578T cell line |
| Canagliflozin (hemihydrate)_SNU-423 | Canagliflozin (hemihydrate) perturbation in SNU-423 cell line |
| Methylthiouracil_Hs 766T | Methylthiouracil perturbation in Hs 766T cell line |
| Trametinib_hTERT-HPNE | Trametinib perturbation in hTERT-HPNE cell line |
| Epirubicin (hydrochloride)_J82 | Epirubicin (hydrochloride) perturbation in J82 cell line |
| Quinidine (15% dihydroquinidine)_J82 | Quinidine (15% dihydroquinidine) perturbation in J82 cell line |
| Glycyrrhizic acid_Hs 766T | Glycyrrhizic acid perturbation in Hs 766T cell line |
| Raltitrexed_hTERT-HPNE | Raltitrexed perturbation in hTERT-HPNE cell line |
| Sunitinib_A-172 | Sunitinib perturbation in A-172 cell line |
| 4EGI-1_hTERT-HPNE | 4EGI-1 perturbation in hTERT-HPNE cell line |
| 8-Hydroxyquinoline_hTERT-HPNE | 8-Hydroxyquinoline perturbation in hTERT-HPNE cell line |
| Bexarotene_Hs 766T | Bexarotene perturbation in Hs 766T cell line |
| Loperamide (hydrochloride)_Hs 766T | Loperamide (hydrochloride) perturbation in Hs 766T cell line |
| Diammonium Glycyrrhizinate_J82 | Diammonium Glycyrrhizinate perturbation in J82 cell line |
| Balsalazide (sodium hydrate)_hTERT-HPNE | Balsalazide (sodium hydrate) perturbation in hTERT-HPNE cell line |
| Neratinib_Hs 766T | Neratinib perturbation in Hs 766T cell line |
| Resveratrol_Hs 766T | Resveratrol perturbation in Hs 766T cell line |
| Dexamethasone_J82 | Dexamethasone perturbation in J82 cell line |
| Terfenadine_hTERT-HPNE | Terfenadine perturbation in hTERT-HPNE cell line |
| Triclosan_SNU-423 | Triclosan perturbation in SNU-423 cell line |
| Dexmedetomidine_HS-578T | Dexmedetomidine perturbation in HS-578T cell line |
| Cabozantinib (S-malate)_J82 | Cabozantinib (S-malate) perturbation in J82 cell line |
| Erlotinib_A-172 | Erlotinib perturbation in A-172 cell line |
| Citalopram (hydrobromide)_Hs 766T | Citalopram (hydrobromide) perturbation in Hs 766T cell line |
| Bendamustine_A-172 | Bendamustine perturbation in A-172 cell line |
| Afatinib_hTERT-HPNE | Afatinib perturbation in hTERT-HPNE cell line |
| Tranilast_hTERT-HPNE | Tranilast perturbation in hTERT-HPNE cell line |
| Fulvestrant_J82 | Fulvestrant perturbation in J82 cell line |
| Lopinavir_J82 | Lopinavir perturbation in J82 cell line |
| Bestatin (hydrochloride)_Hs 766T | Bestatin (hydrochloride) perturbation in Hs 766T cell line |
| Lidocaine (hydrochloride)_hTERT-HPNE | Lidocaine (hydrochloride) perturbation in hTERT-HPNE cell line |
| Pemetrexed_hTERT-HPNE | Pemetrexed perturbation in hTERT-HPNE cell line |
| Minodronic acid_J82 | Minodronic acid perturbation in J82 cell line |
| Orlistat_Hs 766T | Orlistat perturbation in Hs 766T cell line |
| AT7519_J82 | AT7519 perturbation in J82 cell line |
| Imiquimod (maleate)_Hs 766T | Imiquimod (maleate) perturbation in Hs 766T cell line |
| Medroxyprogesterone acetate_H4 | Medroxyprogesterone acetate perturbation in H4 cell line |
| Pexidartinib (hydrochloride)_SW 1271 | Pexidartinib (hydrochloride) perturbation in SW 1271 cell line |
| Ralimetinib dimesylate_SW 1271 | Ralimetinib dimesylate perturbation in SW 1271 cell line |
| Paclitaxel_AN3 CA | Paclitaxel perturbation in AN3 CA cell line |
| Temuterkib_SW 1088 | Temuterkib perturbation in SW 1088 cell line |
| Ciclopirox_RKO | Ciclopirox perturbation in RKO cell line |
| Cabozantinib (S-malate)_hTERT-HPNE | Cabozantinib (S-malate) perturbation in hTERT-HPNE cell line |
| Proglumide_SW 1271 | Proglumide perturbation in SW 1271 cell line |
| Altretamine_SW 1271 | Altretamine perturbation in SW 1271 cell line |
| Neratinib (maleate)_RKO | Neratinib (maleate) perturbation in RKO cell line |
| Baicalin_SW 1271 | Baicalin perturbation in SW 1271 cell line |
| Fulvestrant_hTERT-HPNE | Fulvestrant perturbation in hTERT-HPNE cell line |
| Vitamin K4_SW 1271 | Vitamin K4 perturbation in SW 1271 cell line |
| Tofacitinib (citrate)_RKO | Tofacitinib (citrate) perturbation in RKO cell line |
| Methylthiouracil_RKO | Methylthiouracil perturbation in RKO cell line |
| Glasdegib_NCI-H460 | Glasdegib perturbation in NCI-H460 cell line |
| Edoxaban (tosylate monohydrate)_SW 1271 | Edoxaban (tosylate monohydrate) perturbation in SW 1271 cell line |
| Brimonidine_A498 | Brimonidine perturbation in A498 cell line |
| ULK-101_RKO | ULK-101 perturbation in RKO cell line |
| Piroxicam_SW 1271 | Piroxicam perturbation in SW 1271 cell line |
| Budesonide_J82 | Budesonide perturbation in J82 cell line |
| Pravastatin (sodium)_SW 1271 | Pravastatin (sodium) perturbation in SW 1271 cell line |
| Idoxuridine_SW 1271 | Idoxuridine perturbation in SW 1271 cell line |
| Azithromycin (hydrate)_RKO | Azithromycin (hydrate) perturbation in RKO cell line |
| Pimitespib_SW 1088 | Pimitespib perturbation in SW 1088 cell line |
| Imiquimod (maleate)_LOX-IMVI | Imiquimod (maleate) perturbation in LOX-IMVI cell line |
| S-Adenosyl-L-methionine (disulfate tosylate)_CHP-212 | S-Adenosyl-L-methionine (disulfate tosylate) perturbation in CHP-212 cell line |
| Bicalutamide_SW 1088 | Bicalutamide perturbation in SW 1088 cell line |
| Cytarabine (hydrochloride)_SW 1088 | Cytarabine (hydrochloride) perturbation in SW 1088 cell line |
| Raltitrexed_J82 | Raltitrexed perturbation in J82 cell line |
| Fulvestrant_SW 1271 | Fulvestrant perturbation in SW 1271 cell line |
| Ribociclib_AN3 CA | Ribociclib perturbation in AN3 CA cell line |
| L-Eflornithine (monohydrochloride)_SW 1271 | L-Eflornithine (monohydrochloride) perturbation in SW 1271 cell line |
| Crizotinib (hydrochloride)_NCI-H460 | Crizotinib (hydrochloride) perturbation in NCI-H460 cell line |
| Verapamil_SW 1271 | Verapamil perturbation in SW 1271 cell line |
| Hexylresorcinol_NCI-H2122 | Hexylresorcinol perturbation in NCI-H2122 cell line |
| Phenylephrine (hydrochloride)_SW 1271 | Phenylephrine (hydrochloride) perturbation in SW 1271 cell line |
| Bicalutamide_SW 1271 | Bicalutamide perturbation in SW 1271 cell line |
| Pemetrexed_AN3 CA | Pemetrexed perturbation in AN3 CA cell line |
| Cinacalcet_SW 1271 | Cinacalcet perturbation in SW 1271 cell line |
| Fluvoxamine_SW 1271 | Fluvoxamine perturbation in SW 1271 cell line |
| Bestatin_H4 | Bestatin perturbation in H4 cell line |
| Zileuton_SW 1088 | Zileuton perturbation in SW 1088 cell line |
| Fumaric acid_SW 1271 | Fumaric acid perturbation in SW 1271 cell line |
| Finasteride_SW 1271 | Finasteride perturbation in SW 1271 cell line |
| Ropivacaine (hydrochloride monohydrate)_H4 | Ropivacaine (hydrochloride monohydrate) perturbation in H4 cell line |
| Belumosudil_SW 1271 | Belumosudil perturbation in SW 1271 cell line |
| Bisoprolol (hemifumarate)_RKO | Bisoprolol (hemifumarate) perturbation in RKO cell line |
| Drospirenone_RKO | Drospirenone perturbation in RKO cell line |
| Drospirenone_LOX-IMVI | Drospirenone perturbation in LOX-IMVI cell line |
| Sinomenine_RKO | Sinomenine perturbation in RKO cell line |
| DTP3_hTERT-HPNE | DTP3 perturbation in hTERT-HPNE cell line |
| Aspirin_SW 1271 | Aspirin perturbation in SW 1271 cell line |
| Mitoxantrone (dihydrochloride)_J82 | Mitoxantrone (dihydrochloride) perturbation in J82 cell line |
| Peretinoin_SW 1088 | Peretinoin perturbation in SW 1088 cell line |
| Zileuton_SW 1271 | Zileuton perturbation in SW 1271 cell line |
| Olanzapine_AN3 CA | Olanzapine perturbation in AN3 CA cell line |
| Imiquimod (hydrochloride)_SW 1271 | Imiquimod (hydrochloride) perturbation in SW 1271 cell line |
| Erdafitinib _LOX-IMVI | Erdafitinib perturbation in LOX-IMVI cell line |
| Carbidopa (monohydrate)_LOX-IMVI | Carbidopa (monohydrate) perturbation in LOX-IMVI cell line |
| NVP-BHG712_LOX-IMVI | NVP-BHG712 perturbation in LOX-IMVI cell line |
| venetoclax_LOX-IMVI | venetoclax perturbation in LOX-IMVI cell line |
| Ranolazine_SW 1271 | Ranolazine perturbation in SW 1271 cell line |
| Clonidine (hydrochloride)_NCI-H661 | Clonidine (hydrochloride) perturbation in NCI-H661 cell line |
| Trifluridine_RKO | Trifluridine perturbation in RKO cell line |
| Decitabine_SW 1271 | Decitabine perturbation in SW 1271 cell line |
| Pyridoxine (hydrochloride)_RKO | Pyridoxine (hydrochloride) perturbation in RKO cell line |
| Osimertinib (mesylate)_J82 | Osimertinib (mesylate) perturbation in J82 cell line |
| Budesonide_LOX-IMVI | Budesonide perturbation in LOX-IMVI cell line |
| Flutamide_SW 1271 | Flutamide perturbation in SW 1271 cell line |
| crizotinib_SW 1271 | crizotinib perturbation in SW 1271 cell line |
| Budesonide_RKO | Budesonide perturbation in RKO cell line |
| Budesonide_NCI-H460 | Budesonide perturbation in NCI-H460 cell line |
| Elimusertib hydrochloride_NCI-H2030 | Elimusertib hydrochloride perturbation in NCI-H2030 cell line |
| Zileuton_hTERT-HPNE | Zileuton perturbation in hTERT-HPNE cell line |
| Levobupivacaine (hydrochloride)_SW 1271 | Levobupivacaine (hydrochloride) perturbation in SW 1271 cell line |
| Lopinavir_H4 | Lopinavir perturbation in H4 cell line |
| Celecoxib_SW 1088 | Celecoxib perturbation in SW 1088 cell line |
| Voriconazole_LOX-IMVI | Voriconazole perturbation in LOX-IMVI cell line |
| Entecavir (monohydrate)_SW 1271 | Entecavir (monohydrate) perturbation in SW 1271 cell line |
| Panobinostat_SW 1271 | Panobinostat perturbation in SW 1271 cell line |
| palbociclib_RKO | palbociclib perturbation in RKO cell line |
| Tolcapone_LOX-IMVI | Tolcapone perturbation in LOX-IMVI cell line |
| Bosentan (hydrate)_SW 1271 | Bosentan (hydrate) perturbation in SW 1271 cell line |
| Fluvoxamine (maleate)_CHP-212 | Fluvoxamine (maleate) perturbation in CHP-212 cell line |
| Selinexor _SHP-77 | Selinexor perturbation in SHP-77 cell line |
| Tolcapone_RKO | Tolcapone perturbation in RKO cell line |
| Vilanterol_RKO | Vilanterol perturbation in RKO cell line |
| Darinaparsin_A498 | Darinaparsin perturbation in A498 cell line |
| Berbamine_SW 1271 | Berbamine perturbation in SW 1271 cell line |
| TAK-733_SW 1271 | TAK-733 perturbation in SW 1271 cell line |
| Cepharanthine_SW 1088 | Cepharanthine perturbation in SW 1088 cell line |
| Gallic acid_AN3 CA | Gallic acid perturbation in AN3 CA cell line |
| Nafamostat (mesylate)_RKO | Nafamostat (mesylate) perturbation in RKO cell line |
| Bestatin (hydrochloride)_SW 1271 | Bestatin (hydrochloride) perturbation in SW 1271 cell line |
| Dihydroartemisinin_J82 | Dihydroartemisinin perturbation in J82 cell line |
| AT7519_RKO | AT7519 perturbation in RKO cell line |
| Ivabradine (hydrochloride)_H4 | Ivabradine (hydrochloride) perturbation in H4 cell line |
| Darinaparsin_SW 1088 | Darinaparsin perturbation in SW 1088 cell line |
| Pentoxifylline_hTERT-HPNE | Pentoxifylline perturbation in hTERT-HPNE cell line |
| Gallic acid_SW 1271 | Gallic acid perturbation in SW 1271 cell line |
| Lopinavir_RKO | Lopinavir perturbation in RKO cell line |
| Orlistat_SW 1271 | Orlistat perturbation in SW 1271 cell line |
| Salicylic acid_BT-474 | Salicylic acid perturbation in BT-474 cell line |
| Imiquimod (maleate)_SW 1271 | Imiquimod (maleate) perturbation in SW 1271 cell line |
| Carbamazepine_SW 1271 | Carbamazepine perturbation in SW 1271 cell line |
| AZD2858_SW 1088 | AZD2858 perturbation in SW 1088 cell line |
| Cinacalcet_NCI-H460 | Cinacalcet perturbation in NCI-H460 cell line |
| Sildenafil_SW 1271 | Sildenafil perturbation in SW 1271 cell line |
| Resveratrol_SW 1271 | Resveratrol perturbation in SW 1271 cell line |
| IQ 1_J82 | IQ 1 perturbation in J82 cell line |
| Tazarotene_hTERT-HPNE | Tazarotene perturbation in hTERT-HPNE cell line |
| Gallic acid_SW 1088 | Gallic acid perturbation in SW 1088 cell line |
| LB-100_SW 900 | LB-100 perturbation in SW 900 cell line |
| Crizotinib (hydrochloride)_SW 1271 | Crizotinib (hydrochloride) perturbation in SW 1271 cell line |
| Pemigatinib_C32 | Pemigatinib perturbation in C32 cell line |
| Fluvoxamine (maleate)_SW 1088 | Fluvoxamine (maleate) perturbation in SW 1088 cell line |
| Larotrectinib sulfate_SW 1271 | Larotrectinib sulfate perturbation in SW 1271 cell line |
| Estrone sulfate (potassium)_SW 1088 | Estrone sulfate (potassium) perturbation in SW 1088 cell line |
| Hydroxyurea_SW 1271 | Hydroxyurea perturbation in SW 1271 cell line |
| Futibatinib_SW 1088 | Futibatinib perturbation in SW 1088 cell line |
| Ponatinib_NCI-H460 | Ponatinib perturbation in NCI-H460 cell line |
| Neratinib_RPMI-7951 | Neratinib perturbation in RPMI-7951 cell line |
| HI-TOPK-032_LOX-IMVI | HI-TOPK-032 perturbation in LOX-IMVI cell line |
| Ornidazole_SW 1271 | Ornidazole perturbation in SW 1271 cell line |
| Perindopril (erbumine)_RKO | Perindopril (erbumine) perturbation in RKO cell line |
| Roxadustat_SW 1271 | Roxadustat perturbation in SW 1271 cell line |
| Ciclopirox_SW 1271 | Ciclopirox perturbation in SW 1271 cell line |
| Monocrotaline_SW 1271 | Monocrotaline perturbation in SW 1271 cell line |
| Daptomycin_SW 1271 | Daptomycin perturbation in SW 1271 cell line |
| Atazanavir (sulfate)_SW 1271 | Atazanavir (sulfate) perturbation in SW 1271 cell line |
| Dexmedetomidine_SW 1271 | Dexmedetomidine perturbation in SW 1271 cell line |
| Pentoxifylline_SW 1271 | Pentoxifylline perturbation in SW 1271 cell line |
| Salicylic acid_hTERT-HPNE | Salicylic acid perturbation in hTERT-HPNE cell line |
| Sivelestat (sodium tetrahydrate)_SW 1271 | Sivelestat (sodium tetrahydrate) perturbation in SW 1271 cell line |
| LY2090314_SW 1088 | LY2090314 perturbation in SW 1088 cell line |
| Osimertinib (mesylate)_H4 | Osimertinib (mesylate) perturbation in H4 cell line |
| Ivabradine (hydrochloride)_SW 1271 | Ivabradine (hydrochloride) perturbation in SW 1271 cell line |
| Pemetrexed_SW 1271 | Pemetrexed perturbation in SW 1271 cell line |
| Orlistat_H4 | Orlistat perturbation in H4 cell line |
| Tofacitinib_CHP-212 | Tofacitinib perturbation in CHP-212 cell line |
| L-Thyroxine (sodium salt pentahydrate)_LOX-IMVI | L-Thyroxine (sodium salt pentahydrate) perturbation in LOX-IMVI cell line |
| Riluzole hydrochloride_SW 1088 | Riluzole hydrochloride perturbation in SW 1088 cell line |
| Fedratinib (hydrochloride hydrate)_SW 1271 | Fedratinib (hydrochloride hydrate) perturbation in SW 1271 cell line |
| Afatinib_SW 1271 | Afatinib perturbation in SW 1271 cell line |
| Tolcapone_SW 1271 | Tolcapone perturbation in SW 1271 cell line |
| DTP3_RKO | DTP3 perturbation in RKO cell line |
| Pitavastatin (Calcium)_H4 | Pitavastatin (Calcium) perturbation in H4 cell line |
| Vismodegib_SW 1271 | Vismodegib perturbation in SW 1271 cell line |
| LY-2584702 (tosylate salt)_LOX-IMVI | LY-2584702 (tosylate salt) perturbation in LOX-IMVI cell line |
| Berbamine_NCI-H460 | Berbamine perturbation in NCI-H460 cell line |
| Resveratrol_H4 | Resveratrol perturbation in H4 cell line |
| Tetracycline (hydrochloride)_SW 1271 | Tetracycline (hydrochloride) perturbation in SW 1271 cell line |
| Elimusertib hydrochloride_LOX-IMVI | Elimusertib hydrochloride perturbation in LOX-IMVI cell line |
| Belinostat_SW 1271 | Belinostat perturbation in SW 1271 cell line |
| Idarubicin (hydrochloride)_RKO | Idarubicin (hydrochloride) perturbation in RKO cell line |
| Cloxacillin (sodium)_NCI-H460 | Cloxacillin (sodium) perturbation in NCI-H460 cell line |
| Ferulic acid_SW 1271 | Ferulic acid perturbation in SW 1271 cell line |
| Esmolol (hydrochloride)_SW 1271 | Esmolol (hydrochloride) perturbation in SW 1271 cell line |
| Tolmetin_SW 1271 | Tolmetin perturbation in SW 1271 cell line |
| Diphenhydramine_SW 1271 | Diphenhydramine perturbation in SW 1271 cell line |
| Aspirin_NCI-H460 | Aspirin perturbation in NCI-H460 cell line |
| Irinotecan (hydrochloride)_SW 1271 | Irinotecan (hydrochloride) perturbation in SW 1271 cell line |
| Brimonidine_SW 1088 | Brimonidine perturbation in SW 1088 cell line |
| Pyridoxine (hydrochloride)_SW 1088 | Pyridoxine (hydrochloride) perturbation in SW 1088 cell line |
| Capivasertib_J82 | Capivasertib perturbation in J82 cell line |
| Pimozide_SW 1271 | Pimozide perturbation in SW 1271 cell line |
| Daidzin_SW 1271 | Daidzin perturbation in SW 1271 cell line |
| Fumaric acid_NCI-H460 | Fumaric acid perturbation in NCI-H460 cell line |
| Adenine_SW 1271 | Adenine perturbation in SW 1271 cell line |
| Drospirenone_SW 1271 | Drospirenone perturbation in SW 1271 cell line |
| Canagliflozin_NCI-H460 | Canagliflozin perturbation in NCI-H460 cell line |
| Cysteamine (hydrochloride)_SW 1271 | Cysteamine (hydrochloride) perturbation in SW 1271 cell line |
| Brimonidine_SW 1271 | Brimonidine perturbation in SW 1271 cell line |
| Glasdegib_H4 | Glasdegib perturbation in H4 cell line |
| Pentamidine (isethionate)_SW 1271 | Pentamidine (isethionate) perturbation in SW 1271 cell line |
| Norepinephrine (hydrochloride)_RKO | Norepinephrine (hydrochloride) perturbation in RKO cell line |
| AZD-7648_SW 1088 | AZD-7648 perturbation in SW 1088 cell line |
| Abemaciclib_C32 | Abemaciclib perturbation in C32 cell line |
| Methyl aminolevulinate (hydrochloride)_SW 1088 | Methyl aminolevulinate (hydrochloride) perturbation in SW 1088 cell line |
| Goserelin (acetate)_NCI-H2347 | Goserelin (acetate) perturbation in NCI-H2347 cell line |
| Tucidinostat_NCI-H596 | Tucidinostat perturbation in NCI-H596 cell line |
| Baicalin_SW1417 | Baicalin perturbation in SW1417 cell line |
| Tofacitinib_SW1417 | Tofacitinib perturbation in SW1417 cell line |
| Norepinephrine (hydrochloride)_A-172 | Norepinephrine (hydrochloride) perturbation in A-172 cell line |
| ML264_SNU-423 | ML264 perturbation in SNU-423 cell line |
| AZD-8055_SW 900 | AZD-8055 perturbation in SW 900 cell line |
| Artemether_RKO | Artemether perturbation in RKO cell line |
| 4EGI-1_C32 | 4EGI-1 perturbation in C32 cell line |
| Vilanterol_J82 | Vilanterol perturbation in J82 cell line |
| Fingolimod (hydrochloride)_SW 1088 | Fingolimod (hydrochloride) perturbation in SW 1088 cell line |
| Pimitespib_RPMI-7951 | Pimitespib perturbation in RPMI-7951 cell line |
| Trifluridine_NCI-H2122 | Trifluridine perturbation in NCI-H2122 cell line |
| Homoharringtonine_NCI-H460 | Homoharringtonine perturbation in NCI-H460 cell line |
| Radotinib_SW 1088 | Radotinib perturbation in SW 1088 cell line |
| Ouabain (Octahydrate)_NCI-H596 | Ouabain (Octahydrate) perturbation in NCI-H596 cell line |
| Ixazomib_NCI-H2347 | Ixazomib perturbation in NCI-H2347 cell line |
| LJI308_SK-MEL-2 | LJI308 perturbation in SK-MEL-2 cell line |
| Sonidegib_SW 900 | Sonidegib perturbation in SW 900 cell line |
| Asciminib_AN3 CA | Asciminib perturbation in AN3 CA cell line |
| Palmatine (chloride)_NCI-H2122 | Palmatine (chloride) perturbation in NCI-H2122 cell line |
| Olanzapine_RKO | Olanzapine perturbation in RKO cell line |
| Bisoprolol (hemifumarate)_A498 | Bisoprolol (hemifumarate) perturbation in A498 cell line |
| Monocrotaline_NCI-H460 | Monocrotaline perturbation in NCI-H460 cell line |
| Saquinavir_NCI-H1792 | Saquinavir perturbation in NCI-H1792 cell line |
| 8-Hydroxyquinoline_A498 | 8-Hydroxyquinoline perturbation in A498 cell line |
| Bimatoprost_PANC-1 | Bimatoprost perturbation in PANC-1 cell line |
| Peretinoin_NCI-H661 | Peretinoin perturbation in NCI-H661 cell line |
| Elagolix sodium_SNU-423 | Elagolix sodium perturbation in SNU-423 cell line |
| EX229_SW 1271 | EX229 perturbation in SW 1271 cell line |
| ML264_HOP62 | ML264 perturbation in HOP62 cell line |
| Radotinib_NCI-H2030 | Radotinib perturbation in NCI-H2030 cell line |
| Artemether_LOX-IMVI | Artemether perturbation in LOX-IMVI cell line |
| Mozavaptan_NCI-H661 | Mozavaptan perturbation in NCI-H661 cell line |
| Niclosamide (olamine)_NCI-H2122 | Niclosamide (olamine) perturbation in NCI-H2122 cell line |
| Lonafarnib_RKO | Lonafarnib perturbation in RKO cell line |
| Trametinib_NCI-H2122 | Trametinib perturbation in NCI-H2122 cell line |
| Lipoic acid_CFPAC-1 | Lipoic acid perturbation in CFPAC-1 cell line |
| Vemurafenib_NCI-H2030 | Vemurafenib perturbation in NCI-H2030 cell line |
| Artemether_NCI-H2347 | Artemether perturbation in NCI-H2347 cell line |
| Isocorydine_PANC-1 | Isocorydine perturbation in PANC-1 cell line |
| Gemfibrozil_A549 | Gemfibrozil perturbation in A549 cell line |
| Anethole trithione_J82 | Anethole trithione perturbation in J82 cell line |
| BI-78D3_HOP62 | BI-78D3 perturbation in HOP62 cell line |
| Cysteamine (hydrochloride)_C32 | Cysteamine (hydrochloride) perturbation in C32 cell line |
| Ropivacaine (hydrochloride monohydrate)_SW 1271 | Ropivacaine (hydrochloride monohydrate) perturbation in SW 1271 cell line |
| Flutamide_SK-MEL-2 | Flutamide perturbation in SK-MEL-2 cell line |
| Belumosudil (mesylate)_A549 | Belumosudil (mesylate) perturbation in A549 cell line |
| Ixazomib_RKO | Ixazomib perturbation in RKO cell line |
| Megestrol_SK-MEL-2 | Megestrol perturbation in SK-MEL-2 cell line |
| venetoclax_NCI-H1573 | venetoclax perturbation in NCI-H1573 cell line |
| Vismodegib_NCI-H1792 | Vismodegib perturbation in NCI-H1792 cell line |
| Ixazomib_LOX-IMVI | Ixazomib perturbation in LOX-IMVI cell line |
| Tucidinostat_SK-MEL-2 | Tucidinostat perturbation in SK-MEL-2 cell line |
| Lumateperone (tosylate)_NCI-H460 | Lumateperone (tosylate) perturbation in NCI-H460 cell line |
| Ouabain (Octahydrate)_SK-MEL-2 | Ouabain (Octahydrate) perturbation in SK-MEL-2 cell line |
| Vinblastine (sulfate)_NCI-H2347 | Vinblastine (sulfate) perturbation in NCI-H2347 cell line |
| Diammonium Glycyrrhizinate_SW 1271 | Diammonium Glycyrrhizinate perturbation in SW 1271 cell line |
| Goserelin (acetate)_LOX-IMVI | Goserelin (acetate) perturbation in LOX-IMVI cell line |
| AZD1390_A549 | AZD1390 perturbation in A549 cell line |
| Larotrectinib_RKO | Larotrectinib perturbation in RKO cell line |
| Volasertib_SK-MEL-2 | Volasertib perturbation in SK-MEL-2 cell line |
| Bortezomib_RPMI-7951 | Bortezomib perturbation in RPMI-7951 cell line |
| Tirabrutinib (hydrochloride)_RPMI-7951 | Tirabrutinib (hydrochloride) perturbation in RPMI-7951 cell line |
| Posaconazole_NCI-H596 | Posaconazole perturbation in NCI-H596 cell line |
| Homoharringtonine_RKO | Homoharringtonine perturbation in RKO cell line |
| Trifluridine_NCI-H1573 | Trifluridine perturbation in NCI-H1573 cell line |
| Palmatine (chloride)_AN3 CA | Palmatine (chloride) perturbation in AN3 CA cell line |
| Allopurinol_hTERT-HPNE | Allopurinol perturbation in hTERT-HPNE cell line |
| Docetaxel_A-172 | Docetaxel perturbation in A-172 cell line |
| Saquinavir_J82 | Saquinavir perturbation in J82 cell line |
| Belzutifan_A498 | Belzutifan perturbation in A498 cell line |
| Lapatinib ditosylate_NCI-H596 | Lapatinib ditosylate perturbation in NCI-H596 cell line |
| BAY1125976_NCI-H1573 | BAY1125976 perturbation in NCI-H1573 cell line |
| olaparib_SK-MEL-2 | olaparib perturbation in SK-MEL-2 cell line |
| DT-061_H4 | DT-061 perturbation in H4 cell line |
| Clonidine (hydrochloride)_NCI-H2030 | Clonidine (hydrochloride) perturbation in NCI-H2030 cell line |
| Cysteamine (hydrochloride)_NCI-H2122 | Cysteamine (hydrochloride) perturbation in NCI-H2122 cell line |
| Ropivacaine (hydrochloride monohydrate)_SW1417 | Ropivacaine (hydrochloride monohydrate) perturbation in SW1417 cell line |
| Busulfan_NCI-H2347 | Busulfan perturbation in NCI-H2347 cell line |
| Demeclocycline_HS-578T | Demeclocycline perturbation in HS-578T cell line |
| Quinestrol_A549 | Quinestrol perturbation in A549 cell line |
| OTS514_C32 | OTS514 perturbation in C32 cell line |
| Vemurafenib_AsPC-1 | Vemurafenib perturbation in AsPC-1 cell line |
| Lumateperone (tosylate)_NCI-H2347 | Lumateperone (tosylate) perturbation in NCI-H2347 cell line |
| Ciclopirox_LOX-IMVI | Ciclopirox perturbation in LOX-IMVI cell line |
| Homoharringtonine_LOX-IMVI | Homoharringtonine perturbation in LOX-IMVI cell line |
| LB-100_Hs 766T | LB-100 perturbation in Hs 766T cell line |
| Rapamycin_SW 1088 | Rapamycin perturbation in SW 1088 cell line |
| Sinomenine_SW 900 | Sinomenine perturbation in SW 900 cell line |
| Lumateperone (tosylate)_LOX-IMVI | Lumateperone (tosylate) perturbation in LOX-IMVI cell line |
| Irinotecan_SNU-423 | Irinotecan perturbation in SNU-423 cell line |
| Homoharringtonine_NCI-H2347 | Homoharringtonine perturbation in NCI-H2347 cell line |
| Rimonabant_RKO | Rimonabant perturbation in RKO cell line |
| Palmatine (chloride)_C32 | Palmatine (chloride) perturbation in C32 cell line |
| Lonafarnib_NCI-H460 | Lonafarnib perturbation in NCI-H460 cell line |
| Norepinephrine (hydrochloride)_HS-578T | Norepinephrine (hydrochloride) perturbation in HS-578T cell line |
| Adenine_SW 900 | Adenine perturbation in SW 900 cell line |
| ULK-101_NCI-H23 | ULK-101 perturbation in NCI-H23 cell line |
| Lipoic acid_SNU-423 | Lipoic acid perturbation in SNU-423 cell line |
| 8-Hydroxyquinoline_SW 900 | 8-Hydroxyquinoline perturbation in SW 900 cell line |
| Darolutamide_RPMI-7951 | Darolutamide perturbation in RPMI-7951 cell line |
| Busulfan_RKO | Busulfan perturbation in RKO cell line |
| Sodium Salicylate_H4 | Sodium Salicylate perturbation in H4 cell line |
| Tucatinib_H4 | Tucatinib perturbation in H4 cell line |
| Tolcapone_J82 | Tolcapone perturbation in J82 cell line |
| Pentamidine (isethionate)_NCI-H1573 | Pentamidine (isethionate) perturbation in NCI-H1573 cell line |
| Almonertinib (hydrochloride)_A-172 | Almonertinib (hydrochloride) perturbation in A-172 cell line |
| XRK3F2_H4 | XRK3F2 perturbation in H4 cell line |
| Celecoxib_Hs 766T | Celecoxib perturbation in Hs 766T cell line |
| Sodium Salicylate_NCI-H661 | Sodium Salicylate perturbation in NCI-H661 cell line |
| Allopurinol_RPMI-7951 | Allopurinol perturbation in RPMI-7951 cell line |
| Binimetinib_SW 1271 | Binimetinib perturbation in SW 1271 cell line |
| AZD-8055_A498 | AZD-8055 perturbation in A498 cell line |
| 5-Fluorouracil_NCI-H2030 | 5-Fluorouracil perturbation in NCI-H2030 cell line |
| Lapatinib ditosylate_SK-MEL-2 | Lapatinib ditosylate perturbation in SK-MEL-2 cell line |
| Idoxuridine_NCI-H2030 | Idoxuridine perturbation in NCI-H2030 cell line |
| Rimonabant_LOX-IMVI | Rimonabant perturbation in LOX-IMVI cell line |
| OTS514_NCI-H1573 | OTS514 perturbation in NCI-H1573 cell line |
| Irinotecan_HOP62 | Irinotecan perturbation in HOP62 cell line |
| Lumateperone (tosylate)_RKO | Lumateperone (tosylate) perturbation in RKO cell line |
| Clotrimazole_SW 1088 | Clotrimazole perturbation in SW 1088 cell line |
| Erdafitinib _SW 900 | Erdafitinib perturbation in SW 900 cell line |
| Everolimus_HOP62 | Everolimus perturbation in HOP62 cell line |
| ML264_J82 | ML264 perturbation in J82 cell line |
| Belinostat_HOP62 | Belinostat perturbation in HOP62 cell line |
| Torkinib_SK-MEL-2 | Torkinib perturbation in SK-MEL-2 cell line |
| Peretinoin_HS-578T | Peretinoin perturbation in HS-578T cell line |
| 4EGI-1_SW 900 | 4EGI-1 perturbation in SW 900 cell line |
| Amsacrine_SW1417 | Amsacrine perturbation in SW1417 cell line |
| Gemfibrozil_hTERT-HPNE | Gemfibrozil perturbation in hTERT-HPNE cell line |
| ULK-101_NCI-H460 | ULK-101 perturbation in NCI-H460 cell line |
| Atazanavir (sulfate)_LOX-IMVI | Atazanavir (sulfate) perturbation in LOX-IMVI cell line |
| EX229_NCI-H2030 | EX229 perturbation in NCI-H2030 cell line |
| Methylthiouracil_LOX-IMVI | Methylthiouracil perturbation in LOX-IMVI cell line |
| Dorzolamide (hydrochloride)_NCI-H596 | Dorzolamide (hydrochloride) perturbation in NCI-H596 cell line |
| Saquinavir_CFPAC-1 | Saquinavir perturbation in CFPAC-1 cell line |
| Belumosudil (mesylate)_hTERT-HPNE | Belumosudil (mesylate) perturbation in hTERT-HPNE cell line |
| Tucatinib_A-172 | Tucatinib perturbation in A-172 cell line |
| Vilanterol_SNU-423 | Vilanterol perturbation in SNU-423 cell line |
| LY-2584702 (tosylate salt)_SK-MEL-2 | LY-2584702 (tosylate salt) perturbation in SK-MEL-2 cell line |
| SBI-0640756_RPMI-7951 | SBI-0640756 perturbation in RPMI-7951 cell line |
| Tofacitinib_AsPC-1 | Tofacitinib perturbation in AsPC-1 cell line |
| BAY1125976_A498 | BAY1125976 perturbation in A498 cell line |
| Vilanterol_HOP62 | Vilanterol perturbation in HOP62 cell line |
| Baicalin_AsPC-1 | Baicalin perturbation in AsPC-1 cell line |
| Gefitinib_SK-MEL-2 | Gefitinib perturbation in SK-MEL-2 cell line |
| Voriconazole_CHP-212 | Voriconazole perturbation in CHP-212 cell line |
| EX229_SW 1088 | EX229 perturbation in SW 1088 cell line |
| Adenosine_RKO | Adenosine perturbation in RKO cell line |
| Volasertib_Hs 766T | Volasertib perturbation in Hs 766T cell line |
| Tubulin inhibitor 6_NCI-H2347 | Tubulin inhibitor 6 perturbation in NCI-H2347 cell line |
| Palmatine (chloride)_A498 | Palmatine (chloride) perturbation in A498 cell line |
| Ouabain (Octahydrate)_Hs 766T | Ouabain (Octahydrate) perturbation in Hs 766T cell line |
| Gemcitabine_NCI-H460 | Gemcitabine perturbation in NCI-H460 cell line |
| MK-3903_CFPAC-1 | MK-3903 perturbation in CFPAC-1 cell line |
| Voriconazole_CFPAC-1 | Voriconazole perturbation in CFPAC-1 cell line |
| Entecavir (monohydrate)_NCI-H596 | Entecavir (monohydrate) perturbation in NCI-H596 cell line |
| Ouabain (Octahydrate)_HT-29 | Ouabain (Octahydrate) perturbation in HT-29 cell line |
| NVP-BHG712_SW 900 | NVP-BHG712 perturbation in SW 900 cell line |
| Anethole trithione_SNU-423 | Anethole trithione perturbation in SNU-423 cell line |
| Oleic acid_J82 | Oleic acid perturbation in J82 cell line |
| IQ 1_A-172 | IQ 1 perturbation in A-172 cell line |
| Bentamapimod_NCI-H460 | Bentamapimod perturbation in NCI-H460 cell line |
| Tubulin inhibitor 6_LOX-IMVI | Tubulin inhibitor 6 perturbation in LOX-IMVI cell line |
| Artesunate_SNU-423 | Artesunate perturbation in SNU-423 cell line |
| Fluvoxamine (maleate)_LOX-IMVI | Fluvoxamine (maleate) perturbation in LOX-IMVI cell line |
| DT-061_A-172 | DT-061 perturbation in A-172 cell line |
| Methylthiouracil_NCI-H2347 | Methylthiouracil perturbation in NCI-H2347 cell line |
| Belzutifan_C32 | Belzutifan perturbation in C32 cell line |
| Gemfibrozil_RPMI-7951 | Gemfibrozil perturbation in RPMI-7951 cell line |
| Tetracycline (hydrochloride)_SNU-423 | Tetracycline (hydrochloride) perturbation in SNU-423 cell line |
| c-Kit-IN-1_HOP62 | c-Kit-IN-1 perturbation in HOP62 cell line |
| Infigratinib_NCI-H1792 | Infigratinib perturbation in NCI-H1792 cell line |
| Tomivosertib_SW 900 | Tomivosertib perturbation in SW 900 cell line |
| Bosentan (hydrate)_NCI-H596 | Bosentan (hydrate) perturbation in NCI-H596 cell line |
| Tubulin inhibitor 6_RKO | Tubulin inhibitor 6 perturbation in RKO cell line |
| Dexmedetomidine_NCI-H460 | Dexmedetomidine perturbation in NCI-H460 cell line |
| Selinexor _Panc 03.27 | Selinexor perturbation in Panc 03.27 cell line |
| Lipoic acid_NCI-H1792 | Lipoic acid perturbation in NCI-H1792 cell line |
| Belumosudil (mesylate)_RPMI-7951 | Belumosudil (mesylate) perturbation in RPMI-7951 cell line |
| Tolcapone_CHP-212 | Tolcapone perturbation in CHP-212 cell line |
| Encorafenib_NCI-H460 | Encorafenib perturbation in NCI-H460 cell line |
| Talc_SW 1088 | Talc perturbation in SW 1088 cell line |
| Anethole trithione_HOP62 | Anethole trithione perturbation in HOP62 cell line |
| ETC-206_RPMI-7951 | ETC-206 perturbation in RPMI-7951 cell line |
| Terfenadine_SNU-423 | Terfenadine perturbation in SNU-423 cell line |
| Pralsetinib_SW1417 | Pralsetinib perturbation in SW1417 cell line |
| Paclitaxel_SW 900 | Paclitaxel perturbation in SW 900 cell line |
| Adenosine_NCI-H2347 | Adenosine perturbation in NCI-H2347 cell line |
| Pralsetinib_SW 1271 | Pralsetinib perturbation in SW 1271 cell line |
| Vilanterol_CFPAC-1 | Vilanterol perturbation in CFPAC-1 cell line |
| TAK-733_SK-MEL-2 | TAK-733 perturbation in SK-MEL-2 cell line |
| Ropivacaine (hydrochloride monohydrate)_AsPC-1 | Ropivacaine (hydrochloride monohydrate) perturbation in AsPC-1 cell line |
| Isocorydine_A-172 | Isocorydine perturbation in A-172 cell line |
| (R)-Verapamil (hydrochloride)_RKO | (R)-Verapamil (hydrochloride) perturbation in RKO cell line |
| AZD-7648_NCI-H1573 | AZD-7648 perturbation in NCI-H1573 cell line |
| Tomivosertib_A498 | Tomivosertib perturbation in A498 cell line |
| γ-Oryzanol_Panc 03.27 | γ-Oryzanol perturbation in Panc 03.27 cell line |
| Bentamapimod_NCI-H2347 | Bentamapimod perturbation in NCI-H2347 cell line |
| Gemcitabine_LOX-IMVI | Gemcitabine perturbation in LOX-IMVI cell line |
| Esmolol (hydrochloride)_CFPAC-1 | Esmolol (hydrochloride) perturbation in CFPAC-1 cell line |
| MK-3903_HOP62 | MK-3903 perturbation in HOP62 cell line |
| Saquinavir_LoVo | Saquinavir perturbation in LoVo cell line |
| Pemigatinib_HEC-1-A | Pemigatinib perturbation in HEC-1-A cell line |
| Encorafenib_NCI-H2347 | Encorafenib perturbation in NCI-H2347 cell line |
| ULK-101_LOX-IMVI | ULK-101 perturbation in LOX-IMVI cell line |
| Gemcitabine_RKO | Gemcitabine perturbation in RKO cell line |
| Posaconazole_Hs 766T | Posaconazole perturbation in Hs 766T cell line |
| Fedratinib (hydrochloride hydrate)_NCI-H1792 | Fedratinib (hydrochloride hydrate) perturbation in NCI-H1792 cell line |
| ML264_NCI-H1792 | ML264 perturbation in NCI-H1792 cell line |
| Tofacitinib (citrate)_NCI-H460 | Tofacitinib (citrate) perturbation in NCI-H460 cell line |
| Ponatinib_AsPC-1 | Ponatinib perturbation in AsPC-1 cell line |
| Hydroxyfasudil_NCI-H2347 | Hydroxyfasudil perturbation in NCI-H2347 cell line |
| (R)-Verapamil (hydrochloride)_LOX-IMVI | (R)-Verapamil (hydrochloride) perturbation in LOX-IMVI cell line |
| Saquinavir_HOP62 | Saquinavir perturbation in HOP62 cell line |
| Pimozide_C32 | Pimozide perturbation in C32 cell line |
| Methylthiouracil_NCI-H460 | Methylthiouracil perturbation in NCI-H460 cell line |
| (R)-Verapamil (hydrochloride)_NCI-H2347 | (R)-Verapamil (hydrochloride) perturbation in NCI-H2347 cell line |
| NVP-BHG712_A498 | NVP-BHG712 perturbation in A498 cell line |
| Pentoxifylline_LOX-IMVI | Pentoxifylline perturbation in LOX-IMVI cell line |
| Celecoxib_NCI-H596 | Celecoxib perturbation in NCI-H596 cell line |
| S-Adenosyl-L-methionine (disulfate tosylate)_C32 | S-Adenosyl-L-methionine (disulfate tosylate) perturbation in C32 cell line |
| Bergenin_NCI-H2030 | Bergenin perturbation in NCI-H2030 cell line |
| Rapamycin_SW 1271 | Rapamycin perturbation in SW 1271 cell line |
| Abemaciclib_SW 1088 | Abemaciclib perturbation in SW 1088 cell line |
| Baicalin_NCI-H2030 | Baicalin perturbation in NCI-H2030 cell line |
| LY2090314_HOP62 | LY2090314 perturbation in HOP62 cell line |
| venetoclax_A498 | venetoclax perturbation in A498 cell line |
| Clotrimazole_AsPC-1 | Clotrimazole perturbation in AsPC-1 cell line |
| Temsirolimus_hTERT-HPNE | Temsirolimus perturbation in hTERT-HPNE cell line |
| vincristine_HOP62 | vincristine perturbation in HOP62 cell line |
| Bentamapimod_RKO | Bentamapimod perturbation in RKO cell line |
| BAY1125976_SW 900 | BAY1125976 perturbation in SW 900 cell line |
| Anethole trithione_CFPAC-1 | Anethole trithione perturbation in CFPAC-1 cell line |
| Capivasertib_A549 | Capivasertib perturbation in A549 cell line |
| Quinestrol_hTERT-HPNE | Quinestrol perturbation in hTERT-HPNE cell line |
| Bergenin_SW 1088 | Bergenin perturbation in SW 1088 cell line |
| Gemcitabine_NCI-H2347 | Gemcitabine perturbation in NCI-H2347 cell line |
| TAK-733_NCI-H596 | TAK-733 perturbation in NCI-H596 cell line |
| Tubulin inhibitor 6_NCI-H460 | Tubulin inhibitor 6 perturbation in NCI-H460 cell line |
| Dexmedetomidine_RKO | Dexmedetomidine perturbation in RKO cell line |
| Raltitrexed_SW48 | Raltitrexed perturbation in SW48 cell line |
| Sapanisertib_Panc 03.27 | Sapanisertib perturbation in Panc 03.27 cell line |
| Bentamapimod_LOX-IMVI | Bentamapimod perturbation in LOX-IMVI cell line |
| Terfenadine_CFPAC-1 | Terfenadine perturbation in CFPAC-1 cell line |
| EX229_AsPC-1 | EX229 perturbation in AsPC-1 cell line |
| Futibatinib_RKO | Futibatinib perturbation in RKO cell line |
| Minodronic acid_RPMI-7951 | Minodronic acid perturbation in RPMI-7951 cell line |
| LY2090314_SNU-423 | LY2090314 perturbation in SNU-423 cell line |
| Tolcapone_SNU-423 | Tolcapone perturbation in SNU-423 cell line |
| Nafamostat (mesylate)_RPMI-7951 | Nafamostat (mesylate) perturbation in RPMI-7951 cell line |
| Encorafenib_RKO | Encorafenib perturbation in RKO cell line |
| Abemaciclib_NCI-H2030 | Abemaciclib perturbation in NCI-H2030 cell line |
| vincristine_SNU-423 | vincristine perturbation in SNU-423 cell line |
| Tofacitinib_SW 1088 | Tofacitinib perturbation in SW 1088 cell line |
| Norepinephrine (hydrochloride)_H4 | Norepinephrine (hydrochloride) perturbation in H4 cell line |
| Gallic acid (hydrate)_CFPAC-1 | Gallic acid (hydrate) perturbation in CFPAC-1 cell line |
| PF-06260933_SW 900 | PF-06260933 perturbation in SW 900 cell line |
| Retinoic acid_SK-MEL-2 | Retinoic acid perturbation in SK-MEL-2 cell line |
| Erdafitinib _A498 | Erdafitinib perturbation in A498 cell line |
| LY2090314_C32 | LY2090314 perturbation in C32 cell line |
| Sinomenine_HOP62 | Sinomenine perturbation in HOP62 cell line |
| vincristine_C32 | vincristine perturbation in C32 cell line |
| Brivudine_SW 900 | Brivudine perturbation in SW 900 cell line |
| Riluzole hydrochloride_NCI-H2122 | Riluzole hydrochloride perturbation in NCI-H2122 cell line |
| Carbamazepine_NCI-H460 | Carbamazepine perturbation in NCI-H460 cell line |
| ML264_A498 | ML264 perturbation in A498 cell line |
| Isocorydine_SK-MEL-2 | Isocorydine perturbation in SK-MEL-2 cell line |
| LB-100_A-172 | LB-100 perturbation in A-172 cell line |
| MK-3903_NCI-H1573 | MK-3903 perturbation in NCI-H1573 cell line |
| Pralsetinib_RPMI-7951 | Pralsetinib perturbation in RPMI-7951 cell line |
| Chlorhexidine (diacetate)_Panc 03.27 | Chlorhexidine (diacetate) perturbation in Panc 03.27 cell line |
| Delamanid_LOX-IMVI | Delamanid perturbation in LOX-IMVI cell line |
| Pemigatinib_Hs 766T | Pemigatinib perturbation in Hs 766T cell line |
| TAK-733_A-172 | TAK-733 perturbation in A-172 cell line |
| Delamanid_RKO | Delamanid perturbation in RKO cell line |
| Vandetanib_RPMI-7951 | Vandetanib perturbation in RPMI-7951 cell line |
| 9-ING-41_SW 1271 | 9-ING-41 perturbation in SW 1271 cell line |
| Digitoxin_NCI-H460 | Digitoxin perturbation in NCI-H460 cell line |
| BAY1125976_J82 | BAY1125976 perturbation in J82 cell line |
| S-Adenosyl-L-methionine (disulfate tosylate)_SNU-423 | S-Adenosyl-L-methionine (disulfate tosylate) perturbation in SNU-423 cell line |
| AZD2858_NCI-H2347 | AZD2858 perturbation in NCI-H2347 cell line |
| PH-797804_RKO | PH-797804 perturbation in RKO cell line |
| Saquinavir_NCI-H1573 | Saquinavir perturbation in NCI-H1573 cell line |
| Palmatine (chloride)_J82 | Palmatine (chloride) perturbation in J82 cell line |
| AT7519_SW 1271 | AT7519 perturbation in SW 1271 cell line |
| Salicylic acid_NCI-H2347 | Salicylic acid perturbation in NCI-H2347 cell line |
| Trifluridine_J82 | Trifluridine perturbation in J82 cell line |
| Sinomenine_SNU-423 | Sinomenine perturbation in SNU-423 cell line |
| Irinotecan_SW 900 | Irinotecan perturbation in SW 900 cell line |
| Relugolix_NCI-H2030 | Relugolix perturbation in NCI-H2030 cell line |
| AZD1390_SW1417 | AZD1390 perturbation in SW1417 cell line |
| Alpelisib_H4 | Alpelisib perturbation in H4 cell line |
| GSK1059615_NCI-H460 | GSK1059615 perturbation in NCI-H460 cell line |
| Capivasertib_NCI-H2030 | Capivasertib perturbation in NCI-H2030 cell line |
| Peretinoin_SK-MEL-2 | Peretinoin perturbation in SK-MEL-2 cell line |
| Tranilast_NCI-H1573 | Tranilast perturbation in NCI-H1573 cell line |
| Bestatin (hydrochloride)_RKO | Bestatin (hydrochloride) perturbation in RKO cell line |
| Raltitrexed_NCI-H1792 | Raltitrexed perturbation in NCI-H1792 cell line |
| Clonidine (hydrochloride)_hTERT-HPNE | Clonidine (hydrochloride) perturbation in hTERT-HPNE cell line |
| Rapamycin_RPMI-7951 | Rapamycin perturbation in RPMI-7951 cell line |
| Berberine (chloride hydrate)_NCI-H460 | Berberine (chloride hydrate) perturbation in NCI-H460 cell line |
| Meloxicam_C32 | Meloxicam perturbation in C32 cell line |
| Docetaxel_Hs 766T | Docetaxel perturbation in Hs 766T cell line |
| AZD2858_LOX-IMVI | AZD2858 perturbation in LOX-IMVI cell line |
| Erdafitinib _NCI-H1792 | Erdafitinib perturbation in NCI-H1792 cell line |
| vincristine_NCI-H1573 | vincristine perturbation in NCI-H1573 cell line |
| Amsacrine_RPMI-7951 | Amsacrine perturbation in RPMI-7951 cell line |
| Clotrimazole_SW480 | Clotrimazole perturbation in SW480 cell line |
| Clobetasol propionate_SW 1088 | Clobetasol propionate perturbation in SW 1088 cell line |
| AZD2858_RKO | AZD2858 perturbation in RKO cell line |
| Dabrafenib_H4 | Dabrafenib perturbation in H4 cell line |
| Retinoic acid_A-172 | Retinoic acid perturbation in A-172 cell line |
| AZD-8055_CFPAC-1 | AZD-8055 perturbation in CFPAC-1 cell line |
| Harringtonine_LOX-IMVI | Harringtonine perturbation in LOX-IMVI cell line |
| Abemaciclib_A549 | Abemaciclib perturbation in A549 cell line |
| Bimatoprost_SK-MEL-2 | Bimatoprost perturbation in SK-MEL-2 cell line |
| Verteporfin_SW48 | Verteporfin perturbation in SW48 cell line |
| Balsalazide (sodium hydrate)_CFPAC-1 | Balsalazide (sodium hydrate) perturbation in CFPAC-1 cell line |
| Homoharringtonine_Panc 03.27 | Homoharringtonine perturbation in Panc 03.27 cell line |
| Salicylic acid_RKO | Salicylic acid perturbation in RKO cell line |
| Sonidegib_CFPAC-1 | Sonidegib perturbation in CFPAC-1 cell line |
| Posaconazole_H4 | Posaconazole perturbation in H4 cell line |
| Everolimus_AN3 CA | Everolimus perturbation in AN3 CA cell line |
| Tucatinib_SK-MEL-2 | Tucatinib perturbation in SK-MEL-2 cell line |
| Berberine (chloride hydrate)_NCI-H2347 | Berberine (chloride hydrate) perturbation in NCI-H2347 cell line |
| Anastrozole_H4 | Anastrozole perturbation in H4 cell line |
| EX229_A549 | EX229 perturbation in A549 cell line |
| Belzutifan_SNU-423 | Belzutifan perturbation in SNU-423 cell line |
| Sulfisoxazole_SNU-423 | Sulfisoxazole perturbation in SNU-423 cell line |
| Lapatinib ditosylate_H4 | Lapatinib ditosylate perturbation in H4 cell line |
| Trifluridine_NCI-H1792 | Trifluridine perturbation in NCI-H1792 cell line |
| Torkinib_A-172 | Torkinib perturbation in A-172 cell line |
| Sinomenine_CFPAC-1 | Sinomenine perturbation in CFPAC-1 cell line |
| Apalutamide_SNU-423 | Apalutamide perturbation in SNU-423 cell line |
| Triamcinolone_Hs 766T | Triamcinolone perturbation in Hs 766T cell line |
| Saquinavir_NCI-H2122 | Saquinavir perturbation in NCI-H2122 cell line |
| Carbamazepine_LOX-IMVI | Carbamazepine perturbation in LOX-IMVI cell line |
| Sulfisoxazole_HOP62 | Sulfisoxazole perturbation in HOP62 cell line |
| Lipoic acid_SHP-77 | Lipoic acid perturbation in SHP-77 cell line |
| Clobetasol propionate_AsPC-1 | Clobetasol propionate perturbation in AsPC-1 cell line |
| Capivasertib_AsPC-1 | Capivasertib perturbation in AsPC-1 cell line |
| LY-2584702 (tosylate salt)_A-172 | LY-2584702 (tosylate salt) perturbation in A-172 cell line |
| 8-Hydroxyquinoline_CFPAC-1 | 8-Hydroxyquinoline perturbation in CFPAC-1 cell line |
| Esmolol (hydrochloride)_NCI-H1573 | Esmolol (hydrochloride) perturbation in NCI-H1573 cell line |
| Vinblastine (sulfate)_Panc 03.27 | Vinblastine (sulfate) perturbation in Panc 03.27 cell line |
| Infigratinib_SW48 | Infigratinib perturbation in SW48 cell line |
| Tolcapone_NCI-H2122 | Tolcapone perturbation in NCI-H2122 cell line |
| Temuterkib_RPMI-7951 | Temuterkib perturbation in RPMI-7951 cell line |
| Everolimus_C32 | Everolimus perturbation in C32 cell line |
| GSK1059615_RKO | GSK1059615 perturbation in RKO cell line |
| Bestatin (hydrochloride)_NCI-H460 | Bestatin (hydrochloride) perturbation in NCI-H460 cell line |
| venetoclax_J82 | venetoclax perturbation in J82 cell line |
| Gallic acid (hydrate)_NCI-H1573 | Gallic acid (hydrate) perturbation in NCI-H1573 cell line |
| IQ 1_SK-MEL-2 | IQ 1 perturbation in SK-MEL-2 cell line |
| Norepinephrine (hydrochloride)_Hs 766T | Norepinephrine (hydrochloride) perturbation in Hs 766T cell line |
| Olanzapine_Panc 03.27 | Olanzapine perturbation in Panc 03.27 cell line |
| Ropivacaine (hydrochloride monohydrate)_A549 | Ropivacaine (hydrochloride monohydrate) perturbation in A549 cell line |
| Salicylic acid_NCI-H460 | Salicylic acid perturbation in NCI-H460 cell line |
| ML264_SW 900 | ML264 perturbation in SW 900 cell line |
| Anethole trithione_NCI-H1573 | Anethole trithione perturbation in NCI-H1573 cell line |
| Artemether_Panc 03.27 | Artemether perturbation in Panc 03.27 cell line |
| AZD-8055_SNU-423 | AZD-8055 perturbation in SNU-423 cell line |
| Erdafitinib _J82 | Erdafitinib perturbation in J82 cell line |
| Vilanterol_C32 | Vilanterol perturbation in C32 cell line |
| DT-061_SK-MEL-2 | DT-061 perturbation in SK-MEL-2 cell line |
| Gemfibrozil_SW 1271 | Gemfibrozil perturbation in SW 1271 cell line |
| Palmatine (chloride)_HOP62 | Palmatine (chloride) perturbation in HOP62 cell line |
| Temsirolimus_NCI-H2030 | Temsirolimus perturbation in NCI-H2030 cell line |
| Darinaparsin_RKO | Darinaparsin perturbation in RKO cell line |
| NG25_SW 900 | NG25 perturbation in SW 900 cell line |
| RMC-6236_H4 | RMC-6236 perturbation in H4 cell line |
| Mitoxantrone (dihydrochloride)_NCI-H2347 | Mitoxantrone (dihydrochloride) perturbation in NCI-H2347 cell line |
| Uridine_LOX-IMVI | Uridine perturbation in LOX-IMVI cell line |
| vincristine_SW 900 | vincristine perturbation in SW 900 cell line |
| Quinestrol_SW 1088 | Quinestrol perturbation in SW 1088 cell line |
| Paclitaxel_CFPAC-1 | Paclitaxel perturbation in CFPAC-1 cell line |
| BAY1125976_HOP62 | BAY1125976 perturbation in HOP62 cell line |
| Budesonide_NCI-H1573 | Budesonide perturbation in NCI-H1573 cell line |
| Sulfatinib_SK-MEL-2 | Sulfatinib perturbation in SK-MEL-2 cell line |
| BAY1125976_SNU-423 | BAY1125976 perturbation in SNU-423 cell line |
| Ipatasertib_RKO | Ipatasertib perturbation in RKO cell line |
| Gemfibrozil_AsPC-1 | Gemfibrozil perturbation in AsPC-1 cell line |
| Methotrexate_RKO | Methotrexate perturbation in RKO cell line |
| Eplerenone_CFPAC-1 | Eplerenone perturbation in CFPAC-1 cell line |
| Quinestrol_NCI-H2030 | Quinestrol perturbation in NCI-H2030 cell line |
| Sinomenine_J82 | Sinomenine perturbation in J82 cell line |
| ETC-206_AsPC-1 | ETC-206 perturbation in AsPC-1 cell line |
| Palmatine (chloride)_SNU-423 | Palmatine (chloride) perturbation in SNU-423 cell line |
| γ-Oryzanol_NCI-H2347 | γ-Oryzanol perturbation in NCI-H2347 cell line |
| Volasertib_HS-578T | Volasertib perturbation in HS-578T cell line |
| Belumosudil (mesylate)_AsPC-1 | Belumosudil (mesylate) perturbation in AsPC-1 cell line |
| Mitoxantrone (dihydrochloride)_RKO | Mitoxantrone (dihydrochloride) perturbation in RKO cell line |
| γ-Oryzanol_LOX-IMVI | γ-Oryzanol perturbation in LOX-IMVI cell line |
| Gefitinib_H4 | Gefitinib perturbation in H4 cell line |
| palbociclib_SW 900 | palbociclib perturbation in SW 900 cell line |
| TAK-901_RKO | TAK-901 perturbation in RKO cell line |
| Neratinib_RKO | Neratinib perturbation in RKO cell line |
| Indacaterol (maleate)_LOX-IMVI | Indacaterol (maleate) perturbation in LOX-IMVI cell line |
| Pentamidine (isethionate)_SNU-423 | Pentamidine (isethionate) perturbation in SNU-423 cell line |
| Abemaciclib_RPMI-7951 | Abemaciclib perturbation in RPMI-7951 cell line |
| Hexylresorcinol_C32 | Hexylresorcinol perturbation in C32 cell line |
| MK-3903_SW 900 | MK-3903 perturbation in SW 900 cell line |
| Tofacitinib_RPMI-7951 | Tofacitinib perturbation in RPMI-7951 cell line |
| Baicalin_RPMI-7951 | Baicalin perturbation in RPMI-7951 cell line |
| 4EGI-1_CFPAC-1 | 4EGI-1 perturbation in CFPAC-1 cell line |
| Torkinib_H4 | Torkinib perturbation in H4 cell line |
| Erdafitinib _CFPAC-1 | Erdafitinib perturbation in CFPAC-1 cell line |
| Oleic acid_NCI-H2122 | Oleic acid perturbation in NCI-H2122 cell line |
| TAK-901_LOX-IMVI | TAK-901 perturbation in LOX-IMVI cell line |
| Irinotecan_NCI-H1573 | Irinotecan perturbation in NCI-H1573 cell line |
| Anastrozole_A-172 | Anastrozole perturbation in A-172 cell line |
| Minodronic acid_SW 1088 | Minodronic acid perturbation in SW 1088 cell line |
| Nafamostat (mesylate)_SW 1088 | Nafamostat (mesylate) perturbation in SW 1088 cell line |
| OTS514_HOP62 | OTS514 perturbation in HOP62 cell line |
| Almonertinib (hydrochloride)_SK-MEL-2 | Almonertinib (hydrochloride) perturbation in SK-MEL-2 cell line |
| Mitoxantrone (dihydrochloride)_LOX-IMVI | Mitoxantrone (dihydrochloride) perturbation in LOX-IMVI cell line |
| Saquinavir_A498 | Saquinavir perturbation in A498 cell line |
| Paclitaxel_SNU-423 | Paclitaxel perturbation in SNU-423 cell line |
| BI-3406_NCI-H596 | BI-3406 perturbation in NCI-H596 cell line |
| Dimethyl fumarate_SK-MEL-2 | Dimethyl fumarate perturbation in SK-MEL-2 cell line |
| Triamcinolone_NCI-H596 | Triamcinolone perturbation in NCI-H596 cell line |
| Selinexor _RKO | Selinexor perturbation in RKO cell line |
| APTO-253_SK-MEL-2 | APTO-253 perturbation in SK-MEL-2 cell line |
| Dabrafenib_A-172 | Dabrafenib perturbation in A-172 cell line |
| PF-06260933_CFPAC-1 | PF-06260933 perturbation in CFPAC-1 cell line |
| MK-3903_A498 | MK-3903 perturbation in A498 cell line |
| Oleic acid_C32 | Oleic acid perturbation in C32 cell line |
| Daptomycin_Panc 03.27 | Daptomycin perturbation in Panc 03.27 cell line |
| Anastrozole_HS-578T | Anastrozole perturbation in HS-578T cell line |
| Trifluridine_CFPAC-1 | Trifluridine perturbation in CFPAC-1 cell line |
| c-Kit-IN-1_SW 900 | c-Kit-IN-1 perturbation in SW 900 cell line |
| Selinexor _LOX-IMVI | Selinexor perturbation in LOX-IMVI cell line |
| Tomivosertib_HOP62 | Tomivosertib perturbation in HOP62 cell line |
| Citalopram (hydrobromide)_RKO | Citalopram (hydrobromide) perturbation in RKO cell line |
| Anethole trithione_SW 900 | Anethole trithione perturbation in SW 900 cell line |
| Alpelisib_A-172 | Alpelisib perturbation in A-172 cell line |
| Quinestrol_AsPC-1 | Quinestrol perturbation in AsPC-1 cell line |
| 4EGI-1_HOP62 | 4EGI-1 perturbation in HOP62 cell line |
| Belinostat_SW 900 | Belinostat perturbation in SW 900 cell line |
| Belumosudil (mesylate)_NCI-H2030 | Belumosudil (mesylate) perturbation in NCI-H2030 cell line |
| venetoclax_SNU-423 | venetoclax perturbation in SNU-423 cell line |
| Mitoxantrone (dihydrochloride)_NCI-H460 | Mitoxantrone (dihydrochloride) perturbation in NCI-H460 cell line |
| Verapamil_SW1417 | Verapamil perturbation in SW1417 cell line |
| Atazanavir (sulfate)_Panc 03.27 | Atazanavir (sulfate) perturbation in Panc 03.27 cell line |
| TAK-901_NCI-H460 | TAK-901 perturbation in NCI-H460 cell line |
| Allantoin_LOX-IMVI | Allantoin perturbation in LOX-IMVI cell line |
| Vemurafenib_A549 | Vemurafenib perturbation in A549 cell line |
| Allantoin_RKO | Allantoin perturbation in RKO cell line |
| Vilanterol_SW 900 | Vilanterol perturbation in SW 900 cell line |
| Diammonium Glycyrrhizinate_RPMI-7951 | Diammonium Glycyrrhizinate perturbation in RPMI-7951 cell line |
| AZD1390_NCI-H2030 | AZD1390 perturbation in NCI-H2030 cell line |
| Tolcapone_A498 | Tolcapone perturbation in A498 cell line |
| LY2090314_A498 | LY2090314 perturbation in A498 cell line |
| Infigratinib_NCI-H2122 | Infigratinib perturbation in NCI-H2122 cell line |
| Ouabain (Octahydrate)_A-172 | Ouabain (Octahydrate) perturbation in A-172 cell line |
| Esmolol (hydrochloride)_SW 900 | Esmolol (hydrochloride) perturbation in SW 900 cell line |
| Pimozide_NCI-H1792 | Pimozide perturbation in NCI-H1792 cell line |
| Lidocaine (hydrochloride)_NCI-H1573 | Lidocaine (hydrochloride) perturbation in NCI-H1573 cell line |
| Temsirolimus_AsPC-1 | Temsirolimus perturbation in AsPC-1 cell line |
| Ponatinib_RPMI-7951 | Ponatinib perturbation in RPMI-7951 cell line |
| Gemfibrozil_SW 1088 | Gemfibrozil perturbation in SW 1088 cell line |
| 4EGI-1_SNU-423 | 4EGI-1 perturbation in SNU-423 cell line |
| AZD-8055_J82 | AZD-8055 perturbation in J82 cell line |
| Tucidinostat_A-172 | Tucidinostat perturbation in A-172 cell line |
| Peretinoin_SW 1271 | Peretinoin perturbation in SW 1271 cell line |
| ERK5-IN-2_SW 1271 | ERK5-IN-2 perturbation in SW 1271 cell line |
| Norepinephrine (hydrochloride)_AsPC-1 | Norepinephrine (hydrochloride) perturbation in AsPC-1 cell line |
| Homoharringtonine_SW48 | Homoharringtonine perturbation in SW48 cell line |
| Verteporfin_Panc 03.27 | Verteporfin perturbation in Panc 03.27 cell line |
| Belzutifan_RKO | Belzutifan perturbation in RKO cell line |
| Retinoic acid_RPMI-7951 | Retinoic acid perturbation in RPMI-7951 cell line |
| Goserelin (acetate)_SW 900 | Goserelin (acetate) perturbation in SW 900 cell line |
| PH-797804_CFPAC-1 | PH-797804 perturbation in CFPAC-1 cell line |
| Clotrimazole_NCI-H661 | Clotrimazole perturbation in NCI-H661 cell line |
| Lonafarnib_SW 900 | Lonafarnib perturbation in SW 900 cell line |
| Hesperidin_NCI-H460 | Hesperidin perturbation in NCI-H460 cell line |
| Adenine_NCI-H460 | Adenine perturbation in NCI-H460 cell line |
| AZD-8055_NCI-H2347 | AZD-8055 perturbation in NCI-H2347 cell line |
| S-Adenosyl-L-methionine (disulfate tosylate)_NCI-H460 | S-Adenosyl-L-methionine (disulfate tosylate) perturbation in NCI-H460 cell line |
| Almonertinib (hydrochloride)_SW 1088 | Almonertinib (hydrochloride) perturbation in SW 1088 cell line |
| Darinaparsin_NCI-H1792 | Darinaparsin perturbation in NCI-H1792 cell line |
| Omeprazole_Hs 766T | Omeprazole perturbation in Hs 766T cell line |
| Carbamazepine_HOP62 | Carbamazepine perturbation in HOP62 cell line |
| Furosemide_A549 | Furosemide perturbation in A549 cell line |
| Ixazomib_SW 900 | Ixazomib perturbation in SW 900 cell line |
| Ralimetinib dimesylate_NCI-H661 | Ralimetinib dimesylate perturbation in NCI-H661 cell line |
| (R)-Verapamil (hydrochloride)_NCI-H2122 | (R)-Verapamil (hydrochloride) perturbation in NCI-H2122 cell line |
| Bimatoprost_SW 1271 | Bimatoprost perturbation in SW 1271 cell line |
| Pemigatinib_NCI-H2030 | Pemigatinib perturbation in NCI-H2030 cell line |
| Quinestrol_NCI-H596 | Quinestrol perturbation in NCI-H596 cell line |
| Sulfisoxazole_LOX-IMVI | Sulfisoxazole perturbation in LOX-IMVI cell line |
| γ-Oryzanol_NCI-H1792 | γ-Oryzanol perturbation in NCI-H1792 cell line |
| Fusidic acid_A549 | Fusidic acid perturbation in A549 cell line |
| Darolutamide_Hs 766T | Darolutamide perturbation in Hs 766T cell line |
| Hydroxyfasudil_NCI-H2122 | Hydroxyfasudil perturbation in NCI-H2122 cell line |
| Belzutifan_NCI-H2347 | Belzutifan perturbation in NCI-H2347 cell line |
| Pralsetinib_A-172 | Pralsetinib perturbation in A-172 cell line |
| Vinblastine (sulfate)_SW 900 | Vinblastine (sulfate) perturbation in SW 900 cell line |
| LB-100_RPMI-7951 | LB-100 perturbation in RPMI-7951 cell line |
| Lucanthone_A549 | Lucanthone perturbation in A549 cell line |
| TAK-733_RPMI-7951 | TAK-733 perturbation in RPMI-7951 cell line |
| AZD-8055_LOX-IMVI | AZD-8055 perturbation in LOX-IMVI cell line |
| Oxaliplatin_SK-MEL-2 | Oxaliplatin perturbation in SK-MEL-2 cell line |
| Clobetasol propionate_Hs 766T | Clobetasol propionate perturbation in Hs 766T cell line |
| Cepharanthine_A549 | Cepharanthine perturbation in A549 cell line |
| AZD-8055_RKO | AZD-8055 perturbation in RKO cell line |
| Cysteamine (hydrochloride)_NCI-H23 | Cysteamine (hydrochloride) perturbation in NCI-H23 cell line |
| Clopidogrel_Hs 766T | Clopidogrel perturbation in Hs 766T cell line |
| Clonidine (hydrochloride)_A-172 | Clonidine (hydrochloride) perturbation in A-172 cell line |
| 9-ING-41_SK-MEL-2 | 9-ING-41 perturbation in SK-MEL-2 cell line |
| Salicylic acid_CFPAC-1 | Salicylic acid perturbation in CFPAC-1 cell line |
| Sonidegib_RKO | Sonidegib perturbation in RKO cell line |
| Sildenafil_NCI-H1792 | Sildenafil perturbation in NCI-H1792 cell line |
| Busulfan_A498 | Busulfan perturbation in A498 cell line |
| Triamcinolone_AsPC-1 | Triamcinolone perturbation in AsPC-1 cell line |
| BI-3406_AsPC-1 | BI-3406 perturbation in AsPC-1 cell line |
| Demeclocycline_AsPC-1 | Demeclocycline perturbation in AsPC-1 cell line |
| Celecoxib_RPMI-7951 | Celecoxib perturbation in RPMI-7951 cell line |
| AT7519_SK-MEL-2 | AT7519 perturbation in SK-MEL-2 cell line |
| Demeclocycline_NCI-H2030 | Demeclocycline perturbation in NCI-H2030 cell line |
| Belzutifan_NCI-H460 | Belzutifan perturbation in NCI-H460 cell line |
| AZD1390_SK-MEL-2 | AZD1390 perturbation in SK-MEL-2 cell line |
| Busulfan_SW 900 | Busulfan perturbation in SW 900 cell line |
| Docetaxel_AsPC-1 | Docetaxel perturbation in AsPC-1 cell line |
| Olanzapine_A498 | Olanzapine perturbation in A498 cell line |
| Pentamidine (isethionate)_NCI-H23 | Pentamidine (isethionate) perturbation in NCI-H23 cell line |
| MK-8353_SW 1271 | MK-8353 perturbation in SW 1271 cell line |
| Gemcitabine_NCI-H1573 | Gemcitabine perturbation in NCI-H1573 cell line |
| Volasertib_A549 | Volasertib perturbation in A549 cell line |
| AZD-7648_LOX-IMVI | AZD-7648 perturbation in LOX-IMVI cell line |
| Tofacitinib (citrate)_NCI-H2122 | Tofacitinib (citrate) perturbation in NCI-H2122 cell line |
| Sulfisoxazole_NCI-H460 | Sulfisoxazole perturbation in NCI-H460 cell line |
| Sinomenine_LOX-IMVI | Sinomenine perturbation in LOX-IMVI cell line |
| Lumateperone (tosylate)_SW 900 | Lumateperone (tosylate) perturbation in SW 900 cell line |
| Triamcinolone_SW 1088 | Triamcinolone perturbation in SW 1088 cell line |
| BI-3406_SW 1088 | BI-3406 perturbation in SW 1088 cell line |
| Demeclocycline_SW 1088 | Demeclocycline perturbation in SW 1088 cell line |
| AZD-7648_RKO | AZD-7648 perturbation in RKO cell line |
| (R)-Verapamil (hydrochloride)_NCI-H1573 | (R)-Verapamil (hydrochloride) perturbation in NCI-H1573 cell line |
| Vemurafenib_A-172 | Vemurafenib perturbation in A-172 cell line |
| ULK-101_AN3 CA | ULK-101 perturbation in AN3 CA cell line |
| Selinexor _NCI-H1792 | Selinexor perturbation in NCI-H1792 cell line |
| ULK-101_NCI-H1573 | ULK-101 perturbation in NCI-H1573 cell line |
| S-Adenosyl-L-methionine (disulfate tosylate)_RKO | S-Adenosyl-L-methionine (disulfate tosylate) perturbation in RKO cell line |
| Radotinib_A-172 | Radotinib perturbation in A-172 cell line |
| Dimethyl fumarate_SW 1088 | Dimethyl fumarate perturbation in SW 1088 cell line |
| Pimozide_RKO | Pimozide perturbation in RKO cell line |
| Pemigatinib_AsPC-1 | Pemigatinib perturbation in AsPC-1 cell line |
| Sodium Salicylate_SW 1271 | Sodium Salicylate perturbation in SW 1271 cell line |
| Berberine (chloride hydrate)_CFPAC-1 | Berberine (chloride hydrate) perturbation in CFPAC-1 cell line |
| Lonafarnib_SW48 | Lonafarnib perturbation in SW48 cell line |
| Peretinoin_BT-474 | Peretinoin perturbation in BT-474 cell line |
| TAK-901_J82 | TAK-901 perturbation in J82 cell line |
| Lonafarnib_A498 | Lonafarnib perturbation in A498 cell line |
| Goserelin (acetate)_SW48 | Goserelin (acetate) perturbation in SW48 cell line |
| Torkinib_RPMI-7951 | Torkinib perturbation in RPMI-7951 cell line |
| Hydroxyfasudil_NCI-H1573 | Hydroxyfasudil perturbation in NCI-H1573 cell line |
| AZD-7648_NCI-H2347 | AZD-7648 perturbation in NCI-H2347 cell line |
| ULK-101_C32 | ULK-101 perturbation in C32 cell line |
| Sinomenine_NCI-H2347 | Sinomenine perturbation in NCI-H2347 cell line |
| LJI308_A549 | LJI308 perturbation in A549 cell line |
| Salicylic acid_SNU-423 | Salicylic acid perturbation in SNU-423 cell line |
| Bestatin (hydrochloride)_HOP62 | Bestatin (hydrochloride) perturbation in HOP62 cell line |
| Homoharringtonine_SW 900 | Homoharringtonine perturbation in SW 900 cell line |
| CP21R7_A-172 | CP21R7 perturbation in A-172 cell line |
| (R)-Verapamil (hydrochloride)_C32 | (R)-Verapamil (hydrochloride) perturbation in C32 cell line |
| Peretinoin_SW1417 | Peretinoin perturbation in SW1417 cell line |
| S-Adenosyl-L-methionine (disulfate tosylate)_NCI-H2347 | S-Adenosyl-L-methionine (disulfate tosylate) perturbation in NCI-H2347 cell line |
| Acetohexamide_SW 1271 | Acetohexamide perturbation in SW 1271 cell line |
| Norepinephrine (hydrochloride)_NCI-H2030 | Norepinephrine (hydrochloride) perturbation in NCI-H2030 cell line |
| Pimozide_LOX-IMVI | Pimozide perturbation in LOX-IMVI cell line |
| PF-06260933_NCI-H460 | PF-06260933 perturbation in NCI-H460 cell line |
| ERK5-IN-2_SW 1088 | ERK5-IN-2 perturbation in SW 1088 cell line |
| ULK-101_A498 | ULK-101 perturbation in A498 cell line |
| Fusidic acid_hTERT-HPNE | Fusidic acid perturbation in hTERT-HPNE cell line |
| venetoclax_NCI-H2347 | venetoclax perturbation in NCI-H2347 cell line |
| Fluvoxamine (maleate)_SW 900 | Fluvoxamine (maleate) perturbation in SW 900 cell line |
| Erlotinib_SW 900 | Erlotinib perturbation in SW 900 cell line |
| Cysteamine (hydrochloride)_LOX-IMVI | Cysteamine (hydrochloride) perturbation in LOX-IMVI cell line |
| Abemaciclib_A-172 | Abemaciclib perturbation in A-172 cell line |
| Tubulin inhibitor 6_SW 900 | Tubulin inhibitor 6 perturbation in SW 900 cell line |
| Tomivosertib_RKO | Tomivosertib perturbation in RKO cell line |
| Bimatoprost_NCI-H2030 | Bimatoprost perturbation in NCI-H2030 cell line |
| Erdafitinib _NCI-H2347 | Erdafitinib perturbation in NCI-H2347 cell line |
| Selinexor _HOP62 | Selinexor perturbation in HOP62 cell line |
| Tomivosertib_LOX-IMVI | Tomivosertib perturbation in LOX-IMVI cell line |
| 4EGI-1_NCI-H2347 | 4EGI-1 perturbation in NCI-H2347 cell line |
| 5-Azacytidine_NCI-H596 | 5-Azacytidine perturbation in NCI-H596 cell line |
| Paclitaxel_LOX-IMVI | Paclitaxel perturbation in LOX-IMVI cell line |
| Cysteamine (hydrochloride)_RKO | Cysteamine (hydrochloride) perturbation in RKO cell line |
| Lapatinib ditosylate_RPMI-7951 | Lapatinib ditosylate perturbation in RPMI-7951 cell line |
| Anastrozole_RPMI-7951 | Anastrozole perturbation in RPMI-7951 cell line |
| Homoharringtonine_NCI-H2122 | Homoharringtonine perturbation in NCI-H2122 cell line |
| Goserelin (acetate)_C32 | Goserelin (acetate) perturbation in C32 cell line |
| Resveratrol_CFPAC-1 | Resveratrol perturbation in CFPAC-1 cell line |
| c-Kit-IN-1_Panc 03.27 | c-Kit-IN-1 perturbation in Panc 03.27 cell line |
| Bimatoprost_SW 1088 | Bimatoprost perturbation in SW 1088 cell line |
| Monocrotaline_NCI-H2122 | Monocrotaline perturbation in NCI-H2122 cell line |
| Lonafarnib_C32 | Lonafarnib perturbation in C32 cell line |
| Gemcitabine_A498 | Gemcitabine perturbation in A498 cell line |
| venetoclax_RKO | venetoclax perturbation in RKO cell line |
| TAK-901_CFPAC-1 | TAK-901 perturbation in CFPAC-1 cell line |
| Capivasertib_NCI-H596 | Capivasertib perturbation in NCI-H596 cell line |
| Raltitrexed_LOX-IMVI | Raltitrexed perturbation in LOX-IMVI cell line |
| 5-Azacytidine_SK-MEL-2 | 5-Azacytidine perturbation in SK-MEL-2 cell line |
| Bentamapimod_A498 | Bentamapimod perturbation in A498 cell line |
| NVP-BHG712_RKO | NVP-BHG712 perturbation in RKO cell line |
| Berberine (chloride hydrate)_J82 | Berberine (chloride hydrate) perturbation in J82 cell line |
| MK-8353_AsPC-1 | MK-8353 perturbation in AsPC-1 cell line |
| Paclitaxel_NCI-H2347 | Paclitaxel perturbation in NCI-H2347 cell line |
| Olanzapine_C32 | Olanzapine perturbation in C32 cell line |
| Trametinib_NCI-H460 | Trametinib perturbation in NCI-H460 cell line |
| DT-061_AsPC-1 | DT-061 perturbation in AsPC-1 cell line |
| Bexarotene_AN3 CA | Bexarotene perturbation in AN3 CA cell line |
| Harringtonine_NCI-H1792 | Harringtonine perturbation in NCI-H1792 cell line |
| Erdafitinib _RKO | Erdafitinib perturbation in RKO cell line |
| Clofarabine_NCI-H2122 | Clofarabine perturbation in NCI-H2122 cell line |
| Goserelin (acetate)_NCI-H1573 | Goserelin (acetate) perturbation in NCI-H1573 cell line |
| 4EGI-1_RKO | 4EGI-1 perturbation in RKO cell line |
| Raltitrexed_RKO | Raltitrexed perturbation in RKO cell line |
| Ixazomib_AN3 CA | Ixazomib perturbation in AN3 CA cell line |
| γ-Oryzanol_CFPAC-1 | γ-Oryzanol perturbation in CFPAC-1 cell line |
| Cabozantinib (S-malate)_NCI-H596 | Cabozantinib (S-malate) perturbation in NCI-H596 cell line |
| Isocorydine_NCI-H2030 | Isocorydine perturbation in NCI-H2030 cell line |
| Megestrol_RPMI-7951 | Megestrol perturbation in RPMI-7951 cell line |
| Lumateperone (tosylate)_C32 | Lumateperone (tosylate) perturbation in C32 cell line |
| Paclitaxel_NCI-H460 | Paclitaxel perturbation in NCI-H460 cell line |
| Alpelisib_RPMI-7951 | Alpelisib perturbation in RPMI-7951 cell line |
| Uridine_HOP62 | Uridine perturbation in HOP62 cell line |
| Niclosamide (olamine)_RKO | Niclosamide (olamine) perturbation in RKO cell line |
| Phenylephrine (hydrochloride)_NCI-H596 | Phenylephrine (hydrochloride) perturbation in NCI-H596 cell line |
| BAY1125976_LOX-IMVI | BAY1125976 perturbation in LOX-IMVI cell line |
| Vinblastine (sulfate)_NCI-H2122 | Vinblastine (sulfate) perturbation in NCI-H2122 cell line |
| Clonidine (hydrochloride)_H4 | Clonidine (hydrochloride) perturbation in H4 cell line |
| Vandetanib_H4 | Vandetanib perturbation in H4 cell line |
| Busulfan_C32 | Busulfan perturbation in C32 cell line |
| Volasertib_RPMI-7951 | Volasertib perturbation in RPMI-7951 cell line |
| Demeclocycline_SW 1271 | Demeclocycline perturbation in SW 1271 cell line |
| Azithromycin (hydrate)_J82 | Azithromycin (hydrate) perturbation in J82 cell line |
| MK-8353_NCI-H2030 | MK-8353 perturbation in NCI-H2030 cell line |
| Eplerenone_NCI-H460 | Eplerenone perturbation in NCI-H460 cell line |
| Palmatine (chloride)_RKO | Palmatine (chloride) perturbation in RKO cell line |
| Niclosamide (olamine)_LOX-IMVI | Niclosamide (olamine) perturbation in LOX-IMVI cell line |
| Sapanisertib_HOP62 | Sapanisertib perturbation in HOP62 cell line |
| Bentamapimod_SW 900 | Bentamapimod perturbation in SW 900 cell line |
| BAY1125976_RKO | BAY1125976 perturbation in RKO cell line |
| Rimonabant_C32 | Rimonabant perturbation in C32 cell line |
| SBI-0640756_Hs 766T | SBI-0640756 perturbation in Hs 766T cell line |
| PH-797804_J82 | PH-797804 perturbation in J82 cell line |
| Cysteamine (hydrochloride)_NCI-H460 | Cysteamine (hydrochloride) perturbation in NCI-H460 cell line |
| Gemcitabine_SW 900 | Gemcitabine perturbation in SW 900 cell line |
| AZD1390_Hs 766T | AZD1390 perturbation in Hs 766T cell line |
| Niclosamide (olamine)_NCI-H2347 | Niclosamide (olamine) perturbation in NCI-H2347 cell line |
| Volasertib_hTERT-HPNE | Volasertib perturbation in hTERT-HPNE cell line |
| APTO-253_SW 1271 | APTO-253 perturbation in SW 1271 cell line |
| LJI308_RPMI-7951 | LJI308 perturbation in RPMI-7951 cell line |
| Berbamine (dihydrochloride)_A498 | Berbamine (dihydrochloride) perturbation in A498 cell line |
| OTS514_RKO | OTS514 perturbation in RKO cell line |
| Mitoxantrone (dihydrochloride)_SNU-423 | Mitoxantrone (dihydrochloride) perturbation in SNU-423 cell line |
| Clotrimazole_A-172 | Clotrimazole perturbation in A-172 cell line |
| PF-06260933_NCI-H2347 | PF-06260933 perturbation in NCI-H2347 cell line |
| Sunitinib_SNU-423 | Sunitinib perturbation in SNU-423 cell line |
| Peretinoin_AsPC-1 | Peretinoin perturbation in AsPC-1 cell line |
| Lumateperone (tosylate)_NCI-H1573 | Lumateperone (tosylate) perturbation in NCI-H1573 cell line |
| γ-Oryzanol_HOP62 | γ-Oryzanol perturbation in HOP62 cell line |
| TAK-901_SNU-423 | TAK-901 perturbation in SNU-423 cell line |
| Dabrafenib_RPMI-7951 | Dabrafenib perturbation in RPMI-7951 cell line |
| Tubulin inhibitor 6_SW48 | Tubulin inhibitor 6 perturbation in SW48 cell line |
| Sunitinib_HOP62 | Sunitinib perturbation in HOP62 cell line |
| AZD-7648_NCI-H23 | AZD-7648 perturbation in NCI-H23 cell line |
| Salicylic acid_J82 | Salicylic acid perturbation in J82 cell line |
| Palmatine (chloride)_NCI-H2347 | Palmatine (chloride) perturbation in NCI-H2347 cell line |
| OTS514_LOX-IMVI | OTS514 perturbation in LOX-IMVI cell line |
| Bimatoprost_AsPC-1 | Bimatoprost perturbation in AsPC-1 cell line |
| Rimonabant_NCI-H1573 | Rimonabant perturbation in NCI-H1573 cell line |
| Saquinavir_Panc 03.27 | Saquinavir perturbation in Panc 03.27 cell line |
| Trifluridine_NCI-H2347 | Trifluridine perturbation in NCI-H2347 cell line |
| Fluvoxamine (maleate)_A498 | Fluvoxamine (maleate) perturbation in A498 cell line |
| DTP3_A549 | DTP3 perturbation in A549 cell line |
| ULK-101_SW 900 | ULK-101 perturbation in SW 900 cell line |
| Homoharringtonine_C32 | Homoharringtonine perturbation in C32 cell line |
| Idoxuridine_H4 | Idoxuridine perturbation in H4 cell line |
| 4EGI-1_NCI-H460 | 4EGI-1 perturbation in NCI-H460 cell line |
| AZD2858_J82 | AZD2858 perturbation in J82 cell line |
| Gemfibrozil_Hs 766T | Gemfibrozil perturbation in Hs 766T cell line |
| Acetohexamide_SW 1088 | Acetohexamide perturbation in SW 1088 cell line |
| Medroxyprogesterone acetate_AsPC-1 | Medroxyprogesterone acetate perturbation in AsPC-1 cell line |
| Lactate (calcium)_SK-MEL-2 | Lactate (calcium) perturbation in SK-MEL-2 cell line |
| Ipatasertib_AN3 CA | Ipatasertib perturbation in AN3 CA cell line |
| RMC-6236_NCI-H2030 | RMC-6236 perturbation in NCI-H2030 cell line |
| Lipoic acid_NCI-H2347 | Lipoic acid perturbation in NCI-H2347 cell line |
| ML264_NCI-H460 | ML264 perturbation in NCI-H460 cell line |
| Citalopram (hydrobromide)_NCI-H2122 | Citalopram (hydrobromide) perturbation in NCI-H2122 cell line |
| DT-061_A549 | DT-061 perturbation in A549 cell line |
| γ-Oryzanol_C32 | γ-Oryzanol perturbation in C32 cell line |
| Radotinib_Hs 766T | Radotinib perturbation in Hs 766T cell line |
| LB-100_AsPC-1 | LB-100 perturbation in AsPC-1 cell line |
| (R)-Verapamil (hydrochloride)_J82 | (R)-Verapamil (hydrochloride) perturbation in J82 cell line |
| Fingolimod (hydrochloride)_Hs 766T | Fingolimod (hydrochloride) perturbation in Hs 766T cell line |
| AT7519_NCI-H661 | AT7519 perturbation in NCI-H661 cell line |
| Irinotecan_NCI-H2347 | Irinotecan perturbation in NCI-H2347 cell line |
| TAK-733_AsPC-1 | TAK-733 perturbation in AsPC-1 cell line |
| Hexylresorcinol_RKO | Hexylresorcinol perturbation in RKO cell line |
| Brivudine_NCI-H2347 | Brivudine perturbation in NCI-H2347 cell line |
| Triamcinolone_RPMI-7951 | Triamcinolone perturbation in RPMI-7951 cell line |
| BI-3406_RPMI-7951 | BI-3406 perturbation in RPMI-7951 cell line |
| vincristine_NCI-H23 | vincristine perturbation in NCI-H23 cell line |
| Gemcitabine_J82 | Gemcitabine perturbation in J82 cell line |
| Volasertib_SW 1271 | Volasertib perturbation in SW 1271 cell line |
| TAK-901_C32 | TAK-901 perturbation in C32 cell line |
| Harringtonine_SW 900 | Harringtonine perturbation in SW 900 cell line |
| Celecoxib_AsPC-1 | Celecoxib perturbation in AsPC-1 cell line |
| Omeprazole_HS-578T | Omeprazole perturbation in HS-578T cell line |
| Acetohexamide_A549 | Acetohexamide perturbation in A549 cell line |
| Gefitinib_NCI-H2030 | Gefitinib perturbation in NCI-H2030 cell line |
| Norepinephrine (hydrochloride)_RPMI-7951 | Norepinephrine (hydrochloride) perturbation in RPMI-7951 cell line |
| Oleic acid_NCI-H460 | Oleic acid perturbation in NCI-H460 cell line |
| Irinotecan_RKO | Irinotecan perturbation in RKO cell line |
| APTO-253_RPMI-7951 | APTO-253 perturbation in RPMI-7951 cell line |
| Triamcinolone_hTERT-HPNE | Triamcinolone perturbation in hTERT-HPNE cell line |
| Demeclocycline_hTERT-HPNE | Demeclocycline perturbation in hTERT-HPNE cell line |
| Brivudine_LOX-IMVI | Brivudine perturbation in LOX-IMVI cell line |
| Infigratinib_RKO | Infigratinib perturbation in RKO cell line |
| Rimonabant_SNU-423 | Rimonabant perturbation in SNU-423 cell line |
| LJI308_SW 1271 | LJI308 perturbation in SW 1271 cell line |
| Diammonium Glycyrrhizinate_NCI-H596 | Diammonium Glycyrrhizinate perturbation in NCI-H596 cell line |
| Brivudine_RKO | Brivudine perturbation in RKO cell line |
| Mitoxantrone (dihydrochloride)_NCI-H1573 | Mitoxantrone (dihydrochloride) perturbation in NCI-H1573 cell line |
| Infigratinib_LOX-IMVI | Infigratinib perturbation in LOX-IMVI cell line |
| Irinotecan_LOX-IMVI | Irinotecan perturbation in LOX-IMVI cell line |
| Lumateperone (tosylate)_SNU-423 | Lumateperone (tosylate) perturbation in SNU-423 cell line |
| TAK-901_NCI-H1573 | TAK-901 perturbation in NCI-H1573 cell line |
| Ritonavir_SW 1088 | Ritonavir perturbation in SW 1088 cell line |
| Folic acid_SNU-423 | Folic acid perturbation in SNU-423 cell line |
| Larotrectinib_CFPAC-1 | Larotrectinib perturbation in CFPAC-1 cell line |
| EX229_SK-MEL-2 | EX229 perturbation in SK-MEL-2 cell line |
| Adagrasib_LOX-IMVI | Adagrasib perturbation in LOX-IMVI cell line |
| Pemigatinib_RPMI-7951 | Pemigatinib perturbation in RPMI-7951 cell line |
| Retinoic acid_NCI-H2030 | Retinoic acid perturbation in NCI-H2030 cell line |
| Oleic acid_NCI-H2347 | Oleic acid perturbation in NCI-H2347 cell line |
| ML264_RKO | ML264 perturbation in RKO cell line |
| Gemcitabine_NCI-H1792 | Gemcitabine perturbation in NCI-H1792 cell line |
| Elagolix sodium_RKO | Elagolix sodium perturbation in RKO cell line |
| ML264_LOX-IMVI | ML264 perturbation in LOX-IMVI cell line |
| Artemether_HOP62 | Artemether perturbation in HOP62 cell line |
| Binimetinib_SK-MEL-2 | Binimetinib perturbation in SK-MEL-2 cell line |
| Anastrozole_SW 1271 | Anastrozole perturbation in SW 1271 cell line |
| Berberine (chloride hydrate)_SW 900 | Berberine (chloride hydrate) perturbation in SW 900 cell line |
| Vinblastine (sulfate)_SNU-423 | Vinblastine (sulfate) perturbation in SNU-423 cell line |
| Olanzapine_HOP62 | Olanzapine perturbation in HOP62 cell line |
| BI-78D3_NCI-H2347 | BI-78D3 perturbation in NCI-H2347 cell line |
| Capivasertib_A-172 | Capivasertib perturbation in A-172 cell line |
| Darinaparsin_NCI-H2122 | Darinaparsin perturbation in NCI-H2122 cell line |
| Clonidine (hydrochloride)_Hs 766T | Clonidine (hydrochloride) perturbation in Hs 766T cell line |
| GSK1059615_SW 900 | GSK1059615 perturbation in SW 900 cell line |
| PH-797804_A498 | PH-797804 perturbation in A498 cell line |
| Pasireotide (acetate)_SW 1271 | Pasireotide (acetate) perturbation in SW 1271 cell line |
| Simotinib_SW 1271 | Simotinib perturbation in SW 1271 cell line |
| Rimonabant_CFPAC-1 | Rimonabant perturbation in CFPAC-1 cell line |
| Belumosudil (mesylate)_H4 | Belumosudil (mesylate) perturbation in H4 cell line |
| Lenalidomide (hemihydrate)_SNU-423 | Lenalidomide (hemihydrate) perturbation in SNU-423 cell line |
| Filgotinib_SW 1088 | Filgotinib perturbation in SW 1088 cell line |
| Infigratinib_NCI-H460 | Infigratinib perturbation in NCI-H460 cell line |
| TAK-733_SW 1088 | TAK-733 perturbation in SW 1088 cell line |
| Lidocaine (hydrochloride)_RKO | Lidocaine (hydrochloride) perturbation in RKO cell line |
| Gemfibrozil_H4 | Gemfibrozil perturbation in H4 cell line |
| Lonafarnib_SNU-423 | Lonafarnib perturbation in SNU-423 cell line |
| Cepharanthine_SW 1271 | Cepharanthine perturbation in SW 1271 cell line |
| Oleic acid_RKO | Oleic acid perturbation in RKO cell line |
| AZD1390_PANC-1 | AZD1390 perturbation in PANC-1 cell line |
| Isocorydine_A549 | Isocorydine perturbation in A549 cell line |
| Tazarotene_CFPAC-1 | Tazarotene perturbation in CFPAC-1 cell line |
| Oleic acid_LOX-IMVI | Oleic acid perturbation in LOX-IMVI cell line |
| Goserelin (acetate)_HOP62 | Goserelin (acetate) perturbation in HOP62 cell line |
| Megestrol_SW1417 | Megestrol perturbation in SW1417 cell line |
| Salicylic acid_A498 | Salicylic acid perturbation in A498 cell line |
| Lidocaine (hydrochloride)_LOX-IMVI | Lidocaine (hydrochloride) perturbation in LOX-IMVI cell line |
| Tubulin inhibitor 6_J82 | Tubulin inhibitor 6 perturbation in J82 cell line |
| Amsacrine_Hs 766T | Amsacrine perturbation in Hs 766T cell line |
| Sulfisoxazole_Panc 03.27 | Sulfisoxazole perturbation in Panc 03.27 cell line |
| Perindopril (erbumine)_SK-MEL-2 | Perindopril (erbumine) perturbation in SK-MEL-2 cell line |
| BI-78D3_RKO | BI-78D3 perturbation in RKO cell line |
| Clotrimazole_Hs 766T | Clotrimazole perturbation in Hs 766T cell line |
| Digitoxin_NCI-H2122 | Digitoxin perturbation in NCI-H2122 cell line |
| Gemcitabine_HOP62 | Gemcitabine perturbation in HOP62 cell line |
| ULK-101_SNU-423 | ULK-101 perturbation in SNU-423 cell line |
| MK-3903_LOX-IMVI | MK-3903 perturbation in LOX-IMVI cell line |
| Volasertib_NCI-H2030 | Volasertib perturbation in NCI-H2030 cell line |
| Saquinavir_RKO | Saquinavir perturbation in RKO cell line |
| Selinexor _A498 | Selinexor perturbation in A498 cell line |
| Vilanterol_NCI-H460 | Vilanterol perturbation in NCI-H460 cell line |
| Quinestrol_HS-578T | Quinestrol perturbation in HS-578T cell line |
| Ouabain (Octahydrate)_NCI-H2030 | Ouabain (Octahydrate) perturbation in NCI-H2030 cell line |
| Triamcinolone_A549 | Triamcinolone perturbation in A549 cell line |
| TAK-901_SW 900 | TAK-901 perturbation in SW 900 cell line |
| DT-061_RPMI-7951 | DT-061 perturbation in RPMI-7951 cell line |
| NG25_NCI-H2347 | NG25 perturbation in NCI-H2347 cell line |
| Saquinavir_LOX-IMVI | Saquinavir perturbation in LOX-IMVI cell line |
| Vemurafenib_SK-MEL-2 | Vemurafenib perturbation in SK-MEL-2 cell line |
| Fusidic acid_AsPC-1 | Fusidic acid perturbation in AsPC-1 cell line |
| Gemfibrozil_A-172 | Gemfibrozil perturbation in A-172 cell line |
| ULK-101_HOP62 | ULK-101 perturbation in HOP62 cell line |
| Filgotinib_SW1417 | Filgotinib perturbation in SW1417 cell line |
| Volasertib_SW 1088 | Volasertib perturbation in SW 1088 cell line |
| LY2090314_NCI-H2347 | LY2090314 perturbation in NCI-H2347 cell line |
| MK-3903_RKO | MK-3903 perturbation in RKO cell line |
| Tolcapone_NCI-H2347 | Tolcapone perturbation in NCI-H2347 cell line |
| EX229_Hs 766T | EX229 perturbation in Hs 766T cell line |
| Fingolimod (hydrochloride)_NCI-H596 | Fingolimod (hydrochloride) perturbation in NCI-H596 cell line |
| Belinostat_NCI-H460 | Belinostat perturbation in NCI-H460 cell line |
| Belumosudil (mesylate)_A-172 | Belumosudil (mesylate) perturbation in A-172 cell line |
| Encorafenib_HOP62 | Encorafenib perturbation in HOP62 cell line |
| Torkinib_SW 1271 | Torkinib perturbation in SW 1271 cell line |
| Bentamapimod_SNU-423 | Bentamapimod perturbation in SNU-423 cell line |
| Dabrafenib_SW 1088 | Dabrafenib perturbation in SW 1088 cell line |
| Trimetrexate_SW 1088 | Trimetrexate perturbation in SW 1088 cell line |
| PH-797804_C32 | PH-797804 perturbation in C32 cell line |
| XRK3F2_RPMI-7951 | XRK3F2 perturbation in RPMI-7951 cell line |
| c-Kit-IN-1_NCI-H460 | c-Kit-IN-1 perturbation in NCI-H460 cell line |
| NG25_LOX-IMVI | NG25 perturbation in LOX-IMVI cell line |
| Allopurinol_H4 | Allopurinol perturbation in H4 cell line |
| Tucatinib_RPMI-7951 | Tucatinib perturbation in RPMI-7951 cell line |
| Sodium Salicylate_RPMI-7951 | Sodium Salicylate perturbation in RPMI-7951 cell line |
| Radotinib_SK-MEL-2 | Radotinib perturbation in SK-MEL-2 cell line |
| Saquinavir_NCI-H2347 | Saquinavir perturbation in NCI-H2347 cell line |
| Lumateperone (tosylate)_J82 | Lumateperone (tosylate) perturbation in J82 cell line |
| SBI-0640756_A-172 | SBI-0640756 perturbation in A-172 cell line |
| LY-2584702 (tosylate salt)_SW 1271 | LY-2584702 (tosylate salt) perturbation in SW 1271 cell line |
| Lapatinib ditosylate_AsPC-1 | Lapatinib ditosylate perturbation in AsPC-1 cell line |
| NG25_RKO | NG25 perturbation in RKO cell line |
| Acetohexamide_RPMI-7951 | Acetohexamide perturbation in RPMI-7951 cell line |
| Harringtonine_NCI-H1573 | Harringtonine perturbation in NCI-H1573 cell line |
| Niclosamide (olamine)_Panc 03.27 | Niclosamide (olamine) perturbation in Panc 03.27 cell line |
| Bentamapimod_HOP62 | Bentamapimod perturbation in HOP62 cell line |
| vincristine_RKO | vincristine perturbation in RKO cell line |
| LJI308_NCI-H2030 | LJI308 perturbation in NCI-H2030 cell line |
| Terfenadine_NCI-H460 | Terfenadine perturbation in NCI-H460 cell line |
| Tubulin inhibitor 6_CFPAC-1 | Tubulin inhibitor 6 perturbation in CFPAC-1 cell line |
| APTO-253_A549 | APTO-253 perturbation in A549 cell line |
| MK-3903_NCI-H2347 | MK-3903 perturbation in NCI-H2347 cell line |
| Anastrozole_NCI-H2030 | Anastrozole perturbation in NCI-H2030 cell line |
| Methylthiouracil_HOP62 | Methylthiouracil perturbation in HOP62 cell line |
| Atazanavir (sulfate)_HOP62 | Atazanavir (sulfate) perturbation in HOP62 cell line |
| (R)-Verapamil (hydrochloride)_CFPAC-1 | (R)-Verapamil (hydrochloride) perturbation in CFPAC-1 cell line |
| Azithromycin (hydrate)_NCI-H2122 | Azithromycin (hydrate) perturbation in NCI-H2122 cell line |
| LJI308_AsPC-1 | LJI308 perturbation in AsPC-1 cell line |
| Sapanisertib_SW48 | Sapanisertib perturbation in SW48 cell line |
| Tofacitinib (citrate)_HOP62 | Tofacitinib (citrate) perturbation in HOP62 cell line |
| ULK-101_CFPAC-1 | ULK-101 perturbation in CFPAC-1 cell line |
| Everolimus_LOX-IMVI | Everolimus perturbation in LOX-IMVI cell line |
| ERK5-IN-2_RPMI-7951 | ERK5-IN-2 perturbation in RPMI-7951 cell line |
| Dabrafenib_AsPC-1 | Dabrafenib perturbation in AsPC-1 cell line |
| Esmolol (hydrochloride)_RKO | Esmolol (hydrochloride) perturbation in RKO cell line |
| Peretinoin_RPMI-7951 | Peretinoin perturbation in RPMI-7951 cell line |
| Sivelestat (sodium tetrahydrate)_CFPAC-1 | Sivelestat (sodium tetrahydrate) perturbation in CFPAC-1 cell line |
| PH-797804_NCI-H2122 | PH-797804 perturbation in NCI-H2122 cell line |
| Anethole trithione_NCI-H2347 | Anethole trithione perturbation in NCI-H2347 cell line |
| Vandetanib_NCI-H596 | Vandetanib perturbation in NCI-H596 cell line |
| Pemigatinib_A549 | Pemigatinib perturbation in A549 cell line |
| Terfenadine_NCI-H2347 | Terfenadine perturbation in NCI-H2347 cell line |
| MK-3903_NCI-H460 | MK-3903 perturbation in NCI-H460 cell line |
| Triclosan_A-172 | Triclosan perturbation in A-172 cell line |
| Isocorydine_hTERT-HPNE | Isocorydine perturbation in hTERT-HPNE cell line |
| Everolimus_RKO | Everolimus perturbation in RKO cell line |
| Belinostat_RKO | Belinostat perturbation in RKO cell line |
| Idarubicin (hydrochloride)_SW 1271 | Idarubicin (hydrochloride) perturbation in SW 1271 cell line |
| Ipatasertib_SW48 | Ipatasertib perturbation in SW48 cell line |
| Mifepristone_RKO | Mifepristone perturbation in RKO cell line |
| Levobupivacaine (hydrochloride)_SW 1088 | Levobupivacaine (hydrochloride) perturbation in SW 1088 cell line |
| Flumatinib (mesylate)_SW 1088 | Flumatinib (mesylate) perturbation in SW 1088 cell line |
| Ixazomib_J82 | Ixazomib perturbation in J82 cell line |
| c-Kit-IN-1_RKO | c-Kit-IN-1 perturbation in RKO cell line |
| Isocorydine_RPMI-7951 | Isocorydine perturbation in RPMI-7951 cell line |
| Goserelin (acetate)_J82 | Goserelin (acetate) perturbation in J82 cell line |
| Sildenafil_A498 | Sildenafil perturbation in A498 cell line |
| Osimertinib (mesylate)_NCI-H2122 | Osimertinib (mesylate) perturbation in NCI-H2122 cell line |
| Anethole trithione_RKO | Anethole trithione perturbation in RKO cell line |
| Fusidic acid_NCI-H2030 | Fusidic acid perturbation in NCI-H2030 cell line |
| TAK-901_A498 | TAK-901 perturbation in A498 cell line |
| Artesunate_LOX-IMVI | Artesunate perturbation in LOX-IMVI cell line |
| L-Thyroxine (sodium salt pentahydrate)_NCI-H2030 | L-Thyroxine (sodium salt pentahydrate) perturbation in NCI-H2030 cell line |
| Bergenin_Hs 766T | Bergenin perturbation in Hs 766T cell line |
| Tomivosertib_Panc 03.27 | Tomivosertib perturbation in Panc 03.27 cell line |
| Everolimus_NCI-H2347 | Everolimus perturbation in NCI-H2347 cell line |
| Encorafenib_CFPAC-1 | Encorafenib perturbation in CFPAC-1 cell line |
| Selinexor _SW 900 | Selinexor perturbation in SW 900 cell line |
| Volasertib_AsPC-1 | Volasertib perturbation in AsPC-1 cell line |
| Terfenadine_RKO | Terfenadine perturbation in RKO cell line |
| Acetazolamide_C32 | Acetazolamide perturbation in C32 cell line |
| vincristine_NCI-H460 | vincristine perturbation in NCI-H460 cell line |
| 18β-Glycyrrhetinic acid_AsPC-1 | 18β-Glycyrrhetinic acid perturbation in AsPC-1 cell line |
| Anethole trithione_LOX-IMVI | Anethole trithione perturbation in LOX-IMVI cell line |
| Tolcapone_NCI-H460 | Tolcapone perturbation in NCI-H460 cell line |
| Clonidine (hydrochloride)_SK-MEL-2 | Clonidine (hydrochloride) perturbation in SK-MEL-2 cell line |
| Cinacalcet_NCI-H661 | Cinacalcet perturbation in NCI-H661 cell line |
| Peretinoin_hTERT-HPNE | Peretinoin perturbation in hTERT-HPNE cell line |
| Tucidinostat_AsPC-1 | Tucidinostat perturbation in AsPC-1 cell line |
| Tetracycline (hydrochloride)_RKO | Tetracycline (hydrochloride) perturbation in RKO cell line |
| c-Kit-IN-1_LOX-IMVI | c-Kit-IN-1 perturbation in LOX-IMVI cell line |
| Tucatinib_HOP62 | Tucatinib perturbation in HOP62 cell line |
| Mitoxantrone (dihydrochloride)_NCI-H2030 | Mitoxantrone (dihydrochloride) perturbation in NCI-H2030 cell line |
| ULK-101_hTERT-HPNE | ULK-101 perturbation in hTERT-HPNE cell line |
| Hydroxyfasudil_RPMI-7951 | Hydroxyfasudil perturbation in RPMI-7951 cell line |
| Torkinib_NCI-H1573 | Torkinib perturbation in NCI-H1573 cell line |
| Gemfibrozil_NCI-H460 | Gemfibrozil perturbation in NCI-H460 cell line |
| Cloxacillin (sodium)_C32 | Cloxacillin (sodium) perturbation in C32 cell line |
| Erdafitinib _Hs 766T | Erdafitinib perturbation in Hs 766T cell line |
| γ-Oryzanol_SW 1088 | γ-Oryzanol perturbation in SW 1088 cell line |
| vincristine_HS-578T | vincristine perturbation in HS-578T cell line |
| Apalutamide_SK-MEL-2 | Apalutamide perturbation in SK-MEL-2 cell line |
| Everolimus_A-172 | Everolimus perturbation in A-172 cell line |
| Belumosudil (mesylate)_NCI-H460 | Belumosudil (mesylate) perturbation in NCI-H460 cell line |
| Alpelisib_SW 900 | Alpelisib perturbation in SW 900 cell line |
| Lumateperone (tosylate)_A549 | Lumateperone (tosylate) perturbation in A549 cell line |
| Norepinephrine (hydrochloride)_J82 | Norepinephrine (hydrochloride) perturbation in J82 cell line |
| Nafamostat (mesylate)_LOX-IMVI | Nafamostat (mesylate) perturbation in LOX-IMVI cell line |
| Mitoxantrone (dihydrochloride)_SW 1088 | Mitoxantrone (dihydrochloride) perturbation in SW 1088 cell line |
| Brivudine_NCI-H661 | Brivudine perturbation in NCI-H661 cell line |
| Perindopril (erbumine)_Panc 03.27 | Perindopril (erbumine) perturbation in Panc 03.27 cell line |
| TAK-901_SW 1088 | TAK-901 perturbation in SW 1088 cell line |
| Esmolol (hydrochloride)_A-172 | Esmolol (hydrochloride) perturbation in A-172 cell line |
| AZD-8055_NCI-H596 | AZD-8055 perturbation in NCI-H596 cell line |
| Belzutifan_SK-MEL-2 | Belzutifan perturbation in SK-MEL-2 cell line |
| Volasertib_SW 900 | Volasertib perturbation in SW 900 cell line |
| Selinexor _AsPC-1 | Selinexor perturbation in AsPC-1 cell line |
| Celecoxib_NCI-H2122 | Celecoxib perturbation in NCI-H2122 cell line |
| Quinestrol_NCI-H2347 | Quinestrol perturbation in NCI-H2347 cell line |
| Vilanterol_A-172 | Vilanterol perturbation in A-172 cell line |
| 9-ING-41_RKO | 9-ING-41 perturbation in RKO cell line |
| Dabrafenib_SW 900 | Dabrafenib perturbation in SW 900 cell line |
| Oxaprozin_RPMI-7951 | Oxaprozin perturbation in RPMI-7951 cell line |
| Lapatinib ditosylate_A498 | Lapatinib ditosylate perturbation in A498 cell line |
| Oxaliplatin_LOX-IMVI | Oxaliplatin perturbation in LOX-IMVI cell line |
| AZD-8055_SK-MEL-2 | AZD-8055 perturbation in SK-MEL-2 cell line |
| Pemigatinib_NCI-H1792 | Pemigatinib perturbation in NCI-H1792 cell line |
| Quinestrol_LOX-IMVI | Quinestrol perturbation in LOX-IMVI cell line |
| Bentamapimod_hTERT-HPNE | Bentamapimod perturbation in hTERT-HPNE cell line |
| Omeprazole (sodium)_HOP62 | Omeprazole (sodium) perturbation in HOP62 cell line |
| Minodronic acid_NCI-H2347 | Minodronic acid perturbation in NCI-H2347 cell line |
| Anastrozole_A498 | Anastrozole perturbation in A498 cell line |
| Allantoin_AsPC-1 | Allantoin perturbation in AsPC-1 cell line |
| Posaconazole_A498 | Posaconazole perturbation in A498 cell line |
| Demeclocycline_J82 | Demeclocycline perturbation in J82 cell line |
| Anethole trithione_A-172 | Anethole trithione perturbation in A-172 cell line |
| ERK5-IN-2_CFPAC-1 | ERK5-IN-2 perturbation in CFPAC-1 cell line |
| Rucaparib (phosphate)_SK-MEL-2 | Rucaparib (phosphate) perturbation in SK-MEL-2 cell line |
| ULK-101_RPMI-7951 | ULK-101 perturbation in RPMI-7951 cell line |
| LY-2584702 (tosylate salt)_C32 | LY-2584702 (tosylate salt) perturbation in C32 cell line |
| Oxaliplatin_RKO | Oxaliplatin perturbation in RKO cell line |
| Irinotecan (hydrochloride)_NCI-H596 | Irinotecan (hydrochloride) perturbation in NCI-H596 cell line |
| Quinestrol_RKO | Quinestrol perturbation in RKO cell line |
| Temsirolimus_LOX-IMVI | Temsirolimus perturbation in LOX-IMVI cell line |
| 9-ING-41_LOX-IMVI | 9-ING-41 perturbation in LOX-IMVI cell line |
| MK-8353_SNU-423 | MK-8353 perturbation in SNU-423 cell line |
| Apalutamide_NCI-H596 | Apalutamide perturbation in NCI-H596 cell line |
| Gefitinib_C32 | Gefitinib perturbation in C32 cell line |
| Furosemide_A498 | Furosemide perturbation in A498 cell line |
| Tubulin inhibitor 6_RPMI-7951 | Tubulin inhibitor 6 perturbation in RPMI-7951 cell line |
| Ixazomib_A549 | Ixazomib perturbation in A549 cell line |
| AZD-7648_SK-MEL-2 | AZD-7648 perturbation in SK-MEL-2 cell line |
| Belumosudil (mesylate)_RKO | Belumosudil (mesylate) perturbation in RKO cell line |
| ETC-206_RKO | ETC-206 perturbation in RKO cell line |
| TAK-733_NCI-H1573 | TAK-733 perturbation in NCI-H1573 cell line |
| Filgotinib_NCI-H1573 | Filgotinib perturbation in NCI-H1573 cell line |
| S-Adenosyl-L-methionine (disulfate tosylate)_SK-MEL-2 | S-Adenosyl-L-methionine (disulfate tosylate) perturbation in SK-MEL-2 cell line |
| Goserelin (acetate)_A549 | Goserelin (acetate) perturbation in A549 cell line |
| Lidocaine (hydrochloride)_H4 | Lidocaine (hydrochloride) perturbation in H4 cell line |
| 8-Hydroxyquinoline_SK-MEL-2 | 8-Hydroxyquinoline perturbation in SK-MEL-2 cell line |
| Gemfibrozil_RKO | Gemfibrozil perturbation in RKO cell line |
| DTP3_NCI-H2122 | DTP3 perturbation in NCI-H2122 cell line |
| Oleic acid_NCI-H661 | Oleic acid perturbation in NCI-H661 cell line |
| Clotrimazole_Panc 03.27 | Clotrimazole perturbation in Panc 03.27 cell line |
| Gemfibrozil_LOX-IMVI | Gemfibrozil perturbation in LOX-IMVI cell line |
| Saquinavir_A-172 | Saquinavir perturbation in A-172 cell line |
| Fulvestrant_LOX-IMVI | Fulvestrant perturbation in LOX-IMVI cell line |
| Bisoprolol (hemifumarate)_SK-MEL-2 | Bisoprolol (hemifumarate) perturbation in SK-MEL-2 cell line |
| AZD1390_RKO | AZD1390 perturbation in RKO cell line |
| Isocorydine_SNU-423 | Isocorydine perturbation in SNU-423 cell line |
| Darinaparsin_AsPC-1 | Darinaparsin perturbation in AsPC-1 cell line |
| ETC-206_LOX-IMVI | ETC-206 perturbation in LOX-IMVI cell line |
| Bimiralisib_RKO | Bimiralisib perturbation in RKO cell line |
| Volasertib_SW48 | Volasertib perturbation in SW48 cell line |
| AT7519_NCI-H460 | AT7519 perturbation in NCI-H460 cell line |
| Trifluridine_Hs 766T | Trifluridine perturbation in Hs 766T cell line |
| ETC-206_NCI-H2347 | ETC-206 perturbation in NCI-H2347 cell line |
| Volasertib_A498 | Volasertib perturbation in A498 cell line |
| Ouabain (Octahydrate)_A498 | Ouabain (Octahydrate) perturbation in A498 cell line |
| Ouabain (Octahydrate)_SW48 | Ouabain (Octahydrate) perturbation in SW48 cell line |
| 18β-Glycyrrhetinic acid_A498 | 18β-Glycyrrhetinic acid perturbation in A498 cell line |
| Selinexor _NCI-H2030 | Selinexor perturbation in NCI-H2030 cell line |
| 9-ING-41_NCI-H460 | 9-ING-41 perturbation in NCI-H460 cell line |
| Artemether_A549 | Artemether perturbation in A549 cell line |
| Gemfibrozil_NCI-H2347 | Gemfibrozil perturbation in NCI-H2347 cell line |
| Methylthiouracil_RPMI-7951 | Methylthiouracil perturbation in RPMI-7951 cell line |
| Alpelisib_A498 | Alpelisib perturbation in A498 cell line |
| Capmatinib_A-172 | Capmatinib perturbation in A-172 cell line |
| MK-8353_CFPAC-1 | MK-8353 perturbation in CFPAC-1 cell line |
| Pemigatinib_J82 | Pemigatinib perturbation in J82 cell line |
| Quinestrol_NCI-H460 | Quinestrol perturbation in NCI-H460 cell line |
| Pimozide_SK-MEL-2 | Pimozide perturbation in SK-MEL-2 cell line |
| SBI-0640756_LOX-IMVI | SBI-0640756 perturbation in LOX-IMVI cell line |
| Selinexor _SW 1088 | Selinexor perturbation in SW 1088 cell line |
| Bimatoprost_HOP62 | Bimatoprost perturbation in HOP62 cell line |
| Citalopram (hydrobromide)_NCI-H2030 | Citalopram (hydrobromide) perturbation in NCI-H2030 cell line |
| ERK5-IN-2_SNU-423 | ERK5-IN-2 perturbation in SNU-423 cell line |
| Bentamapimod_A549 | Bentamapimod perturbation in A549 cell line |
| Trimetrexate_NCI-H1573 | Trimetrexate perturbation in NCI-H1573 cell line |
| Dimethyl fumarate_HOP62 | Dimethyl fumarate perturbation in HOP62 cell line |
| Clopidogrel_RKO | Clopidogrel perturbation in RKO cell line |
| Lumateperone (tosylate)_RPMI-7951 | Lumateperone (tosylate) perturbation in RPMI-7951 cell line |
| Busulfan_RPMI-7951 | Busulfan perturbation in RPMI-7951 cell line |
| L-Thyroxine (sodium salt pentahydrate)_NCI-H2122 | L-Thyroxine (sodium salt pentahydrate) perturbation in NCI-H2122 cell line |
| Pasireotide (acetate)_NCI-H2122 | Pasireotide (acetate) perturbation in NCI-H2122 cell line |
| Simotinib_NCI-H2122 | Simotinib perturbation in NCI-H2122 cell line |
| Selinexor _SW1417 | Selinexor perturbation in SW1417 cell line |
| γ-Oryzanol_SW 1271 | γ-Oryzanol perturbation in SW 1271 cell line |
| Celecoxib_A498 | Celecoxib perturbation in A498 cell line |
| Allopurinol_RKO | Allopurinol perturbation in RKO cell line |
| LJI308_NCI-H1573 | LJI308 perturbation in NCI-H1573 cell line |
| Cloxacillin (sodium)_SW 900 | Cloxacillin (sodium) perturbation in SW 900 cell line |
| Clonidine (hydrochloride)_Panc 03.27 | Clonidine (hydrochloride) perturbation in Panc 03.27 cell line |
| Ouabain (Octahydrate)_C32 | Ouabain (Octahydrate) perturbation in C32 cell line |
| 4EGI-1_NCI-H596 | 4EGI-1 perturbation in NCI-H596 cell line |
| Allopurinol_LOX-IMVI | Allopurinol perturbation in LOX-IMVI cell line |
| Cytarabine (hydrochloride)_NCI-H460 | Cytarabine (hydrochloride) perturbation in NCI-H460 cell line |
| Erythromycin_A549 | Erythromycin perturbation in A549 cell line |
| Volasertib_C32 | Volasertib perturbation in C32 cell line |
| TAK-901_SW 1271 | TAK-901 perturbation in SW 1271 cell line |
| Brimonidine_SK-MEL-2 | Brimonidine perturbation in SK-MEL-2 cell line |
| Norepinephrine (hydrochloride)_SNU-423 | Norepinephrine (hydrochloride) perturbation in SNU-423 cell line |
| Darolutamide_RKO | Darolutamide perturbation in RKO cell line |
| Almonertinib (mesylate)_NCI-H460 | Almonertinib (mesylate) perturbation in NCI-H460 cell line |
| Docetaxel_CFPAC-1 | Docetaxel perturbation in CFPAC-1 cell line |
| Clopidogrel_LOX-IMVI | Clopidogrel perturbation in LOX-IMVI cell line |
| Tomivosertib_SK-MEL-2 | Tomivosertib perturbation in SK-MEL-2 cell line |
| Tolcapone_H4 | Tolcapone perturbation in H4 cell line |
| Paclitaxel_SK-MEL-2 | Paclitaxel perturbation in SK-MEL-2 cell line |
| Tolcapone_NCI-H661 | Tolcapone perturbation in NCI-H661 cell line |
| Capivasertib_LOX-IMVI | Capivasertib perturbation in LOX-IMVI cell line |
| TAK-733_A498 | TAK-733 perturbation in A498 cell line |
| Torkinib_SW 900 | Torkinib perturbation in SW 900 cell line |
| DT-061_J82 | DT-061 perturbation in J82 cell line |
| Tomivosertib_NCI-H596 | Tomivosertib perturbation in NCI-H596 cell line |
| Omeprazole_RKO | Omeprazole perturbation in RKO cell line |
| Saquinavir_H4 | Saquinavir perturbation in H4 cell line |
| Azithromycin (hydrate)_SW 1088 | Azithromycin (hydrate) perturbation in SW 1088 cell line |
| Darinaparsin_SW 1271 | Darinaparsin perturbation in SW 1271 cell line |
| 5-Azacytidine_RKO | 5-Azacytidine perturbation in RKO cell line |
| Nevirapine_SK-MEL-2 | Nevirapine perturbation in SK-MEL-2 cell line |
| Lidocaine (hydrochloride)_A-172 | Lidocaine (hydrochloride) perturbation in A-172 cell line |
| LY-2584702 (tosylate salt)_SW 900 | LY-2584702 (tosylate salt) perturbation in SW 900 cell line |
| venetoclax_SK-MEL-2 | venetoclax perturbation in SK-MEL-2 cell line |
| Lumateperone (tosylate)_hTERT-HPNE | Lumateperone (tosylate) perturbation in hTERT-HPNE cell line |
| Triamcinolone_HOP62 | Triamcinolone perturbation in HOP62 cell line |
| BI-3406_HOP62 | BI-3406 perturbation in HOP62 cell line |
| Tucidinostat_NCI-H1573 | Tucidinostat perturbation in NCI-H1573 cell line |
| Demeclocycline_HOP62 | Demeclocycline perturbation in HOP62 cell line |
| Pimitespib_NCI-H460 | Pimitespib perturbation in NCI-H460 cell line |
| Volasertib_NCI-H1573 | Volasertib perturbation in NCI-H1573 cell line |
| Tirabrutinib (hydrochloride)_RKO | Tirabrutinib (hydrochloride) perturbation in RKO cell line |
| Gemcitabine_A549 | Gemcitabine perturbation in A549 cell line |
| Ouabain (Octahydrate)_AN3 CA | Ouabain (Octahydrate) perturbation in AN3 CA cell line |
| Berberine (chloride hydrate)_AsPC-1 | Berberine (chloride hydrate) perturbation in AsPC-1 cell line |
| Ivermectin_LOX-IMVI | Ivermectin perturbation in LOX-IMVI cell line |
| Sapanisertib_SW 1271 | Sapanisertib perturbation in SW 1271 cell line |
| Ouabain (Octahydrate)_NCI-H1573 | Ouabain (Octahydrate) perturbation in NCI-H1573 cell line |
| Azithromycin (hydrate)_NCI-H2030 | Azithromycin (hydrate) perturbation in NCI-H2030 cell line |
| Posaconazole_NCI-H2122 | Posaconazole perturbation in NCI-H2122 cell line |
| Belzutifan_Hs 766T | Belzutifan perturbation in Hs 766T cell line |
| Berberine (chloride hydrate)_NCI-H2030 | Berberine (chloride hydrate) perturbation in NCI-H2030 cell line |
| Pasireotide (acetate)_NCI-H1573 | Pasireotide (acetate) perturbation in NCI-H1573 cell line |
| Berbamine (dihydrochloride)_A549 | Berbamine (dihydrochloride) perturbation in A549 cell line |
| Palmatine (chloride)_SK-MEL-2 | Palmatine (chloride) perturbation in SK-MEL-2 cell line |
| Allantoin_SW 1271 | Allantoin perturbation in SW 1271 cell line |
| Trifluridine_SK-MEL-2 | Trifluridine perturbation in SK-MEL-2 cell line |
| Allopurinol_NCI-H460 | Allopurinol perturbation in NCI-H460 cell line |
| Capivasertib_NCI-H460 | Capivasertib perturbation in NCI-H460 cell line |
| Gefitinib_A498 | Gefitinib perturbation in A498 cell line |
| BI-78D3_HS-578T | BI-78D3 perturbation in HS-578T cell line |
| Tirabrutinib_HOP62 | Tirabrutinib perturbation in HOP62 cell line |
| Bicalutamide_LOX-IMVI | Bicalutamide perturbation in LOX-IMVI cell line |
| Encorafenib_LS 180 | Encorafenib perturbation in LS 180 cell line |
| PH-797804_AsPC-1 | PH-797804 perturbation in AsPC-1 cell line |
| LY-2584702 (tosylate salt)_A498 | LY-2584702 (tosylate salt) perturbation in A498 cell line |
| Clopidogrel_NCI-H460 | Clopidogrel perturbation in NCI-H460 cell line |
| Terfenadine_H4 | Terfenadine perturbation in H4 cell line |
| Isocorydine_J82 | Isocorydine perturbation in J82 cell line |
| Pimitespib_NCI-H2347 | Pimitespib perturbation in NCI-H2347 cell line |
| Ixazomib_RPMI-7951 | Ixazomib perturbation in RPMI-7951 cell line |
| Tubulin inhibitor 6_A549 | Tubulin inhibitor 6 perturbation in A549 cell line |
| Lonafarnib_RPMI-7951 | Lonafarnib perturbation in RPMI-7951 cell line |
| Cinacalcet_RKO | Cinacalcet perturbation in RKO cell line |
| Torkinib_A498 | Torkinib perturbation in A498 cell line |
| Trametinib_NCI-H596 | Trametinib perturbation in NCI-H596 cell line |
| Lidocaine (hydrochloride)_HS-578T | Lidocaine (hydrochloride) perturbation in HS-578T cell line |
| Retinoic acid_SW 900 | Retinoic acid perturbation in SW 900 cell line |
| Torkinib_SW48 | Torkinib perturbation in SW48 cell line |
| Idarubicin (hydrochloride)_SW 900 | Idarubicin (hydrochloride) perturbation in SW 900 cell line |
| PF-06260933_SK-MEL-2 | PF-06260933 perturbation in SK-MEL-2 cell line |
| Fusidic acid_NCI-H1573 | Fusidic acid perturbation in NCI-H1573 cell line |
| Norepinephrine (hydrochloride)_CHP-212 | Norepinephrine (hydrochloride) perturbation in CHP-212 cell line |
| Megestrol_NCI-H2122 | Megestrol perturbation in NCI-H2122 cell line |
| Bimatoprost_J82 | Bimatoprost perturbation in J82 cell line |
| Salicylic acid_AsPC-1 | Salicylic acid perturbation in AsPC-1 cell line |
| Sinomenine_Hs 766T | Sinomenine perturbation in Hs 766T cell line |
| Pentagastrin_HOP62 | Pentagastrin perturbation in HOP62 cell line |
| Triamcinolone_CFPAC-1 | Triamcinolone perturbation in CFPAC-1 cell line |
| Demeclocycline_CFPAC-1 | Demeclocycline perturbation in CFPAC-1 cell line |
| Doxorubicin (hydrochloride)_SK-MEL-2 | Doxorubicin (hydrochloride) perturbation in SK-MEL-2 cell line |
| Acetazolamide_NCI-H2030 | Acetazolamide perturbation in NCI-H2030 cell line |
| Volasertib_NCI-H2122 | Volasertib perturbation in NCI-H2122 cell line |
| Celecoxib_SW 900 | Celecoxib perturbation in SW 900 cell line |
| Tirabrutinib (hydrochloride)_NCI-H460 | Tirabrutinib (hydrochloride) perturbation in NCI-H460 cell line |
| Anastrozole_NCI-H1573 | Anastrozole perturbation in NCI-H1573 cell line |
| Pioglitazone_HOP62 | Pioglitazone perturbation in HOP62 cell line |
| Trifluridine_NCI-H596 | Trifluridine perturbation in NCI-H596 cell line |
| Relugolix_NCI-H460 | Relugolix perturbation in NCI-H460 cell line |
| 5-Azacytidine_NCI-H460 | 5-Azacytidine perturbation in NCI-H460 cell line |
| Digitoxin_NCI-H2030 | Digitoxin perturbation in NCI-H2030 cell line |
| Methylthiouracil_A549 | Methylthiouracil perturbation in A549 cell line |
| BAY1125976_NCI-H596 | BAY1125976 perturbation in NCI-H596 cell line |
| Tofacitinib (citrate)_A549 | Tofacitinib (citrate) perturbation in A549 cell line |
| Methylprednisolone succinate_NCI-H2030 | Methylprednisolone succinate perturbation in NCI-H2030 cell line |
| Ponatinib_RKO | Ponatinib perturbation in RKO cell line |
| Peretinoin_SW 900 | Peretinoin perturbation in SW 900 cell line |
| BAY1125976_A-172 | BAY1125976 perturbation in A-172 cell line |
| NG25_Hs 766T | NG25 perturbation in Hs 766T cell line |
| Ropivacaine (hydrochloride monohydrate)_LOX-IMVI | Ropivacaine (hydrochloride monohydrate) perturbation in LOX-IMVI cell line |
| GSK1059615_A549 | GSK1059615 perturbation in A549 cell line |
| Allantoin_RPMI-7951 | Allantoin perturbation in RPMI-7951 cell line |
| Bergenin_NCI-H460 | Bergenin perturbation in NCI-H460 cell line |
| Lactate (calcium)_LOX-IMVI | Lactate (calcium) perturbation in LOX-IMVI cell line |
| Trifluridine_A-172 | Trifluridine perturbation in A-172 cell line |
| EX229_NCI-H2347 | EX229 perturbation in NCI-H2347 cell line |
| vincristine_HT-29 | vincristine perturbation in HT-29 cell line |
| Palmatine (chloride)_A-172 | Palmatine (chloride) perturbation in A-172 cell line |
| Dabrafenib_CFPAC-1 | Dabrafenib perturbation in CFPAC-1 cell line |
| Talc_LOX-IMVI | Talc perturbation in LOX-IMVI cell line |
| Penfluridol_A498 | Penfluridol perturbation in A498 cell line |
| ULK-101_AsPC-1 | ULK-101 perturbation in AsPC-1 cell line |
| Clotrimazole_NCI-H2347 | Clotrimazole perturbation in NCI-H2347 cell line |
| Citalopram (hydrobromide)_hTERT-HPNE | Citalopram (hydrobromide) perturbation in hTERT-HPNE cell line |
| Goserelin (acetate)_SW 1271 | Goserelin (acetate) perturbation in SW 1271 cell line |
| Ropivacaine (hydrochloride monohydrate)_RKO | Ropivacaine (hydrochloride monohydrate) perturbation in RKO cell line |
| LJI308_CFPAC-1 | LJI308 perturbation in CFPAC-1 cell line |
| Gefitinib_NCI-H1792 | Gefitinib perturbation in NCI-H1792 cell line |
| Fusidic acid_HOP62 | Fusidic acid perturbation in HOP62 cell line |
| Ixazomib_SW 1271 | Ixazomib perturbation in SW 1271 cell line |
| LB-100_J82 | LB-100 perturbation in J82 cell line |
| Tucatinib_A498 | Tucatinib perturbation in A498 cell line |
| Abemaciclib_NCI-H460 | Abemaciclib perturbation in NCI-H460 cell line |
| (R)-Verapamil (hydrochloride)_AsPC-1 | (R)-Verapamil (hydrochloride) perturbation in AsPC-1 cell line |
| Quinestrol_SNU-1 | Quinestrol perturbation in SNU-1 cell line |
| DT-061_A498 | DT-061 perturbation in A498 cell line |
| Tucidinostat_CFPAC-1 | Tucidinostat perturbation in CFPAC-1 cell line |
| Perindopril (erbumine)_NCI-H460 | Perindopril (erbumine) perturbation in NCI-H460 cell line |
| Furosemide_HOP62 | Furosemide perturbation in HOP62 cell line |
| Ponatinib_NCI-H2347 | Ponatinib perturbation in NCI-H2347 cell line |
| Sulfisoxazole_H4 | Sulfisoxazole perturbation in H4 cell line |
| Brivudine_SK-MEL-2 | Brivudine perturbation in SK-MEL-2 cell line |
| MK-3903_Hs 766T | MK-3903 perturbation in Hs 766T cell line |
| Ouabain (Octahydrate)_CFPAC-1 | Ouabain (Octahydrate) perturbation in CFPAC-1 cell line |
| EX229_RKO | EX229 perturbation in RKO cell line |
| 18β-Glycyrrhetinic acid_CFPAC-1 | 18β-Glycyrrhetinic acid perturbation in CFPAC-1 cell line |
| Isocorydine_SW 900 | Isocorydine perturbation in SW 900 cell line |
| Volasertib_CHP-212 | Volasertib perturbation in CHP-212 cell line |
| Bestatin_RKO | Bestatin perturbation in RKO cell line |
| Pyridoxine (hydrochloride)_A-172 | Pyridoxine (hydrochloride) perturbation in A-172 cell line |
| Vinblastine (sulfate)_SW 1271 | Vinblastine (sulfate) perturbation in SW 1271 cell line |
| Tofacitinib (citrate)_NCI-H2030 | Tofacitinib (citrate) perturbation in NCI-H2030 cell line |
| Clotrimazole_RKO | Clotrimazole perturbation in RKO cell line |
| Posaconazole_HOP62 | Posaconazole perturbation in HOP62 cell line |
| Methylthiouracil_NCI-H2030 | Methylthiouracil perturbation in NCI-H2030 cell line |
| Saquinavir_Hs 766T | Saquinavir perturbation in Hs 766T cell line |
| Zileuton_NCI-H1573 | Zileuton perturbation in NCI-H1573 cell line |
| Lapatinib ditosylate_HOP62 | Lapatinib ditosylate perturbation in HOP62 cell line |
| Flutamide_CFPAC-1 | Flutamide perturbation in CFPAC-1 cell line |
| Infigratinib_SK-MEL-2 | Infigratinib perturbation in SK-MEL-2 cell line |
| Ropivacaine (hydrochloride monohydrate)_NCI-H2347 | Ropivacaine (hydrochloride monohydrate) perturbation in NCI-H2347 cell line |
| Decitabine_NCI-H2122 | Decitabine perturbation in NCI-H2122 cell line |
| Irinotecan_SK-MEL-2 | Irinotecan perturbation in SK-MEL-2 cell line |
| MK-8353_A498 | MK-8353 perturbation in A498 cell line |
| Bergenin_RKO | Bergenin perturbation in RKO cell line |
| HI-TOPK-032_RKO | HI-TOPK-032 perturbation in RKO cell line |
| Busulfan_SW 1271 | Busulfan perturbation in SW 1271 cell line |
| Binimetinib_RKO | Binimetinib perturbation in RKO cell line |
| Quinestrol_Panc 03.27 | Quinestrol perturbation in Panc 03.27 cell line |
| Encorafenib_SW 1088 | Encorafenib perturbation in SW 1088 cell line |
| Elagolix sodium_SK-MEL-2 | Elagolix sodium perturbation in SK-MEL-2 cell line |
| Tofacitinib_RKO | Tofacitinib perturbation in RKO cell line |
| Baicalin_RKO | Baicalin perturbation in RKO cell line |
| Fusidic acid_CFPAC-1 | Fusidic acid perturbation in CFPAC-1 cell line |
| LJI308_HOP62 | LJI308 perturbation in HOP62 cell line |
| Abemaciclib_LOX-IMVI | Abemaciclib perturbation in LOX-IMVI cell line |
| LY-2584702 (tosylate salt)_J82 | LY-2584702 (tosylate salt) perturbation in J82 cell line |
| Methylthiouracil_AsPC-1 | Methylthiouracil perturbation in AsPC-1 cell line |
| Norepinephrine (hydrochloride)_NCI-H1573 | Norepinephrine (hydrochloride) perturbation in NCI-H1573 cell line |
| Paclitaxel_A-172 | Paclitaxel perturbation in A-172 cell line |
| c-Kit-IN-1_Hs 766T | c-Kit-IN-1 perturbation in Hs 766T cell line |
| Encorafenib_NCI-H2030 | Encorafenib perturbation in NCI-H2030 cell line |
| Tofacitinib_LOX-IMVI | Tofacitinib perturbation in LOX-IMVI cell line |
| Isocorydine_A498 | Isocorydine perturbation in A498 cell line |
| Tomivosertib_A-172 | Tomivosertib perturbation in A-172 cell line |
| Abemaciclib_RKO | Abemaciclib perturbation in RKO cell line |
| LJI308_SNU-423 | LJI308 perturbation in SNU-423 cell line |
| ML264_SK-MEL-2 | ML264 perturbation in SK-MEL-2 cell line |
| Torkinib_J82 | Torkinib perturbation in J82 cell line |
| Mitoxantrone (dihydrochloride)_RPMI-7951 | Mitoxantrone (dihydrochloride) perturbation in RPMI-7951 cell line |
| Bergenin_LOX-IMVI | Bergenin perturbation in LOX-IMVI cell line |
| Bentamapimod_SW 1088 | Bentamapimod perturbation in SW 1088 cell line |
| DT-061_SW 900 | DT-061 perturbation in SW 900 cell line |
| EX229_NCI-H460 | EX229 perturbation in NCI-H460 cell line |
| Sodium Salicylate_SW 900 | Sodium Salicylate perturbation in SW 900 cell line |
| Tucatinib_SW 900 | Tucatinib perturbation in SW 900 cell line |
| Volasertib_SNU-423 | Volasertib perturbation in SNU-423 cell line |
| Ouabain (Octahydrate)_SNU-423 | Ouabain (Octahydrate) perturbation in SNU-423 cell line |
| Anastrozole_CFPAC-1 | Anastrozole perturbation in CFPAC-1 cell line |
| Bimatoprost_SW48 | Bimatoprost perturbation in SW48 cell line |
| Altretamine_RKO | Altretamine perturbation in RKO cell line |
| Bexarotene_SW1417 | Bexarotene perturbation in SW1417 cell line |
| TAK-901_hTERT-HPNE | TAK-901 perturbation in hTERT-HPNE cell line |
| ULK-101_NCI-H2030 | ULK-101 perturbation in NCI-H2030 cell line |
| Alpelisib_SNU-423 | Alpelisib perturbation in SNU-423 cell line |
| AZD-7648_H4 | AZD-7648 perturbation in H4 cell line |
| NVP-BHG712_A-172 | NVP-BHG712 perturbation in A-172 cell line |
| Abemaciclib_NCI-H2347 | Abemaciclib perturbation in NCI-H2347 cell line |
| Demeclocycline_NCI-H1573 | Demeclocycline perturbation in NCI-H1573 cell line |
| γ-Oryzanol_hTERT-HPNE | γ-Oryzanol perturbation in hTERT-HPNE cell line |
| Triamcinolone_NCI-H1573 | Triamcinolone perturbation in NCI-H1573 cell line |
| Gemcitabine_NCI-H2030 | Gemcitabine perturbation in NCI-H2030 cell line |
| Perindopril (erbumine)_LOX-IMVI | Perindopril (erbumine) perturbation in LOX-IMVI cell line |
| Ouabain (Octahydrate)_HOP62 | Ouabain (Octahydrate) perturbation in HOP62 cell line |
| venetoclax_A-172 | venetoclax perturbation in A-172 cell line |
| Darinaparsin_RPMI-7951 | Darinaparsin perturbation in RPMI-7951 cell line |
| 18β-Glycyrrhetinic acid_HOP62 | 18β-Glycyrrhetinic acid perturbation in HOP62 cell line |
| Acetohexamide_SW 900 | Acetohexamide perturbation in SW 900 cell line |
| S-Adenosyl-L-methionine (disulfate tosylate)_H4 | S-Adenosyl-L-methionine (disulfate tosylate) perturbation in H4 cell line |
| ERK5-IN-2_SW48 | ERK5-IN-2 perturbation in SW48 cell line |
| ULK-101_SW 1088 | ULK-101 perturbation in SW 1088 cell line |
| Lidocaine (hydrochloride)_SK-MEL-2 | Lidocaine (hydrochloride) perturbation in SK-MEL-2 cell line |
| ERK5-IN-2_A498 | ERK5-IN-2 perturbation in A498 cell line |
| Pyridoxine_A498 | Pyridoxine perturbation in A498 cell line |
| Volasertib_HOP62 | Volasertib perturbation in HOP62 cell line |
| Amsacrine_NCI-H460 | Amsacrine perturbation in NCI-H460 cell line |
| Fusidic acid_J82 | Fusidic acid perturbation in J82 cell line |
| Vemurafenib_RKO | Vemurafenib perturbation in RKO cell line |
| TAK-733_HOP62 | TAK-733 perturbation in HOP62 cell line |
| Pentagastrin_SW 900 | Pentagastrin perturbation in SW 900 cell line |
| Peretinoin_C32 | Peretinoin perturbation in C32 cell line |
| Quinidine (15% dihydroquinidine)_RKO | Quinidine (15% dihydroquinidine) perturbation in RKO cell line |
| Isocorydine_NCI-H1573 | Isocorydine perturbation in NCI-H1573 cell line |
| Ritonavir_CFPAC-1 | Ritonavir perturbation in CFPAC-1 cell line |
| NVP-BHG712_H4 | NVP-BHG712 perturbation in H4 cell line |
| Torkinib_CFPAC-1 | Torkinib perturbation in CFPAC-1 cell line |
| Lonafarnib_SW 1088 | Lonafarnib perturbation in SW 1088 cell line |
| Temuterkib_RKO | Temuterkib perturbation in RKO cell line |
| Bimatoprost_C32 | Bimatoprost perturbation in C32 cell line |
| Goserelin (acetate)_SW 1088 | Goserelin (acetate) perturbation in SW 1088 cell line |
| Norepinephrine (hydrochloride)_A498 | Norepinephrine (hydrochloride) perturbation in A498 cell line |
| Homoharringtonine_AsPC-1 | Homoharringtonine perturbation in AsPC-1 cell line |
| Tolcapone_NCI-H596 | Tolcapone perturbation in NCI-H596 cell line |
| TAK-733_SNU-423 | TAK-733 perturbation in SNU-423 cell line |
| IQ 1_NCI-H2122 | IQ 1 perturbation in NCI-H2122 cell line |
| Megestrol_NCI-H1792 | Megestrol perturbation in NCI-H1792 cell line |
| Vemurafenib_NCI-H2347 | Vemurafenib perturbation in NCI-H2347 cell line |
| Peretinoin_NCI-H1573 | Peretinoin perturbation in NCI-H1573 cell line |
| Methylthiouracil_SW 1271 | Methylthiouracil perturbation in SW 1271 cell line |
| Docetaxel_SW 900 | Docetaxel perturbation in SW 900 cell line |
| vincristine_SK-MEL-2 | vincristine perturbation in SK-MEL-2 cell line |
| Demeclocycline_A498 | Demeclocycline perturbation in A498 cell line |
| CP21R7_RKO | CP21R7 perturbation in RKO cell line |
| Almonertinib (mesylate)_Panc 03.27 | Almonertinib (mesylate) perturbation in Panc 03.27 cell line |
| DT-061_NCI-H2122 | DT-061 perturbation in NCI-H2122 cell line |
| Volasertib_NCI-H1792 | Volasertib perturbation in NCI-H1792 cell line |
| Piroxicam_NCI-H460 | Piroxicam perturbation in NCI-H460 cell line |
| Artemether_SW 1088 | Artemether perturbation in SW 1088 cell line |
| Fingolimod (hydrochloride)_RKO | Fingolimod (hydrochloride) perturbation in RKO cell line |
| Radotinib_RKO | Radotinib perturbation in RKO cell line |
| Pralsetinib_NCI-H460 | Pralsetinib perturbation in NCI-H460 cell line |
| Ropivacaine (hydrochloride monohydrate)_NCI-H23 | Ropivacaine (hydrochloride monohydrate) perturbation in NCI-H23 cell line |
| Cloxacillin (sodium)_CFPAC-1 | Cloxacillin (sodium) perturbation in CFPAC-1 cell line |
| Vinblastine (sulfate)_NCI-H2030 | Vinblastine (sulfate) perturbation in NCI-H2030 cell line |
| Bimatoprost_NCI-H1573 | Bimatoprost perturbation in NCI-H1573 cell line |
| Idarubicin (hydrochloride)_HOP62 | Idarubicin (hydrochloride) perturbation in HOP62 cell line |
| Torkinib_HOP62 | Torkinib perturbation in HOP62 cell line |
| L-Eflornithine (monohydrochloride)_Panc 03.27 | L-Eflornithine (monohydrochloride) perturbation in Panc 03.27 cell line |
| Everolimus_SK-MEL-2 | Everolimus perturbation in SK-MEL-2 cell line |
| Sodium Salicylate_NCI-H1573 | Sodium Salicylate perturbation in NCI-H1573 cell line |
| Isocorydine_NCI-H2122 | Isocorydine perturbation in NCI-H2122 cell line |
| Futibatinib_SW 1271 | Futibatinib perturbation in SW 1271 cell line |
| AZD2858_RPMI-7951 | AZD2858 perturbation in RPMI-7951 cell line |
| MK-8353_C32 | MK-8353 perturbation in C32 cell line |
| BI-78D3_Hs 766T | BI-78D3 perturbation in Hs 766T cell line |
| Hydroxyfasudil_SW 1271 | Hydroxyfasudil perturbation in SW 1271 cell line |
| Filgotinib_CFPAC-1 | Filgotinib perturbation in CFPAC-1 cell line |
| Folic acid_NCI-H2030 | Folic acid perturbation in NCI-H2030 cell line |
| Vilanterol_SK-MEL-2 | Vilanterol perturbation in SK-MEL-2 cell line |
| Docetaxel_A498 | Docetaxel perturbation in A498 cell line |
| Belzutifan_A-172 | Belzutifan perturbation in A-172 cell line |
| Gefitinib_HOP62 | Gefitinib perturbation in HOP62 cell line |
| Pralsetinib_NCI-H2347 | Pralsetinib perturbation in NCI-H2347 cell line |
| Methylthiouracil_SW1417 | Methylthiouracil perturbation in SW1417 cell line |
| Lidocaine (hydrochloride)_Hs 766T | Lidocaine (hydrochloride) perturbation in Hs 766T cell line |
| Trimetrexate_J82 | Trimetrexate perturbation in J82 cell line |
| Acetohexamide_NCI-H1573 | Acetohexamide perturbation in NCI-H1573 cell line |
| Torkinib_SNU-423 | Torkinib perturbation in SNU-423 cell line |
| 18β-Glycyrrhetinic acid_J82 | 18β-Glycyrrhetinic acid perturbation in J82 cell line |
| Canagliflozin (hemihydrate)_HOP62 | Canagliflozin (hemihydrate) perturbation in HOP62 cell line |
| Harringtonine_hTERT-HPNE | Harringtonine perturbation in hTERT-HPNE cell line |
| Norepinephrine (hydrochloride)_SW 900 | Norepinephrine (hydrochloride) perturbation in SW 900 cell line |
| Cloxacillin (sodium)_HOP62 | Cloxacillin (sodium) perturbation in HOP62 cell line |
| Darinaparsin_A549 | Darinaparsin perturbation in A549 cell line |
| Pralsetinib_LOX-IMVI | Pralsetinib perturbation in LOX-IMVI cell line |
| Retinoic acid_CFPAC-1 | Retinoic acid perturbation in CFPAC-1 cell line |
| PH-797804_RPMI-7951 | PH-797804 perturbation in RPMI-7951 cell line |
| Pralsetinib_RKO | Pralsetinib perturbation in RKO cell line |
| Everolimus_NCI-H596 | Everolimus perturbation in NCI-H596 cell line |
| Ixazomib_AsPC-1 | Ixazomib perturbation in AsPC-1 cell line |
| Pemigatinib_A498 | Pemigatinib perturbation in A498 cell line |
| Rapamycin_NCI-H2347 | Rapamycin perturbation in NCI-H2347 cell line |
| Megestrol_J82 | Megestrol perturbation in J82 cell line |
| Trifluridine_H4 | Trifluridine perturbation in H4 cell line |
| (R)-Verapamil (hydrochloride)_SW 1271 | (R)-Verapamil (hydrochloride) perturbation in SW 1271 cell line |
| Alpelisib_J82 | Alpelisib perturbation in J82 cell line |
| Bimatoprost_NCI-H2122 | Bimatoprost perturbation in NCI-H2122 cell line |
| DT-061_NCI-H1573 | DT-061 perturbation in NCI-H1573 cell line |
| Lonafarnib_AsPC-1 | Lonafarnib perturbation in AsPC-1 cell line |
| Anethole trithione_SK-MEL-2 | Anethole trithione perturbation in SK-MEL-2 cell line |
| ULK-101_SW 1271 | ULK-101 perturbation in SW 1271 cell line |
| BAY1125976_H4 | BAY1125976 perturbation in H4 cell line |
| LJI308_LOX-IMVI | LJI308 perturbation in LOX-IMVI cell line |
| Abemaciclib_HOP62 | Abemaciclib perturbation in HOP62 cell line |
| Fusidic acid_NCI-H460 | Fusidic acid perturbation in NCI-H460 cell line |
| Gemfibrozil_A498 | Gemfibrozil perturbation in A498 cell line |
| Tubulin inhibitor 6_Hs 766T | Tubulin inhibitor 6 perturbation in Hs 766T cell line |
| Diammonium Glycyrrhizinate_CFPAC-1 | Diammonium Glycyrrhizinate perturbation in CFPAC-1 cell line |
| Volasertib_NCI-H2347 | Volasertib perturbation in NCI-H2347 cell line |
| vincristine_SW 1088 | vincristine perturbation in SW 1088 cell line |
| Belumosudil (mesylate)_A498 | Belumosudil (mesylate) perturbation in A498 cell line |
| Daidzin_A549 | Daidzin perturbation in A549 cell line |
| 5-Azacytidine_C32 | 5-Azacytidine perturbation in C32 cell line |
| Quinestrol_SW 900 | Quinestrol perturbation in SW 900 cell line |
| Cinacalcet_A-427 | Cinacalcet perturbation in A-427 cell line |
| 9-ING-41_SW 900 | 9-ING-41 perturbation in SW 900 cell line |
| Temsirolimus_SW 900 | Temsirolimus perturbation in SW 900 cell line |
| DT-061_Panc 03.27 | DT-061 perturbation in Panc 03.27 cell line |
| Bergenin_HOP62 | Bergenin perturbation in HOP62 cell line |
| NG25_NCI-H2030 | NG25 perturbation in NCI-H2030 cell line |
| Trimetrexate_RKO | Trimetrexate perturbation in RKO cell line |
| Dabrafenib_RKO | Dabrafenib perturbation in RKO cell line |
| Cepharanthine_NCI-H460 | Cepharanthine perturbation in NCI-H460 cell line |
| Levobupivacaine (hydrochloride)_NCI-H460 | Levobupivacaine (hydrochloride) perturbation in NCI-H460 cell line |
| Irinotecan_SW 1271 | Irinotecan perturbation in SW 1271 cell line |
| LJI308_RKO | LJI308 perturbation in RKO cell line |
| Palmatine (chloride)_hTERT-HPNE | Palmatine (chloride) perturbation in hTERT-HPNE cell line |
| Abemaciclib_SNU-423 | Abemaciclib perturbation in SNU-423 cell line |
| vincristine_NCI-H2030 | vincristine perturbation in NCI-H2030 cell line |
| Alpelisib_NCI-H2347 | Alpelisib perturbation in NCI-H2347 cell line |
| Vilanterol_AsPC-1 | Vilanterol perturbation in AsPC-1 cell line |
| Ropivacaine (hydrochloride monohydrate)_CFPAC-1 | Ropivacaine (hydrochloride monohydrate) perturbation in CFPAC-1 cell line |
| BAY1125976_RPMI-7951 | BAY1125976 perturbation in RPMI-7951 cell line |
| Flutamide_LOX-IMVI | Flutamide perturbation in LOX-IMVI cell line |
| Artemether_NCI-H596 | Artemether perturbation in NCI-H596 cell line |
| Tucidinostat_RKO | Tucidinostat perturbation in RKO cell line |
| Gallic acid (hydrate)_AsPC-1 | Gallic acid (hydrate) perturbation in AsPC-1 cell line |
| Lapatinib ditosylate_NCI-H460 | Lapatinib ditosylate perturbation in NCI-H460 cell line |
| Alpelisib_LOX-IMVI | Alpelisib perturbation in LOX-IMVI cell line |
| Volasertib_RKO | Volasertib perturbation in RKO cell line |
| Olanzapine_NCI-H596 | Olanzapine perturbation in NCI-H596 cell line |
| Larotrectinib_SK-MEL-2 | Larotrectinib perturbation in SK-MEL-2 cell line |
| crizotinib_RKO | crizotinib perturbation in RKO cell line |
| Allantoin_A-172 | Allantoin perturbation in A-172 cell line |
| Loperamide (hydrochloride)_NCI-H596 | Loperamide (hydrochloride) perturbation in NCI-H596 cell line |
| 18β-Glycyrrhetinic acid_RKO | 18β-Glycyrrhetinic acid perturbation in RKO cell line |
| EX229_CFPAC-1 | EX229 perturbation in CFPAC-1 cell line |
| S-Adenosyl-L-methionine (disulfate tosylate)_A549 | S-Adenosyl-L-methionine (disulfate tosylate) perturbation in A549 cell line |
| Anethole trithione_AsPC-1 | Anethole trithione perturbation in AsPC-1 cell line |
| Allopurinol_C32 | Allopurinol perturbation in C32 cell line |
| Dabrafenib_NCI-H2347 | Dabrafenib perturbation in NCI-H2347 cell line |
| Ouabain (Octahydrate)_LOX-IMVI | Ouabain (Octahydrate) perturbation in LOX-IMVI cell line |
| Bimatoprost_SNU-1 | Bimatoprost perturbation in SNU-1 cell line |
| Volasertib_LOX-IMVI | Volasertib perturbation in LOX-IMVI cell line |
| Proglumide_HOP62 | Proglumide perturbation in HOP62 cell line |
| Lonafarnib_SK-MEL-2 | Lonafarnib perturbation in SK-MEL-2 cell line |
| Omeprazole_NCI-H1573 | Omeprazole perturbation in NCI-H1573 cell line |
| Megestrol_RKO | Megestrol perturbation in RKO cell line |
| Minodronic acid_SW 900 | Minodronic acid perturbation in SW 900 cell line |
| Ixazomib_SK-MEL-2 | Ixazomib perturbation in SK-MEL-2 cell line |
| Saquinavir_SW 1088 | Saquinavir perturbation in SW 1088 cell line |
| Alpelisib_RKO | Alpelisib perturbation in RKO cell line |
| Niclosamide (olamine)_RPMI-7951 | Niclosamide (olamine) perturbation in RPMI-7951 cell line |
| Furosemide_NCI-H460 | Furosemide perturbation in NCI-H460 cell line |
| Lenalidomide (hemihydrate)_SK-MEL-2 | Lenalidomide (hemihydrate) perturbation in SK-MEL-2 cell line |
| Capivasertib_C32 | Capivasertib perturbation in C32 cell line |
| Pralsetinib_J82 | Pralsetinib perturbation in J82 cell line |
| Cepharanthine_LOX-IMVI | Cepharanthine perturbation in LOX-IMVI cell line |
| Binimetinib_CFPAC-1 | Binimetinib perturbation in CFPAC-1 cell line |
| Berberine (chloride hydrate)_NCI-H661 | Berberine (chloride hydrate) perturbation in NCI-H661 cell line |
| Rimonabant_NCI-H596 | Rimonabant perturbation in NCI-H596 cell line |
| Anastrozole_NCI-H2347 | Anastrozole perturbation in NCI-H2347 cell line |
| Minodronic acid_A498 | Minodronic acid perturbation in A498 cell line |
| Tomivosertib_hTERT-HPNE | Tomivosertib perturbation in hTERT-HPNE cell line |
| Lapatinib ditosylate_NCI-H2347 | Lapatinib ditosylate perturbation in NCI-H2347 cell line |
| Anethole trithione_NCI-H2030 | Anethole trithione perturbation in NCI-H2030 cell line |
| Fusidic acid_RKO | Fusidic acid perturbation in RKO cell line |
| Erdafitinib _RPMI-7951 | Erdafitinib perturbation in RPMI-7951 cell line |
| 4EGI-1_RPMI-7951 | 4EGI-1 perturbation in RPMI-7951 cell line |
| Ipatasertib_A-172 | Ipatasertib perturbation in A-172 cell line |
| Saquinavir_AsPC-1 | Saquinavir perturbation in AsPC-1 cell line |
| Bimatoprost_Panc 03.27 | Bimatoprost perturbation in Panc 03.27 cell line |
| Tazarotene_NCI-H596 | Tazarotene perturbation in NCI-H596 cell line |
| Homoharringtonine_SK-MEL-2 | Homoharringtonine perturbation in SK-MEL-2 cell line |
| Darinaparsin_A-172 | Darinaparsin perturbation in A-172 cell line |
| venetoclax_RPMI-7951 | venetoclax perturbation in RPMI-7951 cell line |
| Oleic acid_SW 1271 | Oleic acid perturbation in SW 1271 cell line |
| Dabrafenib_NCI-H460 | Dabrafenib perturbation in NCI-H460 cell line |
| Cepharanthine_RKO | Cepharanthine perturbation in RKO cell line |
| Anastrozole_RKO | Anastrozole perturbation in RKO cell line |
| Volasertib_NCI-H460 | Volasertib perturbation in NCI-H460 cell line |
| Chlorhexidine (diacetate)_SK-MEL-2 | Chlorhexidine (diacetate) perturbation in SK-MEL-2 cell line |
| EX229_SNU-423 | EX229 perturbation in SNU-423 cell line |
| LY2090314_AsPC-1 | LY2090314 perturbation in AsPC-1 cell line |
| Folic acid_SK-MEL-2 | Folic acid perturbation in SK-MEL-2 cell line |
| vincristine_AsPC-1 | vincristine perturbation in AsPC-1 cell line |
| Posaconazole_RKO | Posaconazole perturbation in RKO cell line |
| Ouabain (Octahydrate)_NCI-H460 | Ouabain (Octahydrate) perturbation in NCI-H460 cell line |
| Pralsetinib_NCI-H1792 | Pralsetinib perturbation in NCI-H1792 cell line |
| Fusidic acid_NCI-H2347 | Fusidic acid perturbation in NCI-H2347 cell line |
| venetoclax_hTERT-HPNE | venetoclax perturbation in hTERT-HPNE cell line |
| Furosemide_LOX-IMVI | Furosemide perturbation in LOX-IMVI cell line |
| 9-ING-41_A498 | 9-ING-41 perturbation in A498 cell line |
| Lapatinib ditosylate_RKO | Lapatinib ditosylate perturbation in RKO cell line |
| Rimonabant_SK-MEL-2 | Rimonabant perturbation in SK-MEL-2 cell line |
| Quinestrol_SW48 | Quinestrol perturbation in SW48 cell line |
| Alpelisib_NCI-H460 | Alpelisib perturbation in NCI-H460 cell line |
| Selinexor _HS-578T | Selinexor perturbation in HS-578T cell line |
| Belinostat_NCI-H2030 | Belinostat perturbation in NCI-H2030 cell line |
| Neratinib (maleate)_SK-MEL-2 | Neratinib (maleate) perturbation in SK-MEL-2 cell line |
| Fulvestrant_SW 900 | Fulvestrant perturbation in SW 900 cell line |
| Gemfibrozil_SW 900 | Gemfibrozil perturbation in SW 900 cell line |
| Roxadustat_NCI-H596 | Roxadustat perturbation in NCI-H596 cell line |
| Clotrimazole_SNU-423 | Clotrimazole perturbation in SNU-423 cell line |
| Anastrozole_LOX-IMVI | Anastrozole perturbation in LOX-IMVI cell line |
| EX229_HOP62 | EX229 perturbation in HOP62 cell line |
| Brivudine_SW 1088 | Brivudine perturbation in SW 1088 cell line |
| Gefitinib_RKO | Gefitinib perturbation in RKO cell line |
| TAK-901_H4 | TAK-901 perturbation in H4 cell line |
| Tofacitinib_J82 | Tofacitinib perturbation in J82 cell line |
| 5-Azacytidine_SW 900 | 5-Azacytidine perturbation in SW 900 cell line |
| Bortezomib_C-33 A | Bortezomib perturbation in C-33 A cell line |
| Quinestrol_C32 | Quinestrol perturbation in C32 cell line |
| Baicalin_J82 | Baicalin perturbation in J82 cell line |
| Mitoxantrone (dihydrochloride)_H4 | Mitoxantrone (dihydrochloride) perturbation in H4 cell line |
| OTS514_A549 | OTS514 perturbation in A549 cell line |
| LY-2584702 (tosylate salt)_RKO | LY-2584702 (tosylate salt) perturbation in RKO cell line |
| Vemurafenib_CFPAC-1 | Vemurafenib perturbation in CFPAC-1 cell line |
| Binimetinib_J82 | Binimetinib perturbation in J82 cell line |
| Torkinib_LOX-IMVI | Torkinib perturbation in LOX-IMVI cell line |
| Adenosine_SK-MEL-2 | Adenosine perturbation in SK-MEL-2 cell line |
| Bortezomib_SW 900 | Bortezomib perturbation in SW 900 cell line |
| Celecoxib_NCI-H460 | Celecoxib perturbation in NCI-H460 cell line |
| Tirabrutinib (hydrochloride)_SW 900 | Tirabrutinib (hydrochloride) perturbation in SW 900 cell line |
| Pentamidine (isethionate)_A549 | Pentamidine (isethionate) perturbation in A549 cell line |
| 5-Fluorouracil_HOP62 | 5-Fluorouracil perturbation in HOP62 cell line |
| Brivudine_NCI-H2030 | Brivudine perturbation in NCI-H2030 cell line |
| Lipoic acid_SW 1088 | Lipoic acid perturbation in SW 1088 cell line |
| Torkinib_RKO | Torkinib perturbation in RKO cell line |
| Temuterkib_CFPAC-1 | Temuterkib perturbation in CFPAC-1 cell line |
| LB-100_NCI-H460 | LB-100 perturbation in NCI-H460 cell line |
| Capmatinib_SW 1271 | Capmatinib perturbation in SW 1271 cell line |
| Abemaciclib_J82 | Abemaciclib perturbation in J82 cell line |
| Ixazomib_Hs 766T | Ixazomib perturbation in Hs 766T cell line |
| Gefitinib_LOX-IMVI | Gefitinib perturbation in LOX-IMVI cell line |
| TAK-733_NCI-H460 | TAK-733 perturbation in NCI-H460 cell line |
| Triclosan_NCI-H1573 | Triclosan perturbation in NCI-H1573 cell line |
| Demeclocycline_Panc 03.27 | Demeclocycline perturbation in Panc 03.27 cell line |
| Temsirolimus_C32 | Temsirolimus perturbation in C32 cell line |
| Amsacrine_HOP62 | Amsacrine perturbation in HOP62 cell line |
| Triamcinolone_Panc 03.27 | Triamcinolone perturbation in Panc 03.27 cell line |
| Cloxacillin (sodium)_NCI-H2347 | Cloxacillin (sodium) perturbation in NCI-H2347 cell line |
| RMC-6236_RKO | RMC-6236 perturbation in RKO cell line |
| Retinoic acid_NCI-H460 | Retinoic acid perturbation in NCI-H460 cell line |
| palbociclib_SW 1271 | palbociclib perturbation in SW 1271 cell line |
| Pralsetinib_HOP62 | Pralsetinib perturbation in HOP62 cell line |
| Vitamin K4_CFPAC-1 | Vitamin K4 perturbation in CFPAC-1 cell line |
| BI-78D3_AsPC-1 | BI-78D3 perturbation in AsPC-1 cell line |
| Cloxacillin (sodium)_LOX-IMVI | Cloxacillin (sodium) perturbation in LOX-IMVI cell line |
| S-Adenosyl-L-methionine (disulfate tosylate)_RPMI-7951 | S-Adenosyl-L-methionine (disulfate tosylate) perturbation in RPMI-7951 cell line |
| Ixazomib citrate_SK-MEL-2 | Ixazomib citrate perturbation in SK-MEL-2 cell line |
| Entecavir (monohydrate)_LOX-IMVI | Entecavir (monohydrate) perturbation in LOX-IMVI cell line |
| Quinestrol_NCI-H1573 | Quinestrol perturbation in NCI-H1573 cell line |
| Niclosamide (olamine)_A549 | Niclosamide (olamine) perturbation in A549 cell line |
| AZD-7648_RPMI-7951 | AZD-7648 perturbation in RPMI-7951 cell line |
| Cabozantinib (S-malate)_SW 900 | Cabozantinib (S-malate) perturbation in SW 900 cell line |
| Tubulin inhibitor 6_SK-MEL-2 | Tubulin inhibitor 6 perturbation in SK-MEL-2 cell line |
| Uridine_H4 | Uridine perturbation in H4 cell line |
| Methylthiouracil_NCI-H596 | Methylthiouracil perturbation in NCI-H596 cell line |
| EX229_NCI-H1792 | EX229 perturbation in NCI-H1792 cell line |
| Torkinib_NCI-H2347 | Torkinib perturbation in NCI-H2347 cell line |
| Lidocaine (hydrochloride)_AsPC-1 | Lidocaine (hydrochloride) perturbation in AsPC-1 cell line |
| Capivasertib_SW 900 | Capivasertib perturbation in SW 900 cell line |
| Artemether_Hs 766T | Artemether perturbation in Hs 766T cell line |
| Pralsetinib_SNU-423 | Pralsetinib perturbation in SNU-423 cell line |
| Palmatine (chloride)_A549 | Palmatine (chloride) perturbation in A549 cell line |
| Daptomycin_SK-MEL-2 | Daptomycin perturbation in SK-MEL-2 cell line |
| Allopurinol_SW 900 | Allopurinol perturbation in SW 900 cell line |
| Radotinib_CFPAC-1 | Radotinib perturbation in CFPAC-1 cell line |
| RMC-6236_LOX-IMVI | RMC-6236 perturbation in LOX-IMVI cell line |
| Olanzapine_Hs 766T | Olanzapine perturbation in Hs 766T cell line |
| AZD1390_NCI-H1573 | AZD1390 perturbation in NCI-H1573 cell line |
| Talc_J82 | Talc perturbation in J82 cell line |
| Verteporfin_SW 1088 | Verteporfin perturbation in SW 1088 cell line |
| Azithromycin (hydrate)_A-172 | Azithromycin (hydrate) perturbation in A-172 cell line |
| Celecoxib_RKO | Celecoxib perturbation in RKO cell line |
| Sulfisoxazole_hTERT-HPNE | Sulfisoxazole perturbation in hTERT-HPNE cell line |
| TAK-733_LOX-IMVI | TAK-733 perturbation in LOX-IMVI cell line |
| Vemurafenib_SNU-423 | Vemurafenib perturbation in SNU-423 cell line |
| Lumateperone (tosylate)_Hs 766T | Lumateperone (tosylate) perturbation in Hs 766T cell line |
| Idarubicin (hydrochloride)_NCI-H2347 | Idarubicin (hydrochloride) perturbation in NCI-H2347 cell line |
| LY-2584702 (tosylate salt)_NCI-H460 | LY-2584702 (tosylate salt) perturbation in NCI-H460 cell line |
| LB-100_LOX-IMVI | LB-100 perturbation in LOX-IMVI cell line |
| BI-78D3_SW 1088 | BI-78D3 perturbation in SW 1088 cell line |
| Furosemide_NCI-H23 | Furosemide perturbation in NCI-H23 cell line |
| LB-100_RKO | LB-100 perturbation in RKO cell line |
| Filgotinib_RKO | Filgotinib perturbation in RKO cell line |
| ETC-206_NCI-H1573 | ETC-206 perturbation in NCI-H1573 cell line |
| TAK-733_RKO | TAK-733 perturbation in RKO cell line |
| Rapamycin_CFPAC-1 | Rapamycin perturbation in CFPAC-1 cell line |
| Raltitrexed_A549 | Raltitrexed perturbation in A549 cell line |
| SBI-0640756_C32 | SBI-0640756 perturbation in C32 cell line |
| Belumosudil (mesylate)_NCI-H1573 | Belumosudil (mesylate) perturbation in NCI-H1573 cell line |
| Anethole trithione_SW 1271 | Anethole trithione perturbation in SW 1271 cell line |
| ULK-101_SK-MEL-2 | ULK-101 perturbation in SK-MEL-2 cell line |
| Bergenin_NCI-H1792 | Bergenin perturbation in NCI-H1792 cell line |
| Torkinib_NCI-H460 | Torkinib perturbation in NCI-H460 cell line |
| Gemfibrozil_NCI-H1573 | Gemfibrozil perturbation in NCI-H1573 cell line |
| Encorafenib_SK-MEL-2 | Encorafenib perturbation in SK-MEL-2 cell line |
| EX229_J82 | EX229 perturbation in J82 cell line |
| Methyl aminolevulinate (hydrochloride)_HOP62 | Methyl aminolevulinate (hydrochloride) perturbation in HOP62 cell line |
| AZD2858_A-172 | AZD2858 perturbation in A-172 cell line |
| Aliskiren_SNU-423 | Aliskiren perturbation in SNU-423 cell line |
| Macitentan_Panc 03.27 | Macitentan perturbation in Panc 03.27 cell line |
| Brivudine_AsPC-1 | Brivudine perturbation in AsPC-1 cell line |
| Radotinib_HOP62 | Radotinib perturbation in HOP62 cell line |
| ML264_NCI-H2030 | ML264 perturbation in NCI-H2030 cell line |
| TAK-733_NCI-H2347 | TAK-733 perturbation in NCI-H2347 cell line |
| Filgotinib_NCI-H2347 | Filgotinib perturbation in NCI-H2347 cell line |
| Entecavir (monohydrate)_NCI-H460 | Entecavir (monohydrate) perturbation in NCI-H460 cell line |
| Pralsetinib_CFPAC-1 | Pralsetinib perturbation in CFPAC-1 cell line |
| Belzutifan_RPMI-7951 | Belzutifan perturbation in RPMI-7951 cell line |
| Topotecan (hydrochloride)_NCI-H596 | Topotecan (hydrochloride) perturbation in NCI-H596 cell line |
| Idarubicin (hydrochloride)_LOX-IMVI | Idarubicin (hydrochloride) perturbation in LOX-IMVI cell line |
| AZD-8055_hTERT-HPNE | AZD-8055 perturbation in hTERT-HPNE cell line |
| Temsirolimus_NCI-H2122 | Temsirolimus perturbation in NCI-H2122 cell line |
| Bentamapimod_SK-MEL-2 | Bentamapimod perturbation in SK-MEL-2 cell line |
| Clotrimazole_J82 | Clotrimazole perturbation in J82 cell line |
| Temuterkib_NCI-H1573 | Temuterkib perturbation in NCI-H1573 cell line |
| Isocorydine_LOX-IMVI | Isocorydine perturbation in LOX-IMVI cell line |
| Radotinib_C32 | Radotinib perturbation in C32 cell line |
| Clotrimazole_SW 900 | Clotrimazole perturbation in SW 900 cell line |
| Erdafitinib _SW 1088 | Erdafitinib perturbation in SW 1088 cell line |
| Acetohexamide_NCI-H460 | Acetohexamide perturbation in NCI-H460 cell line |
| Bestatin (hydrochloride)_NCI-H596 | Bestatin (hydrochloride) perturbation in NCI-H596 cell line |
| Bergenin_SW48 | Bergenin perturbation in SW48 cell line |
| Raltitrexed_SW 1088 | Raltitrexed perturbation in SW 1088 cell line |
| Triclosan_CFPAC-1 | Triclosan perturbation in CFPAC-1 cell line |
| γ-Oryzanol_Hs 766T | γ-Oryzanol perturbation in Hs 766T cell line |
| Bergenin_A498 | Bergenin perturbation in A498 cell line |
| Bimatoprost_NCI-H2347 | Bimatoprost perturbation in NCI-H2347 cell line |
| Darolutamide_NCI-H1792 | Darolutamide perturbation in NCI-H1792 cell line |
| Vilanterol_hTERT-HPNE | Vilanterol perturbation in hTERT-HPNE cell line |
| Amsacrine_NCI-H2122 | Amsacrine perturbation in NCI-H2122 cell line |
| ERK5-IN-2_NCI-H2347 | ERK5-IN-2 perturbation in NCI-H2347 cell line |
| Belumosudil (mesylate)_HOP62 | Belumosudil (mesylate) perturbation in HOP62 cell line |
| venetoclax_SW 1088 | venetoclax perturbation in SW 1088 cell line |
| PF-06260933_AsPC-1 | PF-06260933 perturbation in AsPC-1 cell line |
| Allopurinol_NCI-H1792 | Allopurinol perturbation in NCI-H1792 cell line |
| 4EGI-1_NCI-H2030 | 4EGI-1 perturbation in NCI-H2030 cell line |
| Raltitrexed_NCI-H2030 | Raltitrexed perturbation in NCI-H2030 cell line |
| XRK3F2_NCI-H460 | XRK3F2 perturbation in NCI-H460 cell line |
| EX229_SW 900 | EX229 perturbation in SW 900 cell line |
| Almonertinib (mesylate)_J82 | Almonertinib (mesylate) perturbation in J82 cell line |
| Tucatinib_NCI-H460 | Tucatinib perturbation in NCI-H460 cell line |
| Niclosamide (olamine)_AsPC-1 | Niclosamide (olamine) perturbation in AsPC-1 cell line |
| Isocorydine_RKO | Isocorydine perturbation in RKO cell line |
| Tirabrutinib (hydrochloride)_NCI-H1792 | Tirabrutinib (hydrochloride) perturbation in NCI-H1792 cell line |
| Anethole trithione_hTERT-HPNE | Anethole trithione perturbation in hTERT-HPNE cell line |
| Fedratinib (hydrochloride hydrate)_A549 | Fedratinib (hydrochloride hydrate) perturbation in A549 cell line |
| ML264_A549 | ML264 perturbation in A549 cell line |
| 9-ING-41_CHP-212 | 9-ING-41 perturbation in CHP-212 cell line |
| DT-061_NCI-H460 | DT-061 perturbation in NCI-H460 cell line |
| L-Eflornithine (monohydrochloride)_NCI-H1792 | L-Eflornithine (monohydrochloride) perturbation in NCI-H1792 cell line |
| Hydroxyfasudil_A-172 | Hydroxyfasudil perturbation in A-172 cell line |
| ERK5-IN-2_LOX-IMVI | ERK5-IN-2 perturbation in LOX-IMVI cell line |
| Peretinoin_LOX-IMVI | Peretinoin perturbation in LOX-IMVI cell line |
| Tomivosertib_NCI-H2030 | Tomivosertib perturbation in NCI-H2030 cell line |
| Everolimus_RPMI-7951 | Everolimus perturbation in RPMI-7951 cell line |
| Encorafenib_A-172 | Encorafenib perturbation in A-172 cell line |
| Pimozide_SW1417 | Pimozide perturbation in SW1417 cell line |
| AT7519_CFPAC-1 | AT7519 perturbation in CFPAC-1 cell line |
| Omeprazole_NCI-H1792 | Omeprazole perturbation in NCI-H1792 cell line |
| PH-797804_NCI-H596 | PH-797804 perturbation in NCI-H596 cell line |
| OTS514_AsPC-1 | OTS514 perturbation in AsPC-1 cell line |
| Bimatoprost_LOX-IMVI | Bimatoprost perturbation in LOX-IMVI cell line |
| Phenytoin (sodium)_RKO | Phenytoin (sodium) perturbation in RKO cell line |
| ERK5-IN-2_RKO | ERK5-IN-2 perturbation in RKO cell line |
| Bentamapimod_A-172 | Bentamapimod perturbation in A-172 cell line |
| Talc_SW 900 | Talc perturbation in SW 900 cell line |
| Vinblastine (sulfate)_H4 | Vinblastine (sulfate) perturbation in H4 cell line |
| Paclitaxel_SW 1088 | Paclitaxel perturbation in SW 1088 cell line |
| Isocorydine_NCI-H2347 | Isocorydine perturbation in NCI-H2347 cell line |
| Ivermectin_NCI-H1792 | Ivermectin perturbation in NCI-H1792 cell line |
| Quinestrol_CFPAC-1 | Quinestrol perturbation in CFPAC-1 cell line |
| MK-8353_NCI-H460 | MK-8353 perturbation in NCI-H460 cell line |
| Tomivosertib_SW 1088 | Tomivosertib perturbation in SW 1088 cell line |
| SBI-0640756_HOP62 | SBI-0640756 perturbation in HOP62 cell line |
| Harringtonine_SK-MEL-2 | Harringtonine perturbation in SK-MEL-2 cell line |
| Vinblastine (sulfate)_NCI-H661 | Vinblastine (sulfate) perturbation in NCI-H661 cell line |
| Encorafenib_HS-578T | Encorafenib perturbation in HS-578T cell line |
| Flutamide_Panc 03.27 | Flutamide perturbation in Panc 03.27 cell line |
| Belumosudil (mesylate)_CHP-212 | Belumosudil (mesylate) perturbation in CHP-212 cell line |
| Tucatinib_LOX-IMVI | Tucatinib perturbation in LOX-IMVI cell line |
| OTS514_NCI-H2030 | OTS514 perturbation in NCI-H2030 cell line |
| Sodium Salicylate_LOX-IMVI | Sodium Salicylate perturbation in LOX-IMVI cell line |
| Gemfibrozil_CFPAC-1 | Gemfibrozil perturbation in CFPAC-1 cell line |
| Cysteamine (hydrochloride)_AsPC-1 | Cysteamine (hydrochloride) perturbation in AsPC-1 cell line |
| NG25_RPMI-7951 | NG25 perturbation in RPMI-7951 cell line |
| DT-061_NCI-H2347 | DT-061 perturbation in NCI-H2347 cell line |
| Acetohexamide_RKO | Acetohexamide perturbation in RKO cell line |
| Fulvestrant_CHP-212 | Fulvestrant perturbation in CHP-212 cell line |
| MK-3903_hTERT-HPNE | MK-3903 perturbation in hTERT-HPNE cell line |
| Ouabain (Octahydrate)_Panc 03.27 | Ouabain (Octahydrate) perturbation in Panc 03.27 cell line |
| XRK3F2_RKO | XRK3F2 perturbation in RKO cell line |
| Acetohexamide_LOX-IMVI | Acetohexamide perturbation in LOX-IMVI cell line |
| Tucatinib_RKO | Tucatinib perturbation in RKO cell line |
| Sodium Salicylate_RKO | Sodium Salicylate perturbation in RKO cell line |
| Busulfan_H4 | Busulfan perturbation in H4 cell line |
| Isocorydine_NCI-H460 | Isocorydine perturbation in NCI-H460 cell line |
| Perindopril (erbumine)_SW 900 | Perindopril (erbumine) perturbation in SW 900 cell line |
| Brivudine_A549 | Brivudine perturbation in A549 cell line |
| Pralsetinib_NCI-H1573 | Pralsetinib perturbation in NCI-H1573 cell line |
| Abemaciclib_SW 900 | Abemaciclib perturbation in SW 900 cell line |
| MK-3903_RPMI-7951 | MK-3903 perturbation in RPMI-7951 cell line |
| EX229_A498 | EX229 perturbation in A498 cell line |
| AZD-7648_SW 1271 | AZD-7648 perturbation in SW 1271 cell line |
| Dabrafenib_Panc 03.27 | Dabrafenib perturbation in Panc 03.27 cell line |
| BAY1125976_SW 1088 | BAY1125976 perturbation in SW 1088 cell line |
| MK-8353_LOX-IMVI | MK-8353 perturbation in LOX-IMVI cell line |
| DT-061_RKO | DT-061 perturbation in RKO cell line |
| 9-ING-41_SNU-423 | 9-ING-41 perturbation in SNU-423 cell line |
| Valdecoxib_NCI-H596 | Valdecoxib perturbation in NCI-H596 cell line |
| Meloxicam_RPMI-7951 | Meloxicam perturbation in RPMI-7951 cell line |
| Medroxyprogesterone acetate_NCI-H460 | Medroxyprogesterone acetate perturbation in NCI-H460 cell line |
| Quinestrol_HOP62 | Quinestrol perturbation in HOP62 cell line |
| 4EGI-1_AsPC-1 | 4EGI-1 perturbation in AsPC-1 cell line |
| SBI-0640756_CFPAC-1 | SBI-0640756 perturbation in CFPAC-1 cell line |
| Balsalazide (sodium hydrate)_SW1417 | Balsalazide (sodium hydrate) perturbation in SW1417 cell line |
| Tucatinib_NCI-H2347 | Tucatinib perturbation in NCI-H2347 cell line |
| Trifluridine_NCI-H2030 | Trifluridine perturbation in NCI-H2030 cell line |
| Saquinavir_RPMI-7951 | Saquinavir perturbation in RPMI-7951 cell line |
| CP21R7_NCI-H2122 | CP21R7 perturbation in NCI-H2122 cell line |
| MK-8353_RKO | MK-8353 perturbation in RKO cell line |
| DT-061_LOX-IMVI | DT-061 perturbation in LOX-IMVI cell line |
| Palmatine (chloride)_NCI-H2030 | Palmatine (chloride) perturbation in NCI-H2030 cell line |
| IQ 1_RKO | IQ 1 perturbation in RKO cell line |
| PF-06260933_SW 1088 | PF-06260933 perturbation in SW 1088 cell line |
| Baicalin_SW 900 | Baicalin perturbation in SW 900 cell line |
| ERK5-IN-2_NCI-H460 | ERK5-IN-2 perturbation in NCI-H460 cell line |
| Clonidine (hydrochloride)_NCI-H1573 | Clonidine (hydrochloride) perturbation in NCI-H1573 cell line |
| GSK1059615_SK-MEL-2 | GSK1059615 perturbation in SK-MEL-2 cell line |
| Gemfibrozil_J82 | Gemfibrozil perturbation in J82 cell line |
| Artesunate_A549 | Artesunate perturbation in A549 cell line |
| Uridine_SK-MEL-2 | Uridine perturbation in SK-MEL-2 cell line |
| Amsacrine_A498 | Amsacrine perturbation in A498 cell line |
| Docetaxel_LOX-IMVI | Docetaxel perturbation in LOX-IMVI cell line |
| Clobetasol propionate_CFPAC-1 | Clobetasol propionate perturbation in CFPAC-1 cell line |
| Sildenafil_NCI-H596 | Sildenafil perturbation in NCI-H596 cell line |
| ML264_hTERT-HPNE | ML264 perturbation in hTERT-HPNE cell line |
| Allopurinol_CFPAC-1 | Allopurinol perturbation in CFPAC-1 cell line |
| Berbamine (dihydrochloride)_H4 | Berbamine (dihydrochloride) perturbation in H4 cell line |
| Ropivacaine (hydrochloride monohydrate)_NCI-H1573 | Ropivacaine (hydrochloride monohydrate) perturbation in NCI-H1573 cell line |
| Raltitrexed_SW 1271 | Raltitrexed perturbation in SW 1271 cell line |
| c-Kit-IN-1_A549 | c-Kit-IN-1 perturbation in A549 cell line |
| Allopurinol_CHP-212 | Allopurinol perturbation in CHP-212 cell line |
| Estrone sulfate (potassium)_H4 | Estrone sulfate (potassium) perturbation in H4 cell line |
| AZD-7648_AsPC-1 | AZD-7648 perturbation in AsPC-1 cell line |
| Clotrimazole_C32 | Clotrimazole perturbation in C32 cell line |
| venetoclax_SW 1271 | venetoclax perturbation in SW 1271 cell line |
| Darolutamide_CFPAC-1 | Darolutamide perturbation in CFPAC-1 cell line |
| Retinoic acid_Panc 03.27 | Retinoic acid perturbation in Panc 03.27 cell line |
| Fluvoxamine (maleate)_H4 | Fluvoxamine (maleate) perturbation in H4 cell line |
| Nafamostat (mesylate)_NCI-H1792 | Nafamostat (mesylate) perturbation in NCI-H1792 cell line |
| Homoharringtonine_A-172 | Homoharringtonine perturbation in A-172 cell line |
| APTO-253_NCI-H460 | APTO-253 perturbation in NCI-H460 cell line |
| Erlotinib_H4 | Erlotinib perturbation in H4 cell line |
| Harringtonine_Hs 766T | Harringtonine perturbation in Hs 766T cell line |
| Bicalutamide_SNU-423 | Bicalutamide perturbation in SNU-423 cell line |
| Tirabrutinib_RKO | Tirabrutinib perturbation in RKO cell line |
| Quinestrol_NCI-H1792 | Quinestrol perturbation in NCI-H1792 cell line |
| Pemigatinib_LOX-IMVI | Pemigatinib perturbation in LOX-IMVI cell line |
| Clonidine (hydrochloride)_A498 | Clonidine (hydrochloride) perturbation in A498 cell line |
| Ivermectin_CFPAC-1 | Ivermectin perturbation in CFPAC-1 cell line |
| Ropivacaine (hydrochloride monohydrate)_C32 | Ropivacaine (hydrochloride monohydrate) perturbation in C32 cell line |
| Darinaparsin_NCI-H596 | Darinaparsin perturbation in NCI-H596 cell line |
| Elagolix sodium_RPMI-7951 | Elagolix sodium perturbation in RPMI-7951 cell line |
| Triamcinolone_NCI-H460 | Triamcinolone perturbation in NCI-H460 cell line |
| Vilanterol_A549 | Vilanterol perturbation in A549 cell line |
| Methylthiouracil_H4 | Methylthiouracil perturbation in H4 cell line |
| TAK-901_SK-MEL-2 | TAK-901 perturbation in SK-MEL-2 cell line |
| Vemurafenib_SW 900 | Vemurafenib perturbation in SW 900 cell line |
| ML264_RPMI-7951 | ML264 perturbation in RPMI-7951 cell line |
| Pralsetinib_A498 | Pralsetinib perturbation in A498 cell line |
| Isocorydine_NCI-H23 | Isocorydine perturbation in NCI-H23 cell line |
| Pralsetinib_SW48 | Pralsetinib perturbation in SW48 cell line |
| Docetaxel_NCI-H2347 | Docetaxel perturbation in NCI-H2347 cell line |
| EX229_NCI-H1573 | EX229 perturbation in NCI-H1573 cell line |
| Olanzapine_HS-578T | Olanzapine perturbation in HS-578T cell line |
| Rimonabant_A-172 | Rimonabant perturbation in A-172 cell line |
| Tomivosertib_SW 1271 | Tomivosertib perturbation in SW 1271 cell line |
| Pemigatinib_RKO | Pemigatinib perturbation in RKO cell line |
| Darolutamide_HOP62 | Darolutamide perturbation in HOP62 cell line |
| Norepinephrine (hydrochloride)_LOX-IMVI | Norepinephrine (hydrochloride) perturbation in LOX-IMVI cell line |
| Triclosan_J82 | Triclosan perturbation in J82 cell line |
| Demeclocycline_NCI-H2347 | Demeclocycline perturbation in NCI-H2347 cell line |
| Pyridoxine (hydrochloride)_SW 1271 | Pyridoxine (hydrochloride) perturbation in SW 1271 cell line |
| Pralsetinib_SW 900 | Pralsetinib perturbation in SW 900 cell line |
| Capmatinib_A549 | Capmatinib perturbation in A549 cell line |
| Bentamapimod_H4 | Bentamapimod perturbation in H4 cell line |
| Brivudine_RPMI-7951 | Brivudine perturbation in RPMI-7951 cell line |
| Vemurafenib_A498 | Vemurafenib perturbation in A498 cell line |
| Dimethyl fumarate_LOX-IMVI | Dimethyl fumarate perturbation in LOX-IMVI cell line |
| DT-061_NCI-H23 | DT-061 perturbation in NCI-H23 cell line |
| Encorafenib_H4 | Encorafenib perturbation in H4 cell line |
| APTO-253_RKO | APTO-253 perturbation in RKO cell line |
| Dimethyl fumarate_RKO | Dimethyl fumarate perturbation in RKO cell line |
| Perindopril (erbumine)_C32 | Perindopril (erbumine) perturbation in C32 cell line |
| Olanzapine_A-172 | Olanzapine perturbation in A-172 cell line |
| Allantoin_NCI-H596 | Allantoin perturbation in NCI-H596 cell line |
| Belzutifan_AsPC-1 | Belzutifan perturbation in AsPC-1 cell line |
| Sulfisoxazole_AsPC-1 | Sulfisoxazole perturbation in AsPC-1 cell line |
| Clonidine (hydrochloride)_SW 900 | Clonidine (hydrochloride) perturbation in SW 900 cell line |
| Tofacitinib_NCI-H1573 | Tofacitinib perturbation in NCI-H1573 cell line |
| OTS514_SW 1271 | OTS514 perturbation in SW 1271 cell line |
| Tofacitinib_AN3 CA | Tofacitinib perturbation in AN3 CA cell line |
| Cytarabine (hydrochloride)_CHP-212 | Cytarabine (hydrochloride) perturbation in CHP-212 cell line |
| Lipoic acid_RPMI-7951 | Lipoic acid perturbation in RPMI-7951 cell line |
| Vandetanib_SW 900 | Vandetanib perturbation in SW 900 cell line |
| Pexidartinib (hydrochloride)_NCI-H2122 | Pexidartinib (hydrochloride) perturbation in NCI-H2122 cell line |
| Triamcinolone_RKO | Triamcinolone perturbation in RKO cell line |
| BI-3406_RKO | BI-3406 perturbation in RKO cell line |
| Demeclocycline_RKO | Demeclocycline perturbation in RKO cell line |
| Irinotecan_hTERT-HPNE | Irinotecan perturbation in hTERT-HPNE cell line |
| Sonidegib_AsPC-1 | Sonidegib perturbation in AsPC-1 cell line |
| Dihydroartemisinin_RKO | Dihydroartemisinin perturbation in RKO cell line |
| Rapamycin_SW 900 | Rapamycin perturbation in SW 900 cell line |
| Saquinavir_A549 | Saquinavir perturbation in A549 cell line |
| 5-Azacytidine_HOP62 | 5-Azacytidine perturbation in HOP62 cell line |
| ULK-101_H4 | ULK-101 perturbation in H4 cell line |
| Tirabrutinib (hydrochloride)_HOP62 | Tirabrutinib (hydrochloride) perturbation in HOP62 cell line |
| Hesperidin_SW 1088 | Hesperidin perturbation in SW 1088 cell line |
| ULK-101_NCI-H661 | ULK-101 perturbation in NCI-H661 cell line |
| EX229_NCI-H2122 | EX229 perturbation in NCI-H2122 cell line |
| Cyclosporin A_NCI-H460 | Cyclosporin A perturbation in NCI-H460 cell line |
| Voriconazole_A549 | Voriconazole perturbation in A549 cell line |
| MK-3903_A549 | MK-3903 perturbation in A549 cell line |
| Ivermectin_HOP62 | Ivermectin perturbation in HOP62 cell line |
| Quinestrol_J82 | Quinestrol perturbation in J82 cell line |
| Pemigatinib_NCI-H460 | Pemigatinib perturbation in NCI-H460 cell line |
| Norepinephrine (hydrochloride)_NCI-H2347 | Norepinephrine (hydrochloride) perturbation in NCI-H2347 cell line |
| Pentagastrin_NCI-H460 | Pentagastrin perturbation in NCI-H460 cell line |
| Brivudine_hTERT-HPNE | Brivudine perturbation in hTERT-HPNE cell line |
| Amsacrine_SW 900 | Amsacrine perturbation in SW 900 cell line |
| Demeclocycline_LOX-IMVI | Demeclocycline perturbation in LOX-IMVI cell line |
| Goserelin (acetate)_A-172 | Goserelin (acetate) perturbation in A-172 cell line |
| Gefitinib_Panc 03.27 | Gefitinib perturbation in Panc 03.27 cell line |
| Sinomenine_SHP-77 | Sinomenine perturbation in SHP-77 cell line |
| Sulfisoxazole_SW 900 | Sulfisoxazole perturbation in SW 900 cell line |
| Tomivosertib_NCI-H2122 | Tomivosertib perturbation in NCI-H2122 cell line |
| XRK3F2_PANC-1 | XRK3F2 perturbation in PANC-1 cell line |
| Aliskiren_AsPC-1 | Aliskiren perturbation in AsPC-1 cell line |
| venetoclax_NCI-H2122 | venetoclax perturbation in NCI-H2122 cell line |
| Sinomenine_NCI-H2122 | Sinomenine perturbation in NCI-H2122 cell line |
| 8-Hydroxyquinoline_NCI-H1573 | 8-Hydroxyquinoline perturbation in NCI-H1573 cell line |
| Diphenhydramine_NCI-H2122 | Diphenhydramine perturbation in NCI-H2122 cell line |
| Ferulic acid_NCI-H2122 | Ferulic acid perturbation in NCI-H2122 cell line |
| Aprepitant_NCI-H1573 | Aprepitant perturbation in NCI-H1573 cell line |
| Tetracycline (hydrochloride)_NCI-H2122 | Tetracycline (hydrochloride) perturbation in NCI-H2122 cell line |
| MK-3903_NCI-H2122 | MK-3903 perturbation in NCI-H2122 cell line |
| Belinostat_NCI-H1573 | Belinostat perturbation in NCI-H1573 cell line |
| Omeprazole_COLO 205 | Omeprazole perturbation in COLO 205 cell line |
| IQ 1_NCI-H596 | IQ 1 perturbation in NCI-H596 cell line |
| Binimetinib_LS 180 | Binimetinib perturbation in LS 180 cell line |
| Brivudine_NCI-H1573 | Brivudine perturbation in NCI-H1573 cell line |
| BI-78D3_NCI-H2122 | BI-78D3 perturbation in NCI-H2122 cell line |
| 9-ING-41_AsPC-1 | 9-ING-41 perturbation in AsPC-1 cell line |
| Norepinephrine (hydrochloride)_COLO 205 | Norepinephrine (hydrochloride) perturbation in COLO 205 cell line |
| Goserelin (acetate)_SHP-77 | Goserelin (acetate) perturbation in SHP-77 cell line |
| Erythromycin_NCI-H1573 | Erythromycin perturbation in NCI-H1573 cell line |
| Sildenafil_KATO III | Sildenafil perturbation in KATO III cell line |
| XRK3F2_AsPC-1 | XRK3F2 perturbation in AsPC-1 cell line |
| Chlorhexidine (diacetate)_NCI-H2122 | Chlorhexidine (diacetate) perturbation in NCI-H2122 cell line |
| Ixazomib_NCI-H1573 | Ixazomib perturbation in NCI-H1573 cell line |
| Isocorydine_AsPC-1 | Isocorydine perturbation in AsPC-1 cell line |
| Monocrotaline_NCI-H1573 | Monocrotaline perturbation in NCI-H1573 cell line |
| Salicylic acid_SW 900 | Salicylic acid perturbation in SW 900 cell line |
| Sildenafil_NCI-H1573 | Sildenafil perturbation in NCI-H1573 cell line |
| Cytarabine_COLO 205 | Cytarabine perturbation in COLO 205 cell line |
| Homoharringtonine_KATO III | Homoharringtonine perturbation in KATO III cell line |
| Everolimus_NCI-H460 | Everolimus perturbation in NCI-H460 cell line |
| Bestatin (hydrochloride)_NCI-H1573 | Bestatin (hydrochloride) perturbation in NCI-H1573 cell line |
| Demeclocycline_LS 180 | Demeclocycline perturbation in LS 180 cell line |
| Carbamazepine_NCI-H1573 | Carbamazepine perturbation in NCI-H1573 cell line |
| Bimiralisib_NCI-H460 | Bimiralisib perturbation in NCI-H460 cell line |
| Docetaxel_KATO III | Docetaxel perturbation in KATO III cell line |
| Rifaximin_NCI-H1573 | Rifaximin perturbation in NCI-H1573 cell line |
| Elimusertib hydrochloride_A498 | Elimusertib hydrochloride perturbation in A498 cell line |
| Levobupivacaine (hydrochloride)_NCI-H1573 | Levobupivacaine (hydrochloride) perturbation in NCI-H1573 cell line |
| Torkinib_SHP-77 | Torkinib perturbation in SHP-77 cell line |
| RMC-6236_A498 | RMC-6236 perturbation in A498 cell line |
| Imiquimod (maleate)_SW 1088 | Imiquimod (maleate) perturbation in SW 1088 cell line |
| 18β-Glycyrrhetinic acid_NCI-H2122 | 18β-Glycyrrhetinic acid perturbation in NCI-H2122 cell line |
| Pioglitazone_NCI-H1573 | Pioglitazone perturbation in NCI-H1573 cell line |
| Fulvestrant_SNU-1 | Fulvestrant perturbation in SNU-1 cell line |
| Ranolazine_NCI-H1573 | Ranolazine perturbation in NCI-H1573 cell line |
| Folic acid_AsPC-1 | Folic acid perturbation in AsPC-1 cell line |
| Pyridoxine_NCI-H2122 | Pyridoxine perturbation in NCI-H2122 cell line |
| Captopril_NCI-H1573 | Captopril perturbation in NCI-H1573 cell line |
| Cinacalcet_NCI-H2122 | Cinacalcet perturbation in NCI-H2122 cell line |
| Allopurinol_NCI-H1573 | Allopurinol perturbation in NCI-H1573 cell line |
| 5-Azacytidine_NCI-H1573 | 5-Azacytidine perturbation in NCI-H1573 cell line |
| Relugolix_NCI-H1573 | Relugolix perturbation in NCI-H1573 cell line |
| Triclosan_SW 900 | Triclosan perturbation in SW 900 cell line |
| Capivasertib_NCI-H2122 | Capivasertib perturbation in NCI-H2122 cell line |
| Phenylephrine (hydrochloride)_NCI-H1573 | Phenylephrine (hydrochloride) perturbation in NCI-H1573 cell line |
| Elimusertib hydrochloride_NCI-H460 | Elimusertib hydrochloride perturbation in NCI-H460 cell line |
| Thymol_NCI-H460 | Thymol perturbation in NCI-H460 cell line |
| Darolutamide_SHP-77 | Darolutamide perturbation in SHP-77 cell line |
| AT7519_NCI-H2122 | AT7519 perturbation in NCI-H2122 cell line |
| Quinidine (15% dihydroquinidine)_NCI-H1573 | Quinidine (15% dihydroquinidine) perturbation in NCI-H1573 cell line |
| Trametinib_AsPC-1 | Trametinib perturbation in AsPC-1 cell line |
| 5-Fluorouracil_NCI-H1573 | 5-Fluorouracil perturbation in NCI-H1573 cell line |
| Tofacitinib_SW 900 | Tofacitinib perturbation in SW 900 cell line |
| Diammonium Glycyrrhizinate_NCI-H2122 | Diammonium Glycyrrhizinate perturbation in NCI-H2122 cell line |
| Thymopentin_NCI-H1573 | Thymopentin perturbation in NCI-H1573 cell line |
| Panobinostat_Hs 766T | Panobinostat perturbation in Hs 766T cell line |
| Dexamethasone_AsPC-1 | Dexamethasone perturbation in AsPC-1 cell line |
| Citalopram (hydrobromide)_LoVo | Citalopram (hydrobromide) perturbation in LoVo cell line |
| Futibatinib_LS 180 | Futibatinib perturbation in LS 180 cell line |
| Budesonide_Hs 766T | Budesonide perturbation in Hs 766T cell line |
| Betamethasone dipropionate_Hs 766T | Betamethasone dipropionate perturbation in Hs 766T cell line |
| Budesonide_AsPC-1 | Budesonide perturbation in AsPC-1 cell line |
| Betamethasone dipropionate_AsPC-1 | Betamethasone dipropionate perturbation in AsPC-1 cell line |
| Clobetasol propionate_LoVo | Clobetasol propionate perturbation in LoVo cell line |
| Dexamethasone_RPMI-7951 | Dexamethasone perturbation in RPMI-7951 cell line |
| Zileuton_HS-578T | Zileuton perturbation in HS-578T cell line |
| Dexamethasone_hTERT-HPNE | Dexamethasone perturbation in hTERT-HPNE cell line |
| Betamethasone dipropionate_SNU-423 | Betamethasone dipropionate perturbation in SNU-423 cell line |
| Clobetasol propionate_hTERT-HPNE | Clobetasol propionate perturbation in hTERT-HPNE cell line |
| Budesonide_HOP62 | Budesonide perturbation in HOP62 cell line |
| Budesonide_SNU-423 | Budesonide perturbation in SNU-423 cell line |
| Betamethasone dipropionate_HOP62 | Betamethasone dipropionate perturbation in HOP62 cell line |
| Budesonide_NCI-H1792 | Budesonide perturbation in NCI-H1792 cell line |
| Diammonium Glycyrrhizinate_SW 1088 | Diammonium Glycyrrhizinate perturbation in SW 1088 cell line |
| Triamcinolone_H4 | Triamcinolone perturbation in H4 cell line |
| Betamethasone dipropionate_J82 | Betamethasone dipropionate perturbation in J82 cell line |
| Perindopril (erbumine)_SW 1088 | Perindopril (erbumine) perturbation in SW 1088 cell line |
| Relugolix_SW 1088 | Relugolix perturbation in SW 1088 cell line |
| Verapamil_SW 1088 | Verapamil perturbation in SW 1088 cell line |
| Dexamethasone_SW 1088 | Dexamethasone perturbation in SW 1088 cell line |
| Filgotinib_HS-578T | Filgotinib perturbation in HS-578T cell line |
| Balsalazide (sodium hydrate)_HOP62 | Balsalazide (sodium hydrate) perturbation in HOP62 cell line |
| Lipoic acid_A498 | Lipoic acid perturbation in A498 cell line |
| Trametinib (DMSO_HS-578T | Trametinib (DMSO perturbation in HS-578T cell line |
| Betamethasone dipropionate_C32 | Betamethasone dipropionate perturbation in C32 cell line |
| AZD1390_SW 1088 | AZD1390 perturbation in SW 1088 cell line |
| Nevirapine_HOP62 | Nevirapine perturbation in HOP62 cell line |
| Triamcinolone_SK-MEL-2 | Triamcinolone perturbation in SK-MEL-2 cell line |
| Citalopram (hydrobromide)_J82 | Citalopram (hydrobromide) perturbation in J82 cell line |
| CP21R7_HS-578T | CP21R7 perturbation in HS-578T cell line |
| Rifaximin_SW480 | Rifaximin perturbation in SW480 cell line |
| Bexarotene_SHP-77 | Bexarotene perturbation in SHP-77 cell line |
| APTO-253_SW 1088 | APTO-253 perturbation in SW 1088 cell line |
| Econazole_PANC-1 | Econazole perturbation in PANC-1 cell line |
| Norepinephrine (hydrochloride)_SW 1088 | Norepinephrine (hydrochloride) perturbation in SW 1088 cell line |
| Clobetasol propionate_SK-MEL-2 | Clobetasol propionate perturbation in SK-MEL-2 cell line |
| Cobimetinib_HOP62 | Cobimetinib perturbation in HOP62 cell line |
| Tofacitinib (citrate)_SHP-77 | Tofacitinib (citrate) perturbation in SHP-77 cell line |
| Econazole_HS-578T | Econazole perturbation in HS-578T cell line |
| Bergenin_HS-578T | Bergenin perturbation in HS-578T cell line |
| Dexamethasone_SK-MEL-2 | Dexamethasone perturbation in SK-MEL-2 cell line |
| Cloxacillin (sodium)_SW 1088 | Cloxacillin (sodium) perturbation in SW 1088 cell line |
| Entecavir (monohydrate)_SW 1088 | Entecavir (monohydrate) perturbation in SW 1088 cell line |
| RMC-6236_SW 1088 | RMC-6236 perturbation in SW 1088 cell line |
| Dexamethasone_A-172 | Dexamethasone perturbation in A-172 cell line |
| Elimusertib hydrochloride_SW 1088 | Elimusertib hydrochloride perturbation in SW 1088 cell line |
| Econazole_SK-MEL-2 | Econazole perturbation in SK-MEL-2 cell line |
| Dexamethasone_HS-578T | Dexamethasone perturbation in HS-578T cell line |
| Tirabrutinib_RPMI-7951 | Tirabrutinib perturbation in RPMI-7951 cell line |
| Alpelisib_SW 1088 | Alpelisib perturbation in SW 1088 cell line |
| Clobetasol propionate_H4 | Clobetasol propionate perturbation in H4 cell line |
| Dexamethasone_H4 | Dexamethasone perturbation in H4 cell line |
| Bimatoprost_RPMI-7951 | Bimatoprost perturbation in RPMI-7951 cell line |
| Fostamatinib (disodium hexahydrate)_HOP62 | Fostamatinib (disodium hexahydrate) perturbation in HOP62 cell line |
| Simotinib_SW 1088 | Simotinib perturbation in SW 1088 cell line |
| Baicalin_Hs 766T | Baicalin perturbation in Hs 766T cell line |
| Fusidic acid_SW 1088 | Fusidic acid perturbation in SW 1088 cell line |
| Methotrexate_SW 1088 | Methotrexate perturbation in SW 1088 cell line |
| Betamethasone dipropionate_H4 | Betamethasone dipropionate perturbation in H4 cell line |
| Triamcinolone_J82 | Triamcinolone perturbation in J82 cell line |
| Budesonide_H4 | Budesonide perturbation in H4 cell line |
| (S)-Crizotinib_HOP62 | (S)-Crizotinib perturbation in HOP62 cell line |
| Dapagliflozin ((2S)-1,2-propanediol, hydrate)_SW 1088 | Dapagliflozin ((2S)-1,2-propanediol, hydrate) perturbation in SW 1088 cell line |
| Salicylic acid_SW 1088 | Salicylic acid perturbation in SW 1088 cell line |
| Budesonide_HS-578T | Budesonide perturbation in HS-578T cell line |
| Betamethasone dipropionate_HS-578T | Betamethasone dipropionate perturbation in HS-578T cell line |
| Budesonide_A-172 | Budesonide perturbation in A-172 cell line |
| Pemetrexed_HS-578T | Pemetrexed perturbation in HS-578T cell line |
| Betamethasone dipropionate_A-172 | Betamethasone dipropionate perturbation in A-172 cell line |
| Methylprednisolone succinate_SW 1088 | Methylprednisolone succinate perturbation in SW 1088 cell line |
| Budesonide_SK-MEL-2 | Budesonide perturbation in SK-MEL-2 cell line |
| Medroxyprogesterone acetate_SHP-77 | Medroxyprogesterone acetate perturbation in SHP-77 cell line |
| Entrectinib_HS-578T | Entrectinib perturbation in HS-578T cell line |
| Benztropine (mesylate)_H4 | Benztropine (mesylate) perturbation in H4 cell line |
| Glycyrrhizic acid_SW 1088 | Glycyrrhizic acid perturbation in SW 1088 cell line |
| Oxaprozin_SW 1088 | Oxaprozin perturbation in SW 1088 cell line |
| Tucidinostat_HOP62 | Tucidinostat perturbation in HOP62 cell line |
| PF-06260933_HS-578T | PF-06260933 perturbation in HS-578T cell line |
| Larotrectinib_SW 1088 | Larotrectinib perturbation in SW 1088 cell line |
| Lenalidomide (hemihydrate)_SW 1088 | Lenalidomide (hemihydrate) perturbation in SW 1088 cell line |
| Folic acid_SW 1088 | Folic acid perturbation in SW 1088 cell line |
| Tazarotene_SW 1088 | Tazarotene perturbation in SW 1088 cell line |
| Clobetasol propionate_Panc 03.27 | Clobetasol propionate perturbation in Panc 03.27 cell line |
| Adenosine_Hs 766T | Adenosine perturbation in Hs 766T cell line |
| Lactate (calcium)_HOP62 | Lactate (calcium) perturbation in HOP62 cell line |
| Dexamethasone_SHP-77 | Dexamethasone perturbation in SHP-77 cell line |
| Budesonide_SW 1088 | Budesonide perturbation in SW 1088 cell line |
| Betamethasone dipropionate_SW 1088 | Betamethasone dipropionate perturbation in SW 1088 cell line |
| Lidocaine (hydrochloride)_SW 1088 | Lidocaine (hydrochloride) perturbation in SW 1088 cell line |
| Lactate (calcium)_J82 | Lactate (calcium) perturbation in J82 cell line |
| Adagrasib_SW 1088 | Adagrasib perturbation in SW 1088 cell line |
| Clobetasol propionate_SHP-77 | Clobetasol propionate perturbation in SHP-77 cell line |
| Carbidopa (monohydrate)_SW 1088 | Carbidopa (monohydrate) perturbation in SW 1088 cell line |
| Estrone sulfate (potassium)_HS-578T | Estrone sulfate (potassium) perturbation in HS-578T cell line |
| Abiraterone acetate_SW 1088 | Abiraterone acetate perturbation in SW 1088 cell line |
| Adenosine_HS-578T | Adenosine perturbation in HS-578T cell line |
| Pentoxifylline_HS-578T | Pentoxifylline perturbation in HS-578T cell line |
| Lactate (calcium)_A498 | Lactate (calcium) perturbation in A498 cell line |
| Dexamethasone_NCI-H1792 | Dexamethasone perturbation in NCI-H1792 cell line |
| Cytarabine (hydrochloride)_HOP62 | Cytarabine (hydrochloride) perturbation in HOP62 cell line |
| Dexamethasone_HOP62 | Dexamethasone perturbation in HOP62 cell line |
| Budesonide_hTERT-HPNE | Budesonide perturbation in hTERT-HPNE cell line |
| Budesonide_RPMI-7951 | Budesonide perturbation in RPMI-7951 cell line |
| Silodosin_SW 1088 | Silodosin perturbation in SW 1088 cell line |
| Relugolix_HOP62 | Relugolix perturbation in HOP62 cell line |
| S-Adenosyl-L-methionine (disulfate tosylate)_SW 1088 | S-Adenosyl-L-methionine (disulfate tosylate) perturbation in SW 1088 cell line |
| Adenine_SW 1088 | Adenine perturbation in SW 1088 cell line |
| Betamethasone dipropionate_RPMI-7951 | Betamethasone dipropionate perturbation in RPMI-7951 cell line |
| PF-06260933_LoVo | PF-06260933 perturbation in LoVo cell line |
| Elagolix sodium_COLO 205 | Elagolix sodium perturbation in COLO 205 cell line |
| Oxaliplatin_LS 180 | Oxaliplatin perturbation in LS 180 cell line |
| AZD-7648_SW48 | AZD-7648 perturbation in SW48 cell line |
| Acetohexamide_HEC-1-A | Acetohexamide perturbation in HEC-1-A cell line |
| Isocorydine_HEC-1-A | Isocorydine perturbation in HEC-1-A cell line |
| Balsalazide (sodium hydrate)_SW48 | Balsalazide (sodium hydrate) perturbation in SW48 cell line |
| PF-06260933_SW48 | PF-06260933 perturbation in SW48 cell line |
| Palmatine (chloride)_SW48 | Palmatine (chloride) perturbation in SW48 cell line |
| OTS514_SW48 | OTS514 perturbation in SW48 cell line |
| Cysteamine (hydrochloride)_SW 900 | Cysteamine (hydrochloride) perturbation in SW 900 cell line |
| Pyridoxine (hydrochloride)_SW48 | Pyridoxine (hydrochloride) perturbation in SW48 cell line |
| Tomivosertib_SW48 | Tomivosertib perturbation in SW48 cell line |
| Raltitrexed_SHP-77 | Raltitrexed perturbation in SHP-77 cell line |
| Decitabine_PANC-1 | Decitabine perturbation in PANC-1 cell line |
| Cytarabine (hydrochloride)_SW480 | Cytarabine (hydrochloride) perturbation in SW480 cell line |
| Erdafitinib _SW48 | Erdafitinib perturbation in SW48 cell line |
| ML264_SW48 | ML264 perturbation in SW48 cell line |
| S-Adenosyl-L-methionine (disulfate tosylate)_MIA PaCa-2 | S-Adenosyl-L-methionine (disulfate tosylate) perturbation in MIA PaCa-2 cell line |
| Lidocaine (hydrochloride)_SW48 | Lidocaine (hydrochloride) perturbation in SW48 cell line |
| Hexylresorcinol_SW 900 | Hexylresorcinol perturbation in SW 900 cell line |
| Oleic acid_SW48 | Oleic acid perturbation in SW48 cell line |
| Irinotecan_SW48 | Irinotecan perturbation in SW48 cell line |
| Lipoic acid_SW48 | Lipoic acid perturbation in SW48 cell line |
| Brivudine_SW48 | Brivudine perturbation in SW48 cell line |
| Anethole trithione_SW48 | Anethole trithione perturbation in SW48 cell line |
| CP21R7_A549 | CP21R7 perturbation in A549 cell line |
| NG25_SHP-77 | NG25 perturbation in SHP-77 cell line |
| Rapamycin_SW480 | Rapamycin perturbation in SW480 cell line |
| MK-3903_SW48 | MK-3903 perturbation in SW48 cell line |
| Radotinib_A549 | Radotinib perturbation in A549 cell line |
| Idarubicin (hydrochloride)_PANC-1 | Idarubicin (hydrochloride) perturbation in PANC-1 cell line |
| Capmatinib_SW48 | Capmatinib perturbation in SW48 cell line |
| Tolcapone_SW48 | Tolcapone perturbation in SW48 cell line |
| LY2090314_SW48 | LY2090314 perturbation in SW48 cell line |
| NG25_SW48 | NG25 perturbation in SW48 cell line |
| Carbamazepine_MIA PaCa-2 | Carbamazepine perturbation in MIA PaCa-2 cell line |
| Ouabain (Octahydrate)_LS 180 | Ouabain (Octahydrate) perturbation in LS 180 cell line |
| Lumateperone (tosylate)_SW48 | Lumateperone (tosylate) perturbation in SW48 cell line |
| Olanzapine_SW48 | Olanzapine perturbation in SW48 cell line |
| Ixazomib_SW48 | Ixazomib perturbation in SW48 cell line |
| ULK-101_SW48 | ULK-101 perturbation in SW48 cell line |
| Abiraterone acetate_RKO | Abiraterone acetate perturbation in RKO cell line |
| Gemcitabine_SW48 | Gemcitabine perturbation in SW48 cell line |
| Bentamapimod_SW48 | Bentamapimod perturbation in SW48 cell line |
| Encorafenib_SW48 | Encorafenib perturbation in SW48 cell line |
| Futibatinib_SW 900 | Futibatinib perturbation in SW 900 cell line |
| Radotinib_HEC-1-A | Radotinib perturbation in HEC-1-A cell line |
| LB-100_SW480 | LB-100 perturbation in SW480 cell line |
| Methylthiouracil_SW48 | Methylthiouracil perturbation in SW48 cell line |
| Alpelisib_SW 1271 | Alpelisib perturbation in SW 1271 cell line |
| Sapanisertib_C32 | Sapanisertib perturbation in C32 cell line |
| Fulvestrant_HEC-1-A | Fulvestrant perturbation in HEC-1-A cell line |
| Temsirolimus_HEC-1-A | Temsirolimus perturbation in HEC-1-A cell line |
| PH-797804_SW48 | PH-797804 perturbation in SW48 cell line |
| AZD2858_SW48 | AZD2858 perturbation in SW48 cell line |
| Allantoin_SW48 | Allantoin perturbation in SW48 cell line |
| Darinaparsin_SW48 | Darinaparsin perturbation in SW48 cell line |
| Mitoxantrone (dihydrochloride)_SW48 | Mitoxantrone (dihydrochloride) perturbation in SW48 cell line |
| Fusidic acid_SW48 | Fusidic acid perturbation in SW48 cell line |
| Pasireotide (acetate)_SW48 | Pasireotide (acetate) perturbation in SW48 cell line |
| Anastrozole_SW48 | Anastrozole perturbation in SW48 cell line |
| Hexylresorcinol_PANC-1 | Hexylresorcinol perturbation in PANC-1 cell line |
| Cepharanthine_SHP-77 | Cepharanthine perturbation in SHP-77 cell line |
| Lapatinib ditosylate_SW 900 | Lapatinib ditosylate perturbation in SW 900 cell line |
| Dabrafenib_SW48 | Dabrafenib perturbation in SW48 cell line |
| Megestrol_SW48 | Megestrol perturbation in SW48 cell line |
| Alpelisib_SW48 | Alpelisib perturbation in SW48 cell line |
| Celecoxib_SW48 | Celecoxib perturbation in SW48 cell line |
| NG25_H4 | NG25 perturbation in H4 cell line |
| RMC-6236_SW 900 | RMC-6236 perturbation in SW 900 cell line |
| LB-100_SW48 | LB-100 perturbation in SW48 cell line |
| TAK-733_SW48 | TAK-733 perturbation in SW48 cell line |
| LY-2584702 (tosylate salt)_SW48 | LY-2584702 (tosylate salt) perturbation in SW48 cell line |
| DT-061_SW48 | DT-061 perturbation in SW48 cell line |
| IQ 1_SW48 | IQ 1 perturbation in SW48 cell line |
| MK-8353_SW48 | MK-8353 perturbation in SW48 cell line |
| Rimonabant_SW 1271 | Rimonabant perturbation in SW 1271 cell line |
| Nevirapine_NCI-H661 | Nevirapine perturbation in NCI-H661 cell line |
| Tubulin inhibitor 6_SW 1271 | Tubulin inhibitor 6 perturbation in SW 1271 cell line |
| Norepinephrine (hydrochloride)_SW48 | Norepinephrine (hydrochloride) perturbation in SW48 cell line |
| Nevirapine_PANC-1 | Nevirapine perturbation in PANC-1 cell line |
| APTO-253_SW48 | APTO-253 perturbation in SW48 cell line |
| Tofacitinib (citrate)_SW 1271 | Tofacitinib (citrate) perturbation in SW 1271 cell line |
| BI-3406_SW48 | BI-3406 perturbation in SW48 cell line |
| ETC-206_SW48 | ETC-206 perturbation in SW48 cell line |
| Carbamazepine_HEC-1-A | Carbamazepine perturbation in HEC-1-A cell line |
| 8-Hydroxyquinoline_LS 180 | 8-Hydroxyquinoline perturbation in LS 180 cell line |
| AZD1390_SW 900 | AZD1390 perturbation in SW 900 cell line |
| 9-ING-41_SW48 | 9-ING-41 perturbation in SW48 cell line |
| Oxaliplatin_SW48 | Oxaliplatin perturbation in SW48 cell line |
| Ivermectin_SW 900 | Ivermectin perturbation in SW 900 cell line |
| Bicalutamide_SW48 | Bicalutamide perturbation in SW48 cell line |
| NVP-BHG712_SW480 | NVP-BHG712 perturbation in SW480 cell line |
| 4EGI-1_SW480 | 4EGI-1 perturbation in SW480 cell line |
| Pimitespib_SW48 | Pimitespib perturbation in SW48 cell line |
| Pyridoxine (hydrochloride)_LS 180 | Pyridoxine (hydrochloride) perturbation in LS 180 cell line |
| Allantoin_H4 | Allantoin perturbation in H4 cell line |
| Palmatine (chloride)_LS 180 | Palmatine (chloride) perturbation in LS 180 cell line |
| Doxorubicin (hydrochloride)_SW480 | Doxorubicin (hydrochloride) perturbation in SW480 cell line |
| Busulfan_HEC-1-A | Busulfan perturbation in HEC-1-A cell line |
| HI-TOPK-032_SW48 | HI-TOPK-032 perturbation in SW48 cell line |
| Lidocaine (hydrochloride)_LS 180 | Lidocaine (hydrochloride) perturbation in LS 180 cell line |
| Olanzapine_HEC-1-A | Olanzapine perturbation in HEC-1-A cell line |
| Aprepitant_SW480 | Aprepitant perturbation in SW480 cell line |
| Rapamycin_SW48 | Rapamycin perturbation in SW48 cell line |
| Meloxicam_LS 180 | Meloxicam perturbation in LS 180 cell line |
| Tolcapone_SW480 | Tolcapone perturbation in SW480 cell line |
| CP21R7_SHP-77 | CP21R7 perturbation in SHP-77 cell line |
| Idoxuridine_AsPC-1 | Idoxuridine perturbation in AsPC-1 cell line |
| Belumosudil_HEC-1-A | Belumosudil perturbation in HEC-1-A cell line |
| Gallic acid_Panc 03.27 | Gallic acid perturbation in Panc 03.27 cell line |
| MK-8353_HEC-1-A | MK-8353 perturbation in HEC-1-A cell line |
| Abemaciclib_BT-474 | Abemaciclib perturbation in BT-474 cell line |
| Asciminib_NCI-H1573 | Asciminib perturbation in NCI-H1573 cell line |
| palbociclib_NCI-H1792 | palbociclib perturbation in NCI-H1792 cell line |
| ML264_LoVo | ML264 perturbation in LoVo cell line |
| Peretinoin_PANC-1 | Peretinoin perturbation in PANC-1 cell line |
| Omeprazole (sodium)_HEC-1-A | Omeprazole (sodium) perturbation in HEC-1-A cell line |
| HI-TOPK-032_SW1417 | HI-TOPK-032 perturbation in SW1417 cell line |
| RMC-6236_HT-29 | RMC-6236 perturbation in HT-29 cell line |
| Orlistat_Panc 03.27 | Orlistat perturbation in Panc 03.27 cell line |
| Amsacrine_AsPC-1 | Amsacrine perturbation in AsPC-1 cell line |
| CP21R7_HepG2/C3A | CP21R7 perturbation in HepG2/C3A cell line |
| Olanzapine_LOX-IMVI | Olanzapine perturbation in LOX-IMVI cell line |
| S-Adenosyl-L-methionine (disulfate tosylate)_A498 | S-Adenosyl-L-methionine (disulfate tosylate) perturbation in A498 cell line |
| Tofacitinib_BT-474 | Tofacitinib perturbation in BT-474 cell line |
| DT-061_HEC-1-A | DT-061 perturbation in HEC-1-A cell line |
| Everolimus_J82 | Everolimus perturbation in J82 cell line |
| venetoclax_C32 | venetoclax perturbation in C32 cell line |
| Sinomenine_A498 | Sinomenine perturbation in A498 cell line |
| Bergenin_BT-474 | Bergenin perturbation in BT-474 cell line |
| Epirubicin (hydrochloride)_AsPC-1 | Epirubicin (hydrochloride) perturbation in AsPC-1 cell line |
| Imiquimod (maleate)_Panc 03.27 | Imiquimod (maleate) perturbation in Panc 03.27 cell line |
| Temsirolimus_SW480 | Temsirolimus perturbation in SW480 cell line |
| Artesunate_J82 | Artesunate perturbation in J82 cell line |
| Oleic acid_MIA PaCa-2 | Oleic acid perturbation in MIA PaCa-2 cell line |
| Verteporfin_HOP62 | Verteporfin perturbation in HOP62 cell line |
| 4EGI-1_NCI-H1573 | 4EGI-1 perturbation in NCI-H1573 cell line |
| LY2090314_NCI-H1792 | LY2090314 perturbation in NCI-H1792 cell line |
| Tucatinib_HEC-1-A | Tucatinib perturbation in HEC-1-A cell line |
| Sodium Salicylate_HEC-1-A | Sodium Salicylate perturbation in HEC-1-A cell line |
| Torkinib_HT-29 | Torkinib perturbation in HT-29 cell line |
| Pralsetinib_AsPC-1 | Pralsetinib perturbation in AsPC-1 cell line |
| Raltitrexed_NCI-H1573 | Raltitrexed perturbation in NCI-H1573 cell line |
| Temuterkib_NCI-H2030 | Temuterkib perturbation in NCI-H2030 cell line |
| Gallic acid (hydrate)_J82 | Gallic acid (hydrate) perturbation in J82 cell line |
| BI-78D3_MIA PaCa-2 | BI-78D3 perturbation in MIA PaCa-2 cell line |
| Capmatinib_NCI-H1792 | Capmatinib perturbation in NCI-H1792 cell line |
| Clonidine (hydrochloride)_AsPC-1 | Clonidine (hydrochloride) perturbation in AsPC-1 cell line |
| Paclitaxel_C32 | Paclitaxel perturbation in C32 cell line |
| LY-2584702 (tosylate salt)_HT-29 | LY-2584702 (tosylate salt) perturbation in HT-29 cell line |
| Gallic acid (hydrate)_KATO III | Gallic acid (hydrate) perturbation in KATO III cell line |
| Quinestrol_SW480 | Quinestrol perturbation in SW480 cell line |
| Triamcinolone_A-172 | Triamcinolone perturbation in A-172 cell line |
| Vemurafenib_HepG2/C3A | Vemurafenib perturbation in HepG2/C3A cell line |
| Talc_SW1417 | Talc perturbation in SW1417 cell line |
| Salicylic acid_Panc 03.27 | Salicylic acid perturbation in Panc 03.27 cell line |
| Riluzole hydrochloride_NCI-H1792 | Riluzole hydrochloride perturbation in NCI-H1792 cell line |
| ERK5-IN-2_HEC-1-A | ERK5-IN-2 perturbation in HEC-1-A cell line |
| Phenytoin (sodium)_HEC-1-A | Phenytoin (sodium) perturbation in HEC-1-A cell line |
| Diammonium Glycyrrhizinate_SW1417 | Diammonium Glycyrrhizinate perturbation in SW1417 cell line |
| ML264_CFPAC-1 | ML264 perturbation in CFPAC-1 cell line |
| Everolimus_NCI-H1792 | Everolimus perturbation in NCI-H1792 cell line |
| Pralsetinib_HepG2/C3A | Pralsetinib perturbation in HepG2/C3A cell line |
| Belinostat_NCI-H1792 | Belinostat perturbation in NCI-H1792 cell line |
| AZD2858_Panc 03.27 | AZD2858 perturbation in Panc 03.27 cell line |
| Pralsetinib_NCI-H2030 | Pralsetinib perturbation in NCI-H2030 cell line |
| Triamcinolone_HS-578T | Triamcinolone perturbation in HS-578T cell line |
| Oxaliplatin_A549 | Oxaliplatin perturbation in A549 cell line |
| Retinoic acid_HT-29 | Retinoic acid perturbation in HT-29 cell line |
| Idarubicin (hydrochloride)_HT-29 | Idarubicin (hydrochloride) perturbation in HT-29 cell line |
| Fusidic acid_SK-MEL-2 | Fusidic acid perturbation in SK-MEL-2 cell line |
| Bimatoprost_HEC-1-A | Bimatoprost perturbation in HEC-1-A cell line |
| Azithromycin (hydrate)_Panc 03.27 | Azithromycin (hydrate) perturbation in Panc 03.27 cell line |
| Ralimetinib dimesylate_BT-474 | Ralimetinib dimesylate perturbation in BT-474 cell line |
| Lipoic acid_LoVo | Lipoic acid perturbation in LoVo cell line |
| Furosemide_SK-MEL-2 | Furosemide perturbation in SK-MEL-2 cell line |
| LB-100_HT-29 | LB-100 perturbation in HT-29 cell line |
| Minodronic acid_A549 | Minodronic acid perturbation in A549 cell line |
| TAK-733_HT-29 | TAK-733 perturbation in HT-29 cell line |
| EX229_SW1417 | EX229 perturbation in SW1417 cell line |
| Abemaciclib_SW 1271 | Abemaciclib perturbation in SW 1271 cell line |
| Capmatinib_J82 | Capmatinib perturbation in J82 cell line |
| Irinotecan_MIA PaCa-2 | Irinotecan perturbation in MIA PaCa-2 cell line |
| Gallic acid (hydrate)_NCI-H1792 | Gallic acid (hydrate) perturbation in NCI-H1792 cell line |
| Finasteride_HEC-1-A | Finasteride perturbation in HEC-1-A cell line |
| BAY1125976_C32 | BAY1125976 perturbation in C32 cell line |
| PH-797804_Panc 03.27 | PH-797804 perturbation in Panc 03.27 cell line |
| Oleic acid_CFPAC-1 | Oleic acid perturbation in CFPAC-1 cell line |
| Rucaparib (phosphate)_A498 | Rucaparib (phosphate) perturbation in A498 cell line |
| SBI-0640756_SW480 | SBI-0640756 perturbation in SW480 cell line |
| Methyl aminolevulinate (hydrochloride)_AsPC-1 | Methyl aminolevulinate (hydrochloride) perturbation in AsPC-1 cell line |
| Doxycycline (monohydrate)_A549 | Doxycycline (monohydrate) perturbation in A549 cell line |
| Doxorubicin (hydrochloride)_NCI-H1573 | Doxorubicin (hydrochloride) perturbation in NCI-H1573 cell line |
| Terfenadine_NCI-H1792 | Terfenadine perturbation in NCI-H1792 cell line |
| HI-TOPK-032_SW 1271 | HI-TOPK-032 perturbation in SW 1271 cell line |
| Posaconazole_SK-MEL-2 | Posaconazole perturbation in SK-MEL-2 cell line |
| Ornidazole_NCI-H2347 | Ornidazole perturbation in NCI-H2347 cell line |
| Rapamycin_NCI-H2030 | Rapamycin perturbation in NCI-H2030 cell line |
| Ralimetinib dimesylate_SW1417 | Ralimetinib dimesylate perturbation in SW1417 cell line |
| LY2090314_J82 | LY2090314 perturbation in J82 cell line |
| Artesunate_NCI-H1792 | Artesunate perturbation in NCI-H1792 cell line |
| Rutin (trihydrate)_NCI-H1573 | Rutin (trihydrate) perturbation in NCI-H1573 cell line |
| Celecoxib_HT-29 | Celecoxib perturbation in HT-29 cell line |
| PF-06260933_C32 | PF-06260933 perturbation in C32 cell line |
| Brivudine_LoVo | Brivudine perturbation in LoVo cell line |
| Anastrozole_SK-MEL-2 | Anastrozole perturbation in SK-MEL-2 cell line |
| c-Kit-IN-1_NCI-H1792 | c-Kit-IN-1 perturbation in NCI-H1792 cell line |
| Vitamin K4_AsPC-1 | Vitamin K4 perturbation in AsPC-1 cell line |
| Tofacitinib_SW 1271 | Tofacitinib perturbation in SW 1271 cell line |
| Brivudine_SNU-423 | Brivudine perturbation in SNU-423 cell line |
| Capivasertib_SW480 | Capivasertib perturbation in SW480 cell line |
| Ralimetinib dimesylate_HepG2/C3A | Ralimetinib dimesylate perturbation in HepG2/C3A cell line |
| Pemigatinib_PANC-1 | Pemigatinib perturbation in PANC-1 cell line |
| DTP3_SK-MEL-2 | DTP3 perturbation in SK-MEL-2 cell line |
| Bosentan (hydrate)_SK-MEL-2 | Bosentan (hydrate) perturbation in SK-MEL-2 cell line |
| Alpelisib_HT-29 | Alpelisib perturbation in HT-29 cell line |
| Sulfisoxazole_NCI-H1573 | Sulfisoxazole perturbation in NCI-H1573 cell line |
| Demeclocycline_HEC-1-A | Demeclocycline perturbation in HEC-1-A cell line |
| Tucidinostat_HT-29 | Tucidinostat perturbation in HT-29 cell line |
| Nimesulide_A549 | Nimesulide perturbation in A549 cell line |
| Fluvoxamine (maleate)_NCI-H2347 | Fluvoxamine (maleate) perturbation in NCI-H2347 cell line |
| Panobinostat_NCI-H596 | Panobinostat perturbation in NCI-H596 cell line |
| Volasertib_HT-29 | Volasertib perturbation in HT-29 cell line |
| Canagliflozin_HEC-1-A | Canagliflozin perturbation in HEC-1-A cell line |
| Binimetinib_AsPC-1 | Binimetinib perturbation in AsPC-1 cell line |
| AZD-8055_NCI-H1573 | AZD-8055 perturbation in NCI-H1573 cell line |
| OTS514_A498 | OTS514 perturbation in A498 cell line |
| Temuterkib_SW 1271 | Temuterkib perturbation in SW 1271 cell line |
| Clonidine (hydrochloride)_SW1417 | Clonidine (hydrochloride) perturbation in SW1417 cell line |
| Epirubicin (hydrochloride)_BT-474 | Epirubicin (hydrochloride) perturbation in BT-474 cell line |
| Trimetrexate_Hs 766T | Trimetrexate perturbation in Hs 766T cell line |
| Dabrafenib_Hs 766T | Dabrafenib perturbation in Hs 766T cell line |
| Dabrafenib_HT-29 | Dabrafenib perturbation in HT-29 cell line |
| Trimetrexate_HT-29 | Trimetrexate perturbation in HT-29 cell line |
| Ropivacaine (hydrochloride monohydrate)_HepG2/C3A | Ropivacaine (hydrochloride monohydrate) perturbation in HepG2/C3A cell line |
| Brivudine_NCI-H1792 | Brivudine perturbation in NCI-H1792 cell line |
| Pralsetinib_BT-474 | Pralsetinib perturbation in BT-474 cell line |
| Cloxacillin (sodium)_SK-MEL-2 | Cloxacillin (sodium) perturbation in SK-MEL-2 cell line |
| LJI308_HT-29 | LJI308 perturbation in HT-29 cell line |
| Norepinephrine (hydrochloride)_HEC-1-A | Norepinephrine (hydrochloride) perturbation in HEC-1-A cell line |
| Vemurafenib_SW 1271 | Vemurafenib perturbation in SW 1271 cell line |
| Epirubicin (hydrochloride)_SW1417 | Epirubicin (hydrochloride) perturbation in SW1417 cell line |
| RMC-6236_SK-MEL-2 | RMC-6236 perturbation in SK-MEL-2 cell line |
| Fluvoxamine_A549 | Fluvoxamine perturbation in A549 cell line |
| Docetaxel_H4 | Docetaxel perturbation in H4 cell line |
| Crizotinib (hydrochloride)_Panc 03.27 | Crizotinib (hydrochloride) perturbation in Panc 03.27 cell line |
| Pyridoxine (hydrochloride)_A498 | Pyridoxine (hydrochloride) perturbation in A498 cell line |
| Sulfisoxazole_C32 | Sulfisoxazole perturbation in C32 cell line |
| Almonertinib (mesylate)_A549 | Almonertinib (mesylate) perturbation in A549 cell line |
| Pentagastrin_HEC-1-A | Pentagastrin perturbation in HEC-1-A cell line |
| LB-100_SK-MEL-2 | LB-100 perturbation in SK-MEL-2 cell line |
| Fenofibrate_AsPC-1 | Fenofibrate perturbation in AsPC-1 cell line |
| Furosemide_Hs 766T | Furosemide perturbation in Hs 766T cell line |
| Epirubicin (hydrochloride)_SW 1271 | Epirubicin (hydrochloride) perturbation in SW 1271 cell line |
| Pimitespib_LS 180 | Pimitespib perturbation in LS 180 cell line |
| Aprepitant_MIA PaCa-2 | Aprepitant perturbation in MIA PaCa-2 cell line |
| Cyclosporin A_HEC-1-A | Cyclosporin A perturbation in HEC-1-A cell line |
| Vemurafenib_SW1417 | Vemurafenib perturbation in SW1417 cell line |
| Hesperidin_NCI-H1573 | Hesperidin perturbation in NCI-H1573 cell line |
| Futibatinib_NCI-H2347 | Futibatinib perturbation in NCI-H2347 cell line |
| MK-3903_SNU-423 | MK-3903 perturbation in SNU-423 cell line |
| Anastrozole_HT-29 | Anastrozole perturbation in HT-29 cell line |
| Asciminib_A498 | Asciminib perturbation in A498 cell line |
| Celecoxib_SK-MEL-2 | Celecoxib perturbation in SK-MEL-2 cell line |
| palbociclib_LoVo | palbociclib perturbation in LoVo cell line |
| palbociclib_SNU-423 | palbociclib perturbation in SNU-423 cell line |
| Temuterkib_SW1417 | Temuterkib perturbation in SW1417 cell line |
| Mitoxantrone (dihydrochloride)_Panc 03.27 | Mitoxantrone (dihydrochloride) perturbation in Panc 03.27 cell line |
| palbociclib_MIA PaCa-2 | palbociclib perturbation in MIA PaCa-2 cell line |
| Lapatinib ditosylate_Hs 766T | Lapatinib ditosylate perturbation in Hs 766T cell line |
| MK-3903_LoVo | MK-3903 perturbation in LoVo cell line |
| Lapatinib ditosylate_HT-29 | Lapatinib ditosylate perturbation in HT-29 cell line |
| Sildenafil_Panc 03.27 | Sildenafil perturbation in Panc 03.27 cell line |
| Infigratinib_J82 | Infigratinib perturbation in J82 cell line |
| Norepinephrine (hydrochloride)_PANC-1 | Norepinephrine (hydrochloride) perturbation in PANC-1 cell line |
| CP21R7_SW1417 | CP21R7 perturbation in SW1417 cell line |
| Allopurinol_A549 | Allopurinol perturbation in A549 cell line |
| Aspirin_HS-578T | Aspirin perturbation in HS-578T cell line |
| Pasireotide (acetate)_HT-29 | Pasireotide (acetate) perturbation in HT-29 cell line |
| Balsalazide (sodium hydrate)_NCI-H2122 | Balsalazide (sodium hydrate) perturbation in NCI-H2122 cell line |
| Macitentan_HEC-1-A | Macitentan perturbation in HEC-1-A cell line |
| Ralimetinib dimesylate_AsPC-1 | Ralimetinib dimesylate perturbation in AsPC-1 cell line |
| Capmatinib_MIA PaCa-2 | Capmatinib perturbation in MIA PaCa-2 cell line |
| Methotrexate_Panc 03.27 | Methotrexate perturbation in Panc 03.27 cell line |
| Silodosin_C32 | Silodosin perturbation in C32 cell line |
| Sinomenine_C32 | Sinomenine perturbation in C32 cell line |
| Tolcapone_HOP62 | Tolcapone perturbation in HOP62 cell line |
| Uridine_Panc 03.27 | Uridine perturbation in Panc 03.27 cell line |
| AZD-7648_C32 | AZD-7648 perturbation in C32 cell line |
| Ipatasertib_Panc 03.27 | Ipatasertib perturbation in Panc 03.27 cell line |
| Aliskiren_SW1417 | Aliskiren perturbation in SW1417 cell line |
| NG25_LoVo | NG25 perturbation in LoVo cell line |
| Pimitespib_SW480 | Pimitespib perturbation in SW480 cell line |
| Lucanthone_Hs 766T | Lucanthone perturbation in Hs 766T cell line |
| Lidocaine (hydrochloride)_NCI-H1792 | Lidocaine (hydrochloride) perturbation in NCI-H1792 cell line |
| Darolutamide_A549 | Darolutamide perturbation in A549 cell line |
| Baicalin_SW 1088 | Baicalin perturbation in SW 1088 cell line |
| Amsacrine_SW 1271 | Amsacrine perturbation in SW 1271 cell line |
| Brivudine_J82 | Brivudine perturbation in J82 cell line |
| 4EGI-1_A498 | 4EGI-1 perturbation in A498 cell line |
| Darinaparsin_Panc 03.27 | Darinaparsin perturbation in Panc 03.27 cell line |
| HI-TOPK-032_HepG2/C3A | HI-TOPK-032 perturbation in HepG2/C3A cell line |
| Fusidic acid_HT-29 | Fusidic acid perturbation in HT-29 cell line |
| Lumateperone (tosylate)_Panc 03.27 | Lumateperone (tosylate) perturbation in Panc 03.27 cell line |
| Pentagastrin_HT-29 | Pentagastrin perturbation in HT-29 cell line |
| Fluvoxamine_AsPC-1 | Fluvoxamine perturbation in AsPC-1 cell line |
| Cinacalcet_AsPC-1 | Cinacalcet perturbation in AsPC-1 cell line |
| Bestatin (hydrochloride)_NCI-H2347 | Bestatin (hydrochloride) perturbation in NCI-H2347 cell line |
| Cytarabine (hydrochloride)_AsPC-1 | Cytarabine (hydrochloride) perturbation in AsPC-1 cell line |
| Fedratinib (hydrochloride hydrate)_A498 | Fedratinib (hydrochloride hydrate) perturbation in A498 cell line |
| NG25_C32 | NG25 perturbation in C32 cell line |
| S-Adenosyl-L-methionine (disulfate tosylate)_HOP62 | S-Adenosyl-L-methionine (disulfate tosylate) perturbation in HOP62 cell line |
| Niclosamide (olamine)_J82 | Niclosamide (olamine) perturbation in J82 cell line |
| Belumosudil (mesylate)_SW1417 | Belumosudil (mesylate) perturbation in SW1417 cell line |
| Cyclosporin A_HT-29 | Cyclosporin A perturbation in HT-29 cell line |
| Quinestrol_SW 1271 | Quinestrol perturbation in SW 1271 cell line |
| Oxaliplatin_SW 1271 | Oxaliplatin perturbation in SW 1271 cell line |
| Cysteamine (hydrochloride)_NCI-H1792 | Cysteamine (hydrochloride) perturbation in NCI-H1792 cell line |
| Folic acid_Panc 03.27 | Folic acid perturbation in Panc 03.27 cell line |
| Belinostat_NCI-H2122 | Belinostat perturbation in NCI-H2122 cell line |
| MK-3903_AN3 CA | MK-3903 perturbation in AN3 CA cell line |
| Afatinib_C32 | Afatinib perturbation in C32 cell line |
| Busulfan_Panc 03.27 | Busulfan perturbation in Panc 03.27 cell line |
| Anastrozole_HEC-1-A | Anastrozole perturbation in HEC-1-A cell line |
| Temsirolimus_SW 1271 | Temsirolimus perturbation in SW 1271 cell line |
| Adenine_SNU-423 | Adenine perturbation in SNU-423 cell line |
| Volasertib_PANC-1 | Volasertib perturbation in PANC-1 cell line |
| Lopinavir_BT-474 | Lopinavir perturbation in BT-474 cell line |
| 8-Hydroxyquinoline_MIA PaCa-2 | 8-Hydroxyquinoline perturbation in MIA PaCa-2 cell line |
| Capmatinib_C32 | Capmatinib perturbation in C32 cell line |
| Rimonabant_Panc 03.27 | Rimonabant perturbation in Panc 03.27 cell line |
| Bortezomib_NCI-H2030 | Bortezomib perturbation in NCI-H2030 cell line |
| Almonertinib (hydrochloride)_Hs 766T | Almonertinib (hydrochloride) perturbation in Hs 766T cell line |
| Belumosudil (mesylate)_BT-474 | Belumosudil (mesylate) perturbation in BT-474 cell line |
| Dabrafenib_HCT15 | Dabrafenib perturbation in HCT15 cell line |
| Lapatinib ditosylate_HEC-1-A | Lapatinib ditosylate perturbation in HEC-1-A cell line |
| Imiquimod (hydrochloride)_Hs 766T | Imiquimod (hydrochloride) perturbation in Hs 766T cell line |
| Roxadustat_Panc 03.27 | Roxadustat perturbation in Panc 03.27 cell line |
| Levobupivacaine (hydrochloride)_HEC-1-A | Levobupivacaine (hydrochloride) perturbation in HEC-1-A cell line |
| Lidocaine (hydrochloride)_A498 | Lidocaine (hydrochloride) perturbation in A498 cell line |
| Oleic acid_A498 | Oleic acid perturbation in A498 cell line |
| OTS514_J82 | OTS514 perturbation in J82 cell line |
| Cabozantinib (S-malate)_HepG2/C3A | Cabozantinib (S-malate) perturbation in HepG2/C3A cell line |
| SBI-0640756_SW1417 | SBI-0640756 perturbation in SW1417 cell line |
| Dabrafenib_PANC-1 | Dabrafenib perturbation in PANC-1 cell line |
| Pentamidine (isethionate)_KATO III | Pentamidine (isethionate) perturbation in KATO III cell line |
| Pimitespib_AsPC-1 | Pimitespib perturbation in AsPC-1 cell line |
| HI-TOPK-032_A549 | HI-TOPK-032 perturbation in A549 cell line |
| Terfenadine_NCI-H2122 | Terfenadine perturbation in NCI-H2122 cell line |
| Tolcapone_NCI-H1573 | Tolcapone perturbation in NCI-H1573 cell line |
| Docetaxel_HT-29 | Docetaxel perturbation in HT-29 cell line |
| palbociclib_C32 | palbociclib perturbation in C32 cell line |
| Lucanthone_HEC-1-A | Lucanthone perturbation in HEC-1-A cell line |
| Rosiglitazone_Panc 03.27 | Rosiglitazone perturbation in Panc 03.27 cell line |
| Saquinavir_C32 | Saquinavir perturbation in C32 cell line |
| Delamanid_NCI-H2347 | Delamanid perturbation in NCI-H2347 cell line |
| SBI-0640756_BT-474 | SBI-0640756 perturbation in BT-474 cell line |
| Monocrotaline_Panc 03.27 | Monocrotaline perturbation in Panc 03.27 cell line |
| Arbutin_C32 | Arbutin perturbation in C32 cell line |
| Fumaric acid_SK-MEL-2 | Fumaric acid perturbation in SK-MEL-2 cell line |
| Minodronic acid_SW 1271 | Minodronic acid perturbation in SW 1271 cell line |
| Tomivosertib_J82 | Tomivosertib perturbation in J82 cell line |
| Triclosan_SW1417 | Triclosan perturbation in SW1417 cell line |
| Everolimus_NCI-H1573 | Everolimus perturbation in NCI-H1573 cell line |
| Ranolazine_HT-29 | Ranolazine perturbation in HT-29 cell line |
| Baicalin_SW480 | Baicalin perturbation in SW480 cell line |
| Alpelisib_HEC-1-A | Alpelisib perturbation in HEC-1-A cell line |
| Palmatine (chloride)_NCI-H1792 | Palmatine (chloride) perturbation in NCI-H1792 cell line |
| BI-3406_HT-29 | BI-3406 perturbation in HT-29 cell line |
| Demeclocycline_HT-29 | Demeclocycline perturbation in HT-29 cell line |
| Ixazomib_Panc 03.27 | Ixazomib perturbation in Panc 03.27 cell line |
| AZD-7648_CFPAC-1 | AZD-7648 perturbation in CFPAC-1 cell line |
| Lapatinib ditosylate_PANC-1 | Lapatinib ditosylate perturbation in PANC-1 cell line |
| Belumosudil_NCI-H596 | Belumosudil perturbation in NCI-H596 cell line |
| Anethole trithione_C32 | Anethole trithione perturbation in C32 cell line |
| Abemaciclib_SW480 | Abemaciclib perturbation in SW480 cell line |
| Lenalidomide (hemihydrate)_Panc 03.27 | Lenalidomide (hemihydrate) perturbation in Panc 03.27 cell line |
| Irinotecan (hydrochloride)_SNU-423 | Irinotecan (hydrochloride) perturbation in SNU-423 cell line |
| Acetohexamide_SK-MEL-2 | Acetohexamide perturbation in SK-MEL-2 cell line |
| Goserelin (acetate)_Panc 03.27 | Goserelin (acetate) perturbation in Panc 03.27 cell line |
| Bexarotene_Panc 03.27 | Bexarotene perturbation in Panc 03.27 cell line |
| Volasertib_HEC-1-A | Volasertib perturbation in HEC-1-A cell line |
| SBI-0640756_SW 1271 | SBI-0640756 perturbation in SW 1271 cell line |
| Lonafarnib_Panc 03.27 | Lonafarnib perturbation in Panc 03.27 cell line |
| MK-8353_SK-MEL-2 | MK-8353 perturbation in SK-MEL-2 cell line |
| Dabrafenib_HEC-1-A | Dabrafenib perturbation in HEC-1-A cell line |
| AT7519_SW1417 | AT7519 perturbation in SW1417 cell line |
| Trimetrexate_HEC-1-A | Trimetrexate perturbation in HEC-1-A cell line |
| vincristine_NCI-H2122 | vincristine perturbation in NCI-H2122 cell line |
| Relugolix_AsPC-1 | Relugolix perturbation in AsPC-1 cell line |
| L-Eflornithine (monohydrochloride)_AsPC-1 | L-Eflornithine (monohydrochloride) perturbation in AsPC-1 cell line |
| Infigratinib_A498 | Infigratinib perturbation in A498 cell line |
| Bimiralisib_SW 1271 | Bimiralisib perturbation in SW 1271 cell line |
| Valdecoxib_NCI-H2347 | Valdecoxib perturbation in NCI-H2347 cell line |
| Norepinephrine (hydrochloride)_HT-29 | Norepinephrine (hydrochloride) perturbation in HT-29 cell line |
| Hydroxyurea_Panc 03.27 | Hydroxyurea perturbation in Panc 03.27 cell line |
| Ferulic acid_C32 | Ferulic acid perturbation in C32 cell line |
| OTS514_NCI-H1792 | OTS514 perturbation in NCI-H1792 cell line |
| Fenofibrate_A549 | Fenofibrate perturbation in A549 cell line |
| Oxaliplatin_SW1417 | Oxaliplatin perturbation in SW1417 cell line |
| Naproxen_A549 | Naproxen perturbation in A549 cell line |
| Loperamide (hydrochloride)_Panc 03.27 | Loperamide (hydrochloride) perturbation in Panc 03.27 cell line |
| Quinestrol_SW1417 | Quinestrol perturbation in SW1417 cell line |
| Brivudine_A498 | Brivudine perturbation in A498 cell line |
| Balsalazide (sodium hydrate)_LoVo | Balsalazide (sodium hydrate) perturbation in LoVo cell line |
| Methylprednisolone succinate_NCI-H2347 | Methylprednisolone succinate perturbation in NCI-H2347 cell line |
| Penfluridol_NCI-H596 | Penfluridol perturbation in NCI-H596 cell line |
| Rutin (trihydrate)_NCI-H1792 | Rutin (trihydrate) perturbation in NCI-H1792 cell line |
| Ribociclib_NCI-H1573 | Ribociclib perturbation in NCI-H1573 cell line |
| Cytarabine (hydrochloride)_BT-474 | Cytarabine (hydrochloride) perturbation in BT-474 cell line |
| Quinestrol_HepG2/C3A | Quinestrol perturbation in HepG2/C3A cell line |
| ERK5-IN-2_HT-29 | ERK5-IN-2 perturbation in HT-29 cell line |
| Encorafenib_Panc 03.27 | Encorafenib perturbation in Panc 03.27 cell line |
| Vilanterol_A498 | Vilanterol perturbation in A498 cell line |
| Brivudine_C32 | Brivudine perturbation in C32 cell line |
| Cytarabine (hydrochloride)_SW1417 | Cytarabine (hydrochloride) perturbation in SW1417 cell line |
| Bentamapimod_Panc 03.27 | Bentamapimod perturbation in Panc 03.27 cell line |
| Piroxicam_A549 | Piroxicam perturbation in A549 cell line |
| Ivermectin_SW 1271 | Ivermectin perturbation in SW 1271 cell line |
| BAY1125976_MIA PaCa-2 | BAY1125976 perturbation in MIA PaCa-2 cell line |
| Fluvoxamine_SW1417 | Fluvoxamine perturbation in SW1417 cell line |
| Irinotecan_C32 | Irinotecan perturbation in C32 cell line |
| Sulfisoxazole_NCI-H1792 | Sulfisoxazole perturbation in NCI-H1792 cell line |
| Lipoic acid_C32 | Lipoic acid perturbation in C32 cell line |
| Lucanthone_A-172 | Lucanthone perturbation in A-172 cell line |
| Torkinib_HCT15 | Torkinib perturbation in HCT15 cell line |
| Retinoic acid_HEC-1-A | Retinoic acid perturbation in HEC-1-A cell line |
| Sinomenine_KATO III | Sinomenine perturbation in KATO III cell line |
| Bimatoprost_HT-29 | Bimatoprost perturbation in HT-29 cell line |
| 9-ING-41_HepG2/C3A | 9-ING-41 perturbation in HepG2/C3A cell line |
| Fumaric acid_Hs 766T | Fumaric acid perturbation in Hs 766T cell line |
| LB-100_HEC-1-A | LB-100 perturbation in HEC-1-A cell line |
| Anethole trithione_A498 | Anethole trithione perturbation in A498 cell line |
| Nevirapine_CHP-212 | Nevirapine perturbation in CHP-212 cell line |
| TAK-733_HEC-1-A | TAK-733 perturbation in HEC-1-A cell line |
| Pentagastrin_SK-MEL-2 | Pentagastrin perturbation in SK-MEL-2 cell line |
| Finasteride_Hs 766T | Finasteride perturbation in Hs 766T cell line |
| c-Kit-IN-1_A498 | c-Kit-IN-1 perturbation in A498 cell line |
| Gemcitabine_Panc 03.27 | Gemcitabine perturbation in Panc 03.27 cell line |
| Glycyrrhizic acid_Panc 03.27 | Glycyrrhizic acid perturbation in Panc 03.27 cell line |
| (S)-Crizotinib_Hs 766T | (S)-Crizotinib perturbation in Hs 766T cell line |
| Phenylephrine (hydrochloride)_SW1417 | Phenylephrine (hydrochloride) perturbation in SW1417 cell line |
| Isocorydine_HT-29 | Isocorydine perturbation in HT-29 cell line |
| Triclosan_NCI-H2030 | Triclosan perturbation in NCI-H2030 cell line |
| Pimitespib_BT-474 | Pimitespib perturbation in BT-474 cell line |
| ULK-101_Panc 03.27 | ULK-101 perturbation in Panc 03.27 cell line |
| Capivasertib_SW 1271 | Capivasertib perturbation in SW 1271 cell line |
| SBI-0640756_AsPC-1 | SBI-0640756 perturbation in AsPC-1 cell line |
| Minodronic acid_HepG2/C3A | Minodronic acid perturbation in HepG2/C3A cell line |
| Celecoxib_HEC-1-A | Celecoxib perturbation in HEC-1-A cell line |
| (R)-Verapamil (hydrochloride)_Panc 03.27 | (R)-Verapamil (hydrochloride) perturbation in Panc 03.27 cell line |
| Imiquimod (hydrochloride)_SK-MEL-2 | Imiquimod (hydrochloride) perturbation in SK-MEL-2 cell line |
| Pimitespib_SW1417 | Pimitespib perturbation in SW1417 cell line |
| Pravastatin (sodium)_A549 | Pravastatin (sodium) perturbation in A549 cell line |
| Rapamycin_A549 | Rapamycin perturbation in A549 cell line |
| Pimitespib_SW 1271 | Pimitespib perturbation in SW 1271 cell line |
| MK-8353_HT-29 | MK-8353 perturbation in HT-29 cell line |
| Cabozantinib (S-malate)_BT-474 | Cabozantinib (S-malate) perturbation in BT-474 cell line |
| Adenine_NCI-H1792 | Adenine perturbation in NCI-H1792 cell line |
| Amsacrine_SW480 | Amsacrine perturbation in SW480 cell line |
| Entecavir (monohydrate)_HEC-1-A | Entecavir (monohydrate) perturbation in HEC-1-A cell line |
| IQ 1_HT-29 | IQ 1 perturbation in HT-29 cell line |
| Norepinephrine (hydrochloride)_SK-MEL-2 | Norepinephrine (hydrochloride) perturbation in SK-MEL-2 cell line |
| Clopidogrel_SW1417 | Clopidogrel perturbation in SW1417 cell line |
| Capivasertib_SW1417 | Capivasertib perturbation in SW1417 cell line |
| Fluvoxamine (maleate)_Panc 03.27 | Fluvoxamine (maleate) perturbation in Panc 03.27 cell line |
| Idarubicin (hydrochloride)_H4 | Idarubicin (hydrochloride) perturbation in H4 cell line |
| Aprepitant_A498 | Aprepitant perturbation in A498 cell line |
| Omeprazole (sodium)_HT-29 | Omeprazole (sodium) perturbation in HT-29 cell line |
| Ixazomib citrate_Panc 03.27 | Ixazomib citrate perturbation in Panc 03.27 cell line |
| RMC-6236_HEC-1-A | RMC-6236 perturbation in HEC-1-A cell line |
| Docetaxel (Trihydrate)_NCI-H460 | Docetaxel (Trihydrate) perturbation in NCI-H460 cell line |
| Lidocaine (hydrochloride)_C32 | Lidocaine (hydrochloride) perturbation in C32 cell line |
| Nafamostat (mesylate)_AsPC-1 | Nafamostat (mesylate) perturbation in AsPC-1 cell line |
| DT-061_Hs 766T | DT-061 perturbation in Hs 766T cell line |
| palbociclib_A498 | palbociclib perturbation in A498 cell line |
| Darolutamide_SW1417 | Darolutamide perturbation in SW1417 cell line |
| DT-061_HT-29 | DT-061 perturbation in HT-29 cell line |
| Paclitaxel_HOP62 | Paclitaxel perturbation in HOP62 cell line |
| Doxycycline (monohydrate)_AsPC-1 | Doxycycline (monohydrate) perturbation in AsPC-1 cell line |
| ML264_NCI-H1573 | ML264 perturbation in NCI-H1573 cell line |
| Methyl aminolevulinate (hydrochloride)_A549 | Methyl aminolevulinate (hydrochloride) perturbation in A549 cell line |
| XRK3F2_HT-29 | XRK3F2 perturbation in HT-29 cell line |
| Crizotinib (hydrochloride)_NCI-H2347 | Crizotinib (hydrochloride) perturbation in NCI-H2347 cell line |
| NVP-BHG712_SNU-423 | NVP-BHG712 perturbation in SNU-423 cell line |
| Relugolix_BT-474 | Relugolix perturbation in BT-474 cell line |
| Capmatinib_A498 | Capmatinib perturbation in A498 cell line |
| Torkinib_HEC-1-A | Torkinib perturbation in HEC-1-A cell line |
| Adenosine_Panc 03.27 | Adenosine perturbation in Panc 03.27 cell line |
| Tucatinib_HT-29 | Tucatinib perturbation in HT-29 cell line |
| Omeprazole_SW1417 | Omeprazole perturbation in SW1417 cell line |
| DTP3_HEC-1-A | DTP3 perturbation in HEC-1-A cell line |
| NVP-BHG712_MIA PaCa-2 | NVP-BHG712 perturbation in MIA PaCa-2 cell line |
| Aspirin_HT-29 | Aspirin perturbation in HT-29 cell line |
| AZD1390_HepG2/C3A | AZD1390 perturbation in HepG2/C3A cell line |
| Plicamycin_Hs 766T | Plicamycin perturbation in Hs 766T cell line |
| venetoclax_MIA PaCa-2 | venetoclax perturbation in MIA PaCa-2 cell line |
| Futibatinib_SNU-1 | Futibatinib perturbation in SNU-1 cell line |
| AT7519_AsPC-1 | AT7519 perturbation in AsPC-1 cell line |
| ML264_C32 | ML264 perturbation in C32 cell line |
| LY-2584702 (tosylate salt)_HEC-1-A | LY-2584702 (tosylate salt) perturbation in HEC-1-A cell line |
| Demeclocycline_SK-MEL-2 | Demeclocycline perturbation in SK-MEL-2 cell line |
| ETC-206_HepG2/C3A | ETC-206 perturbation in HepG2/C3A cell line |
| Acetohexamide_HT-29 | Acetohexamide perturbation in HT-29 cell line |
| Erdafitinib _SNU-423 | Erdafitinib perturbation in SNU-423 cell line |
| Resveratrol_NCI-H1792 | Resveratrol perturbation in NCI-H1792 cell line |
| Lapatinib ditosylate_A549 | Lapatinib ditosylate perturbation in A549 cell line |
| 5-Azacytidine_Hs 766T | 5-Azacytidine perturbation in Hs 766T cell line |
| Tubulin inhibitor 6_C32 | Tubulin inhibitor 6 perturbation in C32 cell line |
| Penfluridol_BT-474 | Penfluridol perturbation in BT-474 cell line |
| Posaconazole_A549 | Posaconazole perturbation in A549 cell line |
| Bortezomib_HT-29 | Bortezomib perturbation in HT-29 cell line |
| Topotecan (hydrochloride)_NCI-H2122 | Topotecan (hydrochloride) perturbation in NCI-H2122 cell line |
| Tucatinib_BT-474 | Tucatinib perturbation in BT-474 cell line |
| Sodium Salicylate_BT-474 | Sodium Salicylate perturbation in BT-474 cell line |
| Fluvoxamine (maleate)_C32 | Fluvoxamine (maleate) perturbation in C32 cell line |
| Ipatasertib_NCI-H1792 | Ipatasertib perturbation in NCI-H1792 cell line |
| Acetohexamide_BT-474 | Acetohexamide perturbation in BT-474 cell line |
| Oleic acid_Panc 03.27 | Oleic acid perturbation in Panc 03.27 cell line |
| Verapamil_Hs 766T | Verapamil perturbation in Hs 766T cell line |
| Sapanisertib_NCI-H1792 | Sapanisertib perturbation in NCI-H1792 cell line |
| Almonertinib (hydrochloride)_HepG2/C3A | Almonertinib (hydrochloride) perturbation in HepG2/C3A cell line |
| Rimonabant_SHP-77 | Rimonabant perturbation in SHP-77 cell line |
| Dabrafenib_SW480 | Dabrafenib perturbation in SW480 cell line |
| Cytarabine_A549 | Cytarabine perturbation in A549 cell line |
| Canagliflozin_COLO 205 | Canagliflozin perturbation in COLO 205 cell line |
| Sodium Salicylate_SW1417 | Sodium Salicylate perturbation in SW1417 cell line |
| Omeprazole_HT-29 | Omeprazole perturbation in HT-29 cell line |
| Nafamostat (mesylate)_SK-MEL-2 | Nafamostat (mesylate) perturbation in SK-MEL-2 cell line |
| XRK3F2_SW1417 | XRK3F2 perturbation in SW1417 cell line |
| Tucidinostat_LS 180 | Tucidinostat perturbation in LS 180 cell line |
| Ornidazole_A498 | Ornidazole perturbation in A498 cell line |
| Epirubicin (hydrochloride)_A-172 | Epirubicin (hydrochloride) perturbation in A-172 cell line |
| Docetaxel_HepG2/C3A | Docetaxel perturbation in HepG2/C3A cell line |
| Clofarabine_A498 | Clofarabine perturbation in A498 cell line |
| Abemaciclib_HEC-1-A | Abemaciclib perturbation in HEC-1-A cell line |
| Sulfisoxazole_NCI-H2347 | Sulfisoxazole perturbation in NCI-H2347 cell line |
| DT-061_SW1417 | DT-061 perturbation in SW1417 cell line |
| Darolutamide_HT-29 | Darolutamide perturbation in HT-29 cell line |
| Minodronic acid_NCI-H596 | Minodronic acid perturbation in NCI-H596 cell line |
| MK-8353_BT-474 | MK-8353 perturbation in BT-474 cell line |
| Ranolazine_AsPC-1 | Ranolazine perturbation in AsPC-1 cell line |
| Quinestrol_SK-MEL-2 | Quinestrol perturbation in SK-MEL-2 cell line |
| Elagolix sodium_Panc 03.27 | Elagolix sodium perturbation in Panc 03.27 cell line |
| Docetaxel_SW 1088 | Docetaxel perturbation in SW 1088 cell line |
| Capivasertib_HT-29 | Capivasertib perturbation in HT-29 cell line |
| ML264_Panc 03.27 | ML264 perturbation in Panc 03.27 cell line |
| Fedratinib (hydrochloride hydrate)_Panc 03.27 | Fedratinib (hydrochloride hydrate) perturbation in Panc 03.27 cell line |
| Capivasertib_Hs 766T | Capivasertib perturbation in Hs 766T cell line |
| Thymopentin_HEC-1-A | Thymopentin perturbation in HEC-1-A cell line |
| IQ 1_SW1417 | IQ 1 perturbation in SW1417 cell line |
| Temsirolimus_SK-MEL-2 | Temsirolimus perturbation in SK-MEL-2 cell line |
| Bendamustine_NCI-H1573 | Bendamustine perturbation in NCI-H1573 cell line |
| Tofacitinib_HEC-1-A | Tofacitinib perturbation in HEC-1-A cell line |
| Baicalin_HEC-1-A | Baicalin perturbation in HEC-1-A cell line |
| Simotinib_A549 | Simotinib perturbation in A549 cell line |
| Dihydroartemisinin_AsPC-1 | Dihydroartemisinin perturbation in AsPC-1 cell line |
| Docetaxel_NCI-H2030 | Docetaxel perturbation in NCI-H2030 cell line |
| Chlorhexidine (diacetate)_A498 | Chlorhexidine (diacetate) perturbation in A498 cell line |
| Levobupivacaine (hydrochloride)_A549 | Levobupivacaine (hydrochloride) perturbation in A549 cell line |
| Pemigatinib_COLO 205 | Pemigatinib perturbation in COLO 205 cell line |
| Tazarotene_SW 900 | Tazarotene perturbation in SW 900 cell line |
| 18β-Glycyrrhetinic acid_A549 | 18β-Glycyrrhetinic acid perturbation in A549 cell line |
| Hydroxyfasudil_C32 | Hydroxyfasudil perturbation in C32 cell line |
| Citalopram (hydrobromide)_NCI-H1792 | Citalopram (hydrobromide) perturbation in NCI-H1792 cell line |
| Futibatinib_C32 | Futibatinib perturbation in C32 cell line |
| Tucidinostat_A549 | Tucidinostat perturbation in A549 cell line |
| IQ 1_SW 1271 | IQ 1 perturbation in SW 1271 cell line |
| Artemether_A498 | Artemether perturbation in A498 cell line |
| Brivudine_Panc 03.27 | Brivudine perturbation in Panc 03.27 cell line |
| Dexmedetomidine_C32 | Dexmedetomidine perturbation in C32 cell line |
| Dexamethasone_HT-29 | Dexamethasone perturbation in HT-29 cell line |
| Bentamapimod_C32 | Bentamapimod perturbation in C32 cell line |
| Pasireotide (acetate)_SW480 | Pasireotide (acetate) perturbation in SW480 cell line |
| Flutamide_A549 | Flutamide perturbation in A549 cell line |
| Infigratinib_Panc 03.27 | Infigratinib perturbation in Panc 03.27 cell line |
| Vinblastine (sulfate)_A498 | Vinblastine (sulfate) perturbation in A498 cell line |
| Irinotecan_Panc 03.27 | Irinotecan perturbation in Panc 03.27 cell line |
| Ipatasertib_J82 | Ipatasertib perturbation in J82 cell line |
| Lipoic acid_Panc 03.27 | Lipoic acid perturbation in Panc 03.27 cell line |
| DT-061_SW 1271 | DT-061 perturbation in SW 1271 cell line |
| EX229_HEC-1-A | EX229 perturbation in HEC-1-A cell line |
| BI-3406_HepG2/C3A | BI-3406 perturbation in HepG2/C3A cell line |
| Bestatin_HEC-1-A | Bestatin perturbation in HEC-1-A cell line |
| Tubulin inhibitor 6_NCI-H2122 | Tubulin inhibitor 6 perturbation in NCI-H2122 cell line |
| Bicalutamide_HT-29 | Bicalutamide perturbation in HT-29 cell line |
| Cyclosporin A_AsPC-1 | Cyclosporin A perturbation in AsPC-1 cell line |
| XRK3F2_SW 1271 | XRK3F2 perturbation in SW 1271 cell line |
| Lenalidomide (hemihydrate)_A498 | Lenalidomide (hemihydrate) perturbation in A498 cell line |
| Almonertinib (mesylate)_Hs 766T | Almonertinib (mesylate) perturbation in Hs 766T cell line |
| Tucatinib_SW 1271 | Tucatinib perturbation in SW 1271 cell line |
| Neratinib_J82 | Neratinib perturbation in J82 cell line |
| Fluvoxamine_HT-29 | Fluvoxamine perturbation in HT-29 cell line |
| ERK5-IN-2_BT-474 | ERK5-IN-2 perturbation in BT-474 cell line |
| Allantoin_NCI-H1792 | Allantoin perturbation in NCI-H1792 cell line |
| Baicalin_H4 | Baicalin perturbation in H4 cell line |
| Lapatinib ditosylate_SW480 | Lapatinib ditosylate perturbation in SW480 cell line |
| Cytarabine (hydrochloride)_Hs 766T | Cytarabine (hydrochloride) perturbation in Hs 766T cell line |
| Goserelin (acetate)_A498 | Goserelin (acetate) perturbation in A498 cell line |
| Menadione_NCI-H1573 | Menadione perturbation in NCI-H1573 cell line |
| Bimatoprost_BT-474 | Bimatoprost perturbation in BT-474 cell line |
| APTO-253_NCI-H2030 | APTO-253 perturbation in NCI-H2030 cell line |
| Salicylic acid_MIA PaCa-2 | Salicylic acid perturbation in MIA PaCa-2 cell line |
| Imiquimod (hydrochloride)_AsPC-1 | Imiquimod (hydrochloride) perturbation in AsPC-1 cell line |
| Betamethasone dipropionate_Panc 03.27 | Betamethasone dipropionate perturbation in Panc 03.27 cell line |
| Diammonium Glycyrrhizinate_HEC-1-A | Diammonium Glycyrrhizinate perturbation in HEC-1-A cell line |
| Hesperidin_NCI-H2347 | Hesperidin perturbation in NCI-H2347 cell line |
| Tadalafil_C32 | Tadalafil perturbation in C32 cell line |
| 8-Hydroxyquinoline_NCI-H2347 | 8-Hydroxyquinoline perturbation in NCI-H2347 cell line |
| AZD2858_MIA PaCa-2 | AZD2858 perturbation in MIA PaCa-2 cell line |
| SBI-0640756_SK-MEL-2 | SBI-0640756 perturbation in SK-MEL-2 cell line |
| Pralsetinib_HEC-1-A | Pralsetinib perturbation in HEC-1-A cell line |
| Penfluridol_AsPC-1 | Penfluridol perturbation in AsPC-1 cell line |
| Pentagastrin_SW 1271 | Pentagastrin perturbation in SW 1271 cell line |
| Hydroxyurea_NCI-H1573 | Hydroxyurea perturbation in NCI-H1573 cell line |
| Retinoic acid_A549 | Retinoic acid perturbation in A549 cell line |
| Berbamine_A549 | Berbamine perturbation in A549 cell line |
| Oxaliplatin_HT-29 | Oxaliplatin perturbation in HT-29 cell line |
| Vinblastine (sulfate)_AN3 CA | Vinblastine (sulfate) perturbation in AN3 CA cell line |
| ERK5-IN-2_HepG2/C3A | ERK5-IN-2 perturbation in HepG2/C3A cell line |
| Terfenadine_Panc 03.27 | Terfenadine perturbation in Panc 03.27 cell line |
| Quinestrol_HT-29 | Quinestrol perturbation in HT-29 cell line |
| Cabozantinib (S-malate)_SK-MEL-2 | Cabozantinib (S-malate) perturbation in SK-MEL-2 cell line |
| (R)-Verapamil (hydrochloride)_SW48 | (R)-Verapamil (hydrochloride) perturbation in SW48 cell line |
| NVP-BHG712_NCI-H2347 | NVP-BHG712 perturbation in NCI-H2347 cell line |
| (R)-Verapamil (hydrochloride)_A498 | (R)-Verapamil (hydrochloride) perturbation in A498 cell line |
| Sodium Salicylate_AsPC-1 | Sodium Salicylate perturbation in AsPC-1 cell line |
| Bimatoprost_HepG2/C3A | Bimatoprost perturbation in HepG2/C3A cell line |
| Temsirolimus_HT-29 | Temsirolimus perturbation in HT-29 cell line |
| Clopidogrel_SK-MEL-2 | Clopidogrel perturbation in SK-MEL-2 cell line |
| Tofacitinib_A-172 | Tofacitinib perturbation in A-172 cell line |
| Anethole trithione_Panc 03.27 | Anethole trithione perturbation in Panc 03.27 cell line |
| ERK5-IN-2_NCI-H2030 | ERK5-IN-2 perturbation in NCI-H2030 cell line |
| Oxaprozin_A498 | Oxaprozin perturbation in A498 cell line |
| Capivasertib_SK-MEL-2 | Capivasertib perturbation in SK-MEL-2 cell line |
| AT7519_HT-29 | AT7519 perturbation in HT-29 cell line |
| Allopurinol_SK-MEL-2 | Allopurinol perturbation in SK-MEL-2 cell line |
| Bestatin_HS-578T | Bestatin perturbation in HS-578T cell line |
| APTO-253_SW1417 | APTO-253 perturbation in SW1417 cell line |
| Aliskiren_PANC-1 | Aliskiren perturbation in PANC-1 cell line |
| Vortioxetine_HEC-1-A | Vortioxetine perturbation in HEC-1-A cell line |
| Isocorydine_HepG2/C3A | Isocorydine perturbation in HepG2/C3A cell line |
| Rapamycin_HEC-1-A | Rapamycin perturbation in HEC-1-A cell line |
| Osimertinib (mesylate)_NCI-H1792 | Osimertinib (mesylate) perturbation in NCI-H1792 cell line |
| Belinostat_Panc 03.27 | Belinostat perturbation in Panc 03.27 cell line |
| Dapagliflozin ((2S)-1,2-propanediol, hydrate)_NCI-H1792 | Dapagliflozin ((2S)-1,2-propanediol, hydrate) perturbation in NCI-H1792 cell line |
| Demeclocycline_SW1417 | Demeclocycline perturbation in SW1417 cell line |
| BI-3406_SW1417 | BI-3406 perturbation in SW1417 cell line |
| Docetaxel_SW 1271 | Docetaxel perturbation in SW 1271 cell line |
| Temuterkib_PANC-1 | Temuterkib perturbation in PANC-1 cell line |
| Bortezomib_SK-MEL-2 | Bortezomib perturbation in SK-MEL-2 cell line |
| Ferulic acid_Panc 03.27 | Ferulic acid perturbation in Panc 03.27 cell line |
| Doxorubicin (hydrochloride)_NCI-H460 | Doxorubicin (hydrochloride) perturbation in NCI-H460 cell line |
| Ivermectin_SK-MEL-2 | Ivermectin perturbation in SK-MEL-2 cell line |
| Vilanterol_Panc 03.27 | Vilanterol perturbation in Panc 03.27 cell line |
| Minodronic acid_HT-29 | Minodronic acid perturbation in HT-29 cell line |
| Encorafenib_A498 | Encorafenib perturbation in A498 cell line |
| Demeclocycline_BT-474 | Demeclocycline perturbation in BT-474 cell line |
| Omeprazole (sodium)_HepG2/C3A | Omeprazole (sodium) perturbation in HepG2/C3A cell line |
| Sapanisertib_MIA PaCa-2 | Sapanisertib perturbation in MIA PaCa-2 cell line |
| vincristine_Panc 03.27 | vincristine perturbation in Panc 03.27 cell line |
| IQ 1_HepG2/C3A | IQ 1 perturbation in HepG2/C3A cell line |
| Bicalutamide_SK-MEL-2 | Bicalutamide perturbation in SK-MEL-2 cell line |
| NG25_Panc 03.27 | NG25 perturbation in Panc 03.27 cell line |
| Hydroxyurea_NCI-H2122 | Hydroxyurea perturbation in NCI-H2122 cell line |
| Peretinoin_COLO 205 | Peretinoin perturbation in COLO 205 cell line |
| MK-8353_HepG2/C3A | MK-8353 perturbation in HepG2/C3A cell line |
| Tranilast_Panc 03.27 | Tranilast perturbation in Panc 03.27 cell line |
| Finasteride_AsPC-1 | Finasteride perturbation in AsPC-1 cell line |
| Fluvoxamine_SK-MEL-2 | Fluvoxamine perturbation in SK-MEL-2 cell line |
| Aliskiren_HEC-1-A | Aliskiren perturbation in HEC-1-A cell line |
| Tirabrutinib_SW1417 | Tirabrutinib perturbation in SW1417 cell line |
| Docetaxel (Trihydrate)_SNU-423 | Docetaxel (Trihydrate) perturbation in SNU-423 cell line |
| BI-3406_SW 1271 | BI-3406 perturbation in SW 1271 cell line |
| Idarubicin (hydrochloride)_LS 180 | Idarubicin (hydrochloride) perturbation in LS 180 cell line |
| Entecavir (monohydrate)_A549 | Entecavir (monohydrate) perturbation in A549 cell line |
| DT-061_HepG2/C3A | DT-061 perturbation in HepG2/C3A cell line |
| Darinaparsin_HOP62 | Darinaparsin perturbation in HOP62 cell line |
| Capmatinib_Panc 03.27 | Capmatinib perturbation in Panc 03.27 cell line |
| Canagliflozin_SW 1271 | Canagliflozin perturbation in SW 1271 cell line |
| CP21R7_HEC-1-A | CP21R7 perturbation in HEC-1-A cell line |
| Folic acid_NCI-H1573 | Folic acid perturbation in NCI-H1573 cell line |
| Pemigatinib_BT-474 | Pemigatinib perturbation in BT-474 cell line |
| AZD1390_HT-29 | AZD1390 perturbation in HT-29 cell line |
| Pimitespib_SK-MEL-2 | Pimitespib perturbation in SK-MEL-2 cell line |
| Penfluridol_HepG2/C3A | Penfluridol perturbation in HepG2/C3A cell line |
| Folic acid_AN3 CA | Folic acid perturbation in AN3 CA cell line |
| Tucatinib_HepG2/C3A | Tucatinib perturbation in HepG2/C3A cell line |
| ERK5-IN-2_AsPC-1 | ERK5-IN-2 perturbation in AsPC-1 cell line |
| Norepinephrine (hydrochloride)_SW 1271 | Norepinephrine (hydrochloride) perturbation in SW 1271 cell line |
| Acetohexamide_NCI-H2030 | Acetohexamide perturbation in NCI-H2030 cell line |
| palbociclib_Panc 03.27 | palbociclib perturbation in Panc 03.27 cell line |
| Gefitinib_A549 | Gefitinib perturbation in A549 cell line |
| Bestatin (hydrochloride)_J82 | Bestatin (hydrochloride) perturbation in J82 cell line |
| Ligustrazine_C32 | Ligustrazine perturbation in C32 cell line |
| Pemigatinib_SW1417 | Pemigatinib perturbation in SW1417 cell line |
| Tubulin inhibitor 6_A498 | Tubulin inhibitor 6 perturbation in A498 cell line |
| Amsacrine_PANC-1 | Amsacrine perturbation in PANC-1 cell line |
| Zileuton_BT-474 | Zileuton perturbation in BT-474 cell line |
| Tucatinib_NCI-H2030 | Tucatinib perturbation in NCI-H2030 cell line |
| Belumosudil (mesylate)_HT-29 | Belumosudil (mesylate) perturbation in HT-29 cell line |
| Cyclosporin A_SW1417 | Cyclosporin A perturbation in SW1417 cell line |
| Phenylephrine (hydrochloride)_SK-MEL-2 | Phenylephrine (hydrochloride) perturbation in SK-MEL-2 cell line |
| Fumaric acid_AsPC-1 | Fumaric acid perturbation in AsPC-1 cell line |
| Lopinavir_Hs 766T | Lopinavir perturbation in Hs 766T cell line |
| Fluvoxamine_NCI-H596 | Fluvoxamine perturbation in NCI-H596 cell line |
| Pentagastrin_SW1417 | Pentagastrin perturbation in SW1417 cell line |
| BAY1125976_NCI-H2347 | BAY1125976 perturbation in NCI-H2347 cell line |
| Doxorubicin (hydrochloride)_RKO | Doxorubicin (hydrochloride) perturbation in RKO cell line |
| Fusidic acid_SW1417 | Fusidic acid perturbation in SW1417 cell line |
| Acetazolamide_A498 | Acetazolamide perturbation in A498 cell line |
| Methyl aminolevulinate (hydrochloride)_Hs 766T | Methyl aminolevulinate (hydrochloride) perturbation in Hs 766T cell line |
| Quinestrol_PANC-1 | Quinestrol perturbation in PANC-1 cell line |
| Homoharringtonine_SNU-423 | Homoharringtonine perturbation in SNU-423 cell line |
| Captopril_A549 | Captopril perturbation in A549 cell line |
| Radotinib_HT-29 | Radotinib perturbation in HT-29 cell line |
| Tofacitinib (citrate)_NCI-H1792 | Tofacitinib (citrate) perturbation in NCI-H1792 cell line |
| Homoharringtonine_MIA PaCa-2 | Homoharringtonine perturbation in MIA PaCa-2 cell line |
| Ropivacaine (hydrochloride monohydrate)_SK-MEL-2 | Ropivacaine (hydrochloride monohydrate) perturbation in SK-MEL-2 cell line |
| Fusidic acid_BT-474 | Fusidic acid perturbation in BT-474 cell line |
| Cepharanthine_SW1417 | Cepharanthine perturbation in SW1417 cell line |
| Aliskiren_HT-29 | Aliskiren perturbation in HT-29 cell line |
| Methylprednisolone succinate_A498 | Methylprednisolone succinate perturbation in A498 cell line |
| Homoharringtonine_HOP62 | Homoharringtonine perturbation in HOP62 cell line |
| Bimatoprost_LS 180 | Bimatoprost perturbation in LS 180 cell line |
| IQ 1_A549 | IQ 1 perturbation in A549 cell line |
| CP21R7_HT-29 | CP21R7 perturbation in HT-29 cell line |
| Lucanthone_BT-474 | Lucanthone perturbation in BT-474 cell line |
| Mitoxantrone (dihydrochloride)_C32 | Mitoxantrone (dihydrochloride) perturbation in C32 cell line |
| Sapanisertib_NCI-H1573 | Sapanisertib perturbation in NCI-H1573 cell line |
| Belumosudil_A549 | Belumosudil perturbation in A549 cell line |
| Pasireotide (acetate)_SW1417 | Pasireotide (acetate) perturbation in SW1417 cell line |
| Temuterkib_HT-29 | Temuterkib perturbation in HT-29 cell line |
| Pitavastatin (Calcium)_NCI-H1573 | Pitavastatin (Calcium) perturbation in NCI-H1573 cell line |
| GSK1059615_A498 | GSK1059615 perturbation in A498 cell line |
| Tubulin inhibitor 6_NCI-H1792 | Tubulin inhibitor 6 perturbation in NCI-H1792 cell line |
| Dabrafenib_SW 1271 | Dabrafenib perturbation in SW 1271 cell line |
| Clotrimazole_SK-MEL-2 | Clotrimazole perturbation in SK-MEL-2 cell line |
| Fluvoxamine (maleate)_NCI-H1792 | Fluvoxamine (maleate) perturbation in NCI-H1792 cell line |
| Berberine (chloride hydrate)_A498 | Berberine (chloride hydrate) perturbation in A498 cell line |
| Thymol_HepG2/C3A | Thymol perturbation in HepG2/C3A cell line |
| AZD-7648_Panc 03.27 | AZD-7648 perturbation in Panc 03.27 cell line |
| Ipatasertib_C32 | Ipatasertib perturbation in C32 cell line |
| Anastrozole_SW1417 | Anastrozole perturbation in SW1417 cell line |
| Rimonabant_HOP62 | Rimonabant perturbation in HOP62 cell line |
| Vemurafenib_HT-29 | Vemurafenib perturbation in HT-29 cell line |
| Bendamustine_NCI-H1792 | Bendamustine perturbation in NCI-H1792 cell line |
| Retinoic acid_AsPC-1 | Retinoic acid perturbation in AsPC-1 cell line |
| Drospirenone_Panc 03.27 | Drospirenone perturbation in Panc 03.27 cell line |
| Lumateperone (tosylate)_MIA PaCa-2 | Lumateperone (tosylate) perturbation in MIA PaCa-2 cell line |
| Plicamycin_A549 | Plicamycin perturbation in A549 cell line |
| DTP3_NCI-H2030 | DTP3 perturbation in NCI-H2030 cell line |
| Pyridoxine_SW480 | Pyridoxine perturbation in SW480 cell line |
| Penfluridol_A549 | Penfluridol perturbation in A549 cell line |
| Benproperine (phosphate)_Panc 03.27 | Benproperine (phosphate) perturbation in Panc 03.27 cell line |
| Neratinib_NCI-H1573 | Neratinib perturbation in NCI-H1573 cell line |
| Ribociclib_NCI-H2347 | Ribociclib perturbation in NCI-H2347 cell line |
| LY-2584702 (tosylate salt)_HepG2/C3A | LY-2584702 (tosylate salt) perturbation in HepG2/C3A cell line |
| Fenofibrate_NCI-H596 | Fenofibrate perturbation in NCI-H596 cell line |
| Busulfan_SNU-423 | Busulfan perturbation in SNU-423 cell line |
| Darinaparsin_C32 | Darinaparsin perturbation in C32 cell line |
| Berbamine_AsPC-1 | Berbamine perturbation in AsPC-1 cell line |
| XRK3F2_A549 | XRK3F2 perturbation in A549 cell line |
| Pralsetinib_Hs 766T | Pralsetinib perturbation in Hs 766T cell line |
| Abemaciclib_SK-MEL-2 | Abemaciclib perturbation in SK-MEL-2 cell line |
| Methotrexate_NCI-H2122 | Methotrexate perturbation in NCI-H2122 cell line |
| Fumaric acid_A549 | Fumaric acid perturbation in A549 cell line |
| Pralsetinib_HT-29 | Pralsetinib perturbation in HT-29 cell line |
| Homoharringtonine_CFPAC-1 | Homoharringtonine perturbation in CFPAC-1 cell line |
| Fostamatinib (disodium hexahydrate)_J82 | Fostamatinib (disodium hexahydrate) perturbation in J82 cell line |
| Sonidegib_Panc 03.27 | Sonidegib perturbation in Panc 03.27 cell line |
| Quinestrol_HEC-1-A | Quinestrol perturbation in HEC-1-A cell line |
| Dabrafenib_BT-474 | Dabrafenib perturbation in BT-474 cell line |
| Vinblastine (sulfate)_HOP62 | Vinblastine (sulfate) perturbation in HOP62 cell line |
| Oxaliplatin_HEC-1-A | Oxaliplatin perturbation in HEC-1-A cell line |
| Piroxicam_HT-29 | Piroxicam perturbation in HT-29 cell line |
| Tolmetin_Panc 03.27 | Tolmetin perturbation in Panc 03.27 cell line |
| DTP3_AsPC-1 | DTP3 perturbation in AsPC-1 cell line |
| Allantoin_C32 | Allantoin perturbation in C32 cell line |
| Rimonabant (Hydrochloride)_AsPC-1 | Rimonabant (Hydrochloride) perturbation in AsPC-1 cell line |
| LJI308_SW1417 | LJI308 perturbation in SW1417 cell line |
| 9-ING-41_HEC-1-A | 9-ING-41 perturbation in HEC-1-A cell line |
| Sodium Salicylate_SW480 | Sodium Salicylate perturbation in SW480 cell line |
| SBI-0640756_PANC-1 | SBI-0640756 perturbation in PANC-1 cell line |
| Retinoic acid_HepG2/C3A | Retinoic acid perturbation in HepG2/C3A cell line |
| Bergenin_SK-MEL-2 | Bergenin perturbation in SK-MEL-2 cell line |
| Pemetrexed_NCI-H2347 | Pemetrexed perturbation in NCI-H2347 cell line |
| Dabrafenib_SW1417 | Dabrafenib perturbation in SW1417 cell line |
| ERK5-IN-2_A549 | ERK5-IN-2 perturbation in A549 cell line |
| Phenytoin (sodium)_A549 | Phenytoin (sodium) perturbation in A549 cell line |
| Baicalin_SK-MEL-2 | Baicalin perturbation in SK-MEL-2 cell line |
| Tofacitinib_SK-MEL-2 | Tofacitinib perturbation in SK-MEL-2 cell line |
| Clonidine (hydrochloride)_HT-29 | Clonidine (hydrochloride) perturbation in HT-29 cell line |
| Entecavir (monohydrate)_AsPC-1 | Entecavir (monohydrate) perturbation in AsPC-1 cell line |
| Ixazomib_MIA PaCa-2 | Ixazomib perturbation in MIA PaCa-2 cell line |
| Irinotecan (hydrochloride)_Panc 03.27 | Irinotecan (hydrochloride) perturbation in Panc 03.27 cell line |
| Volasertib_SW1417 | Volasertib perturbation in SW1417 cell line |
| Panobinostat_AsPC-1 | Panobinostat perturbation in AsPC-1 cell line |
| ML264_NCI-H2347 | ML264 perturbation in NCI-H2347 cell line |
| Bestatin (hydrochloride)_A498 | Bestatin (hydrochloride) perturbation in A498 cell line |
| Idoxuridine_HT-29 | Idoxuridine perturbation in HT-29 cell line |
| Tucidinostat_SW1417 | Tucidinostat perturbation in SW1417 cell line |
| LB-100_HepG2/C3A | LB-100 perturbation in HepG2/C3A cell line |
| Lonafarnib_MIA PaCa-2 | Lonafarnib perturbation in MIA PaCa-2 cell line |
| Lucanthone_SW 1271 | Lucanthone perturbation in SW 1271 cell line |
| (S)-Crizotinib_A549 | (S)-Crizotinib perturbation in A549 cell line |
| Belzutifan_Panc 03.27 | Belzutifan perturbation in Panc 03.27 cell line |
| Elagolix sodium_NCI-H2347 | Elagolix sodium perturbation in NCI-H2347 cell line |
| Alpelisib_SW1417 | Alpelisib perturbation in SW1417 cell line |
| Doxycycline (monohydrate)_HEC-1-A | Doxycycline (monohydrate) perturbation in HEC-1-A cell line |
| Rifaximin_SW1417 | Rifaximin perturbation in SW1417 cell line |
| Selinexor _C32 | Selinexor perturbation in C32 cell line |
| RMC-6236_AsPC-1 | RMC-6236 perturbation in AsPC-1 cell line |
| Finasteride_A549 | Finasteride perturbation in A549 cell line |
| TAK-901_NCI-H2122 | TAK-901 perturbation in NCI-H2122 cell line |
| Triclosan_HEC-1-A | Triclosan perturbation in HEC-1-A cell line |
| Fusidic acid_SW 1271 | Fusidic acid perturbation in SW 1271 cell line |
| Doxorubicin (hydrochloride)_Panc 03.27 | Doxorubicin (hydrochloride) perturbation in Panc 03.27 cell line |
| Clotrimazole_HT-29 | Clotrimazole perturbation in HT-29 cell line |
| Salicylic acid_C32 | Salicylic acid perturbation in C32 cell line |
| Delamanid_NCI-H1573 | Delamanid perturbation in NCI-H1573 cell line |
| Alpelisib_HepG2/C3A | Alpelisib perturbation in HepG2/C3A cell line |
| Tucidinostat_NCI-H2030 | Tucidinostat perturbation in NCI-H2030 cell line |
| Temuterkib_SK-MEL-2 | Temuterkib perturbation in SK-MEL-2 cell line |
| Vinblastine (sulfate)_NCI-H1792 | Vinblastine (sulfate) perturbation in NCI-H1792 cell line |
| Celecoxib_SW1417 | Celecoxib perturbation in SW1417 cell line |
| L-Thyroxine (sodium salt pentahydrate)_AsPC-1 | L-Thyroxine (sodium salt pentahydrate) perturbation in AsPC-1 cell line |
| ULK-101_LoVo | ULK-101 perturbation in LoVo cell line |
| Nimesulide_HEC-1-A | Nimesulide perturbation in HEC-1-A cell line |
| crizotinib_NCI-H2030 | crizotinib perturbation in NCI-H2030 cell line |
| Levobupivacaine (hydrochloride)_AsPC-1 | Levobupivacaine (hydrochloride) perturbation in AsPC-1 cell line |
| TAK-733_BT-474 | TAK-733 perturbation in BT-474 cell line |
| Dapagliflozin ((2S)-1,2-propanediol, hydrate)_C32 | Dapagliflozin ((2S)-1,2-propanediol, hydrate) perturbation in C32 cell line |
| Capmatinib_NCI-H2347 | Capmatinib perturbation in NCI-H2347 cell line |
| AZD2858_C32 | AZD2858 perturbation in C32 cell line |
| Ralimetinib dimesylate_HT-29 | Ralimetinib dimesylate perturbation in HT-29 cell line |
| Vismodegib_NCI-H2347 | Vismodegib perturbation in NCI-H2347 cell line |
| Selinexor _SW48 | Selinexor perturbation in SW48 cell line |
| RMC-6236_SW 1271 | RMC-6236 perturbation in SW 1271 cell line |
| Citalopram (hydrobromide)_A498 | Citalopram (hydrobromide) perturbation in A498 cell line |
| Volasertib_HepG2/C3A | Volasertib perturbation in HepG2/C3A cell line |
| Rutin (trihydrate)_Panc 03.27 | Rutin (trihydrate) perturbation in Panc 03.27 cell line |
| EX229_HT-29 | EX229 perturbation in HT-29 cell line |
| TAK-733_SW1417 | TAK-733 perturbation in SW1417 cell line |
| Malotilate_A549 | Malotilate perturbation in A549 cell line |
| Ornidazole_J82 | Ornidazole perturbation in J82 cell line |
| vincristine_NCI-H2347 | vincristine perturbation in NCI-H2347 cell line |
| Tucidinostat_HepG2/C3A | Tucidinostat perturbation in HepG2/C3A cell line |
| Artemether_NCI-H1792 | Artemether perturbation in NCI-H1792 cell line |
| Gemcitabine_SNU-423 | Gemcitabine perturbation in SNU-423 cell line |
| Docetaxel_SW480 | Docetaxel perturbation in SW480 cell line |
| Osimertinib (mesylate)_NCI-H1573 | Osimertinib (mesylate) perturbation in NCI-H1573 cell line |
| Elimusertib hydrochloride_BT-474 | Elimusertib hydrochloride perturbation in BT-474 cell line |
| Cytarabine_AsPC-1 | Cytarabine perturbation in AsPC-1 cell line |
| Retinoic acid_SW1417 | Retinoic acid perturbation in SW1417 cell line |
| BAY1125976_Panc 03.27 | BAY1125976 perturbation in Panc 03.27 cell line |
| Larotrectinib_NCI-H1792 | Larotrectinib perturbation in NCI-H1792 cell line |
| DTP3_SW 1271 | DTP3 perturbation in SW 1271 cell line |
| Dabrafenib_HepG2/C3A | Dabrafenib perturbation in HepG2/C3A cell line |
| Trimetrexate_HepG2/C3A | Trimetrexate perturbation in HepG2/C3A cell line |
| Palmatine (chloride)_Panc 03.27 | Palmatine (chloride) perturbation in Panc 03.27 cell line |
| Cinacalcet_HEC-1-A | Cinacalcet perturbation in HEC-1-A cell line |
| Cytarabine (hydrochloride)_HEC-1-A | Cytarabine (hydrochloride) perturbation in HEC-1-A cell line |
| Elimusertib hydrochloride_SW1417 | Elimusertib hydrochloride perturbation in SW1417 cell line |
| Norepinephrine (hydrochloride)_A549 | Norepinephrine (hydrochloride) perturbation in A549 cell line |
| Lenalidomide (hemihydrate)_NCI-H1792 | Lenalidomide (hemihydrate) perturbation in NCI-H1792 cell line |
| palbociclib_NCI-H2347 | palbociclib perturbation in NCI-H2347 cell line |
| Retinoic acid_BT-474 | Retinoic acid perturbation in BT-474 cell line |
| PF-06260933_Panc 03.27 | PF-06260933 perturbation in Panc 03.27 cell line |
| Berberine (chloride hydrate)_NCI-H2122 | Berberine (chloride hydrate) perturbation in NCI-H2122 cell line |
| Encorafenib_MIA PaCa-2 | Encorafenib perturbation in MIA PaCa-2 cell line |
| CP21R7_SK-MEL-2 | CP21R7 perturbation in SK-MEL-2 cell line |
| Lonafarnib_NCI-H1792 | Lonafarnib perturbation in NCI-H1792 cell line |
| Anastrozole_AsPC-1 | Anastrozole perturbation in AsPC-1 cell line |
| Capivasertib_PANC-1 | Capivasertib perturbation in PANC-1 cell line |
| Imiquimod (hydrochloride)_A549 | Imiquimod (hydrochloride) perturbation in A549 cell line |
| Zileuton_A549 | Zileuton perturbation in A549 cell line |
| Raltitrexed_Panc 03.27 | Raltitrexed perturbation in Panc 03.27 cell line |
| Rapamycin_SK-MEL-2 | Rapamycin perturbation in SK-MEL-2 cell line |
| 4EGI-1_Panc 03.27 | 4EGI-1 perturbation in Panc 03.27 cell line |
| Tirabrutinib (hydrochloride)_HEC-1-A | Tirabrutinib (hydrochloride) perturbation in HEC-1-A cell line |
| Torkinib_BT-474 | Torkinib perturbation in BT-474 cell line |
| Bortezomib_HEC-1-A | Bortezomib perturbation in HEC-1-A cell line |
| Erdafitinib _Panc 03.27 | Erdafitinib perturbation in Panc 03.27 cell line |
| Furosemide_HepG2/C3A | Furosemide perturbation in HepG2/C3A cell line |
| Artemether_J82 | Artemether perturbation in J82 cell line |
| Idoxuridine_SK-MEL-2 | Idoxuridine perturbation in SK-MEL-2 cell line |
| Elimusertib hydrochloride_SW 1271 | Elimusertib hydrochloride perturbation in SW 1271 cell line |
| Gemcitabine_CFPAC-1 | Gemcitabine perturbation in CFPAC-1 cell line |
| NVP-BHG712_Panc 03.27 | NVP-BHG712 perturbation in Panc 03.27 cell line |
| Ligustrazine_NCI-H1792 | Ligustrazine perturbation in NCI-H1792 cell line |
| Cyclosporin A_A549 | Cyclosporin A perturbation in A549 cell line |
| Vinblastine (sulfate)_KATO III | Vinblastine (sulfate) perturbation in KATO III cell line |
| DTP3_SW1417 | DTP3 perturbation in SW1417 cell line |
| Homoharringtonine_NCI-H1792 | Homoharringtonine perturbation in NCI-H1792 cell line |
| Nevirapine_Panc 03.27 | Nevirapine perturbation in Panc 03.27 cell line |
| Altretamine_Hs 766T | Altretamine perturbation in Hs 766T cell line |
| Retinoic acid_SW 1271 | Retinoic acid perturbation in SW 1271 cell line |
| Torkinib_SW1417 | Torkinib perturbation in SW1417 cell line |
| venetoclax_Panc 03.27 | venetoclax perturbation in Panc 03.27 cell line |
| Amsacrine_SK-MEL-2 | Amsacrine perturbation in SK-MEL-2 cell line |
| Anastrozole_HepG2/C3A | Anastrozole perturbation in HepG2/C3A cell line |
| Cepharanthine_HepG2/C3A | Cepharanthine perturbation in HepG2/C3A cell line |
| LB-100_SW 1271 | LB-100 perturbation in SW 1271 cell line |
| Cytarabine (hydrochloride)_PANC-1 | Cytarabine (hydrochloride) perturbation in PANC-1 cell line |
| Imiquimod (maleate)_C32 | Imiquimod (maleate) perturbation in C32 cell line |
| Alpelisib_AsPC-1 | Alpelisib perturbation in AsPC-1 cell line |
| Trametinib_SNU-1 | Trametinib perturbation in SNU-1 cell line |
| olaparib_HepG2/C3A | olaparib perturbation in HepG2/C3A cell line |
| Abemaciclib_Hs 766T | Abemaciclib perturbation in Hs 766T cell line |
| Abemaciclib_HT-29 | Abemaciclib perturbation in HT-29 cell line |
| Cysteamine (hydrochloride)_Panc 03.27 | Cysteamine (hydrochloride) perturbation in Panc 03.27 cell line |
| Lonafarnib_J82 | Lonafarnib perturbation in J82 cell line |
| Pasireotide (acetate)_HepG2/C3A | Pasireotide (acetate) perturbation in HepG2/C3A cell line |
| RMC-6236_SW1417 | RMC-6236 perturbation in SW1417 cell line |
| Tubulin inhibitor 6_HOP62 | Tubulin inhibitor 6 perturbation in HOP62 cell line |
| Tirabrutinib_A549 | Tirabrutinib perturbation in A549 cell line |
| Fusidic acid_HepG2/C3A | Fusidic acid perturbation in HepG2/C3A cell line |
| Capivasertib_HEC-1-A | Capivasertib perturbation in HEC-1-A cell line |
| Ouabain (Octahydrate)_AsPC-1 | Ouabain (Octahydrate) perturbation in AsPC-1 cell line |
| Paclitaxel_Panc 03.27 | Paclitaxel perturbation in Panc 03.27 cell line |
| Entecavir (monohydrate)_SW1417 | Entecavir (monohydrate) perturbation in SW1417 cell line |
| Sulfatinib_A549 | Sulfatinib perturbation in A549 cell line |
| Thymopentin_HT-29 | Thymopentin perturbation in HT-29 cell line |
| Baicalin_HT-29 | Baicalin perturbation in HT-29 cell line |
| Tofacitinib_HT-29 | Tofacitinib perturbation in HT-29 cell line |
| Rimonabant_NCI-H1792 | Rimonabant perturbation in NCI-H1792 cell line |
| Erdafitinib _HT-29 | Erdafitinib perturbation in HT-29 cell line |
| Temsirolimus_NCI-H2347 | Temsirolimus perturbation in NCI-H2347 cell line |
| 4EGI-1_Hs 766T | 4EGI-1 perturbation in Hs 766T cell line |
| 4EGI-1_HT-29 | 4EGI-1 perturbation in HT-29 cell line |
| Thymol_NCI-H1573 | Thymol perturbation in NCI-H1573 cell line |
| Rimonabant_A549 | Rimonabant perturbation in A549 cell line |
| Pitavastatin (Calcium)_HepG2/C3A | Pitavastatin (Calcium) perturbation in HepG2/C3A cell line |
| venetoclax_HT-29 | venetoclax perturbation in HT-29 cell line |
| Methylprednisolone succinate_SW1417 | Methylprednisolone succinate perturbation in SW1417 cell line |
| Sulfisoxazole_SK-MEL-2 | Sulfisoxazole perturbation in SK-MEL-2 cell line |
| NVP-BHG712_Hs 766T | NVP-BHG712 perturbation in Hs 766T cell line |
| Rimonabant (Hydrochloride)_NCI-H1573 | Rimonabant (Hydrochloride) perturbation in NCI-H1573 cell line |
| Pasireotide (acetate)_A498 | Pasireotide (acetate) perturbation in A498 cell line |
| Chlorhexidine (diacetate)_A549 | Chlorhexidine (diacetate) perturbation in A549 cell line |
| Flumatinib (mesylate)_A498 | Flumatinib (mesylate) perturbation in A498 cell line |
| NVP-BHG712_HT-29 | NVP-BHG712 perturbation in HT-29 cell line |
| TAK-901_HepG2/C3A | TAK-901 perturbation in HepG2/C3A cell line |
| Oxaliplatin_NCI-H2347 | Oxaliplatin perturbation in NCI-H2347 cell line |
| Oleic acid_HEC-1-A | Oleic acid perturbation in HEC-1-A cell line |
| Crizotinib (hydrochloride)_AsPC-1 | Crizotinib (hydrochloride) perturbation in AsPC-1 cell line |
| Elagolix sodium_HEC-1-A | Elagolix sodium perturbation in HEC-1-A cell line |
| L-Thyroxine (sodium salt pentahydrate)_SHP-77 | L-Thyroxine (sodium salt pentahydrate) perturbation in SHP-77 cell line |
| PH-797804_SW 1271 | PH-797804 perturbation in SW 1271 cell line |
| Cobimetinib_AsPC-1 | Cobimetinib perturbation in AsPC-1 cell line |
| GSK1059615_SW1417 | GSK1059615 perturbation in SW1417 cell line |
| Rosiglitazone_A549 | Rosiglitazone perturbation in A549 cell line |
| Canagliflozin (hemihydrate)_NCI-H1573 | Canagliflozin (hemihydrate) perturbation in NCI-H1573 cell line |
| Cysteamine (hydrochloride)_HT-29 | Cysteamine (hydrochloride) perturbation in HT-29 cell line |
| Monocrotaline_A549 | Monocrotaline perturbation in A549 cell line |
| Pentagastrin_NCI-H1792 | Pentagastrin perturbation in NCI-H1792 cell line |
| BI-3406_KATO III | BI-3406 perturbation in KATO III cell line |
| Asciminib_Hs 766T | Asciminib perturbation in Hs 766T cell line |
| Berberine (chloride hydrate)_SW1417 | Berberine (chloride hydrate) perturbation in SW1417 cell line |
| Homoharringtonine_A549 | Homoharringtonine perturbation in A549 cell line |
| Sonidegib_SK-MEL-2 | Sonidegib perturbation in SK-MEL-2 cell line |
| Eplerenone_Hs 766T | Eplerenone perturbation in Hs 766T cell line |
| Roxadustat_A549 | Roxadustat perturbation in A549 cell line |
| Orlistat_BT-474 | Orlistat perturbation in BT-474 cell line |
| IQ 1_SNU-423 | IQ 1 perturbation in SNU-423 cell line |
| Rimonabant (Hydrochloride)_C32 | Rimonabant (Hydrochloride) perturbation in C32 cell line |
| Baicalin_Panc 03.27 | Baicalin perturbation in Panc 03.27 cell line |
| Ritonavir_C32 | Ritonavir perturbation in C32 cell line |
| Resveratrol_NCI-H2030 | Resveratrol perturbation in NCI-H2030 cell line |
| Darinaparsin_HepG2/C3A | Darinaparsin perturbation in HepG2/C3A cell line |
| ML264_HEC-1-A | ML264 perturbation in HEC-1-A cell line |
| Ralimetinib dimesylate_Panc 03.27 | Ralimetinib dimesylate perturbation in Panc 03.27 cell line |
| Brivudine_HEC-1-A | Brivudine perturbation in HEC-1-A cell line |
| Allantoin_HepG2/C3A | Allantoin perturbation in HepG2/C3A cell line |
| Doxorubicin (hydrochloride)_HT-29 | Doxorubicin (hydrochloride) perturbation in HT-29 cell line |
| Uridine_AsPC-1 | Uridine perturbation in AsPC-1 cell line |
| Lonafarnib_A549 | Lonafarnib perturbation in A549 cell line |
| Pentamidine (isethionate)_HT-29 | Pentamidine (isethionate) perturbation in HT-29 cell line |
| Pentamidine (isethionate)_Hs 766T | Pentamidine (isethionate) perturbation in Hs 766T cell line |
| Berberine (chloride hydrate)_SW 1271 | Berberine (chloride hydrate) perturbation in SW 1271 cell line |
| Tucidinostat_SHP-77 | Tucidinostat perturbation in SHP-77 cell line |
| (S)-Crizotinib_SNU-423 | (S)-Crizotinib perturbation in SNU-423 cell line |
| Rutin (trihydrate)_Hs 766T | Rutin (trihydrate) perturbation in Hs 766T cell line |
| LJI308_A498 | LJI308 perturbation in A498 cell line |
| EX229_Panc 03.27 | EX229 perturbation in Panc 03.27 cell line |
| Celecoxib_NCI-H1573 | Celecoxib perturbation in NCI-H1573 cell line |
| Retinoic acid_C32 | Retinoic acid perturbation in C32 cell line |
| OTS514_HT-29 | OTS514 perturbation in HT-29 cell line |
| OTS514_Hs 766T | OTS514 perturbation in Hs 766T cell line |
| Macitentan_J82 | Macitentan perturbation in J82 cell line |
| Irinotecan_HEC-1-A | Irinotecan perturbation in HEC-1-A cell line |
| PH-797804_SW1417 | PH-797804 perturbation in SW1417 cell line |
| Drospirenone_SK-MEL-2 | Drospirenone perturbation in SK-MEL-2 cell line |
| Trimetrexate_A498 | Trimetrexate perturbation in A498 cell line |
| Dabrafenib_A498 | Dabrafenib perturbation in A498 cell line |
| crizotinib_A498 | crizotinib perturbation in A498 cell line |
| Fenofibrate_Panc 03.27 | Fenofibrate perturbation in Panc 03.27 cell line |
| Harringtonine_SW1417 | Harringtonine perturbation in SW1417 cell line |
| Loperamide (hydrochloride)_A549 | Loperamide (hydrochloride) perturbation in A549 cell line |
| Ropivacaine (hydrochloride monohydrate)_Panc 03.27 | Ropivacaine (hydrochloride monohydrate) perturbation in Panc 03.27 cell line |
| Palmatine (chloride)_HT-29 | Palmatine (chloride) perturbation in HT-29 cell line |
| BAY1125976_HT-29 | BAY1125976 perturbation in HT-29 cell line |
| Bestatin (hydrochloride)_SW1417 | Bestatin (hydrochloride) perturbation in SW1417 cell line |
| ML264_PANC-1 | ML264 perturbation in PANC-1 cell line |
| Peretinoin_LoVo | Peretinoin perturbation in LoVo cell line |
| Talc_Panc 03.27 | Talc perturbation in Panc 03.27 cell line |
| Salicylic acid_SW1417 | Salicylic acid perturbation in SW1417 cell line |
| Selinexor _HepG2/C3A | Selinexor perturbation in HepG2/C3A cell line |
| PF-06260933_HT-29 | PF-06260933 perturbation in HT-29 cell line |
| Homoharringtonine_LS 180 | Homoharringtonine perturbation in LS 180 cell line |
| PF-06260933_Hs 766T | PF-06260933 perturbation in Hs 766T cell line |
| Ponatinib_Panc 03.27 | Ponatinib perturbation in Panc 03.27 cell line |
| 8-Hydroxyquinoline_NCI-H596 | 8-Hydroxyquinoline perturbation in NCI-H596 cell line |
| AZD2858_SW1417 | AZD2858 perturbation in SW1417 cell line |
| TAK-901_AsPC-1 | TAK-901 perturbation in AsPC-1 cell line |
| Tolcapone_PANC-1 | Tolcapone perturbation in PANC-1 cell line |
| Epirubicin (hydrochloride)_Panc 03.27 | Epirubicin (hydrochloride) perturbation in Panc 03.27 cell line |
| Panobinostat_SW 900 | Panobinostat perturbation in SW 900 cell line |
| Indacaterol (maleate)_SW 1271 | Indacaterol (maleate) perturbation in SW 1271 cell line |
| NG25_PANC-1 | NG25 perturbation in PANC-1 cell line |
| Eplerenone_SK-MEL-2 | Eplerenone perturbation in SK-MEL-2 cell line |
| Balsalazide (sodium hydrate)_HT-29 | Balsalazide (sodium hydrate) perturbation in HT-29 cell line |
| Menadione_A549 | Menadione perturbation in A549 cell line |
| Capmatinib_H4 | Capmatinib perturbation in H4 cell line |
| Pralsetinib_Panc 03.27 | Pralsetinib perturbation in Panc 03.27 cell line |
| c-Kit-IN-1_HEC-1-A | c-Kit-IN-1 perturbation in HEC-1-A cell line |
| AZD2858_NCI-H2030 | AZD2858 perturbation in NCI-H2030 cell line |
| Rucaparib (phosphate)_HT-29 | Rucaparib (phosphate) perturbation in HT-29 cell line |
| Hydroxyfasudil_A549 | Hydroxyfasudil perturbation in A549 cell line |
| Carbamazepine_AsPC-1 | Carbamazepine perturbation in AsPC-1 cell line |
| Harringtonine_HepG2/C3A | Harringtonine perturbation in HepG2/C3A cell line |
| APTO-253_LoVo | APTO-253 perturbation in LoVo cell line |
| Diphenhydramine_HT-29 | Diphenhydramine perturbation in HT-29 cell line |
| Anethole trithione_HEC-1-A | Anethole trithione perturbation in HEC-1-A cell line |
| L-Eflornithine (monohydrochloride)_NCI-H2347 | L-Eflornithine (monohydrochloride) perturbation in NCI-H2347 cell line |
| APTO-253_MIA PaCa-2 | APTO-253 perturbation in MIA PaCa-2 cell line |
| ULK-101_A549 | ULK-101 perturbation in A549 cell line |
| Fingolimod (hydrochloride)_SNU-1 | Fingolimod (hydrochloride) perturbation in SNU-1 cell line |
| Erdafitinib _SK-MEL-2 | Erdafitinib perturbation in SK-MEL-2 cell line |
| Ipatasertib_SW 1271 | Ipatasertib perturbation in SW 1271 cell line |
| Sivelestat (sodium tetrahydrate)_A549 | Sivelestat (sodium tetrahydrate) perturbation in A549 cell line |
| Trimetrexate_C32 | Trimetrexate perturbation in C32 cell line |
| Dabrafenib_C32 | Dabrafenib perturbation in C32 cell line |
| PH-797804_HepG2/C3A | PH-797804 perturbation in HepG2/C3A cell line |
| Allopurinol_NCI-H2347 | Allopurinol perturbation in NCI-H2347 cell line |
| Peretinoin_NCI-H1792 | Peretinoin perturbation in NCI-H1792 cell line |
| Demeclocycline_MIA PaCa-2 | Demeclocycline perturbation in MIA PaCa-2 cell line |
| palbociclib_PANC-1 | palbociclib perturbation in PANC-1 cell line |
| Tadalafil_A549 | Tadalafil perturbation in A549 cell line |
| Pyridoxine_NCI-H1792 | Pyridoxine perturbation in NCI-H1792 cell line |
| Irinotecan (hydrochloride)_Hs 766T | Irinotecan (hydrochloride) perturbation in Hs 766T cell line |
| Delamanid_HepG2/C3A | Delamanid perturbation in HepG2/C3A cell line |
| Raltitrexed_SK-MEL-2 | Raltitrexed perturbation in SK-MEL-2 cell line |
| Flutamide_NCI-H1573 | Flutamide perturbation in NCI-H1573 cell line |
| Rapamycin_Panc 03.27 | Rapamycin perturbation in Panc 03.27 cell line |
| Tubulin inhibitor 6_SW480 | Tubulin inhibitor 6 perturbation in SW480 cell line |
| Glycyrrhizic acid_A549 | Glycyrrhizic acid perturbation in A549 cell line |
| Belzutifan_HT-29 | Belzutifan perturbation in HT-29 cell line |
| Ferulic acid_HEC-1-A | Ferulic acid perturbation in HEC-1-A cell line |
| Topotecan (hydrochloride)_A549 | Topotecan (hydrochloride) perturbation in A549 cell line |
| Medroxyprogesterone acetate_NCI-H1792 | Medroxyprogesterone acetate perturbation in NCI-H1792 cell line |
| Flumatinib (mesylate)_NCI-H1573 | Flumatinib (mesylate) perturbation in NCI-H1573 cell line |
| Sapanisertib_SW1417 | Sapanisertib perturbation in SW1417 cell line |
| Bendamustine_A549 | Bendamustine perturbation in A549 cell line |
| NG25_HEC-1-A | NG25 perturbation in HEC-1-A cell line |
| Cytarabine_C32 | Cytarabine perturbation in C32 cell line |
| Docetaxel_HOP62 | Docetaxel perturbation in HOP62 cell line |
| Delamanid_AsPC-1 | Delamanid perturbation in AsPC-1 cell line |
| Tolcapone_HEC-1-A | Tolcapone perturbation in HEC-1-A cell line |
| LY2090314_HEC-1-A | LY2090314 perturbation in HEC-1-A cell line |
| Tucatinib_NCI-H1792 | Tucatinib perturbation in NCI-H1792 cell line |
| Sapanisertib_BT-474 | Sapanisertib perturbation in BT-474 cell line |
| Lapatinib ditosylate_C32 | Lapatinib ditosylate perturbation in C32 cell line |
| Gemcitabine_SW480 | Gemcitabine perturbation in SW480 cell line |
| Posaconazole_C32 | Posaconazole perturbation in C32 cell line |
| Vismodegib_HEC-1-A | Vismodegib perturbation in HEC-1-A cell line |
| Finasteride_J82 | Finasteride perturbation in J82 cell line |
| Ipatasertib_SW1417 | Ipatasertib perturbation in SW1417 cell line |
| DTP3_A498 | DTP3 perturbation in A498 cell line |
| Anastrozole_C32 | Anastrozole perturbation in C32 cell line |
| Cepharanthine_C32 | Cepharanthine perturbation in C32 cell line |
| AZD-7648_HT-29 | AZD-7648 perturbation in HT-29 cell line |
| Sinomenine_HT-29 | Sinomenine perturbation in HT-29 cell line |
| MK-3903_HEC-1-A | MK-3903 perturbation in HEC-1-A cell line |
| Pemigatinib_HOP62 | Pemigatinib perturbation in HOP62 cell line |
| Cytarabine_NCI-H1573 | Cytarabine perturbation in NCI-H1573 cell line |
| Belinostat_PANC-1 | Belinostat perturbation in PANC-1 cell line |
| Everolimus_PANC-1 | Everolimus perturbation in PANC-1 cell line |
| Pasireotide (acetate)_C32 | Pasireotide (acetate) perturbation in C32 cell line |
| Simotinib_C32 | Simotinib perturbation in C32 cell line |
| Hesperidin_HT-29 | Hesperidin perturbation in HT-29 cell line |
| Mitoxantrone (dihydrochloride)_SW1417 | Mitoxantrone (dihydrochloride) perturbation in SW1417 cell line |
| Temuterkib_Panc 03.27 | Temuterkib perturbation in Panc 03.27 cell line |
| S-Adenosyl-L-methionine (disulfate tosylate)_HT-29 | S-Adenosyl-L-methionine (disulfate tosylate) perturbation in HT-29 cell line |
| Rutin (trihydrate)_SK-MEL-2 | Rutin (trihydrate) perturbation in SK-MEL-2 cell line |
| Cloxacillin (sodium)_A498 | Cloxacillin (sodium) perturbation in A498 cell line |
| Fusidic acid_C32 | Fusidic acid perturbation in C32 cell line |
| Bicalutamide_NCI-H2347 | Bicalutamide perturbation in NCI-H2347 cell line |
| ERK5-IN-2_J82 | ERK5-IN-2 perturbation in J82 cell line |
| Benproperine (phosphate)_HT-29 | Benproperine (phosphate) perturbation in HT-29 cell line |
| Cytarabine (hydrochloride)_NCI-H2347 | Cytarabine (hydrochloride) perturbation in NCI-H2347 cell line |
| Bestatin (hydrochloride)_AsPC-1 | Bestatin (hydrochloride) perturbation in AsPC-1 cell line |
| TAK-901_BT-474 | TAK-901 perturbation in BT-474 cell line |
| Lapatinib ditosylate_NCI-H1573 | Lapatinib ditosylate perturbation in NCI-H1573 cell line |
| Drospirenone_HT-29 | Drospirenone perturbation in HT-29 cell line |
| Vemurafenib_Panc 03.27 | Vemurafenib perturbation in Panc 03.27 cell line |
| OTS514_SK-MEL-2 | OTS514 perturbation in SK-MEL-2 cell line |
| Acetohexamide_A498 | Acetohexamide perturbation in A498 cell line |
| NG25_HT-29 | NG25 perturbation in HT-29 cell line |
| Tubulin inhibitor 6_HepG2/C3A | Tubulin inhibitor 6 perturbation in HepG2/C3A cell line |
| Topotecan (hydrochloride)_AsPC-1 | Topotecan (hydrochloride) perturbation in AsPC-1 cell line |
| Fluvoxamine (maleate)_HepG2/C3A | Fluvoxamine (maleate) perturbation in HepG2/C3A cell line |
| Homoharringtonine_SW1417 | Homoharringtonine perturbation in SW1417 cell line |
| Lucanthone_MIA PaCa-2 | Lucanthone perturbation in MIA PaCa-2 cell line |
| Tolcapone_HT-29 | Tolcapone perturbation in HT-29 cell line |
| Gemcitabine_AsPC-1 | Gemcitabine perturbation in AsPC-1 cell line |
| Pentagastrin_C32 | Pentagastrin perturbation in C32 cell line |
| Thymol_NCI-H1792 | Thymol perturbation in NCI-H1792 cell line |
| Ritonavir_NCI-H1792 | Ritonavir perturbation in NCI-H1792 cell line |
| Lonafarnib_SW 1271 | Lonafarnib perturbation in SW 1271 cell line |
| SBI-0640756_Panc 03.27 | SBI-0640756 perturbation in Panc 03.27 cell line |
| LB-100_KATO III | LB-100 perturbation in KATO III cell line |
| Capmatinib_HT-29 | Capmatinib perturbation in HT-29 cell line |
| Sodium Salicylate_A498 | Sodium Salicylate perturbation in A498 cell line |
| Lumateperone (tosylate)_BT-474 | Lumateperone (tosylate) perturbation in BT-474 cell line |
| palbociclib_HT-29 | palbociclib perturbation in HT-29 cell line |
| Entecavir (monohydrate)_NCI-H1792 | Entecavir (monohydrate) perturbation in NCI-H1792 cell line |
| Bimiralisib_Panc 03.27 | Bimiralisib perturbation in Panc 03.27 cell line |
| Doxorubicin (hydrochloride)_A-172 | Doxorubicin (hydrochloride) perturbation in A-172 cell line |
| Sinomenine_HEC-1-A | Sinomenine perturbation in HEC-1-A cell line |
| AZD-7648_HEC-1-A | AZD-7648 perturbation in HEC-1-A cell line |
| Panobinostat_NCI-H1792 | Panobinostat perturbation in NCI-H1792 cell line |
| Anastrozole_LoVo | Anastrozole perturbation in LoVo cell line |
| Pentoxifylline_AsPC-1 | Pentoxifylline perturbation in AsPC-1 cell line |
| Lapatinib ditosylate_LoVo | Lapatinib ditosylate perturbation in LoVo cell line |
| 8-Hydroxyquinoline_HEC-1-A | 8-Hydroxyquinoline perturbation in HEC-1-A cell line |
| Silodosin_HEC-1-A | Silodosin perturbation in HEC-1-A cell line |
| MK-3903_HT-29 | MK-3903 perturbation in HT-29 cell line |
| Rimonabant_SW1417 | Rimonabant perturbation in SW1417 cell line |
| AZD1390_Panc 03.27 | AZD1390 perturbation in Panc 03.27 cell line |
| Captopril_A498 | Captopril perturbation in A498 cell line |
| Imiquimod (maleate)_A549 | Imiquimod (maleate) perturbation in A549 cell line |
| IQ 1_A498 | IQ 1 perturbation in A498 cell line |
| Gemfibrozil_Panc 03.27 | Gemfibrozil perturbation in Panc 03.27 cell line |
| Lumateperone (tosylate)_SW1417 | Lumateperone (tosylate) perturbation in SW1417 cell line |
| Omeprazole (sodium)_A498 | Omeprazole (sodium) perturbation in A498 cell line |
| Lopinavir_Panc 03.27 | Lopinavir perturbation in Panc 03.27 cell line |
| Rimonabant_BT-474 | Rimonabant perturbation in BT-474 cell line |
| Fenofibrate_NCI-H2347 | Fenofibrate perturbation in NCI-H2347 cell line |
| Belumosudil (mesylate)_Panc 03.27 | Belumosudil (mesylate) perturbation in Panc 03.27 cell line |
| Olanzapine_SW 1271 | Olanzapine perturbation in SW 1271 cell line |
| Busulfan_SW1417 | Busulfan perturbation in SW1417 cell line |
| Sulfisoxazole_PANC-1 | Sulfisoxazole perturbation in PANC-1 cell line |
| Imiquimod (hydrochloride)_NCI-H1573 | Imiquimod (hydrochloride) perturbation in NCI-H1573 cell line |
| AZD-8055_HEC-1-A | AZD-8055 perturbation in HEC-1-A cell line |
| Olanzapine_SW1417 | Olanzapine perturbation in SW1417 cell line |
| Rimonabant (Hydrochloride)_J82 | Rimonabant (Hydrochloride) perturbation in J82 cell line |
| Oxaliplatin_Panc 03.27 | Oxaliplatin perturbation in Panc 03.27 cell line |
| Harringtonine_A549 | Harringtonine perturbation in A549 cell line |
| Artemether_SW1417 | Artemether perturbation in SW1417 cell line |
| Futibatinib_HepG2/C3A | Futibatinib perturbation in HepG2/C3A cell line |
| Sonidegib_HEC-1-A | Sonidegib perturbation in HEC-1-A cell line |
| Lidocaine (hydrochloride)_NCI-H596 | Lidocaine (hydrochloride) perturbation in NCI-H596 cell line |
| Lumateperone (tosylate)_SW 1271 | Lumateperone (tosylate) perturbation in SW 1271 cell line |
| Gallic acid (hydrate)_HT-29 | Gallic acid (hydrate) perturbation in HT-29 cell line |
| Atazanavir (sulfate)_AsPC-1 | Atazanavir (sulfate) perturbation in AsPC-1 cell line |
| TAK-733_NCI-H1792 | TAK-733 perturbation in NCI-H1792 cell line |
| Balsalazide (sodium hydrate)_HEC-1-A | Balsalazide (sodium hydrate) perturbation in HEC-1-A cell line |
| Rucaparib (phosphate)_HEC-1-A | Rucaparib (phosphate) perturbation in HEC-1-A cell line |
| Dabrafenib_LoVo | Dabrafenib perturbation in LoVo cell line |
| Vinblastine (sulfate)_SW1417 | Vinblastine (sulfate) perturbation in SW1417 cell line |
| Salicylic acid_A549 | Salicylic acid perturbation in A549 cell line |
| Bosentan (hydrate)_J82 | Bosentan (hydrate) perturbation in J82 cell line |
| c-Kit-IN-1_HT-29 | c-Kit-IN-1 perturbation in HT-29 cell line |
| (S)-Crizotinib_A498 | (S)-Crizotinib perturbation in A498 cell line |
| AT7519_Panc 03.27 | AT7519 perturbation in Panc 03.27 cell line |
| DTP3_J82 | DTP3 perturbation in J82 cell line |
| Dabrafenib_MIA PaCa-2 | Dabrafenib perturbation in MIA PaCa-2 cell line |
| Fedratinib (hydrochloride hydrate)_SK-MEL-2 | Fedratinib (hydrochloride hydrate) perturbation in SK-MEL-2 cell line |
| Dabrafenib_SNU-423 | Dabrafenib perturbation in SNU-423 cell line |
| BI-3406_C32 | BI-3406 perturbation in C32 cell line |
| Demeclocycline_C32 | Demeclocycline perturbation in C32 cell line |
| Temsirolimus_Panc 03.27 | Temsirolimus perturbation in Panc 03.27 cell line |
| Hesperidin_PANC-1 | Hesperidin perturbation in PANC-1 cell line |
| Norepinephrine (hydrochloride)_C32 | Norepinephrine (hydrochloride) perturbation in C32 cell line |
| (R)-Verapamil (hydrochloride)_NCI-H2030 | (R)-Verapamil (hydrochloride) perturbation in NCI-H2030 cell line |
| Volasertib_MIA PaCa-2 | Volasertib perturbation in MIA PaCa-2 cell line |
| Everolimus_HT-29 | Everolimus perturbation in HT-29 cell line |
| Fluvoxamine (maleate)_AsPC-1 | Fluvoxamine (maleate) perturbation in AsPC-1 cell line |
| BI-78D3_SK-MEL-2 | BI-78D3 perturbation in SK-MEL-2 cell line |
| Tucidinostat_MIA PaCa-2 | Tucidinostat perturbation in MIA PaCa-2 cell line |
| Lapatinib ditosylate_CFPAC-1 | Lapatinib ditosylate perturbation in CFPAC-1 cell line |
| Sinomenine_PANC-1 | Sinomenine perturbation in PANC-1 cell line |
| Gemcitabine_HepG2/C3A | Gemcitabine perturbation in HepG2/C3A cell line |
| Dimethyl fumarate_C32 | Dimethyl fumarate perturbation in C32 cell line |
| Tofacitinib_NCI-H2347 | Tofacitinib perturbation in NCI-H2347 cell line |
| Riluzole hydrochloride_HT-29 | Riluzole hydrochloride perturbation in HT-29 cell line |
| Irinotecan (hydrochloride)_HEC-1-A | Irinotecan (hydrochloride) perturbation in HEC-1-A cell line |
| Triclosan_Panc 03.27 | Triclosan perturbation in Panc 03.27 cell line |
| Sulfisoxazole_HEC-1-A | Sulfisoxazole perturbation in HEC-1-A cell line |
| Idarubicin (hydrochloride)_NCI-H1792 | Idarubicin (hydrochloride) perturbation in NCI-H1792 cell line |
| Minodronic acid_Panc 03.27 | Minodronic acid perturbation in Panc 03.27 cell line |
| Mebendazole_NCI-H2122 | Mebendazole perturbation in NCI-H2122 cell line |
| Imiquimod (hydrochloride)_NCI-H2122 | Imiquimod (hydrochloride) perturbation in NCI-H2122 cell line |
| Entecavir (monohydrate)_J82 | Entecavir (monohydrate) perturbation in J82 cell line |
| Dihydroartemisinin_NCI-H1573 | Dihydroartemisinin perturbation in NCI-H1573 cell line |
| PH-797804_A549 | PH-797804 perturbation in A549 cell line |
| Oleic acid_SK-MEL-2 | Oleic acid perturbation in SK-MEL-2 cell line |
| Doxycycline (monohydrate)_Panc 03.27 | Doxycycline (monohydrate) perturbation in Panc 03.27 cell line |
| Canagliflozin_NCI-H1573 | Canagliflozin perturbation in NCI-H1573 cell line |
| Tadalafil_HepG2/C3A | Tadalafil perturbation in HepG2/C3A cell line |
| Delamanid_A549 | Delamanid perturbation in A549 cell line |
| Brivudine_HT-29 | Brivudine perturbation in HT-29 cell line |
| Brivudine_Hs 766T | Brivudine perturbation in Hs 766T cell line |
| ULK-101_SW1417 | ULK-101 perturbation in SW1417 cell line |
| LB-100_HOP62 | LB-100 perturbation in HOP62 cell line |
| Paclitaxel_HCT15 | Paclitaxel perturbation in HCT15 cell line |
| palbociclib_SK-MEL-2 | palbociclib perturbation in SK-MEL-2 cell line |
| Nimesulide_Panc 03.27 | Nimesulide perturbation in Panc 03.27 cell line |
| (R)-Verapamil (hydrochloride)_SW1417 | (R)-Verapamil (hydrochloride) perturbation in SW1417 cell line |
| Celecoxib_MIA PaCa-2 | Celecoxib perturbation in MIA PaCa-2 cell line |
| Gemcitabine_BT-474 | Gemcitabine perturbation in BT-474 cell line |
| MK-3903_SK-MEL-2 | MK-3903 perturbation in SK-MEL-2 cell line |
| Trimetrexate_NCI-H1792 | Trimetrexate perturbation in NCI-H1792 cell line |
| Pimitespib_Panc 03.27 | Pimitespib perturbation in Panc 03.27 cell line |
| Entrectinib_HEC-1-A | Entrectinib perturbation in HEC-1-A cell line |
| TAK-733_LoVo | TAK-733 perturbation in LoVo cell line |
| Rutin (trihydrate)_HEC-1-A | Rutin (trihydrate) perturbation in HEC-1-A cell line |
| Ligustrazine_AsPC-1 | Ligustrazine perturbation in AsPC-1 cell line |
| Lipoic acid_HT-29 | Lipoic acid perturbation in HT-29 cell line |
| NVP-BHG712_PANC-1 | NVP-BHG712 perturbation in PANC-1 cell line |
| Lenalidomide (hemihydrate)_HepG2/C3A | Lenalidomide (hemihydrate) perturbation in HepG2/C3A cell line |
| Gemcitabine_SW1417 | Gemcitabine perturbation in SW1417 cell line |
| TAK-733_MIA PaCa-2 | TAK-733 perturbation in MIA PaCa-2 cell line |
| Irinotecan_HT-29 | Irinotecan perturbation in HT-29 cell line |
| LB-100_SNU-423 | LB-100 perturbation in SNU-423 cell line |
| OTS514_HEC-1-A | OTS514 perturbation in HEC-1-A cell line |
| Ciclopirox_AsPC-1 | Ciclopirox perturbation in AsPC-1 cell line |
| Capivasertib_SNU-1 | Capivasertib perturbation in SNU-1 cell line |
| Tadalafil_BT-474 | Tadalafil perturbation in BT-474 cell line |
| Infigratinib_HT-29 | Infigratinib perturbation in HT-29 cell line |
| Phenylephrine (hydrochloride)_Panc 03.27 | Phenylephrine (hydrochloride) perturbation in Panc 03.27 cell line |
| Lonafarnib_HepG2/C3A | Lonafarnib perturbation in HepG2/C3A cell line |
| Pasireotide (acetate)_J82 | Pasireotide (acetate) perturbation in J82 cell line |
| Hexylresorcinol_HT-29 | Hexylresorcinol perturbation in HT-29 cell line |
| Hydroxyfasudil_BT-474 | Hydroxyfasudil perturbation in BT-474 cell line |
| Lapatinib ditosylate_J82 | Lapatinib ditosylate perturbation in J82 cell line |
| Cinacalcet_Panc 03.27 | Cinacalcet perturbation in Panc 03.27 cell line |
| NVP-BHG712_HCT15 | NVP-BHG712 perturbation in HCT15 cell line |
| LY2090314_SK-MEL-2 | LY2090314 perturbation in SK-MEL-2 cell line |
| Tolcapone_SK-MEL-2 | Tolcapone perturbation in SK-MEL-2 cell line |
| Futibatinib_BT-474 | Futibatinib perturbation in BT-474 cell line |
| Busulfan_AsPC-1 | Busulfan perturbation in AsPC-1 cell line |
| Tazarotene_AsPC-1 | Tazarotene perturbation in AsPC-1 cell line |
| Olanzapine_NCI-H2030 | Olanzapine perturbation in NCI-H2030 cell line |
| Ligustrazine_COLO 205 | Ligustrazine perturbation in COLO 205 cell line |
| Olanzapine_HepG2/C3A | Olanzapine perturbation in HepG2/C3A cell line |
| Epirubicin (hydrochloride)_NCI-H460 | Epirubicin (hydrochloride) perturbation in NCI-H460 cell line |
| Temuterkib_NCI-H2347 | Temuterkib perturbation in NCI-H2347 cell line |
| 18β-Glycyrrhetinic acid_NCI-H1792 | 18β-Glycyrrhetinic acid perturbation in NCI-H1792 cell line |
| Malotilate_A498 | Malotilate perturbation in A498 cell line |
| Sodium Salicylate_AN3 CA | Sodium Salicylate perturbation in AN3 CA cell line |
| Busulfan_SW 1088 | Busulfan perturbation in SW 1088 cell line |
| Tirabrutinib (hydrochloride)_Panc 03.27 | Tirabrutinib (hydrochloride) perturbation in Panc 03.27 cell line |
| 4EGI-1_HEC-1-A | 4EGI-1 perturbation in HEC-1-A cell line |
| Tucatinib_NCI-H1573 | Tucatinib perturbation in NCI-H1573 cell line |
| Selinexor _SW480 | Selinexor perturbation in SW480 cell line |
| Pasireotide (acetate)_NCI-H1792 | Pasireotide (acetate) perturbation in NCI-H1792 cell line |
| Clonidine (hydrochloride)_NCI-H2347 | Clonidine (hydrochloride) perturbation in NCI-H2347 cell line |
| Artesunate_NCI-H596 | Artesunate perturbation in NCI-H596 cell line |
| Belumosudil_C32 | Belumosudil perturbation in C32 cell line |
| Sildenafil_A549 | Sildenafil perturbation in A549 cell line |
| Busulfan_NCI-H2030 | Busulfan perturbation in NCI-H2030 cell line |
| Omeprazole_Panc 03.27 | Omeprazole perturbation in Panc 03.27 cell line |
| Olanzapine_AsPC-1 | Olanzapine perturbation in AsPC-1 cell line |
| DT-061_C32 | DT-061 perturbation in C32 cell line |
| Fusidic acid_NCI-H1792 | Fusidic acid perturbation in NCI-H1792 cell line |
| Nevirapine_HEC-1-A | Nevirapine perturbation in HEC-1-A cell line |
| Rimonabant_HepG2/C3A | Rimonabant perturbation in HepG2/C3A cell line |
| NVP-BHG712_HEC-1-A | NVP-BHG712 perturbation in HEC-1-A cell line |
| Doxorubicin (hydrochloride)_H4 | Doxorubicin (hydrochloride) perturbation in H4 cell line |
| Dabrafenib_J82 | Dabrafenib perturbation in J82 cell line |
| Oleic acid_Hs 766T | Oleic acid perturbation in Hs 766T cell line |
| Macitentan_A498 | Macitentan perturbation in A498 cell line |
| Neratinib (maleate)_HepG2/C3A | Neratinib (maleate) perturbation in HepG2/C3A cell line |
| Mebendazole_A498 | Mebendazole perturbation in A498 cell line |
| Terfenadine_SK-MEL-2 | Terfenadine perturbation in SK-MEL-2 cell line |
| Vinblastine (sulfate)_COLO 205 | Vinblastine (sulfate) perturbation in COLO 205 cell line |
| Cysteamine (hydrochloride)_HEC-1-A | Cysteamine (hydrochloride) perturbation in HEC-1-A cell line |
| Volasertib_J82 | Volasertib perturbation in J82 cell line |
| Penfluridol_C32 | Penfluridol perturbation in C32 cell line |
| MK-8353_NCI-H1573 | MK-8353 perturbation in NCI-H1573 cell line |
| RMC-6236_LoVo | RMC-6236 perturbation in LoVo cell line |
| Aspirin_C32 | Aspirin perturbation in C32 cell line |
| Sodium Salicylate_C32 | Sodium Salicylate perturbation in C32 cell line |
| Tucatinib_C32 | Tucatinib perturbation in C32 cell line |
| Asciminib_HEC-1-A | Asciminib perturbation in HEC-1-A cell line |
| RMC-6236_MIA PaCa-2 | RMC-6236 perturbation in MIA PaCa-2 cell line |
| XRK3F2_C32 | XRK3F2 perturbation in C32 cell line |
| Furosemide_NCI-H1792 | Furosemide perturbation in NCI-H1792 cell line |
| Acetohexamide_C32 | Acetohexamide perturbation in C32 cell line |
| Bisoprolol (hemifumarate)_HS-578T | Bisoprolol (hemifumarate) perturbation in HS-578T cell line |
| Homoharringtonine_SW 1088 | Homoharringtonine perturbation in SW 1088 cell line |
| Tubulin inhibitor 6_SW1417 | Tubulin inhibitor 6 perturbation in SW1417 cell line |
| Bendamustine_BT-474 | Bendamustine perturbation in BT-474 cell line |
| Lapatinib ditosylate_NCI-H1792 | Lapatinib ditosylate perturbation in NCI-H1792 cell line |
| Panobinostat_SNU-423 | Panobinostat perturbation in SNU-423 cell line |
| Artesunate_SK-MEL-2 | Artesunate perturbation in SK-MEL-2 cell line |
| Clopidogrel_Panc 03.27 | Clopidogrel perturbation in Panc 03.27 cell line |
| ML264_HT-29 | ML264 perturbation in HT-29 cell line |
| Homoharringtonine_HepG2/C3A | Homoharringtonine perturbation in HepG2/C3A cell line |
| Capivasertib_Panc 03.27 | Capivasertib perturbation in Panc 03.27 cell line |
| Bexarotene_AsPC-1 | Bexarotene perturbation in AsPC-1 cell line |
| Ciclopirox_HepG2/C3A | Ciclopirox perturbation in HepG2/C3A cell line |
| Fluvoxamine (maleate)_SW1417 | Fluvoxamine (maleate) perturbation in SW1417 cell line |
| Lopinavir_A498 | Lopinavir perturbation in A498 cell line |
| vincristine_HepG2/C3A | vincristine perturbation in HepG2/C3A cell line |
| Salicylic acid_PANC-1 | Salicylic acid perturbation in PANC-1 cell line |
| Fluvoxamine (maleate)_HT-29 | Fluvoxamine (maleate) perturbation in HT-29 cell line |
| Brivudine_SW 1271 | Brivudine perturbation in SW 1271 cell line |
| Tofacitinib_SNU-423 | Tofacitinib perturbation in SNU-423 cell line |
| Tirabrutinib (hydrochloride)_C32 | Tirabrutinib (hydrochloride) perturbation in C32 cell line |
| IQ 1_Panc 03.27 | IQ 1 perturbation in Panc 03.27 cell line |
| Tubulin inhibitor 6_HT-29 | Tubulin inhibitor 6 perturbation in HT-29 cell line |
| Capmatinib_NCI-H2030 | Capmatinib perturbation in NCI-H2030 cell line |
| NG25_HepG2/C3A | NG25 perturbation in HepG2/C3A cell line |
| MK-8353_Panc 03.27 | MK-8353 perturbation in Panc 03.27 cell line |
| Temuterkib_NCI-H1792 | Temuterkib perturbation in NCI-H1792 cell line |
| Everolimus_AsPC-1 | Everolimus perturbation in AsPC-1 cell line |
| Belzutifan_SW480 | Belzutifan perturbation in SW480 cell line |
| Belinostat_AsPC-1 | Belinostat perturbation in AsPC-1 cell line |
| Afatinib_HepG2/C3A | Afatinib perturbation in HepG2/C3A cell line |
| Baicalin_LoVo | Baicalin perturbation in LoVo cell line |
| crizotinib_NCI-H2347 | crizotinib perturbation in NCI-H2347 cell line |
| Tranilast_NCI-H2030 | Tranilast perturbation in NCI-H2030 cell line |
| Artemether_SK-MEL-2 | Artemether perturbation in SK-MEL-2 cell line |
| Afatinib_NCI-H2030 | Afatinib perturbation in NCI-H2030 cell line |
| Capivasertib_NCI-H1573 | Capivasertib perturbation in NCI-H1573 cell line |
| Capivasertib_AN3 CA | Capivasertib perturbation in AN3 CA cell line |
| Omeprazole_C32 | Omeprazole perturbation in C32 cell line |
| Olanzapine_SK-MEL-2 | Olanzapine perturbation in SK-MEL-2 cell line |
| Rapamycin_J82 | Rapamycin perturbation in J82 cell line |
| LY2090314_NCI-H2030 | LY2090314 perturbation in NCI-H2030 cell line |
| Baicalin_HOP62 | Baicalin perturbation in HOP62 cell line |
| Clonidine (hydrochloride)_J82 | Clonidine (hydrochloride) perturbation in J82 cell line |
| Tofacitinib (citrate)_Hs 766T | Tofacitinib (citrate) perturbation in Hs 766T cell line |
| Oleic acid_SW1417 | Oleic acid perturbation in SW1417 cell line |
| Plicamycin_Panc 03.27 | Plicamycin perturbation in Panc 03.27 cell line |
| Lidocaine (hydrochloride)_SW1417 | Lidocaine (hydrochloride) perturbation in SW1417 cell line |
| Atazanavir (sulfate)_Hs 766T | Atazanavir (sulfate) perturbation in Hs 766T cell line |
| Tucatinib_Panc 03.27 | Tucatinib perturbation in Panc 03.27 cell line |
| palbociclib_HepG2/C3A | palbociclib perturbation in HepG2/C3A cell line |
| XRK3F2_Panc 03.27 | XRK3F2 perturbation in Panc 03.27 cell line |
| Terfenadine_AsPC-1 | Terfenadine perturbation in AsPC-1 cell line |
| palbociclib_NCI-H2030 | palbociclib perturbation in NCI-H2030 cell line |
| BI-78D3_SW1417 | BI-78D3 perturbation in SW1417 cell line |
| Hesperidin_A549 | Hesperidin perturbation in A549 cell line |
| LJI308_NCI-H2347 | LJI308 perturbation in NCI-H2347 cell line |
| Betamethasone dipropionate_SW 1271 | Betamethasone dipropionate perturbation in SW 1271 cell line |
| Verteporfin_SW1417 | Verteporfin perturbation in SW1417 cell line |
| MK-3903_AsPC-1 | MK-3903 perturbation in AsPC-1 cell line |
| Mozavaptan_Panc 03.27 | Mozavaptan perturbation in Panc 03.27 cell line |
| AZD2858_HEC-1-A | AZD2858 perturbation in HEC-1-A cell line |
| Voriconazole_AsPC-1 | Voriconazole perturbation in AsPC-1 cell line |
| Dexmedetomidine_HT-29 | Dexmedetomidine perturbation in HT-29 cell line |
| Posaconazole_NCI-H2347 | Posaconazole perturbation in NCI-H2347 cell line |
| c-Kit-IN-1_NCI-H2030 | c-Kit-IN-1 perturbation in NCI-H2030 cell line |
| palbociclib_AsPC-1 | palbociclib perturbation in AsPC-1 cell line |
| Rapamycin_NCI-H1792 | Rapamycin perturbation in NCI-H1792 cell line |
| ERK5-IN-2_Panc 03.27 | ERK5-IN-2 perturbation in Panc 03.27 cell line |
| Pyridoxine_Panc 03.27 | Pyridoxine perturbation in Panc 03.27 cell line |
| Phenytoin (sodium)_Panc 03.27 | Phenytoin (sodium) perturbation in Panc 03.27 cell line |
| BI-78D3_SW 1271 | BI-78D3 perturbation in SW 1271 cell line |
| Salicylic acid_HEC-1-A | Salicylic acid perturbation in HEC-1-A cell line |
| Rucaparib (phosphate)_A549 | Rucaparib (phosphate) perturbation in A549 cell line |
| Pimitespib_C32 | Pimitespib perturbation in C32 cell line |
| Cytarabine (hydrochloride)_NCI-H1573 | Cytarabine (hydrochloride) perturbation in NCI-H1573 cell line |
| Balsalazide (sodium hydrate)_A549 | Balsalazide (sodium hydrate) perturbation in A549 cell line |
| Fumaric acid_Panc 03.27 | Fumaric acid perturbation in Panc 03.27 cell line |
| Amsacrine_NCI-H1792 | Amsacrine perturbation in NCI-H1792 cell line |
| Betamethasone dipropionate_BT-474 | Betamethasone dipropionate perturbation in BT-474 cell line |
| 8-Hydroxyquinoline_SW480 | 8-Hydroxyquinoline perturbation in SW480 cell line |
| Harringtonine_HEC-1-A | Harringtonine perturbation in HEC-1-A cell line |
| Lidocaine (hydrochloride)_SW 1271 | Lidocaine (hydrochloride) perturbation in SW 1271 cell line |
| Medroxyprogesterone acetate_Panc 03.27 | Medroxyprogesterone acetate perturbation in Panc 03.27 cell line |
| Berberine (chloride hydrate)_PANC-1 | Berberine (chloride hydrate) perturbation in PANC-1 cell line |
| Bentamapimod_HT-29 | Bentamapimod perturbation in HT-29 cell line |
| Temuterkib_J82 | Temuterkib perturbation in J82 cell line |
| Aprepitant_AsPC-1 | Aprepitant perturbation in AsPC-1 cell line |
| Isocorydine_Panc 03.27 | Isocorydine perturbation in Panc 03.27 cell line |
| Tazarotene_SK-MEL-2 | Tazarotene perturbation in SK-MEL-2 cell line |
| Topotecan (hydrochloride)_Hs 766T | Topotecan (hydrochloride) perturbation in Hs 766T cell line |
| Infigratinib_SW1417 | Infigratinib perturbation in SW1417 cell line |
| AT7519_A498 | AT7519 perturbation in A498 cell line |
| Cytarabine (hydrochloride)_C32 | Cytarabine (hydrochloride) perturbation in C32 cell line |
| Tolcapone_AsPC-1 | Tolcapone perturbation in AsPC-1 cell line |
| Gemcitabine_HT-29 | Gemcitabine perturbation in HT-29 cell line |
| Irinotecan_SW1417 | Irinotecan perturbation in SW1417 cell line |
| Ciclopirox_NCI-H596 | Ciclopirox perturbation in NCI-H596 cell line |
| Everolimus_HepG2/C3A | Everolimus perturbation in HepG2/C3A cell line |
| Lumateperone (tosylate)_SK-MEL-2 | Lumateperone (tosylate) perturbation in SK-MEL-2 cell line |
| Lipoic acid_SW1417 | Lipoic acid perturbation in SW1417 cell line |
| Valdecoxib_NCI-H661 | Valdecoxib perturbation in NCI-H661 cell line |
| Oxaprozin_Hs 766T | Oxaprozin perturbation in Hs 766T cell line |
| Brivudine_BT-474 | Brivudine perturbation in BT-474 cell line |
| palbociclib_COLO 205 | palbociclib perturbation in COLO 205 cell line |
| Quinestrol_A498 | Quinestrol perturbation in A498 cell line |
| Vismodegib_AsPC-1 | Vismodegib perturbation in AsPC-1 cell line |
| Belumosudil (mesylate)_SW 900 | Belumosudil (mesylate) perturbation in SW 900 cell line |
| Capmatinib_AsPC-1 | Capmatinib perturbation in AsPC-1 cell line |
| Oxaliplatin_A498 | Oxaliplatin perturbation in A498 cell line |
| Tadalafil_HT-29 | Tadalafil perturbation in HT-29 cell line |
| (R)-Verapamil (hydrochloride)_HT-29 | (R)-Verapamil (hydrochloride) perturbation in HT-29 cell line |
| Clonidine (hydrochloride)_NCI-H1792 | Clonidine (hydrochloride) perturbation in NCI-H1792 cell line |
| Irinotecan_BT-474 | Irinotecan perturbation in BT-474 cell line |
| Simotinib_NCI-H2347 | Simotinib perturbation in NCI-H2347 cell line |
| Sivelestat (sodium tetrahydrate)_HT-29 | Sivelestat (sodium tetrahydrate) perturbation in HT-29 cell line |
| Vilanterol_HepG2/C3A | Vilanterol perturbation in HepG2/C3A cell line |
| Aprepitant_COLO 205 | Aprepitant perturbation in COLO 205 cell line |
| ML264_SW 1271 | ML264 perturbation in SW 1271 cell line |
| olaparib_NCI-H2347 | olaparib perturbation in NCI-H2347 cell line |
| Allantoin_HEC-1-A | Allantoin perturbation in HEC-1-A cell line |
| Amsacrine_MIA PaCa-2 | Amsacrine perturbation in MIA PaCa-2 cell line |
| NG25_SW 1271 | NG25 perturbation in SW 1271 cell line |
| Oxaliplatin_C32 | Oxaliplatin perturbation in C32 cell line |
| Fenofibrate_NCI-H1792 | Fenofibrate perturbation in NCI-H1792 cell line |
| Rutin (trihydrate)_A549 | Rutin (trihydrate) perturbation in A549 cell line |
| Irinotecan_NCI-H2030 | Irinotecan perturbation in NCI-H2030 cell line |
| Belinostat_BT-474 | Belinostat perturbation in BT-474 cell line |
| AZD1390_NCI-H2122 | AZD1390 perturbation in NCI-H2122 cell line |
| Brivudine_HepG2/C3A | Brivudine perturbation in HepG2/C3A cell line |
| vincristine_SW 1271 | vincristine perturbation in SW 1271 cell line |
| Lonafarnib_HT-29 | Lonafarnib perturbation in HT-29 cell line |
| Goserelin (acetate)_HT-29 | Goserelin (acetate) perturbation in HT-29 cell line |
| Irinotecan_HepG2/C3A | Irinotecan perturbation in HepG2/C3A cell line |
| Cytarabine (hydrochloride)_A498 | Cytarabine (hydrochloride) perturbation in A498 cell line |
| ML264_AsPC-1 | ML264 perturbation in AsPC-1 cell line |
| Canagliflozin_Panc 03.27 | Canagliflozin perturbation in Panc 03.27 cell line |
| Doxycycline (monohydrate)_NCI-H1573 | Doxycycline (monohydrate) perturbation in NCI-H1573 cell line |
| Panobinostat_NCI-H2347 | Panobinostat perturbation in NCI-H2347 cell line |
| Belinostat_SW1417 | Belinostat perturbation in SW1417 cell line |
| Vilanterol_BT-474 | Vilanterol perturbation in BT-474 cell line |
| Dihydroartemisinin_Panc 03.27 | Dihydroartemisinin perturbation in Panc 03.27 cell line |
| Ixazomib_HT-29 | Ixazomib perturbation in HT-29 cell line |
| Norepinephrine (hydrochloride)_Panc 03.27 | Norepinephrine (hydrochloride) perturbation in Panc 03.27 cell line |
| LY-2584702 (tosylate salt)_NCI-H2347 | LY-2584702 (tosylate salt) perturbation in NCI-H2347 cell line |
| Idarubicin (hydrochloride)_NCI-H460 | Idarubicin (hydrochloride) perturbation in NCI-H460 cell line |
| venetoclax_SW480 | venetoclax perturbation in SW480 cell line |
| Artesunate_SW1417 | Artesunate perturbation in SW1417 cell line |
| Fluvoxamine (maleate)_SK-MEL-2 | Fluvoxamine (maleate) perturbation in SK-MEL-2 cell line |
| Anethole trithione_SW1417 | Anethole trithione perturbation in SW1417 cell line |
| MK-3903_SW 1271 | MK-3903 perturbation in SW 1271 cell line |
| Clotrimazole_NCI-H1792 | Clotrimazole perturbation in NCI-H1792 cell line |
| CP21R7_CFPAC-1 | CP21R7 perturbation in CFPAC-1 cell line |
| Dimethyl fumarate_Panc 03.27 | Dimethyl fumarate perturbation in Panc 03.27 cell line |
| Epirubicin (hydrochloride)_HOP62 | Epirubicin (hydrochloride) perturbation in HOP62 cell line |
| Vinblastine (sulfate)_HT-29 | Vinblastine (sulfate) perturbation in HT-29 cell line |
| Vinblastine (sulfate)_Hs 766T | Vinblastine (sulfate) perturbation in Hs 766T cell line |
| APTO-253_Panc 03.27 | APTO-253 perturbation in Panc 03.27 cell line |
| Epirubicin (hydrochloride)_SNU-423 | Epirubicin (hydrochloride) perturbation in SNU-423 cell line |
| DTP3_NCI-H2347 | DTP3 perturbation in NCI-H2347 cell line |
| 9-ING-41_NCI-H1573 | 9-ING-41 perturbation in NCI-H1573 cell line |
| Pralsetinib_LoVo | Pralsetinib perturbation in LoVo cell line |
| Artemether_HT-29 | Artemether perturbation in HT-29 cell line |
| Berbamine (dihydrochloride)_SK-MEL-2 | Berbamine (dihydrochloride) perturbation in SK-MEL-2 cell line |
| Doxycycline (monohydrate)_C32 | Doxycycline (monohydrate) perturbation in C32 cell line |
| AT7519_NCI-H1573 | AT7519 perturbation in NCI-H1573 cell line |
| Olanzapine_HT-29 | Olanzapine perturbation in HT-29 cell line |
| Pralsetinib_MIA PaCa-2 | Pralsetinib perturbation in MIA PaCa-2 cell line |
| Darinaparsin_PANC-1 | Darinaparsin perturbation in PANC-1 cell line |
| Pitavastatin (Calcium)_HEC-1-A | Pitavastatin (Calcium) perturbation in HEC-1-A cell line |
| Pemigatinib_Panc 03.27 | Pemigatinib perturbation in Panc 03.27 cell line |
| BI-78D3_HepG2/C3A | BI-78D3 perturbation in HepG2/C3A cell line |
| Busulfan_HT-29 | Busulfan perturbation in HT-29 cell line |
| Berbamine_NCI-H2347 | Berbamine perturbation in NCI-H2347 cell line |
| Gemcitabine_SK-MEL-2 | Gemcitabine perturbation in SK-MEL-2 cell line |
| Folic acid_HT-29 | Folic acid perturbation in HT-29 cell line |
| Allopurinol_A498 | Allopurinol perturbation in A498 cell line |
| Vemurafenib_LoVo | Vemurafenib perturbation in LoVo cell line |
| Saquinavir_SW1417 | Saquinavir perturbation in SW1417 cell line |
| Terfenadine_SW 1271 | Terfenadine perturbation in SW 1271 cell line |
| Quinidine (15% dihydroquinidine)_SNU-423 | Quinidine (15% dihydroquinidine) perturbation in SNU-423 cell line |
| PF-06260933_SW480 | PF-06260933 perturbation in SW480 cell line |
| Bimiralisib_NCI-H1573 | Bimiralisib perturbation in NCI-H1573 cell line |
| Indacaterol (maleate)_HEC-1-A | Indacaterol (maleate) perturbation in HEC-1-A cell line |
| Arbutin_SW1417 | Arbutin perturbation in SW1417 cell line |
| venetoclax_A549 | venetoclax perturbation in A549 cell line |
| Vemurafenib_MIA PaCa-2 | Vemurafenib perturbation in MIA PaCa-2 cell line |
| palbociclib_BT-474 | palbociclib perturbation in BT-474 cell line |
| Lumateperone (tosylate)_HT-29 | Lumateperone (tosylate) perturbation in HT-29 cell line |
| Pentagastrin_Panc 03.27 | Pentagastrin perturbation in Panc 03.27 cell line |
| Oleic acid_HepG2/C3A | Oleic acid perturbation in HepG2/C3A cell line |
| Mitoxantrone (dihydrochloride)_HEC-1-A | Mitoxantrone (dihydrochloride) perturbation in HEC-1-A cell line |
| (R)-Verapamil (hydrochloride)_SK-MEL-2 | (R)-Verapamil (hydrochloride) perturbation in SK-MEL-2 cell line |
| Imiquimod (hydrochloride)_Panc 03.27 | Imiquimod (hydrochloride) perturbation in Panc 03.27 cell line |
| Baicalin_NCI-H1792 | Baicalin perturbation in NCI-H1792 cell line |
| Dexmedetomidine_NCI-H596 | Dexmedetomidine perturbation in NCI-H596 cell line |
| Tadalafil_SK-MEL-2 | Tadalafil perturbation in SK-MEL-2 cell line |
| Rimonabant_HT-29 | Rimonabant perturbation in HT-29 cell line |
| Lidocaine (hydrochloride)_HepG2/C3A | Lidocaine (hydrochloride) perturbation in HepG2/C3A cell line |
| Arbutin_BT-474 | Arbutin perturbation in BT-474 cell line |
| 4EGI-1_A549 | 4EGI-1 perturbation in A549 cell line |
| HI-TOPK-032_NCI-H1792 | HI-TOPK-032 perturbation in NCI-H1792 cell line |
| Temuterkib_MIA PaCa-2 | Temuterkib perturbation in MIA PaCa-2 cell line |
| Artesunate_SW 1271 | Artesunate perturbation in SW 1271 cell line |
| palbociclib_SW1417 | palbociclib perturbation in SW1417 cell line |
| Docetaxel_Panc 03.27 | Docetaxel perturbation in Panc 03.27 cell line |
| Celecoxib_NCI-H2347 | Celecoxib perturbation in NCI-H2347 cell line |
| Bimiralisib_C32 | Bimiralisib perturbation in C32 cell line |
| Capmatinib_SW1417 | Capmatinib perturbation in SW1417 cell line |
| CP21R7_SNU-423 | CP21R7 perturbation in SNU-423 cell line |
| NG25_BT-474 | NG25 perturbation in BT-474 cell line |
| Pentoxifylline_SK-MEL-2 | Pentoxifylline perturbation in SK-MEL-2 cell line |
| Hydroxyfasudil_SK-MEL-2 | Hydroxyfasudil perturbation in SK-MEL-2 cell line |
| Roxadustat_HT-29 | Roxadustat perturbation in HT-29 cell line |
| Tirabrutinib (hydrochloride)_A498 | Tirabrutinib (hydrochloride) perturbation in A498 cell line |
| Darinaparsin_HEC-1-A | Darinaparsin perturbation in HEC-1-A cell line |
| Capivasertib_SHP-77 | Capivasertib perturbation in SHP-77 cell line |
| vincristine_SW1417 | vincristine perturbation in SW1417 cell line |
| ML264_HepG2/C3A | ML264 perturbation in HepG2/C3A cell line |
| Eplerenone_A549 | Eplerenone perturbation in A549 cell line |
| Tolcapone_SW1417 | Tolcapone perturbation in SW1417 cell line |
| Gemfibrozil_C32 | Gemfibrozil perturbation in C32 cell line |
| Vismodegib_BT-474 | Vismodegib perturbation in BT-474 cell line |
| Relugolix_A498 | Relugolix perturbation in A498 cell line |
| Methyl aminolevulinate (hydrochloride)_LoVo | Methyl aminolevulinate (hydrochloride) perturbation in LoVo cell line |
| Vilanterol_SW 1271 | Vilanterol perturbation in SW 1271 cell line |
| NG25_SW1417 | NG25 perturbation in SW1417 cell line |
| Proglumide_NCI-H1792 | Proglumide perturbation in NCI-H1792 cell line |
| Lipoic acid_AsPC-1 | Lipoic acid perturbation in AsPC-1 cell line |
| Sapanisertib_HEC-1-A | Sapanisertib perturbation in HEC-1-A cell line |
| ETC-206_LoVo | ETC-206 perturbation in LoVo cell line |
| Baicalin_SW48 | Baicalin perturbation in SW48 cell line |
| Drospirenone_SW1417 | Drospirenone perturbation in SW1417 cell line |
| Oleic acid_A549 | Oleic acid perturbation in A549 cell line |
| AZD-8055_SW 1271 | AZD-8055 perturbation in SW 1271 cell line |
| venetoclax_NCI-H2030 | venetoclax perturbation in NCI-H2030 cell line |
| Belumosudil (mesylate)_LoVo | Belumosudil (mesylate) perturbation in LoVo cell line |
| Olanzapine_HCT15 | Olanzapine perturbation in HCT15 cell line |
| Chlorhexidine (diacetate)_HEC-1-A | Chlorhexidine (diacetate) perturbation in HEC-1-A cell line |
| Raltitrexed_HepG2/C3A | Raltitrexed perturbation in HepG2/C3A cell line |
| Indacaterol (maleate)_Hs 766T | Indacaterol (maleate) perturbation in Hs 766T cell line |
| Fumaric acid_NCI-H2347 | Fumaric acid perturbation in NCI-H2347 cell line |
| 4EGI-1_HepG2/C3A | 4EGI-1 perturbation in HepG2/C3A cell line |
| γ-Oryzanol_HT-29 | γ-Oryzanol perturbation in HT-29 cell line |
| AZD-7648_BT-474 | AZD-7648 perturbation in BT-474 cell line |
| ETC-206_MIA PaCa-2 | ETC-206 perturbation in MIA PaCa-2 cell line |
| Palmatine (chloride)_AsPC-1 | Palmatine (chloride) perturbation in AsPC-1 cell line |
| Lapatinib ditosylate_Panc 03.27 | Lapatinib ditosylate perturbation in Panc 03.27 cell line |
| Phenytoin (sodium)_NCI-H2347 | Phenytoin (sodium) perturbation in NCI-H2347 cell line |
| Mitoxantrone (dihydrochloride)_Hs 766T | Mitoxantrone (dihydrochloride) perturbation in Hs 766T cell line |
| Mitoxantrone (dihydrochloride)_HT-29 | Mitoxantrone (dihydrochloride) perturbation in HT-29 cell line |
| Econazole_A498 | Econazole perturbation in A498 cell line |
| Vemurafenib_NCI-H1573 | Vemurafenib perturbation in NCI-H1573 cell line |
| Peretinoin_NCI-H2347 | Peretinoin perturbation in NCI-H2347 cell line |
| S-Adenosyl-L-methionine (disulfate tosylate)_SW1417 | S-Adenosyl-L-methionine (disulfate tosylate) perturbation in SW1417 cell line |
| AZD1390_LoVo | AZD1390 perturbation in LoVo cell line |
| TAK-901_HT-29 | TAK-901 perturbation in HT-29 cell line |
| Bimiralisib_MIA PaCa-2 | Bimiralisib perturbation in MIA PaCa-2 cell line |
| Posaconazole_Panc 03.27 | Posaconazole perturbation in Panc 03.27 cell line |
| AZD-7648_SW1417 | AZD-7648 perturbation in SW1417 cell line |
| NVP-BHG712_SW 1088 | NVP-BHG712 perturbation in SW 1088 cell line |
| Sinomenine_SW1417 | Sinomenine perturbation in SW1417 cell line |
| Capivasertib_NCI-H1792 | Capivasertib perturbation in NCI-H1792 cell line |
| Pemetrexed_A549 | Pemetrexed perturbation in A549 cell line |
| Verteporfin_A549 | Verteporfin perturbation in A549 cell line |
| Aliskiren_C32 | Aliskiren perturbation in C32 cell line |
| Anastrozole_Panc 03.27 | Anastrozole perturbation in Panc 03.27 cell line |
| olaparib_Panc 03.27 | olaparib perturbation in Panc 03.27 cell line |
| Ipatasertib_HT-29 | Ipatasertib perturbation in HT-29 cell line |
| Relugolix_NCI-H1792 | Relugolix perturbation in NCI-H1792 cell line |
| Doxorubicin (hydrochloride)_AsPC-1 | Doxorubicin (hydrochloride) perturbation in AsPC-1 cell line |
| SBI-0640756_MIA PaCa-2 | SBI-0640756 perturbation in MIA PaCa-2 cell line |
| Cysteamine (hydrochloride)_HepG2/C3A | Cysteamine (hydrochloride) perturbation in HepG2/C3A cell line |
| Salicylic acid_SK-MEL-2 | Salicylic acid perturbation in SK-MEL-2 cell line |
| Fingolimod (hydrochloride)_NCI-H1573 | Fingolimod (hydrochloride) perturbation in NCI-H1573 cell line |
| Simotinib_Panc 03.27 | Simotinib perturbation in Panc 03.27 cell line |
| L-Thyroxine (sodium salt pentahydrate)_Panc 03.27 | L-Thyroxine (sodium salt pentahydrate) perturbation in Panc 03.27 cell line |
| Flumatinib (mesylate)_Panc 03.27 | Flumatinib (mesylate) perturbation in Panc 03.27 cell line |
| Sulfisoxazole_SW 1271 | Sulfisoxazole perturbation in SW 1271 cell line |
| Tomivosertib_HepG2/C3A | Tomivosertib perturbation in HepG2/C3A cell line |
| Fusidic acid_Panc 03.27 | Fusidic acid perturbation in Panc 03.27 cell line |
| Paclitaxel_HepG2/C3A | Paclitaxel perturbation in HepG2/C3A cell line |
| Bestatin (hydrochloride)_SK-MEL-2 | Bestatin (hydrochloride) perturbation in SK-MEL-2 cell line |
| Adagrasib_A549 | Adagrasib perturbation in A549 cell line |
| Rutin (trihydrate)_AsPC-1 | Rutin (trihydrate) perturbation in AsPC-1 cell line |
| Vemurafenib_C32 | Vemurafenib perturbation in C32 cell line |
| Sapanisertib_HT-29 | Sapanisertib perturbation in HT-29 cell line |
| Daidzin_BT-474 | Daidzin perturbation in BT-474 cell line |
| Belzutifan_SW1417 | Belzutifan perturbation in SW1417 cell line |
| Allantoin_HT-29 | Allantoin perturbation in HT-29 cell line |
| Vortioxetine_NCI-H1573 | Vortioxetine perturbation in NCI-H1573 cell line |
| Asciminib_AsPC-1 | Asciminib perturbation in AsPC-1 cell line |
| Epirubicin (hydrochloride)_C32 | Epirubicin (hydrochloride) perturbation in C32 cell line |
| Alpelisib_Panc 03.27 | Alpelisib perturbation in Panc 03.27 cell line |
| Eplerenone_AsPC-1 | Eplerenone perturbation in AsPC-1 cell line |
| Hydroxyfasudil_HS-578T | Hydroxyfasudil perturbation in HS-578T cell line |
| Pralsetinib_C32 | Pralsetinib perturbation in C32 cell line |
| Paclitaxel_AsPC-1 | Paclitaxel perturbation in AsPC-1 cell line |
| Clonidine (hydrochloride)_C32 | Clonidine (hydrochloride) perturbation in C32 cell line |
| Naproxen_A498 | Naproxen perturbation in A498 cell line |
| Belzutifan_BT-474 | Belzutifan perturbation in BT-474 cell line |
| 18β-Glycyrrhetinic acid_Panc 03.27 | 18β-Glycyrrhetinic acid perturbation in Panc 03.27 cell line |
| Ropivacaine (hydrochloride monohydrate)_A498 | Ropivacaine (hydrochloride monohydrate) perturbation in A498 cell line |
| Volasertib_Panc 03.27 | Volasertib perturbation in Panc 03.27 cell line |
| Lenalidomide (hemihydrate)_HEC-1-A | Lenalidomide (hemihydrate) perturbation in HEC-1-A cell line |
| venetoclax_COLO 205 | venetoclax perturbation in COLO 205 cell line |
| Ixazomib_HEC-1-A | Ixazomib perturbation in HEC-1-A cell line |
| IQ 1_NCI-H2347 | IQ 1 perturbation in NCI-H2347 cell line |
| LJI308_Panc 03.27 | LJI308 perturbation in Panc 03.27 cell line |
| AT7519_MIA PaCa-2 | AT7519 perturbation in MIA PaCa-2 cell line |
| Bestatin_A498 | Bestatin perturbation in A498 cell line |
| PF-06260933_NCI-H2030 | PF-06260933 perturbation in NCI-H2030 cell line |
| Trimetrexate_Panc 03.27 | Trimetrexate perturbation in Panc 03.27 cell line |
| Epirubicin (hydrochloride)_NCI-H1573 | Epirubicin (hydrochloride) perturbation in NCI-H1573 cell line |
| S-Adenosyl-L-methionine (disulfate tosylate)_SW 1271 | S-Adenosyl-L-methionine (disulfate tosylate) perturbation in SW 1271 cell line |
| Hesperidin_SW 1271 | Hesperidin perturbation in SW 1271 cell line |
| Rapamycin_C32 | Rapamycin perturbation in C32 cell line |
| Sodium Salicylate_NCI-H2347 | Sodium Salicylate perturbation in NCI-H2347 cell line |
| Quinestrol_SNU-423 | Quinestrol perturbation in SNU-423 cell line |
| Aspirin_NCI-H2347 | Aspirin perturbation in NCI-H2347 cell line |
| Berberine (chloride hydrate)_SK-MEL-2 | Berberine (chloride hydrate) perturbation in SK-MEL-2 cell line |
| Amsacrine_C32 | Amsacrine perturbation in C32 cell line |
| Clotrimazole_A498 | Clotrimazole perturbation in A498 cell line |
| Imiquimod (maleate)_NCI-H596 | Imiquimod (maleate) perturbation in NCI-H596 cell line |
| 5-Azacytidine_J82 | 5-Azacytidine perturbation in J82 cell line |
| AZD-8055_SW1417 | AZD-8055 perturbation in SW1417 cell line |
| Dapagliflozin ((2S)-1,2-propanediol, hydrate)_Hs 766T | Dapagliflozin ((2S)-1,2-propanediol, hydrate) perturbation in Hs 766T cell line |
| Dapagliflozin ((2S)-1,2-propanediol, hydrate)_HT-29 | Dapagliflozin ((2S)-1,2-propanediol, hydrate) perturbation in HT-29 cell line |
| Ipatasertib_SK-MEL-2 | Ipatasertib perturbation in SK-MEL-2 cell line |
| Elimusertib hydrochloride_Panc 03.27 | Elimusertib hydrochloride perturbation in Panc 03.27 cell line |
| AZD2858_HT-29 | AZD2858 perturbation in HT-29 cell line |
| PF-06260933_SW1417 | PF-06260933 perturbation in SW1417 cell line |
| 4EGI-1_SW 1271 | 4EGI-1 perturbation in SW 1271 cell line |
| S-Adenosyl-L-methionine (disulfate tosylate)_AsPC-1 | S-Adenosyl-L-methionine (disulfate tosylate) perturbation in AsPC-1 cell line |
| vincristine_LS 180 | vincristine perturbation in LS 180 cell line |
| Tubulin inhibitor 6_PANC-1 | Tubulin inhibitor 6 perturbation in PANC-1 cell line |
| Hesperidin_AsPC-1 | Hesperidin perturbation in AsPC-1 cell line |
| Capivasertib_CFPAC-1 | Capivasertib perturbation in CFPAC-1 cell line |
| Pioglitazone_NCI-H2347 | Pioglitazone perturbation in NCI-H2347 cell line |
| Belumosudil (mesylate)_J82 | Belumosudil (mesylate) perturbation in J82 cell line |
| Ropivacaine (hydrochloride monohydrate)_AN3 CA | Ropivacaine (hydrochloride monohydrate) perturbation in AN3 CA cell line |
| Resveratrol_SK-MEL-2 | Resveratrol perturbation in SK-MEL-2 cell line |
| Hydroxyfasudil_HEC-1-A | Hydroxyfasudil perturbation in HEC-1-A cell line |
| Salicylic acid_HT-29 | Salicylic acid perturbation in HT-29 cell line |
| Fluvoxamine (maleate)_PANC-1 | Fluvoxamine (maleate) perturbation in PANC-1 cell line |
| Capmatinib_LS 180 | Capmatinib perturbation in LS 180 cell line |
| Menadione_HEC-1-A | Menadione perturbation in HEC-1-A cell line |
| Idoxuridine_A498 | Idoxuridine perturbation in A498 cell line |
| Bestatin_C32 | Bestatin perturbation in C32 cell line |
| 5-Fluorouracil_A498 | 5-Fluorouracil perturbation in A498 cell line |
| Idarubicin (hydrochloride)_Panc 03.27 | Idarubicin (hydrochloride) perturbation in Panc 03.27 cell line |
| BAY1125976_SW1417 | BAY1125976 perturbation in SW1417 cell line |
| Dapagliflozin_Panc 03.27 | Dapagliflozin perturbation in Panc 03.27 cell line |
| EX229_C32 | EX229 perturbation in C32 cell line |
| Bimiralisib_J82 | Bimiralisib perturbation in J82 cell line |
| Cytarabine (hydrochloride)_SNU-423 | Cytarabine (hydrochloride) perturbation in SNU-423 cell line |
| NVP-BHG712_SW 1271 | NVP-BHG712 perturbation in SW 1271 cell line |
| HI-TOPK-032_NCI-H2122 | HI-TOPK-032 perturbation in NCI-H2122 cell line |
| Pemigatinib_NCI-H2347 | Pemigatinib perturbation in NCI-H2347 cell line |
| Rapamycin_A498 | Rapamycin perturbation in A498 cell line |
| Palmatine (chloride)_SW1417 | Palmatine (chloride) perturbation in SW1417 cell line |
| Pimozide_COLO 205 | Pimozide perturbation in COLO 205 cell line |
| Cyclosporin A_NCI-H2347 | Cyclosporin A perturbation in NCI-H2347 cell line |
| AZD1390_J82 | AZD1390 perturbation in J82 cell line |
| Glycyrrhizic acid_HEC-1-A | Glycyrrhizic acid perturbation in HEC-1-A cell line |
| Ferulic acid_A549 | Ferulic acid perturbation in A549 cell line |
| Doxorubicin (hydrochloride)_BT-474 | Doxorubicin (hydrochloride) perturbation in BT-474 cell line |
| Sulfisoxazole_NCI-H2030 | Sulfisoxazole perturbation in NCI-H2030 cell line |
| Oxaliplatin_NCI-H1792 | Oxaliplatin perturbation in NCI-H1792 cell line |
| SBI-0640756_J82 | SBI-0640756 perturbation in J82 cell line |
| OTS514_SW1417 | OTS514 perturbation in SW1417 cell line |
| PH-797804_HT-29 | PH-797804 perturbation in HT-29 cell line |
| Gemcitabine_HEC-1-A | Gemcitabine perturbation in HEC-1-A cell line |
| TAK-733_Panc 03.27 | TAK-733 perturbation in Panc 03.27 cell line |
| Doxorubicin (hydrochloride)_SW1417 | Doxorubicin (hydrochloride) perturbation in SW1417 cell line |
| Belzutifan_HepG2/C3A | Belzutifan perturbation in HepG2/C3A cell line |
| Mitoxantrone (dihydrochloride)_SK-MEL-2 | Mitoxantrone (dihydrochloride) perturbation in SK-MEL-2 cell line |
| (R)-Verapamil (hydrochloride)_HEC-1-A | (R)-Verapamil (hydrochloride) perturbation in HEC-1-A cell line |
| Sildenafil_SK-MEL-2 | Sildenafil perturbation in SK-MEL-2 cell line |
| Paclitaxel_SW 1271 | Paclitaxel perturbation in SW 1271 cell line |
| Rutin (trihydrate)_BT-474 | Rutin (trihydrate) perturbation in BT-474 cell line |
| Pimozide_AsPC-1 | Pimozide perturbation in AsPC-1 cell line |
| Everolimus_A549 | Everolimus perturbation in A549 cell line |
| Celecoxib_Panc 03.27 | Celecoxib perturbation in Panc 03.27 cell line |
| Pimitespib_MIA PaCa-2 | Pimitespib perturbation in MIA PaCa-2 cell line |
| Sulfisoxazole_HepG2/C3A | Sulfisoxazole perturbation in HepG2/C3A cell line |
| Bestatin_NCI-H1573 | Bestatin perturbation in NCI-H1573 cell line |
| LY2090314_SW480 | LY2090314 perturbation in SW480 cell line |
| Dihydroartemisinin_NCI-H2347 | Dihydroartemisinin perturbation in NCI-H2347 cell line |
| Eplerenone_BT-474 | Eplerenone perturbation in BT-474 cell line |
| Vismodegib_A549 | Vismodegib perturbation in A549 cell line |
| Entecavir (monohydrate)_Panc 03.27 | Entecavir (monohydrate) perturbation in Panc 03.27 cell line |
| Canagliflozin_NCI-H2347 | Canagliflozin perturbation in NCI-H2347 cell line |
| LY2090314_A549 | LY2090314 perturbation in A549 cell line |
| Paclitaxel_BT-474 | Paclitaxel perturbation in BT-474 cell line |
| Asciminib_SW1417 | Asciminib perturbation in SW1417 cell line |
| Infigratinib_RPMI-7951 | Infigratinib perturbation in RPMI-7951 cell line |
| Altretamine_C32 | Altretamine perturbation in C32 cell line |
| Bendamustine_HEC-1-A | Bendamustine perturbation in HEC-1-A cell line |
| NG25_A549 | NG25 perturbation in A549 cell line |
| Temuterkib_A498 | Temuterkib perturbation in A498 cell line |
| Pimozide_HepG2/C3A | Pimozide perturbation in HepG2/C3A cell line |
| S-Adenosyl-L-methionine (disulfate tosylate)_HepG2/C3A | S-Adenosyl-L-methionine (disulfate tosylate) perturbation in HepG2/C3A cell line |
| Adenine_HepG2/C3A | Adenine perturbation in HepG2/C3A cell line |
| NVP-BHG712_SW1417 | NVP-BHG712 perturbation in SW1417 cell line |
| 4EGI-1_BT-474 | 4EGI-1 perturbation in BT-474 cell line |
| Torkinib_Panc 03.27 | Torkinib perturbation in Panc 03.27 cell line |
| Thymol_Panc 03.27 | Thymol perturbation in Panc 03.27 cell line |
| venetoclax_SW1417 | venetoclax perturbation in SW1417 cell line |
| Vemurafenib_SHP-77 | Vemurafenib perturbation in SHP-77 cell line |
| Fingolimod (hydrochloride)_A498 | Fingolimod (hydrochloride) perturbation in A498 cell line |
| ULK-101_PANC-1 | ULK-101 perturbation in PANC-1 cell line |
| Bortezomib_SNU-423 | Bortezomib perturbation in SNU-423 cell line |
| Bestatin_NCI-H2122 | Bestatin perturbation in NCI-H2122 cell line |
| Baicalin_C32 | Baicalin perturbation in C32 cell line |
| LY-2584702 (tosylate salt)_Panc 03.27 | LY-2584702 (tosylate salt) perturbation in Panc 03.27 cell line |
| Erdafitinib _SW1417 | Erdafitinib perturbation in SW1417 cell line |
| Rucaparib (phosphate)_AsPC-1 | Rucaparib (phosphate) perturbation in AsPC-1 cell line |
| Acetazolamide_Hs 766T | Acetazolamide perturbation in Hs 766T cell line |
| Procainamide (hydrochloride)_BT-474 | Procainamide (hydrochloride) perturbation in BT-474 cell line |
| Methyl aminolevulinate (hydrochloride)_A498 | Methyl aminolevulinate (hydrochloride) perturbation in A498 cell line |
| PF-06260933_SW 1271 | PF-06260933 perturbation in SW 1271 cell line |
| palbociclib_A549 | palbociclib perturbation in A549 cell line |
| Tadalafil_PANC-1 | Tadalafil perturbation in PANC-1 cell line |
| BAY1125976_NCI-H2122 | BAY1125976 perturbation in NCI-H2122 cell line |
| Rapamycin_AsPC-1 | Rapamycin perturbation in AsPC-1 cell line |
| Vitamin K4_HepG2/C3A | Vitamin K4 perturbation in HepG2/C3A cell line |
| Piroxicam_HepG2/C3A | Piroxicam perturbation in HepG2/C3A cell line |
| Temuterkib_AsPC-1 | Temuterkib perturbation in AsPC-1 cell line |
| Radotinib_AsPC-1 | Radotinib perturbation in AsPC-1 cell line |
| CP21R7_AsPC-1 | CP21R7 perturbation in AsPC-1 cell line |
| Balsalazide (sodium hydrate)_A498 | Balsalazide (sodium hydrate) perturbation in A498 cell line |
| Clotrimazole_HepG2/C3A | Clotrimazole perturbation in HepG2/C3A cell line |
| HI-TOPK-032_AsPC-1 | HI-TOPK-032 perturbation in AsPC-1 cell line |
| Bergenin_AsPC-1 | Bergenin perturbation in AsPC-1 cell line |
| Gallic acid (hydrate)_HOP62 | Gallic acid (hydrate) perturbation in HOP62 cell line |
| Altretamine_AsPC-1 | Altretamine perturbation in AsPC-1 cell line |
| Relugolix_HepG2/C3A | Relugolix perturbation in HepG2/C3A cell line |
| Rucaparib (phosphate)_SNU-423 | Rucaparib (phosphate) perturbation in SNU-423 cell line |
| Bimiralisib_AsPC-1 | Bimiralisib perturbation in AsPC-1 cell line |
| AZD1390_AsPC-1 | AZD1390 perturbation in AsPC-1 cell line |
| Levobupivacaine (hydrochloride)_A-172 | Levobupivacaine (hydrochloride) perturbation in A-172 cell line |
| c-Kit-IN-1_SW48 | c-Kit-IN-1 perturbation in SW48 cell line |
| Vitamin K4_A549 | Vitamin K4 perturbation in A549 cell line |
| Minodronic acid_AsPC-1 | Minodronic acid perturbation in AsPC-1 cell line |
| Oxaliplatin_AsPC-1 | Oxaliplatin perturbation in AsPC-1 cell line |
| Ciclopirox_A498 | Ciclopirox perturbation in A498 cell line |
| Mebendazole_AsPC-1 | Mebendazole perturbation in AsPC-1 cell line |
| Sapanisertib_CFPAC-1 | Sapanisertib perturbation in CFPAC-1 cell line |
| Tucatinib_AsPC-1 | Tucatinib perturbation in AsPC-1 cell line |
| IQ 1_AsPC-1 | IQ 1 perturbation in AsPC-1 cell line |
| Belumosudil_HepG2/C3A | Belumosudil perturbation in HepG2/C3A cell line |
| Aspirin_HepG2/C3A | Aspirin perturbation in HepG2/C3A cell line |
| Pyridoxine_AsPC-1 | Pyridoxine perturbation in AsPC-1 cell line |
| Omeprazole (sodium)_A549 | Omeprazole (sodium) perturbation in A549 cell line |
| Elimusertib hydrochloride_AsPC-1 | Elimusertib hydrochloride perturbation in AsPC-1 cell line |
| Dapagliflozin_AsPC-1 | Dapagliflozin perturbation in AsPC-1 cell line |
| Tazarotene_SNU-423 | Tazarotene perturbation in SNU-423 cell line |
| Chlorhexidine (diacetate)_SNU-423 | Chlorhexidine (diacetate) perturbation in SNU-423 cell line |
| Cloxacillin (sodium)_AsPC-1 | Cloxacillin (sodium) perturbation in AsPC-1 cell line |
| Cepharanthine_AsPC-1 | Cepharanthine perturbation in AsPC-1 cell line |
| Furosemide_AsPC-1 | Furosemide perturbation in AsPC-1 cell line |
| Ixazomib citrate_CFPAC-1 | Ixazomib citrate perturbation in CFPAC-1 cell line |
| Dexmedetomidine_SNU-423 | Dexmedetomidine perturbation in SNU-423 cell line |
| Trimetrexate_AsPC-1 | Trimetrexate perturbation in AsPC-1 cell line |
| Tofacitinib (citrate)_SNU-423 | Tofacitinib (citrate) perturbation in SNU-423 cell line |
| Megestrol_AsPC-1 | Megestrol perturbation in AsPC-1 cell line |
| Erlotinib_SNU-423 | Erlotinib perturbation in SNU-423 cell line |
| Neratinib (maleate)_A549 | Neratinib (maleate) perturbation in A549 cell line |
| Tazarotene_A549 | Tazarotene perturbation in A549 cell line |
| Aspirin_SNU-423 | Aspirin perturbation in SNU-423 cell line |
| Ligustrazine_A549 | Ligustrazine perturbation in A549 cell line |
| Sapanisertib_HepG2/C3A | Sapanisertib perturbation in HepG2/C3A cell line |
| Meloxicam_A-172 | Meloxicam perturbation in A-172 cell line |
| Sapanisertib_AsPC-1 | Sapanisertib perturbation in AsPC-1 cell line |
| Afatinib_A-172 | Afatinib perturbation in A-172 cell line |
| Glasdegib_A549 | Glasdegib perturbation in A549 cell line |
| Gallic acid_AsPC-1 | Gallic acid perturbation in AsPC-1 cell line |
| Verteporfin_A-172 | Verteporfin perturbation in A-172 cell line |
| (R)-Verapamil (hydrochloride)_A549 | (R)-Verapamil (hydrochloride) perturbation in A549 cell line |
| Ranolazine_SNU-423 | Ranolazine perturbation in SNU-423 cell line |
| Macitentan_HOP62 | Macitentan perturbation in HOP62 cell line |
| Azithromycin (hydrate)_AsPC-1 | Azithromycin (hydrate) perturbation in AsPC-1 cell line |
| AZD2858_AsPC-1 | AZD2858 perturbation in AsPC-1 cell line |
| Glycyrrhizic acid_AsPC-1 | Glycyrrhizic acid perturbation in AsPC-1 cell line |
| Daptomycin_HepG2/C3A | Daptomycin perturbation in HepG2/C3A cell line |
| Lapatinib ditosylate_SNU-423 | Lapatinib ditosylate perturbation in SNU-423 cell line |
| Adenosine_HepG2/C3A | Adenosine perturbation in HepG2/C3A cell line |
| Hydroxyfasudil_AsPC-1 | Hydroxyfasudil perturbation in AsPC-1 cell line |
| Dexmedetomidine_AsPC-1 | Dexmedetomidine perturbation in AsPC-1 cell line |
| Encorafenib_AsPC-1 | Encorafenib perturbation in AsPC-1 cell line |
| Adenosine_AsPC-1 | Adenosine perturbation in AsPC-1 cell line |
| Tofacitinib (citrate)_AsPC-1 | Tofacitinib (citrate) perturbation in AsPC-1 cell line |
| Tubulin inhibitor 6_AsPC-1 | Tubulin inhibitor 6 perturbation in AsPC-1 cell line |
| Lumateperone (tosylate)_AsPC-1 | Lumateperone (tosylate) perturbation in AsPC-1 cell line |
| Hydroxyurea_HepG2/C3A | Hydroxyurea perturbation in HepG2/C3A cell line |
| Neratinib (maleate)_AsPC-1 | Neratinib (maleate) perturbation in AsPC-1 cell line |
| Rimonabant_AsPC-1 | Rimonabant perturbation in AsPC-1 cell line |
| Chlorhexidine (diacetate)_HepG2/C3A | Chlorhexidine (diacetate) perturbation in HepG2/C3A cell line |
| Gefitinib_SNU-423 | Gefitinib perturbation in SNU-423 cell line |
| Larotrectinib_AsPC-1 | Larotrectinib perturbation in AsPC-1 cell line |
| Resveratrol_A549 | Resveratrol perturbation in A549 cell line |
| Larotrectinib sulfate_AsPC-1 | Larotrectinib sulfate perturbation in AsPC-1 cell line |
| Ipatasertib_A549 | Ipatasertib perturbation in A549 cell line |
| Riluzole hydrochloride_AsPC-1 | Riluzole hydrochloride perturbation in AsPC-1 cell line |
| Artesunate_AsPC-1 | Artesunate perturbation in AsPC-1 cell line |
| Silodosin_A549 | Silodosin perturbation in A549 cell line |
| Afatinib_AsPC-1 | Afatinib perturbation in AsPC-1 cell line |
| NG25_AsPC-1 | NG25 perturbation in AsPC-1 cell line |
| Esmolol (hydrochloride)_HepG2/C3A | Esmolol (hydrochloride) perturbation in HepG2/C3A cell line |
| Rapamycin_HOP62 | Rapamycin perturbation in HOP62 cell line |
| Elagolix sodium_AsPC-1 | Elagolix sodium perturbation in AsPC-1 cell line |
| Fluvoxamine_SW48 | Fluvoxamine perturbation in SW48 cell line |
| Gallic acid_A-172 | Gallic acid perturbation in A-172 cell line |
| PF-06260933_A549 | PF-06260933 perturbation in A549 cell line |
| Oleic acid_AsPC-1 | Oleic acid perturbation in AsPC-1 cell line |
| Capivasertib_SW48 | Capivasertib perturbation in SW48 cell line |
| Retinoic acid_RKO | Retinoic acid perturbation in RKO cell line |
| Elagolix sodium_HepG2/C3A | Elagolix sodium perturbation in HepG2/C3A cell line |
| Irinotecan_AsPC-1 | Irinotecan perturbation in AsPC-1 cell line |
| Infigratinib_AsPC-1 | Infigratinib perturbation in AsPC-1 cell line |
| Abiraterone acetate_A549 | Abiraterone acetate perturbation in A549 cell line |
| Abemaciclib_A498 | Abemaciclib perturbation in A498 cell line |
| Pyridoxine (hydrochloride)_HepG2/C3A | Pyridoxine (hydrochloride) perturbation in HepG2/C3A cell line |
| Raltitrexed_AsPC-1 | Raltitrexed perturbation in AsPC-1 cell line |
| Erdafitinib _AsPC-1 | Erdafitinib perturbation in AsPC-1 cell line |
| PF-06260933_HepG2/C3A | PF-06260933 perturbation in HepG2/C3A cell line |
| venetoclax_AsPC-1 | venetoclax perturbation in AsPC-1 cell line |
| Tetracycline (hydrochloride)_A549 | Tetracycline (hydrochloride) perturbation in A549 cell line |
| Lumateperone (tosylate)_A-172 | Lumateperone (tosylate) perturbation in A-172 cell line |
| Phenylephrine (hydrochloride)_SNU-423 | Phenylephrine (hydrochloride) perturbation in SNU-423 cell line |
| Balsalazide (sodium hydrate)_AsPC-1 | Balsalazide (sodium hydrate) perturbation in AsPC-1 cell line |
| AZD-7648_HepG2/C3A | AZD-7648 perturbation in HepG2/C3A cell line |
| Dinaciclib_KATO III | Dinaciclib perturbation in KATO III cell line |
| Tolmetin_C-33 A | Tolmetin perturbation in C-33 A cell line |
| Belinostat_KATO III | Belinostat perturbation in KATO III cell line |
| Altretamine_BT-474 | Altretamine perturbation in BT-474 cell line |
| Rucaparib (phosphate)_SHP-77 | Rucaparib (phosphate) perturbation in SHP-77 cell line |
| Diammonium Glycyrrhizinate_BT-474 | Diammonium Glycyrrhizinate perturbation in BT-474 cell line |
| Meloxicam_KATO III | Meloxicam perturbation in KATO III cell line |
| (S)-Crizotinib_HEC-1-A | (S)-Crizotinib perturbation in HEC-1-A cell line |
| Clotrimazole_BT-474 | Clotrimazole perturbation in BT-474 cell line |
| Clobetasol propionate_SW480 | Clobetasol propionate perturbation in SW480 cell line |
| 5-Fluorouracil_BT-474 | 5-Fluorouracil perturbation in BT-474 cell line |
| Amsacrine_BT-474 | Amsacrine perturbation in BT-474 cell line |
| crizotinib_HT-29 | crizotinib perturbation in HT-29 cell line |
| Neratinib_SNU-1 | Neratinib perturbation in SNU-1 cell line |
| Entrectinib_C-33 A | Entrectinib perturbation in C-33 A cell line |
| AZD1390_BT-474 | AZD1390 perturbation in BT-474 cell line |
| Posaconazole_HEC-1-A | Posaconazole perturbation in HEC-1-A cell line |
| Cepharanthine_HEC-1-A | Cepharanthine perturbation in HEC-1-A cell line |
| Cabozantinib (S-malate)_NCI-H2030 | Cabozantinib (S-malate) perturbation in NCI-H2030 cell line |
| Bexarotene_SNU-1 | Bexarotene perturbation in SNU-1 cell line |
| Pimitespib_NCI-H2030 | Pimitespib perturbation in NCI-H2030 cell line |
| Doxycycline (monohydrate)_BT-474 | Doxycycline (monohydrate) perturbation in BT-474 cell line |
| Posaconazole_PANC-1 | Posaconazole perturbation in PANC-1 cell line |
| Tazarotene_SNU-1 | Tazarotene perturbation in SNU-1 cell line |
| Fluvoxamine_BT-474 | Fluvoxamine perturbation in BT-474 cell line |
| Sapanisertib_RKO | Sapanisertib perturbation in RKO cell line |
| Berbamine_HEC-1-A | Berbamine perturbation in HEC-1-A cell line |
| (S)-Crizotinib_HT-29 | (S)-Crizotinib perturbation in HT-29 cell line |
| Dexamethasone_BT-474 | Dexamethasone perturbation in BT-474 cell line |
| L-Eflornithine (monohydrochloride)_BT-474 | L-Eflornithine (monohydrochloride) perturbation in BT-474 cell line |
| Omeprazole_BT-474 | Omeprazole perturbation in BT-474 cell line |
| Bexarotene_C-33 A | Bexarotene perturbation in C-33 A cell line |
| GSK1059615_MIA PaCa-2 | GSK1059615 perturbation in MIA PaCa-2 cell line |
| Cobimetinib_KATO III | Cobimetinib perturbation in KATO III cell line |
| Finasteride_BT-474 | Finasteride perturbation in BT-474 cell line |
| Atazanavir (sulfate)_NCI-H2122 | Atazanavir (sulfate) perturbation in NCI-H2122 cell line |
| Sivelestat (sodium tetrahydrate)_AN3 CA | Sivelestat (sodium tetrahydrate) perturbation in AN3 CA cell line |
| Neratinib_KATO III | Neratinib perturbation in KATO III cell line |
| Encorafenib_SHP-77 | Encorafenib perturbation in SHP-77 cell line |
| Ritonavir_SW480 | Ritonavir perturbation in SW480 cell line |
| Meloxicam_SNU-1 | Meloxicam perturbation in SNU-1 cell line |
| Methylthiouracil_C-33 A | Methylthiouracil perturbation in C-33 A cell line |
| Menadione_C-33 A | Menadione perturbation in C-33 A cell line |
| Bestatin (hydrochloride)_KATO III | Bestatin (hydrochloride) perturbation in KATO III cell line |
| Trametinib_RKO | Trametinib perturbation in RKO cell line |
| Lopinavir_HT-29 | Lopinavir perturbation in HT-29 cell line |
| Levobupivacaine (hydrochloride)_BT-474 | Levobupivacaine (hydrochloride) perturbation in BT-474 cell line |
| Berbamine_NCI-H2030 | Berbamine perturbation in NCI-H2030 cell line |
| GSK1059615_C-33 A | GSK1059615 perturbation in C-33 A cell line |
| Abiraterone acetate_SNU-1 | Abiraterone acetate perturbation in SNU-1 cell line |
| Regorafenib_NCI-H2030 | Regorafenib perturbation in NCI-H2030 cell line |
| Citalopram (hydrobromide)_C-33 A | Citalopram (hydrobromide) perturbation in C-33 A cell line |
| Panobinostat_BT-474 | Panobinostat perturbation in BT-474 cell line |
| crizotinib_C-33 A | crizotinib perturbation in C-33 A cell line |
| Abiraterone acetate_HT-29 | Abiraterone acetate perturbation in HT-29 cell line |
| Paclitaxel_HT-29 | Paclitaxel perturbation in HT-29 cell line |
| (S)-Crizotinib_MIA PaCa-2 | (S)-Crizotinib perturbation in MIA PaCa-2 cell line |
| Posaconazole_C-33 A | Posaconazole perturbation in C-33 A cell line |
| Panobinostat_NCI-H2122 | Panobinostat perturbation in NCI-H2122 cell line |
| Niclosamide (olamine)_HT-29 | Niclosamide (olamine) perturbation in HT-29 cell line |
| Betamethasone dipropionate_HEC-1-A | Betamethasone dipropionate perturbation in HEC-1-A cell line |
| Bestatin (hydrochloride)_BT-474 | Bestatin (hydrochloride) perturbation in BT-474 cell line |
| Aspirin_KATO III | Aspirin perturbation in KATO III cell line |
| Relugolix_RKO | Relugolix perturbation in RKO cell line |
| c-Kit-IN-1_NCI-H661 | c-Kit-IN-1 perturbation in NCI-H661 cell line |
| Dapagliflozin_C-33 A | Dapagliflozin perturbation in C-33 A cell line |
| Pitavastatin (Calcium)_BT-474 | Pitavastatin (Calcium) perturbation in BT-474 cell line |
| Carbamazepine_NCI-H2030 | Carbamazepine perturbation in NCI-H2030 cell line |
| Valdecoxib_NCI-H2030 | Valdecoxib perturbation in NCI-H2030 cell line |
| Sildenafil_BT-474 | Sildenafil perturbation in BT-474 cell line |
| Roxadustat_BT-474 | Roxadustat perturbation in BT-474 cell line |
| Berbamine (dihydrochloride)_NCI-H2030 | Berbamine (dihydrochloride) perturbation in NCI-H2030 cell line |
| Lactate (calcium)_RKO | Lactate (calcium) perturbation in RKO cell line |
| Monocrotaline_BT-474 | Monocrotaline perturbation in BT-474 cell line |
| Ciclopirox_BT-474 | Ciclopirox perturbation in BT-474 cell line |
| Dapagliflozin_KATO III | Dapagliflozin perturbation in KATO III cell line |
| Glasdegib_NCI-H2030 | Glasdegib perturbation in NCI-H2030 cell line |
| Olanzapine_BT-474 | Olanzapine perturbation in BT-474 cell line |
| Artemether_BT-474 | Artemether perturbation in BT-474 cell line |
| Sivelestat (sodium tetrahydrate)_BT-474 | Sivelestat (sodium tetrahydrate) perturbation in BT-474 cell line |
| Menadione_BT-474 | Menadione perturbation in BT-474 cell line |
| Rimonabant_NCI-H2030 | Rimonabant perturbation in NCI-H2030 cell line |
| Methylthiouracil_BT-474 | Methylthiouracil perturbation in BT-474 cell line |
| Niclosamide (olamine)_NCI-H661 | Niclosamide (olamine) perturbation in NCI-H661 cell line |
| Berbamine (dihydrochloride)_BT-474 | Berbamine (dihydrochloride) perturbation in BT-474 cell line |
| (S)-Crizotinib_SNU-1 | (S)-Crizotinib perturbation in SNU-1 cell line |
| 5-Fluorouracil_KATO III | 5-Fluorouracil perturbation in KATO III cell line |
| Lidocaine (hydrochloride)_BT-474 | Lidocaine (hydrochloride) perturbation in BT-474 cell line |
| Chlorhexidine (diacetate)_NCI-H596 | Chlorhexidine (diacetate) perturbation in NCI-H596 cell line |
| Menadione_HT-29 | Menadione perturbation in HT-29 cell line |
| Temsirolimus_A498 | Temsirolimus perturbation in A498 cell line |
| Tirabrutinib (hydrochloride)_C-33 A | Tirabrutinib (hydrochloride) perturbation in C-33 A cell line |
| Ferulic acid_BT-474 | Ferulic acid perturbation in BT-474 cell line |
| Esmolol (hydrochloride)_BT-474 | Esmolol (hydrochloride) perturbation in BT-474 cell line |
| Omeprazole_C-33 A | Omeprazole perturbation in C-33 A cell line |
| Ivermectin_C-33 A | Ivermectin perturbation in C-33 A cell line |
| Perindopril (erbumine)_KATO III | Perindopril (erbumine) perturbation in KATO III cell line |
| Tofacitinib (citrate)_NCI-H596 | Tofacitinib (citrate) perturbation in NCI-H596 cell line |
| Meloxicam_BT-474 | Meloxicam perturbation in BT-474 cell line |
| Phenylephrine (hydrochloride)_C-33 A | Phenylephrine (hydrochloride) perturbation in C-33 A cell line |
| Ranolazine_SNU-1 | Ranolazine perturbation in SNU-1 cell line |
| 8-Hydroxyquinoline_BT-474 | 8-Hydroxyquinoline perturbation in BT-474 cell line |
| Benproperine (phosphate)_BT-474 | Benproperine (phosphate) perturbation in BT-474 cell line |
| Bexarotene_PANC-1 | Bexarotene perturbation in PANC-1 cell line |
| Berbamine (dihydrochloride)_HS-578T | Berbamine (dihydrochloride) perturbation in HS-578T cell line |
| Dexamethasone_KATO III | Dexamethasone perturbation in KATO III cell line |
| Nimesulide_KATO III | Nimesulide perturbation in KATO III cell line |
| Perindopril (erbumine)_C-33 A | Perindopril (erbumine) perturbation in C-33 A cell line |
| Darolutamide_KATO III | Darolutamide perturbation in KATO III cell line |
| Vitamin K4_A-427 | Vitamin K4 perturbation in A-427 cell line |
| Radotinib_C-33 A | Radotinib perturbation in C-33 A cell line |
| Sonidegib_NCI-H2030 | Sonidegib perturbation in NCI-H2030 cell line |
| Vortioxetine_SHP-77 | Vortioxetine perturbation in SHP-77 cell line |
| Canagliflozin (hemihydrate)_SNU-1 | Canagliflozin (hemihydrate) perturbation in SNU-1 cell line |
| Pentamidine (isethionate)_BT-474 | Pentamidine (isethionate) perturbation in BT-474 cell line |
| Edoxaban (tosylate monohydrate)_C-33 A | Edoxaban (tosylate monohydrate) perturbation in C-33 A cell line |
| Cabozantinib (S-malate)_SNU-423 | Cabozantinib (S-malate) perturbation in SNU-423 cell line |
| Orlistat_HT-29 | Orlistat perturbation in HT-29 cell line |
| Brimonidine_BT-474 | Brimonidine perturbation in BT-474 cell line |
| Berbamine_SNU-1 | Berbamine perturbation in SNU-1 cell line |
| Furosemide_MIA PaCa-2 | Furosemide perturbation in MIA PaCa-2 cell line |
| Carbidopa (monohydrate)_SW 1271 | Carbidopa (monohydrate) perturbation in SW 1271 cell line |
| 5-Fluorouracil_C-33 A | 5-Fluorouracil perturbation in C-33 A cell line |
| Dinaciclib_A-427 | Dinaciclib perturbation in A-427 cell line |
| Drospirenone_SW 900 | Drospirenone perturbation in SW 900 cell line |
| Budesonide_C-33 A | Budesonide perturbation in C-33 A cell line |
| Elagolix sodium_SW 900 | Elagolix sodium perturbation in SW 900 cell line |
| Elagolix sodium_AN3 CA | Elagolix sodium perturbation in AN3 CA cell line |
| Ferulic acid_SW 900 | Ferulic acid perturbation in SW 900 cell line |
| Ropivacaine (hydrochloride monohydrate)_HCT15 | Ropivacaine (hydrochloride monohydrate) perturbation in HCT15 cell line |
| Berbamine (dihydrochloride)_SW 900 | Berbamine (dihydrochloride) perturbation in SW 900 cell line |
| Dinaciclib_SW 900 | Dinaciclib perturbation in SW 900 cell line |
| Dinaciclib_SHP-77 | Dinaciclib perturbation in SHP-77 cell line |
| Cyclosporin A_LS 180 | Cyclosporin A perturbation in LS 180 cell line |
| Fluvoxamine_HCT15 | Fluvoxamine perturbation in HCT15 cell line |
| Rosiglitazone_SW480 | Rosiglitazone perturbation in SW480 cell line |
| Elagolix sodium_HCT15 | Elagolix sodium perturbation in HCT15 cell line |
| Dinaciclib_LS 180 | Dinaciclib perturbation in LS 180 cell line |
| AZD2858_LS 180 | AZD2858 perturbation in LS 180 cell line |
| Fumaric acid_SW 900 | Fumaric acid perturbation in SW 900 cell line |
| Aspirin_C-33 A | Aspirin perturbation in C-33 A cell line |
| Triamcinolone_SHP-77 | Triamcinolone perturbation in SHP-77 cell line |
| Trametinib_RPMI-7951 | Trametinib perturbation in RPMI-7951 cell line |
| Mifepristone_SW1417 | Mifepristone perturbation in SW1417 cell line |
| Nevirapine_NCI-H2030 | Nevirapine perturbation in NCI-H2030 cell line |
| Epirubicin (hydrochloride)_SW 900 | Epirubicin (hydrochloride) perturbation in SW 900 cell line |
| Vinblastine (sulfate)_RKO | Vinblastine (sulfate) perturbation in RKO cell line |
| AZD2858_SNU-1 | AZD2858 perturbation in SNU-1 cell line |
| Proglumide_SW1417 | Proglumide perturbation in SW1417 cell line |
| Gemcitabine_NCI-H23 | Gemcitabine perturbation in NCI-H23 cell line |
| Everolimus_MIA PaCa-2 | Everolimus perturbation in MIA PaCa-2 cell line |
| Benproperine (phosphate)_AN3 CA | Benproperine (phosphate) perturbation in AN3 CA cell line |
| Demeclocycline_PANC-1 | Demeclocycline perturbation in PANC-1 cell line |
| Trimetrexate_PANC-1 | Trimetrexate perturbation in PANC-1 cell line |
| Selinexor _NCI-H23 | Selinexor perturbation in NCI-H23 cell line |
| 5-Azacytidine_SW 1271 | 5-Azacytidine perturbation in SW 1271 cell line |
| Trimetrexate_HS-578T | Trimetrexate perturbation in HS-578T cell line |
| Dexamethasone_SW1417 | Dexamethasone perturbation in SW1417 cell line |
| Tomivosertib_MIA PaCa-2 | Tomivosertib perturbation in MIA PaCa-2 cell line |
| Glycyrrhizic acid_NCI-H2122 | Glycyrrhizic acid perturbation in NCI-H2122 cell line |
| GSK1059615_LoVo | GSK1059615 perturbation in LoVo cell line |
| Azithromycin (hydrate)_MIA PaCa-2 | Azithromycin (hydrate) perturbation in MIA PaCa-2 cell line |
| Tofacitinib_NCI-H661 | Tofacitinib perturbation in NCI-H661 cell line |
| PF-06260933_NCI-H23 | PF-06260933 perturbation in NCI-H23 cell line |
| Abemaciclib_NCI-H661 | Abemaciclib perturbation in NCI-H661 cell line |
| Selinexor _NCI-H2122 | Selinexor perturbation in NCI-H2122 cell line |
| Captopril_SW480 | Captopril perturbation in SW480 cell line |
| Dapagliflozin_SW 1271 | Dapagliflozin perturbation in SW 1271 cell line |
| Lenalidomide (hemihydrate)_J82 | Lenalidomide (hemihydrate) perturbation in J82 cell line |
| Tubulin inhibitor 6_MIA PaCa-2 | Tubulin inhibitor 6 perturbation in MIA PaCa-2 cell line |
| Ipatasertib_SW 1088 | Ipatasertib perturbation in SW 1088 cell line |
| Pyridoxine_MIA PaCa-2 | Pyridoxine perturbation in MIA PaCa-2 cell line |
| Trimetrexate_NCI-H2122 | Trimetrexate perturbation in NCI-H2122 cell line |
| Terfenadine_NCI-H661 | Terfenadine perturbation in NCI-H661 cell line |
| Everolimus_HCT15 | Everolimus perturbation in HCT15 cell line |
| c-Kit-IN-1_PANC-1 | c-Kit-IN-1 perturbation in PANC-1 cell line |
| Sunitinib_BT-474 | Sunitinib perturbation in BT-474 cell line |
| Folic acid_SW 1271 | Folic acid perturbation in SW 1271 cell line |
| Fluvoxamine (maleate)_SW 1271 | Fluvoxamine (maleate) perturbation in SW 1271 cell line |
| Tomivosertib_HCT15 | Tomivosertib perturbation in HCT15 cell line |
| Tomivosertib_NCI-H661 | Tomivosertib perturbation in NCI-H661 cell line |
| Asciminib_NCI-H661 | Asciminib perturbation in NCI-H661 cell line |
| Brimonidine_PANC-1 | Brimonidine perturbation in PANC-1 cell line |
| OTS514_NCI-H661 | OTS514 perturbation in NCI-H661 cell line |
| Afatinib_SW 1088 | Afatinib perturbation in SW 1088 cell line |
| Abemaciclib_MIA PaCa-2 | Abemaciclib perturbation in MIA PaCa-2 cell line |
| Trimetrexate_NCI-H2347 | Trimetrexate perturbation in NCI-H2347 cell line |
| Gallic acid_NCI-H661 | Gallic acid perturbation in NCI-H661 cell line |
| Carbamazepine_NCI-H661 | Carbamazepine perturbation in NCI-H661 cell line |
| Mitoxantrone (dihydrochloride)_PANC-1 | Mitoxantrone (dihydrochloride) perturbation in PANC-1 cell line |
| Terfenadine_SW1417 | Terfenadine perturbation in SW1417 cell line |
| Triclosan_NCI-H2122 | Triclosan perturbation in NCI-H2122 cell line |
| Selinexor _PANC-1 | Selinexor perturbation in PANC-1 cell line |
| Gemfibrozil_MIA PaCa-2 | Gemfibrozil perturbation in MIA PaCa-2 cell line |
| Lenalidomide (hemihydrate)_NCI-H661 | Lenalidomide (hemihydrate) perturbation in NCI-H661 cell line |
| Larotrectinib_NCI-H661 | Larotrectinib perturbation in NCI-H661 cell line |
| Pimitespib_J82 | Pimitespib perturbation in J82 cell line |
| Homoharringtonine_HCT15 | Homoharringtonine perturbation in HCT15 cell line |
| Pyridoxine_NCI-H460 | Pyridoxine perturbation in NCI-H460 cell line |
| Altretamine_NCI-H2122 | Altretamine perturbation in NCI-H2122 cell line |
| Phenylephrine (hydrochloride)_RPMI-7951 | Phenylephrine (hydrochloride) perturbation in RPMI-7951 cell line |
| Diphenhydramine_SW 900 | Diphenhydramine perturbation in SW 900 cell line |
| Dorzolamide (hydrochloride)_Hs 766T | Dorzolamide (hydrochloride) perturbation in Hs 766T cell line |
| Lactate (calcium)_SW 1271 | Lactate (calcium) perturbation in SW 1271 cell line |
| Procainamide (hydrochloride)_AN3 CA | Procainamide (hydrochloride) perturbation in AN3 CA cell line |
| Mozavaptan_HCT15 | Mozavaptan perturbation in HCT15 cell line |
| Proglumide_BT-474 | Proglumide perturbation in BT-474 cell line |
| Dihydroartemisinin_A-172 | Dihydroartemisinin perturbation in A-172 cell line |
| Betamethasone dipropionate_LoVo | Betamethasone dipropionate perturbation in LoVo cell line |
| Methyl aminolevulinate (hydrochloride)_COLO 205 | Methyl aminolevulinate (hydrochloride) perturbation in COLO 205 cell line |
| Captopril_HCT15 | Captopril perturbation in HCT15 cell line |
| Lipoic acid_MIA PaCa-2 | Lipoic acid perturbation in MIA PaCa-2 cell line |
| Omeprazole (sodium)_HCT15 | Omeprazole (sodium) perturbation in HCT15 cell line |
| Quinidine (15% dihydroquinidine)_COLO 205 | Quinidine (15% dihydroquinidine) perturbation in COLO 205 cell line |
| Fulvestrant_LS 180 | Fulvestrant perturbation in LS 180 cell line |
| Levobupivacaine (hydrochloride)_NCI-H596 | Levobupivacaine (hydrochloride) perturbation in NCI-H596 cell line |
| Silodosin_NCI-H2122 | Silodosin perturbation in NCI-H2122 cell line |
| Hesperidin_NCI-H2122 | Hesperidin perturbation in NCI-H2122 cell line |
| Ataluren_J82 | Ataluren perturbation in J82 cell line |
| Zileuton_H4 | Zileuton perturbation in H4 cell line |
| Pemigatinib_NCI-H661 | Pemigatinib perturbation in NCI-H661 cell line |
| Zileuton_HCT15 | Zileuton perturbation in HCT15 cell line |
| Abiraterone acetate_SW 900 | Abiraterone acetate perturbation in SW 900 cell line |
| Eplerenone_SW 900 | Eplerenone perturbation in SW 900 cell line |
| LJI308_Hs 766T | LJI308 perturbation in Hs 766T cell line |
| Pioglitazone_HCT15 | Pioglitazone perturbation in HCT15 cell line |
| Macitentan_H4 | Macitentan perturbation in H4 cell line |
| Fulvestrant_RPMI-7951 | Fulvestrant perturbation in RPMI-7951 cell line |
| Regorafenib_HT-29 | Regorafenib perturbation in HT-29 cell line |
| Pemetrexed_J82 | Pemetrexed perturbation in J82 cell line |
| Verteporfin_J82 | Verteporfin perturbation in J82 cell line |
| Irinotecan (hydrochloride)_NCI-H2122 | Irinotecan (hydrochloride) perturbation in NCI-H2122 cell line |
| Ivermectin_A549 | Ivermectin perturbation in A549 cell line |
| Proglumide_SW 1088 | Proglumide perturbation in SW 1088 cell line |
| Ranolazine_H4 | Ranolazine perturbation in H4 cell line |
| Bortezomib_A549 | Bortezomib perturbation in A549 cell line |
| Vandetanib_SW 1271 | Vandetanib perturbation in SW 1271 cell line |
| Canagliflozin_HCT15 | Canagliflozin perturbation in HCT15 cell line |
| olaparib_Hs 766T | olaparib perturbation in Hs 766T cell line |
| Procainamide (hydrochloride)_A498 | Procainamide (hydrochloride) perturbation in A498 cell line |
| Niclosamide (olamine)_SW 900 | Niclosamide (olamine) perturbation in SW 900 cell line |
| Econazole_NCI-H2030 | Econazole perturbation in NCI-H2030 cell line |
| Ponatinib_COLO 205 | Ponatinib perturbation in COLO 205 cell line |
| Epirubicin (hydrochloride)_RPMI-7951 | Epirubicin (hydrochloride) perturbation in RPMI-7951 cell line |
| Ataluren_A498 | Ataluren perturbation in A498 cell line |
| Sinomenine_LoVo | Sinomenine perturbation in LoVo cell line |
| Pravastatin (sodium)_hTERT-HPNE | Pravastatin (sodium) perturbation in hTERT-HPNE cell line |
| Rifaximin_H4 | Rifaximin perturbation in H4 cell line |
| Benproperine (phosphate)_HOP62 | Benproperine (phosphate) perturbation in HOP62 cell line |
| 18β-Glycyrrhetinic acid_HCT15 | 18β-Glycyrrhetinic acid perturbation in HCT15 cell line |
| Bestatin_SW480 | Bestatin perturbation in SW480 cell line |
| Clopidogrel_SW 1088 | Clopidogrel perturbation in SW 1088 cell line |
| Pemetrexed_SW48 | Pemetrexed perturbation in SW48 cell line |
| Allopurinol_SW 1088 | Allopurinol perturbation in SW 1088 cell line |
| Bestatin_A549 | Bestatin perturbation in A549 cell line |
| Malotilate_Hs 766T | Malotilate perturbation in Hs 766T cell line |
| Malotilate_HT-29 | Malotilate perturbation in HT-29 cell line |
| Verteporfin_SW 900 | Verteporfin perturbation in SW 900 cell line |
| Meloxicam_NCI-H2122 | Meloxicam perturbation in NCI-H2122 cell line |
| Lucanthone_HCT15 | Lucanthone perturbation in HCT15 cell line |
| olaparib_HCT15 | olaparib perturbation in HCT15 cell line |
| L-Thyroxine (sodium salt pentahydrate)_HCT15 | L-Thyroxine (sodium salt pentahydrate) perturbation in HCT15 cell line |
| Arbutin_NCI-H2122 | Arbutin perturbation in NCI-H2122 cell line |
| Daidzin_CFPAC-1 | Daidzin perturbation in CFPAC-1 cell line |
| Darolutamide_COLO 205 | Darolutamide perturbation in COLO 205 cell line |
| Tetracycline (hydrochloride)_NCI-H1573 | Tetracycline (hydrochloride) perturbation in NCI-H1573 cell line |
| Captopril_SK-MEL-2 | Captopril perturbation in SK-MEL-2 cell line |
| Ataluren_SW 900 | Ataluren perturbation in SW 900 cell line |
| Fedratinib (hydrochloride hydrate)_SW 900 | Fedratinib (hydrochloride hydrate) perturbation in SW 900 cell line |
| Thymopentin_LS 180 | Thymopentin perturbation in LS 180 cell line |
| Methyl aminolevulinate (hydrochloride)_LS 180 | Methyl aminolevulinate (hydrochloride) perturbation in LS 180 cell line |
| Canagliflozin (hemihydrate)_PANC-1 | Canagliflozin (hemihydrate) perturbation in PANC-1 cell line |
| Quinidine (15% dihydroquinidine)_SW480 | Quinidine (15% dihydroquinidine) perturbation in SW480 cell line |
| Bisoprolol (hemifumarate)_KATO III | Bisoprolol (hemifumarate) perturbation in KATO III cell line |
| Econazole_hTERT-HPNE | Econazole perturbation in hTERT-HPNE cell line |
| Thymol_HCT15 | Thymol perturbation in HCT15 cell line |
| Belinostat_A498 | Belinostat perturbation in A498 cell line |
| Dorzolamide (hydrochloride)_HCT15 | Dorzolamide (hydrochloride) perturbation in HCT15 cell line |
| Oxaprozin_Panc 03.27 | Oxaprozin perturbation in Panc 03.27 cell line |
| Pentamidine (isethionate)_MIA PaCa-2 | Pentamidine (isethionate) perturbation in MIA PaCa-2 cell line |
| Fulvestrant_COLO 205 | Fulvestrant perturbation in COLO 205 cell line |
| Quinidine (15% dihydroquinidine)_LS 180 | Quinidine (15% dihydroquinidine) perturbation in LS 180 cell line |
| Cloxacillin (sodium)_HCT15 | Cloxacillin (sodium) perturbation in HCT15 cell line |
| 5-Fluorouracil_A549 | 5-Fluorouracil perturbation in A549 cell line |
| Canagliflozin (hemihydrate)_HCT15 | Canagliflozin (hemihydrate) perturbation in HCT15 cell line |
| Berbamine_H4 | Berbamine perturbation in H4 cell line |
| Epirubicin (hydrochloride)_LS 180 | Epirubicin (hydrochloride) perturbation in LS 180 cell line |
| Oxaprozin_SNU-1 | Oxaprozin perturbation in SNU-1 cell line |
| Gallic acid (hydrate)_SW 900 | Gallic acid (hydrate) perturbation in SW 900 cell line |
| Adagrasib_NCI-H1573 | Adagrasib perturbation in NCI-H1573 cell line |
| Panobinostat_HEC-1-A | Panobinostat perturbation in HEC-1-A cell line |
| Naproxen_hTERT-HPNE | Naproxen perturbation in hTERT-HPNE cell line |
| Captopril_HT-29 | Captopril perturbation in HT-29 cell line |
| Bestatin_RPMI-7951 | Bestatin perturbation in RPMI-7951 cell line |
| Captopril_Hs 766T | Captopril perturbation in Hs 766T cell line |
| Abiraterone acetate_MIA PaCa-2 | Abiraterone acetate perturbation in MIA PaCa-2 cell line |
| Verteporfin_NCI-H1573 | Verteporfin perturbation in NCI-H1573 cell line |
| Procainamide (hydrochloride)_LoVo | Procainamide (hydrochloride) perturbation in LoVo cell line |
| Dapagliflozin_HCT15 | Dapagliflozin perturbation in HCT15 cell line |
| Pentamidine (isethionate)_CFPAC-1 | Pentamidine (isethionate) perturbation in CFPAC-1 cell line |
| Procainamide (hydrochloride)_MIA PaCa-2 | Procainamide (hydrochloride) perturbation in MIA PaCa-2 cell line |
| NVP-BHG712_LoVo | NVP-BHG712 perturbation in LoVo cell line |
| Nafamostat (mesylate)_COLO 205 | Nafamostat (mesylate) perturbation in COLO 205 cell line |
| Carbamazepine_LoVo | Carbamazepine perturbation in LoVo cell line |
| Tirabrutinib (hydrochloride)_Hs 766T | Tirabrutinib (hydrochloride) perturbation in Hs 766T cell line |
| APTO-253_AsPC-1 | APTO-253 perturbation in AsPC-1 cell line |
| Monocrotaline_A498 | Monocrotaline perturbation in A498 cell line |
| Acetazolamide_LoVo | Acetazolamide perturbation in LoVo cell line |
| Bestatin_NCI-H661 | Bestatin perturbation in NCI-H661 cell line |
| Dihydroartemisinin_COLO 205 | Dihydroartemisinin perturbation in COLO 205 cell line |
| Hydroxyurea_SW 900 | Hydroxyurea perturbation in SW 900 cell line |
| Berberine (chloride hydrate)_LoVo | Berberine (chloride hydrate) perturbation in LoVo cell line |
| Talc_H4 | Talc perturbation in H4 cell line |
| Clotrimazole_HCT15 | Clotrimazole perturbation in HCT15 cell line |
| Loperamide (hydrochloride)_SW 900 | Loperamide (hydrochloride) perturbation in SW 900 cell line |
| Fostamatinib (disodium hexahydrate)_A-427 | Fostamatinib (disodium hexahydrate) perturbation in A-427 cell line |
| Cytarabine_LS 180 | Cytarabine perturbation in LS 180 cell line |
| Loperamide (hydrochloride)_A498 | Loperamide (hydrochloride) perturbation in A498 cell line |
| Baicalin_HCT15 | Baicalin perturbation in HCT15 cell line |
| Proglumide_H4 | Proglumide perturbation in H4 cell line |
| SBI-0640756_NCI-H596 | SBI-0640756 perturbation in NCI-H596 cell line |
| Methylthiouracil_NCI-H2122 | Methylthiouracil perturbation in NCI-H2122 cell line |
| Phenylephrine (hydrochloride)_Hs 766T | Phenylephrine (hydrochloride) perturbation in Hs 766T cell line |
| Dihydroartemisinin_SW 1088 | Dihydroartemisinin perturbation in SW 1088 cell line |
| olaparib_LS 180 | olaparib perturbation in LS 180 cell line |
| Dorzolamide (hydrochloride)_hTERT-HPNE | Dorzolamide (hydrochloride) perturbation in hTERT-HPNE cell line |
| Bosentan (hydrate)_RPMI-7951 | Bosentan (hydrate) perturbation in RPMI-7951 cell line |
| Levobupivacaine (hydrochloride)_LS 180 | Levobupivacaine (hydrochloride) perturbation in LS 180 cell line |
| Proglumide_HCT15 | Proglumide perturbation in HCT15 cell line |
| Canagliflozin (hemihydrate)_hTERT-HPNE | Canagliflozin (hemihydrate) perturbation in hTERT-HPNE cell line |
| Econazole_H4 | Econazole perturbation in H4 cell line |
| Mozavaptan_SW 1088 | Mozavaptan perturbation in SW 1088 cell line |
| Raltitrexed_NCI-H2347 | Raltitrexed perturbation in NCI-H2347 cell line |
| olaparib_RPMI-7951 | olaparib perturbation in RPMI-7951 cell line |
| Malotilate_BT-474 | Malotilate perturbation in BT-474 cell line |
| Vitamin K4_HCT15 | Vitamin K4 perturbation in HCT15 cell line |
| Fingolimod (hydrochloride)_HCT15 | Fingolimod (hydrochloride) perturbation in HCT15 cell line |
| Malotilate_SW1417 | Malotilate perturbation in SW1417 cell line |
| Fostamatinib (disodium hexahydrate)_SW48 | Fostamatinib (disodium hexahydrate) perturbation in SW48 cell line |
| Dexmedetomidine_SW 900 | Dexmedetomidine perturbation in SW 900 cell line |
| IQ 1_SW 1088 | IQ 1 perturbation in SW 1088 cell line |
| Monocrotaline_AN3 CA | Monocrotaline perturbation in AN3 CA cell line |
| 5-Fluorouracil_HCT15 | 5-Fluorouracil perturbation in HCT15 cell line |
| Homoharringtonine_AN3 CA | Homoharringtonine perturbation in AN3 CA cell line |
| Canagliflozin (hemihydrate)_A549 | Canagliflozin (hemihydrate) perturbation in A549 cell line |
| Trametinib (DMSO_RPMI-7951 | Trametinib (DMSO perturbation in RPMI-7951 cell line |
| Tofacitinib (citrate)_A498 | Tofacitinib (citrate) perturbation in A498 cell line |
| Bendamustine_SW48 | Bendamustine perturbation in SW48 cell line |
| Tazarotene_AN3 CA | Tazarotene perturbation in AN3 CA cell line |
| Estrone sulfate (potassium)_A498 | Estrone sulfate (potassium) perturbation in A498 cell line |
| Ouabain (Octahydrate)_hTERT-HPNE | Ouabain (Octahydrate) perturbation in hTERT-HPNE cell line |
| Vandetanib_HCT15 | Vandetanib perturbation in HCT15 cell line |
| Sildenafil_LoVo | Sildenafil perturbation in LoVo cell line |
| Oxaprozin_SW 900 | Oxaprozin perturbation in SW 900 cell line |
| Bosentan (hydrate)_A549 | Bosentan (hydrate) perturbation in A549 cell line |
| Epirubicin (hydrochloride)_HCT15 | Epirubicin (hydrochloride) perturbation in HCT15 cell line |
| Osimertinib (mesylate)_KATO III | Osimertinib (mesylate) perturbation in KATO III cell line |
| Larotrectinib sulfate_NCI-H2122 | Larotrectinib sulfate perturbation in NCI-H2122 cell line |
| 5-Fluorouracil_H4 | 5-Fluorouracil perturbation in H4 cell line |
| Celecoxib_LS 180 | Celecoxib perturbation in LS 180 cell line |
| Fulvestrant_Hs 766T | Fulvestrant perturbation in Hs 766T cell line |
| Fingolimod (hydrochloride)_HT-29 | Fingolimod (hydrochloride) perturbation in HT-29 cell line |
| Crizotinib (hydrochloride)_NCI-H2122 | Crizotinib (hydrochloride) perturbation in NCI-H2122 cell line |
| Nafamostat (mesylate)_H4 | Nafamostat (mesylate) perturbation in H4 cell line |
| Ixazomib citrate_NCI-H1792 | Ixazomib citrate perturbation in NCI-H1792 cell line |
| Glasdegib_KATO III | Glasdegib perturbation in KATO III cell line |
| Tazarotene_LoVo | Tazarotene perturbation in LoVo cell line |
| Quinidine (15% dihydroquinidine)_HT-29 | Quinidine (15% dihydroquinidine) perturbation in HT-29 cell line |
| SBI-0640756_H4 | SBI-0640756 perturbation in H4 cell line |
| Darolutamide_A-172 | Darolutamide perturbation in A-172 cell line |
| Azithromycin (hydrate)_A498 | Azithromycin (hydrate) perturbation in A498 cell line |
| Verteporfin_NCI-H2347 | Verteporfin perturbation in NCI-H2347 cell line |
| Atazanavir (sulfate)_J82 | Atazanavir (sulfate) perturbation in J82 cell line |
| Fulvestrant_H4 | Fulvestrant perturbation in H4 cell line |
| Methylprednisolone succinate_SW 900 | Methylprednisolone succinate perturbation in SW 900 cell line |
| Macitentan_RPMI-7951 | Macitentan perturbation in RPMI-7951 cell line |
| Ixazomib citrate_KATO III | Ixazomib citrate perturbation in KATO III cell line |
| Acetazolamide_SW 900 | Acetazolamide perturbation in SW 900 cell line |
| Rifaximin_SW 1088 | Rifaximin perturbation in SW 1088 cell line |
| Dihydroartemisinin_A549 | Dihydroartemisinin perturbation in A549 cell line |
| Crizotinib (hydrochloride)_SW48 | Crizotinib (hydrochloride) perturbation in SW48 cell line |
| γ-Oryzanol_SW 900 | γ-Oryzanol perturbation in SW 900 cell line |
| L-Eflornithine (monohydrochloride)_H4 | L-Eflornithine (monohydrochloride) perturbation in H4 cell line |
| Darolutamide_HCT15 | Darolutamide perturbation in HCT15 cell line |
| Topotecan (hydrochloride)_MIA PaCa-2 | Topotecan (hydrochloride) perturbation in MIA PaCa-2 cell line |
| Pioglitazone_SW480 | Pioglitazone perturbation in SW480 cell line |
| Naproxen_Hs 766T | Naproxen perturbation in Hs 766T cell line |
| Orlistat_NCI-H2122 | Orlistat perturbation in NCI-H2122 cell line |
| Futibatinib_MIA PaCa-2 | Futibatinib perturbation in MIA PaCa-2 cell line |
| Lucanthone_COLO 205 | Lucanthone perturbation in COLO 205 cell line |
| Cabozantinib (S-malate)_H4 | Cabozantinib (S-malate) perturbation in H4 cell line |
| Phenylephrine (hydrochloride)_H4 | Phenylephrine (hydrochloride) perturbation in H4 cell line |
| Loperamide (hydrochloride)_J82 | Loperamide (hydrochloride) perturbation in J82 cell line |
| Indacaterol (maleate)_SHP-77 | Indacaterol (maleate) perturbation in SHP-77 cell line |
| Verapamil_HEC-1-A | Verapamil perturbation in HEC-1-A cell line |
| Finasteride_hTERT-HPNE | Finasteride perturbation in hTERT-HPNE cell line |
| Harringtonine_A-427 | Harringtonine perturbation in A-427 cell line |
| Econazole_Hs 766T | Econazole perturbation in Hs 766T cell line |
| Bendamustine_LoVo | Bendamustine perturbation in LoVo cell line |
| Lucanthone_SW48 | Lucanthone perturbation in SW48 cell line |
| olaparib_A498 | olaparib perturbation in A498 cell line |
| olaparib_SW48 | olaparib perturbation in SW48 cell line |
| Procainamide (hydrochloride)_HT-29 | Procainamide (hydrochloride) perturbation in HT-29 cell line |
| Penfluridol_LoVo | Penfluridol perturbation in LoVo cell line |
| Infigratinib_HCT15 | Infigratinib perturbation in HCT15 cell line |
| Canagliflozin_KATO III | Canagliflozin perturbation in KATO III cell line |
| Captopril_LoVo | Captopril perturbation in LoVo cell line |
| Vinblastine (sulfate)_LS 180 | Vinblastine (sulfate) perturbation in LS 180 cell line |
| Nafamostat (mesylate)_NCI-H2347 | Nafamostat (mesylate) perturbation in NCI-H2347 cell line |
| Malotilate_KATO III | Malotilate perturbation in KATO III cell line |
| Berbamine_NCI-H2122 | Berbamine perturbation in NCI-H2122 cell line |
| Ataluren_HCT15 | Ataluren perturbation in HCT15 cell line |
| Tazarotene_LS 180 | Tazarotene perturbation in LS 180 cell line |
| Levobupivacaine (hydrochloride)_SW 900 | Levobupivacaine (hydrochloride) perturbation in SW 900 cell line |
| Pasireotide (acetate)_SW 900 | Pasireotide (acetate) perturbation in SW 900 cell line |
| Fedratinib (hydrochloride hydrate)_H4 | Fedratinib (hydrochloride hydrate) perturbation in H4 cell line |
| Uridine_COLO 205 | Uridine perturbation in COLO 205 cell line |
| Malotilate_NCI-H1792 | Malotilate perturbation in NCI-H1792 cell line |
| Ornidazole_LS 180 | Ornidazole perturbation in LS 180 cell line |
| olaparib_SW 900 | olaparib perturbation in SW 900 cell line |
| Niclosamide (olamine)_Hs 766T | Niclosamide (olamine) perturbation in Hs 766T cell line |
| Verteporfin_HCT15 | Verteporfin perturbation in HCT15 cell line |
| Canagliflozin (hemihydrate)_SW 900 | Canagliflozin (hemihydrate) perturbation in SW 900 cell line |
| Saquinavir_HCT15 | Saquinavir perturbation in HCT15 cell line |
| Aprepitant_HCT15 | Aprepitant perturbation in HCT15 cell line |
| Finasteride_NCI-H1792 | Finasteride perturbation in NCI-H1792 cell line |
| Tranilast_H4 | Tranilast perturbation in H4 cell line |
| Dorzolamide (hydrochloride)_SW 900 | Dorzolamide (hydrochloride) perturbation in SW 900 cell line |
| Filgotinib_A498 | Filgotinib perturbation in A498 cell line |
| Tirabrutinib (hydrochloride)_NCI-H2347 | Tirabrutinib (hydrochloride) perturbation in NCI-H2347 cell line |
| Aprepitant_H4 | Aprepitant perturbation in H4 cell line |
| Vismodegib_HCT15 | Vismodegib perturbation in HCT15 cell line |
| Mebendazole_CHP-212 | Mebendazole perturbation in CHP-212 cell line |
| Methotrexate_SW 1271 | Methotrexate perturbation in SW 1271 cell line |
| Captopril_KATO III | Captopril perturbation in KATO III cell line |
| Oxaprozin_A549 | Oxaprozin perturbation in A549 cell line |
| Arbutin_PANC-1 | Arbutin perturbation in PANC-1 cell line |
| Malotilate_MIA PaCa-2 | Malotilate perturbation in MIA PaCa-2 cell line |
| L-Thyroxine (sodium salt pentahydrate)_NCI-H1573 | L-Thyroxine (sodium salt pentahydrate) perturbation in NCI-H1573 cell line |
| Ferulic acid_HCT15 | Ferulic acid perturbation in HCT15 cell line |
| Tranilast_HEC-1-A | Tranilast perturbation in HEC-1-A cell line |
| Verteporfin_HS-578T | Verteporfin perturbation in HS-578T cell line |
| olaparib_NCI-H1573 | olaparib perturbation in NCI-H1573 cell line |
| Dapagliflozin ((2S)-1,2-propanediol, hydrate)_COLO 205 | Dapagliflozin ((2S)-1,2-propanediol, hydrate) perturbation in COLO 205 cell line |
| Berbamine_SW 900 | Berbamine perturbation in SW 900 cell line |
| Bosentan (hydrate)_A498 | Bosentan (hydrate) perturbation in A498 cell line |
| Dihydroartemisinin_CFPAC-1 | Dihydroartemisinin perturbation in CFPAC-1 cell line |
| Vinblastine (sulfate)_RPMI-7951 | Vinblastine (sulfate) perturbation in RPMI-7951 cell line |
| Fostamatinib (disodium hexahydrate)_A549 | Fostamatinib (disodium hexahydrate) perturbation in A549 cell line |
| S-Adenosyl-L-methionine (disulfate tosylate)_Hs 766T | S-Adenosyl-L-methionine (disulfate tosylate) perturbation in Hs 766T cell line |
| Hesperidin_Hs 766T | Hesperidin perturbation in Hs 766T cell line |
| Lucanthone_LoVo | Lucanthone perturbation in LoVo cell line |
| LY2090314_Hs 766T | LY2090314 perturbation in Hs 766T cell line |
| Dexmedetomidine_COLO 205 | Dexmedetomidine perturbation in COLO 205 cell line |
| L-Thyroxine (sodium salt pentahydrate)_LoVo | L-Thyroxine (sodium salt pentahydrate) perturbation in LoVo cell line |
| Bexarotene_SW 1271 | Bexarotene perturbation in SW 1271 cell line |
| Fingolimod (hydrochloride)_NCI-H23 | Fingolimod (hydrochloride) perturbation in NCI-H23 cell line |
| Daptomycin_SW 1088 | Daptomycin perturbation in SW 1088 cell line |
| Finasteride_SW 900 | Finasteride perturbation in SW 900 cell line |
| Meloxicam_Hs 766T | Meloxicam perturbation in Hs 766T cell line |
| Oxaprozin_COLO 205 | Oxaprozin perturbation in COLO 205 cell line |
| Acetazolamide_A549 | Acetazolamide perturbation in A549 cell line |
| (S)-Crizotinib_SW 900 | (S)-Crizotinib perturbation in SW 900 cell line |
| ULK-101_COLO 205 | ULK-101 perturbation in COLO 205 cell line |
| Dorzolamide (hydrochloride)_NCI-H1792 | Dorzolamide (hydrochloride) perturbation in NCI-H1792 cell line |
| Auranofin_NCI-H460 | Auranofin perturbation in NCI-H460 cell line |
| γ-Oryzanol_RPMI-7951 | γ-Oryzanol perturbation in RPMI-7951 cell line |
| Rimonabant (Hydrochloride)_KATO III | Rimonabant (Hydrochloride) perturbation in KATO III cell line |
| Silodosin_HCT15 | Silodosin perturbation in HCT15 cell line |
| Bendamustine_COLO 205 | Bendamustine perturbation in COLO 205 cell line |
| olaparib_CHP-212 | olaparib perturbation in CHP-212 cell line |
| Sinomenine_HCT15 | Sinomenine perturbation in HCT15 cell line |
| olaparib_CFPAC-1 | olaparib perturbation in CFPAC-1 cell line |
| Bestatin_NCI-H460 | Bestatin perturbation in NCI-H460 cell line |
| Bimatoprost_A498 | Bimatoprost perturbation in A498 cell line |
| Dorzolamide (hydrochloride)_KATO III | Dorzolamide (hydrochloride) perturbation in KATO III cell line |
| Malotilate_NCI-H1573 | Malotilate perturbation in NCI-H1573 cell line |
| Plicamycin_SW 900 | Plicamycin perturbation in SW 900 cell line |
| Rosiglitazone_SW 1271 | Rosiglitazone perturbation in SW 1271 cell line |
| Canagliflozin (hemihydrate)_J82 | Canagliflozin (hemihydrate) perturbation in J82 cell line |
| Canagliflozin (hemihydrate)_KATO III | Canagliflozin (hemihydrate) perturbation in KATO III cell line |
| (S)-Crizotinib_NCI-H1573 | (S)-Crizotinib perturbation in NCI-H1573 cell line |
| olaparib_KATO III | olaparib perturbation in KATO III cell line |
| Eplerenone_HCT15 | Eplerenone perturbation in HCT15 cell line |
| Allopurinol_SNU-1 | Allopurinol perturbation in SNU-1 cell line |
| Asciminib_HCT15 | Asciminib perturbation in HCT15 cell line |
| Levobupivacaine (hydrochloride)_KATO III | Levobupivacaine (hydrochloride) perturbation in KATO III cell line |
| Carbidopa (monohydrate)_HCT15 | Carbidopa (monohydrate) perturbation in HCT15 cell line |
| Talc_NCI-H23 | Talc perturbation in NCI-H23 cell line |
| Nevirapine_HCT15 | Nevirapine perturbation in HCT15 cell line |
| Sulfatinib_SW 900 | Sulfatinib perturbation in SW 900 cell line |
| Acetazolamide_RPMI-7951 | Acetazolamide perturbation in RPMI-7951 cell line |
| Pentamidine (isethionate)_H4 | Pentamidine (isethionate) perturbation in H4 cell line |
| Ritonavir_MIA PaCa-2 | Ritonavir perturbation in MIA PaCa-2 cell line |
| Indacaterol (maleate)_A549 | Indacaterol (maleate) perturbation in A549 cell line |
| γ-Oryzanol_A549 | γ-Oryzanol perturbation in A549 cell line |
| Bosentan (hydrate)_LoVo | Bosentan (hydrate) perturbation in LoVo cell line |
| Pentamidine (isethionate)_PANC-1 | Pentamidine (isethionate) perturbation in PANC-1 cell line |
| Methyl aminolevulinate (hydrochloride)_NCI-H460 | Methyl aminolevulinate (hydrochloride) perturbation in NCI-H460 cell line |
| Niclosamide (olamine)_PANC-1 | Niclosamide (olamine) perturbation in PANC-1 cell line |
| Econazole_NCI-H23 | Econazole perturbation in NCI-H23 cell line |
| Fulvestrant_A498 | Fulvestrant perturbation in A498 cell line |
| Dorzolamide (hydrochloride)_NCI-H23 | Dorzolamide (hydrochloride) perturbation in NCI-H23 cell line |
| Terfenadine_COLO 205 | Terfenadine perturbation in COLO 205 cell line |
| Econazole_HOP62 | Econazole perturbation in HOP62 cell line |
| AZD2858_NCI-H661 | AZD2858 perturbation in NCI-H661 cell line |
| Dapagliflozin ((2S)-1,2-propanediol, hydrate)_H4 | Dapagliflozin ((2S)-1,2-propanediol, hydrate) perturbation in H4 cell line |
| Delamanid_HCT15 | Delamanid perturbation in HCT15 cell line |
| Rifaximin_NCI-H2347 | Rifaximin perturbation in NCI-H2347 cell line |
| Bestatin_CFPAC-1 | Bestatin perturbation in CFPAC-1 cell line |
| Proglumide_MIA PaCa-2 | Proglumide perturbation in MIA PaCa-2 cell line |
| Delamanid_H4 | Delamanid perturbation in H4 cell line |
| Nafamostat (mesylate)_SW 900 | Nafamostat (mesylate) perturbation in SW 900 cell line |
| Fostamatinib (disodium hexahydrate)_HT-29 | Fostamatinib (disodium hexahydrate) perturbation in HT-29 cell line |
| Valdecoxib_HEC-1-A | Valdecoxib perturbation in HEC-1-A cell line |
| Almonertinib (mesylate)_AN3 CA | Almonertinib (mesylate) perturbation in AN3 CA cell line |
| Acetazolamide_HCT15 | Acetazolamide perturbation in HCT15 cell line |
| Pentoxifylline_HT-29 | Pentoxifylline perturbation in HT-29 cell line |
| Levobupivacaine (hydrochloride)_RKO | Levobupivacaine (hydrochloride) perturbation in RKO cell line |
| Digitoxin_HCT15 | Digitoxin perturbation in HCT15 cell line |
| Proglumide_CFPAC-1 | Proglumide perturbation in CFPAC-1 cell line |
| Belinostat_SW 1088 | Belinostat perturbation in SW 1088 cell line |
| Carbamazepine_H4 | Carbamazepine perturbation in H4 cell line |
| Ralimetinib dimesylate_MIA PaCa-2 | Ralimetinib dimesylate perturbation in MIA PaCa-2 cell line |
| Methylprednisolone succinate_H4 | Methylprednisolone succinate perturbation in H4 cell line |
| Methyl aminolevulinate (hydrochloride)_KATO III | Methyl aminolevulinate (hydrochloride) perturbation in KATO III cell line |
| Naproxen_NCI-H1792 | Naproxen perturbation in NCI-H1792 cell line |
| Resveratrol_HCT15 | Resveratrol perturbation in HCT15 cell line |
| γ-Oryzanol_H4 | γ-Oryzanol perturbation in H4 cell line |
| Indacaterol (maleate)_H4 | Indacaterol (maleate) perturbation in H4 cell line |
| Ribociclib_SW 1088 | Ribociclib perturbation in SW 1088 cell line |
| Darolutamide_SW 900 | Darolutamide perturbation in SW 900 cell line |
| Eplerenone_LS 180 | Eplerenone perturbation in LS 180 cell line |
| Verteporfin_AsPC-1 | Verteporfin perturbation in AsPC-1 cell line |
| Neratinib_HCT15 | Neratinib perturbation in HCT15 cell line |
| Abiraterone acetate_LS 180 | Abiraterone acetate perturbation in LS 180 cell line |
| Sildenafil_HCT15 | Sildenafil perturbation in HCT15 cell line |
| Atazanavir (sulfate)_NCI-H596 | Atazanavir (sulfate) perturbation in NCI-H596 cell line |
| Indacaterol (maleate)_HCT15 | Indacaterol (maleate) perturbation in HCT15 cell line |
| NVP-BHG712_A549 | NVP-BHG712 perturbation in A549 cell line |
| Ponatinib_KATO III | Ponatinib perturbation in KATO III cell line |
| Quinidine (15% dihydroquinidine)_LoVo | Quinidine (15% dihydroquinidine) perturbation in LoVo cell line |
| Nimesulide_SW 900 | Nimesulide perturbation in SW 900 cell line |
| Sunitinib_HEC-1-A | Sunitinib perturbation in HEC-1-A cell line |
| Darolutamide_A498 | Darolutamide perturbation in A498 cell line |
| Omeprazole_A498 | Omeprazole perturbation in A498 cell line |
| Pentamidine (isethionate)_SW480 | Pentamidine (isethionate) perturbation in SW480 cell line |
| Aliskiren_LoVo | Aliskiren perturbation in LoVo cell line |
| Methylprednisolone succinate_HS-578T | Methylprednisolone succinate perturbation in HS-578T cell line |
| Cinacalcet_SW 900 | Cinacalcet perturbation in SW 900 cell line |
| Levobupivacaine (hydrochloride)_NCI-H23 | Levobupivacaine (hydrochloride) perturbation in NCI-H23 cell line |
| Fingolimod (hydrochloride)_LoVo | Fingolimod (hydrochloride) perturbation in LoVo cell line |
| Tofacitinib_SW48 | Tofacitinib perturbation in SW48 cell line |
| Loperamide (hydrochloride)_HCT15 | Loperamide (hydrochloride) perturbation in HCT15 cell line |
| Sildenafil_Hs 766T | Sildenafil perturbation in Hs 766T cell line |
| Procainamide (hydrochloride)_SW 1088 | Procainamide (hydrochloride) perturbation in SW 1088 cell line |
| OTS514_COLO 205 | OTS514 perturbation in COLO 205 cell line |
| Belinostat_hTERT-HPNE | Belinostat perturbation in hTERT-HPNE cell line |
| Lipoic acid_LS 180 | Lipoic acid perturbation in LS 180 cell line |
| Ixazomib_HCT15 | Ixazomib perturbation in HCT15 cell line |
| Artemether_H4 | Artemether perturbation in H4 cell line |
| Uridine_Hs 766T | Uridine perturbation in Hs 766T cell line |
| Fenofibrate_SW 900 | Fenofibrate perturbation in SW 900 cell line |
| Proglumide_A498 | Proglumide perturbation in A498 cell line |
| Naproxen_SW 900 | Naproxen perturbation in SW 900 cell line |
| Darinaparsin_Hs 766T | Darinaparsin perturbation in Hs 766T cell line |
| Larotrectinib_HCT15 | Larotrectinib perturbation in HCT15 cell line |
| Diammonium Glycyrrhizinate_SW 900 | Diammonium Glycyrrhizinate perturbation in SW 900 cell line |
| Rosiglitazone_HCT15 | Rosiglitazone perturbation in HCT15 cell line |
| Talc_A498 | Talc perturbation in A498 cell line |
| Ponatinib_A498 | Ponatinib perturbation in A498 cell line |
| Pemetrexed_LS 180 | Pemetrexed perturbation in LS 180 cell line |
| Fulvestrant_CFPAC-1 | Fulvestrant perturbation in CFPAC-1 cell line |
| Naproxen_SW48 | Naproxen perturbation in SW48 cell line |
| OTS514_SW 1088 | OTS514 perturbation in SW 1088 cell line |
| Ornidazole_HCT15 | Ornidazole perturbation in HCT15 cell line |
| Procainamide (hydrochloride)_COLO 205 | Procainamide (hydrochloride) perturbation in COLO 205 cell line |
| Nafamostat (mesylate)_HOP62 | Nafamostat (mesylate) perturbation in HOP62 cell line |
| Ligustrazine_PANC-1 | Ligustrazine perturbation in PANC-1 cell line |
| Benproperine (phosphate)_SW 1271 | Benproperine (phosphate) perturbation in SW 1271 cell line |
| Diammonium Glycyrrhizinate_SHP-77 | Diammonium Glycyrrhizinate perturbation in SHP-77 cell line |
| Tazarotene_HCT15 | Tazarotene perturbation in HCT15 cell line |
| Methyl aminolevulinate (hydrochloride)_SW 900 | Methyl aminolevulinate (hydrochloride) perturbation in SW 900 cell line |
| Fostamatinib (disodium hexahydrate)_HCT15 | Fostamatinib (disodium hexahydrate) perturbation in HCT15 cell line |
| LY2090314_LS 180 | LY2090314 perturbation in LS 180 cell line |
| Bicalutamide_HOP62 | Bicalutamide perturbation in HOP62 cell line |
| Fingolimod (hydrochloride)_SW 900 | Fingolimod (hydrochloride) perturbation in SW 900 cell line |
| 5-Fluorouracil_SW48 | 5-Fluorouracil perturbation in SW48 cell line |
| Atazanavir (sulfate)_HCT15 | Atazanavir (sulfate) perturbation in HCT15 cell line |
| Tofacitinib (citrate)_HCT15 | Tofacitinib (citrate) perturbation in HCT15 cell line |
| Berbamine (dihydrochloride)_HCT15 | Berbamine (dihydrochloride) perturbation in HCT15 cell line |
| PH-797804_Hs 766T | PH-797804 perturbation in Hs 766T cell line |
| Bendamustine_HCT15 | Bendamustine perturbation in HCT15 cell line |
| Verteporfin_hTERT-HPNE | Verteporfin perturbation in hTERT-HPNE cell line |
| Bestatin_AN3 CA | Bestatin perturbation in AN3 CA cell line |
| Quinidine (15% dihydroquinidine)_SW 900 | Quinidine (15% dihydroquinidine) perturbation in SW 900 cell line |
| ULK-101_HEC-1-A | ULK-101 perturbation in HEC-1-A cell line |
| Arbutin_LS 180 | Arbutin perturbation in LS 180 cell line |
| Futibatinib_PANC-1 | Futibatinib perturbation in PANC-1 cell line |
| Dexmedetomidine_PANC-1 | Dexmedetomidine perturbation in PANC-1 cell line |
| Oxaprozin_HCT15 | Oxaprozin perturbation in HCT15 cell line |
| Dorzolamide (hydrochloride)_Panc 03.27 | Dorzolamide (hydrochloride) perturbation in Panc 03.27 cell line |
| Loperamide (hydrochloride)_A-172 | Loperamide (hydrochloride) perturbation in A-172 cell line |
| Malotilate_NCI-H2347 | Malotilate perturbation in NCI-H2347 cell line |
| Bicalutamide_CFPAC-1 | Bicalutamide perturbation in CFPAC-1 cell line |
| Pentoxifylline_H4 | Pentoxifylline perturbation in H4 cell line |
| Topotecan (hydrochloride)_HCT15 | Topotecan (hydrochloride) perturbation in HCT15 cell line |
| Pravastatin (sodium)_SW 900 | Pravastatin (sodium) perturbation in SW 900 cell line |
| Carbidopa (monohydrate)_SW1417 | Carbidopa (monohydrate) perturbation in SW1417 cell line |
| Sivelestat (sodium tetrahydrate)_NCI-H661 | Sivelestat (sodium tetrahydrate) perturbation in NCI-H661 cell line |
| 5-Fluorouracil_SW 900 | 5-Fluorouracil perturbation in SW 900 cell line |
| Glasdegib_HCT15 | Glasdegib perturbation in HCT15 cell line |
| Belinostat_LS 180 | Belinostat perturbation in LS 180 cell line |
| Bisoprolol (hemifumarate)_SW 1088 | Bisoprolol (hemifumarate) perturbation in SW 1088 cell line |
| Carbamazepine_Hs 766T | Carbamazepine perturbation in Hs 766T cell line |
| Clonidine (hydrochloride)_SW 1088 | Clonidine (hydrochloride) perturbation in SW 1088 cell line |
| XRK3F2_NCI-H661 | XRK3F2 perturbation in NCI-H661 cell line |
| Oxaprozin_NCI-H460 | Oxaprozin perturbation in NCI-H460 cell line |
| Betamethasone dipropionate_C-33 A | Betamethasone dipropionate perturbation in C-33 A cell line |
| Ranolazine_SK-MEL-2 | Ranolazine perturbation in SK-MEL-2 cell line |
| Futibatinib_A-427 | Futibatinib perturbation in A-427 cell line |
| BI-78D3_SNU-1 | BI-78D3 perturbation in SNU-1 cell line |
| Resveratrol_CHP-212 | Resveratrol perturbation in CHP-212 cell line |
| Folic acid_A-427 | Folic acid perturbation in A-427 cell line |
| Talc_SK-MEL-2 | Talc perturbation in SK-MEL-2 cell line |
| Ralimetinib dimesylate_SK-MEL-2 | Ralimetinib dimesylate perturbation in SK-MEL-2 cell line |
| Cabozantinib (S-malate)_HCT15 | Cabozantinib (S-malate) perturbation in HCT15 cell line |
| Ipatasertib_SW 900 | Ipatasertib perturbation in SW 900 cell line |
| Triclosan_RKO | Triclosan perturbation in RKO cell line |
| Idoxuridine_SNU-1 | Idoxuridine perturbation in SNU-1 cell line |
| TAK-733_SW 900 | TAK-733 perturbation in SW 900 cell line |
| Aspirin_SNU-1 | Aspirin perturbation in SNU-1 cell line |
| Pravastatin (sodium)_CHP-212 | Pravastatin (sodium) perturbation in CHP-212 cell line |
| Pentoxifylline_NCI-H596 | Pentoxifylline perturbation in NCI-H596 cell line |
| Relugolix_CHP-212 | Relugolix perturbation in CHP-212 cell line |
| Thymopentin_AN3 CA | Thymopentin perturbation in AN3 CA cell line |
| DTP3_KATO III | DTP3 perturbation in KATO III cell line |
| Carbidopa (monohydrate)_C32 | Carbidopa (monohydrate) perturbation in C32 cell line |
| Afatinib_J82 | Afatinib perturbation in J82 cell line |
| Erlotinib_LOX-IMVI | Erlotinib perturbation in LOX-IMVI cell line |
| 5-Azacytidine_SW 1088 | 5-Azacytidine perturbation in SW 1088 cell line |
| Pexidartinib (hydrochloride)_A549 | Pexidartinib (hydrochloride) perturbation in A549 cell line |
| Estrone sulfate (potassium)_C32 | Estrone sulfate (potassium) perturbation in C32 cell line |
| HI-TOPK-032_A-172 | HI-TOPK-032 perturbation in A-172 cell line |
| Bergenin_A-172 | Bergenin perturbation in A-172 cell line |
| Ouabain (Octahydrate)_SW1417 | Ouabain (Octahydrate) perturbation in SW1417 cell line |
| olaparib_SW 1271 | olaparib perturbation in SW 1271 cell line |
| Lopinavir_NCI-H661 | Lopinavir perturbation in NCI-H661 cell line |
| Carbidopa (monohydrate)_Hs 766T | Carbidopa (monohydrate) perturbation in Hs 766T cell line |
| Regorafenib_C32 | Regorafenib perturbation in C32 cell line |
| Ritonavir_J82 | Ritonavir perturbation in J82 cell line |
| Quinidine (15% dihydroquinidine)_NCI-H460 | Quinidine (15% dihydroquinidine) perturbation in NCI-H460 cell line |
| Estrone sulfate (potassium)_Hs 766T | Estrone sulfate (potassium) perturbation in Hs 766T cell line |
| Bergenin_J82 | Bergenin perturbation in J82 cell line |
| Busulfan_Hs 766T | Busulfan perturbation in Hs 766T cell line |
| Drospirenone_SW48 | Drospirenone perturbation in SW48 cell line |
| Sonidegib_C-33 A | Sonidegib perturbation in C-33 A cell line |
| Drospirenone_SHP-77 | Drospirenone perturbation in SHP-77 cell line |
| Tolmetin_SHP-77 | Tolmetin perturbation in SHP-77 cell line |
| Irinotecan (hydrochloride)_NCI-H1573 | Irinotecan (hydrochloride) perturbation in NCI-H1573 cell line |
| NVP-BHG712_C-33 A | NVP-BHG712 perturbation in C-33 A cell line |
| Tolmetin_NCI-H1573 | Tolmetin perturbation in NCI-H1573 cell line |
| Tolmetin_AN3 CA | Tolmetin perturbation in AN3 CA cell line |
| Drospirenone_AN3 CA | Drospirenone perturbation in AN3 CA cell line |
| Riluzole hydrochloride_CFPAC-1 | Riluzole hydrochloride perturbation in CFPAC-1 cell line |
| Dihydroartemisinin_HCT15 | Dihydroartemisinin perturbation in HCT15 cell line |
| Decitabine_HCT15 | Decitabine perturbation in HCT15 cell line |
| Almonertinib (mesylate)_LS 180 | Almonertinib (mesylate) perturbation in LS 180 cell line |
| Pemetrexed_SHP-77 | Pemetrexed perturbation in SHP-77 cell line |
| Regorafenib_HCT15 | Regorafenib perturbation in HCT15 cell line |
| Belinostat_AN3 CA | Belinostat perturbation in AN3 CA cell line |
| Riluzole hydrochloride_AN3 CA | Riluzole hydrochloride perturbation in AN3 CA cell line |
| Flumatinib (mesylate)_HCT15 | Flumatinib (mesylate) perturbation in HCT15 cell line |
| Artesunate_AN3 CA | Artesunate perturbation in AN3 CA cell line |
| Riluzole hydrochloride_SW48 | Riluzole hydrochloride perturbation in SW48 cell line |
| DTP3_HCT15 | DTP3 perturbation in HCT15 cell line |
| Artesunate_SHP-77 | Artesunate perturbation in SHP-77 cell line |
| Arbutin_SW 900 | Arbutin perturbation in SW 900 cell line |
| Tolcapone_SHP-77 | Tolcapone perturbation in SHP-77 cell line |
| Drospirenone_NCI-H1792 | Drospirenone perturbation in NCI-H1792 cell line |
| Pemetrexed_NCI-H1573 | Pemetrexed perturbation in NCI-H1573 cell line |
| Almonertinib (mesylate)_SW 1271 | Almonertinib (mesylate) perturbation in SW 1271 cell line |
| Riluzole hydrochloride_C-33 A | Riluzole hydrochloride perturbation in C-33 A cell line |
| Carbamazepine_NCI-H23 | Carbamazepine perturbation in NCI-H23 cell line |
| 5-Azacytidine_BT-474 | 5-Azacytidine perturbation in BT-474 cell line |
| Pemetrexed_Panc 03.27 | Pemetrexed perturbation in Panc 03.27 cell line |
| Clofarabine_SHP-77 | Clofarabine perturbation in SHP-77 cell line |
| Fumaric acid_BT-474 | Fumaric acid perturbation in BT-474 cell line |
| Homoharringtonine_C-33 A | Homoharringtonine perturbation in C-33 A cell line |
| Quinidine (15% dihydroquinidine)_HCT15 | Quinidine (15% dihydroquinidine) perturbation in HCT15 cell line |
| Belumosudil_COLO 205 | Belumosudil perturbation in COLO 205 cell line |
| Uridine_CFPAC-1 | Uridine perturbation in CFPAC-1 cell line |
| Adenosine_C-33 A | Adenosine perturbation in C-33 A cell line |
| Lumateperone (tosylate)_NCI-H2122 | Lumateperone (tosylate) perturbation in NCI-H2122 cell line |
| Triamcinolone_BT-474 | Triamcinolone perturbation in BT-474 cell line |
| Macitentan_BT-474 | Macitentan perturbation in BT-474 cell line |
| Pralsetinib_NCI-H661 | Pralsetinib perturbation in NCI-H661 cell line |
| Olanzapine_NCI-H2122 | Olanzapine perturbation in NCI-H2122 cell line |
| Edoxaban (tosylate monohydrate)_H4 | Edoxaban (tosylate monohydrate) perturbation in H4 cell line |
| Uridine_AN3 CA | Uridine perturbation in AN3 CA cell line |
| Pasireotide (acetate)_BT-474 | Pasireotide (acetate) perturbation in BT-474 cell line |
| Fumaric acid_SW480 | Fumaric acid perturbation in SW480 cell line |
| Gemfibrozil_HCT15 | Gemfibrozil perturbation in HCT15 cell line |
| Mebendazole_RPMI-7951 | Mebendazole perturbation in RPMI-7951 cell line |
| Drospirenone_SNU-1 | Drospirenone perturbation in SNU-1 cell line |
| Crizotinib (hydrochloride)_NCI-H1573 | Crizotinib (hydrochloride) perturbation in NCI-H1573 cell line |
| Bortezomib_NCI-H661 | Bortezomib perturbation in NCI-H661 cell line |
| Crizotinib (hydrochloride)_SHP-77 | Crizotinib (hydrochloride) perturbation in SHP-77 cell line |
| Darinaparsin_C-33 A | Darinaparsin perturbation in C-33 A cell line |
| Darinaparsin_SHP-77 | Darinaparsin perturbation in SHP-77 cell line |
| Betamethasone dipropionate_HCT15 | Betamethasone dipropionate perturbation in HCT15 cell line |
| L-Eflornithine (monohydrochloride)_NCI-H23 | L-Eflornithine (monohydrochloride) perturbation in NCI-H23 cell line |
| Cyclosporin A_NCI-H1792 | Cyclosporin A perturbation in NCI-H1792 cell line |
| ERK5-IN-2_CHP-212 | ERK5-IN-2 perturbation in CHP-212 cell line |
| Allantoin_SW 1088 | Allantoin perturbation in SW 1088 cell line |
| Filgotinib_AN3 CA | Filgotinib perturbation in AN3 CA cell line |
| Cepharanthine_C-33 A | Cepharanthine perturbation in C-33 A cell line |
| Lucanthone_SW 900 | Lucanthone perturbation in SW 900 cell line |
| Pemetrexed_HCT15 | Pemetrexed perturbation in HCT15 cell line |
| Pitavastatin (Calcium)_SW 1271 | Pitavastatin (Calcium) perturbation in SW 1271 cell line |
| Dabrafenib_AN3 CA | Dabrafenib perturbation in AN3 CA cell line |
| NG25_NCI-H661 | NG25 perturbation in NCI-H661 cell line |
| Lapatinib ditosylate_NCI-H2122 | Lapatinib ditosylate perturbation in NCI-H2122 cell line |
| Pasireotide (acetate)_AN3 CA | Pasireotide (acetate) perturbation in AN3 CA cell line |
| Artesunate_HCT15 | Artesunate perturbation in HCT15 cell line |
| Riluzole hydrochloride_NCI-H661 | Riluzole hydrochloride perturbation in NCI-H661 cell line |
| Fusidic acid_LoVo | Fusidic acid perturbation in LoVo cell line |
| Crizotinib (hydrochloride)_hTERT-HPNE | Crizotinib (hydrochloride) perturbation in hTERT-HPNE cell line |
| Sulfisoxazole_HCT15 | Sulfisoxazole perturbation in HCT15 cell line |
| Isocorydine_C-33 A | Isocorydine perturbation in C-33 A cell line |
| Harringtonine_SW480 | Harringtonine perturbation in SW480 cell line |
| Apalutamide_NCI-H661 | Apalutamide perturbation in NCI-H661 cell line |
| Tolmetin_HCT15 | Tolmetin perturbation in HCT15 cell line |
| Drospirenone_HCT15 | Drospirenone perturbation in HCT15 cell line |
| Chlorhexidine (diacetate)_SW 1271 | Chlorhexidine (diacetate) perturbation in SW 1271 cell line |
| Belumosudil_C-33 A | Belumosudil perturbation in C-33 A cell line |
| Verteporfin_NCI-H596 | Verteporfin perturbation in NCI-H596 cell line |
| Tucatinib_C-33 A | Tucatinib perturbation in C-33 A cell line |
| Gefitinib_CHP-212 | Gefitinib perturbation in CHP-212 cell line |
| Mozavaptan_NCI-H1573 | Mozavaptan perturbation in NCI-H1573 cell line |
| Nimesulide_NCI-H2122 | Nimesulide perturbation in NCI-H2122 cell line |
| Carbamazepine_HCT15 | Carbamazepine perturbation in HCT15 cell line |
| Riluzole hydrochloride_NCI-H2030 | Riluzole hydrochloride perturbation in NCI-H2030 cell line |
| Riluzole hydrochloride_BT-474 | Riluzole hydrochloride perturbation in BT-474 cell line |
| Quinidine (15% dihydroquinidine)_CHP-212 | Quinidine (15% dihydroquinidine) perturbation in CHP-212 cell line |
| Oxaliplatin_AN3 CA | Oxaliplatin perturbation in AN3 CA cell line |
| Crizotinib (hydrochloride)_HCT15 | Crizotinib (hydrochloride) perturbation in HCT15 cell line |
| Sonidegib_SW 1271 | Sonidegib perturbation in SW 1271 cell line |
| Drospirenone_BT-474 | Drospirenone perturbation in BT-474 cell line |
| Apalutamide_SW 1271 | Apalutamide perturbation in SW 1271 cell line |
| Olanzapine_NCI-H661 | Olanzapine perturbation in NCI-H661 cell line |
| Decitabine_NCI-H23 | Decitabine perturbation in NCI-H23 cell line |
| Pentamidine (isethionate)_NCI-H2030 | Pentamidine (isethionate) perturbation in NCI-H2030 cell line |
| Triamcinolone_NCI-H23 | Triamcinolone perturbation in NCI-H23 cell line |
| Vortioxetine_AN3 CA | Vortioxetine perturbation in AN3 CA cell line |
| Homoharringtonine_NCI-H661 | Homoharringtonine perturbation in NCI-H661 cell line |
| Belumosudil_LOX-IMVI | Belumosudil perturbation in LOX-IMVI cell line |
| Lumateperone (tosylate)_HCT15 | Lumateperone (tosylate) perturbation in HCT15 cell line |
| Pemetrexed_RPMI-7951 | Pemetrexed perturbation in RPMI-7951 cell line |
| CP21R7_C-33 A | CP21R7 perturbation in C-33 A cell line |
| Daptomycin_HCT15 | Daptomycin perturbation in HCT15 cell line |
| 5-Azacytidine_CHP-212 | 5-Azacytidine perturbation in CHP-212 cell line |
| Quinidine (15% dihydroquinidine)_SW48 | Quinidine (15% dihydroquinidine) perturbation in SW48 cell line |
| Elimusertib hydrochloride_SNU-1 | Elimusertib hydrochloride perturbation in SNU-1 cell line |
| Dexmedetomidine_HCT15 | Dexmedetomidine perturbation in HCT15 cell line |
| palbociclib_CHP-212 | palbociclib perturbation in CHP-212 cell line |
| Quinidine (15% dihydroquinidine)_BT-474 | Quinidine (15% dihydroquinidine) perturbation in BT-474 cell line |
| Capmatinib_A-427 | Capmatinib perturbation in A-427 cell line |
| Tirabrutinib (hydrochloride)_SW 1271 | Tirabrutinib (hydrochloride) perturbation in SW 1271 cell line |
| Pemetrexed_C32 | Pemetrexed perturbation in C32 cell line |
| Budesonide_A-427 | Budesonide perturbation in A-427 cell line |
| Rutin (trihydrate)_CHP-212 | Rutin (trihydrate) perturbation in CHP-212 cell line |
| Pemigatinib_SW 1088 | Pemigatinib perturbation in SW 1088 cell line |
| Belumosudil (mesylate)_SK-MEL-2 | Belumosudil (mesylate) perturbation in SK-MEL-2 cell line |
| Fulvestrant_SK-MEL-2 | Fulvestrant perturbation in SK-MEL-2 cell line |
| Carbamazepine_KATO III | Carbamazepine perturbation in KATO III cell line |
| Elimusertib hydrochloride_A549 | Elimusertib hydrochloride perturbation in A549 cell line |
| Crizotinib (hydrochloride)_CHP-212 | Crizotinib (hydrochloride) perturbation in CHP-212 cell line |
| Crizotinib (hydrochloride)_A-427 | Crizotinib (hydrochloride) perturbation in A-427 cell line |
| Carbamazepine_A-427 | Carbamazepine perturbation in A-427 cell line |
| Methylthiouracil_CHP-212 | Methylthiouracil perturbation in CHP-212 cell line |
| Crizotinib (hydrochloride)_C-33 A | Crizotinib (hydrochloride) perturbation in C-33 A cell line |
| Carbamazepine_BT-474 | Carbamazepine perturbation in BT-474 cell line |
| Ritonavir_A-427 | Ritonavir perturbation in A-427 cell line |
| Crizotinib (hydrochloride)_BT-474 | Crizotinib (hydrochloride) perturbation in BT-474 cell line |
| Tucidinostat_A-427 | Tucidinostat perturbation in A-427 cell line |
| Dabrafenib_CHP-212 | Dabrafenib perturbation in CHP-212 cell line |
| Carbamazepine_A549 | Carbamazepine perturbation in A549 cell line |
| Fulvestrant_Panc 03.27 | Fulvestrant perturbation in Panc 03.27 cell line |
| Aspirin_A-427 | Aspirin perturbation in A-427 cell line |
| Crizotinib (hydrochloride)_A549 | Crizotinib (hydrochloride) perturbation in A549 cell line |
| Pemetrexed_BT-474 | Pemetrexed perturbation in BT-474 cell line |
| Crizotinib (hydrochloride)_HS-578T | Crizotinib (hydrochloride) perturbation in HS-578T cell line |
| Entrectinib_NCI-H2030 | Entrectinib perturbation in NCI-H2030 cell line |
| Carbamazepine_SK-MEL-2 | Carbamazepine perturbation in SK-MEL-2 cell line |
| Darinaparsin_SK-MEL-2 | Darinaparsin perturbation in SK-MEL-2 cell line |
| Quinidine (15% dihydroquinidine)_C-33 A | Quinidine (15% dihydroquinidine) perturbation in C-33 A cell line |
| Hexylresorcinol_hTERT-HPNE | Hexylresorcinol perturbation in hTERT-HPNE cell line |
| Eplerenone_J82 | Eplerenone perturbation in J82 cell line |
| Bortezomib_SNU-1 | Bortezomib perturbation in SNU-1 cell line |
| Clobetasol propionate_C-33 A | Clobetasol propionate perturbation in C-33 A cell line |
| Nevirapine_C-33 A | Nevirapine perturbation in C-33 A cell line |
| Idarubicin (hydrochloride)_AN3 CA | Idarubicin (hydrochloride) perturbation in AN3 CA cell line |
| Verteporfin_C-33 A | Verteporfin perturbation in C-33 A cell line |
| Medroxyprogesterone acetate_BT-474 | Medroxyprogesterone acetate perturbation in BT-474 cell line |
| Allantoin_BT-474 | Allantoin perturbation in BT-474 cell line |
| Budesonide_BT-474 | Budesonide perturbation in BT-474 cell line |
| Econazole_BT-474 | Econazole perturbation in BT-474 cell line |
| Binimetinib_BT-474 | Binimetinib perturbation in BT-474 cell line |
| Aprepitant_KATO III | Aprepitant perturbation in KATO III cell line |
| Ponatinib_BT-474 | Ponatinib perturbation in BT-474 cell line |
| Ataluren_KATO III | Ataluren perturbation in KATO III cell line |
| Trametinib_KATO III | Trametinib perturbation in KATO III cell line |
| Betamethasone dipropionate_SW 900 | Betamethasone dipropionate perturbation in SW 900 cell line |
| Crizotinib (hydrochloride)_KATO III | Crizotinib (hydrochloride) perturbation in KATO III cell line |
| γ-Oryzanol_KATO III | γ-Oryzanol perturbation in KATO III cell line |
| (S)-Crizotinib_COLO 205 | (S)-Crizotinib perturbation in COLO 205 cell line |
| Budesonide_NCI-H2347 | Budesonide perturbation in NCI-H2347 cell line |
| Posaconazole_BT-474 | Posaconazole perturbation in BT-474 cell line |
| Atazanavir (sulfate)_KATO III | Atazanavir (sulfate) perturbation in KATO III cell line |
| Trametinib (DMSO_BT-474 | Trametinib (DMSO perturbation in BT-474 cell line |
| Gefitinib_BT-474 | Gefitinib perturbation in BT-474 cell line |
| Bimatoprost_SNU-423 | Bimatoprost perturbation in SNU-423 cell line |
| GSK1059615_HepG2/C3A | GSK1059615 perturbation in HepG2/C3A cell line |
| Dexamethasone_SW 900 | Dexamethasone perturbation in SW 900 cell line |
| Almonertinib (mesylate)_KATO III | Almonertinib (mesylate) perturbation in KATO III cell line |
| Lactate (calcium)_SW 900 | Lactate (calcium) perturbation in SW 900 cell line |
| Trametinib_BT-474 | Trametinib perturbation in BT-474 cell line |
| Ribociclib_CHP-212 | Ribociclib perturbation in CHP-212 cell line |
| Adagrasib_SNU-423 | Adagrasib perturbation in SNU-423 cell line |
| Brimonidine_NCI-H1573 | Brimonidine perturbation in NCI-H1573 cell line |
| ERK5-IN-2_NCI-H661 | ERK5-IN-2 perturbation in NCI-H661 cell line |
| Imiquimod (hydrochloride)_HS-578T | Imiquimod (hydrochloride) perturbation in HS-578T cell line |
| Thymopentin_BT-474 | Thymopentin perturbation in BT-474 cell line |
| Nevirapine_C32 | Nevirapine perturbation in C32 cell line |
| Procainamide (hydrochloride)_C32 | Procainamide (hydrochloride) perturbation in C32 cell line |
| Entrectinib_A-427 | Entrectinib perturbation in A-427 cell line |
| Finasteride_NCI-H661 | Finasteride perturbation in NCI-H661 cell line |
| Benproperine (phosphate)_SHP-77 | Benproperine (phosphate) perturbation in SHP-77 cell line |
| (S)-Crizotinib_NCI-H661 | (S)-Crizotinib perturbation in NCI-H661 cell line |
| Carbidopa (monohydrate)_AN3 CA | Carbidopa (monohydrate) perturbation in AN3 CA cell line |
| Fenofibrate_BT-474 | Fenofibrate perturbation in BT-474 cell line |
| Belumosudil_NCI-H661 | Belumosudil perturbation in NCI-H661 cell line |
| Vandetanib_HepG2/C3A | Vandetanib perturbation in HepG2/C3A cell line |
| Vandetanib_SW 1088 | Vandetanib perturbation in SW 1088 cell line |
| Omeprazole (sodium)_NCI-H661 | Omeprazole (sodium) perturbation in NCI-H661 cell line |
| Econazole_SW 1271 | Econazole perturbation in SW 1271 cell line |
| Acetohexamide_NCI-H661 | Acetohexamide perturbation in NCI-H661 cell line |
| Bexarotene_NCI-H460 | Bexarotene perturbation in NCI-H460 cell line |
| Entrectinib_NCI-H1573 | Entrectinib perturbation in NCI-H1573 cell line |
| Carbidopa (monohydrate)_NCI-H2122 | Carbidopa (monohydrate) perturbation in NCI-H2122 cell line |
| Pexidartinib (hydrochloride)_SW1417 | Pexidartinib (hydrochloride) perturbation in SW1417 cell line |
| Penfluridol_NCI-H661 | Penfluridol perturbation in NCI-H661 cell line |
| Tranilast_J82 | Tranilast perturbation in J82 cell line |
| Plicamycin_NCI-H661 | Plicamycin perturbation in NCI-H661 cell line |
| Pioglitazone_NCI-H661 | Pioglitazone perturbation in NCI-H661 cell line |
| Apalutamide_NCI-H1573 | Apalutamide perturbation in NCI-H1573 cell line |
| Tolmetin_C32 | Tolmetin perturbation in C32 cell line |
| Bendamustine_NCI-H2347 | Bendamustine perturbation in NCI-H2347 cell line |
| Meloxicam_CHP-212 | Meloxicam perturbation in CHP-212 cell line |
| Idoxuridine_SW1417 | Idoxuridine perturbation in SW1417 cell line |
| Fostamatinib (disodium hexahydrate)_LOX-IMVI | Fostamatinib (disodium hexahydrate) perturbation in LOX-IMVI cell line |
| Diphenhydramine_C32 | Diphenhydramine perturbation in C32 cell line |
| Cyclosporin A_NCI-H661 | Cyclosporin A perturbation in NCI-H661 cell line |
| Bisoprolol (hemifumarate)_NCI-H2122 | Bisoprolol (hemifumarate) perturbation in NCI-H2122 cell line |
| Benztropine (mesylate)_NCI-H2122 | Benztropine (mesylate) perturbation in NCI-H2122 cell line |
| Belzutifan_NCI-H1573 | Belzutifan perturbation in NCI-H1573 cell line |
| Edoxaban (tosylate monohydrate)_BT-474 | Edoxaban (tosylate monohydrate) perturbation in BT-474 cell line |
| Asciminib_SW 900 | Asciminib perturbation in SW 900 cell line |
| Sonidegib_AN3 CA | Sonidegib perturbation in AN3 CA cell line |
| Abiraterone acetate_C-33 A | Abiraterone acetate perturbation in C-33 A cell line |
| Tranilast_CHP-212 | Tranilast perturbation in CHP-212 cell line |
| Macitentan_NCI-H661 | Macitentan perturbation in NCI-H661 cell line |
| Verteporfin_KATO III | Verteporfin perturbation in KATO III cell line |
| Sulfatinib_NCI-H661 | Sulfatinib perturbation in NCI-H661 cell line |
| Auranofin_SW 1088 | Auranofin perturbation in SW 1088 cell line |
| Belumosudil_HS-578T | Belumosudil perturbation in HS-578T cell line |
| Canagliflozin_NCI-H661 | Canagliflozin perturbation in NCI-H661 cell line |
| Ferulic acid_CHP-212 | Ferulic acid perturbation in CHP-212 cell line |
| Pitavastatin (Calcium)_Panc 03.27 | Pitavastatin (Calcium) perturbation in Panc 03.27 cell line |
| Doxycycline (monohydrate)_hTERT-HPNE | Doxycycline (monohydrate) perturbation in hTERT-HPNE cell line |
| Hesperidin_C32 | Hesperidin perturbation in C32 cell line |
| Thymopentin_NCI-H2030 | Thymopentin perturbation in NCI-H2030 cell line |
| Asciminib_SHP-77 | Asciminib perturbation in SHP-77 cell line |
| 5-Fluorouracil_SW 1271 | 5-Fluorouracil perturbation in SW 1271 cell line |
| Methyl aminolevulinate (hydrochloride)_BT-474 | Methyl aminolevulinate (hydrochloride) perturbation in BT-474 cell line |
| Benproperine (phosphate)_C32 | Benproperine (phosphate) perturbation in C32 cell line |
| Niclosamide (olamine)_C-33 A | Niclosamide (olamine) perturbation in C-33 A cell line |
| Methyl aminolevulinate (hydrochloride)_SW1417 | Methyl aminolevulinate (hydrochloride) perturbation in SW1417 cell line |
| Bergenin_HepG2/C3A | Bergenin perturbation in HepG2/C3A cell line |
| Fulvestrant_SW1417 | Fulvestrant perturbation in SW1417 cell line |
| Medroxyprogesterone acetate_NCI-H596 | Medroxyprogesterone acetate perturbation in NCI-H596 cell line |
| Trametinib (DMSO_NCI-H661 | Trametinib (DMSO perturbation in NCI-H661 cell line |
| Canagliflozin (hemihydrate)_HS-578T | Canagliflozin (hemihydrate) perturbation in HS-578T cell line |
| Meloxicam_AN3 CA | Meloxicam perturbation in AN3 CA cell line |
| Voriconazole_NCI-H1573 | Voriconazole perturbation in NCI-H1573 cell line |
| (S)-Crizotinib_SK-MEL-2 | (S)-Crizotinib perturbation in SK-MEL-2 cell line |
| Panobinostat_HS-578T | Panobinostat perturbation in HS-578T cell line |
| Voriconazole_AN3 CA | Voriconazole perturbation in AN3 CA cell line |
| Aprepitant_AN3 CA | Aprepitant perturbation in AN3 CA cell line |
| Megestrol_NCI-H661 | Megestrol perturbation in NCI-H661 cell line |
| Irinotecan (hydrochloride)_CHP-212 | Irinotecan (hydrochloride) perturbation in CHP-212 cell line |
| Voriconazole_C32 | Voriconazole perturbation in C32 cell line |
| Bosentan (hydrate)_HS-578T | Bosentan (hydrate) perturbation in HS-578T cell line |
| Entrectinib_KATO III | Entrectinib perturbation in KATO III cell line |
| Capmatinib_NCI-H1573 | Capmatinib perturbation in NCI-H1573 cell line |
| Aprepitant_C32 | Aprepitant perturbation in C32 cell line |
| Capmatinib_AN3 CA | Capmatinib perturbation in AN3 CA cell line |
| Rimonabant (Hydrochloride)_HS-578T | Rimonabant (Hydrochloride) perturbation in HS-578T cell line |
| Voriconazole_NCI-H2122 | Voriconazole perturbation in NCI-H2122 cell line |
| Gallic acid (hydrate)_C32 | Gallic acid (hydrate) perturbation in C32 cell line |
| Bisoprolol (hemifumarate)_CHP-212 | Bisoprolol (hemifumarate) perturbation in CHP-212 cell line |
| Nimesulide_SW 1088 | Nimesulide perturbation in SW 1088 cell line |
| Doxycycline (monohydrate)_SW1417 | Doxycycline (monohydrate) perturbation in SW1417 cell line |
| Orlistat_NCI-H2347 | Orlistat perturbation in NCI-H2347 cell line |
| Benproperine (phosphate)_CHP-212 | Benproperine (phosphate) perturbation in CHP-212 cell line |
| Asciminib_KATO III | Asciminib perturbation in KATO III cell line |
| Abiraterone acetate_KATO III | Abiraterone acetate perturbation in KATO III cell line |
| Canagliflozin_Hs 766T | Canagliflozin perturbation in Hs 766T cell line |
| Cytarabine_NCI-H661 | Cytarabine perturbation in NCI-H661 cell line |
| Omeprazole (sodium)_NCI-H596 | Omeprazole (sodium) perturbation in NCI-H596 cell line |
| Hesperidin_CHP-212 | Hesperidin perturbation in CHP-212 cell line |
| Lucanthone_NCI-H661 | Lucanthone perturbation in NCI-H661 cell line |
| Belumosudil_SK-MEL-2 | Belumosudil perturbation in SK-MEL-2 cell line |
| Tetracycline (hydrochloride)_AN3 CA | Tetracycline (hydrochloride) perturbation in AN3 CA cell line |
| Orlistat_LOX-IMVI | Orlistat perturbation in LOX-IMVI cell line |
| L-Thyroxine (sodium salt pentahydrate)_NCI-H661 | L-Thyroxine (sodium salt pentahydrate) perturbation in NCI-H661 cell line |
| RMC-6236_NCI-H661 | RMC-6236 perturbation in NCI-H661 cell line |
| Hexylresorcinol_NCI-H1573 | Hexylresorcinol perturbation in NCI-H1573 cell line |
| Tranilast_SW 900 | Tranilast perturbation in SW 900 cell line |
| Benztropine (mesylate)_KATO III | Benztropine (mesylate) perturbation in KATO III cell line |
| Pitavastatin (Calcium)_NCI-H2347 | Pitavastatin (Calcium) perturbation in NCI-H2347 cell line |
| Cloxacillin (sodium)_NCI-H661 | Cloxacillin (sodium) perturbation in NCI-H661 cell line |
| Ivabradine (hydrochloride)_AN3 CA | Ivabradine (hydrochloride) perturbation in AN3 CA cell line |
| Menadione_Panc 03.27 | Menadione perturbation in Panc 03.27 cell line |
| Indacaterol (maleate)_NCI-H2347 | Indacaterol (maleate) perturbation in NCI-H2347 cell line |
| Entrectinib_SNU-423 | Entrectinib perturbation in SNU-423 cell line |
| Rimonabant (Hydrochloride)_NCI-H661 | Rimonabant (Hydrochloride) perturbation in NCI-H661 cell line |
| Ribociclib_C32 | Ribociclib perturbation in C32 cell line |
| Meloxicam_C-33 A | Meloxicam perturbation in C-33 A cell line |
| Ivabradine (hydrochloride)_C32 | Ivabradine (hydrochloride) perturbation in C32 cell line |
| Nafamostat (mesylate)_HepG2/C3A | Nafamostat (mesylate) perturbation in HepG2/C3A cell line |
| DTP3_NCI-H661 | DTP3 perturbation in NCI-H661 cell line |
| Sulfatinib_NCI-H596 | Sulfatinib perturbation in NCI-H596 cell line |
| Dapagliflozin_NCI-H661 | Dapagliflozin perturbation in NCI-H661 cell line |
| Adagrasib_AN3 CA | Adagrasib perturbation in AN3 CA cell line |
| Cobimetinib_NCI-H2347 | Cobimetinib perturbation in NCI-H2347 cell line |
| Brivudine_NCI-H2122 | Brivudine perturbation in NCI-H2122 cell line |
| Neratinib_NCI-H460 | Neratinib perturbation in NCI-H460 cell line |
| Gemfibrozil_HepG2/C3A | Gemfibrozil perturbation in HepG2/C3A cell line |
| Fedratinib (hydrochloride hydrate)_C32 | Fedratinib (hydrochloride hydrate) perturbation in C32 cell line |
| Trametinib_CHP-212 | Trametinib perturbation in CHP-212 cell line |
| Acetohexamide_Hs 766T | Acetohexamide perturbation in Hs 766T cell line |
| Ivermectin_BT-474 | Ivermectin perturbation in BT-474 cell line |
| Atazanavir (sulfate)_AN3 CA | Atazanavir (sulfate) perturbation in AN3 CA cell line |
| Plicamycin_BT-474 | Plicamycin perturbation in BT-474 cell line |
| Erlotinib_C32 | Erlotinib perturbation in C32 cell line |
| Atazanavir (sulfate)_NCI-H1573 | Atazanavir (sulfate) perturbation in NCI-H1573 cell line |
| Ixazomib citrate_C32 | Ixazomib citrate perturbation in C32 cell line |
| Sivelestat (sodium tetrahydrate)_NCI-H2122 | Sivelestat (sodium tetrahydrate) perturbation in NCI-H2122 cell line |
| Penfluridol_SW1417 | Penfluridol perturbation in SW1417 cell line |
| Imiquimod (maleate)_SNU-423 | Imiquimod (maleate) perturbation in SNU-423 cell line |
| Verapamil_HT-29 | Verapamil perturbation in HT-29 cell line |
| Aspirin_SW1417 | Aspirin perturbation in SW1417 cell line |
| Pentoxifylline_NCI-H2122 | Pentoxifylline perturbation in NCI-H2122 cell line |
| Bestatin (hydrochloride)_CFPAC-1 | Bestatin (hydrochloride) perturbation in CFPAC-1 cell line |
| Captopril_SW1417 | Captopril perturbation in SW1417 cell line |
| Dexmedetomidine_NCI-H2122 | Dexmedetomidine perturbation in NCI-H2122 cell line |
| Methylthiouracil_C32 | Methylthiouracil perturbation in C32 cell line |
| Omeprazole (sodium)_SW1417 | Omeprazole (sodium) perturbation in SW1417 cell line |
| Captopril_BT-474 | Captopril perturbation in BT-474 cell line |
| Fenofibrate_NCI-H661 | Fenofibrate perturbation in NCI-H661 cell line |
| Perindopril (erbumine)_NCI-H661 | Perindopril (erbumine) perturbation in NCI-H661 cell line |
| Oxaprozin_AN3 CA | Oxaprozin perturbation in AN3 CA cell line |
| Altretamine_NCI-H661 | Altretamine perturbation in NCI-H661 cell line |
| Auranofin_NCI-H661 | Auranofin perturbation in NCI-H661 cell line |
| Canagliflozin_SW 1088 | Canagliflozin perturbation in SW 1088 cell line |
| Digitoxin_CHP-212 | Digitoxin perturbation in CHP-212 cell line |
| Imiquimod (maleate)_CHP-212 | Imiquimod (maleate) perturbation in CHP-212 cell line |
| Glasdegib_C32 | Glasdegib perturbation in C32 cell line |
| Mozavaptan_BT-474 | Mozavaptan perturbation in BT-474 cell line |
| Oxaprozin_C32 | Oxaprozin perturbation in C32 cell line |
| Dexmedetomidine_NCI-H1573 | Dexmedetomidine perturbation in NCI-H1573 cell line |
| Thymopentin_NCI-H661 | Thymopentin perturbation in NCI-H661 cell line |
| Penfluridol_SW 1271 | Penfluridol perturbation in SW 1271 cell line |
| Baicalin_NCI-H661 | Baicalin perturbation in NCI-H661 cell line |
| GSK1059615_CHP-212 | GSK1059615 perturbation in CHP-212 cell line |
| Topotecan (hydrochloride)_C32 | Topotecan (hydrochloride) perturbation in C32 cell line |
| Glycyrrhizic acid_C32 | Glycyrrhizic acid perturbation in C32 cell line |
| Sunitinib_KATO III | Sunitinib perturbation in KATO III cell line |
| Orlistat_CHP-212 | Orlistat perturbation in CHP-212 cell line |
| Indacaterol (maleate)_KATO III | Indacaterol (maleate) perturbation in KATO III cell line |
| Menadione_AN3 CA | Menadione perturbation in AN3 CA cell line |
| Panobinostat_hTERT-HPNE | Panobinostat perturbation in hTERT-HPNE cell line |
| Aliskiren_NCI-H661 | Aliskiren perturbation in NCI-H661 cell line |
| Phenytoin (sodium)_SW 1088 | Phenytoin (sodium) perturbation in SW 1088 cell line |
| Methyl aminolevulinate (hydrochloride)_NCI-H661 | Methyl aminolevulinate (hydrochloride) perturbation in NCI-H661 cell line |
| Fingolimod (hydrochloride)_NCI-H661 | Fingolimod (hydrochloride) perturbation in NCI-H661 cell line |
| (S)-Crizotinib_HepG2/C3A | (S)-Crizotinib perturbation in HepG2/C3A cell line |
| Canagliflozin_SW1417 | Canagliflozin perturbation in SW1417 cell line |
| Macitentan_SW 1271 | Macitentan perturbation in SW 1271 cell line |
| Penfluridol_COLO 205 | Penfluridol perturbation in COLO 205 cell line |
| Decitabine_SW1417 | Decitabine perturbation in SW1417 cell line |
| Quinidine (15% dihydroquinidine)_NCI-H661 | Quinidine (15% dihydroquinidine) perturbation in NCI-H661 cell line |
| Hydroxyurea_C32 | Hydroxyurea perturbation in C32 cell line |
| Pitavastatin (Calcium)_CHP-212 | Pitavastatin (Calcium) perturbation in CHP-212 cell line |
| Canagliflozin_BT-474 | Canagliflozin perturbation in BT-474 cell line |
| Loperamide (hydrochloride)_C32 | Loperamide (hydrochloride) perturbation in C32 cell line |
| Bexarotene_NCI-H1573 | Bexarotene perturbation in NCI-H1573 cell line |
| Indacaterol (maleate)_CHP-212 | Indacaterol (maleate) perturbation in CHP-212 cell line |
| Fostamatinib (disodium hexahydrate)_SW 900 | Fostamatinib (disodium hexahydrate) perturbation in SW 900 cell line |
| (S)-Crizotinib_NCI-H2030 | (S)-Crizotinib perturbation in NCI-H2030 cell line |
| Tirabrutinib_BT-474 | Tirabrutinib perturbation in BT-474 cell line |
| Roxadustat_AN3 CA | Roxadustat perturbation in AN3 CA cell line |
| Dexmedetomidine_C-33 A | Dexmedetomidine perturbation in C-33 A cell line |
| Homoharringtonine_NCI-H1573 | Homoharringtonine perturbation in NCI-H1573 cell line |
| Epirubicin (hydrochloride)_NCI-H661 | Epirubicin (hydrochloride) perturbation in NCI-H661 cell line |
| Ligustrazine_AN3 CA | Ligustrazine perturbation in AN3 CA cell line |
| Tucidinostat_RPMI-7951 | Tucidinostat perturbation in RPMI-7951 cell line |
| Neratinib (maleate)_C32 | Neratinib (maleate) perturbation in C32 cell line |
| Ornidazole_C32 | Ornidazole perturbation in C32 cell line |
| Lumateperone (tosylate)_AN3 CA | Lumateperone (tosylate) perturbation in AN3 CA cell line |
| Pravastatin (sodium)_NCI-H661 | Pravastatin (sodium) perturbation in NCI-H661 cell line |
| Thymopentin_HS-578T | Thymopentin perturbation in HS-578T cell line |
| Rosiglitazone_C32 | Rosiglitazone perturbation in C32 cell line |
| Monocrotaline_C32 | Monocrotaline perturbation in C32 cell line |
| Lonafarnib_NCI-H2122 | Lonafarnib perturbation in NCI-H2122 cell line |
| Clofarabine_AN3 CA | Clofarabine perturbation in AN3 CA cell line |
| Thymol_A549 | Thymol perturbation in A549 cell line |
| 5-Fluorouracil_NCI-H661 | 5-Fluorouracil perturbation in NCI-H661 cell line |
| Pioglitazone_BT-474 | Pioglitazone perturbation in BT-474 cell line |
| Methotrexate_NCI-H1573 | Methotrexate perturbation in NCI-H1573 cell line |
| Panobinostat_SW 1088 | Panobinostat perturbation in SW 1088 cell line |
| Pitavastatin (Calcium)_C32 | Pitavastatin (Calcium) perturbation in C32 cell line |
| Docetaxel (Trihydrate)_AN3 CA | Docetaxel (Trihydrate) perturbation in AN3 CA cell line |
| Tirabrutinib (hydrochloride)_HS-578T | Tirabrutinib (hydrochloride) perturbation in HS-578T cell line |
| Flumatinib (mesylate)_BT-474 | Flumatinib (mesylate) perturbation in BT-474 cell line |
| Darinaparsin_NCI-H1573 | Darinaparsin perturbation in NCI-H1573 cell line |
| Hydroxyurea_CHP-212 | Hydroxyurea perturbation in CHP-212 cell line |
| olaparib_SW1417 | olaparib perturbation in SW1417 cell line |
| Sunitinib_C32 | Sunitinib perturbation in C32 cell line |
| Neratinib_C32 | Neratinib perturbation in C32 cell line |
| Bestatin (hydrochloride)_C-33 A | Bestatin (hydrochloride) perturbation in C-33 A cell line |
| (S)-Crizotinib_LS 180 | (S)-Crizotinib perturbation in LS 180 cell line |
| Posaconazole_SW1417 | Posaconazole perturbation in SW1417 cell line |
| TAK-901_AN3 CA | TAK-901 perturbation in AN3 CA cell line |
| Sunitinib_AN3 CA | Sunitinib perturbation in AN3 CA cell line |
| Sildenafil_AN3 CA | Sildenafil perturbation in AN3 CA cell line |
| Canagliflozin (hemihydrate)_COLO 205 | Canagliflozin (hemihydrate) perturbation in COLO 205 cell line |
| Trimetrexate_BT-474 | Trimetrexate perturbation in BT-474 cell line |
| Rosiglitazone_CHP-212 | Rosiglitazone perturbation in CHP-212 cell line |
| Altretamine_NCI-H596 | Altretamine perturbation in NCI-H596 cell line |
| Ligustrazine_CHP-212 | Ligustrazine perturbation in CHP-212 cell line |
| Crizotinib (hydrochloride)_AN3 CA | Crizotinib (hydrochloride) perturbation in AN3 CA cell line |
| Orlistat_SW 900 | Orlistat perturbation in SW 900 cell line |
| Roxadustat_CHP-212 | Roxadustat perturbation in CHP-212 cell line |
| Rapamycin_Hs 766T | Rapamycin perturbation in Hs 766T cell line |
| Bendamustine_J82 | Bendamustine perturbation in J82 cell line |
| crizotinib_SW1417 | crizotinib perturbation in SW1417 cell line |
| 5-Fluorouracil_Hs 766T | 5-Fluorouracil perturbation in Hs 766T cell line |
| Pitavastatin (Calcium)_NCI-H2122 | Pitavastatin (Calcium) perturbation in NCI-H2122 cell line |
| Clofarabine_CHP-212 | Clofarabine perturbation in CHP-212 cell line |
| Valdecoxib_C-33 A | Valdecoxib perturbation in C-33 A cell line |
| Crizotinib (hydrochloride)_C32 | Crizotinib (hydrochloride) perturbation in C32 cell line |
| Filgotinib_BT-474 | Filgotinib perturbation in BT-474 cell line |
| Cobimetinib_SHP-77 | Cobimetinib perturbation in SHP-77 cell line |
| 18β-Glycyrrhetinic acid_HepG2/C3A | 18β-Glycyrrhetinic acid perturbation in HepG2/C3A cell line |
| crizotinib_HepG2/C3A | crizotinib perturbation in HepG2/C3A cell line |
| Methyl aminolevulinate (hydrochloride)_NCI-H596 | Methyl aminolevulinate (hydrochloride) perturbation in NCI-H596 cell line |
| crizotinib_SW 1088 | crizotinib perturbation in SW 1088 cell line |
| L-Eflornithine (monohydrochloride)_NCI-H661 | L-Eflornithine (monohydrochloride) perturbation in NCI-H661 cell line |
| Dapagliflozin ((2S)-1,2-propanediol, hydrate)_NCI-H1573 | Dapagliflozin ((2S)-1,2-propanediol, hydrate) perturbation in NCI-H1573 cell line |
| Clobetasol propionate_NCI-H661 | Clobetasol propionate perturbation in NCI-H661 cell line |
| Capivasertib_NCI-H661 | Capivasertib perturbation in NCI-H661 cell line |
| Bendamustine_CHP-212 | Bendamustine perturbation in CHP-212 cell line |
| Berbamine (dihydrochloride)_CHP-212 | Berbamine (dihydrochloride) perturbation in CHP-212 cell line |
| Bestatin (hydrochloride)_AN3 CA | Bestatin (hydrochloride) perturbation in AN3 CA cell line |
| Cabozantinib (S-malate)_NCI-H661 | Cabozantinib (S-malate) perturbation in NCI-H661 cell line |
| Erlotinib_CHP-212 | Erlotinib perturbation in CHP-212 cell line |
| Voriconazole_NCI-H2347 | Voriconazole perturbation in NCI-H2347 cell line |
| Tadalafil_CHP-212 | Tadalafil perturbation in CHP-212 cell line |
| Dexamethasone_NCI-H661 | Dexamethasone perturbation in NCI-H661 cell line |
| Bosentan (hydrate)_SW1417 | Bosentan (hydrate) perturbation in SW1417 cell line |
| Rimonabant (Hydrochloride)_BT-474 | Rimonabant (Hydrochloride) perturbation in BT-474 cell line |
| Nimesulide_NCI-H661 | Nimesulide perturbation in NCI-H661 cell line |
| Valdecoxib_AN3 CA | Valdecoxib perturbation in AN3 CA cell line |
| Valdecoxib_NCI-H1573 | Valdecoxib perturbation in NCI-H1573 cell line |
| Menadione_CHP-212 | Menadione perturbation in CHP-212 cell line |
| Glasdegib_CHP-212 | Glasdegib perturbation in CHP-212 cell line |
| Digitoxin_C32 | Digitoxin perturbation in C32 cell line |
| Berberine (chloride hydrate)_NCI-H1573 | Berberine (chloride hydrate) perturbation in NCI-H1573 cell line |
| Thymopentin_Hs 766T | Thymopentin perturbation in Hs 766T cell line |
| Fulvestrant_HS-578T | Fulvestrant perturbation in HS-578T cell line |
| Lopinavir_HS-578T | Lopinavir perturbation in HS-578T cell line |
| Imiquimod (maleate)_BT-474 | Imiquimod (maleate) perturbation in BT-474 cell line |
| Pitavastatin (Calcium)_SW 1088 | Pitavastatin (Calcium) perturbation in SW 1088 cell line |
| Cytarabine_SHP-77 | Cytarabine perturbation in SHP-77 cell line |
| Dorzolamide (hydrochloride)_C32 | Dorzolamide (hydrochloride) perturbation in C32 cell line |
| Oxaprozin_hTERT-HPNE | Oxaprozin perturbation in hTERT-HPNE cell line |
| Posaconazole_SHP-77 | Posaconazole perturbation in SHP-77 cell line |
| (S)-Crizotinib_CHP-212 | (S)-Crizotinib perturbation in CHP-212 cell line |
| Rimonabant (Hydrochloride)_AN3 CA | Rimonabant (Hydrochloride) perturbation in AN3 CA cell line |
| Bosentan (hydrate)_C32 | Bosentan (hydrate) perturbation in C32 cell line |
| Methotrexate_HepG2/C3A | Methotrexate perturbation in HepG2/C3A cell line |
| Entecavir (monohydrate)_AN3 CA | Entecavir (monohydrate) perturbation in AN3 CA cell line |
| Idarubicin (hydrochloride)_NCI-H2122 | Idarubicin (hydrochloride) perturbation in NCI-H2122 cell line |
| Phenytoin (sodium)_CHP-212 | Phenytoin (sodium) perturbation in CHP-212 cell line |
| Mozavaptan_CHP-212 | Mozavaptan perturbation in CHP-212 cell line |
| Penfluridol_CHP-212 | Penfluridol perturbation in CHP-212 cell line |
| Fulvestrant_NCI-H2347 | Fulvestrant perturbation in NCI-H2347 cell line |
| Elimusertib hydrochloride_AN3 CA | Elimusertib hydrochloride perturbation in AN3 CA cell line |
| Dapagliflozin ((2S)-1,2-propanediol, hydrate)_BT-474 | Dapagliflozin ((2S)-1,2-propanediol, hydrate) perturbation in BT-474 cell line |
| Fedratinib (hydrochloride hydrate)_NCI-H661 | Fedratinib (hydrochloride hydrate) perturbation in NCI-H661 cell line |
| Elagolix sodium_NCI-H661 | Elagolix sodium perturbation in NCI-H661 cell line |
| Berbamine_AN3 CA | Berbamine perturbation in AN3 CA cell line |
| BI-78D3_HCT15 | BI-78D3 perturbation in HCT15 cell line |
| Adagrasib_NCI-H661 | Adagrasib perturbation in NCI-H661 cell line |
| Celecoxib_C32 | Celecoxib perturbation in C32 cell line |
| Dapagliflozin ((2S)-1,2-propanediol, hydrate)_SW1417 | Dapagliflozin ((2S)-1,2-propanediol, hydrate) perturbation in SW1417 cell line |
| Flumatinib (mesylate)_NCI-H2122 | Flumatinib (mesylate) perturbation in NCI-H2122 cell line |
| crizotinib_C32 | crizotinib perturbation in C32 cell line |
| Sulfatinib_CHP-212 | Sulfatinib perturbation in CHP-212 cell line |
| Ribociclib_HS-578T | Ribociclib perturbation in HS-578T cell line |
| Aprepitant_NCI-H661 | Aprepitant perturbation in NCI-H661 cell line |
| Clobetasol propionate_NCI-H2347 | Clobetasol propionate perturbation in NCI-H2347 cell line |
| Imiquimod (hydrochloride)_CHP-212 | Imiquimod (hydrochloride) perturbation in CHP-212 cell line |
| Meloxicam_NCI-H661 | Meloxicam perturbation in NCI-H661 cell line |
| palbociclib_NCI-H661 | palbociclib perturbation in NCI-H661 cell line |
| Trametinib (DMSO_AN3 CA | Trametinib (DMSO perturbation in AN3 CA cell line |
| Cyclosporin A_CHP-212 | Cyclosporin A perturbation in CHP-212 cell line |
| crizotinib_AN3 CA | crizotinib perturbation in AN3 CA cell line |
| Simotinib_NCI-H1573 | Simotinib perturbation in NCI-H1573 cell line |
| Phenylephrine (hydrochloride)_NCI-H2347 | Phenylephrine (hydrochloride) perturbation in NCI-H2347 cell line |
| Dexamethasone_NCI-H2347 | Dexamethasone perturbation in NCI-H2347 cell line |
| Methotrexate_BT-474 | Methotrexate perturbation in BT-474 cell line |
| Entecavir (monohydrate)_SHP-77 | Entecavir (monohydrate) perturbation in SHP-77 cell line |
| olaparib_AN3 CA | olaparib perturbation in AN3 CA cell line |
| (S)-Crizotinib_KATO III | (S)-Crizotinib perturbation in KATO III cell line |
| Uridine_SW1417 | Uridine perturbation in SW1417 cell line |
| Imiquimod (maleate)_HepG2/C3A | Imiquimod (maleate) perturbation in HepG2/C3A cell line |
| Niclosamide (olamine)_NCI-H596 | Niclosamide (olamine) perturbation in NCI-H596 cell line |
| olaparib_C32 | olaparib perturbation in C32 cell line |
| Decitabine_CHP-212 | Decitabine perturbation in CHP-212 cell line |
| Neratinib_SW1417 | Neratinib perturbation in SW1417 cell line |
| Canagliflozin_CHP-212 | Canagliflozin perturbation in CHP-212 cell line |
| Flumatinib (mesylate)_C32 | Flumatinib (mesylate) perturbation in C32 cell line |
| Posaconazole_AN3 CA | Posaconazole perturbation in AN3 CA cell line |
| Belinostat_NCI-H661 | Belinostat perturbation in NCI-H661 cell line |
| Indacaterol (maleate)_SW1417 | Indacaterol (maleate) perturbation in SW1417 cell line |
| Neratinib_BT-474 | Neratinib perturbation in BT-474 cell line |
| (R)-Verapamil (hydrochloride)_LS 180 | (R)-Verapamil (hydrochloride) perturbation in LS 180 cell line |
| Lucanthone_C32 | Lucanthone perturbation in C32 cell line |
| Cyclosporin A_C32 | Cyclosporin A perturbation in C32 cell line |
| Lucanthone_SNU-423 | Lucanthone perturbation in SNU-423 cell line |
| Tirabrutinib_NCI-H1573 | Tirabrutinib perturbation in NCI-H1573 cell line |
| Larotrectinib_SW 1271 | Larotrectinib perturbation in SW 1271 cell line |
| Procainamide (hydrochloride)_HS-578T | Procainamide (hydrochloride) perturbation in HS-578T cell line |
| Roxadustat_SW1417 | Roxadustat perturbation in SW1417 cell line |
| Sonidegib_NCI-H661 | Sonidegib perturbation in NCI-H661 cell line |
| Trametinib (DMSO_CHP-212 | Trametinib (DMSO perturbation in CHP-212 cell line |
| (S)-Crizotinib_C-33 A | (S)-Crizotinib perturbation in C-33 A cell line |
| Penfluridol_SHP-77 | Penfluridol perturbation in SHP-77 cell line |
| crizotinib_CHP-212 | crizotinib perturbation in CHP-212 cell line |
| Macitentan_C32 | Macitentan perturbation in C32 cell line |
| Ouabain (Octahydrate)_CHP-212 | Ouabain (Octahydrate) perturbation in CHP-212 cell line |
| Asciminib_HS-578T | Asciminib perturbation in HS-578T cell line |
| Almonertinib (hydrochloride)_AN3 CA | Almonertinib (hydrochloride) perturbation in AN3 CA cell line |
| Neratinib (maleate)_BT-474 | Neratinib (maleate) perturbation in BT-474 cell line |
| Irinotecan (hydrochloride)_NCI-H661 | Irinotecan (hydrochloride) perturbation in NCI-H661 cell line |
| Daidzin_NCI-H661 | Daidzin perturbation in NCI-H661 cell line |
| APTO-253_NCI-H1573 | APTO-253 perturbation in NCI-H1573 cell line |
| Docetaxel_NCI-H2122 | Docetaxel perturbation in NCI-H2122 cell line |
| Hydroxyurea_BT-474 | Hydroxyurea perturbation in BT-474 cell line |
| Lopinavir_SNU-1 | Lopinavir perturbation in SNU-1 cell line |
| Canagliflozin_C32 | Canagliflozin perturbation in C32 cell line |
| Hydroxyurea_SW1417 | Hydroxyurea perturbation in SW1417 cell line |
| Benztropine (mesylate)_NCI-H661 | Benztropine (mesylate) perturbation in NCI-H661 cell line |
| Fedratinib (hydrochloride hydrate)_NCI-H596 | Fedratinib (hydrochloride hydrate) perturbation in NCI-H596 cell line |
| Penfluridol_SW 900 | Penfluridol perturbation in SW 900 cell line |
| Mifepristone_HT-29 | Mifepristone perturbation in HT-29 cell line |
| Almonertinib (hydrochloride)_NCI-H2122 | Almonertinib (hydrochloride) perturbation in NCI-H2122 cell line |
| Pitavastatin (Calcium)_hTERT-HPNE | Pitavastatin (Calcium) perturbation in hTERT-HPNE cell line |
| Cytarabine_CHP-212 | Cytarabine perturbation in CHP-212 cell line |
| Adenine_NCI-H661 | Adenine perturbation in NCI-H661 cell line |
| Econazole_NCI-H2347 | Econazole perturbation in NCI-H2347 cell line |
| Mozavaptan_C32 | Mozavaptan perturbation in C32 cell line |
| Penfluridol_NCI-H2122 | Penfluridol perturbation in NCI-H2122 cell line |
| Rimonabant (Hydrochloride)_CHP-212 | Rimonabant (Hydrochloride) perturbation in CHP-212 cell line |
| Carbidopa (monohydrate)_NCI-H661 | Carbidopa (monohydrate) perturbation in NCI-H661 cell line |
| ERK5-IN-2_C32 | ERK5-IN-2 perturbation in C32 cell line |
| Tadalafil_SW1417 | Tadalafil perturbation in SW1417 cell line |
| Aspirin_NCI-H2122 | Aspirin perturbation in NCI-H2122 cell line |
| Clofarabine_COLO 205 | Clofarabine perturbation in COLO 205 cell line |
| Methylprednisolone succinate_hTERT-HPNE | Methylprednisolone succinate perturbation in hTERT-HPNE cell line |
| Raltitrexed_NCI-H661 | Raltitrexed perturbation in NCI-H661 cell line |
| Pioglitazone_C-33 A | Pioglitazone perturbation in C-33 A cell line |
| (S)-Crizotinib_C32 | (S)-Crizotinib perturbation in C32 cell line |
| Pyridoxine_AN3 CA | Pyridoxine perturbation in AN3 CA cell line |
| Brimonidine_NCI-H661 | Brimonidine perturbation in NCI-H661 cell line |
| Tranilast_SK-MEL-2 | Tranilast perturbation in SK-MEL-2 cell line |
| Belumosudil_NCI-H2122 | Belumosudil perturbation in NCI-H2122 cell line |
| Finasteride_C32 | Finasteride perturbation in C32 cell line |
| Mozavaptan_AN3 CA | Mozavaptan perturbation in AN3 CA cell line |
| Menadione_SW1417 | Menadione perturbation in SW1417 cell line |
| Panobinostat_CFPAC-1 | Panobinostat perturbation in CFPAC-1 cell line |
| Entrectinib_NCI-H661 | Entrectinib perturbation in NCI-H661 cell line |
| Rutin (trihydrate)_NCI-H661 | Rutin (trihydrate) perturbation in NCI-H661 cell line |
| Plicamycin_AN3 CA | Plicamycin perturbation in AN3 CA cell line |
| Penfluridol_AN3 CA | Penfluridol perturbation in AN3 CA cell line |
| Menadione_SW 1271 | Menadione perturbation in SW 1271 cell line |
| Atazanavir (sulfate)_SW1417 | Atazanavir (sulfate) perturbation in SW1417 cell line |
| Doxorubicin (hydrochloride)_NCI-H661 | Doxorubicin (hydrochloride) perturbation in NCI-H661 cell line |
| Belumosudil_NCI-H1573 | Belumosudil perturbation in NCI-H1573 cell line |
| Plicamycin_C32 | Plicamycin perturbation in C32 cell line |
| Hesperidin_HS-578T | Hesperidin perturbation in HS-578T cell line |
| Rosiglitazone_NCI-H2030 | Rosiglitazone perturbation in NCI-H2030 cell line |
| ERK5-IN-2_NCI-H2122 | ERK5-IN-2 perturbation in NCI-H2122 cell line |
| Panobinostat_MIA PaCa-2 | Panobinostat perturbation in MIA PaCa-2 cell line |
| DT-061_AN3 CA | DT-061 perturbation in AN3 CA cell line |
| Bestatin (hydrochloride)_NCI-H661 | Bestatin (hydrochloride) perturbation in NCI-H661 cell line |
| Bexarotene_NCI-H596 | Bexarotene perturbation in NCI-H596 cell line |
| Darolutamide_NCI-H1573 | Darolutamide perturbation in NCI-H1573 cell line |
| Ouabain (Octahydrate)_NCI-H2347 | Ouabain (Octahydrate) perturbation in NCI-H2347 cell line |
| Indacaterol (maleate)_HS-578T | Indacaterol (maleate) perturbation in HS-578T cell line |
| Dapagliflozin ((2S)-1,2-propanediol, hydrate)_NCI-H661 | Dapagliflozin ((2S)-1,2-propanediol, hydrate) perturbation in NCI-H661 cell line |
| Clobetasol propionate_AN3 CA | Clobetasol propionate perturbation in AN3 CA cell line |
| Verapamil_C32 | Verapamil perturbation in C32 cell line |
| Entrectinib_RPMI-7951 | Entrectinib perturbation in RPMI-7951 cell line |
| SBI-0640756_A498 | SBI-0640756 perturbation in A498 cell line |
| MK-3903_HepG2/C3A | MK-3903 perturbation in HepG2/C3A cell line |
| Cabozantinib (S-malate)_C32 | Cabozantinib (S-malate) perturbation in C32 cell line |
| Pimitespib_NCI-H2122 | Pimitespib perturbation in NCI-H2122 cell line |
| Doxycycline (monohydrate)_SW 900 | Doxycycline (monohydrate) perturbation in SW 900 cell line |
| Saquinavir_HepG2/C3A | Saquinavir perturbation in HepG2/C3A cell line |
| Arbutin_SW 1088 | Arbutin perturbation in SW 1088 cell line |
| Omeprazole_AN3 CA | Omeprazole perturbation in AN3 CA cell line |
| Pemetrexed_SW1417 | Pemetrexed perturbation in SW1417 cell line |
| Cytarabine (hydrochloride)_AN3 CA | Cytarabine (hydrochloride) perturbation in AN3 CA cell line |
| Fluvoxamine_AN3 CA | Fluvoxamine perturbation in AN3 CA cell line |
| Doxycycline (monohydrate)_A498 | Doxycycline (monohydrate) perturbation in A498 cell line |
| Orlistat_NCI-H661 | Orlistat perturbation in NCI-H661 cell line |
| Econazole_CHP-212 | Econazole perturbation in CHP-212 cell line |
| Procainamide (hydrochloride)_RPMI-7951 | Procainamide (hydrochloride) perturbation in RPMI-7951 cell line |
| Altretamine_CHP-212 | Altretamine perturbation in CHP-212 cell line |
| Nimesulide_AN3 CA | Nimesulide perturbation in AN3 CA cell line |
| Rosiglitazone_NCI-H596 | Rosiglitazone perturbation in NCI-H596 cell line |
| Phenylephrine (hydrochloride)_AN3 CA | Phenylephrine (hydrochloride) perturbation in AN3 CA cell line |
| Methylprednisolone succinate_NCI-H661 | Methylprednisolone succinate perturbation in NCI-H661 cell line |
| Ferulic acid_SW 1088 | Ferulic acid perturbation in SW 1088 cell line |
| Sildenafil_NCI-H661 | Sildenafil perturbation in NCI-H661 cell line |
| Neratinib_NCI-H661 | Neratinib perturbation in NCI-H661 cell line |
| Osimertinib (mesylate)_HS-578T | Osimertinib (mesylate) perturbation in HS-578T cell line |
| Binimetinib_KATO III | Binimetinib perturbation in KATO III cell line |
| Bisoprolol (hemifumarate)_hTERT-HPNE | Bisoprolol (hemifumarate) perturbation in hTERT-HPNE cell line |
| Phenylephrine (hydrochloride)_SHP-77 | Phenylephrine (hydrochloride) perturbation in SHP-77 cell line |
| Lopinavir_NCI-H2122 | Lopinavir perturbation in NCI-H2122 cell line |
| Indacaterol (maleate)_NCI-H661 | Indacaterol (maleate) perturbation in NCI-H661 cell line |
| Gallic acid (hydrate)_BT-474 | Gallic acid (hydrate) perturbation in BT-474 cell line |
| Cinacalcet_SHP-77 | Cinacalcet perturbation in SHP-77 cell line |
| Sapanisertib_NCI-H661 | Sapanisertib perturbation in NCI-H661 cell line |
| Methyl aminolevulinate (hydrochloride)_CHP-212 | Methyl aminolevulinate (hydrochloride) perturbation in CHP-212 cell line |
| Bosentan (hydrate)_NCI-H2347 | Bosentan (hydrate) perturbation in NCI-H2347 cell line |
| Fingolimod (hydrochloride)_CHP-212 | Fingolimod (hydrochloride) perturbation in CHP-212 cell line |
| Auranofin_J82 | Auranofin perturbation in J82 cell line |
| Tazarotene_Hs 766T | Tazarotene perturbation in Hs 766T cell line |
| Selinexor _HCT15 | Selinexor perturbation in HCT15 cell line |
| Vortioxetine_CHP-212 | Vortioxetine perturbation in CHP-212 cell line |
| Verapamil_SHP-77 | Verapamil perturbation in SHP-77 cell line |
| Tolcapone_BT-474 | Tolcapone perturbation in BT-474 cell line |
| Adagrasib_HepG2/C3A | Adagrasib perturbation in HepG2/C3A cell line |
| Crizotinib (hydrochloride)_NCI-H661 | Crizotinib (hydrochloride) perturbation in NCI-H661 cell line |
| Fluvoxamine_SW 900 | Fluvoxamine perturbation in SW 900 cell line |
| Fulvestrant_C32 | Fulvestrant perturbation in C32 cell line |
| Monocrotaline_HT-29 | Monocrotaline perturbation in HT-29 cell line |
| ETC-206_C32 | ETC-206 perturbation in C32 cell line |
| Belumosudil (mesylate)_C32 | Belumosudil (mesylate) perturbation in C32 cell line |
| Methyl aminolevulinate (hydrochloride)_SNU-423 | Methyl aminolevulinate (hydrochloride) perturbation in SNU-423 cell line |
| Citalopram (hydrobromide)_NCI-H661 | Citalopram (hydrobromide) perturbation in NCI-H661 cell line |
| 5-Fluorouracil_NCI-H2122 | 5-Fluorouracil perturbation in NCI-H2122 cell line |
| Hesperidin_BT-474 | Hesperidin perturbation in BT-474 cell line |
| Doxycycline (monohydrate)_CHP-212 | Doxycycline (monohydrate) perturbation in CHP-212 cell line |
| Silodosin_BT-474 | Silodosin perturbation in BT-474 cell line |
| Bexarotene_NCI-H661 | Bexarotene perturbation in NCI-H661 cell line |
| Benztropine (mesylate)_SW1417 | Benztropine (mesylate) perturbation in SW1417 cell line |
| Penfluridol_NCI-H460 | Penfluridol perturbation in NCI-H460 cell line |
| Cytarabine (hydrochloride)_KATO III | Cytarabine (hydrochloride) perturbation in KATO III cell line |
| Bicalutamide_KATO III | Bicalutamide perturbation in KATO III cell line |
| Econazole_SHP-77 | Econazole perturbation in SHP-77 cell line |
| Thymopentin_SHP-77 | Thymopentin perturbation in SHP-77 cell line |
| Vitamin K4_AN3 CA | Vitamin K4 perturbation in AN3 CA cell line |
| Belumosudil_NCI-H460 | Belumosudil perturbation in NCI-H460 cell line |
| Asciminib_NCI-H2030 | Asciminib perturbation in NCI-H2030 cell line |
| Idoxuridine_NCI-H1573 | Idoxuridine perturbation in NCI-H1573 cell line |
| Doxorubicin (hydrochloride)_SW 1088 | Doxorubicin (hydrochloride) perturbation in SW 1088 cell line |
| Belumosudil_NCI-H2347 | Belumosudil perturbation in NCI-H2347 cell line |
| (S)-Crizotinib_NCI-H460 | (S)-Crizotinib perturbation in NCI-H460 cell line |
| Radotinib_NCI-H2122 | Radotinib perturbation in NCI-H2122 cell line |
| Voriconazole_RPMI-7951 | Voriconazole perturbation in RPMI-7951 cell line |
| Sinomenine_SW 1271 | Sinomenine perturbation in SW 1271 cell line |
| Econazole_C-33 A | Econazole perturbation in C-33 A cell line |
| Idoxuridine_C32 | Idoxuridine perturbation in C32 cell line |
| Methyl aminolevulinate (hydrochloride)_NCI-H2122 | Methyl aminolevulinate (hydrochloride) perturbation in NCI-H2122 cell line |
| Pravastatin (sodium)_C32 | Pravastatin (sodium) perturbation in C32 cell line |
| Vortioxetine_C32 | Vortioxetine perturbation in C32 cell line |
| Niclosamide (olamine)_SW 1088 | Niclosamide (olamine) perturbation in SW 1088 cell line |
| Penfluridol_NCI-H2347 | Penfluridol perturbation in NCI-H2347 cell line |
| Osimertinib (mesylate)_HT-29 | Osimertinib (mesylate) perturbation in HT-29 cell line |
| Capivasertib_CHP-212 | Capivasertib perturbation in CHP-212 cell line |
| Berbamine (dihydrochloride)_NCI-H661 | Berbamine (dihydrochloride) perturbation in NCI-H661 cell line |
| Abemaciclib_NCI-H2122 | Abemaciclib perturbation in NCI-H2122 cell line |
| Darolutamide_CHP-212 | Darolutamide perturbation in CHP-212 cell line |
| Bergenin_NCI-H2122 | Bergenin perturbation in NCI-H2122 cell line |
| Thymopentin_NCI-H2122 | Thymopentin perturbation in NCI-H2122 cell line |
| Fenofibrate_C32 | Fenofibrate perturbation in C32 cell line |
| Verapamil_CHP-212 | Verapamil perturbation in CHP-212 cell line |
| Naproxen_C32 | Naproxen perturbation in C32 cell line |
| Methylthiouracil_NCI-H661 | Methylthiouracil perturbation in NCI-H661 cell line |
| Phenylephrine (hydrochloride)_HOP62 | Phenylephrine (hydrochloride) perturbation in HOP62 cell line |
| Atazanavir (sulfate)_NCI-H661 | Atazanavir (sulfate) perturbation in NCI-H661 cell line |
| (S)-Crizotinib_NCI-H23 | (S)-Crizotinib perturbation in NCI-H23 cell line |
| Loperamide (hydrochloride)_HS-578T | Loperamide (hydrochloride) perturbation in HS-578T cell line |
| Glasdegib_NCI-H661 | Glasdegib perturbation in NCI-H661 cell line |
| Asciminib_BT-474 | Asciminib perturbation in BT-474 cell line |
| Lumateperone (tosylate)_HS-578T | Lumateperone (tosylate) perturbation in HS-578T cell line |
| Econazole_NCI-H1573 | Econazole perturbation in NCI-H1573 cell line |
| Auranofin_C32 | Auranofin perturbation in C32 cell line |
| Vandetanib_C-33 A | Vandetanib perturbation in C-33 A cell line |
| Fluvoxamine_CHP-212 | Fluvoxamine perturbation in CHP-212 cell line |
| Bosentan (hydrate)_Panc 03.27 | Bosentan (hydrate) perturbation in Panc 03.27 cell line |
| Dexamethasone_CHP-212 | Dexamethasone perturbation in CHP-212 cell line |
| Auranofin_NCI-H1573 | Auranofin perturbation in NCI-H1573 cell line |
| Phenylephrine (hydrochloride)_CHP-212 | Phenylephrine (hydrochloride) perturbation in CHP-212 cell line |
| Benztropine (mesylate)_NCI-H2030 | Benztropine (mesylate) perturbation in NCI-H2030 cell line |
| Dexamethasone_CFPAC-1 | Dexamethasone perturbation in CFPAC-1 cell line |
| Benproperine (phosphate)_NCI-H2030 | Benproperine (phosphate) perturbation in NCI-H2030 cell line |
| Proglumide_AN3 CA | Proglumide perturbation in AN3 CA cell line |
| Acetazolamide_HT-29 | Acetazolamide perturbation in HT-29 cell line |
| Ribociclib_SNU-423 | Ribociclib perturbation in SNU-423 cell line |
| Idoxuridine_HepG2/C3A | Idoxuridine perturbation in HepG2/C3A cell line |
| Rapamycin_HepG2/C3A | Rapamycin perturbation in HepG2/C3A cell line |
| Proglumide_HepG2/C3A | Proglumide perturbation in HepG2/C3A cell line |
| Tirabrutinib (hydrochloride)_HepG2/C3A | Tirabrutinib (hydrochloride) perturbation in HepG2/C3A cell line |
| Sunitinib_NCI-H460 | Sunitinib perturbation in NCI-H460 cell line |
| Lopinavir_HepG2/C3A | Lopinavir perturbation in HepG2/C3A cell line |
| Triclosan_SK-MEL-2 | Triclosan perturbation in SK-MEL-2 cell line |
| Macitentan_HepG2/C3A | Macitentan perturbation in HepG2/C3A cell line |
| Panobinostat_SW480 | Panobinostat perturbation in SW480 cell line |
| L-Eflornithine (monohydrochloride)_PANC-1 | L-Eflornithine (monohydrochloride) perturbation in PANC-1 cell line |
| Dinaciclib_CFPAC-1 | Dinaciclib perturbation in CFPAC-1 cell line |
| Meloxicam_RKO | Meloxicam perturbation in RKO cell line |
| Berbamine (dihydrochloride)_CFPAC-1 | Berbamine (dihydrochloride) perturbation in CFPAC-1 cell line |
| Harringtonine_AN3 CA | Harringtonine perturbation in AN3 CA cell line |
| Dinaciclib_SNU-423 | Dinaciclib perturbation in SNU-423 cell line |
| Sunitinib_SW 1088 | Sunitinib perturbation in SW 1088 cell line |
| SBI-0640756_NCI-H2347 | SBI-0640756 perturbation in NCI-H2347 cell line |
| Afatinib_H4 | Afatinib perturbation in H4 cell line |
| Terfenadine_PANC-1 | Terfenadine perturbation in PANC-1 cell line |
| Acetazolamide_HepG2/C3A | Acetazolamide perturbation in HepG2/C3A cell line |
| olaparib_SNU-423 | olaparib perturbation in SNU-423 cell line |
| Talc_NCI-H460 | Talc perturbation in NCI-H460 cell line |
| LY-2584702 (tosylate salt)_KATO III | LY-2584702 (tosylate salt) perturbation in KATO III cell line |
| Osimertinib (mesylate)_A549 | Osimertinib (mesylate) perturbation in A549 cell line |
| Peretinoin_AN3 CA | Peretinoin perturbation in AN3 CA cell line |
| Asciminib_PANC-1 | Asciminib perturbation in PANC-1 cell line |
| Loperamide (hydrochloride)_HepG2/C3A | Loperamide (hydrochloride) perturbation in HepG2/C3A cell line |
| Vismodegib_SK-MEL-2 | Vismodegib perturbation in SK-MEL-2 cell line |
| Roxadustat_HepG2/C3A | Roxadustat perturbation in HepG2/C3A cell line |
| Thymopentin_SNU-423 | Thymopentin perturbation in SNU-423 cell line |
| Niclosamide (olamine)_HepG2/C3A | Niclosamide (olamine) perturbation in HepG2/C3A cell line |
| Daidzin_HepG2/C3A | Daidzin perturbation in HepG2/C3A cell line |
| Quinidine (15% dihydroquinidine)_HepG2/C3A | Quinidine (15% dihydroquinidine) perturbation in HepG2/C3A cell line |
| Aliskiren_COLO 205 | Aliskiren perturbation in COLO 205 cell line |
| Pravastatin (sodium)_HepG2/C3A | Pravastatin (sodium) perturbation in HepG2/C3A cell line |
| Abemaciclib_COLO 205 | Abemaciclib perturbation in COLO 205 cell line |
| BI-78D3_KATO III | BI-78D3 perturbation in KATO III cell line |
| Diammonium Glycyrrhizinate_HepG2/C3A | Diammonium Glycyrrhizinate perturbation in HepG2/C3A cell line |
| Oxaliplatin_HepG2/C3A | Oxaliplatin perturbation in HepG2/C3A cell line |
| Belumosudil (mesylate)_COLO 205 | Belumosudil (mesylate) perturbation in COLO 205 cell line |
| (S)-Crizotinib_SW1417 | (S)-Crizotinib perturbation in SW1417 cell line |
| Fumaric acid_HepG2/C3A | Fumaric acid perturbation in HepG2/C3A cell line |
| DT-061_COLO 205 | DT-061 perturbation in COLO 205 cell line |
| Bimatoprost_COLO 205 | Bimatoprost perturbation in COLO 205 cell line |
| Lapatinib ditosylate_HepG2/C3A | Lapatinib ditosylate perturbation in HepG2/C3A cell line |
| Larotrectinib_LS 180 | Larotrectinib perturbation in LS 180 cell line |
| Azithromycin (hydrate)_HepG2/C3A | Azithromycin (hydrate) perturbation in HepG2/C3A cell line |
| BI-3406_CFPAC-1 | BI-3406 perturbation in CFPAC-1 cell line |
| (R)-Verapamil (hydrochloride)_COLO 205 | (R)-Verapamil (hydrochloride) perturbation in COLO 205 cell line |
| Ixazomib_HepG2/C3A | Ixazomib perturbation in HepG2/C3A cell line |
| Goserelin (acetate)_HepG2/C3A | Goserelin (acetate) perturbation in HepG2/C3A cell line |
| Larotrectinib_COLO 205 | Larotrectinib perturbation in COLO 205 cell line |
| Rosiglitazone_HepG2/C3A | Rosiglitazone perturbation in HepG2/C3A cell line |
| Monocrotaline_HepG2/C3A | Monocrotaline perturbation in HepG2/C3A cell line |
| Clonidine (hydrochloride)_KATO III | Clonidine (hydrochloride) perturbation in KATO III cell line |
| Diammonium Glycyrrhizinate_KATO III | Diammonium Glycyrrhizinate perturbation in KATO III cell line |
| Balsalazide (sodium hydrate)_HepG2/C3A | Balsalazide (sodium hydrate) perturbation in HepG2/C3A cell line |
| AZD-8055_HepG2/C3A | AZD-8055 perturbation in HepG2/C3A cell line |
| Diphenhydramine_HepG2/C3A | Diphenhydramine perturbation in HepG2/C3A cell line |
| Benproperine (phosphate)_HepG2/C3A | Benproperine (phosphate) perturbation in HepG2/C3A cell line |
| Perindopril (erbumine)_BT-474 | Perindopril (erbumine) perturbation in BT-474 cell line |
| Bestatin_BT-474 | Bestatin perturbation in BT-474 cell line |
| Fedratinib (hydrochloride hydrate)_KATO III | Fedratinib (hydrochloride hydrate) perturbation in KATO III cell line |
| Ivabradine (hydrochloride)_KATO III | Ivabradine (hydrochloride) perturbation in KATO III cell line |
| Cepharanthine_Hs 766T | Cepharanthine perturbation in Hs 766T cell line |
| Nafamostat (mesylate)_BT-474 | Nafamostat (mesylate) perturbation in BT-474 cell line |
| Entrectinib_NCI-H1792 | Entrectinib perturbation in NCI-H1792 cell line |
| Drospirenone_KATO III | Drospirenone perturbation in KATO III cell line |
| Almonertinib (mesylate)_BT-474 | Almonertinib (mesylate) perturbation in BT-474 cell line |
| Daidzin_KATO III | Daidzin perturbation in KATO III cell line |
| Phenylephrine (hydrochloride)_BT-474 | Phenylephrine (hydrochloride) perturbation in BT-474 cell line |
| Darolutamide_BT-474 | Darolutamide perturbation in BT-474 cell line |
| Allopurinol_BT-474 | Allopurinol perturbation in BT-474 cell line |
| Aspirin_BT-474 | Aspirin perturbation in BT-474 cell line |
| Cabozantinib (S-malate)_Hs 766T | Cabozantinib (S-malate) perturbation in Hs 766T cell line |
| Osimertinib (mesylate)_LoVo | Osimertinib (mesylate) perturbation in LoVo cell line |
| Acetazolamide_KATO III | Acetazolamide perturbation in KATO III cell line |
| Plicamycin_AsPC-1 | Plicamycin perturbation in AsPC-1 cell line |
| Sulfatinib_BT-474 | Sulfatinib perturbation in BT-474 cell line |
| Pentagastrin_BT-474 | Pentagastrin perturbation in BT-474 cell line |
| Imiquimod (hydrochloride)_BT-474 | Imiquimod (hydrochloride) perturbation in BT-474 cell line |
| Mebendazole_BT-474 | Mebendazole perturbation in BT-474 cell line |
| Simotinib_BT-474 | Simotinib perturbation in BT-474 cell line |
| Oxaprozin_KATO III | Oxaprozin perturbation in KATO III cell line |
| Topotecan (hydrochloride)_KATO III | Topotecan (hydrochloride) perturbation in KATO III cell line |
| Cytarabine_BT-474 | Cytarabine perturbation in BT-474 cell line |
| Aspirin_LS 180 | Aspirin perturbation in LS 180 cell line |
| crizotinib_BT-474 | crizotinib perturbation in BT-474 cell line |
| Pitavastatin (Calcium)_A-427 | Pitavastatin (Calcium) perturbation in A-427 cell line |
| Ornidazole_KATO III | Ornidazole perturbation in KATO III cell line |
| Posaconazole_AsPC-1 | Posaconazole perturbation in AsPC-1 cell line |
| Posaconazole_NCI-H2030 | Posaconazole perturbation in NCI-H2030 cell line |
| Methylprednisolone succinate_BT-474 | Methylprednisolone succinate perturbation in BT-474 cell line |
| Valdecoxib_BT-474 | Valdecoxib perturbation in BT-474 cell line |
| Aspirin_LoVo | Aspirin perturbation in LoVo cell line |
| Delamanid_BT-474 | Delamanid perturbation in BT-474 cell line |
| Entrectinib_Hs 766T | Entrectinib perturbation in Hs 766T cell line |
| Pioglitazone_KATO III | Pioglitazone perturbation in KATO III cell line |
| Osimertinib (mesylate)_BT-474 | Osimertinib (mesylate) perturbation in BT-474 cell line |
| Sunitinib_SW 1271 | Sunitinib perturbation in SW 1271 cell line |
| Osimertinib (mesylate)_LS 180 | Osimertinib (mesylate) perturbation in LS 180 cell line |
| Ornidazole_BT-474 | Ornidazole perturbation in BT-474 cell line |
| Berbamine_KATO III | Berbamine perturbation in KATO III cell line |
| Loperamide (hydrochloride)_BT-474 | Loperamide (hydrochloride) perturbation in BT-474 cell line |
| Glycyrrhizic acid_BT-474 | Glycyrrhizic acid perturbation in BT-474 cell line |
| Sunitinib_LS 180 | Sunitinib perturbation in LS 180 cell line |
| Berbamine_LoVo | Berbamine perturbation in LoVo cell line |
| Posaconazole_KATO III | Posaconazole perturbation in KATO III cell line |
| Glasdegib_BT-474 | Glasdegib perturbation in BT-474 cell line |
| Atazanavir (sulfate)_BT-474 | Atazanavir (sulfate) perturbation in BT-474 cell line |
| Fostamatinib (disodium hexahydrate)_BT-474 | Fostamatinib (disodium hexahydrate) perturbation in BT-474 cell line |
| Entrectinib_HCT15 | Entrectinib perturbation in HCT15 cell line |
| Pitavastatin (Calcium)_HS-578T | Pitavastatin (Calcium) perturbation in HS-578T cell line |
| Fedratinib (hydrochloride hydrate)_BT-474 | Fedratinib (hydrochloride hydrate) perturbation in BT-474 cell line |
| Pravastatin (sodium)_KATO III | Pravastatin (sodium) perturbation in KATO III cell line |
| Vortioxetine_KATO III | Vortioxetine perturbation in KATO III cell line |
| Vandetanib_KATO III | Vandetanib perturbation in KATO III cell line |
| Verteporfin_BT-474 | Verteporfin perturbation in BT-474 cell line |
| Ivabradine (hydrochloride)_BT-474 | Ivabradine (hydrochloride) perturbation in BT-474 cell line |
| Infigratinib_BT-474 | Infigratinib perturbation in BT-474 cell line |
| Tetracycline (hydrochloride)_BT-474 | Tetracycline (hydrochloride) perturbation in BT-474 cell line |
| Auranofin_KATO III | Auranofin perturbation in KATO III cell line |
| Allopurinol_KATO III | Allopurinol perturbation in KATO III cell line |
| 5-Azacytidine_KATO III | 5-Azacytidine perturbation in KATO III cell line |
| Vismodegib_LS 180 | Vismodegib perturbation in LS 180 cell line |
| PF-06260933_BT-474 | PF-06260933 perturbation in BT-474 cell line |
| Entrectinib_SW 1271 | Entrectinib perturbation in SW 1271 cell line |
| Nevirapine_BT-474 | Nevirapine perturbation in BT-474 cell line |
| Pexidartinib (hydrochloride)_SK-MEL-2 | Pexidartinib (hydrochloride) perturbation in SK-MEL-2 cell line |
| PF-06260933_A-427 | PF-06260933 perturbation in A-427 cell line |
| Fedratinib (hydrochloride hydrate)_MIA PaCa-2 | Fedratinib (hydrochloride hydrate) perturbation in MIA PaCa-2 cell line |
| Esmolol (hydrochloride)_J82 | Esmolol (hydrochloride) perturbation in J82 cell line |
| Cysteamine (hydrochloride)_AN3 CA | Cysteamine (hydrochloride) perturbation in AN3 CA cell line |
| Pentagastrin_HS-578T | Pentagastrin perturbation in HS-578T cell line |
| Lonafarnib_NCI-H2347 | Lonafarnib perturbation in NCI-H2347 cell line |
| Cysteamine (hydrochloride)_NCI-H1573 | Cysteamine (hydrochloride) perturbation in NCI-H1573 cell line |
| Raltitrexed_C32 | Raltitrexed perturbation in C32 cell line |
| Fedratinib (hydrochloride hydrate)_SNU-423 | Fedratinib (hydrochloride hydrate) perturbation in SNU-423 cell line |
| Elagolix sodium_HOP62 | Elagolix sodium perturbation in HOP62 cell line |
| Binimetinib_SW1417 | Binimetinib perturbation in SW1417 cell line |
| Delamanid_SNU-1 | Delamanid perturbation in SNU-1 cell line |
| Fedratinib (hydrochloride hydrate)_LoVo | Fedratinib (hydrochloride hydrate) perturbation in LoVo cell line |
| IQ 1_HEC-1-A | IQ 1 perturbation in HEC-1-A cell line |
| CP21R7_NCI-H2030 | CP21R7 perturbation in NCI-H2030 cell line |
| Adagrasib_HOP62 | Adagrasib perturbation in HOP62 cell line |
| Bergenin_SW1417 | Bergenin perturbation in SW1417 cell line |
| Fumaric acid_NCI-H661 | Fumaric acid perturbation in NCI-H661 cell line |
| AZD-8055_C-33 A | AZD-8055 perturbation in C-33 A cell line |
| PF-06260933_NCI-H2122 | PF-06260933 perturbation in NCI-H2122 cell line |
| BAY1125976_A-427 | BAY1125976 perturbation in A-427 cell line |
| Hexylresorcinol_CHP-212 | Hexylresorcinol perturbation in CHP-212 cell line |
| Pimozide_SHP-77 | Pimozide perturbation in SHP-77 cell line |
| Ribociclib_CFPAC-1 | Ribociclib perturbation in CFPAC-1 cell line |
| Medroxyprogesterone acetate_PANC-1 | Medroxyprogesterone acetate perturbation in PANC-1 cell line |
| Flutamide_NCI-H596 | Flutamide perturbation in NCI-H596 cell line |
| Fedratinib (hydrochloride hydrate)_HOP62 | Fedratinib (hydrochloride hydrate) perturbation in HOP62 cell line |
| Megestrol_NCI-H596 | Megestrol perturbation in NCI-H596 cell line |
| Tubulin inhibitor 6_NCI-H23 | Tubulin inhibitor 6 perturbation in NCI-H23 cell line |
| Mebendazole_HS-578T | Mebendazole perturbation in HS-578T cell line |
| Erdafitinib _AN3 CA | Erdafitinib perturbation in AN3 CA cell line |
| XRK3F2_HEC-1-A | XRK3F2 perturbation in HEC-1-A cell line |
| Clofarabine_NCI-H460 | Clofarabine perturbation in NCI-H460 cell line |
| Erdafitinib _NCI-H1573 | Erdafitinib perturbation in NCI-H1573 cell line |
| Daidzin_SW48 | Daidzin perturbation in SW48 cell line |
| ETC-206_A549 | ETC-206 perturbation in A549 cell line |
| Raltitrexed_AN3 CA | Raltitrexed perturbation in AN3 CA cell line |
| Infigratinib_CHP-212 | Infigratinib perturbation in CHP-212 cell line |
| Temuterkib_HepG2/C3A | Temuterkib perturbation in HepG2/C3A cell line |
| Belzutifan_C-33 A | Belzutifan perturbation in C-33 A cell line |
| Brivudine_CHP-212 | Brivudine perturbation in CHP-212 cell line |
| Bimiralisib_A549 | Bimiralisib perturbation in A549 cell line |
| Benztropine (mesylate)_SHP-77 | Benztropine (mesylate) perturbation in SHP-77 cell line |
| Oxaliplatin_SW480 | Oxaliplatin perturbation in SW480 cell line |
| LJI308_NCI-H596 | LJI308 perturbation in NCI-H596 cell line |
| Peretinoin_HCT15 | Peretinoin perturbation in HCT15 cell line |
| Lonafarnib_LOX-IMVI | Lonafarnib perturbation in LOX-IMVI cell line |
| Talc_SW 1271 | Talc perturbation in SW 1271 cell line |
| NVP-BHG712_AN3 CA | NVP-BHG712 perturbation in AN3 CA cell line |
| Lidocaine (hydrochloride)_HOP62 | Lidocaine (hydrochloride) perturbation in HOP62 cell line |
| Cilostazol_C32 | Cilostazol perturbation in C32 cell line |
| AZD-8055_SHP-77 | AZD-8055 perturbation in SHP-77 cell line |
| Peretinoin_HEC-1-A | Peretinoin perturbation in HEC-1-A cell line |
| Belzutifan_SW48 | Belzutifan perturbation in SW48 cell line |
| AT7519_A549 | AT7519 perturbation in A549 cell line |
| Ropivacaine (hydrochloride monohydrate)_BT-474 | Ropivacaine (hydrochloride monohydrate) perturbation in BT-474 cell line |
| Sonidegib_SHP-77 | Sonidegib perturbation in SHP-77 cell line |
| Cepharanthine_SK-MEL-2 | Cepharanthine perturbation in SK-MEL-2 cell line |
| Fedratinib (hydrochloride hydrate)_CFPAC-1 | Fedratinib (hydrochloride hydrate) perturbation in CFPAC-1 cell line |
| Sulfisoxazole_SW48 | Sulfisoxazole perturbation in SW48 cell line |
| Fedratinib (hydrochloride hydrate)_CHP-212 | Fedratinib (hydrochloride hydrate) perturbation in CHP-212 cell line |
| SBI-0640756_LS 180 | SBI-0640756 perturbation in LS 180 cell line |
| Dexmedetomidine_NCI-H23 | Dexmedetomidine perturbation in NCI-H23 cell line |
| Eplerenone_A-427 | Eplerenone perturbation in A-427 cell line |
| Berbamine_HT-29 | Berbamine perturbation in HT-29 cell line |
| Esmolol (hydrochloride)_NCI-H1792 | Esmolol (hydrochloride) perturbation in NCI-H1792 cell line |
| Medroxyprogesterone acetate_HEC-1-A | Medroxyprogesterone acetate perturbation in HEC-1-A cell line |
| Hydroxyfasudil_NCI-H23 | Hydroxyfasudil perturbation in NCI-H23 cell line |
| Budesonide_LoVo | Budesonide perturbation in LoVo cell line |
| IQ 1_NCI-H661 | IQ 1 perturbation in NCI-H661 cell line |
| PF-06260933_AN3 CA | PF-06260933 perturbation in AN3 CA cell line |
| Cytarabine_NCI-H596 | Cytarabine perturbation in NCI-H596 cell line |
| IQ 1_H4 | IQ 1 perturbation in H4 cell line |
| XRK3F2_HCT15 | XRK3F2 perturbation in HCT15 cell line |
| Fumaric acid_HEC-1-A | Fumaric acid perturbation in HEC-1-A cell line |
| Cysteamine (hydrochloride)_A-427 | Cysteamine (hydrochloride) perturbation in A-427 cell line |
| Gallic acid_SNU-1 | Gallic acid perturbation in SNU-1 cell line |
| Bimiralisib_LS 180 | Bimiralisib perturbation in LS 180 cell line |
| Ciclopirox_NCI-H2347 | Ciclopirox perturbation in NCI-H2347 cell line |
| Brivudine_HOP62 | Brivudine perturbation in HOP62 cell line |
| Cilostazol_AN3 CA | Cilostazol perturbation in AN3 CA cell line |
| Lidocaine (hydrochloride)_CHP-212 | Lidocaine (hydrochloride) perturbation in CHP-212 cell line |
| Cilostazol_NCI-H1573 | Cilostazol perturbation in NCI-H1573 cell line |
| Erdafitinib _NCI-H2122 | Erdafitinib perturbation in NCI-H2122 cell line |
| Trametinib_AN3 CA | Trametinib perturbation in AN3 CA cell line |
| Raltitrexed_A-427 | Raltitrexed perturbation in A-427 cell line |
| Vortioxetine_NCI-H2030 | Vortioxetine perturbation in NCI-H2030 cell line |
| IQ 1_HCT15 | IQ 1 perturbation in HCT15 cell line |
| Bisoprolol (hemifumarate)_C-33 A | Bisoprolol (hemifumarate) perturbation in C-33 A cell line |
| AZD-8055_SW48 | AZD-8055 perturbation in SW48 cell line |
| Cepharanthine_NCI-H596 | Cepharanthine perturbation in NCI-H596 cell line |
| NG25_J82 | NG25 perturbation in J82 cell line |
| Neratinib (maleate)_LOX-IMVI | Neratinib (maleate) perturbation in LOX-IMVI cell line |
| Belzutifan_SHP-77 | Belzutifan perturbation in SHP-77 cell line |
| OTS514_AN3 CA | OTS514 perturbation in AN3 CA cell line |
| 4EGI-1_A-427 | 4EGI-1 perturbation in A-427 cell line |
| Esmolol (hydrochloride)_MIA PaCa-2 | Esmolol (hydrochloride) perturbation in MIA PaCa-2 cell line |
| 8-Hydroxyquinoline_NCI-H2122 | 8-Hydroxyquinoline perturbation in NCI-H2122 cell line |
| Ferulic acid_MIA PaCa-2 | Ferulic acid perturbation in MIA PaCa-2 cell line |
| Ranolazine_HEC-1-A | Ranolazine perturbation in HEC-1-A cell line |
| Raltitrexed_C-33 A | Raltitrexed perturbation in C-33 A cell line |
| Lonafarnib_NCI-H23 | Lonafarnib perturbation in NCI-H23 cell line |
| Riluzole hydrochloride_HOP62 | Riluzole hydrochloride perturbation in HOP62 cell line |
| Mebendazole_NCI-H661 | Mebendazole perturbation in NCI-H661 cell line |
| Ferulic acid_LoVo | Ferulic acid perturbation in LoVo cell line |
| Fostamatinib (disodium hexahydrate)_RKO | Fostamatinib (disodium hexahydrate) perturbation in RKO cell line |
| Esmolol (hydrochloride)_LoVo | Esmolol (hydrochloride) perturbation in LoVo cell line |
| Bisoprolol (hemifumarate)_A-427 | Bisoprolol (hemifumarate) perturbation in A-427 cell line |
| Flutamide_HT-29 | Flutamide perturbation in HT-29 cell line |
| AZD-8055_C32 | AZD-8055 perturbation in C32 cell line |
| Rapamycin_BT-474 | Rapamycin perturbation in BT-474 cell line |
| Cilostazol_SHP-77 | Cilostazol perturbation in SHP-77 cell line |
| Riluzole hydrochloride_MIA PaCa-2 | Riluzole hydrochloride perturbation in MIA PaCa-2 cell line |
| Entrectinib_SHP-77 | Entrectinib perturbation in SHP-77 cell line |
| Triamcinolone_HEC-1-A | Triamcinolone perturbation in HEC-1-A cell line |
| Canagliflozin (hemihydrate)_NCI-H596 | Canagliflozin (hemihydrate) perturbation in NCI-H596 cell line |
| Mifepristone_MIA PaCa-2 | Mifepristone perturbation in MIA PaCa-2 cell line |
| Docetaxel_HCT15 | Docetaxel perturbation in HCT15 cell line |
| Pentagastrin_H4 | Pentagastrin perturbation in H4 cell line |
| Adenine_A-427 | Adenine perturbation in A-427 cell line |
| Mebendazole_PANC-1 | Mebendazole perturbation in PANC-1 cell line |
| Pexidartinib (hydrochloride)_NCI-H2030 | Pexidartinib (hydrochloride) perturbation in NCI-H2030 cell line |
| MK-3903_CHP-212 | MK-3903 perturbation in CHP-212 cell line |
| Riluzole hydrochloride_LoVo | Riluzole hydrochloride perturbation in LoVo cell line |
| Glycyrrhizic acid_NCI-H460 | Glycyrrhizic acid perturbation in NCI-H460 cell line |
| Cabozantinib (S-malate)_SW480 | Cabozantinib (S-malate) perturbation in SW480 cell line |
| Docetaxel_PANC-1 | Docetaxel perturbation in PANC-1 cell line |
| Ponatinib_NCI-H2030 | Ponatinib perturbation in NCI-H2030 cell line |
| Mebendazole_HCT15 | Mebendazole perturbation in HCT15 cell line |
| AZD-8055_AN3 CA | AZD-8055 perturbation in AN3 CA cell line |
| Fostamatinib (disodium hexahydrate)_NCI-H2347 | Fostamatinib (disodium hexahydrate) perturbation in NCI-H2347 cell line |
| Ritonavir_NCI-H596 | Ritonavir perturbation in NCI-H596 cell line |
| Ixazomib citrate_RKO | Ixazomib citrate perturbation in RKO cell line |
| Rucaparib (phosphate)_NCI-H1573 | Rucaparib (phosphate) perturbation in NCI-H1573 cell line |
| Daptomycin_LOX-IMVI | Daptomycin perturbation in LOX-IMVI cell line |
| Talc_HepG2/C3A | Talc perturbation in HepG2/C3A cell line |
| Torkinib_NCI-H596 | Torkinib perturbation in NCI-H596 cell line |
| Vandetanib_BT-474 | Vandetanib perturbation in BT-474 cell line |
| Paclitaxel_C-33 A | Paclitaxel perturbation in C-33 A cell line |
| Cilostazol_SW48 | Cilostazol perturbation in SW48 cell line |
| PF-06260933_SHP-77 | PF-06260933 perturbation in SHP-77 cell line |
| vincristine_CHP-212 | vincristine perturbation in CHP-212 cell line |
| Naproxen_AsPC-1 | Naproxen perturbation in AsPC-1 cell line |
| AZD-7648_AN3 CA | AZD-7648 perturbation in AN3 CA cell line |
| Cilostazol_C-33 A | Cilostazol perturbation in C-33 A cell line |
| Rimonabant_NCI-H23 | Rimonabant perturbation in NCI-H23 cell line |
| Furosemide_HT-29 | Furosemide perturbation in HT-29 cell line |
| Belzutifan_A-427 | Belzutifan perturbation in A-427 cell line |
| Meloxicam_HOP62 | Meloxicam perturbation in HOP62 cell line |
| Vilanterol_CHP-212 | Vilanterol perturbation in CHP-212 cell line |
| 4EGI-1_SHP-77 | 4EGI-1 perturbation in SHP-77 cell line |
| Ferulic acid_CFPAC-1 | Ferulic acid perturbation in CFPAC-1 cell line |
| Cilostazol_SW 900 | Cilostazol perturbation in SW 900 cell line |
| Omeprazole (sodium)_HS-578T | Omeprazole (sodium) perturbation in HS-578T cell line |
| IQ 1_HS-578T | IQ 1 perturbation in HS-578T cell line |
| Belzutifan_NCI-H2122 | Belzutifan perturbation in NCI-H2122 cell line |
| Irinotecan (hydrochloride)_A-427 | Irinotecan (hydrochloride) perturbation in A-427 cell line |
| Belinostat_CHP-212 | Belinostat perturbation in CHP-212 cell line |
| Benztropine (mesylate)_NCI-H1573 | Benztropine (mesylate) perturbation in NCI-H1573 cell line |
| Sunitinib_Panc 03.27 | Sunitinib perturbation in Panc 03.27 cell line |
| Ribociclib_KATO III | Ribociclib perturbation in KATO III cell line |
| Benproperine (phosphate)_NCI-H1573 | Benproperine (phosphate) perturbation in NCI-H1573 cell line |
| TAK-901_Panc 03.27 | TAK-901 perturbation in Panc 03.27 cell line |
| BI-3406_PANC-1 | BI-3406 perturbation in PANC-1 cell line |
| Cysteamine (hydrochloride)_A498 | Cysteamine (hydrochloride) perturbation in A498 cell line |
| Riluzole hydrochloride_CHP-212 | Riluzole hydrochloride perturbation in CHP-212 cell line |
| Triamcinolone_PANC-1 | Triamcinolone perturbation in PANC-1 cell line |
| Cysteamine (hydrochloride)_SW48 | Cysteamine (hydrochloride) perturbation in SW48 cell line |
| Vemurafenib_BT-474 | Vemurafenib perturbation in BT-474 cell line |
| Drospirenone_NCI-H1573 | Drospirenone perturbation in NCI-H1573 cell line |
| c-Kit-IN-1_CHP-212 | c-Kit-IN-1 perturbation in CHP-212 cell line |
| Sodium Salicylate_HS-578T | Sodium Salicylate perturbation in HS-578T cell line |
| NVP-BHG712_SW48 | NVP-BHG712 perturbation in SW48 cell line |
| AT7519_hTERT-HPNE | AT7519 perturbation in hTERT-HPNE cell line |
| Cytarabine (hydrochloride)_LS 180 | Cytarabine (hydrochloride) perturbation in LS 180 cell line |
| Binimetinib_NCI-H2030 | Binimetinib perturbation in NCI-H2030 cell line |
| XRK3F2_HS-578T | XRK3F2 perturbation in HS-578T cell line |
| Ciclopirox_NCI-H23 | Ciclopirox perturbation in NCI-H23 cell line |
| Anethole trithione_CHP-212 | Anethole trithione perturbation in CHP-212 cell line |
| Clopidogrel_A549 | Clopidogrel perturbation in A549 cell line |
| Rucaparib (phosphate)_A-427 | Rucaparib (phosphate) perturbation in A-427 cell line |
| Dexmedetomidine_LOX-IMVI | Dexmedetomidine perturbation in LOX-IMVI cell line |
| Docetaxel_HEC-1-A | Docetaxel perturbation in HEC-1-A cell line |
| Cepharanthine_HT-29 | Cepharanthine perturbation in HT-29 cell line |
| vincristine_MIA PaCa-2 | vincristine perturbation in MIA PaCa-2 cell line |
| Dimethyl fumarate_NCI-H661 | Dimethyl fumarate perturbation in NCI-H661 cell line |
| Oxaliplatin_hTERT-HPNE | Oxaliplatin perturbation in hTERT-HPNE cell line |
| CP21R7_BT-474 | CP21R7 perturbation in BT-474 cell line |
| Drospirenone_C32 | Drospirenone perturbation in C32 cell line |
| Terfenadine_CHP-212 | Terfenadine perturbation in CHP-212 cell line |
| Glycyrrhizic acid_NCI-H2347 | Glycyrrhizic acid perturbation in NCI-H2347 cell line |
| LB-100_NCI-H596 | LB-100 perturbation in NCI-H596 cell line |
| AZD-8055_A-427 | AZD-8055 perturbation in A-427 cell line |
| Brivudine_KATO III | Brivudine perturbation in KATO III cell line |
| Pentoxifylline_RKO | Pentoxifylline perturbation in RKO cell line |
| Tomivosertib_SHP-77 | Tomivosertib perturbation in SHP-77 cell line |
| Flutamide_PANC-1 | Flutamide perturbation in PANC-1 cell line |
| Drospirenone_MIA PaCa-2 | Drospirenone perturbation in MIA PaCa-2 cell line |
| Verteporfin_SHP-77 | Verteporfin perturbation in SHP-77 cell line |
| AZD-7648_HOP62 | AZD-7648 perturbation in HOP62 cell line |
| Esmolol (hydrochloride)_A-427 | Esmolol (hydrochloride) perturbation in A-427 cell line |
| Fedratinib (hydrochloride hydrate)_SW48 | Fedratinib (hydrochloride hydrate) perturbation in SW48 cell line |
| Lopinavir_SW1417 | Lopinavir perturbation in SW1417 cell line |
| Mifepristone_NCI-H2122 | Mifepristone perturbation in NCI-H2122 cell line |
| Furosemide_HEC-1-A | Furosemide perturbation in HEC-1-A cell line |
| Drospirenone_SNU-423 | Drospirenone perturbation in SNU-423 cell line |
| Adenine_HOP62 | Adenine perturbation in HOP62 cell line |
| ETC-206_SW1417 | ETC-206 perturbation in SW1417 cell line |
| Drospirenone_LoVo | Drospirenone perturbation in LoVo cell line |
| LJI308_HCT15 | LJI308 perturbation in HCT15 cell line |
| AZD-7648_LoVo | AZD-7648 perturbation in LoVo cell line |
| Riluzole hydrochloride_A-427 | Riluzole hydrochloride perturbation in A-427 cell line |
| Bimiralisib_SW1417 | Bimiralisib perturbation in SW1417 cell line |
| Ropivacaine (hydrochloride monohydrate)_SW480 | Ropivacaine (hydrochloride monohydrate) perturbation in SW480 cell line |
| ETC-206_BT-474 | ETC-206 perturbation in BT-474 cell line |
| Mebendazole_Hs 766T | Mebendazole perturbation in Hs 766T cell line |
| Lidocaine (hydrochloride)_SHP-77 | Lidocaine (hydrochloride) perturbation in SHP-77 cell line |
| Drospirenone_HOP62 | Drospirenone perturbation in HOP62 cell line |
| Elagolix sodium_A498 | Elagolix sodium perturbation in A498 cell line |
| Mebendazole_HT-29 | Mebendazole perturbation in HT-29 cell line |
| Neratinib (maleate)_Panc 03.27 | Neratinib (maleate) perturbation in Panc 03.27 cell line |
| Rucaparib (phosphate)_CHP-212 | Rucaparib (phosphate) perturbation in CHP-212 cell line |
| Simotinib_HEC-1-A | Simotinib perturbation in HEC-1-A cell line |
| Ropivacaine (hydrochloride monohydrate)_LS 180 | Ropivacaine (hydrochloride monohydrate) perturbation in LS 180 cell line |
| Elagolix sodium_SHP-77 | Elagolix sodium perturbation in SHP-77 cell line |
| L-Thyroxine (sodium salt pentahydrate)_HEC-1-A | L-Thyroxine (sodium salt pentahydrate) perturbation in HEC-1-A cell line |
| Torkinib_HS-578T | Torkinib perturbation in HS-578T cell line |
| Ouabain (Octahydrate)_HCT15 | Ouabain (Octahydrate) perturbation in HCT15 cell line |
| Anethole trithione_A-427 | Anethole trithione perturbation in A-427 cell line |
| vincristine_AN3 CA | vincristine perturbation in AN3 CA cell line |
| Adagrasib_SHP-77 | Adagrasib perturbation in SHP-77 cell line |
| Sapanisertib_NCI-H23 | Sapanisertib perturbation in NCI-H23 cell line |
| Binimetinib_A549 | Binimetinib perturbation in A549 cell line |
| Pimozide_MIA PaCa-2 | Pimozide perturbation in MIA PaCa-2 cell line |
| Bergenin_A549 | Bergenin perturbation in A549 cell line |
| Tolmetin_CHP-212 | Tolmetin perturbation in CHP-212 cell line |
| Flutamide_HCT15 | Flutamide perturbation in HCT15 cell line |
| PH-797804_NCI-H2347 | PH-797804 perturbation in NCI-H2347 cell line |
| Gallic acid_NCI-H460 | Gallic acid perturbation in NCI-H460 cell line |
| Piroxicam_hTERT-HPNE | Piroxicam perturbation in hTERT-HPNE cell line |
| Pexidartinib (hydrochloride)_SW480 | Pexidartinib (hydrochloride) perturbation in SW480 cell line |
| Pyridoxine (hydrochloride)_J82 | Pyridoxine (hydrochloride) perturbation in J82 cell line |
| c-Kit-IN-1_NCI-H2122 | c-Kit-IN-1 perturbation in NCI-H2122 cell line |
| (S)-Crizotinib_NCI-H596 | (S)-Crizotinib perturbation in NCI-H596 cell line |
| Sonidegib_CHP-212 | Sonidegib perturbation in CHP-212 cell line |
| Fedratinib (hydrochloride hydrate)_SHP-77 | Fedratinib (hydrochloride hydrate) perturbation in SHP-77 cell line |
| Cabozantinib (S-malate)_AsPC-1 | Cabozantinib (S-malate) perturbation in AsPC-1 cell line |
| Minodronic acid_SW1417 | Minodronic acid perturbation in SW1417 cell line |
| Benztropine (mesylate)_CFPAC-1 | Benztropine (mesylate) perturbation in CFPAC-1 cell line |
| Anastrozole_NCI-H661 | Anastrozole perturbation in NCI-H661 cell line |
| BI-78D3_C-33 A | BI-78D3 perturbation in C-33 A cell line |
| Benztropine (mesylate)_CHP-212 | Benztropine (mesylate) perturbation in CHP-212 cell line |
| Irinotecan (hydrochloride)_HOP62 | Irinotecan (hydrochloride) perturbation in HOP62 cell line |
| BI-78D3_SW 900 | BI-78D3 perturbation in SW 900 cell line |
| Terfenadine_C32 | Terfenadine perturbation in C32 cell line |
| Mifepristone_AN3 CA | Mifepristone perturbation in AN3 CA cell line |
| Megestrol_HEC-1-A | Megestrol perturbation in HEC-1-A cell line |
| Darolutamide_AsPC-1 | Darolutamide perturbation in AsPC-1 cell line |
| Riluzole hydrochloride_NCI-H1573 | Riluzole hydrochloride perturbation in NCI-H1573 cell line |
| Drospirenone_CHP-212 | Drospirenone perturbation in CHP-212 cell line |
| Cepharanthine_HCT15 | Cepharanthine perturbation in HCT15 cell line |
| Berbamine_HS-578T | Berbamine perturbation in HS-578T cell line |
| Allantoin_NCI-H23 | Allantoin perturbation in NCI-H23 cell line |
| Budesonide_SW48 | Budesonide perturbation in SW48 cell line |
| AZD-7648_CHP-212 | AZD-7648 perturbation in CHP-212 cell line |
| Esmolol (hydrochloride)_AN3 CA | Esmolol (hydrochloride) perturbation in AN3 CA cell line |
| palbociclib_A-427 | palbociclib perturbation in A-427 cell line |
| Digitoxin_RKO | Digitoxin perturbation in RKO cell line |
| Ciclopirox_SNU-1 | Ciclopirox perturbation in SNU-1 cell line |
| Belzutifan_HOP62 | Belzutifan perturbation in HOP62 cell line |
| Adenine_CHP-212 | Adenine perturbation in CHP-212 cell line |
| Pasireotide (acetate)_HCT15 | Pasireotide (acetate) perturbation in HCT15 cell line |
| Gallic acid_NCI-H2347 | Gallic acid perturbation in NCI-H2347 cell line |
| Hexylresorcinol_SHP-77 | Hexylresorcinol perturbation in SHP-77 cell line |
| Riluzole hydrochloride_C32 | Riluzole hydrochloride perturbation in C32 cell line |
| TAK-733_HS-578T | TAK-733 perturbation in HS-578T cell line |
| Talc_A549 | Talc perturbation in A549 cell line |
| Ribociclib_SHP-77 | Ribociclib perturbation in SHP-77 cell line |
| Gallic acid_LOX-IMVI | Gallic acid perturbation in LOX-IMVI cell line |
| CP21R7_hTERT-HPNE | CP21R7 perturbation in hTERT-HPNE cell line |
| Gallic acid (hydrate)_AN3 CA | Gallic acid (hydrate) perturbation in AN3 CA cell line |
| 5-Azacytidine_AsPC-1 | 5-Azacytidine perturbation in AsPC-1 cell line |
| Elagolix sodium_C-33 A | Elagolix sodium perturbation in C-33 A cell line |
| Simotinib_PANC-1 | Simotinib perturbation in PANC-1 cell line |
| Rucaparib (phosphate)_MIA PaCa-2 | Rucaparib (phosphate) perturbation in MIA PaCa-2 cell line |
| Fedratinib (hydrochloride hydrate)_C-33 A | Fedratinib (hydrochloride hydrate) perturbation in C-33 A cell line |
| Rucaparib (phosphate)_HOP62 | Rucaparib (phosphate) perturbation in HOP62 cell line |
| ETC-206_SW 1271 | ETC-206 perturbation in SW 1271 cell line |
| vincristine_A-427 | vincristine perturbation in A-427 cell line |
| AT7519_BT-474 | AT7519 perturbation in BT-474 cell line |
| Tranilast_A-427 | Tranilast perturbation in A-427 cell line |
| Gallic acid_RKO | Gallic acid perturbation in RKO cell line |
| HI-TOPK-032_LS 180 | HI-TOPK-032 perturbation in LS 180 cell line |
| Cepharanthine_NCI-H661 | Cepharanthine perturbation in NCI-H661 cell line |
| Cytarabine (hydrochloride)_NCI-H2030 | Cytarabine (hydrochloride) perturbation in NCI-H2030 cell line |
| Digitoxin_NCI-H2347 | Digitoxin perturbation in NCI-H2347 cell line |
| TAK-901_NCI-H2347 | TAK-901 perturbation in NCI-H2347 cell line |
| vincristine_C-33 A | vincristine perturbation in C-33 A cell line |
| ML264_A-427 | ML264 perturbation in A-427 cell line |
| Fedratinib (hydrochloride hydrate)_A-427 | Fedratinib (hydrochloride hydrate) perturbation in A-427 cell line |
| Esmolol (hydrochloride)_SW48 | Esmolol (hydrochloride) perturbation in SW48 cell line |
| Peretinoin_HT-29 | Peretinoin perturbation in HT-29 cell line |
| Bergenin_hTERT-HPNE | Bergenin perturbation in hTERT-HPNE cell line |
| Vilanterol_SW48 | Vilanterol perturbation in SW48 cell line |
| Almonertinib (hydrochloride)_NCI-H596 | Almonertinib (hydrochloride) perturbation in NCI-H596 cell line |
| Atazanavir (sulfate)_SNU-1 | Atazanavir (sulfate) perturbation in SNU-1 cell line |
| Elimusertib hydrochloride_HEC-1-A | Elimusertib hydrochloride perturbation in HEC-1-A cell line |
| Mebendazole_NCI-H596 | Mebendazole perturbation in NCI-H596 cell line |
| Lopinavir_AsPC-1 | Lopinavir perturbation in AsPC-1 cell line |
| Sapanisertib_LOX-IMVI | Sapanisertib perturbation in LOX-IMVI cell line |
| Niclosamide (olamine)_HOP62 | Niclosamide (olamine) perturbation in HOP62 cell line |
| Cysteamine (hydrochloride)_CHP-212 | Cysteamine (hydrochloride) perturbation in CHP-212 cell line |
| Edoxaban (tosylate monohydrate)_A549 | Edoxaban (tosylate monohydrate) perturbation in A549 cell line |
| Pentagastrin_NCI-H596 | Pentagastrin perturbation in NCI-H596 cell line |
| AZD2858_NCI-H23 | AZD2858 perturbation in NCI-H23 cell line |
| SBI-0640756_COLO 205 | SBI-0640756 perturbation in COLO 205 cell line |
| Oxaliplatin_NCI-H2030 | Oxaliplatin perturbation in NCI-H2030 cell line |
| Cyclosporin A_NCI-H596 | Cyclosporin A perturbation in NCI-H596 cell line |
| Lidocaine (hydrochloride)_A-427 | Lidocaine (hydrochloride) perturbation in A-427 cell line |
| Pyridoxine (hydrochloride)_HOP62 | Pyridoxine (hydrochloride) perturbation in HOP62 cell line |
| Procainamide (hydrochloride)_CFPAC-1 | Procainamide (hydrochloride) perturbation in CFPAC-1 cell line |
| Tubulin inhibitor 6_SNU-1 | Tubulin inhibitor 6 perturbation in SNU-1 cell line |
| LY-2584702 (tosylate salt)_NCI-H661 | LY-2584702 (tosylate salt) perturbation in NCI-H661 cell line |
| Brivudine_AN3 CA | Brivudine perturbation in AN3 CA cell line |
| Sunitinib_RKO | Sunitinib perturbation in RKO cell line |
| Darinaparsin_NCI-H2347 | Darinaparsin perturbation in NCI-H2347 cell line |
| LJI308_HS-578T | LJI308 perturbation in HS-578T cell line |
| DTP3_PANC-1 | DTP3 perturbation in PANC-1 cell line |
| palbociclib_C-33 A | palbociclib perturbation in C-33 A cell line |
| Minodronic acid_NCI-H2030 | Minodronic acid perturbation in NCI-H2030 cell line |
| Mifepristone_SHP-77 | Mifepristone perturbation in SHP-77 cell line |
| Riluzole hydrochloride_SHP-77 | Riluzole hydrochloride perturbation in SHP-77 cell line |
| Trametinib_HOP62 | Trametinib perturbation in HOP62 cell line |
| PH-797804_NCI-H23 | PH-797804 perturbation in NCI-H23 cell line |
| Cilostazol_MIA PaCa-2 | Cilostazol perturbation in MIA PaCa-2 cell line |
| Gemfibrozil_COLO 205 | Gemfibrozil perturbation in COLO 205 cell line |
| 4EGI-1_CHP-212 | 4EGI-1 perturbation in CHP-212 cell line |
| Berbamine (dihydrochloride)_SNU-1 | Berbamine (dihydrochloride) perturbation in SNU-1 cell line |
| Delamanid_NCI-H23 | Delamanid perturbation in NCI-H23 cell line |
| Idoxuridine_A549 | Idoxuridine perturbation in A549 cell line |
| γ-Oryzanol_RKO | γ-Oryzanol perturbation in RKO cell line |
| ETC-206_COLO 205 | ETC-206 perturbation in COLO 205 cell line |
| Raltitrexed_CHP-212 | Raltitrexed perturbation in CHP-212 cell line |
| Binimetinib_RPMI-7951 | Binimetinib perturbation in RPMI-7951 cell line |
| Terfenadine_SW48 | Terfenadine perturbation in SW48 cell line |
| Mebendazole_SK-MEL-2 | Mebendazole perturbation in SK-MEL-2 cell line |
| Belzutifan_J82 | Belzutifan perturbation in J82 cell line |
| Furosemide_HS-578T | Furosemide perturbation in HS-578T cell line |
| Talc_hTERT-HPNE | Talc perturbation in hTERT-HPNE cell line |
| Terfenadine_C-33 A | Terfenadine perturbation in C-33 A cell line |
| Topotecan (hydrochloride)_SNU-1 | Topotecan (hydrochloride) perturbation in SNU-1 cell line |
| IQ 1_Hs 766T | IQ 1 perturbation in Hs 766T cell line |
| Darinaparsin_NCI-H460 | Darinaparsin perturbation in NCI-H460 cell line |
| Canagliflozin_NCI-H596 | Canagliflozin perturbation in NCI-H596 cell line |
| Verteporfin_C32 | Verteporfin perturbation in C32 cell line |
| Cysteamine (hydrochloride)_LoVo | Cysteamine (hydrochloride) perturbation in LoVo cell line |
| Abiraterone acetate_LoVo | Abiraterone acetate perturbation in LoVo cell line |
| Allantoin_NCI-H2347 | Allantoin perturbation in NCI-H2347 cell line |
| Clonidine (hydrochloride)_LS 180 | Clonidine (hydrochloride) perturbation in LS 180 cell line |
| Cabozantinib (S-malate)_SW1417 | Cabozantinib (S-malate) perturbation in SW1417 cell line |
| Estrone sulfate (potassium)_Panc 03.27 | Estrone sulfate (potassium) perturbation in Panc 03.27 cell line |
| Irinotecan (hydrochloride)_KATO III | Irinotecan (hydrochloride) perturbation in KATO III cell line |
| ML264_AN3 CA | ML264 perturbation in AN3 CA cell line |
| SBI-0640756_SW 1088 | SBI-0640756 perturbation in SW 1088 cell line |
| palbociclib_SW48 | palbociclib perturbation in SW48 cell line |
| BAY1125976_CHP-212 | BAY1125976 perturbation in CHP-212 cell line |
| Cysteamine (hydrochloride)_MIA PaCa-2 | Cysteamine (hydrochloride) perturbation in MIA PaCa-2 cell line |
| Ipatasertib_NCI-H460 | Ipatasertib perturbation in NCI-H460 cell line |
| 9-ING-41_COLO 205 | 9-ING-41 perturbation in COLO 205 cell line |
| Fedratinib (hydrochloride hydrate)_NCI-H1573 | Fedratinib (hydrochloride hydrate) perturbation in NCI-H1573 cell line |
| Gallic acid_NCI-H23 | Gallic acid perturbation in NCI-H23 cell line |
| Lopinavir_NCI-H2030 | Lopinavir perturbation in NCI-H2030 cell line |
| Cepharanthine_HS-578T | Cepharanthine perturbation in HS-578T cell line |
| Bimiralisib_SW 1088 | Bimiralisib perturbation in SW 1088 cell line |
| Berbamine_HCT15 | Berbamine perturbation in HCT15 cell line |
| Methylthiouracil_Panc 03.27 | Methylthiouracil perturbation in Panc 03.27 cell line |
| Gemfibrozil_NCI-H2030 | Gemfibrozil perturbation in NCI-H2030 cell line |
| Tofacitinib (citrate)_Panc 03.27 | Tofacitinib (citrate) perturbation in Panc 03.27 cell line |
| Raltitrexed_HOP62 | Raltitrexed perturbation in HOP62 cell line |
| Esmolol (hydrochloride)_C-33 A | Esmolol (hydrochloride) perturbation in C-33 A cell line |
| vincristine_SW48 | vincristine perturbation in SW48 cell line |
| Raltitrexed_MIA PaCa-2 | Raltitrexed perturbation in MIA PaCa-2 cell line |
| ETC-206_SW 1088 | ETC-206 perturbation in SW 1088 cell line |
| Fostamatinib (disodium hexahydrate)_Panc 03.27 | Fostamatinib (disodium hexahydrate) perturbation in Panc 03.27 cell line |
| Cilostazol_CFPAC-1 | Cilostazol perturbation in CFPAC-1 cell line |
| NVP-BHG712_HOP62 | NVP-BHG712 perturbation in HOP62 cell line |
| Lidocaine (hydrochloride)_AN3 CA | Lidocaine (hydrochloride) perturbation in AN3 CA cell line |
| Cilostazol_CHP-212 | Cilostazol perturbation in CHP-212 cell line |
| Raltitrexed_LoVo | Raltitrexed perturbation in LoVo cell line |
| Dinaciclib_Panc 03.27 | Dinaciclib perturbation in Panc 03.27 cell line |
| Irinotecan (hydrochloride)_LOX-IMVI | Irinotecan (hydrochloride) perturbation in LOX-IMVI cell line |
| Docetaxel (Trihydrate)_NCI-H1792 | Docetaxel (Trihydrate) perturbation in NCI-H1792 cell line |
| Pexidartinib (hydrochloride)_PANC-1 | Pexidartinib (hydrochloride) perturbation in PANC-1 cell line |
| Flutamide_LS 180 | Flutamide perturbation in LS 180 cell line |
| Phenytoin (sodium)_SW 1271 | Phenytoin (sodium) perturbation in SW 1271 cell line |
| Ciclopirox_SW48 | Ciclopirox perturbation in SW48 cell line |
| Mebendazole_NCI-H2030 | Mebendazole perturbation in NCI-H2030 cell line |
| AT7519_NCI-H596 | AT7519 perturbation in NCI-H596 cell line |
| L-Eflornithine (monohydrochloride)_HT-29 | L-Eflornithine (monohydrochloride) perturbation in HT-29 cell line |
| Adenosine_AN3 CA | Adenosine perturbation in AN3 CA cell line |
| XRK3F2_BT-474 | XRK3F2 perturbation in BT-474 cell line |
| Anastrozole_A549 | Anastrozole perturbation in A549 cell line |
| Pentagastrin_NCI-H2030 | Pentagastrin perturbation in NCI-H2030 cell line |
| Belzutifan_LOX-IMVI | Belzutifan perturbation in LOX-IMVI cell line |
| Delamanid_CHP-212 | Delamanid perturbation in CHP-212 cell line |
| Dinaciclib_NCI-H1573 | Dinaciclib perturbation in NCI-H1573 cell line |
| Ivabradine (hydrochloride)_SNU-1 | Ivabradine (hydrochloride) perturbation in SNU-1 cell line |
| Topotecan (hydrochloride)_A-427 | Topotecan (hydrochloride) perturbation in A-427 cell line |
| Mebendazole_SW 1088 | Mebendazole perturbation in SW 1088 cell line |
| Glycyrrhizic acid_A-427 | Glycyrrhizic acid perturbation in A-427 cell line |
| Lonafarnib_C-33 A | Lonafarnib perturbation in C-33 A cell line |
| Irinotecan (hydrochloride)_RKO | Irinotecan (hydrochloride) perturbation in RKO cell line |
| Oxaliplatin_NCI-H596 | Oxaliplatin perturbation in NCI-H596 cell line |
| Raltitrexed_NCI-H23 | Raltitrexed perturbation in NCI-H23 cell line |
| LJI308_SW480 | LJI308 perturbation in SW480 cell line |
| BI-3406_COLO 205 | BI-3406 perturbation in COLO 205 cell line |
| Ponatinib_NCI-H661 | Ponatinib perturbation in NCI-H661 cell line |
| Adenosine_C32 | Adenosine perturbation in C32 cell line |
| Piroxicam_A-172 | Piroxicam perturbation in A-172 cell line |
| Cabozantinib (S-malate)_HT-29 | Cabozantinib (S-malate) perturbation in HT-29 cell line |
| Tubulin inhibitor 6_NCI-H1573 | Tubulin inhibitor 6 perturbation in NCI-H1573 cell line |
| Gallic acid_HOP62 | Gallic acid perturbation in HOP62 cell line |
| Tubulin inhibitor 6_AN3 CA | Tubulin inhibitor 6 perturbation in AN3 CA cell line |
| Berbamine_hTERT-HPNE | Berbamine perturbation in hTERT-HPNE cell line |
| Harringtonine_CFPAC-1 | Harringtonine perturbation in CFPAC-1 cell line |
| Ouabain (Octahydrate)_SW480 | Ouabain (Octahydrate) perturbation in SW480 cell line |
| Talc_PANC-1 | Talc perturbation in PANC-1 cell line |
| Ciclopirox_SHP-77 | Ciclopirox perturbation in SHP-77 cell line |
| Bergenin_HEC-1-A | Bergenin perturbation in HEC-1-A cell line |
| Canagliflozin_AsPC-1 | Canagliflozin perturbation in AsPC-1 cell line |
| Erythromycin_A-427 | Erythromycin perturbation in A-427 cell line |
| Pentoxifylline_A-427 | Pentoxifylline perturbation in A-427 cell line |
| Vemurafenib_HS-578T | Vemurafenib perturbation in HS-578T cell line |
| Binimetinib_HEC-1-A | Binimetinib perturbation in HEC-1-A cell line |
| Gallic acid_MIA PaCa-2 | Gallic acid perturbation in MIA PaCa-2 cell line |
| Megestrol_SW480 | Megestrol perturbation in SW480 cell line |
| Irinotecan (hydrochloride)_NCI-H2347 | Irinotecan (hydrochloride) perturbation in NCI-H2347 cell line |
| Dexmedetomidine_A-427 | Dexmedetomidine perturbation in A-427 cell line |
| Daptomycin_AN3 CA | Daptomycin perturbation in AN3 CA cell line |
| Berbamine (dihydrochloride)_NCI-H1573 | Berbamine (dihydrochloride) perturbation in NCI-H1573 cell line |
| Encorafenib_A-427 | Encorafenib perturbation in A-427 cell line |
| Flutamide_SW480 | Flutamide perturbation in SW480 cell line |
| Gallic acid_LoVo | Gallic acid perturbation in LoVo cell line |
| Decitabine_AsPC-1 | Decitabine perturbation in AsPC-1 cell line |
| S-Adenosyl-L-methionine (disulfate tosylate)_LOX-IMVI | S-Adenosyl-L-methionine (disulfate tosylate) perturbation in LOX-IMVI cell line |
| Pimozide_NCI-H2347 | Pimozide perturbation in NCI-H2347 cell line |
| Delamanid_HOP62 | Delamanid perturbation in HOP62 cell line |
| Tirabrutinib_AsPC-1 | Tirabrutinib perturbation in AsPC-1 cell line |
| Piroxicam_HS-578T | Piroxicam perturbation in HS-578T cell line |
| Bergenin_HCT15 | Bergenin perturbation in HCT15 cell line |
| Lonafarnib_SHP-77 | Lonafarnib perturbation in SHP-77 cell line |
| Isocorydine_SW1417 | Isocorydine perturbation in SW1417 cell line |
| Adenosine_A-427 | Adenosine perturbation in A-427 cell line |
| Alpelisib_A549 | Alpelisib perturbation in A549 cell line |
| Mebendazole_COLO 205 | Mebendazole perturbation in COLO 205 cell line |
| Irinotecan (hydrochloride)_NCI-H460 | Irinotecan (hydrochloride) perturbation in NCI-H460 cell line |
| Megestrol_A549 | Megestrol perturbation in A549 cell line |
| Delamanid_LoVo | Delamanid perturbation in LoVo cell line |
| Almonertinib (hydrochloride)_COLO 205 | Almonertinib (hydrochloride) perturbation in COLO 205 cell line |
| Quinidine (15% dihydroquinidine)_A-172 | Quinidine (15% dihydroquinidine) perturbation in A-172 cell line |
| Fedratinib (hydrochloride hydrate)_SNU-1 | Fedratinib (hydrochloride hydrate) perturbation in SNU-1 cell line |
| Anastrozole_LS 180 | Anastrozole perturbation in LS 180 cell line |
| Benztropine (mesylate)_LOX-IMVI | Benztropine (mesylate) perturbation in LOX-IMVI cell line |
| Cilostazol_NCI-H23 | Cilostazol perturbation in NCI-H23 cell line |
| Delamanid_SNU-423 | Delamanid perturbation in SNU-423 cell line |
| Delamanid_MIA PaCa-2 | Delamanid perturbation in MIA PaCa-2 cell line |
| Cepharanthine_SW480 | Cepharanthine perturbation in SW480 cell line |
| Lenalidomide (hemihydrate)_SW48 | Lenalidomide (hemihydrate) perturbation in SW48 cell line |
| Anastrozole_SW480 | Anastrozole perturbation in SW480 cell line |
| Futibatinib_AN3 CA | Futibatinib perturbation in AN3 CA cell line |
| Bergenin_NCI-H661 | Bergenin perturbation in NCI-H661 cell line |
| ETC-206_NCI-H596 | ETC-206 perturbation in NCI-H596 cell line |
| Berbamine (dihydrochloride)_A-427 | Berbamine (dihydrochloride) perturbation in A-427 cell line |
| Daptomycin_A-427 | Daptomycin perturbation in A-427 cell line |
| Binimetinib_NCI-H661 | Binimetinib perturbation in NCI-H661 cell line |
| Medroxyprogesterone acetate_SW1417 | Medroxyprogesterone acetate perturbation in SW1417 cell line |
| Hydroxyfasudil_AN3 CA | Hydroxyfasudil perturbation in AN3 CA cell line |
| Larotrectinib sulfate_SW48 | Larotrectinib sulfate perturbation in SW48 cell line |
| Benproperine (phosphate)_NCI-H2347 | Benproperine (phosphate) perturbation in NCI-H2347 cell line |
| Tubulin inhibitor 6_A-427 | Tubulin inhibitor 6 perturbation in A-427 cell line |
| Adenine_NCI-H2347 | Adenine perturbation in NCI-H2347 cell line |
| Econazole_NCI-H661 | Econazole perturbation in NCI-H661 cell line |
| Ciclopirox_C-33 A | Ciclopirox perturbation in C-33 A cell line |
| Bergenin_PANC-1 | Bergenin perturbation in PANC-1 cell line |
| Bimiralisib_NCI-H596 | Bimiralisib perturbation in NCI-H596 cell line |
| Talc_HEC-1-A | Talc perturbation in HEC-1-A cell line |
| Darinaparsin_CHP-212 | Darinaparsin perturbation in CHP-212 cell line |
| Eplerenone_LOX-IMVI | Eplerenone perturbation in LOX-IMVI cell line |
| Brimonidine_RKO | Brimonidine perturbation in RKO cell line |
| Gallic acid (hydrate)_Panc 03.27 | Gallic acid (hydrate) perturbation in Panc 03.27 cell line |
| Medroxyprogesterone acetate_NCI-H2030 | Medroxyprogesterone acetate perturbation in NCI-H2030 cell line |
| Futibatinib_SHP-77 | Futibatinib perturbation in SHP-77 cell line |
| Tubulin inhibitor 6_C-33 A | Tubulin inhibitor 6 perturbation in C-33 A cell line |
| Ivermectin_NCI-H596 | Ivermectin perturbation in NCI-H596 cell line |
| Peretinoin_HepG2/C3A | Peretinoin perturbation in HepG2/C3A cell line |
| Delamanid_NCI-H1792 | Delamanid perturbation in NCI-H1792 cell line |
| Dimethyl fumarate_BT-474 | Dimethyl fumarate perturbation in BT-474 cell line |
| Sapanisertib_CHP-212 | Sapanisertib perturbation in CHP-212 cell line |
| Pexidartinib (hydrochloride)_HS-578T | Pexidartinib (hydrochloride) perturbation in HS-578T cell line |
| Abiraterone acetate_LOX-IMVI | Abiraterone acetate perturbation in LOX-IMVI cell line |
| Piroxicam_HEC-1-A | Piroxicam perturbation in HEC-1-A cell line |
| Daptomycin_C-33 A | Daptomycin perturbation in C-33 A cell line |
| Phenytoin (sodium)_NCI-H2030 | Phenytoin (sodium) perturbation in NCI-H2030 cell line |
| Imiquimod (maleate)_KATO III | Imiquimod (maleate) perturbation in KATO III cell line |
| Pyridoxine_NCI-H2030 | Pyridoxine perturbation in NCI-H2030 cell line |
| Medroxyprogesterone acetate_SW 1088 | Medroxyprogesterone acetate perturbation in SW 1088 cell line |
| Dorzolamide (hydrochloride)_LS 180 | Dorzolamide (hydrochloride) perturbation in LS 180 cell line |
| AZD-8055_NCI-H23 | AZD-8055 perturbation in NCI-H23 cell line |
| Mebendazole_SW 1271 | Mebendazole perturbation in SW 1271 cell line |
| Relugolix_NCI-H596 | Relugolix perturbation in NCI-H596 cell line |
| Almonertinib (hydrochloride)_SW 1271 | Almonertinib (hydrochloride) perturbation in SW 1271 cell line |
| Dimethyl fumarate_SW1417 | Dimethyl fumarate perturbation in SW1417 cell line |
| Sunitinib_CFPAC-1 | Sunitinib perturbation in CFPAC-1 cell line |
| Clopidogrel_NCI-H596 | Clopidogrel perturbation in NCI-H596 cell line |
| Brimonidine_NCI-H2347 | Brimonidine perturbation in NCI-H2347 cell line |
| Gemcitabine_SHP-77 | Gemcitabine perturbation in SHP-77 cell line |
| Sunitinib_CHP-212 | Sunitinib perturbation in CHP-212 cell line |
| Allantoin_HOP62 | Allantoin perturbation in HOP62 cell line |
| Cepharanthine_RPMI-7951 | Cepharanthine perturbation in RPMI-7951 cell line |
| TAK-901_CHP-212 | TAK-901 perturbation in CHP-212 cell line |
| Belzutifan_NCI-H23 | Belzutifan perturbation in NCI-H23 cell line |
| Anastrozole_hTERT-HPNE | Anastrozole perturbation in hTERT-HPNE cell line |
| Idoxuridine_HEC-1-A | Idoxuridine perturbation in HEC-1-A cell line |
| Allopurinol_NCI-H596 | Allopurinol perturbation in NCI-H596 cell line |
| 4EGI-1_LOX-IMVI | 4EGI-1 perturbation in LOX-IMVI cell line |
| NG25_SNU-1 | NG25 perturbation in SNU-1 cell line |
| XRK3F2_COLO 205 | XRK3F2 perturbation in COLO 205 cell line |
| Rimonabant_A-427 | Rimonabant perturbation in A-427 cell line |
| Pentoxifylline_SW48 | Pentoxifylline perturbation in SW48 cell line |
| Lonafarnib_AN3 CA | Lonafarnib perturbation in AN3 CA cell line |
| Gallic acid_J82 | Gallic acid perturbation in J82 cell line |
| Abiraterone acetate_NCI-H2347 | Abiraterone acetate perturbation in NCI-H2347 cell line |
| Allantoin_LoVo | Allantoin perturbation in LoVo cell line |
| Talc_HS-578T | Talc perturbation in HS-578T cell line |
| TAK-733_A549 | TAK-733 perturbation in A549 cell line |
| Ranolazine_SW1417 | Ranolazine perturbation in SW1417 cell line |
| γ-Oryzanol_CHP-212 | γ-Oryzanol perturbation in CHP-212 cell line |
| Dexmedetomidine_A498 | Dexmedetomidine perturbation in A498 cell line |
| Decitabine_BT-474 | Decitabine perturbation in BT-474 cell line |
| Dinaciclib_C-33 A | Dinaciclib perturbation in C-33 A cell line |
| Futibatinib_SW48 | Futibatinib perturbation in SW48 cell line |
| Piroxicam_PANC-1 | Piroxicam perturbation in PANC-1 cell line |
| Dorzolamide (hydrochloride)_A549 | Dorzolamide (hydrochloride) perturbation in A549 cell line |
| Mifepristone_SNU-1 | Mifepristone perturbation in SNU-1 cell line |
| Darinaparsin_LoVo | Darinaparsin perturbation in LoVo cell line |
| Dexamethasone_NCI-H596 | Dexamethasone perturbation in NCI-H596 cell line |
| Riluzole hydrochloride_SNU-1 | Riluzole hydrochloride perturbation in SNU-1 cell line |
| Tazarotene_C32 | Tazarotene perturbation in C32 cell line |
| PF-06260933_RKO | PF-06260933 perturbation in RKO cell line |
| Tubulin inhibitor 6_SHP-77 | Tubulin inhibitor 6 perturbation in SHP-77 cell line |
| Dinaciclib_A498 | Dinaciclib perturbation in A498 cell line |
| Adenosine_SW48 | Adenosine perturbation in SW48 cell line |
| PF-06260933_LOX-IMVI | PF-06260933 perturbation in LOX-IMVI cell line |
| Talc_A-172 | Talc perturbation in A-172 cell line |
| Cilostazol_NCI-H2347 | Cilostazol perturbation in NCI-H2347 cell line |
| Nimesulide_NCI-H596 | Nimesulide perturbation in NCI-H596 cell line |
| Harringtonine_KATO III | Harringtonine perturbation in KATO III cell line |
| Atazanavir (sulfate)_SHP-77 | Atazanavir (sulfate) perturbation in SHP-77 cell line |
| Mebendazole_SW1417 | Mebendazole perturbation in SW1417 cell line |
| LY-2584702 (tosylate salt)_A549 | LY-2584702 (tosylate salt) perturbation in A549 cell line |
| Drospirenone_NCI-H23 | Drospirenone perturbation in NCI-H23 cell line |
| Bimiralisib_HT-29 | Bimiralisib perturbation in HT-29 cell line |
| Neratinib_SNU-423 | Neratinib perturbation in SNU-423 cell line |
| Binimetinib_HS-578T | Binimetinib perturbation in HS-578T cell line |
| XRK3F2_NCI-H2030 | XRK3F2 perturbation in NCI-H2030 cell line |
| Allantoin_CHP-212 | Allantoin perturbation in CHP-212 cell line |
| Rimonabant_AN3 CA | Rimonabant perturbation in AN3 CA cell line |
| Vemurafenib_HEC-1-A | Vemurafenib perturbation in HEC-1-A cell line |
| HI-TOPK-032_HS-578T | HI-TOPK-032 perturbation in HS-578T cell line |
| Aspirin_NCI-H2030 | Aspirin perturbation in NCI-H2030 cell line |
| ETC-206_HT-29 | ETC-206 perturbation in HT-29 cell line |
| Cilostazol_RKO | Cilostazol perturbation in RKO cell line |
| 9-ING-41_NCI-H661 | 9-ING-41 perturbation in NCI-H661 cell line |
| Fedratinib (hydrochloride hydrate)_NCI-H460 | Fedratinib (hydrochloride hydrate) perturbation in NCI-H460 cell line |
| 5-Azacytidine_HS-578T | 5-Azacytidine perturbation in HS-578T cell line |
| Uridine_NCI-H1573 | Uridine perturbation in NCI-H1573 cell line |
| Resveratrol_NCI-H1573 | Resveratrol perturbation in NCI-H1573 cell line |
| Gallic acid_SHP-77 | Gallic acid perturbation in SHP-77 cell line |
| Peretinoin_LS 180 | Peretinoin perturbation in LS 180 cell line |
| Ribociclib_RKO | Ribociclib perturbation in RKO cell line |
| NG25_NCI-H23 | NG25 perturbation in NCI-H23 cell line |
| Ivabradine (hydrochloride)_LOX-IMVI | Ivabradine (hydrochloride) perturbation in LOX-IMVI cell line |
| Tranilast_NCI-H23 | Tranilast perturbation in NCI-H23 cell line |
| Ciclopirox_HOP62 | Ciclopirox perturbation in HOP62 cell line |
| Belzutifan_SNU-1 | Belzutifan perturbation in SNU-1 cell line |
| Glycyrrhizic acid_KATO III | Glycyrrhizic acid perturbation in KATO III cell line |
| Elagolix sodium_NCI-H460 | Elagolix sodium perturbation in NCI-H460 cell line |
| Oxaliplatin_H4 | Oxaliplatin perturbation in H4 cell line |
| Pimozide_Panc 03.27 | Pimozide perturbation in Panc 03.27 cell line |
| Pexidartinib (hydrochloride)_NCI-H596 | Pexidartinib (hydrochloride) perturbation in NCI-H596 cell line |
| 18β-Glycyrrhetinic acid_SW 1271 | 18β-Glycyrrhetinic acid perturbation in SW 1271 cell line |
| Adenine_Panc 03.27 | Adenine perturbation in Panc 03.27 cell line |
| S-Adenosyl-L-methionine (disulfate tosylate)_Panc 03.27 | S-Adenosyl-L-methionine (disulfate tosylate) perturbation in Panc 03.27 cell line |
| GSK1059615_SW48 | GSK1059615 perturbation in SW48 cell line |
| Darolutamide_HS-578T | Darolutamide perturbation in HS-578T cell line |
| Delamanid_SW 900 | Delamanid perturbation in SW 900 cell line |
| Goserelin (acetate)_CHP-212 | Goserelin (acetate) perturbation in CHP-212 cell line |
| Lumateperone (tosylate)_HOP62 | Lumateperone (tosylate) perturbation in HOP62 cell line |
| Bimiralisib_HEC-1-A | Bimiralisib perturbation in HEC-1-A cell line |
| Minodronic acid_H4 | Minodronic acid perturbation in H4 cell line |
| Ivabradine (hydrochloride)_NCI-H2347 | Ivabradine (hydrochloride) perturbation in NCI-H2347 cell line |
| Rimonabant (Hydrochloride)_NCI-H2030 | Rimonabant (Hydrochloride) perturbation in NCI-H2030 cell line |
| BI-3406_hTERT-HPNE | BI-3406 perturbation in hTERT-HPNE cell line |
| Betamethasone dipropionate_NCI-H2347 | Betamethasone dipropionate perturbation in NCI-H2347 cell line |
| Delamanid_C-33 A | Delamanid perturbation in C-33 A cell line |
| 9-ING-41_HCT15 | 9-ING-41 perturbation in HCT15 cell line |
| Cabozantinib (S-malate)_HS-578T | Cabozantinib (S-malate) perturbation in HS-578T cell line |
| Minodronic acid_PANC-1 | Minodronic acid perturbation in PANC-1 cell line |
| Lapatinib ditosylate_BT-474 | Lapatinib ditosylate perturbation in BT-474 cell line |
| LY-2584702 (tosylate salt)_SW 1088 | LY-2584702 (tosylate salt) perturbation in SW 1088 cell line |
| Peretinoin_SW480 | Peretinoin perturbation in SW480 cell line |
| Clofarabine_HOP62 | Clofarabine perturbation in HOP62 cell line |
| Ropivacaine (hydrochloride monohydrate)_NCI-H596 | Ropivacaine (hydrochloride monohydrate) perturbation in NCI-H596 cell line |
| Naproxen_NCI-H596 | Naproxen perturbation in NCI-H596 cell line |
| Anastrozole_BT-474 | Anastrozole perturbation in BT-474 cell line |
| IQ 1_LS 180 | IQ 1 perturbation in LS 180 cell line |
| Ciclopirox_CHP-212 | Ciclopirox perturbation in CHP-212 cell line |
| Adenine_SNU-1 | Adenine perturbation in SNU-1 cell line |
| Gallic acid_C-33 A | Gallic acid perturbation in C-33 A cell line |
| Sapanisertib_A-427 | Sapanisertib perturbation in A-427 cell line |
| ETC-206_HCT15 | ETC-206 perturbation in HCT15 cell line |
| Darinaparsin_A-427 | Darinaparsin perturbation in A-427 cell line |
| Artesunate_NCI-H23 | Artesunate perturbation in NCI-H23 cell line |
| Elagolix sodium_LOX-IMVI | Elagolix sodium perturbation in LOX-IMVI cell line |
| MK-8353_LS 180 | MK-8353 perturbation in LS 180 cell line |
| Fedratinib (hydrochloride hydrate)_RKO | Fedratinib (hydrochloride hydrate) perturbation in RKO cell line |
| Anethole trithione_NCI-H23 | Anethole trithione perturbation in NCI-H23 cell line |
| Perindopril (erbumine)_NCI-H596 | Perindopril (erbumine) perturbation in NCI-H596 cell line |
| Delamanid_SW48 | Delamanid perturbation in SW48 cell line |
| Harringtonine_SHP-77 | Harringtonine perturbation in SHP-77 cell line |
| Peretinoin_A549 | Peretinoin perturbation in A549 cell line |
| Vinblastine (sulfate)_LoVo | Vinblastine (sulfate) perturbation in LoVo cell line |
| Uridine_A-427 | Uridine perturbation in A-427 cell line |
| Methylthiouracil_KATO III | Methylthiouracil perturbation in KATO III cell line |
| Mebendazole_hTERT-HPNE | Mebendazole perturbation in hTERT-HPNE cell line |
| Delamanid_SHP-77 | Delamanid perturbation in SHP-77 cell line |
| γ-Oryzanol_NCI-H2122 | γ-Oryzanol perturbation in NCI-H2122 cell line |
| SBI-0640756_HCT15 | SBI-0640756 perturbation in HCT15 cell line |
| Allantoin_AN3 CA | Allantoin perturbation in AN3 CA cell line |
| Lonafarnib_LoVo | Lonafarnib perturbation in LoVo cell line |
| Fedratinib (hydrochloride hydrate)_NCI-H2347 | Fedratinib (hydrochloride hydrate) perturbation in NCI-H2347 cell line |
| Cytarabine (hydrochloride)_HS-578T | Cytarabine (hydrochloride) perturbation in HS-578T cell line |
| XRK3F2_LS 180 | XRK3F2 perturbation in LS 180 cell line |
| Torkinib_COLO 205 | Torkinib perturbation in COLO 205 cell line |
| Ferulic acid_NCI-H23 | Ferulic acid perturbation in NCI-H23 cell line |
| Fluvoxamine_HS-578T | Fluvoxamine perturbation in HS-578T cell line |
| Tofacitinib_NCI-H596 | Tofacitinib perturbation in NCI-H596 cell line |
| Sunitinib_A-427 | Sunitinib perturbation in A-427 cell line |
| Abemaciclib_NCI-H596 | Abemaciclib perturbation in NCI-H596 cell line |
| Tubulin inhibitor 6_KATO III | Tubulin inhibitor 6 perturbation in KATO III cell line |
| Dorzolamide (hydrochloride)_AsPC-1 | Dorzolamide (hydrochloride) perturbation in AsPC-1 cell line |
| AZD1390_H4 | AZD1390 perturbation in H4 cell line |
| Salicylic acid_SW48 | Salicylic acid perturbation in SW48 cell line |
| LY-2584702 (tosylate salt)_COLO 205 | LY-2584702 (tosylate salt) perturbation in COLO 205 cell line |
| IQ 1_SW480 | IQ 1 perturbation in SW480 cell line |
| Riluzole hydrochloride_NCI-H23 | Riluzole hydrochloride perturbation in NCI-H23 cell line |
| Pentagastrin_hTERT-HPNE | Pentagastrin perturbation in hTERT-HPNE cell line |
| ETC-206_PANC-1 | ETC-206 perturbation in PANC-1 cell line |
| Mifepristone_NCI-H23 | Mifepristone perturbation in NCI-H23 cell line |
| Bimiralisib_H4 | Bimiralisib perturbation in H4 cell line |
| IQ 1_RPMI-7951 | IQ 1 perturbation in RPMI-7951 cell line |
| Allantoin_SHP-77 | Allantoin perturbation in SHP-77 cell line |
| PH-797804_AN3 CA | PH-797804 perturbation in AN3 CA cell line |
| PH-797804_NCI-H1573 | PH-797804 perturbation in NCI-H1573 cell line |
| Glycyrrhizic acid_HOP62 | Glycyrrhizic acid perturbation in HOP62 cell line |
| Delamanid_AN3 CA | Delamanid perturbation in AN3 CA cell line |
| Trametinib_Panc 03.27 | Trametinib perturbation in Panc 03.27 cell line |
| Eplerenone_SNU-1 | Eplerenone perturbation in SNU-1 cell line |
| CP21R7_NCI-H596 | CP21R7 perturbation in NCI-H596 cell line |
| Pentagastrin_LS 180 | Pentagastrin perturbation in LS 180 cell line |
| Azithromycin (hydrate)_AN3 CA | Azithromycin (hydrate) perturbation in AN3 CA cell line |
| Cysteamine (hydrochloride)_SNU-1 | Cysteamine (hydrochloride) perturbation in SNU-1 cell line |
| palbociclib_LOX-IMVI | palbociclib perturbation in LOX-IMVI cell line |
| Oxaliplatin_HS-578T | Oxaliplatin perturbation in HS-578T cell line |
| Capivasertib_HCT15 | Capivasertib perturbation in HCT15 cell line |
| Sunitinib_SW 900 | Sunitinib perturbation in SW 900 cell line |
| Dexamethasone_HEC-1-A | Dexamethasone perturbation in HEC-1-A cell line |
| Mebendazole_LS 180 | Mebendazole perturbation in LS 180 cell line |
| Brivudine_NCI-H23 | Brivudine perturbation in NCI-H23 cell line |
| 9-ING-41_HS-578T | 9-ING-41 perturbation in HS-578T cell line |
| Megestrol_NCI-H2030 | Megestrol perturbation in NCI-H2030 cell line |
| ETC-206_A-172 | ETC-206 perturbation in A-172 cell line |
| Flutamide_NCI-H2030 | Flutamide perturbation in NCI-H2030 cell line |
| Glycyrrhizic acid_MIA PaCa-2 | Glycyrrhizic acid perturbation in MIA PaCa-2 cell line |
| Radotinib_NCI-H596 | Radotinib perturbation in NCI-H596 cell line |
| Raltitrexed_SNU-1 | Raltitrexed perturbation in SNU-1 cell line |
| Vemurafenib_NCI-H596 | Vemurafenib perturbation in NCI-H596 cell line |
| Cabozantinib (S-malate)_PANC-1 | Cabozantinib (S-malate) perturbation in PANC-1 cell line |
| Dexmedetomidine_HOP62 | Dexmedetomidine perturbation in HOP62 cell line |
| Quinidine (15% dihydroquinidine)_NCI-H596 | Quinidine (15% dihydroquinidine) perturbation in NCI-H596 cell line |
| Ivabradine (hydrochloride)_NCI-H23 | Ivabradine (hydrochloride) perturbation in NCI-H23 cell line |
| Delamanid_C32 | Delamanid perturbation in C32 cell line |
| Pentagastrin_SW480 | Pentagastrin perturbation in SW480 cell line |
| IQ 1_hTERT-HPNE | IQ 1 perturbation in hTERT-HPNE cell line |
| Sapanisertib_C-33 A | Sapanisertib perturbation in C-33 A cell line |
| Gallic acid_A-427 | Gallic acid perturbation in A-427 cell line |
| Darinaparsin_SW 900 | Darinaparsin perturbation in SW 900 cell line |
| Dexmedetomidine_LoVo | Dexmedetomidine perturbation in LoVo cell line |
| Budesonide_NCI-H23 | Budesonide perturbation in NCI-H23 cell line |
| Nafamostat (mesylate)_HS-578T | Nafamostat (mesylate) perturbation in HS-578T cell line |
| Rimonabant (Hydrochloride)_SW 1271 | Rimonabant (Hydrochloride) perturbation in SW 1271 cell line |
| Tubulin inhibitor 6_CHP-212 | Tubulin inhibitor 6 perturbation in CHP-212 cell line |
| Talc_HT-29 | Talc perturbation in HT-29 cell line |
| Dexmedetomidine_MIA PaCa-2 | Dexmedetomidine perturbation in MIA PaCa-2 cell line |
| Encorafenib_SNU-423 | Encorafenib perturbation in SNU-423 cell line |
| Mifepristone_LOX-IMVI | Mifepristone perturbation in LOX-IMVI cell line |
| Riluzole hydrochloride_LOX-IMVI | Riluzole hydrochloride perturbation in LOX-IMVI cell line |
| Mebendazole_A549 | Mebendazole perturbation in A549 cell line |
| γ-Oryzanol_SHP-77 | γ-Oryzanol perturbation in SHP-77 cell line |
| Oleic acid_NCI-H23 | Oleic acid perturbation in NCI-H23 cell line |
| Adenosine_HOP62 | Adenosine perturbation in HOP62 cell line |
| L-Eflornithine (monohydrochloride)_HEC-1-A | L-Eflornithine (monohydrochloride) perturbation in HEC-1-A cell line |
| Methotrexate_SW48 | Methotrexate perturbation in SW48 cell line |
| Ouabain (Octahydrate)_COLO 205 | Ouabain (Octahydrate) perturbation in COLO 205 cell line |
| Topotecan (hydrochloride)_CFPAC-1 | Topotecan (hydrochloride) perturbation in CFPAC-1 cell line |
| Adenosine_MIA PaCa-2 | Adenosine perturbation in MIA PaCa-2 cell line |
| Cytarabine_NCI-H2030 | Cytarabine perturbation in NCI-H2030 cell line |
| Procainamide (hydrochloride)_Panc 03.27 | Procainamide (hydrochloride) perturbation in Panc 03.27 cell line |
| Norepinephrine (hydrochloride)_SW480 | Norepinephrine (hydrochloride) perturbation in SW480 cell line |
| Adenosine_LoVo | Adenosine perturbation in LoVo cell line |
| Epirubicin (hydrochloride)_NCI-H596 | Epirubicin (hydrochloride) perturbation in NCI-H596 cell line |
| Pentagastrin_A549 | Pentagastrin perturbation in A549 cell line |
| Riluzole hydrochloride_RKO | Riluzole hydrochloride perturbation in RKO cell line |
| Oxaliplatin_A-172 | Oxaliplatin perturbation in A-172 cell line |
| Ipatasertib_SHP-77 | Ipatasertib perturbation in SHP-77 cell line |
| Cilostazol_SNU-1 | Cilostazol perturbation in SNU-1 cell line |
| AZD1390_HS-578T | AZD1390 perturbation in HS-578T cell line |
| Fedratinib (hydrochloride hydrate)_NCI-H23 | Fedratinib (hydrochloride hydrate) perturbation in NCI-H23 cell line |
| Terfenadine_LOX-IMVI | Terfenadine perturbation in LOX-IMVI cell line |
| Esmolol (hydrochloride)_NCI-H2347 | Esmolol (hydrochloride) perturbation in NCI-H2347 cell line |
| Daptomycin_LoVo | Daptomycin perturbation in LoVo cell line |
| Gallic acid_NCI-H1573 | Gallic acid perturbation in NCI-H1573 cell line |
| Amsacrine_NCI-H596 | Amsacrine perturbation in NCI-H596 cell line |
| Bimiralisib_HS-578T | Bimiralisib perturbation in HS-578T cell line |
| Bentamapimod_CHP-212 | Bentamapimod perturbation in CHP-212 cell line |
| ETC-206_HS-578T | ETC-206 perturbation in HS-578T cell line |
| Dexmedetomidine_CHP-212 | Dexmedetomidine perturbation in CHP-212 cell line |
| Elagolix sodium_NCI-H23 | Elagolix sodium perturbation in NCI-H23 cell line |
| Dexmedetomidine_CFPAC-1 | Dexmedetomidine perturbation in CFPAC-1 cell line |
| Celecoxib_SW 1271 | Celecoxib perturbation in SW 1271 cell line |
| Encorafenib_CHP-212 | Encorafenib perturbation in CHP-212 cell line |
| Riluzole hydrochloride_NCI-H2347 | Riluzole hydrochloride perturbation in NCI-H2347 cell line |
| Allopurinol_HEC-1-A | Allopurinol perturbation in HEC-1-A cell line |
| GSK1059615_AN3 CA | GSK1059615 perturbation in AN3 CA cell line |
| Hydroxyfasudil_CHP-212 | Hydroxyfasudil perturbation in CHP-212 cell line |
| Tubulin inhibitor 6_LoVo | Tubulin inhibitor 6 perturbation in LoVo cell line |
| Sapanisertib_SHP-77 | Sapanisertib perturbation in SHP-77 cell line |
| ERK5-IN-2_hTERT-HPNE | ERK5-IN-2 perturbation in hTERT-HPNE cell line |
| Sivelestat (sodium tetrahydrate)_hTERT-HPNE | Sivelestat (sodium tetrahydrate) perturbation in hTERT-HPNE cell line |
| Torkinib_AN3 CA | Torkinib perturbation in AN3 CA cell line |
| 9-ING-41_NCI-H2347 | 9-ING-41 perturbation in NCI-H2347 cell line |
| Rucaparib (phosphate)_NCI-H596 | Rucaparib (phosphate) perturbation in NCI-H596 cell line |
| Raltitrexed_HT-29 | Raltitrexed perturbation in HT-29 cell line |
| Irinotecan (hydrochloride)_SK-MEL-2 | Irinotecan (hydrochloride) perturbation in SK-MEL-2 cell line |
| Lactate (calcium)_SNU-1 | Lactate (calcium) perturbation in SNU-1 cell line |
| BI-78D3_HEC-1-A | BI-78D3 perturbation in HEC-1-A cell line |
| ETC-206_NCI-H460 | ETC-206 perturbation in NCI-H460 cell line |
| Minodronic acid_LOX-IMVI | Minodronic acid perturbation in LOX-IMVI cell line |
| Budesonide_HCT15 | Budesonide perturbation in HCT15 cell line |
| Cepharanthine_SW48 | Cepharanthine perturbation in SW48 cell line |
| Levobupivacaine (hydrochloride)_SW48 | Levobupivacaine (hydrochloride) perturbation in SW48 cell line |
| Glycyrrhizic acid_hTERT-HPNE | Glycyrrhizic acid perturbation in hTERT-HPNE cell line |
| AZD1390_NCI-H460 | AZD1390 perturbation in NCI-H460 cell line |
| XRK3F2_SNU-423 | XRK3F2 perturbation in SNU-423 cell line |
| APTO-253_KATO III | APTO-253 perturbation in KATO III cell line |
| L-Thyroxine (sodium salt pentahydrate)_SW48 | L-Thyroxine (sodium salt pentahydrate) perturbation in SW48 cell line |
| LB-100_A-427 | LB-100 perturbation in A-427 cell line |
| XRK3F2_MIA PaCa-2 | XRK3F2 perturbation in MIA PaCa-2 cell line |
| TAK-733_A-427 | TAK-733 perturbation in A-427 cell line |
| Goserelin (acetate)_LS 180 | Goserelin (acetate) perturbation in LS 180 cell line |
| Delamanid_SW 1271 | Delamanid perturbation in SW 1271 cell line |
| Gallic acid_BT-474 | Gallic acid perturbation in BT-474 cell line |
| Sulfisoxazole_NCI-H596 | Sulfisoxazole perturbation in NCI-H596 cell line |
| Lapatinib ditosylate_SW48 | Lapatinib ditosylate perturbation in SW48 cell line |
| Fumaric acid_CFPAC-1 | Fumaric acid perturbation in CFPAC-1 cell line |
| Ivabradine (hydrochloride)_NCI-H661 | Ivabradine (hydrochloride) perturbation in NCI-H661 cell line |
| BI-3406_J82 | BI-3406 perturbation in J82 cell line |
| IQ 1_HOP62 | IQ 1 perturbation in HOP62 cell line |
| Peretinoin_CFPAC-1 | Peretinoin perturbation in CFPAC-1 cell line |
| Phenytoin (sodium)_CFPAC-1 | Phenytoin (sodium) perturbation in CFPAC-1 cell line |
| Ivabradine (hydrochloride)_PANC-1 | Ivabradine (hydrochloride) perturbation in PANC-1 cell line |
| Cytarabine_A498 | Cytarabine perturbation in A498 cell line |
| IQ 1_MIA PaCa-2 | IQ 1 perturbation in MIA PaCa-2 cell line |
| Tofacitinib_Panc 03.27 | Tofacitinib perturbation in Panc 03.27 cell line |
| Gallic acid_SW1417 | Gallic acid perturbation in SW1417 cell line |
| Binimetinib_Panc 03.27 | Binimetinib perturbation in Panc 03.27 cell line |
| Brivudine_HCT15 | Brivudine perturbation in HCT15 cell line |
| Furosemide_SW48 | Furosemide perturbation in SW48 cell line |
| Dorzolamide (hydrochloride)_NCI-H1573 | Dorzolamide (hydrochloride) perturbation in NCI-H1573 cell line |
| Fedratinib (hydrochloride hydrate)_HEC-1-A | Fedratinib (hydrochloride hydrate) perturbation in HEC-1-A cell line |
| Terfenadine_HS-578T | Terfenadine perturbation in HS-578T cell line |
| Fedratinib (hydrochloride hydrate)_HCT15 | Fedratinib (hydrochloride hydrate) perturbation in HCT15 cell line |
| Bosentan (hydrate)_NCI-H2122 | Bosentan (hydrate) perturbation in NCI-H2122 cell line |
| Dexamethasone_NCI-H23 | Dexamethasone perturbation in NCI-H23 cell line |
| Pimozide_NCI-H596 | Pimozide perturbation in NCI-H596 cell line |
| Lumateperone (tosylate)_LS 180 | Lumateperone (tosylate) perturbation in LS 180 cell line |
| Isocorydine_HOP62 | Isocorydine perturbation in HOP62 cell line |
| Dinaciclib_hTERT-HPNE | Dinaciclib perturbation in hTERT-HPNE cell line |
| Alpelisib_SHP-77 | Alpelisib perturbation in SHP-77 cell line |
| AZD1390_LOX-IMVI | AZD1390 perturbation in LOX-IMVI cell line |
| Docetaxel_J82 | Docetaxel perturbation in J82 cell line |
| XRK3F2_CHP-212 | XRK3F2 perturbation in CHP-212 cell line |
| LJI308_SW48 | LJI308 perturbation in SW48 cell line |
| Lidocaine (hydrochloride)_PANC-1 | Lidocaine (hydrochloride) perturbation in PANC-1 cell line |
| Delamanid_SW1417 | Delamanid perturbation in SW1417 cell line |
| DTP3_A-427 | DTP3 perturbation in A-427 cell line |
| Binimetinib_SNU-1 | Binimetinib perturbation in SNU-1 cell line |
| Torkinib_A-427 | Torkinib perturbation in A-427 cell line |
| Anethole trithione_HS-578T | Anethole trithione perturbation in HS-578T cell line |
| Peretinoin_HOP62 | Peretinoin perturbation in HOP62 cell line |
| Mebendazole_KATO III | Mebendazole perturbation in KATO III cell line |
| γ-Oryzanol_AsPC-1 | γ-Oryzanol perturbation in AsPC-1 cell line |
| 18β-Glycyrrhetinic acid_SW48 | 18β-Glycyrrhetinic acid perturbation in SW48 cell line |
| Mebendazole_J82 | Mebendazole perturbation in J82 cell line |
| Rimonabant_SW480 | Rimonabant perturbation in SW480 cell line |
| Trimetrexate_SHP-77 | Trimetrexate perturbation in SHP-77 cell line |
| Auranofin_SNU-1 | Auranofin perturbation in SNU-1 cell line |
| Fumaric acid_LoVo | Fumaric acid perturbation in LoVo cell line |
| Riluzole hydrochloride_HS-578T | Riluzole hydrochloride perturbation in HS-578T cell line |
| ML264_NCI-H661 | ML264 perturbation in NCI-H661 cell line |
| L-Thyroxine (sodium salt pentahydrate)_C-33 A | L-Thyroxine (sodium salt pentahydrate) perturbation in C-33 A cell line |
| Fedratinib (hydrochloride hydrate)_PANC-1 | Fedratinib (hydrochloride hydrate) perturbation in PANC-1 cell line |
| Oxaliplatin_NCI-H460 | Oxaliplatin perturbation in NCI-H460 cell line |
| AZD-7648_NCI-H596 | AZD-7648 perturbation in NCI-H596 cell line |
| Phenytoin (sodium)_LoVo | Phenytoin (sodium) perturbation in LoVo cell line |
| Tubulin inhibitor 6_hTERT-HPNE | Tubulin inhibitor 6 perturbation in hTERT-HPNE cell line |
| Medroxyprogesterone acetate_HOP62 | Medroxyprogesterone acetate perturbation in HOP62 cell line |
| Pyridoxine_LoVo | Pyridoxine perturbation in LoVo cell line |
| Flutamide_SW48 | Flutamide perturbation in SW48 cell line |
| AZD1390_NCI-H2347 | AZD1390 perturbation in NCI-H2347 cell line |
| MK-8353_CHP-212 | MK-8353 perturbation in CHP-212 cell line |
| Phenytoin (sodium)_MIA PaCa-2 | Phenytoin (sodium) perturbation in MIA PaCa-2 cell line |
| Sildenafil_AsPC-1 | Sildenafil perturbation in AsPC-1 cell line |
| IQ 1_CHP-212 | IQ 1 perturbation in CHP-212 cell line |
| Peretinoin_MIA PaCa-2 | Peretinoin perturbation in MIA PaCa-2 cell line |
| Procainamide (hydrochloride)_NCI-H596 | Procainamide (hydrochloride) perturbation in NCI-H596 cell line |
| Cysteamine (hydrochloride)_SK-MEL-2 | Cysteamine (hydrochloride) perturbation in SK-MEL-2 cell line |
| Tubulin inhibitor 6_LS 180 | Tubulin inhibitor 6 perturbation in LS 180 cell line |
| Panobinostat_C-33 A | Panobinostat perturbation in C-33 A cell line |
| Verapamil_NCI-H2347 | Verapamil perturbation in NCI-H2347 cell line |
| Terfenadine_HEC-1-A | Terfenadine perturbation in HEC-1-A cell line |
| Cabozantinib (S-malate)_LOX-IMVI | Cabozantinib (S-malate) perturbation in LOX-IMVI cell line |
| LJI308_AN3 CA | LJI308 perturbation in AN3 CA cell line |
| Ciclopirox_hTERT-HPNE | Ciclopirox perturbation in hTERT-HPNE cell line |
| Darolutamide_LOX-IMVI | Darolutamide perturbation in LOX-IMVI cell line |
| AT7519_NCI-H23 | AT7519 perturbation in NCI-H23 cell line |
| NVP-BHG712_NCI-H596 | NVP-BHG712 perturbation in NCI-H596 cell line |
| Norepinephrine (hydrochloride)_MIA PaCa-2 | Norepinephrine (hydrochloride) perturbation in MIA PaCa-2 cell line |
| Daptomycin_LS 180 | Daptomycin perturbation in LS 180 cell line |
| Encorafenib_A549 | Encorafenib perturbation in A549 cell line |
| Norepinephrine (hydrochloride)_LoVo | Norepinephrine (hydrochloride) perturbation in LoVo cell line |
| Cabozantinib (S-malate)_RKO | Cabozantinib (S-malate) perturbation in RKO cell line |
| palbociclib_HCT15 | palbociclib perturbation in HCT15 cell line |
| Oxaliplatin_NCI-H23 | Oxaliplatin perturbation in NCI-H23 cell line |
| XRK3F2_J82 | XRK3F2 perturbation in J82 cell line |
| vincristine_NCI-H661 | vincristine perturbation in NCI-H661 cell line |
| Ivermectin_RKO | Ivermectin perturbation in RKO cell line |
| LJI308_C32 | LJI308 perturbation in C32 cell line |
| Hexylresorcinol_HS-578T | Hexylresorcinol perturbation in HS-578T cell line |
| TAK-733_SHP-77 | TAK-733 perturbation in SHP-77 cell line |
| Clofarabine_hTERT-HPNE | Clofarabine perturbation in hTERT-HPNE cell line |
| BI-3406_LoVo | BI-3406 perturbation in LoVo cell line |
| Lapatinib ditosylate_A-427 | Lapatinib ditosylate perturbation in A-427 cell line |
| Thymol_C-33 A | Thymol perturbation in C-33 A cell line |
| Flutamide_AN3 CA | Flutamide perturbation in AN3 CA cell line |
| Anastrozole_A-427 | Anastrozole perturbation in A-427 cell line |
| Mebendazole_CFPAC-1 | Mebendazole perturbation in CFPAC-1 cell line |
| Rimonabant_hTERT-HPNE | Rimonabant perturbation in hTERT-HPNE cell line |
| Riluzole hydrochloride_HEC-1-A | Riluzole hydrochloride perturbation in HEC-1-A cell line |
| Irinotecan (hydrochloride)_HT-29 | Irinotecan (hydrochloride) perturbation in HT-29 cell line |
| Berbamine_SW48 | Berbamine perturbation in SW48 cell line |
| Paclitaxel_NCI-H596 | Paclitaxel perturbation in NCI-H596 cell line |
| Delamanid_NCI-H2030 | Delamanid perturbation in NCI-H2030 cell line |
| Pentagastrin_CHP-212 | Pentagastrin perturbation in CHP-212 cell line |
| Cysteamine (hydrochloride)_NCI-H596 | Cysteamine (hydrochloride) perturbation in NCI-H596 cell line |
| IQ 1_KATO III | IQ 1 perturbation in KATO III cell line |
| Vilanterol_HEC-1-A | Vilanterol perturbation in HEC-1-A cell line |
| Fumaric acid_NCI-H1792 | Fumaric acid perturbation in NCI-H1792 cell line |
| Eplerenone_NCI-H596 | Eplerenone perturbation in NCI-H596 cell line |
| Belumosudil_KATO III | Belumosudil perturbation in KATO III cell line |
| Furosemide_A-427 | Furosemide perturbation in A-427 cell line |
| NVP-BHG712_SK-MEL-2 | NVP-BHG712 perturbation in SK-MEL-2 cell line |
| Pemigatinib_CHP-212 | Pemigatinib perturbation in CHP-212 cell line |
| Cyclosporin A_CFPAC-1 | Cyclosporin A perturbation in CFPAC-1 cell line |
| L-Eflornithine (monohydrochloride)_RKO | L-Eflornithine (monohydrochloride) perturbation in RKO cell line |
| Esmolol (hydrochloride)_HCT15 | Esmolol (hydrochloride) perturbation in HCT15 cell line |
| LJI308_NCI-H2122 | LJI308 perturbation in NCI-H2122 cell line |
| Furosemide_C32 | Furosemide perturbation in C32 cell line |
| Cepharanthine_AN3 CA | Cepharanthine perturbation in AN3 CA cell line |
| OTS514_NCI-H596 | OTS514 perturbation in NCI-H596 cell line |
| vincristine_HEC-1-A | vincristine perturbation in HEC-1-A cell line |
| CP21R7_Panc 03.27 | CP21R7 perturbation in Panc 03.27 cell line |
| Dimethyl fumarate_CFPAC-1 | Dimethyl fumarate perturbation in CFPAC-1 cell line |
| LJI308_A-427 | LJI308 perturbation in A-427 cell line |
| Anethole trithione_PANC-1 | Anethole trithione perturbation in PANC-1 cell line |
| Doxorubicin (hydrochloride)_NCI-H596 | Doxorubicin (hydrochloride) perturbation in NCI-H596 cell line |
| Gallic acid_NCI-H2030 | Gallic acid perturbation in NCI-H2030 cell line |
| Vitamin K4_Panc 03.27 | Vitamin K4 perturbation in Panc 03.27 cell line |
| Nimesulide_NCI-H2347 | Nimesulide perturbation in NCI-H2347 cell line |
| Dorzolamide (hydrochloride)_SHP-77 | Dorzolamide (hydrochloride) perturbation in SHP-77 cell line |
| Furosemide_AN3 CA | Furosemide perturbation in AN3 CA cell line |
| Belumosudil (mesylate)_NCI-H23 | Belumosudil (mesylate) perturbation in NCI-H23 cell line |
| Mebendazole_SNU-423 | Mebendazole perturbation in SNU-423 cell line |
| Riluzole hydrochloride_PANC-1 | Riluzole hydrochloride perturbation in PANC-1 cell line |
| Decitabine_CFPAC-1 | Decitabine perturbation in CFPAC-1 cell line |
| Mifepristone_PANC-1 | Mifepristone perturbation in PANC-1 cell line |
| ETC-206_NCI-H23 | ETC-206 perturbation in NCI-H23 cell line |
| Elagolix sodium_HS-578T | Elagolix sodium perturbation in HS-578T cell line |
| Piroxicam_SNU-1 | Piroxicam perturbation in SNU-1 cell line |
| Mebendazole_MIA PaCa-2 | Mebendazole perturbation in MIA PaCa-2 cell line |
| Ouabain (Octahydrate)_A-427 | Ouabain (Octahydrate) perturbation in A-427 cell line |
| TAK-733_C-33 A | TAK-733 perturbation in C-33 A cell line |
| Sunitinib_SW1417 | Sunitinib perturbation in SW1417 cell line |
| Brivudine_A-172 | Brivudine perturbation in A-172 cell line |
| Mebendazole_LoVo | Mebendazole perturbation in LoVo cell line |
| LB-100_C-33 A | LB-100 perturbation in C-33 A cell line |
| Harringtonine_AsPC-1 | Harringtonine perturbation in AsPC-1 cell line |
| Almonertinib (mesylate)_NCI-H2347 | Almonertinib (mesylate) perturbation in NCI-H2347 cell line |
| ULK-101_LS 180 | ULK-101 perturbation in LS 180 cell line |
| AZD1390_NCI-H23 | AZD1390 perturbation in NCI-H23 cell line |
| LY-2584702 (tosylate salt)_SHP-77 | LY-2584702 (tosylate salt) perturbation in SHP-77 cell line |
| Pentagastrin_LoVo | Pentagastrin perturbation in LoVo cell line |
| Saquinavir_HEC-1-A | Saquinavir perturbation in HEC-1-A cell line |
| Fedratinib (hydrochloride hydrate)_HS-578T | Fedratinib (hydrochloride hydrate) perturbation in HS-578T cell line |
| Peretinoin_J82 | Peretinoin perturbation in J82 cell line |
| Lapatinib ditosylate_AN3 CA | Lapatinib ditosylate perturbation in AN3 CA cell line |
| Pentagastrin_SNU-423 | Pentagastrin perturbation in SNU-423 cell line |
| Trametinib (DMSO_NCI-H2122 | Trametinib (DMSO perturbation in NCI-H2122 cell line |
| Mebendazole_HOP62 | Mebendazole perturbation in HOP62 cell line |
| Fluvoxamine_NCI-H2347 | Fluvoxamine perturbation in NCI-H2347 cell line |
| Mifepristone_NCI-H661 | Mifepristone perturbation in NCI-H661 cell line |
| Almonertinib (hydrochloride)_HOP62 | Almonertinib (hydrochloride) perturbation in HOP62 cell line |
| CP21R7_NCI-H23 | CP21R7 perturbation in NCI-H23 cell line |
| IQ 1_SHP-77 | IQ 1 perturbation in SHP-77 cell line |
| Cepharanthine_HOP62 | Cepharanthine perturbation in HOP62 cell line |
| Infigratinib_NCI-H596 | Infigratinib perturbation in NCI-H596 cell line |
| Peretinoin_C-33 A | Peretinoin perturbation in C-33 A cell line |
| Encorafenib_COLO 205 | Encorafenib perturbation in COLO 205 cell line |
| Raltitrexed_HS-578T | Raltitrexed perturbation in HS-578T cell line |
| Talc_RKO | Talc perturbation in RKO cell line |
| vincristine_Hs 766T | vincristine perturbation in Hs 766T cell line |
| Daptomycin_NCI-H2030 | Daptomycin perturbation in NCI-H2030 cell line |
| AZD-8055_PANC-1 | AZD-8055 perturbation in PANC-1 cell line |
| Harringtonine_LS 180 | Harringtonine perturbation in LS 180 cell line |
| Irinotecan (hydrochloride)_HCT15 | Irinotecan (hydrochloride) perturbation in HCT15 cell line |
| Medroxyprogesterone acetate_SW 900 | Medroxyprogesterone acetate perturbation in SW 900 cell line |
| Pimozide_HEC-1-A | Pimozide perturbation in HEC-1-A cell line |
| Cepharanthine_MIA PaCa-2 | Cepharanthine perturbation in MIA PaCa-2 cell line |
| Lucanthone_HOP62 | Lucanthone perturbation in HOP62 cell line |
| Zileuton_C32 | Zileuton perturbation in C32 cell line |
| Brivudine_NCI-H596 | Brivudine perturbation in NCI-H596 cell line |
| Mebendazole_C32 | Mebendazole perturbation in C32 cell line |
| Tubulin inhibitor 6_NCI-H2030 | Tubulin inhibitor 6 perturbation in NCI-H2030 cell line |
| TAK-733_J82 | TAK-733 perturbation in J82 cell line |
| Medroxyprogesterone acetate_C-33 A | Medroxyprogesterone acetate perturbation in C-33 A cell line |
| Cepharanthine_LoVo | Cepharanthine perturbation in LoVo cell line |
| XRK3F2_SW48 | XRK3F2 perturbation in SW48 cell line |
| LJI308_CHP-212 | LJI308 perturbation in CHP-212 cell line |
| NVP-BHG712_HS-578T | NVP-BHG712 perturbation in HS-578T cell line |
| Docetaxel_C32 | Docetaxel perturbation in C32 cell line |
| XRK3F2_SHP-77 | XRK3F2 perturbation in SHP-77 cell line |
| Irinotecan (hydrochloride)_PANC-1 | Irinotecan (hydrochloride) perturbation in PANC-1 cell line |
| Cysteamine (hydrochloride)_HS-578T | Cysteamine (hydrochloride) perturbation in HS-578T cell line |
| Oxaliplatin_SNU-1 | Oxaliplatin perturbation in SNU-1 cell line |
| Pentagastrin_NCI-H1573 | Pentagastrin perturbation in NCI-H1573 cell line |
| Sodium Salicylate_SHP-77 | Sodium Salicylate perturbation in SHP-77 cell line |
| Abiraterone acetate_HS-578T | Abiraterone acetate perturbation in HS-578T cell line |
| Azithromycin (hydrate)_LS 180 | Azithromycin (hydrate) perturbation in LS 180 cell line |
| BI-3406_A-427 | BI-3406 perturbation in A-427 cell line |
| Triamcinolone_A-427 | Triamcinolone perturbation in A-427 cell line |
| Ivabradine (hydrochloride)_NCI-H596 | Ivabradine (hydrochloride) perturbation in NCI-H596 cell line |
| Decitabine_A-427 | Decitabine perturbation in A-427 cell line |
| Plicamycin_SHP-77 | Plicamycin perturbation in SHP-77 cell line |
| Ranolazine_NCI-H2122 | Ranolazine perturbation in NCI-H2122 cell line |
| Belzutifan_PANC-1 | Belzutifan perturbation in PANC-1 cell line |
| Furosemide_LoVo | Furosemide perturbation in LoVo cell line |
| Temuterkib_NCI-H23 | Temuterkib perturbation in NCI-H23 cell line |
| Atazanavir (sulfate)_NCI-H2030 | Atazanavir (sulfate) perturbation in NCI-H2030 cell line |
| Anastrozole_HOP62 | Anastrozole perturbation in HOP62 cell line |
| Benztropine (mesylate)_HEC-1-A | Benztropine (mesylate) perturbation in HEC-1-A cell line |
| Pexidartinib (hydrochloride)_RKO | Pexidartinib (hydrochloride) perturbation in RKO cell line |
| Mebendazole_NCI-H1573 | Mebendazole perturbation in NCI-H1573 cell line |
| Glasdegib_AsPC-1 | Glasdegib perturbation in AsPC-1 cell line |
| Megestrol_CHP-212 | Megestrol perturbation in CHP-212 cell line |
| Rifaximin_CFPAC-1 | Rifaximin perturbation in CFPAC-1 cell line |
| Mebendazole_AN3 CA | Mebendazole perturbation in AN3 CA cell line |
| MK-8353_SW 900 | MK-8353 perturbation in SW 900 cell line |
| Gallic acid_LS 180 | Gallic acid perturbation in LS 180 cell line |
| IQ 1_C-33 A | IQ 1 perturbation in C-33 A cell line |
| ERK5-IN-2_SHP-77 | ERK5-IN-2 perturbation in SHP-77 cell line |
| Phenytoin (sodium)_SHP-77 | Phenytoin (sodium) perturbation in SHP-77 cell line |
| Tubulin inhibitor 6_COLO 205 | Tubulin inhibitor 6 perturbation in COLO 205 cell line |
| Cilostazol_HS-578T | Cilostazol perturbation in HS-578T cell line |
| Clonidine (hydrochloride)_NCI-H23 | Clonidine (hydrochloride) perturbation in NCI-H23 cell line |
| IQ 1_SW 900 | IQ 1 perturbation in SW 900 cell line |
| Dexmedetomidine_HepG2/C3A | Dexmedetomidine perturbation in HepG2/C3A cell line |
| LJI308_MIA PaCa-2 | LJI308 perturbation in MIA PaCa-2 cell line |
| Dexmedetomidine_NCI-H2030 | Dexmedetomidine perturbation in NCI-H2030 cell line |
| S-Adenosyl-L-methionine (disulfate tosylate)_HCT15 | S-Adenosyl-L-methionine (disulfate tosylate) perturbation in HCT15 cell line |
| Flumatinib (mesylate)_CFPAC-1 | Flumatinib (mesylate) perturbation in CFPAC-1 cell line |
| Isocorydine_SW48 | Isocorydine perturbation in SW48 cell line |
| BI-78D3_NCI-H596 | BI-78D3 perturbation in NCI-H596 cell line |
| OTS514_HS-578T | OTS514 perturbation in HS-578T cell line |
| Cepharanthine_CHP-212 | Cepharanthine perturbation in CHP-212 cell line |
| Fumaric acid_SHP-77 | Fumaric acid perturbation in SHP-77 cell line |
| Pimozide_PANC-1 | Pimozide perturbation in PANC-1 cell line |
| 9-ING-41_Panc 03.27 | 9-ING-41 perturbation in Panc 03.27 cell line |
| Triamcinolone_C32 | Triamcinolone perturbation in C32 cell line |
| Dorzolamide (hydrochloride)_J82 | Dorzolamide (hydrochloride) perturbation in J82 cell line |
| Ranolazine_AN3 CA | Ranolazine perturbation in AN3 CA cell line |
| Anastrozole_CHP-212 | Anastrozole perturbation in CHP-212 cell line |
| Zileuton_A-427 | Zileuton perturbation in A-427 cell line |
| Mebendazole_A-427 | Mebendazole perturbation in A-427 cell line |
| XRK3F2_SW 900 | XRK3F2 perturbation in SW 900 cell line |
| Fumaric acid_SW48 | Fumaric acid perturbation in SW48 cell line |
| Bergenin_NCI-H2347 | Bergenin perturbation in NCI-H2347 cell line |
| HI-TOPK-032_NCI-H2347 | HI-TOPK-032 perturbation in NCI-H2347 cell line |
| AZD-7648_PANC-1 | AZD-7648 perturbation in PANC-1 cell line |
| Mitoxantrone (dihydrochloride)_hTERT-HPNE | Mitoxantrone (dihydrochloride) perturbation in hTERT-HPNE cell line |
| Ixazomib citrate_AsPC-1 | Ixazomib citrate perturbation in AsPC-1 cell line |
| Medroxyprogesterone acetate_SW48 | Medroxyprogesterone acetate perturbation in SW48 cell line |
| Megestrol_HOP62 | Megestrol perturbation in HOP62 cell line |
| Pexidartinib (hydrochloride)_NCI-H460 | Pexidartinib (hydrochloride) perturbation in NCI-H460 cell line |
| Drospirenone_PANC-1 | Drospirenone perturbation in PANC-1 cell line |
| Flutamide_MIA PaCa-2 | Flutamide perturbation in MIA PaCa-2 cell line |
| Pentagastrin_A-427 | Pentagastrin perturbation in A-427 cell line |
| Gallic acid_SW480 | Gallic acid perturbation in SW480 cell line |
| Peretinoin_SW48 | Peretinoin perturbation in SW48 cell line |
| Megestrol_LoVo | Megestrol perturbation in LoVo cell line |
| Belzutifan_HEC-1-A | Belzutifan perturbation in HEC-1-A cell line |
| Cabozantinib (S-malate)_SNU-1 | Cabozantinib (S-malate) perturbation in SNU-1 cell line |
| Raltitrexed_PANC-1 | Raltitrexed perturbation in PANC-1 cell line |
| LY-2584702 (tosylate salt)_CHP-212 | LY-2584702 (tosylate salt) perturbation in CHP-212 cell line |
| Lenalidomide (hemihydrate)_NCI-H2030 | Lenalidomide (hemihydrate) perturbation in NCI-H2030 cell line |
| CP21R7_NCI-H2347 | CP21R7 perturbation in NCI-H2347 cell line |
| NVP-BHG712_NCI-H661 | NVP-BHG712 perturbation in NCI-H661 cell line |
| 4EGI-1_PANC-1 | 4EGI-1 perturbation in PANC-1 cell line |
| Isocorydine_AN3 CA | Isocorydine perturbation in AN3 CA cell line |
| Darolutamide_SNU-1 | Darolutamide perturbation in SNU-1 cell line |
| Pentagastrin_C-33 A | Pentagastrin perturbation in C-33 A cell line |
| Cilostazol_HEC-1-A | Cilostazol perturbation in HEC-1-A cell line |
| Pentamidine (isethionate)_HEC-1-A | Pentamidine (isethionate) perturbation in HEC-1-A cell line |
| Decitabine_SHP-77 | Decitabine perturbation in SHP-77 cell line |
| Mebendazole_C-33 A | Mebendazole perturbation in C-33 A cell line |
| Rucaparib (phosphate)_HS-578T | Rucaparib (phosphate) perturbation in HS-578T cell line |
| vincristine_NCI-H596 | vincristine perturbation in NCI-H596 cell line |
| Medroxyprogesterone acetate_C32 | Medroxyprogesterone acetate perturbation in C32 cell line |
| Almonertinib (hydrochloride)_SW 900 | Almonertinib (hydrochloride) perturbation in SW 900 cell line |
| Topotecan (hydrochloride)_SW1417 | Topotecan (hydrochloride) perturbation in SW1417 cell line |
| Allantoin_A549 | Allantoin perturbation in A549 cell line |
| Radotinib_NCI-H2347 | Radotinib perturbation in NCI-H2347 cell line |
| Mebendazole_SW 900 | Mebendazole perturbation in SW 900 cell line |
| Isocorydine_C32 | Isocorydine perturbation in C32 cell line |
| Vandetanib_NCI-H460 | Vandetanib perturbation in NCI-H460 cell line |
| L-Eflornithine (monohydrochloride)_SNU-1 | L-Eflornithine (monohydrochloride) perturbation in SNU-1 cell line |
| Fluvoxamine_Panc 03.27 | Fluvoxamine perturbation in Panc 03.27 cell line |
| ERK5-IN-2_NCI-H1573 | ERK5-IN-2 perturbation in NCI-H1573 cell line |
| Triamcinolone_SW48 | Triamcinolone perturbation in SW48 cell line |
| Irinotecan (hydrochloride)_HS-578T | Irinotecan (hydrochloride) perturbation in HS-578T cell line |
| Adenosine_SW 1271 | Adenosine perturbation in SW 1271 cell line |
| Berbamine_MIA PaCa-2 | Berbamine perturbation in MIA PaCa-2 cell line |
| Cysteamine (hydrochloride)_PANC-1 | Cysteamine (hydrochloride) perturbation in PANC-1 cell line |
| Encorafenib_BT-474 | Encorafenib perturbation in BT-474 cell line |
| Dorzolamide (hydrochloride)_CHP-212 | Dorzolamide (hydrochloride) perturbation in CHP-212 cell line |
| Decitabine_SW48 | Decitabine perturbation in SW48 cell line |
| Norepinephrine (hydrochloride)_SHP-77 | Norepinephrine (hydrochloride) perturbation in SHP-77 cell line |
| Diammonium Glycyrrhizinate_NCI-H23 | Diammonium Glycyrrhizinate perturbation in NCI-H23 cell line |
| Medroxyprogesterone acetate_AN3 CA | Medroxyprogesterone acetate perturbation in AN3 CA cell line |
| Gallic acid_hTERT-HPNE | Gallic acid perturbation in hTERT-HPNE cell line |
| IQ 1_A-427 | IQ 1 perturbation in A-427 cell line |
| Cysteamine (hydrochloride)_H4 | Cysteamine (hydrochloride) perturbation in H4 cell line |
| Raltitrexed_HCT15 | Raltitrexed perturbation in HCT15 cell line |
| Niclosamide (olamine)_HEC-1-A | Niclosamide (olamine) perturbation in HEC-1-A cell line |
| Loperamide (hydrochloride)_SW 1088 | Loperamide (hydrochloride) perturbation in SW 1088 cell line |
| Belzutifan_HS-578T | Belzutifan perturbation in HS-578T cell line |
| Darinaparsin_LS 180 | Darinaparsin perturbation in LS 180 cell line |
| PF-06260933_HEC-1-A | PF-06260933 perturbation in HEC-1-A cell line |
| Voriconazole_NCI-H596 | Voriconazole perturbation in NCI-H596 cell line |
| Fumaric acid_NCI-H1573 | Fumaric acid perturbation in NCI-H1573 cell line |
| MK-3903_NCI-H596 | MK-3903 perturbation in NCI-H596 cell line |
| Pentagastrin_SHP-77 | Pentagastrin perturbation in SHP-77 cell line |
| Cilostazol_PANC-1 | Cilostazol perturbation in PANC-1 cell line |
| XRK3F2_AN3 CA | XRK3F2 perturbation in AN3 CA cell line |
| PF-06260933_HCT15 | PF-06260933 perturbation in HCT15 cell line |
| Proglumide_NCI-H23 | Proglumide perturbation in NCI-H23 cell line |
| Cytarabine (hydrochloride)_SNU-1 | Cytarabine (hydrochloride) perturbation in SNU-1 cell line |
| IQ 1_C32 | IQ 1 perturbation in C32 cell line |
| Irinotecan (hydrochloride)_A-172 | Irinotecan (hydrochloride) perturbation in A-172 cell line |
| Riluzole hydrochloride_SK-MEL-2 | Riluzole hydrochloride perturbation in SK-MEL-2 cell line |
| Allantoin_LS 180 | Allantoin perturbation in LS 180 cell line |
| Malotilate_C-33 A | Malotilate perturbation in C-33 A cell line |
| Raltitrexed_HEC-1-A | Raltitrexed perturbation in HEC-1-A cell line |
| Dinaciclib_SW1417 | Dinaciclib perturbation in SW1417 cell line |
| Terfenadine_NCI-H596 | Terfenadine perturbation in NCI-H596 cell line |
| Loperamide (hydrochloride)_AsPC-1 | Loperamide (hydrochloride) perturbation in AsPC-1 cell line |
| OTS514_PANC-1 | OTS514 perturbation in PANC-1 cell line |
| TAK-733_CHP-212 | TAK-733 perturbation in CHP-212 cell line |
| Piroxicam_NCI-H2347 | Piroxicam perturbation in NCI-H2347 cell line |
| Delamanid_hTERT-HPNE | Delamanid perturbation in hTERT-HPNE cell line |
| Mebendazole_SHP-77 | Mebendazole perturbation in SHP-77 cell line |
| Cilostazol_NCI-H661 | Cilostazol perturbation in NCI-H661 cell line |
| Edoxaban (tosylate monohydrate)_NCI-H2347 | Edoxaban (tosylate monohydrate) perturbation in NCI-H2347 cell line |
| Piroxicam_LOX-IMVI | Piroxicam perturbation in LOX-IMVI cell line |
| Abiraterone acetate_HEC-1-A | Abiraterone acetate perturbation in HEC-1-A cell line |
| Berbamine_CFPAC-1 | Berbamine perturbation in CFPAC-1 cell line |
| Cabozantinib (S-malate)_Panc 03.27 | Cabozantinib (S-malate) perturbation in Panc 03.27 cell line |
| Fumaric acid_A-427 | Fumaric acid perturbation in A-427 cell line |
| Bergenin_NCI-H23 | Bergenin perturbation in NCI-H23 cell line |
| Berbamine_CHP-212 | Berbamine perturbation in CHP-212 cell line |
| Delamanid_RPMI-7951 | Delamanid perturbation in RPMI-7951 cell line |
| Esmolol (hydrochloride)_NCI-H596 | Esmolol (hydrochloride) perturbation in NCI-H596 cell line |
| S-Adenosyl-L-methionine (disulfate tosylate)_HS-578T | S-Adenosyl-L-methionine (disulfate tosylate) perturbation in HS-578T cell line |
| IQ 1_NCI-H1573 | IQ 1 perturbation in NCI-H1573 cell line |
| Medroxyprogesterone acetate_A-427 | Medroxyprogesterone acetate perturbation in A-427 cell line |
| IQ 1_AN3 CA | IQ 1 perturbation in AN3 CA cell line |
| Dimethyl fumarate_C-33 A | Dimethyl fumarate perturbation in C-33 A cell line |
| Roxadustat_SW 1088 | Roxadustat perturbation in SW 1088 cell line |
| Cyclosporin A_SW48 | Cyclosporin A perturbation in SW48 cell line |
| Megestrol_KATO III | Megestrol perturbation in KATO III cell line |
| Belinostat_NCI-H596 | Belinostat perturbation in NCI-H596 cell line |
| Pentagastrin_SW48 | Pentagastrin perturbation in SW48 cell line |
| BAY1125976_NCI-H661 | BAY1125976 perturbation in NCI-H661 cell line |
| Canagliflozin (hemihydrate)_MIA PaCa-2 | Canagliflozin (hemihydrate) perturbation in MIA PaCa-2 cell line |
| Fedratinib (hydrochloride hydrate)_HT-29 | Fedratinib (hydrochloride hydrate) perturbation in HT-29 cell line |
| Piroxicam_RKO | Piroxicam perturbation in RKO cell line |
| ERK5-IN-2_A-427 | ERK5-IN-2 perturbation in A-427 cell line |
| Peretinoin_A-427 | Peretinoin perturbation in A-427 cell line |
| Fedratinib (hydrochloride hydrate)_SW1417 | Fedratinib (hydrochloride hydrate) perturbation in SW1417 cell line |
| Oxaliplatin_C-33 A | Oxaliplatin perturbation in C-33 A cell line |
| Gallic acid_HEC-1-A | Gallic acid perturbation in HEC-1-A cell line |
| Binimetinib_MIA PaCa-2 | Binimetinib perturbation in MIA PaCa-2 cell line |
| ETC-206_A498 | ETC-206 perturbation in A498 cell line |
| Oxaliplatin_SW 900 | Oxaliplatin perturbation in SW 900 cell line |
| Lenalidomide (hemihydrate)_NCI-H596 | Lenalidomide (hemihydrate) perturbation in NCI-H596 cell line |
| Bimiralisib_SW48 | Bimiralisib perturbation in SW48 cell line |
| Lactate (calcium)_CHP-212 | Lactate (calcium) perturbation in CHP-212 cell line |
| Ferulic acid_AsPC-1 | Ferulic acid perturbation in AsPC-1 cell line |
| HI-TOPK-032_HOP62 | HI-TOPK-032 perturbation in HOP62 cell line |
| Cytarabine (hydrochloride)_A-427 | Cytarabine (hydrochloride) perturbation in A-427 cell line |
| Quinidine (15% dihydroquinidine)_NCI-H1792 | Quinidine (15% dihydroquinidine) perturbation in NCI-H1792 cell line |
| SBI-0640756_SHP-77 | SBI-0640756 perturbation in SHP-77 cell line |
| Estrone sulfate (potassium)_HT-29 | Estrone sulfate (potassium) perturbation in HT-29 cell line |
| Naproxen_CHP-212 | Naproxen perturbation in CHP-212 cell line |
| Ropivacaine (hydrochloride monohydrate)_CHP-212 | Ropivacaine (hydrochloride monohydrate) perturbation in CHP-212 cell line |
| Daptomycin_HT-29 | Daptomycin perturbation in HT-29 cell line |
| SBI-0640756_SW48 | SBI-0640756 perturbation in SW48 cell line |
| Ipatasertib_HS-578T | Ipatasertib perturbation in HS-578T cell line |
| Irinotecan (hydrochloride)_LS 180 | Irinotecan (hydrochloride) perturbation in LS 180 cell line |
| Darolutamide_C32 | Darolutamide perturbation in C32 cell line |
| Adenosine_HT-29 | Adenosine perturbation in HT-29 cell line |
| Delamanid_PANC-1 | Delamanid perturbation in PANC-1 cell line |
| Phenytoin (sodium)_SNU-1 | Phenytoin (sodium) perturbation in SNU-1 cell line |
| Minodronic acid_C-33 A | Minodronic acid perturbation in C-33 A cell line |
| Dinaciclib_Hs 766T | Dinaciclib perturbation in Hs 766T cell line |
| Verapamil_AN3 CA | Verapamil perturbation in AN3 CA cell line |
| Delamanid_NCI-H661 | Delamanid perturbation in NCI-H661 cell line |
| Cilostazol_hTERT-HPNE | Cilostazol perturbation in hTERT-HPNE cell line |
| Belzutifan_LS 180 | Belzutifan perturbation in LS 180 cell line |
| Darinaparsin_HS-578T | Darinaparsin perturbation in HS-578T cell line |
| Fumaric acid_SNU-1 | Fumaric acid perturbation in SNU-1 cell line |
| Sapanisertib_HS-578T | Sapanisertib perturbation in HS-578T cell line |
| AZD-7648_A549 | AZD-7648 perturbation in A549 cell line |
| Pexidartinib (hydrochloride)_CFPAC-1 | Pexidartinib (hydrochloride) perturbation in CFPAC-1 cell line |
| Talc_MIA PaCa-2 | Talc perturbation in MIA PaCa-2 cell line |
| HI-TOPK-032_CHP-212 | HI-TOPK-032 perturbation in CHP-212 cell line |
| Bergenin_CHP-212 | Bergenin perturbation in CHP-212 cell line |
| Ivabradine (hydrochloride)_SW1417 | Ivabradine (hydrochloride) perturbation in SW1417 cell line |
| Cabozantinib (S-malate)_NCI-H2122 | Cabozantinib (S-malate) perturbation in NCI-H2122 cell line |
| Dexmedetomidine_Hs 766T | Dexmedetomidine perturbation in Hs 766T cell line |
| vincristine_COLO 205 | vincristine perturbation in COLO 205 cell line |
| Minodronic acid_SW48 | Minodronic acid perturbation in SW48 cell line |
| Allantoin_HS-578T | Allantoin perturbation in HS-578T cell line |
| Binimetinib_CHP-212 | Binimetinib perturbation in CHP-212 cell line |
| Oxaliplatin_SHP-77 | Oxaliplatin perturbation in SHP-77 cell line |
| Peretinoin_Panc 03.27 | Peretinoin perturbation in Panc 03.27 cell line |
| Cobimetinib_HS-578T | Cobimetinib perturbation in HS-578T cell line |
| Vemurafenib_KATO III | Vemurafenib perturbation in KATO III cell line |
| XRK3F2_SNU-1 | XRK3F2 perturbation in SNU-1 cell line |
| Flumatinib (mesylate)_LOX-IMVI | Flumatinib (mesylate) perturbation in LOX-IMVI cell line |
| Hydroxyfasudil_HT-29 | Hydroxyfasudil perturbation in HT-29 cell line |
| Darolutamide_NCI-H2122 | Darolutamide perturbation in NCI-H2122 cell line |
| Temsirolimus_SHP-77 | Temsirolimus perturbation in SHP-77 cell line |
| 9-ING-41_SHP-77 | 9-ING-41 perturbation in SHP-77 cell line |
| Fenofibrate_MIA PaCa-2 | Fenofibrate perturbation in MIA PaCa-2 cell line |
| Cabozantinib (S-malate)_A-427 | Cabozantinib (S-malate) perturbation in A-427 cell line |
| NVP-BHG712_RPMI-7951 | NVP-BHG712 perturbation in RPMI-7951 cell line |
| L-Thyroxine (sodium salt pentahydrate)_RKO | L-Thyroxine (sodium salt pentahydrate) perturbation in RKO cell line |
| LJI308_NCI-H460 | LJI308 perturbation in NCI-H460 cell line |
| Busulfan_NCI-H596 | Busulfan perturbation in NCI-H596 cell line |
| Eplerenone_hTERT-HPNE | Eplerenone perturbation in hTERT-HPNE cell line |
| Ciclopirox_SK-MEL-2 | Ciclopirox perturbation in SK-MEL-2 cell line |
| Abiraterone acetate_hTERT-HPNE | Abiraterone acetate perturbation in hTERT-HPNE cell line |
| Talc_HOP62 | Talc perturbation in HOP62 cell line |
| Ribociclib_SW1417 | Ribociclib perturbation in SW1417 cell line |
| AT7519_SW48 | AT7519 perturbation in SW48 cell line |
| NVP-BHG712_hTERT-HPNE | NVP-BHG712 perturbation in hTERT-HPNE cell line |
| Glycyrrhizic acid_HT-29 | Glycyrrhizic acid perturbation in HT-29 cell line |
| IQ 1_SNU-1 | IQ 1 perturbation in SNU-1 cell line |
| Elagolix sodium_SW 1271 | Elagolix sodium perturbation in SW 1271 cell line |
| Monocrotaline_NCI-H596 | Monocrotaline perturbation in NCI-H596 cell line |
| L-Eflornithine (monohydrochloride)_NCI-H2122 | L-Eflornithine (monohydrochloride) perturbation in NCI-H2122 cell line |
| Adenine_LS 180 | Adenine perturbation in LS 180 cell line |
| Bimiralisib_C-33 A | Bimiralisib perturbation in C-33 A cell line |
| Ivermectin_A-427 | Ivermectin perturbation in A-427 cell line |
| Esmolol (hydrochloride)_NCI-H2030 | Esmolol (hydrochloride) perturbation in NCI-H2030 cell line |
| Bimiralisib_SW 900 | Bimiralisib perturbation in SW 900 cell line |
| Verapamil_A-427 | Verapamil perturbation in A-427 cell line |
| AZD1390_C-33 A | AZD1390 perturbation in C-33 A cell line |
| Pexidartinib (hydrochloride)_HOP62 | Pexidartinib (hydrochloride) perturbation in HOP62 cell line |
| Gemfibrozil_C-33 A | Gemfibrozil perturbation in C-33 A cell line |
| Benproperine (phosphate)_LS 180 | Benproperine (phosphate) perturbation in LS 180 cell line |
| ETC-206_SW 900 | ETC-206 perturbation in SW 900 cell line |
| Irinotecan (hydrochloride)_A549 | Irinotecan (hydrochloride) perturbation in A549 cell line |
| Pexidartinib (hydrochloride)_MIA PaCa-2 | Pexidartinib (hydrochloride) perturbation in MIA PaCa-2 cell line |
| Flutamide_NCI-H460 | Flutamide perturbation in NCI-H460 cell line |
| Gallic acid_HCT15 | Gallic acid perturbation in HCT15 cell line |
| Belumosudil (mesylate)_C-33 A | Belumosudil (mesylate) perturbation in C-33 A cell line |
| ETC-206_C-33 A | ETC-206 perturbation in C-33 A cell line |
| Cepharanthine_NCI-H2347 | Cepharanthine perturbation in NCI-H2347 cell line |
| Minodronic acid_SHP-77 | Minodronic acid perturbation in SHP-77 cell line |
| Bisoprolol (hemifumarate)_LS 180 | Bisoprolol (hemifumarate) perturbation in LS 180 cell line |
| Methylthiouracil_SK-MEL-2 | Methylthiouracil perturbation in SK-MEL-2 cell line |
| L-Eflornithine (monohydrochloride)_C-33 A | L-Eflornithine (monohydrochloride) perturbation in C-33 A cell line |
| Gemfibrozil_A-427 | Gemfibrozil perturbation in A-427 cell line |
| 18β-Glycyrrhetinic acid_NCI-H23 | 18β-Glycyrrhetinic acid perturbation in NCI-H23 cell line |
| Rimonabant (Hydrochloride)_RKO | Rimonabant (Hydrochloride) perturbation in RKO cell line |
| Quinidine (15% dihydroquinidine)_CFPAC-1 | Quinidine (15% dihydroquinidine) perturbation in CFPAC-1 cell line |
| Estrone sulfate (potassium)_NCI-H596 | Estrone sulfate (potassium) perturbation in NCI-H596 cell line |
| Belumosudil (mesylate)_A-427 | Belumosudil (mesylate) perturbation in A-427 cell line |
| Infigratinib_NCI-H2030 | Infigratinib perturbation in NCI-H2030 cell line |
| ETC-206_A-427 | ETC-206 perturbation in A-427 cell line |
| NVP-BHG712_LS 180 | NVP-BHG712 perturbation in LS 180 cell line |
| Adenine_hTERT-HPNE | Adenine perturbation in hTERT-HPNE cell line |
| Fedratinib (hydrochloride hydrate)_AsPC-1 | Fedratinib (hydrochloride hydrate) perturbation in AsPC-1 cell line |
| Flutamide_NCI-H23 | Flutamide perturbation in NCI-H23 cell line |
| Minodronic acid_AN3 CA | Minodronic acid perturbation in AN3 CA cell line |
| AZD1390_A-427 | AZD1390 perturbation in A-427 cell line |
| γ-Oryzanol_NCI-H661 | γ-Oryzanol perturbation in NCI-H661 cell line |
| Pimozide_RPMI-7951 | Pimozide perturbation in RPMI-7951 cell line |
| Megestrol_NCI-H23 | Megestrol perturbation in NCI-H23 cell line |
| Tubulin inhibitor 6_NCI-H596 | Tubulin inhibitor 6 perturbation in NCI-H596 cell line |
| AZD-7648_hTERT-HPNE | AZD-7648 perturbation in hTERT-HPNE cell line |
| 9-ING-41_C32 | 9-ING-41 perturbation in C32 cell line |
| Nevirapine_SW480 | Nevirapine perturbation in SW480 cell line |
| Gefitinib_NCI-H2347 | Gefitinib perturbation in NCI-H2347 cell line |
| Cabozantinib (S-malate)_C-33 A | Cabozantinib (S-malate) perturbation in C-33 A cell line |
| Dexamethasone_SW48 | Dexamethasone perturbation in SW48 cell line |
| Ipatasertib_PANC-1 | Ipatasertib perturbation in PANC-1 cell line |
| Pimozide_hTERT-HPNE | Pimozide perturbation in hTERT-HPNE cell line |
| Oxaliplatin_NCI-H1573 | Oxaliplatin perturbation in NCI-H1573 cell line |
| Terfenadine_BT-474 | Terfenadine perturbation in BT-474 cell line |
| Fostamatinib (disodium hexahydrate)_NCI-H596 | Fostamatinib (disodium hexahydrate) perturbation in NCI-H596 cell line |
| Ivabradine (hydrochloride)_NCI-H2030 | Ivabradine (hydrochloride) perturbation in NCI-H2030 cell line |
| CP21R7_CHP-212 | CP21R7 perturbation in CHP-212 cell line |
| Mebendazole_SNU-1 | Mebendazole perturbation in SNU-1 cell line |
| Piroxicam_MIA PaCa-2 | Piroxicam perturbation in MIA PaCa-2 cell line |
| γ-Oryzanol_HCT15 | γ-Oryzanol perturbation in HCT15 cell line |
| Tomivosertib_LS 180 | Tomivosertib perturbation in LS 180 cell line |
| Ipatasertib_NCI-H661 | Ipatasertib perturbation in NCI-H661 cell line |
| Raltitrexed_SW480 | Raltitrexed perturbation in SW480 cell line |
| Panobinostat_RKO | Panobinostat perturbation in RKO cell line |
| Adenosine_NCI-H596 | Adenosine perturbation in NCI-H596 cell line |
| Trifluridine_A549 | Trifluridine perturbation in A549 cell line |
| Trametinib_LS 180 | Trametinib perturbation in LS 180 cell line |
| Nafamostat (mesylate)_A-427 | Nafamostat (mesylate) perturbation in A-427 cell line |
| Niclosamide (olamine)_SW480 | Niclosamide (olamine) perturbation in SW480 cell line |
| Minodronic acid_A-427 | Minodronic acid perturbation in A-427 cell line |
| Anastrozole_NCI-H23 | Anastrozole perturbation in NCI-H23 cell line |
| Menadione_NCI-H596 | Menadione perturbation in NCI-H596 cell line |
| Lidocaine (hydrochloride)_NCI-H2030 | Lidocaine (hydrochloride) perturbation in NCI-H2030 cell line |
| Ribociclib_AsPC-1 | Ribociclib perturbation in AsPC-1 cell line |
| APTO-253_SNU-1 | APTO-253 perturbation in SNU-1 cell line |
| Clopidogrel_SW48 | Clopidogrel perturbation in SW48 cell line |
| Bimiralisib_AN3 CA | Bimiralisib perturbation in AN3 CA cell line |
| Brivudine_COLO 205 | Brivudine perturbation in COLO 205 cell line |
| Oleic acid_NCI-H2030 | Oleic acid perturbation in NCI-H2030 cell line |
| Encorafenib_NCI-H596 | Encorafenib perturbation in NCI-H596 cell line |
| Cabozantinib (S-malate)_A498 | Cabozantinib (S-malate) perturbation in A498 cell line |
| ETC-206_AN3 CA | ETC-206 perturbation in AN3 CA cell line |
| Nafamostat (mesylate)_NCI-H2122 | Nafamostat (mesylate) perturbation in NCI-H2122 cell line |
| Vortioxetine_CFPAC-1 | Vortioxetine perturbation in CFPAC-1 cell line |
| Rimonabant_Hs 766T | Rimonabant perturbation in Hs 766T cell line |
| Saquinavir_BT-474 | Saquinavir perturbation in BT-474 cell line |
| Irinotecan (hydrochloride)_hTERT-HPNE | Irinotecan (hydrochloride) perturbation in hTERT-HPNE cell line |
| Temuterkib_LoVo | Temuterkib perturbation in LoVo cell line |
| Irinotecan_COLO 205 | Irinotecan perturbation in COLO 205 cell line |
| BAY1125976_LS 180 | BAY1125976 perturbation in LS 180 cell line |
| Elagolix sodium_SW 1088 | Elagolix sodium perturbation in SW 1088 cell line |
| Irinotecan (hydrochloride)_RPMI-7951 | Irinotecan (hydrochloride) perturbation in RPMI-7951 cell line |
| Paclitaxel_A549 | Paclitaxel perturbation in A549 cell line |
| Dexmedetomidine_SK-MEL-2 | Dexmedetomidine perturbation in SK-MEL-2 cell line |
| 9-ING-41_A-427 | 9-ING-41 perturbation in A-427 cell line |
| CP21R7_LoVo | CP21R7 perturbation in LoVo cell line |
| Cabozantinib (S-malate)_SHP-77 | Cabozantinib (S-malate) perturbation in SHP-77 cell line |
| AZD1390_C32 | AZD1390 perturbation in C32 cell line |
| Fedratinib (hydrochloride hydrate)_NCI-H2030 | Fedratinib (hydrochloride hydrate) perturbation in NCI-H2030 cell line |
| Clonidine (hydrochloride)_CHP-212 | Clonidine (hydrochloride) perturbation in CHP-212 cell line |
| Elagolix sodium_NCI-H2030 | Elagolix sodium perturbation in NCI-H2030 cell line |
| Fedratinib (hydrochloride hydrate)_HepG2/C3A | Fedratinib (hydrochloride hydrate) perturbation in HepG2/C3A cell line |
| Monocrotaline_Hs 766T | Monocrotaline perturbation in Hs 766T cell line |
| Glycyrrhizic acid_NCI-H596 | Glycyrrhizic acid perturbation in NCI-H596 cell line |
| LB-100_NCI-H2347 | LB-100 perturbation in NCI-H2347 cell line |
| Cepharanthine_NCI-H23 | Cepharanthine perturbation in NCI-H23 cell line |
| Fedratinib (hydrochloride hydrate)_SW 1088 | Fedratinib (hydrochloride hydrate) perturbation in SW 1088 cell line |
| Lonafarnib_NCI-H661 | Lonafarnib perturbation in NCI-H661 cell line |
| AZD1390_HOP62 | AZD1390 perturbation in HOP62 cell line |
| Lidocaine (hydrochloride)_A549 | Lidocaine (hydrochloride) perturbation in A549 cell line |
| Glycyrrhizic acid_A-172 | Glycyrrhizic acid perturbation in A-172 cell line |
| Brivudine_LS 180 | Brivudine perturbation in LS 180 cell line |
| Furosemide_Panc 03.27 | Furosemide perturbation in Panc 03.27 cell line |
| NVP-BHG712_NCI-H2030 | NVP-BHG712 perturbation in NCI-H2030 cell line |
| Tubulin inhibitor 6_HS-578T | Tubulin inhibitor 6 perturbation in HS-578T cell line |
| Minodronic acid_CHP-212 | Minodronic acid perturbation in CHP-212 cell line |
| Mebendazole_NCI-H23 | Mebendazole perturbation in NCI-H23 cell line |
| Pyridoxine_NCI-H2347 | Pyridoxine perturbation in NCI-H2347 cell line |
| Ribociclib_SW480 | Ribociclib perturbation in SW480 cell line |
| Vemurafenib_AN3 CA | Vemurafenib perturbation in AN3 CA cell line |
| Pentagastrin_NCI-H23 | Pentagastrin perturbation in NCI-H23 cell line |
| Riluzole hydrochloride_hTERT-HPNE | Riluzole hydrochloride perturbation in hTERT-HPNE cell line |
| Daptomycin_HS-578T | Daptomycin perturbation in HS-578T cell line |
| Gemfibrozil_HOP62 | Gemfibrozil perturbation in HOP62 cell line |
| Budesonide_SW480 | Budesonide perturbation in SW480 cell line |
| Lonafarnib_PANC-1 | Lonafarnib perturbation in PANC-1 cell line |
| AZD1390_MIA PaCa-2 | AZD1390 perturbation in MIA PaCa-2 cell line |
| Larotrectinib sulfate_PANC-1 | Larotrectinib sulfate perturbation in PANC-1 cell line |
| Methylthiouracil_HS-578T | Methylthiouracil perturbation in HS-578T cell line |
| Edoxaban (tosylate monohydrate)_NCI-H2122 | Edoxaban (tosylate monohydrate) perturbation in NCI-H2122 cell line |
| Medroxyprogesterone acetate_RKO | Medroxyprogesterone acetate perturbation in RKO cell line |
| Cilostazol_AsPC-1 | Cilostazol perturbation in AsPC-1 cell line |
| Flutamide_SNU-1 | Flutamide perturbation in SNU-1 cell line |
| BAY1125976_COLO 205 | BAY1125976 perturbation in COLO 205 cell line |
| Ribociclib_LS 180 | Ribociclib perturbation in LS 180 cell line |
| AT7519_CHP-212 | AT7519 perturbation in CHP-212 cell line |
| Fingolimod (hydrochloride)_AN3 CA | Fingolimod (hydrochloride) perturbation in AN3 CA cell line |
| Bergenin_SHP-77 | Bergenin perturbation in SHP-77 cell line |
| IQ 1_NCI-H460 | IQ 1 perturbation in NCI-H460 cell line |
| Brivudine_SW480 | Brivudine perturbation in SW480 cell line |
| Ciclopirox_HEC-1-A | Ciclopirox perturbation in HEC-1-A cell line |
| Abiraterone acetate_NCI-H2030 | Abiraterone acetate perturbation in NCI-H2030 cell line |
| Delamanid_NCI-H596 | Delamanid perturbation in NCI-H596 cell line |
| Piroxicam_A-427 | Piroxicam perturbation in A-427 cell line |
| Ponatinib_SW 900 | Ponatinib perturbation in SW 900 cell line |
| Cysteamine (hydrochloride)_NCI-H2030 | Cysteamine (hydrochloride) perturbation in NCI-H2030 cell line |
| Docetaxel_NCI-H23 | Docetaxel perturbation in NCI-H23 cell line |
| Azithromycin (hydrate)_NCI-H596 | Azithromycin (hydrate) perturbation in NCI-H596 cell line |
| Oxaliplatin_CHP-212 | Oxaliplatin perturbation in CHP-212 cell line |
| Sapanisertib_Hs 766T | Sapanisertib perturbation in Hs 766T cell line |
| Eplerenone_NCI-H2030 | Eplerenone perturbation in NCI-H2030 cell line |
| Belzutifan_SW 1271 | Belzutifan perturbation in SW 1271 cell line |
| ETC-206_CFPAC-1 | ETC-206 perturbation in CFPAC-1 cell line |
| Piroxicam_C32 | Piroxicam perturbation in C32 cell line |
| Cepharanthine_SNU-1 | Cepharanthine perturbation in SNU-1 cell line |
| ETC-206_CHP-212 | ETC-206 perturbation in CHP-212 cell line |
| Raltitrexed_COLO 205 | Raltitrexed perturbation in COLO 205 cell line |
| Megestrol_Panc 03.27 | Megestrol perturbation in Panc 03.27 cell line |
| Vemurafenib_A-427 | Vemurafenib perturbation in A-427 cell line |
| L-Thyroxine (sodium salt pentahydrate)_SNU-1 | L-Thyroxine (sodium salt pentahydrate) perturbation in SNU-1 cell line |
| Simotinib_SNU-1 | Simotinib perturbation in SNU-1 cell line |
| Ciclopirox_HCT15 | Ciclopirox perturbation in HCT15 cell line |
| Lopinavir_CFPAC-1 | Lopinavir perturbation in CFPAC-1 cell line |
| XRK3F2_LOX-IMVI | XRK3F2 perturbation in LOX-IMVI cell line |
| Gemfibrozil_CHP-212 | Gemfibrozil perturbation in CHP-212 cell line |
| Cobimetinib_HT-29 | Cobimetinib perturbation in HT-29 cell line |
| Cilostazol_SW 1088 | Cilostazol perturbation in SW 1088 cell line |
| Ropivacaine (hydrochloride monohydrate)_SW48 | Ropivacaine (hydrochloride monohydrate) perturbation in SW48 cell line |
| AZD1390_CHP-212 | AZD1390 perturbation in CHP-212 cell line |
| NVP-BHG712_COLO 205 | NVP-BHG712 perturbation in COLO 205 cell line |
| Trametinib_NCI-H2030 | Trametinib perturbation in NCI-H2030 cell line |
| Vemurafenib_NCI-H2122 | Vemurafenib perturbation in NCI-H2122 cell line |
| Bimiralisib_CHP-212 | Bimiralisib perturbation in CHP-212 cell line |
| Ivabradine (hydrochloride)_A549 | Ivabradine (hydrochloride) perturbation in A549 cell line |
| Fingolimod (hydrochloride)_NCI-H2122 | Fingolimod (hydrochloride) perturbation in NCI-H2122 cell line |
| Ciclopirox_NCI-H661 | Ciclopirox perturbation in NCI-H661 cell line |
| IQ 1_LOX-IMVI | IQ 1 perturbation in LOX-IMVI cell line |
| Glycyrrhizic acid_HS-578T | Glycyrrhizic acid perturbation in HS-578T cell line |
| Pralsetinib_AN3 CA | Pralsetinib perturbation in AN3 CA cell line |
| Cysteamine (hydrochloride)_COLO 205 | Cysteamine (hydrochloride) perturbation in COLO 205 cell line |
| Rimonabant_HCT15 | Rimonabant perturbation in HCT15 cell line |
| SBI-0640756_CHP-212 | SBI-0640756 perturbation in CHP-212 cell line |
| Acetazolamide_NCI-H596 | Acetazolamide perturbation in NCI-H596 cell line |
| Rucaparib (phosphate)_SW1417 | Rucaparib (phosphate) perturbation in SW1417 cell line |
| Oxaliplatin_HOP62 | Oxaliplatin perturbation in HOP62 cell line |
| Oxaliplatin_SNU-423 | Oxaliplatin perturbation in SNU-423 cell line |
| Tofacitinib_C-33 A | Tofacitinib perturbation in C-33 A cell line |
| Bergenin_SW 900 | Bergenin perturbation in SW 900 cell line |
| vincristine_hTERT-HPNE | vincristine perturbation in hTERT-HPNE cell line |
| Selinexor _HT-29 | Selinexor perturbation in HT-29 cell line |
| Norepinephrine (hydrochloride)_NCI-H23 | Norepinephrine (hydrochloride) perturbation in NCI-H23 cell line |
| Loperamide (hydrochloride)_HEC-1-A | Loperamide (hydrochloride) perturbation in HEC-1-A cell line |
| NG25_hTERT-HPNE | NG25 perturbation in hTERT-HPNE cell line |
| Ribociclib_A549 | Ribociclib perturbation in A549 cell line |
| Procainamide (hydrochloride)_AsPC-1 | Procainamide (hydrochloride) perturbation in AsPC-1 cell line |
| Folic acid_HCT15 | Folic acid perturbation in HCT15 cell line |
| AT7519_HOP62 | AT7519 perturbation in HOP62 cell line |
| Oxaliplatin_LoVo | Oxaliplatin perturbation in LoVo cell line |
| Hexylresorcinol_A549 | Hexylresorcinol perturbation in A549 cell line |
| Digitoxin_NCI-H596 | Digitoxin perturbation in NCI-H596 cell line |
| Peretinoin_NCI-H460 | Peretinoin perturbation in NCI-H460 cell line |
| Baicalin_A-427 | Baicalin perturbation in A-427 cell line |
| Medroxyprogesterone acetate_NCI-H23 | Medroxyprogesterone acetate perturbation in NCI-H23 cell line |
| Dexmedetomidine_HEC-1-A | Dexmedetomidine perturbation in HEC-1-A cell line |
| Sunitinib_NCI-H596 | Sunitinib perturbation in NCI-H596 cell line |
| Rucaparib (phosphate)_NCI-H2030 | Rucaparib (phosphate) perturbation in NCI-H2030 cell line |
| Futibatinib_HEC-1-A | Futibatinib perturbation in HEC-1-A cell line |
| Bergenin_A-427 | Bergenin perturbation in A-427 cell line |
| HI-TOPK-032_A-427 | HI-TOPK-032 perturbation in A-427 cell line |
| ETC-206_J82 | ETC-206 perturbation in J82 cell line |
| Binimetinib_A-427 | Binimetinib perturbation in A-427 cell line |
| Zileuton_NCI-H2347 | Zileuton perturbation in NCI-H2347 cell line |
| Mebendazole_NCI-H2347 | Mebendazole perturbation in NCI-H2347 cell line |
| Pyridoxine_NCI-H23 | Pyridoxine perturbation in NCI-H23 cell line |
| ERK5-IN-2_NCI-H23 | ERK5-IN-2 perturbation in NCI-H23 cell line |
| Cytarabine (hydrochloride)_MIA PaCa-2 | Cytarabine (hydrochloride) perturbation in MIA PaCa-2 cell line |
| Phenytoin (sodium)_NCI-H23 | Phenytoin (sodium) perturbation in NCI-H23 cell line |
| Berbamine (dihydrochloride)_PANC-1 | Berbamine (dihydrochloride) perturbation in PANC-1 cell line |
| Peretinoin_NCI-H23 | Peretinoin perturbation in NCI-H23 cell line |
| Lonafarnib_HS-578T | Lonafarnib perturbation in HS-578T cell line |
| Norepinephrine (hydrochloride)_NCI-H460 | Norepinephrine (hydrochloride) perturbation in NCI-H460 cell line |
| Talc_AN3 CA | Talc perturbation in AN3 CA cell line |
| Cabozantinib (S-malate)_CHP-212 | Cabozantinib (S-malate) perturbation in CHP-212 cell line |
| Niclosamide (olamine)_BT-474 | Niclosamide (olamine) perturbation in BT-474 cell line |
| Tubulin inhibitor 6_NCI-H661 | Tubulin inhibitor 6 perturbation in NCI-H661 cell line |
| MK-3903_SW480 | MK-3903 perturbation in SW480 cell line |
| Almonertinib (mesylate)_MIA PaCa-2 | Almonertinib (mesylate) perturbation in MIA PaCa-2 cell line |
| Cabozantinib (S-malate)_CFPAC-1 | Cabozantinib (S-malate) perturbation in CFPAC-1 cell line |
| Benztropine (mesylate)_AsPC-1 | Benztropine (mesylate) perturbation in AsPC-1 cell line |
| Talc_NCI-H1573 | Talc perturbation in NCI-H1573 cell line |
| Topotecan (hydrochloride)_HEC-1-A | Topotecan (hydrochloride) perturbation in HEC-1-A cell line |
| Cilostazol_BT-474 | Cilostazol perturbation in BT-474 cell line |
| Delamanid_Hs 766T | Delamanid perturbation in Hs 766T cell line |
| Clotrimazole_NCI-H1573 | Clotrimazole perturbation in NCI-H1573 cell line |
| Dinaciclib_NCI-H661 | Dinaciclib perturbation in NCI-H661 cell line |
| Almonertinib (hydrochloride)_RKO | Almonertinib (hydrochloride) perturbation in RKO cell line |
| Mebendazole_RKO | Mebendazole perturbation in RKO cell line |
| Belzutifan_NCI-H2030 | Belzutifan perturbation in NCI-H2030 cell line |
| Pentagastrin_LOX-IMVI | Pentagastrin perturbation in LOX-IMVI cell line |
| Riluzole hydrochloride_A549 | Riluzole hydrochloride perturbation in A549 cell line |
| Uridine_NCI-H596 | Uridine perturbation in NCI-H596 cell line |
| Ipatasertib_NCI-H596 | Ipatasertib perturbation in NCI-H596 cell line |
| Piroxicam_SW48 | Piroxicam perturbation in SW48 cell line |
| Tubulin inhibitor 6_HCT15 | Tubulin inhibitor 6 perturbation in HCT15 cell line |
| Mebendazole_LOX-IMVI | Mebendazole perturbation in LOX-IMVI cell line |
| Irinotecan (hydrochloride)_NCI-H2030 | Irinotecan (hydrochloride) perturbation in NCI-H2030 cell line |
| L-Eflornithine (monohydrochloride)_CHP-212 | L-Eflornithine (monohydrochloride) perturbation in CHP-212 cell line |
| Docetaxel (Trihydrate)_NCI-H596 | Docetaxel (Trihydrate) perturbation in NCI-H596 cell line |
| Piroxicam_C-33 A | Piroxicam perturbation in C-33 A cell line |
| Pentoxifylline_PANC-1 | Pentoxifylline perturbation in PANC-1 cell line |
| Methyl aminolevulinate (hydrochloride)_SHP-77 | Methyl aminolevulinate (hydrochloride) perturbation in SHP-77 cell line |
| Abemaciclib_AN3 CA | Abemaciclib perturbation in AN3 CA cell line |
| Ixazomib citrate_HEC-1-A | Ixazomib citrate perturbation in HEC-1-A cell line |
| Betamethasone dipropionate_hTERT-HPNE | Betamethasone dipropionate perturbation in hTERT-HPNE cell line |
| BI-3406_NCI-H2347 | BI-3406 perturbation in NCI-H2347 cell line |
| Talc_A-427 | Talc perturbation in A-427 cell line |
| Triamcinolone_NCI-H2347 | Triamcinolone perturbation in NCI-H2347 cell line |
| Irinotecan (hydrochloride)_AsPC-1 | Irinotecan (hydrochloride) perturbation in AsPC-1 cell line |
| Gallic acid_Hs 766T | Gallic acid perturbation in Hs 766T cell line |
| Vemurafenib_SW48 | Vemurafenib perturbation in SW48 cell line |
| Ponatinib_A-427 | Ponatinib perturbation in A-427 cell line |
| Tubulin inhibitor 6_HEC-1-A | Tubulin inhibitor 6 perturbation in HEC-1-A cell line |
| Esmolol (hydrochloride)_SW480 | Esmolol (hydrochloride) perturbation in SW480 cell line |
| Lactate (calcium)_NCI-H2122 | Lactate (calcium) perturbation in NCI-H2122 cell line |
| Darolutamide_LoVo | Darolutamide perturbation in LoVo cell line |
| Rimonabant_HS-578T | Rimonabant perturbation in HS-578T cell line |
| vincristine_A549 | vincristine perturbation in A549 cell line |
| Anethole trithione_LS 180 | Anethole trithione perturbation in LS 180 cell line |
| Cabozantinib (S-malate)_MIA PaCa-2 | Cabozantinib (S-malate) perturbation in MIA PaCa-2 cell line |
| Docetaxel_NCI-H460 | Docetaxel perturbation in NCI-H460 cell line |
| Ponatinib_NCI-H2122 | Ponatinib perturbation in NCI-H2122 cell line |
| Omeprazole (sodium)_NCI-H23 | Omeprazole (sodium) perturbation in NCI-H23 cell line |
| Cabozantinib (S-malate)_LoVo | Cabozantinib (S-malate) perturbation in LoVo cell line |
| Daptomycin_HEC-1-A | Daptomycin perturbation in HEC-1-A cell line |
| IQ 1_NCI-H23 | IQ 1 perturbation in NCI-H23 cell line |
| Mifepristone_SW480 | Mifepristone perturbation in SW480 cell line |
| Temuterkib_SHP-77 | Temuterkib perturbation in SHP-77 cell line |
| Mebendazole_NCI-H460 | Mebendazole perturbation in NCI-H460 cell line |
| Decitabine_RKO | Decitabine perturbation in RKO cell line |
| CP21R7_SW48 | CP21R7 perturbation in SW48 cell line |
| Atazanavir (sulfate)_HEC-1-A | Atazanavir (sulfate) perturbation in HEC-1-A cell line |
| Adenosine_HEC-1-A | Adenosine perturbation in HEC-1-A cell line |
| Cobimetinib_SK-MEL-2 | Cobimetinib perturbation in SK-MEL-2 cell line |
| Ribociclib_RPMI-7951 | Ribociclib perturbation in RPMI-7951 cell line |
| 9-ING-41_J82 | 9-ING-41 perturbation in J82 cell line |
| Drospirenone_NCI-H2030 | Drospirenone perturbation in NCI-H2030 cell line |
| Glycyrrhizic acid_PANC-1 | Glycyrrhizic acid perturbation in PANC-1 cell line |
| Topotecan (hydrochloride)_PANC-1 | Topotecan (hydrochloride) perturbation in PANC-1 cell line |
| Pexidartinib (hydrochloride)_A-427 | Pexidartinib (hydrochloride) perturbation in A-427 cell line |
| Glycyrrhizic acid_NCI-H661 | Glycyrrhizic acid perturbation in NCI-H661 cell line |
| Verapamil_HOP62 | Verapamil perturbation in HOP62 cell line |
| Sodium Salicylate_NCI-H23 | Sodium Salicylate perturbation in NCI-H23 cell line |
| Belzutifan_COLO 205 | Belzutifan perturbation in COLO 205 cell line |
| Raltitrexed_SW1417 | Raltitrexed perturbation in SW1417 cell line |
| NVP-BHG712_BT-474 | NVP-BHG712 perturbation in BT-474 cell line |
| Oxaliplatin_J82 | Oxaliplatin perturbation in J82 cell line |
| Dimethyl fumarate_NCI-H2347 | Dimethyl fumarate perturbation in NCI-H2347 cell line |
| L-Eflornithine (monohydrochloride)_LoVo | L-Eflornithine (monohydrochloride) perturbation in LoVo cell line |
| Relugolix_LoVo | Relugolix perturbation in LoVo cell line |
| Encorafenib_HCT15 | Encorafenib perturbation in HCT15 cell line |
| Fostamatinib (disodium hexahydrate)_HEC-1-A | Fostamatinib (disodium hexahydrate) perturbation in HEC-1-A cell line |
| BI-3406_LOX-IMVI | BI-3406 perturbation in LOX-IMVI cell line |
| Bergenin_C32 | Bergenin perturbation in C32 cell line |
| Aliskiren_NCI-H2030 | Aliskiren perturbation in NCI-H2030 cell line |
| Phenytoin (sodium)_PANC-1 | Phenytoin (sodium) perturbation in PANC-1 cell line |
| Erdafitinib _C32 | Erdafitinib perturbation in C32 cell line |
| Berbamine (dihydrochloride)_NCI-H23 | Berbamine (dihydrochloride) perturbation in NCI-H23 cell line |
| Daptomycin_NCI-H23 | Daptomycin perturbation in NCI-H23 cell line |
| Fumaric acid_PANC-1 | Fumaric acid perturbation in PANC-1 cell line |
| Phenytoin (sodium)_H4 | Phenytoin (sodium) perturbation in H4 cell line |
| Baicalin_BT-474 | Baicalin perturbation in BT-474 cell line |
| Aliskiren_HepG2/C3A | Aliskiren perturbation in HepG2/C3A cell line |
| Piroxicam_AsPC-1 | Piroxicam perturbation in AsPC-1 cell line |
| DTP3_Hs 766T | DTP3 perturbation in Hs 766T cell line |
| Almonertinib (mesylate)_RPMI-7951 | Almonertinib (mesylate) perturbation in RPMI-7951 cell line |
| AT7519_SW480 | AT7519 perturbation in SW480 cell line |
| Infigratinib_CFPAC-1 | Infigratinib perturbation in CFPAC-1 cell line |
| Rapamycin_COLO 205 | Rapamycin perturbation in COLO 205 cell line |
| Atazanavir (sulfate)_NCI-H23 | Atazanavir (sulfate) perturbation in NCI-H23 cell line |
| Verteporfin_SNU-423 | Verteporfin perturbation in SNU-423 cell line |
| Brimonidine_C32 | Brimonidine perturbation in C32 cell line |
| Adenosine_NCI-H23 | Adenosine perturbation in NCI-H23 cell line |
| Malotilate_HS-578T | Malotilate perturbation in HS-578T cell line |
| Naproxen_BT-474 | Naproxen perturbation in BT-474 cell line |
| Levobupivacaine (hydrochloride)_SK-MEL-2 | Levobupivacaine (hydrochloride) perturbation in SK-MEL-2 cell line |
| Gemfibrozil_SW480 | Gemfibrozil perturbation in SW480 cell line |
| Ivabradine (hydrochloride)_HOP62 | Ivabradine (hydrochloride) perturbation in HOP62 cell line |
| (R)-Verapamil (hydrochloride)_NCI-H23 | (R)-Verapamil (hydrochloride) perturbation in NCI-H23 cell line |
| Trifluridine_C32 | Trifluridine perturbation in C32 cell line |
| Pravastatin (sodium)_NCI-H2030 | Pravastatin (sodium) perturbation in NCI-H2030 cell line |
| Chlorhexidine (diacetate)_RKO | Chlorhexidine (diacetate) perturbation in RKO cell line |
| Arbutin_CFPAC-1 | Arbutin perturbation in CFPAC-1 cell line |
| Methyl aminolevulinate (hydrochloride)_SW 1271 | Methyl aminolevulinate (hydrochloride) perturbation in SW 1271 cell line |
| Adenosine_LOX-IMVI | Adenosine perturbation in LOX-IMVI cell line |
| Ixazomib_NCI-H23 | Ixazomib perturbation in NCI-H23 cell line |
| Allopurinol_SW480 | Allopurinol perturbation in SW480 cell line |
| Riluzole hydrochloride_SNU-423 | Riluzole hydrochloride perturbation in SNU-423 cell line |
| Artesunate_MIA PaCa-2 | Artesunate perturbation in MIA PaCa-2 cell line |
| Omeprazole_SW480 | Omeprazole perturbation in SW480 cell line |
| Olanzapine_NCI-H23 | Olanzapine perturbation in NCI-H23 cell line |
| Berbamine (dihydrochloride)_RKO | Berbamine (dihydrochloride) perturbation in RKO cell line |
| Cilostazol_A498 | Cilostazol perturbation in A498 cell line |
| Artesunate_HOP62 | Artesunate perturbation in HOP62 cell line |
| vincristine_CFPAC-1 | vincristine perturbation in CFPAC-1 cell line |
| L-Eflornithine (monohydrochloride)_SW480 | L-Eflornithine (monohydrochloride) perturbation in SW480 cell line |
| Oxaliplatin_RPMI-7951 | Oxaliplatin perturbation in RPMI-7951 cell line |
| Malotilate_PANC-1 | Malotilate perturbation in PANC-1 cell line |
| Adenine_NCI-H1573 | Adenine perturbation in NCI-H1573 cell line |
| Arbutin_HOP62 | Arbutin perturbation in HOP62 cell line |
| Almonertinib (mesylate)_SW480 | Almonertinib (mesylate) perturbation in SW480 cell line |
| Malotilate_H4 | Malotilate perturbation in H4 cell line |
| Everolimus_CHP-212 | Everolimus perturbation in CHP-212 cell line |
| Cinacalcet_SW480 | Cinacalcet perturbation in SW480 cell line |
| Adenine_C32 | Adenine perturbation in C32 cell line |
| Levobupivacaine (hydrochloride)_Hs 766T | Levobupivacaine (hydrochloride) perturbation in Hs 766T cell line |
| c-Kit-IN-1_CFPAC-1 | c-Kit-IN-1 perturbation in CFPAC-1 cell line |
| Artesunate_CFPAC-1 | Artesunate perturbation in CFPAC-1 cell line |
| Futibatinib_LOX-IMVI | Futibatinib perturbation in LOX-IMVI cell line |
| Roxadustat_NCI-H23 | Roxadustat perturbation in NCI-H23 cell line |
| Tolcapone_C32 | Tolcapone perturbation in C32 cell line |
| Diammonium Glycyrrhizinate_SW480 | Diammonium Glycyrrhizinate perturbation in SW480 cell line |
| Bisoprolol (hemifumarate)_SNU-423 | Bisoprolol (hemifumarate) perturbation in SNU-423 cell line |
| Flumatinib (mesylate)_HEC-1-A | Flumatinib (mesylate) perturbation in HEC-1-A cell line |
| Allopurinol_NCI-H2030 | Allopurinol perturbation in NCI-H2030 cell line |
| Dapagliflozin ((2S)-1,2-propanediol, hydrate)_LOX-IMVI | Dapagliflozin ((2S)-1,2-propanediol, hydrate) perturbation in LOX-IMVI cell line |
| Medroxyprogesterone acetate_SK-MEL-2 | Medroxyprogesterone acetate perturbation in SK-MEL-2 cell line |
| Fusidic acid_HEC-1-A | Fusidic acid perturbation in HEC-1-A cell line |
| Balsalazide (sodium hydrate)_CHP-212 | Balsalazide (sodium hydrate) perturbation in CHP-212 cell line |
| Drospirenone_CFPAC-1 | Drospirenone perturbation in CFPAC-1 cell line |
| Econazole_SW480 | Econazole perturbation in SW480 cell line |
| Lucanthone_H4 | Lucanthone perturbation in H4 cell line |
| Fluvoxamine_SW 1088 | Fluvoxamine perturbation in SW 1088 cell line |
| Sonidegib_HOP62 | Sonidegib perturbation in HOP62 cell line |
| Almonertinib (mesylate)_NCI-H2030 | Almonertinib (mesylate) perturbation in NCI-H2030 cell line |
| Citalopram (hydrobromide)_NCI-H23 | Citalopram (hydrobromide) perturbation in NCI-H23 cell line |
| Fluvoxamine_NCI-H2030 | Fluvoxamine perturbation in NCI-H2030 cell line |
| Vemurafenib_SW480 | Vemurafenib perturbation in SW480 cell line |
| Peretinoin_Hs 766T | Peretinoin perturbation in Hs 766T cell line |
| Methotrexate_LOX-IMVI | Methotrexate perturbation in LOX-IMVI cell line |
| Temuterkib_SW480 | Temuterkib perturbation in SW480 cell line |
| Infigratinib_C32 | Infigratinib perturbation in C32 cell line |
| Riluzole hydrochloride_A498 | Riluzole hydrochloride perturbation in A498 cell line |
| Osimertinib (mesylate)_NCI-H23 | Osimertinib (mesylate) perturbation in NCI-H23 cell line |
| CP21R7_SW480 | CP21R7 perturbation in SW480 cell line |
| DTP3_H4 | DTP3 perturbation in H4 cell line |
| Rutin (trihydrate)_HOP62 | Rutin (trihydrate) perturbation in HOP62 cell line |
| Pentamidine (isethionate)_HOP62 | Pentamidine (isethionate) perturbation in HOP62 cell line |
| Fingolimod (hydrochloride)_SW480 | Fingolimod (hydrochloride) perturbation in SW480 cell line |
| Radotinib_SW480 | Radotinib perturbation in SW480 cell line |
| Vortioxetine_SW480 | Vortioxetine perturbation in SW480 cell line |
| Malotilate_SK-MEL-2 | Malotilate perturbation in SK-MEL-2 cell line |
| Clonidine (hydrochloride)_SW480 | Clonidine (hydrochloride) perturbation in SW480 cell line |
| Decitabine_SK-MEL-2 | Decitabine perturbation in SK-MEL-2 cell line |
| Dihydroartemisinin_SK-MEL-2 | Dihydroartemisinin perturbation in SK-MEL-2 cell line |
| BI-3406_SK-MEL-2 | BI-3406 perturbation in SK-MEL-2 cell line |
| Doxorubicin (hydrochloride)_CHP-212 | Doxorubicin (hydrochloride) perturbation in CHP-212 cell line |
| Digitoxin_NCI-H23 | Digitoxin perturbation in NCI-H23 cell line |
| Vortioxetine_A-172 | Vortioxetine perturbation in A-172 cell line |
| Imiquimod (hydrochloride)_NCI-H2030 | Imiquimod (hydrochloride) perturbation in NCI-H2030 cell line |
| NVP-BHG712_NCI-H23 | NVP-BHG712 perturbation in NCI-H23 cell line |
| Bestatin_PANC-1 | Bestatin perturbation in PANC-1 cell line |
| 4EGI-1_NCI-H23 | 4EGI-1 perturbation in NCI-H23 cell line |
| Trimetrexate_SW480 | Trimetrexate perturbation in SW480 cell line |
| Cyclosporin A_NCI-H2030 | Cyclosporin A perturbation in NCI-H2030 cell line |
| Minodronic acid_SK-MEL-2 | Minodronic acid perturbation in SK-MEL-2 cell line |
| Brimonidine_NCI-H23 | Brimonidine perturbation in NCI-H23 cell line |
| Tucidinostat_SW480 | Tucidinostat perturbation in SW480 cell line |
| Rimonabant_A498 | Rimonabant perturbation in A498 cell line |
| 18β-Glycyrrhetinic acid_SW480 | 18β-Glycyrrhetinic acid perturbation in SW480 cell line |
| Tofacitinib (citrate)_C32 | Tofacitinib (citrate) perturbation in C32 cell line |
| Tolmetin_RKO | Tolmetin perturbation in RKO cell line |
| Abiraterone acetate_NCI-H23 | Abiraterone acetate perturbation in NCI-H23 cell line |
| Alpelisib_SW480 | Alpelisib perturbation in SW480 cell line |
| Tirabrutinib_NCI-H2030 | Tirabrutinib perturbation in NCI-H2030 cell line |
| Pentoxifylline_C32 | Pentoxifylline perturbation in C32 cell line |
| Ranolazine_SW 1088 | Ranolazine perturbation in SW 1088 cell line |
| Entrectinib_NCI-H23 | Entrectinib perturbation in NCI-H23 cell line |
| Altretamine_H4 | Altretamine perturbation in H4 cell line |
| Fusidic acid_SW480 | Fusidic acid perturbation in SW480 cell line |
| Captopril_SW 1271 | Captopril perturbation in SW 1271 cell line |
| Malotilate_NCI-H2030 | Malotilate perturbation in NCI-H2030 cell line |
| Bisoprolol (hemifumarate)_LOX-IMVI | Bisoprolol (hemifumarate) perturbation in LOX-IMVI cell line |
| Uridine_J82 | Uridine perturbation in J82 cell line |
| AZD2858_HOP62 | AZD2858 perturbation in HOP62 cell line |
| Salicylic acid_HOP62 | Salicylic acid perturbation in HOP62 cell line |
| Tofacitinib_H4 | Tofacitinib perturbation in H4 cell line |
| Baicalin_PANC-1 | Baicalin perturbation in PANC-1 cell line |
| Norepinephrine (hydrochloride)_BT-474 | Norepinephrine (hydrochloride) perturbation in BT-474 cell line |
| Asciminib_LOX-IMVI | Asciminib perturbation in LOX-IMVI cell line |
| Aliskiren_H4 | Aliskiren perturbation in H4 cell line |
| Oxaliplatin_Hs 766T | Oxaliplatin perturbation in Hs 766T cell line |
| Diphenhydramine_NCI-H23 | Diphenhydramine perturbation in NCI-H23 cell line |
| CP21R7_PANC-1 | CP21R7 perturbation in PANC-1 cell line |
| Ixazomib_C32 | Ixazomib perturbation in C32 cell line |
| Artesunate_Panc 03.27 | Artesunate perturbation in Panc 03.27 cell line |
| Clonidine (hydrochloride)_HEC-1-A | Clonidine (hydrochloride) perturbation in HEC-1-A cell line |
| Mozavaptan_NCI-H2030 | Mozavaptan perturbation in NCI-H2030 cell line |
| Riluzole hydrochloride_Panc 03.27 | Riluzole hydrochloride perturbation in Panc 03.27 cell line |
| Mitoxantrone (dihydrochloride)_CHP-212 | Mitoxantrone (dihydrochloride) perturbation in CHP-212 cell line |
| Finasteride_SW 1088 | Finasteride perturbation in SW 1088 cell line |
| Levobupivacaine (hydrochloride)_RPMI-7951 | Levobupivacaine (hydrochloride) perturbation in RPMI-7951 cell line |
| L-Eflornithine (monohydrochloride)_SK-MEL-2 | L-Eflornithine (monohydrochloride) perturbation in SK-MEL-2 cell line |
| Esmolol (hydrochloride)_Panc 03.27 | Esmolol (hydrochloride) perturbation in Panc 03.27 cell line |
| Pimozide_NCI-H23 | Pimozide perturbation in NCI-H23 cell line |
| Almonertinib (mesylate)_SK-MEL-2 | Almonertinib (mesylate) perturbation in SK-MEL-2 cell line |
| Methotrexate_HOP62 | Methotrexate perturbation in HOP62 cell line |
| Panobinostat_A549 | Panobinostat perturbation in A549 cell line |
| TAK-733_SW480 | TAK-733 perturbation in SW480 cell line |
| Cloxacillin (sodium)_A549 | Cloxacillin (sodium) perturbation in A549 cell line |
| Piroxicam_H4 | Piroxicam perturbation in H4 cell line |
| Bisoprolol (hemifumarate)_NCI-H23 | Bisoprolol (hemifumarate) perturbation in NCI-H23 cell line |
| Entrectinib_RKO | Entrectinib perturbation in RKO cell line |
| Retinoic acid_SW480 | Retinoic acid perturbation in SW480 cell line |
| Indacaterol (maleate)_HOP62 | Indacaterol (maleate) perturbation in HOP62 cell line |
| ETC-206_Hs 766T | ETC-206 perturbation in Hs 766T cell line |
| Adenine_NCI-H23 | Adenine perturbation in NCI-H23 cell line |
| Olanzapine_CHP-212 | Olanzapine perturbation in CHP-212 cell line |
| Ciclopirox_MIA PaCa-2 | Ciclopirox perturbation in MIA PaCa-2 cell line |
| Vismodegib_NCI-H23 | Vismodegib perturbation in NCI-H23 cell line |
| Norepinephrine (hydrochloride)_hTERT-HPNE | Norepinephrine (hydrochloride) perturbation in hTERT-HPNE cell line |
| Cloxacillin (sodium)_NCI-H2030 | Cloxacillin (sodium) perturbation in NCI-H2030 cell line |
| Isocorydine_SW480 | Isocorydine perturbation in SW480 cell line |
| Arbutin_NCI-H23 | Arbutin perturbation in NCI-H23 cell line |
| Methotrexate_C32 | Methotrexate perturbation in C32 cell line |
| Ixazomib_CFPAC-1 | Ixazomib perturbation in CFPAC-1 cell line |
| Ritonavir_NCI-H2030 | Ritonavir perturbation in NCI-H2030 cell line |
| Dimethyl fumarate_RPMI-7951 | Dimethyl fumarate perturbation in RPMI-7951 cell line |
| Ixazomib_CHP-212 | Ixazomib perturbation in CHP-212 cell line |
| ERK5-IN-2_SW480 | ERK5-IN-2 perturbation in SW480 cell line |
| Meloxicam_NCI-H23 | Meloxicam perturbation in NCI-H23 cell line |
| Neratinib (maleate)_HOP62 | Neratinib (maleate) perturbation in HOP62 cell line |
| Chlorhexidine (diacetate)_MIA PaCa-2 | Chlorhexidine (diacetate) perturbation in MIA PaCa-2 cell line |
| Voriconazole_NCI-H23 | Voriconazole perturbation in NCI-H23 cell line |
| Furosemide_SW 1271 | Furosemide perturbation in SW 1271 cell line |
| Dapagliflozin_NCI-H2030 | Dapagliflozin perturbation in NCI-H2030 cell line |
| Ipatasertib_NCI-H2122 | Ipatasertib perturbation in NCI-H2122 cell line |
| Diphenhydramine_Panc 03.27 | Diphenhydramine perturbation in Panc 03.27 cell line |
| Retinoic acid_SW 1088 | Retinoic acid perturbation in SW 1088 cell line |
| Tetracycline (hydrochloride)_NCI-H23 | Tetracycline (hydrochloride) perturbation in NCI-H23 cell line |
| ETC-206_H4 | ETC-206 perturbation in H4 cell line |
| Ixazomib_SNU-423 | Ixazomib perturbation in SNU-423 cell line |
| Docetaxel_RPMI-7951 | Docetaxel perturbation in RPMI-7951 cell line |
| Esmolol (hydrochloride)_NCI-H23 | Esmolol (hydrochloride) perturbation in NCI-H23 cell line |
| TAK-733_NCI-H2030 | TAK-733 perturbation in NCI-H2030 cell line |
| Sivelestat (sodium tetrahydrate)_SNU-423 | Sivelestat (sodium tetrahydrate) perturbation in SNU-423 cell line |
| Arbutin_RKO | Arbutin perturbation in RKO cell line |
| (R)-Verapamil (hydrochloride)_MIA PaCa-2 | (R)-Verapamil (hydrochloride) perturbation in MIA PaCa-2 cell line |
| Cloxacillin (sodium)_SW 1271 | Cloxacillin (sodium) perturbation in SW 1271 cell line |
| Pyridoxine (hydrochloride)_Panc 03.27 | Pyridoxine (hydrochloride) perturbation in Panc 03.27 cell line |
| 18β-Glycyrrhetinic acid_NCI-H2030 | 18β-Glycyrrhetinic acid perturbation in NCI-H2030 cell line |
| 5-Azacytidine_H4 | 5-Azacytidine perturbation in H4 cell line |
| Arbutin_LOX-IMVI | Arbutin perturbation in LOX-IMVI cell line |
| Capivasertib_H4 | Capivasertib perturbation in H4 cell line |
| Daptomycin_CFPAC-1 | Daptomycin perturbation in CFPAC-1 cell line |
| Zileuton_SW480 | Zileuton perturbation in SW480 cell line |
| Ropivacaine (hydrochloride monohydrate)_Hs 766T | Ropivacaine (hydrochloride monohydrate) perturbation in Hs 766T cell line |
| Gefitinib_SW 1271 | Gefitinib perturbation in SW 1271 cell line |
| Ribociclib_NCI-H23 | Ribociclib perturbation in NCI-H23 cell line |
| Cyclosporin A_SW480 | Cyclosporin A perturbation in SW480 cell line |
| Olanzapine_J82 | Olanzapine perturbation in J82 cell line |
| Pravastatin (sodium)_SK-MEL-2 | Pravastatin (sodium) perturbation in SK-MEL-2 cell line |
| (R)-Verapamil (hydrochloride)_CHP-212 | (R)-Verapamil (hydrochloride) perturbation in CHP-212 cell line |
| Phenytoin (sodium)_RPMI-7951 | Phenytoin (sodium) perturbation in RPMI-7951 cell line |
| Anastrozole_SW 1088 | Anastrozole perturbation in SW 1088 cell line |
| Esmolol (hydrochloride)_LOX-IMVI | Esmolol (hydrochloride) perturbation in LOX-IMVI cell line |
| Fumaric acid_RPMI-7951 | Fumaric acid perturbation in RPMI-7951 cell line |
| GSK1059615_C32 | GSK1059615 perturbation in C32 cell line |
| Gemcitabine_CHP-212 | Gemcitabine perturbation in CHP-212 cell line |
| Demeclocycline_SW480 | Demeclocycline perturbation in SW480 cell line |
| Bendamustine_SNU-423 | Bendamustine perturbation in SNU-423 cell line |
| Triamcinolone_SW480 | Triamcinolone perturbation in SW480 cell line |
| Ixazomib citrate_HOP62 | Ixazomib citrate perturbation in HOP62 cell line |
| Salicylic acid_NCI-H2122 | Salicylic acid perturbation in NCI-H2122 cell line |
| Piroxicam_SK-MEL-2 | Piroxicam perturbation in SK-MEL-2 cell line |
| Almonertinib (mesylate)_H4 | Almonertinib (mesylate) perturbation in H4 cell line |
| Aspirin_HOP62 | Aspirin perturbation in HOP62 cell line |
| NG25_HS-578T | NG25 perturbation in HS-578T cell line |
| Sodium Salicylate_HOP62 | Sodium Salicylate perturbation in HOP62 cell line |
| Dexmedetomidine_RPMI-7951 | Dexmedetomidine perturbation in RPMI-7951 cell line |
| (R)-Verapamil (hydrochloride)_hTERT-HPNE | (R)-Verapamil (hydrochloride) perturbation in hTERT-HPNE cell line |
| Relugolix_NCI-H23 | Relugolix perturbation in NCI-H23 cell line |
| Capmatinib_HS-578T | Capmatinib perturbation in HS-578T cell line |
| Dimethyl fumarate_J82 | Dimethyl fumarate perturbation in J82 cell line |
| RMC-6236_C32 | RMC-6236 perturbation in C32 cell line |
| Tolmetin_SK-MEL-2 | Tolmetin perturbation in SK-MEL-2 cell line |
| Econazole_Panc 03.27 | Econazole perturbation in Panc 03.27 cell line |
| Medroxyprogesterone acetate_CHP-212 | Medroxyprogesterone acetate perturbation in CHP-212 cell line |
| Ixazomib_SW480 | Ixazomib perturbation in SW480 cell line |
| Arbutin_HS-578T | Arbutin perturbation in HS-578T cell line |
| Darolutamide_NCI-H23 | Darolutamide perturbation in NCI-H23 cell line |
| Uridine_NCI-H2030 | Uridine perturbation in NCI-H2030 cell line |
| Malotilate_J82 | Malotilate perturbation in J82 cell line |
| Cilostazol_Hs 766T | Cilostazol perturbation in Hs 766T cell line |
| Allantoin_NCI-H2030 | Allantoin perturbation in NCI-H2030 cell line |
| Bestatin_Panc 03.27 | Bestatin perturbation in Panc 03.27 cell line |
| Dapagliflozin_C32 | Dapagliflozin perturbation in C32 cell line |
| Artesunate_HS-578T | Artesunate perturbation in HS-578T cell line |
| BI-78D3_H4 | BI-78D3 perturbation in H4 cell line |
| Neratinib (maleate)_SW480 | Neratinib (maleate) perturbation in SW480 cell line |
| Phenytoin (sodium)_HOP62 | Phenytoin (sodium) perturbation in HOP62 cell line |
| Adenosine_RPMI-7951 | Adenosine perturbation in RPMI-7951 cell line |
| Mozavaptan_HOP62 | Mozavaptan perturbation in HOP62 cell line |
| Ferulic acid_HS-578T | Ferulic acid perturbation in HS-578T cell line |
| Fumaric acid_HOP62 | Fumaric acid perturbation in HOP62 cell line |
| Temsirolimus_NCI-H23 | Temsirolimus perturbation in NCI-H23 cell line |
| Balsalazide (sodium hydrate)_Hs 766T | Balsalazide (sodium hydrate) perturbation in Hs 766T cell line |
| 18β-Glycyrrhetinic acid_C32 | 18β-Glycyrrhetinic acid perturbation in C32 cell line |
| Tucatinib_J82 | Tucatinib perturbation in J82 cell line |
| Sodium Salicylate_J82 | Sodium Salicylate perturbation in J82 cell line |
| APTO-253_SNU-423 | APTO-253 perturbation in SNU-423 cell line |
| Adenosine_SW480 | Adenosine perturbation in SW480 cell line |
| Docetaxel_CHP-212 | Docetaxel perturbation in CHP-212 cell line |
| Rimonabant_RPMI-7951 | Rimonabant perturbation in RPMI-7951 cell line |
| Salicylic acid_NCI-H2030 | Salicylic acid perturbation in NCI-H2030 cell line |
| Malotilate_HOP62 | Malotilate perturbation in HOP62 cell line |
| Minodronic acid_NCI-H23 | Minodronic acid perturbation in NCI-H23 cell line |
| Berbamine (dihydrochloride)_SW480 | Berbamine (dihydrochloride) perturbation in SW480 cell line |
| Allantoin_SW1417 | Allantoin perturbation in SW1417 cell line |
| Voriconazole_H4 | Voriconazole perturbation in H4 cell line |
| (R)-Verapamil (hydrochloride)_SW480 | (R)-Verapamil (hydrochloride) perturbation in SW480 cell line |
| Olanzapine_hTERT-HPNE | Olanzapine perturbation in hTERT-HPNE cell line |
| Cepharanthine_NCI-H1573 | Cepharanthine perturbation in NCI-H1573 cell line |
| Anethole trithione_H4 | Anethole trithione perturbation in H4 cell line |
| Almonertinib (mesylate)_RKO | Almonertinib (mesylate) perturbation in RKO cell line |
| Artesunate_PANC-1 | Artesunate perturbation in PANC-1 cell line |
| Fluvoxamine_RKO | Fluvoxamine perturbation in RKO cell line |
| Demeclocycline_CHP-212 | Demeclocycline perturbation in CHP-212 cell line |
| Fulvestrant_NCI-H23 | Fulvestrant perturbation in NCI-H23 cell line |
| Esmolol (hydrochloride)_H4 | Esmolol (hydrochloride) perturbation in H4 cell line |
| Lopinavir_NCI-H23 | Lopinavir perturbation in NCI-H23 cell line |
| Malotilate_CFPAC-1 | Malotilate perturbation in CFPAC-1 cell line |
| Belinostat_H4 | Belinostat perturbation in H4 cell line |
| Ferulic acid_PANC-1 | Ferulic acid perturbation in PANC-1 cell line |
| Cyclosporin A_MIA PaCa-2 | Cyclosporin A perturbation in MIA PaCa-2 cell line |
| Imiquimod (hydrochloride)_HOP62 | Imiquimod (hydrochloride) perturbation in HOP62 cell line |
| Riluzole hydrochloride_H4 | Riluzole hydrochloride perturbation in H4 cell line |
| Hydroxyfasudil_SW480 | Hydroxyfasudil perturbation in SW480 cell line |
| Fusidic acid_MIA PaCa-2 | Fusidic acid perturbation in MIA PaCa-2 cell line |
| Bestatin_NCI-H2347 | Bestatin perturbation in NCI-H2347 cell line |
| Sodium Salicylate_SW48 | Sodium Salicylate perturbation in SW48 cell line |
| Radotinib_NCI-H23 | Radotinib perturbation in NCI-H23 cell line |
| 18β-Glycyrrhetinic acid_CHP-212 | 18β-Glycyrrhetinic acid perturbation in CHP-212 cell line |
| Dapagliflozin ((2S)-1,2-propanediol, hydrate)_SW480 | Dapagliflozin ((2S)-1,2-propanediol, hydrate) perturbation in SW480 cell line |
| Arbutin_Hs 766T | Arbutin perturbation in Hs 766T cell line |
| Artemether_SW 1271 | Artemether perturbation in SW 1271 cell line |
| Allantoin_hTERT-HPNE | Allantoin perturbation in hTERT-HPNE cell line |
| Drospirenone_HEC-1-A | Drospirenone perturbation in HEC-1-A cell line |
| Malotilate_C32 | Malotilate perturbation in C32 cell line |
| Carbamazepine_SW480 | Carbamazepine perturbation in SW480 cell line |
| Fusidic acid_CHP-212 | Fusidic acid perturbation in CHP-212 cell line |
| L-Thyroxine (sodium salt pentahydrate)_CFPAC-1 | L-Thyroxine (sodium salt pentahydrate) perturbation in CFPAC-1 cell line |
| Cepharanthine_CFPAC-1 | Cepharanthine perturbation in CFPAC-1 cell line |
| Econazole_RKO | Econazole perturbation in RKO cell line |
| Piroxicam_NCI-H23 | Piroxicam perturbation in NCI-H23 cell line |
| Anethole trithione_Hs 766T | Anethole trithione perturbation in Hs 766T cell line |
| Dihydroartemisinin_C32 | Dihydroartemisinin perturbation in C32 cell line |
| Pentoxifylline_NCI-H2030 | Pentoxifylline perturbation in NCI-H2030 cell line |
| Artesunate_Hs 766T | Artesunate perturbation in Hs 766T cell line |
| Bisoprolol (hemifumarate)_H4 | Bisoprolol (hemifumarate) perturbation in H4 cell line |
| Drospirenone_H4 | Drospirenone perturbation in H4 cell line |
| Riluzole hydrochloride_Hs 766T | Riluzole hydrochloride perturbation in Hs 766T cell line |
| APTO-253_C32 | APTO-253 perturbation in C32 cell line |
| (R)-Verapamil (hydrochloride)_SW 1088 | (R)-Verapamil (hydrochloride) perturbation in SW 1088 cell line |
| Rapamycin_NCI-H23 | Rapamycin perturbation in NCI-H23 cell line |
| Triamcinolone_AN3 CA | Triamcinolone perturbation in AN3 CA cell line |
| Vortioxetine_NCI-H23 | Vortioxetine perturbation in NCI-H23 cell line |
| Idoxuridine_NCI-H23 | Idoxuridine perturbation in NCI-H23 cell line |
| Filgotinib_HOP62 | Filgotinib perturbation in HOP62 cell line |
| Darinaparsin_SW480 | Darinaparsin perturbation in SW480 cell line |
| Pyridoxine_C32 | Pyridoxine perturbation in C32 cell line |
| Ixazomib_NCI-H2030 | Ixazomib perturbation in NCI-H2030 cell line |
| Arbutin_SK-MEL-2 | Arbutin perturbation in SK-MEL-2 cell line |
| Fumaric acid_C32 | Fumaric acid perturbation in C32 cell line |
| Uridine_SW480 | Uridine perturbation in SW480 cell line |
| Methotrexate_SW480 | Methotrexate perturbation in SW480 cell line |
| (R)-Verapamil (hydrochloride)_BT-474 | (R)-Verapamil (hydrochloride) perturbation in BT-474 cell line |
| Filgotinib_SNU-423 | Filgotinib perturbation in SNU-423 cell line |
| NG25_SK-MEL-2 | NG25 perturbation in SK-MEL-2 cell line |
| Anastrozole_J82 | Anastrozole perturbation in J82 cell line |
| Abiraterone acetate_PANC-1 | Abiraterone acetate perturbation in PANC-1 cell line |
| Pentoxifylline_SW1417 | Pentoxifylline perturbation in SW1417 cell line |
| Abiraterone acetate_NCI-H661 | Abiraterone acetate perturbation in NCI-H661 cell line |
| γ-Oryzanol_SW480 | γ-Oryzanol perturbation in SW480 cell line |
| DTP3_HOP62 | DTP3 perturbation in HOP62 cell line |
| Salicylic acid_RPMI-7951 | Salicylic acid perturbation in RPMI-7951 cell line |
| Celecoxib_CHP-212 | Celecoxib perturbation in CHP-212 cell line |
| Mifepristone_SK-MEL-2 | Mifepristone perturbation in SK-MEL-2 cell line |
| Vortioxetine_LOX-IMVI | Vortioxetine perturbation in LOX-IMVI cell line |
| LB-100_CHP-212 | LB-100 perturbation in CHP-212 cell line |
| DTP3_MIA PaCa-2 | DTP3 perturbation in MIA PaCa-2 cell line |
